<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12469128</PMID><DateCompleted><Year>2003</Year><Month>03</Month><Day>07</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1097-6256</ISSN><JournalIssue CitedMedium="Print"><Volume>6</Volume><Issue>1</Issue><PubDate><Year>2003</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Nature neuroscience</Title><ISOAbbreviation>Nat Neurosci</ISOAbbreviation></Journal><ArticleTitle>Sonic hedgehog regulates adult neural progenitor proliferation in vitro and in vivo.</ArticleTitle><Pagination><StartPage>21</StartPage><EndPage>27</EndPage><MedlinePgn>21-7</MedlinePgn></Pagination><Abstract><AbstractText>Neural stem cells exist in the developing and adult nervous systems of all mammals, but the basic mechanisms that control their behavior are not yet well understood. Here, we investigated the role of Sonic hedgehog (Shh), a factor vital for neural development, in regulating adult hippocampal neural stem cells. We found high expression of the Shh receptor Patched in both the adult rat hippocampus and neural progenitor cells isolated from this region. In addition, Shh elicited a strong, dose-dependent proliferative response in progenitors in vitro. Furthermore, adeno-associated viral vector delivery of shh cDNA to the hippocampus elicited a 3.3-fold increase in cell proliferation. Finally, the pharmacological inhibitor of Shh signaling cyclopamine reduced hippocampal neural progenitor proliferation in vivo. This work identifies Shh as a regulator of adult hippocampal neural stem cells.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Karen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Chemical Engineering and The Helen Wills Neuroscience Institute, 201 Gilman Hall, University of California, Berkeley, California 94720-1462, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaspar</LastName><ForeName>Brian K</ForeName><Initials>BK</Initials></Author><Author ValidYN="Y"><LastName>Gage</LastName><ForeName>Fred H</ForeName><Initials>FH</Initials></Author><Author ValidYN="Y"><LastName>Schaffer</LastName><ForeName>David V</ForeName><Initials>DV</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Neurosci</MedlineTA><NlmUniqueID>9809671</NlmUniqueID><ISSNLinking>1097-6256</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053823">Hedgehog Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000072079">Patched Receptors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011956">Receptors, Cell Surface</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015534">Trans-Activators</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Nat Neurosci. 2003 Jun;6(6):645</RefSource></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005455" MajorTopicYN="N">Fluorescent Antibody Technique</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018507" MajorTopicYN="N">Gene Expression Regulation, Developmental</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053823" MajorTopicYN="N">Hedgehog Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000254" MajorTopicYN="Y">growth &amp; development</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009473" MajorTopicYN="N">Neuronal Plasticity</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072079" MajorTopicYN="N">Patched Receptors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011956" MajorTopicYN="N">Receptors, Cell Surface</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013234" MajorTopicYN="N">Stem Cells</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015534" MajorTopicYN="N">Trans-Activators</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2002</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2002</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2002</Year><Month>12</Month><Day>7</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>3</Month><Day>8</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2002</Year><Month>12</Month><Day>7</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12469128</ArticleId><ArticleId IdType="doi">10.1038/nn983</ArticleId><ArticleId IdType="pii">nn983</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12471034</PMID><DateCompleted><Year>2003</Year><Month>04</Month><Day>08</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0021-9258</ISSN><JournalIssue CitedMedium="Print"><Volume>278</Volume><Issue>9</Issue><PubDate><Year>2003</Year><Month>Feb</Month><Day>28</Day></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J Biol Chem</ISOAbbreviation></Journal><ArticleTitle>APH-1 interacts with mature and immature forms of presenilins and nicastrin and may play a role in maturation of presenilin.nicastrin complexes.</ArticleTitle><Pagination><StartPage>7374</StartPage><EndPage>7380</EndPage><MedlinePgn>7374-80</MedlinePgn></Pagination><Abstract><AbstractText>APH-1 and PEN-2 genes modulate the function of nicastrin and the presenilins in Caenorhabditis elegans. Preliminary studies in transfected mammalian cells overexpressing tagged APH-1 proteins suggest that this genetic interaction is mediated by a direct physical interaction. Using the APH-1 protein encoded on human chromosome 1 (APH-1(1)L; also known as APH-1a) as an archetype, we report here that endogenous forms of APH-1 are predominantly expressed in intracellular membrane compartments, including the endoplasmic reticulum and cis-Golgi. APH-1 proteins directly interact with immature and mature forms of the presenilins and nicastrin within high molecular weight complexes that display gamma- and epsilon-secretase activity. Indeed APH-1 proteins can bind to the nicastrin delta312-369 loss of function mutant, which does not undergo glycosylation maturation and is not trafficking beyond the endoplasmic reticulum. The levels of expression of endogenous APH-1(1)L can be suppressed by overexpression of any other members of the APH-1 family, suggesting that their abundance is coordinately regulated. Finally, although the absence of APH-1 destabilizes the presenilins, in contrast to nicastrin and PEN-2, APH-1 itself is only modestly destabilized in cells lacking functional expression of presenilin 1 or presenilin 2. Taken together, our data suggest that APH-1 proteins, and APH-1(1) in particular, may have a role in the initial assembly and maturation of presenilin.nicastrin complexes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Yongjun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Centre for Research in Neurodegenerative Diseases, Department of Medicine, University of Toronto, Toronto, Ontario M5S 3H2, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Fusheng</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Sanjo</LastName><ForeName>Nobuo</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Kawarai</LastName><ForeName>Toshitaka</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Hasegawa</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Duthie</LastName><ForeName>Monica</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Wenping</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Ruan</LastName><ForeName>Xueying</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Luthra</LastName><ForeName>Anchla</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Mount</LastName><ForeName>Howard T J</ForeName><Initials>HT</Initials></Author><Author ValidYN="Y"><LastName>Tandon</LastName><ForeName>Anurag</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Fraser</LastName><ForeName>Paul E</ForeName><Initials>PE</Initials></Author><Author ValidYN="Y"><LastName>St George-Hyslop</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2002</Year><Month>12</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018076">DNA, Complementary</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508853">PSEN1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508861">PSEN2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053764">Presenilin-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053766">Presenilin-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014283">Triiodobenzoic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C413604">nicastrin protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="C475154">APH1A protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D053829">Amyloid Precursor Protein Secretases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010450">Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010447">Peptide Hydrolases</NameOfSubstance></Chemical><Chemical><RegistryNumber>HW8W27HTXX</RegistryNumber><NameOfSubstance UI="C044834">iodixanol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053829" MajorTopicYN="N">Amyloid Precursor Protein Secretases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002384" MajorTopicYN="N">Catalysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002498" MajorTopicYN="N">Centrifugation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018076" MajorTopicYN="N">DNA, Complementary</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010450" MajorTopicYN="N">Endopeptidases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004721" MajorTopicYN="N">Endoplasmic Reticulum</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006031" MajorTopicYN="N">Glycosylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006056" MajorTopicYN="N">Golgi Apparatus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010447" MajorTopicYN="N">Peptide Hydrolases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011233" MajorTopicYN="N">Precipitin Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053764" MajorTopicYN="N">Presenilin-1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053766" MajorTopicYN="N">Presenilin-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017386" MajorTopicYN="N">Sequence Homology, Amino Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013696" MajorTopicYN="N">Temperature</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014162" MajorTopicYN="N">Transfection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014283" MajorTopicYN="N">Triiodobenzoic Acids</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2002</Year><Month>12</Month><Day>10</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>4</Month><Day>9</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2002</Year><Month>12</Month><Day>10</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12471034</ArticleId><ArticleId IdType="doi">10.1074/jbc.M209499200</ArticleId><ArticleId IdType="pii">S0021-9258(19)32675-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12475931</PMID><DateCompleted><Year>2003</Year><Month>01</Month><Day>21</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>99</Volume><Issue>26</Issue><PubDate><Year>2002</Year><Month>Dec</Month><Day>24</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Noninvasive real-time imaging of apoptosis.</ArticleTitle><Pagination><StartPage>16551</StartPage><EndPage>16555</EndPage><MedlinePgn>16551-5</MedlinePgn></Pagination><Abstract><AbstractText>Strict coordination of proliferation and programmed cell death (apoptosis) is essential for normal physiology. An imbalance in these two opposing processes results in various diseases including AIDS, neurodegenerative disorders, myelodysplastic syndromes, ischemiareperfusion injury, cancer, autoimmune disease, among others. Objective and quantitative noninvasive imaging of apoptosis would be a significant advance for rapid and dynamic screening as well as validation of experimental therapeutic agents. Here, we report the development of a recombinant luciferase reporter molecule that when expressed in mammalian cells has attenuated levels of reporter activity. In cells undergoing apoptosis, a caspase-3-specific cleavage of the recombinant product occurs, resulting in the restoration of luciferase activity that can be detected in living animals with bioluminescence imaging. The ability to image apoptosis noninvasively and dynamically over time provides an opportunity for high-throughput screening of proapoptotic and antiapoptotic compounds and for target validation in vivo in both cell lines and transgenic animals.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Laxman</LastName><ForeName>Bharathi</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Center for Molecular Imaging, University of Michigan Medical School, 1150 West Medical Center Drive, Medical Sciences Research Building III, Room 9303, Ann Arbor, MI 48109-0648, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>Daniel E</ForeName><Initials>DE</Initials></Author><Author ValidYN="Y"><LastName>Bhojani</LastName><ForeName>Mahaveer Swaroop</ForeName><Initials>MS</Initials></Author><Author ValidYN="Y"><LastName>Hamstra</LastName><ForeName>Daniel A</ForeName><Initials>DA</Initials></Author><Author ValidYN="Y"><LastName>Chenevert</LastName><ForeName>Thomas L</ForeName><Initials>TL</Initials></Author><Author ValidYN="Y"><LastName>Ross</LastName><ForeName>Brian D</ForeName><Initials>BD</Initials></Author><Author ValidYN="Y"><LastName>Rehemtulla</LastName><ForeName>Alnawaz</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R24CA83099</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1R43CA91448-01</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>5P20CA86442</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1P50CA93990</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R43 CA091448</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R24 CA083099</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 CA093990</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2002</Year><Month>12</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051017">Apoptosis Regulatory Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011960">Receptors, Estrogen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053221">TNF-Related Apoptosis-Inducing Ligand</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C505653">TNFSF10 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C505654">Tnfsf10 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.13.12.-</RegistryNumber><NameOfSubstance UI="D008156">Luciferases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="C505407">CASP3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="C505409">Casp3 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D053148">Caspase 3</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D020169">Caspases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="Y">Apoptosis</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051017" MajorTopicYN="N">Apoptosis Regulatory Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053148" MajorTopicYN="N">Caspase 3</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020169" MajorTopicYN="N">Caspases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004789" MajorTopicYN="N">Enzyme Activation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005910" MajorTopicYN="N">Glioma</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008156" MajorTopicYN="N">Luciferases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008163" MajorTopicYN="N">Luminescent Measurements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011960" MajorTopicYN="N">Receptors, Estrogen</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053221" MajorTopicYN="N">TNF-Related Apoptosis-Inducing Ligand</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014407" MajorTopicYN="N">Tumor Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2002</Year><Month>12</Month><Day>12</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>1</Month><Day>22</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2002</Year><Month>12</Month><Day>12</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2003</Year><Month>6</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12475931</ArticleId><ArticleId IdType="pmc">PMC139181</ArticleId><ArticleId IdType="doi">10.1073/pnas.252644499</ArticleId><ArticleId IdType="pii">252644499</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gambhir S. S., Herschman, H. R., Cherry, S. R., Barrio, J. R., Satyamurthy, N., Toyokuni, T., Phelps, M. E., Larson, S. M., Balatoni, J., Finn, R., et al. (2000) Neoplasia 2, 118-138.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1550287</ArticleId><ArticleId IdType="pubmed">10933072</ArticleId></ArticleIdList></Reference><Reference><Citation>Weissleder R., Moore, A., Mahmood, U., Bhorade, R., Benveniste, H., Chiocca, E. A. &amp; Basilion, J. P. (2000) Nat. Med. 6, 351-355.</Citation><ArticleIdList><ArticleId IdType="pubmed">10700241</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponomarev V., Doubrovin, M., Lyddane, C., Beresten, T., Balatoni, J., Bornman, W., Finn, R., Akhurst, T., Larson, S., Blasberg, R., et al. (2001) Neoplasia 3, 480-488.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1506564</ArticleId><ArticleId IdType="pubmed">11774030</ArticleId></ArticleIdList></Reference><Reference><Citation>Doubrovin M., Ponomarev, V., Beresten, T., Balatoni, J., Bornmann, W., Finn, R., Humm, J., Larson, S., Sadelain, M., Blasberg, R. &amp; Tjuvajev, J. G. (2001) Proc. Natl. Acad. Sci. USA 98, 9300-9305.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC55415</ArticleId><ArticleId IdType="pubmed">11481488</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehemtulla A., Hall, D. E., Stegman, L. D., Chen, G., Bhojani, M. S., Chenevert, T. L. &amp; Ross, B. D. (2002) Mol. Imaging 1, 43-55.</Citation><ArticleIdList><ArticleId IdType="pubmed">12920860</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung C. H., Mahmood, U., Bredow, S. &amp; Weissleder, R. (2000) Cancer Res. 60, 4953-4958.</Citation><ArticleIdList><ArticleId IdType="pubmed">10987312</ArticleId></ArticleIdList></Reference><Reference><Citation>Sameni M., Moin, K. &amp; Sloane, B. F. (2000) Neoplasia 2, 496-504.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1508086</ArticleId><ArticleId IdType="pubmed">11228542</ArticleId></ArticleIdList></Reference><Reference><Citation>Bremer C., Tung, C. H. &amp; Weissleder, R. (2001) Nat. Med. 7, 743-748.</Citation><ArticleIdList><ArticleId IdType="pubmed">11385514</ArticleId></ArticleIdList></Reference><Reference><Citation>Littlewood T. D., Hancock, D. C., Danielian, P. S., Parker, M. G. &amp; Evan, G. I. (1995) Nucleic Acids Res. 23, 1686-1690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC306922</ArticleId><ArticleId IdType="pubmed">7784172</ArticleId></ArticleIdList></Reference><Reference><Citation>Chinnaiyan A. M., Prasad, U., Shankar, S., Hamstra, D. A., Shanaiah, M., Chenevert, T. L., Ross, B. D. &amp; Rehemtulla, A. (2000) Proc. Natl. Acad. Sci. USA 97, 1754-1759.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC26508</ArticleId><ArticleId IdType="pubmed">10677530</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehemtulla A., Stegman, L. D., Cardozo, S. J., Gupta, S., Hall, D. E., Contag, C. H. &amp; Ross, B. D. (2000) Neoplasia 2, 491-495.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1508085</ArticleId><ArticleId IdType="pubmed">11228541</ArticleId></ArticleIdList></Reference><Reference><Citation>Eilers M., Picard, D., Yamamoto, K. R. &amp; Bishop, J. M. (1989) Nature 340, 66-68.</Citation><ArticleIdList><ArticleId IdType="pubmed">2662015</ArticleId></ArticleIdList></Reference><Reference><Citation>Superti-Furga G., Bergers, G., Picard, D. &amp; Busslinger, M. (1991) Proc. Natl. Acad. Sci. USA 88, 5114-5118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC51822</ArticleId><ArticleId IdType="pubmed">1711219</ArticleId></ArticleIdList></Reference><Reference><Citation>Israel D. I. &amp; Kaufman, R. J. (1993) Proc. Natl. Acad. Sci. USA 90, 4290-4294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC46492</ArticleId><ArticleId IdType="pubmed">8483945</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman J. M. (2000) Neoplasia 2, 5-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1531863</ArticleId><ArticleId IdType="pubmed">10933064</ArticleId></ArticleIdList></Reference><Reference><Citation>Evelhoch J. L., Gillies, R. J., Karczmar, G. S., Koutcher, J. A., Maxwell, R. J., Nalcioglu, O., Raghunand, N., Ronen, S. M., Ross, B. D. &amp; Swartz, H. M. (2000) Neoplasia 2, 152-165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1531871</ArticleId><ArticleId IdType="pubmed">10933074</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurhanewicz J., Vigneron, D. B. &amp; Nelson, S. J. (2000) Neoplasia 2, 166-189.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1531872</ArticleId><ArticleId IdType="pubmed">10933075</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan O., Firon, M., Vivi, A., Navon, G. &amp; Tsarfaty, I. (2000) Neoplasia 2, 365-377.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1550289</ArticleId><ArticleId IdType="pubmed">11005571</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleige G., Nolte, C., Synowitz, M., Seeberger, F., Kettenmann, H. &amp; Zimmer, C. (2001) Neoplasia 3, 489-499.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1506563</ArticleId><ArticleId IdType="pubmed">11774031</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogdanov A., Matuszewski, L., Bremer, C., Petrovsky, A. &amp; Weissleder, R. (2002) Mol. Imaging 1, 16-23.</Citation><ArticleIdList><ArticleId IdType="pubmed">12920857</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogemann D., Josephson, L., Weissleder, R. &amp; Basilion, J. P. (2000) Bioconjugate Chem. 11, 941-946.</Citation><ArticleIdList><ArticleId IdType="pubmed">11087345</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillies R. J., Bhujwalla, Z. M., Evelhoch, J., Garwood, M., Neeman, M., Robinson, S. P., Sotak, C. H. &amp; Van Der Sanden, B. (2000) Neoplasia 2, 139-151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1531870</ArticleId><ArticleId IdType="pubmed">10933073</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhujwalla Z. M., Artemov, D., Natarajan, K., Ackerstaff, E. &amp; Solaiyappan, M. (2001) Neoplasia 3, 143-153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1505415</ArticleId><ArticleId IdType="pubmed">11420750</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilatus U., Ackerstaff, E., Artemov, D., Mori, N., Gillies, R. J. &amp; Bhujwalla, Z. M. (2000) Neoplasia 2, 273-279.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1507569</ArticleId><ArticleId IdType="pubmed">10935513</ArticleId></ArticleIdList></Reference><Reference><Citation>Chenevert T. L., Stegman, L. D., Taylor, J. M., Robertson, P. L., Greenberg, H. S., Rehemtulla, A. &amp; Ross, B. D. (2000) J. Natl. Cancer Inst. 92, 2029-2036.</Citation><ArticleIdList><ArticleId IdType="pubmed">11121466</ArticleId></ArticleIdList></Reference><Reference><Citation>Stegman L. D., Rehemtulla, A., Beattie, B., Kievit, E., Lawrence, T. S., Blasberg, R. G., Tjuvajev, J. G. &amp; Ross, B. D. (1999) Proc. Natl. Acad. Sci. USA. 96, 9821-9826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC22294</ArticleId><ArticleId IdType="pubmed">10449778</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter G., Barton, E. R. &amp; Sweeney, H. L. (2000) Proc. Natl. Acad. Sci. USA 97, 5151-5155.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC25797</ArticleId><ArticleId IdType="pubmed">10805778</ArticleId></ArticleIdList></Reference><Reference><Citation>Auricchio A., Zhou, R., Wilson, J. M. &amp; Glickson, J. D. (2001) Proc. Natl. Acad. Sci. USA 97, 5205-5210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC33188</ArticleId><ArticleId IdType="pubmed">11296261</ArticleId></ArticleIdList></Reference><Reference><Citation>Tjuvajev J. G., Joshi, A., Callegari, J., Lindsley, L., Joshi, R., Balatoni, J., Finn, R., Larson, S. M., Sadelain, M. &amp; Blasberg, R. G. (1999) Neoplasia 1, 315-320.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1508100</ArticleId><ArticleId IdType="pubmed">10935486</ArticleId></ArticleIdList></Reference><Reference><Citation>Gambhir S. S., Barrio, J. R., Phelps, M. E., Iyer, M., Namavari, M., Satyamurthy, N., Wu, L., Green, L. A., Bauer, E., MacLaren, D. C., et al. (1999) Proc. Natl. Acad. Sci. USA. 96, 2333-2338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC26784</ArticleId><ArticleId IdType="pubmed">10051642</ArticleId></ArticleIdList></Reference><Reference><Citation>Mankoff D. A., Dehdashti, F. &amp; Shields, A. F. (2000) Neoplasia 2, 71-88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1531868</ArticleId><ArticleId IdType="pubmed">10933070</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyszlewski M., Blake, H. M., Dahlheimer, J. L., Pica, C. M. &amp; Piwnica-Worms, D. (2002) Mol. Imaging 1, 24-36.</Citation><ArticleIdList><ArticleId IdType="pubmed">12920858</ArticleId></ArticleIdList></Reference><Reference><Citation>Hackman T., Doubrovin, M., Balatoni, J., Beresten, T., Ponomarev, V., Beattie, B., Finn, R., Bornmann, W., Blasberg, R. &amp; Tjuvajev, J. G. G. (2002) Mol. Imaging 1, 36-42.</Citation><ArticleIdList><ArticleId IdType="pubmed">12920859</ArticleId></ArticleIdList></Reference><Reference><Citation>Hay R. V., Cao, B., Skinner, R. S., Wang, L.-M., Su, Y., Resau, J. H., Woude, G. F. V. &amp; Gross, M. D. (2002) Mol. Imaging 1, 56-62.</Citation><ArticleIdList><ArticleId IdType="pubmed">12920861</ArticleId></ArticleIdList></Reference><Reference><Citation>Burt B. M., Humm, J. L., Kooby, D. A., Squire, O. D., Mastorides, S., Larson, S. M. &amp; Fong, Y. (2001) Neoplasia 3, 189-195.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1505592</ArticleId><ArticleId IdType="pubmed">11494112</ArticleId></ArticleIdList></Reference><Reference><Citation>Kristensen C. A., Hamberg, L. M., Hunter, G. J., Roberge, S., Kierstead, D., Wolf, G. L. &amp; Jain, R. K. (1999) Neoplasia 1, 518-525.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1508121</ArticleId><ArticleId IdType="pubmed">10935499</ArticleId></ArticleIdList></Reference><Reference><Citation>Paulus M. J., Gleason, S. S., Kennel, S. J., Hunsicker, P. R. &amp; Johnson, D. K. (2000) Neoplasia 2, 62-70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1531867</ArticleId><ArticleId IdType="pubmed">10933069</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokol D. L., Zhang, X., Lu, P. &amp; Gewirtz, A. M. (1998) Proc. Natl. Acad. Sci. USA 95, 11538-11543.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC21676</ArticleId><ArticleId IdType="pubmed">9751701</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs A., Dubrovin, M., Hewett, J., Sena-Esteves, M., Tan, C. W., Slack, M., Sadelain, M., Breakefield, X. O. &amp; Tjuvajev, J. G. (1999) Neoplasia 1, 154-161.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1508134</ArticleId><ArticleId IdType="pubmed">10933050</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimoto J. G., Pitris, C., Boppart, S. A. &amp; Brezinski, M. E. (2000) Neoplasia 2, 9-25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1531864</ArticleId><ArticleId IdType="pubmed">10933065</ArticleId></ArticleIdList></Reference><Reference><Citation>Tromberg B. J., Shah, N., Lanning, R., Cerussi, A., Espinoza, J., Pham, T., Svaasand, L. &amp; Butler, J. (2000) Neoplasia 2, 26-40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1531865</ArticleId><ArticleId IdType="pubmed">10933066</ArticleId></ArticleIdList></Reference><Reference><Citation>Vajkoczy P., Ullrich, A. &amp; Menger, M. D. (2000) Neoplasia 2, 53-61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1531866</ArticleId><ArticleId IdType="pubmed">10933068</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramanujam N. (2000) Neoplasia 2, 89-117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1531869</ArticleId><ArticleId IdType="pubmed">10933071</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen M. W., Holm, S., Lund, E. L., Hojgaard, L. &amp; Kristjansen, P. E. (2001) Neoplasia 3, 80-87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1505028</ArticleId><ArticleId IdType="pubmed">11326319</ArticleId></ArticleIdList></Reference><Reference><Citation>Kragh M., Quistorff, B., Lund, E. L. &amp; Kristjansen, P. E. (2001) Neoplasia 3, 324-330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1505857</ArticleId><ArticleId IdType="pubmed">11571632</ArticleId></ArticleIdList></Reference><Reference><Citation>Vordermark D., Shibata, T. &amp; Martin Brown, J. (2001) Neoplasia 3, 527-534.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1506559</ArticleId><ArticleId IdType="pubmed">11774035</ArticleId></ArticleIdList></Reference><Reference><Citation>Edinger M., Sweeney, T. J., Tucker, A. A., Olomu, A. B., Negrin, R. S. &amp; Contag, C. H. (1999) Neoplasia 1, 303-310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1508101</ArticleId><ArticleId IdType="pubmed">10935484</ArticleId></ArticleIdList></Reference><Reference><Citation>Contag C. H., Jenkins, D., Contag, P. R. &amp; Negrin, R. S. (2000) Neoplasia 2, 41-52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1550286</ArticleId><ArticleId IdType="pubmed">10933067</ArticleId></ArticleIdList></Reference><Reference><Citation>Padera T. P., Stoll, B. R., So, P. T. C. &amp; Jain, R. K. (2002) Mol. Imaging 1, 9-15.</Citation><ArticleIdList><ArticleId IdType="pubmed">12920856</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawrysz D. J. &amp; Sevick-Muraca, E. M. (2000) Neoplasia 2, 388-417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1507982</ArticleId><ArticleId IdType="pubmed">11191107</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12481027</PMID><DateCompleted><Year>2003</Year><Month>01</Month><Day>21</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>99</Volume><Issue>26</Issue><PubDate><Year>2002</Year><Month>Dec</Month><Day>24</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR.</ArticleTitle><Pagination><StartPage>16742</StartPage><EndPage>16747</EndPage><MedlinePgn>16742-7</MedlinePgn></Pagination><Abstract><AbstractText>We present a structural model for amyloid fibrils formed by the 40-residue beta-amyloid peptide associated with Alzheimer's disease (Abeta(1-40)), based on a set of experimental constraints from solid state NMR spectroscopy. The model additionally incorporates the cross-beta structural motif established by x-ray fiber diffraction and satisfies constraints on Abeta(1-40) fibril dimensions and mass-per-length determined from electron microscopy. Approximately the first 10 residues of Abeta(1-40) are structurally disordered in the fibrils. Residues 12-24 and 30-40 adopt beta-strand conformations and form parallel beta-sheets through intermolecular hydrogen bonding. Residues 25-29 contain a bend of the peptide backbone that brings the two beta-sheets in contact through sidechain-sidechain interactions. A single cross-beta unit is then a double-layered beta-sheet structure with a hydrophobic core and one hydrophobic face. The only charged sidechains in the core are those of D23 and K28, which form salt bridges. Fibrils with minimum mass-per-length and diameter consist of two cross-beta units with their hydrophobic faces juxtaposed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Petkova</LastName><ForeName>Aneta T</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892-0520, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishii</LastName><ForeName>Yoshitaka</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Balbach</LastName><ForeName>John J</ForeName><Initials>JJ</Initials></Author><Author ValidYN="Y"><LastName>Antzutkin</LastName><ForeName>Oleg N</ForeName><Initials>ON</Initials></Author><Author ValidYN="Y"><LastName>Leapman</LastName><ForeName>Richard D</ForeName><Initials>RD</Initials></Author><Author ValidYN="Y"><LastName>Delaglio</LastName><ForeName>Frank</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Tycko</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2002</Year><Month>12</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C078592">amyloid beta-protein (1-40)</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Proc Natl Acad Sci U S A. 2003 Jan 21;100(2):383-5. doi: 10.1073/pnas.0337745100.</RefSource><PMID Version="1">12525689</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="Y">Models, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019906" MajorTopicYN="N">Nuclear Magnetic Resonance, Biomolecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017433" MajorTopicYN="Y">Protein Structure, Secondary</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2002</Year><Month>12</Month><Day>14</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>1</Month><Day>22</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2002</Year><Month>12</Month><Day>14</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2003</Year><Month>6</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12481027</ArticleId><ArticleId IdType="pmc">PMC139214</ArticleId><ArticleId IdType="doi">10.1073/pnas.262663499</ArticleId><ArticleId IdType="pii">262663499</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sipe J. D. (1992) Annu. Rev. Biochem. 61, 947-975.</Citation><ArticleIdList><ArticleId IdType="pubmed">1497327</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunde M., Serpell, L. C., Bartlam, M., Fraser, P. E., Pepys, M. B. &amp; Blake, C. C. F. (1997) J. Mol. Biol. 273, 729-739.</Citation><ArticleIdList><ArticleId IdType="pubmed">9356260</ArticleId></ArticleIdList></Reference><Reference><Citation>Inouye H., Fraser, P. E. &amp; Kirschner, D. A. (1993) Biophys. J. 64, 502-519.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1262353</ArticleId><ArticleId IdType="pubmed">8457674</ArticleId></ArticleIdList></Reference><Reference><Citation>Glenner G. G. &amp; Wong, C. W. (1984) Biochem. Biophys. Res. Commun. 120, 885-890.</Citation><ArticleIdList><ArticleId IdType="pubmed">6375662</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwatsubo T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N. &amp; Ihara, Y. (1994) Neuron 13, 45-53.</Citation><ArticleIdList><ArticleId IdType="pubmed">8043280</ArticleId></ArticleIdList></Reference><Reference><Citation>George A. R. &amp; Howlett, D. R. (1999) Biopolymers 50, 733-741.</Citation><ArticleIdList><ArticleId IdType="pubmed">10547528</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L. P., Darden, T. A., Bartolotti, L., Kominos, D. &amp; Pedersen, L. G. (1999) Biophys. J. 76, 2871-2878.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1300259</ArticleId><ArticleId IdType="pubmed">10354415</ArticleId></ArticleIdList></Reference><Reference><Citation>Tjernberg L. O., Callaway, D. J. E., Tjernberg, A., Hahne, S., Lilliehook, C., Terenius, L., Thyberg, J. &amp; Nordstedt, C. (1999) J. Biol. Chem. 274, 12619-12625.</Citation><ArticleIdList><ArticleId IdType="pubmed">10212241</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaney M. O., Webster, S. D., Kuo, Y. M. &amp; Roher, A. E. (1998) Protein Eng. 11, 761-767.</Citation><ArticleIdList><ArticleId IdType="pubmed">9796824</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazo N. D. &amp; Downing, D. T. (1998) Biochemistry 37, 1731-1735.</Citation><ArticleIdList><ArticleId IdType="pubmed">9492738</ArticleId></ArticleIdList></Reference><Reference><Citation>Antzutkin O. N., Balbach, J. J., Leapman, R. D., Rizzo, N. W., Reed, J. &amp; Tycko, R. (2000) Proc. Natl. Acad. Sci. USA 97, 13045-13050.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC27175</ArticleId><ArticleId IdType="pubmed">11069287</ArticleId></ArticleIdList></Reference><Reference><Citation>Balbach J. J., Petkova, A. T., Oyler, N. A., Antzutkin, O. N., Gordon, D. G., Meredith, S. C. &amp; Tycko, R. (2002) Biophys. J. 83, 1205-1216.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1302222</ArticleId><ArticleId IdType="pubmed">12124300</ArticleId></ArticleIdList></Reference><Reference><Citation>Antzutkin O. N., Leapman, R. D., Balbach, J. J. &amp; Tycko, R. (2002) Biochemistry 41, 15436-15450.</Citation><ArticleIdList><ArticleId IdType="pubmed">12484785</ArticleId></ArticleIdList></Reference><Reference><Citation>Benzinger T. L. S., Gregory, D. M., Burkoth, T. S., Miller-Auer, H., Lynn, D. G., Botto, R. E. &amp; Meredith, S. C. (1998) Proc. Natl. Acad. Sci. USA 95, 13407-13412.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC24832</ArticleId><ArticleId IdType="pubmed">9811813</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkoth T. S., Benzinger, T. L. S., Urban, V., Morgan, D. M., Gregory, D. M., Thiyagarajan, P., Botto, R. E., Meredith, S. C. &amp; Lynn, D. G. (2000) J. Am. Chem. Soc. 122, 7883-7889.</Citation></Reference><Reference><Citation>Benzinger T. L. S., Gregory, D. M., Burkoth, T. S., Miller-Auer, H., Lynn, D. G., Botto, R. E. &amp; Meredith, S. C. (2000) Biochemistry 39, 3491-3499.</Citation><ArticleIdList><ArticleId IdType="pubmed">10727245</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishii Y. (2001) J. Chem. Phys. 114, 8473-8483.</Citation></Reference><Reference><Citation>Balbach J. J., Ishii, Y., Antzutkin, O. N., Leapman, R. D., Rizzo, N. W., Dyda, F., Reed, J. &amp; Tycko, R. (2000) Biochemistry 39, 13748-13759.</Citation><ArticleIdList><ArticleId IdType="pubmed">11076514</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldus M., Petkova, A. T., Herzfeld, J. &amp; Griffin, R. G. (1998) Mol. Phys. 95, 1197-1207.</Citation></Reference><Reference><Citation>Ishii Y., Balbach, J. J. &amp; Tycko, R. (2001) Chem. Phys. 266, 231-236.</Citation></Reference><Reference><Citation>Blanco F. J. &amp; Tycko, R. (2001) J. Magn. Reson. 149, 131-138.</Citation></Reference><Reference><Citation>Petkova A. T. &amp; Tycko, R. (2002) J. Magn. Reson. 155, 293-299.</Citation><ArticleIdList><ArticleId IdType="pubmed">12036340</ArticleId></ArticleIdList></Reference><Reference><Citation>Tycko R., Weliky, D. P. &amp; Berger, A. E. (1996) J. Chem. Phys. 105, 7915-7930.</Citation></Reference><Reference><Citation>Cornilescu G., Delaglio, F. &amp; Bax, A. (1999) J. Biomol. NMR 13, 289-302.</Citation><ArticleIdList><ArticleId IdType="pubmed">10212987</ArticleId></ArticleIdList></Reference><Reference><Citation>Herzfeld J. &amp; Berger, A. E. (1980) J. Chem. Phys. 73, 6021-6030.</Citation></Reference><Reference><Citation>Koradi R., Billeter, M. &amp; W&#xfc;thrich, K. (1996) J. Mol. Graphics 14, 51-55.</Citation><ArticleIdList><ArticleId IdType="pubmed">8744573</ArticleId></ArticleIdList></Reference><Reference><Citation>Malinchik S. B., Inouye, H., Szumowski, K. E. &amp; Kirschner, D. A. (1998) Biophys. J. 74, 537-545.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1299406</ArticleId><ArticleId IdType="pubmed">9449354</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraser P. E., Nguyen, J. T., Inouye, H., Surewicz, W. K., Selkoe, D. J., Podlisny, M. B. &amp; Kirschner, D. A. (1992) Biochemistry 31, 10716-10723.</Citation><ArticleIdList><ArticleId IdType="pubmed">1420187</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldsbury C. S., Wirtz, S., Muller, S. A., Sunderji, S., Wicki, P., Aebi, U. &amp; Frey, P. (2000) J. Struct. Biol. 130, 217-231.</Citation><ArticleIdList><ArticleId IdType="pubmed">10940227</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimenez J. L., Nettleton, E. J., Bouchard, M., Robinson, C. V., Dobson, C. M. &amp; Saibil, H. R. (2002) Proc. Natl. Acad. Sci. USA 99, 9196-9201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC123117</ArticleId><ArticleId IdType="pubmed">12093917</ArticleId></ArticleIdList></Reference><Reference><Citation>Harper J. D., Lieber, C. M. &amp; Lansbury, P. T. (1997) Chem. Biol. 4, 951-959.</Citation><ArticleIdList><ArticleId IdType="pubmed">9427660</ArticleId></ArticleIdList></Reference><Reference><Citation>Weliky D. P., Bennett, A. E., Zvi, A., Anglister, J., Steinbach, P. J. &amp; Tycko, R. (1999) Nat. Struct. Biol. 6, 141-145.</Citation><ArticleIdList><ArticleId IdType="pubmed">10048925</ArticleId></ArticleIdList></Reference><Reference><Citation>Long H. W. &amp; Tycko, R. (1998) J. Am. Chem. Soc. 120, 7039-7048.</Citation></Reference><Reference><Citation>Hilbich C., Kisterswoike, B., Reed, J., Masters, C. L. &amp; Beyreuther, K. (1991) J. Mol. Biol. 218, 149-163.</Citation><ArticleIdList><ArticleId IdType="pubmed">2002499</ArticleId></ArticleIdList></Reference><Reference><Citation>Roher A. E., Lowenson, J. D., Clarke, S., Wolkow, C., Wang, R., Cotter, R. J., Reardon, I. M., Zurcherneely, H. A., Heinrikson, R. L., Ball, M. J. &amp; Greenberg, B. D. (1993) J. Biol. Chem. 268, 3072-3083.</Citation><ArticleIdList><ArticleId IdType="pubmed">8428986</ArticleId></ArticleIdList></Reference><Reference><Citation>Saido T. C., Yamao-Harigaya, W., Iwatsubo, T. &amp; Kawashima, S. (1996) Neurosci. Lett. 215, 173-176.</Citation><ArticleIdList><ArticleId IdType="pubmed">8899741</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal I., Williams, A., Murphy, C., Bledsoe, B. &amp; Wetzel, R. (2001) Biochemistry 40, 11757-11767.</Citation><ArticleIdList><ArticleId IdType="pubmed">11570876</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito H. (1986) Magn. Reson. Chem. 24, 835-852.</Citation></Reference><Reference><Citation>Iwadate M., Asakura, T. &amp; Williamson, M. P. (1999) J. Biomol. NMR 13, 199-211.</Citation><ArticleIdList><ArticleId IdType="pubmed">10212983</ArticleId></ArticleIdList></Reference><Reference><Citation>de Dios A. C., Pearson, J. G. &amp; Oldfield, E. (1993) Science 260, 1491-1496.</Citation><ArticleIdList><ArticleId IdType="pubmed">8502992</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilbich C., Kisterswoike, B., Reed, J., Masters, C. L. &amp; Beyreuther, K. (1992) J. Mol. Biol. 228, 460-473.</Citation><ArticleIdList><ArticleId IdType="pubmed">1453457</ArticleId></ArticleIdList></Reference><Reference><Citation>Harper J. D., Wong, S. S., Lieber, C. M. &amp; Lansbury, P. T. (1999) Biochemistry 38, 8972-8980.</Citation><ArticleIdList><ArticleId IdType="pubmed">10413470</ArticleId></ArticleIdList></Reference><Reference><Citation>Halverson K., Fraser, P. E., Kirschner, D. A. &amp; Lansbury, P. T. (1990) Biochemistry 29, 2639-2644.</Citation><ArticleIdList><ArticleId IdType="pubmed">2346740</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin J., Clore, G. M. &amp; Gronenborn, A. M. (1996) Biochemistry 35, 7-13.</Citation><ArticleIdList><ArticleId IdType="pubmed">8555200</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu L. Y., Kemple, M. D., Yuan, P. &amp; Prendergast, F. G. (1995) Biochemistry 34, 13196-13202.</Citation><ArticleIdList><ArticleId IdType="pubmed">7548083</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaroniec C. P., Tounge, B. A., Herzfeld, J. &amp; Griffin, R. G. (2001) J. Am. Chem. Soc. 123, 3507-3519.</Citation><ArticleIdList><ArticleId IdType="pubmed">11472123</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma B. &amp; Nussinov, R. (2002) Proc. Natl. Acad. Sci. USA 99, 14126-14131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC137848</ArticleId><ArticleId IdType="pubmed">12391326</ArticleId></ArticleIdList></Reference><Reference><Citation>Perutz M. F., Finch, J. T., Berriman, J. &amp; Lesk, A. (2002) Proc. Natl. Acad. Sci. USA 99, 5591-5595.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC122814</ArticleId><ArticleId IdType="pubmed">11960014</ArticleId></ArticleIdList></Reference><Reference><Citation>Wille H., Michelitsch, M. D., Guenebaut, V., Supattapone, S., Serban, A., Cohen, F. E., Agard, D. A. &amp; Prusiner, S. B. (2002) Proc. Natl. Acad. Sci. USA 99, 3563-3568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC122563</ArticleId><ArticleId IdType="pubmed">11891310</ArticleId></ArticleIdList></Reference><Reference><Citation>Emsley P., Charles, I. G., Fairweather, N. F. &amp; Isaacs, N. W. (1996) Nature 381, 90-92.</Citation><ArticleIdList><ArticleId IdType="pubmed">8609998</ArticleId></ArticleIdList></Reference><Reference><Citation>Wishart D. S., Bigam, C. G., Holm, A., Hodges, R. S. &amp; Sykes, B. D. (1995) J. Biomol. NMR 5, 67-81.</Citation><ArticleIdList><ArticleId IdType="pubmed">7881273</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12482085</PMID><DateCompleted><Year>2003</Year><Month>01</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1053-8119</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2002</Year><Month>Sep</Month></PubDate></JournalIssue><Title>NeuroImage</Title><ISOAbbreviation>Neuroimage</ISOAbbreviation></Journal><ArticleTitle>Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET.</ArticleTitle><Pagination><StartPage>302</StartPage><EndPage>316</EndPage><MedlinePgn>302-16</MedlinePgn></Pagination><Abstract><AbstractText>A new diagnostic indicator of FDG PET scan abnormality, based on age-adjusted t statistics and an automated voxel-based procedure, is presented and validated in a large data set comprising 110 normal controls and 395 patients with probable Alzheimer's disease (AD) that were studied in eight participating centers. The effect of differences in spatial resolution of PET scanners was minimized effectively by filtering and masking. In controls FDG uptake declined significantly with age in anterior cingulate and frontolateral perisylvian cortex. In patients with probable AD decline of FDG uptake in posterior cingulate, temporoparietal, and prefrontal association cortex was related to dementia severity. These effects were clearly distinct from age effects in controls, suggesting that the disease process of AD is not related to normal aging. Women with probable AD had significantly more frontal metabolic impairment than men. The new indicator of metabolic abnormality in AD-related regions provided 93% sensitivity and specificity for distinction of mild to moderate probable AD from normals, and 84% sensitivity at 93% specificity for detection of very mild probable AD (defined by Mini Mental Score 24 or better). All regions related to AD severity were already affected in very mild AD, suggesting that all vulnerable areas are affected to a similar degree already at disease onset. Ventromedial frontal cortex was also abnormal. In conclusion, automated analysis of multicenter FDG PET is feasible, provides insights into AD pathophysiology, and can be used potentially as a sensitive biomarker for early AD diagnosis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Herholz</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>University Cologne, Neurological Clinic and Max-Planck-Institute for Neurological Research, 50931 K&#xf6;ln, Germany. karl.herholz@pet.mpin-koeln.mpg.de</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salmon</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Perani</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Baron</LastName><ForeName>J C</ForeName><Initials>JC</Initials></Author><Author ValidYN="Y"><LastName>Holthoff</LastName><ForeName>V</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Fr&#xf6;lich</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Sch&#xf6;nknecht</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Ito</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Mielke</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Kalbe</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Z&#xfc;ndorf</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Delbeuck</LastName><ForeName>X</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Pelati</LastName><ForeName>O</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Anchisi</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Fazio</LastName><ForeName>F</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Kerrouche</LastName><ForeName>N</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Desgranges</LastName><ForeName>B</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Eustache</LastName><ForeName>F</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Beuthien-Baumann</LastName><ForeName>B</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Menzel</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Schr&#xf6;der</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Kato</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Arahata</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Henze</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Heiss</LastName><ForeName>W D</ForeName><Initials>WD</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuroimage</MedlineTA><NlmUniqueID>9215515</NlmUniqueID><ISSNLinking>1053-8119</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019275">Radiopharmaceuticals</NameOfSubstance></Chemical><Chemical><RegistryNumber>0Z5B2CJX4D</RegistryNumber><NameOfSubstance UI="D019788">Fluorodeoxyglucose F18</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001931" MajorTopicYN="N">Brain Mapping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019788" MajorTopicYN="Y">Fluorodeoxyglucose F18</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007090" MajorTopicYN="N">Image Interpretation, Computer-Assisted</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011877" MajorTopicYN="N">Radionuclide Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019275" MajorTopicYN="Y">Radiopharmaceuticals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012016" MajorTopicYN="N">Reference Values</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012044" MajorTopicYN="N">Regression Analysis</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2002</Year><Month>12</Month><Day>17</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>1</Month><Day>15</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2002</Year><Month>12</Month><Day>17</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12482085</ArticleId><ArticleId IdType="doi">10.1006/nimg.2002.1208</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12486146</PMID><DateCompleted><Year>2003</Year><Month>01</Month><Day>23</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1529-2401</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>24</Issue><PubDate><Year>2002</Year><Month>Dec</Month><Day>15</Day></PubDate></JournalIssue><Title>The Journal of neuroscience : the official journal of the Society for Neuroscience</Title><ISOAbbreviation>J Neurosci</ISOAbbreviation></Journal><ArticleTitle>Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation.</ArticleTitle><Pagination><StartPage>10539</StartPage><EndPage>10548</EndPage><MedlinePgn>10539-48</MedlinePgn></Pagination><Abstract><AbstractText>The most frequent human apolipoprotein (apo) E isoforms, E3 and E4, differentially affect Alzheimer's disease (AD) risk (E4 &gt; E3) and age of onset (E4 &lt; E3). Compared with apoE3, apoE4 promotes the cerebral deposition of amyloid beta (Abeta) peptides, which are derived from the amyloid precursor protein (APP) and play a central role in AD. However, it is uncertain whether Abeta deposition into plaques is the main mechanism by which apoE isoforms affect AD. We analyzed murine apoE-deficient transgenic mice expressing in their brains human APP (hAPP) and Abeta together with apoE3 or apoE4. Because cognitive decline in AD correlates better with decreases in synaptophysin-immunoreactive presynaptic terminals, choline acetyltransferase (ChAT) activity, and ChAT-positive fibers than with plaque load, we compared these parameters in hAPP/apoE3 and hAPP/apoE4 mice and singly transgenic controls at 6-7, 12-15, and 19-24 months of age. Brain aging in the context of high levels of nondeposited human Abeta resulted in progressive synaptic/cholinergic deficits. ApoE3 delayed the synaptic deficits until old age, whereas apoE4 was not protective at any of the ages analyzed. Old hAPP/apoE4 mice had more plaques than old hAPP/apoE3 mice, but synaptic/cholinergic deficits preceded plaque formation in hAPP/apoE4 mice. Moreover, despite their different plaque loads, old hAPP/apoE4 and hAPP/apoE3 mice had comparable synaptic/cholinergic deficits, and these deficits were found not only in the hippocampus but also in the neocortex, which in most mice contained no plaques. Thus, apoE3, but not apoE4, delays age- and Abeta-dependent synaptic deficits through a plaque-independent mechanism. This difference could contribute to the differential effects of apoE isoforms on the risk and onset of AD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Buttini</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Gladstone Institute of Neurological Disease, University of California, San Francisco, California 94141-9100, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Gui-Qiu</ForeName><Initials>GQ</Initials></Author><Author ValidYN="Y"><LastName>Shockley</LastName><ForeName>Kristina</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yadong</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Brian</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Masliah</LastName><ForeName>Eliezer</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Mallory</LastName><ForeName>Margaret</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Yeo</LastName><ForeName>Tracy</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Longo</LastName><ForeName>Frank M</ForeName><Initials>FM</Initials></Author><Author ValidYN="Y"><LastName>Mucke</LastName><ForeName>Lennart</ForeName><Initials>L</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS041787</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG011385</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R37 AG011385</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS41787</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA094141</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG11385</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosci</MedlineTA><NlmUniqueID>8102140</NlmUniqueID><ISSNLinking>0270-6474</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053318">Apolipoprotein E3</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053327">Apolipoprotein E4</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001057">Apolipoproteins E</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020033">Protein Isoforms</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016708">Synaptophysin</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.1.6</RegistryNumber><NameOfSubstance UI="D002795">Choline O-Acetyltransferase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053318" MajorTopicYN="N">Apolipoprotein E3</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053327" MajorTopicYN="N">Apolipoprotein E4</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001057" MajorTopicYN="N">Apolipoproteins E</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002795" MajorTopicYN="N">Choline O-Acetyltransferase</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002799" MajorTopicYN="N">Cholinergic Fibers</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017729" MajorTopicYN="N">Presynaptic Terminals</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020033" MajorTopicYN="N">Protein Isoforms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016708" MajorTopicYN="N">Synaptophysin</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2002</Year><Month>12</Month><Day>18</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>1</Month><Day>24</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2002</Year><Month>12</Month><Day>18</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2003</Year><Month>6</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12486146</ArticleId><ArticleId IdType="pmc">PMC6758409</ArticleId><ArticleId IdType="pii">22/24/10539</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.22-24-10539.2002</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Allen SJ, MacGowan SH, Tyler S, Wilcock GK, Robertson AGS, Holden PH, Smith SKF, Dawbarn D. Reduced cholinergic function in normal and Alzheimer's disease brain is associated with apolipoprotein E4 genotype. Neurosci Lett. 1997;239:33&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">9547165</ArticleId></ArticleIdList></Reference><Reference><Citation>Arendt T, Schindler C, Br&#xfc;ckner MK, Eschrich K, Bigl V, Zedlick D, Marcova L. Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein &#x3b5;4 allele. J Neurosci. 1997;17:516&#x2013;529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6573225</ArticleId><ArticleId IdType="pubmed">8987775</ArticleId></ArticleIdList></Reference><Reference><Citation>Berr C, Hauw J-J, Dela&#xe4;re P, Duyckaerts C, Amouyel P. Apolipoprotein E allele 4 is linked to increased deposition of the amyloid &#x3b2;-peptide (A-&#x3b2;) in cases with or without Alzheimer's disease. Neurosci Lett. 1994;178:221&#x2013;224.</Citation><ArticleIdList><ArticleId IdType="pubmed">7824200</ArticleId></ArticleIdList></Reference><Reference><Citation>Bierer L, Haroutunian V, Gabriel S, Knott PJ, Carlin LS, Purohit DP, Perl DP, Schmeidler J, Kanof P, Davis KL. Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J Neurochem. 1995;64:749&#x2013;760.</Citation><ArticleIdList><ArticleId IdType="pubmed">7830069</ArticleId></ArticleIdList></Reference><Reference><Citation>Boncristiano S, Calhoun ME, Kelly PH, Pfeifer M, Bondolfi L, Stalder M, Phinney AL, Abramowski D, Sturchler-Pierrat C, Enz A, Sommer B, Staufenbiel M, Jucker M. Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis. J Neurosci. 2002;22:3234&#x2013;3243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6757538</ArticleId><ArticleId IdType="pubmed">11943824</ArticleId></ArticleIdList></Reference><Reference><Citation>Bookheimer SY, Strojwas MH, Cohen MS, Saunders AM, Pericak-Vance MA, Mazziotta JC, Small GW. Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med. 2000;343:450&#x2013;456.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2831477</ArticleId><ArticleId IdType="pubmed">10944562</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyles JK, Pitas RE, Wilson E, Mahley RW, Taylor JM. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest. 1985;76:1501&#x2013;1513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC424114</ArticleId><ArticleId IdType="pubmed">3932467</ArticleId></ArticleIdList></Reference><Reference><Citation>Bronfman FC, Tesseur I, Hofker MH, Havekens LM, Van Leuven F. No evidence for cholinergic problems in apolipoprotein E knockout and apolipoprotein E4 transgenic mice. Neuroscience. 2000;97:411&#x2013;418.</Citation><ArticleIdList><ArticleId IdType="pubmed">10828523</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown DF, Risser RC, Bigio EH, Tripp P, Stiegler A, Welch E, Eagan KP, Hladik CL, White CLI. Neocortical synapse density and Braak stage in the Lewy body variant of Alzheimer disease: a comparison with classic Alzheimer disease and normal aging. J Neuropathol Exp Neurol. 1998;57:955&#x2013;960.</Citation><ArticleIdList><ArticleId IdType="pubmed">9786245</ArticleId></ArticleIdList></Reference><Reference><Citation>Buttini M, Orth M, Bellosta S, Akeefe H, Pitas RE, Wyss-Coray T, Mucke L, Mahley RW. Expression of human apolipoprotein E3 or E4 in the brains of Apoe&#x2212;/&#x2212; mice: isoform-specific effects on neurodegeneration. J Neurosci. 1999;19:4867&#x2013;4880.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6782676</ArticleId><ArticleId IdType="pubmed">10366621</ArticleId></ArticleIdList></Reference><Reference><Citation>Buttini M, Akeefe H, Lin C, Mahley RW, Pitas RE, Wyss-Coray T, Mucke L. Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease. Neuroscience. 2000;97:207&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pubmed">10799751</ArticleId></ArticleIdList></Reference><Reference><Citation>Calhoun ME, Wiederhold KH, Abramowski D, Phinney AL, Probst A, Sturchler-Pierrat C, Staufenbiel M, Sommer B, Jucker M. Neuron loss in APP transgenic mice. Nature. 1998;395:755&#x2013;756.</Citation><ArticleIdList><ArticleId IdType="pubmed">9796810</ArticleId></ArticleIdList></Reference><Reference><Citation>Caselli RJ, Graff-Radford NR, Reiman M, Weaver A, Osborne D, Lucas J, Uecker A, Thibodeau SN. Preclinical memory decline in cognitively normal apolipoprotein E-&#x3b5;4 homozygotes. Neurology. 1999;53:201&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pubmed">10408560</ArticleId></ArticleIdList></Reference><Reference><Citation>Caselli RJ, Osborne D, Reiman EM, Hentz JG, Barbieri CJ, Saunders AM, Hardy J, Graff-Radford NR, Hall GR, Alexander GE. Preclinical cognitive decline in late middle-aged asymptomatic apolipoprotein E-&#x3b5;4/4 homozygotes: a replication study. J Neurol Sci. 2001;189:93&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">11535238</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman J, Korczyn AD, Karussis DM, Michaelson DM. The effects of APOE genotype on age at onset and progression of neurodegenerative diseases. Neurology. 2001;57:1482&#x2013;1485.</Citation><ArticleIdList><ArticleId IdType="pubmed">11673593</ArticleId></ArticleIdList></Reference><Reference><Citation>Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261:921&#x2013;923.</Citation><ArticleIdList><ArticleId IdType="pubmed">8346443</ArticleId></ArticleIdList></Reference><Reference><Citation>Corey-Bloom J, Tiraboschi P, Hansen LA, Alford M, Schoos B, Sabbagh MN, Masliah E, Thal LJ. E4 allele dosage does not predict cholinergic activity or synapse loss in Alzheimer's disease. Neurology. 2000;54:403&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pubmed">10668702</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings JL. Cholinesterase inhibitors: a new class of psychotropic compounds. Am J Psychiatry. 2000;157:4&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">10618007</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies P. Neurotransmitter-related enzymes in senile dementia of the Alzheimer type. Brain Res. 1979;171:319&#x2013;327.</Citation><ArticleIdList><ArticleId IdType="pubmed">37989</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis JN, Chisholm JC. The &#x201c;amyloid cascade hypothesis&#x201d; of AD: decoy or real McCoy? Trends Neurosci. 1997;20:558&#x2013;559.</Citation><ArticleIdList><ArticleId IdType="pubmed">9416666</ArticleId></ArticleIdList></Reference><Reference><Citation>DeKosky ST, Scheff SW. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol. 1990;27:457&#x2013;464.</Citation><ArticleIdList><ArticleId IdType="pubmed">2360787</ArticleId></ArticleIdList></Reference><Reference><Citation>Dekroon RM, Armati PJ. Synthesis and processing of apolipoprotein E in human brain cultures. Glia. 2001;33:298&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pubmed">11246228</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong LM, Weisgraber KH. Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins. J Biol Chem. 1996;271:19053&#x2013;19057.</Citation><ArticleIdList><ArticleId IdType="pubmed">8702576</ArticleId></ArticleIdList></Reference><Reference><Citation>Farlow MR, Lahiri DK, Poirier J, Davignon J, Schneider L, Hui SL. Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer's disease. Neurology. 1998;50:669&#x2013;677.</Citation><ArticleIdList><ArticleId IdType="pubmed">9521254</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. JAMA. 1997;278:1349&#x2013;1356.</Citation><ArticleIdList><ArticleId IdType="pubmed">9343467</ArticleId></ArticleIdList></Reference><Reference><Citation>Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F, Guido T, Hagopian S, Johnson-Wood K, Khan K, Lee M, Leibowitz P, Lieberburg I, Little S, Masliah E, McConlogue L. Alzheimer-type neuropathology in transgenic mice overexpressing V717F &#x3b2;-amyloid precursor protein. Nature. 1995;373:523&#x2013;527.</Citation><ArticleIdList><ArticleId IdType="pubmed">7845465</ArticleId></ArticleIdList></Reference><Reference><Citation>Gearing M, Mori H, Mirra SS. A&#x3b2;-peptide length and apolipoprotein E genotype in Alzheimer's disease. Ann Neurol. 1996;39:395&#x2013;399.</Citation><ArticleIdList><ArticleId IdType="pubmed">8602762</ArticleId></ArticleIdList></Reference><Reference><Citation>Geula C, Wu CK, Saroff D, Lorenzo A, Yuan J, Yankner BA. Aging renders the brain vulnerable to amyloid &#x3b2;-protein neurotoxicity. Nat Med. 1998;4:827&#x2013;831.</Citation><ArticleIdList><ArticleId IdType="pubmed">9662375</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilmor ML, Erickson JD, Varoqui H, Hersh LB, Bennett DA, Cochran EJ, Mufson EJ, Levey AI. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol. 1999;411:693&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pubmed">10421878</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon I, Grauer E, Genis I, Sehayek E, Michaelson DM. Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice. Neurosci Lett. 1995;199:1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">8584214</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenwood PM, Sunderland T, Friz JL, Parasuraman R. Genetics and visual attention: selective deficits in healthy adult carriers of the C&#x3b5;4 allele of the apolipoprotein E gene. Proc Natl Acad Sci USA. 2000;97:11661&#x2013;11666.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC17257</ArticleId><ArticleId IdType="pubmed">11027364</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartley DM, Walsh DM, Ye CP, Diehl T, Vasquez S, Vassilev PM, Teplow DB, Selkoe DJ. Protofibrillar intermediates of amyloid &#x3b2;-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J Neurosci. 1999;19:8876&#x2013;8884.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6782787</ArticleId><ArticleId IdType="pubmed">10516307</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinonen O, Lehtovirta M, Soininen H, Helisalmi S, Mannermaa A, Sorvari H, Kosunen O, Palj&#xe4;rvi L, Ryyn&#xe4;nen M, Riekkinen Sr PJ. Alzheimer pathology of patients carrying apolipoprotein E &#x3b5;4 allele. Neurobiol Aging. 1995;16:505&#x2013;513.</Citation><ArticleIdList><ArticleId IdType="pubmed">8544899</ArticleId></ArticleIdList></Reference><Reference><Citation>Holcomb LA, Gordon MN, Jantzen P, Hsiao K, Duff K, Morgan D. Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits. Behav Genet. 1999;29:177&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">10547924</ArticleId></ArticleIdList></Reference><Reference><Citation>Holtzman DM, Fagan AM. Potential role of apoE in structural plasticity in the nervous system. Implications for disorders of the central nervous system. Trends Cardiovasc Med. 1998;8:250&#x2013;255.</Citation><ArticleIdList><ArticleId IdType="pubmed">14987560</ArticleId></ArticleIdList></Reference><Reference><Citation>Holtzman DM, Bales KR, Wu S, Bhat P, Parsadanian M, Fagan AM, Chang LK, Sun Y, Paul SM. Expression of human apolipoprotein E reduces amyloid-&#x3b2; deposition in a mouse model of Alzheimer's disease. J Clin Invest. 1999;103:R15&#x2013;R21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC408154</ArticleId><ArticleId IdType="pubmed">10079115</ArticleId></ArticleIdList></Reference><Reference><Citation>Holtzman DM, Bales KR, Tenkova T, Fagan AM, Parsadanian M, Sartorius LJ, Mackey B, Olney J, McKeel D, Wozniak D, Paul SM. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA. 2000a;97:2892&#x2013;2897.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC16026</ArticleId><ArticleId IdType="pubmed">10694577</ArticleId></ArticleIdList></Reference><Reference><Citation>Holtzman DM, Fagan AM, Mackey B, Tenkova T, Sartorius L, Paul SM, Bales K, Ashe KH, Irizarry MC, Hyman BT. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model. Ann Neurol. 2000b;47:739&#x2013;747.</Citation><ArticleIdList><ArticleId IdType="pubmed">10852539</ArticleId></ArticleIdList></Reference><Reference><Citation>Horsburgh K, McCulloch J, Nilsen M, Roses AD, Nicoll JAR. Increased neuronal damage and apoE immunoreactivity in human apolipoprotein E, E4 isoform-specific, transgenic mice after global cerebral ischaemia. Eur J Neurosci. 2000;12:4309&#x2013;4317.</Citation><ArticleIdList><ArticleId IdType="pubmed">11122341</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsia A, Masliah E, McConlogue L, Yu G, Tatsuno G, Hu K, Kholodenko D, Malenka RC, Nicoll RA, Mucke L. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc Natl Acad Sci USA. 1999;96:3228&#x2013;3233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC15924</ArticleId><ArticleId IdType="pubmed">10077666</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Schwendner SW, Rall SC, Jr, Mahley RW. Hypolipidemic and hyperlipidemic phenotypes in transgenic mice expressing human apolipoprotein E2. J Biol Chem. 1996;271:29146&#x2013;29151.</Citation><ArticleIdList><ArticleId IdType="pubmed">8910571</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Liu XQ, Wyss-Coray T, Brecht WJ, Sanan DA, Mahley RW. Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons. Proc Natl Acad Sci USA. 2001;98:8838&#x2013;8843.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC37522</ArticleId><ArticleId IdType="pubmed">11447277</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyman BT, West HL, Rebeck GW, Buldyrev SV, Mantegna RN, Ukleja M, Havlin S, Stanley HE. Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome). Proc Natl Acad Sci USA. 1995;92:3586&#x2013;3590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC42212</ArticleId><ArticleId IdType="pubmed">7724603</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishii K, Tamaoka A, Mizusawa H, Shoji S, Ohtake T, Fraser PE, Takahashi H, Tsuji S, Gearing M, Mizutani T, Yamada S, Kato M, St. George-Hyslop PH, Mirra SS, Mori H. A&#x3b2;1&#x2013;40 but not A&#x3b2;1&#x2013;42 levels in cortex correlate with apolipoprotein E &#x3b5;4 allele dosage in sporadic Alzheimer's disease. Brain Res. 1997;748:250&#x2013;252.</Citation><ArticleIdList><ArticleId IdType="pubmed">9067471</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji ZS, Pitas RE, Mahley RW. Differential cellular accumulation/retention of apolipoprotein E mediated by cell surface heparan sulfate proteoglycans. J Biol Chem. 1998;273:13452&#x2013;13460.</Citation><ArticleIdList><ArticleId IdType="pubmed">9593678</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji ZS, Miranda RD, Newhouse YM, Weisgraber KH, Huang Y, Mahley RW. Apolipoprotein E4 potentiates amyloid &#x3b2; peptide-induced lysosomal leakage and apoptosis in neuronal cells. J Biol Chem. 2002;277:21821&#x2013;21828.</Citation><ArticleIdList><ArticleId IdType="pubmed">11912196</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson JK, McCleary R, Oshita MH, Cotman CW. Initiation and propagation stages of &#x3b2;-amyloid are associated with distinctive apolipoprotein E, age, and gender profiles. Brain Res. 1998;798:18&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">9666062</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson-Wood K, Lee M, Motter R, Hu K, Gordon G, Barbour R, Khan K, Gordon M, Tan H, Games D, Lieberburg I, Schenk D, Seubert P, McConlogue L. Amyloid precursor protein processing and A&#x3b2;42 deposition in a transgenic mouse model of Alzheimer disease. Proc Natl Acad Sci USA. 1997;94:1550&#x2013;1555.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC19829</ArticleId><ArticleId IdType="pubmed">9037091</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein WL, Krafft GA, Finch CE. Targeting small A&#x3b2; oligomers: the solution to an Alzheimer's disease conundrum. Trends Neurosci. 2001;24:219&#x2013;224.</Citation><ArticleIdList><ArticleId IdType="pubmed">11250006</ArticleId></ArticleIdList></Reference><Reference><Citation>Knowles RB, Wyart C, Buldyrev SV, Cruz L, Urbanc B, Hasselmo ME, Stanley HE, Hyman BT. Plaque-induced neurite abnormalities: implications for disruption of neural networks in Alzheimer's disease. Proc Natl Acad Sci USA. 1999;96:5274&#x2013;5279.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC21854</ArticleId><ArticleId IdType="pubmed">10220456</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL. Diffusible, nonfibrillar ligands derived from A&#x3b2;1&#x2013;42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA. 1998;95:6448&#x2013;6453.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC27787</ArticleId><ArticleId IdType="pubmed">9600986</ArticleId></ArticleIdList></Reference><Reference><Citation>Langlais PJ, Thal L, Hansen L, Galasko D, Alford M, Masliah E. Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies. Neurology. 1993;43:1927&#x2013;1934.</Citation><ArticleIdList><ArticleId IdType="pubmed">8105420</ArticleId></ArticleIdList></Reference><Reference><Citation>Lue L-F, Kuo Y-M, Roher AE, Brachova L, Shen Y, Sue L, Beach T, Kurth JH, Rydel RE, Rogers J. Soluble amyloid &#x3b2; peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol. 1999;155:853&#x2013;862.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1866907</ArticleId><ArticleId IdType="pubmed">10487842</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma J, Brewer HB, Jr, Potter H. Alzheimer A&#x3b2; neurotoxicity: promotion by antichymotrypsin, ApoE4: inhibition by A&#x3b2;-related peptides. Neurobiol Aging. 1996;17:773&#x2013;780.</Citation><ArticleIdList><ArticleId IdType="pubmed">8892351</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahley R, Huang Y. Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond. Curr Opin Lipidol. 1999;10:207&#x2013;217.</Citation><ArticleIdList><ArticleId IdType="pubmed">10431657</ArticleId></ArticleIdList></Reference><Reference><Citation>Masliah E, Mallory M, Alford M, Ge N, Mucke L. Abnormal synaptic regeneration in hAPP695 transgenic and apoE knockout mice. In: Iqbal K, Mortimer J, Winblad B, Wisniewski H, editors. Research advances in Alzheimer's disease and related disorders. Wiley; New York: 1995a. pp. 405&#x2013;414.</Citation></Reference><Reference><Citation>Masliah E, Mallory M, Ge N, Alford M, Veinbergs I, Roses AD. Neurodegeneration in the central nervous system of apoE-deficient mice. Exp Neurol. 1995b;136:107&#x2013;122.</Citation><ArticleIdList><ArticleId IdType="pubmed">7498401</ArticleId></ArticleIdList></Reference><Reference><Citation>Masliah E, Sisk A, Mallory M, Mucke L, Schenk D, Games D. Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F &#x3b2;-amyloid precursor protein and Alzheimer's disease. J Neurosci. 1996;16:5795&#x2013;5811.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6578961</ArticleId><ArticleId IdType="pubmed">8795633</ArticleId></ArticleIdList></Reference><Reference><Citation>Masliah E, Rockenstein E, Veinbergs I, Sagara Y, Mallory M, Hashimoto M, Mucke L. &#x3b2;-Amyloid peptides enhance &#x3b1;-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease. Proc Natl Acad Sci USA. 2001;98:12245&#x2013;12250.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC59799</ArticleId><ArticleId IdType="pubmed">11572944</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauch DH, N&#xe4;gler K, Schumacher S, G&#xf6;ritz C, M&#xfc;ller E-C, Otto A, Pfrieger FW. CNS synaptogenesis promoted by glia-derived cholesterol. Science. 2001;294:1354&#x2013;1357.</Citation><ArticleIdList><ArticleId IdType="pubmed">11701931</ArticleId></ArticleIdList></Reference><Reference><Citation>McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, Beyreuther K, Bush AI, Masters CL. Soluble pool of A&#x3b2; amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol. 1999;46:860&#x2013;866.</Citation><ArticleIdList><ArticleId IdType="pubmed">10589538</ArticleId></ArticleIdList></Reference><Reference><Citation>McNamara MJ, Gomez-Isla T, Hyman BT. Apolipoprotein E genotype and deposits of A&#x3b2;40 and A&#x3b2;42 in Alzheimer disease. Arch Neurol. 1998;55:1001&#x2013;1004.</Citation><ArticleIdList><ArticleId IdType="pubmed">9678319</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyata M, Smith JD. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and &#x3b2;-amyloid peptides. Nat Genet. 1996;14:55&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">8782820</ArticleId></ArticleIdList></Reference><Reference><Citation>Mucke L, Masliah E, Yu G-Q, Mallory M, Rockenstein EM, Tatsuno G, Hu K, Kholodenko D, Johnson-Wood K, McConlogue L. High-level neuronal expression of A&#x3b2;1&#x2013;42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci. 2000;20:4050&#x2013;4058.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772621</ArticleId><ArticleId IdType="pubmed">10818140</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakano S, Asada T, Matsuda H, Uno M, Takasaki M. Donepezil hydrochloride preserves regional cerebral blood flow in patients with Alzheimer's disease. J Nucl Med. 2001;42:1441&#x2013;1445.</Citation><ArticleIdList><ArticleId IdType="pubmed">11585854</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbantoglu J, Tirado-Santiago G, Lahasa&#xef;ni A, Poirier J, Goncalves O, Verge G, Momoli F, Welner SA, Massicotte G, Julien JP, Shapiro ML. Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein. Nature. 1997;387:500&#x2013;505.</Citation><ArticleIdList><ArticleId IdType="pubmed">9168112</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#xe4;slund J, Haroutunian V, Mohs R, Davis KL, Davies P, Greengard P, Buxbaum JD. Correlation between elevated levels of amyloid &#x3b2;-peptide in the brain and cognitive decline. JAMA. 2000;283:1571&#x2013;1577.</Citation><ArticleIdList><ArticleId IdType="pubmed">10735393</ArticleId></ArticleIdList></Reference><Reference><Citation>Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science. 1994;264:850&#x2013;852.</Citation><ArticleIdList><ArticleId IdType="pubmed">8171342</ArticleId></ArticleIdList></Reference><Reference><Citation>Nathan BP, Chang K-C, Bellosta S, Brisch E, Ge N, Mahley RW, Pitas RE. The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization. J Biol Chem. 1995;270:19791&#x2013;19799.</Citation><ArticleIdList><ArticleId IdType="pubmed">7649988</ArticleId></ArticleIdList></Reference><Reference><Citation>Neary D, Snowden JS, Mann DMA, Bowen DM, Sims NR, Northen B, Yates PO, Davison AN. Alzheimer's disease: a correlative study. J Neurol Neurosurg Psychiatry. 1986;49:229&#x2013;237.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1028720</ArticleId><ArticleId IdType="pubmed">2420941</ArticleId></ArticleIdList></Reference><Reference><Citation>Oda T, Wals P, Osterburg HH, Johnson SA, Pasinetti GM, Morgan TE, Rozovsky I, Stine WB, Snyder SW, Holzman TF, Krafft GA, Finch CE. Clusterin (apoJ) alters the aggregation of amyloid &#x3b2;-peptide (A&#x3b2;1&#x2013;42) and forms slowly sedimenting A&#x3b2; complexes that cause oxidative stress. Exp Neurol. 1995;136:22&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">7589331</ArticleId></ArticleIdList></Reference><Reference><Citation>Permanne B, Perez C, Soto C, Frangione B, Wisniewski T. Detection of apolipoprotein E/dimeric soluble amyloid &#x3b2; complexes in Alzheimer's disease brain supernatants. Biochem Biophys Res Commun. 1997;240:715&#x2013;720.</Citation><ArticleIdList><ArticleId IdType="pubmed">9398632</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J. 1978;2:1457&#x2013;1459.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1608703</ArticleId><ArticleId IdType="pubmed">719462</ArticleId></ArticleIdList></Reference><Reference><Citation>Pike CJ, Burdick D, Walencewicz AJ, Glabe CG, Cotman CW. Neurodegeneration induced by &#x3b2;-amyloid peptides in vitro: the role of peptide assembly state. J Neurosci. 1993;13:1676&#x2013;1687.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6576726</ArticleId><ArticleId IdType="pubmed">8463843</ArticleId></ArticleIdList></Reference><Reference><Citation>Poirier J, Delisle MC, Quirion R, Aubert I, Farlow M, Lahiri D, Hui S, Bertrand P, Nalbantoglu J, Gilfix BM, Gauthier S. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proc Natl Acad Sci USA. 1995;92:12260&#x2013;12264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC40336</ArticleId><ArticleId IdType="pubmed">8618881</ArticleId></ArticleIdList></Reference><Reference><Citation>Price DL, Sisodia SS, Borchelt DR. Genetic neurodegenerative diseases: the human illness and transgenic models. Science. 1998;282:1079&#x2013;1083.</Citation><ArticleIdList><ArticleId IdType="pubmed">9804539</ArticleId></ArticleIdList></Reference><Reference><Citation>Raber J, Wong D, Buttini M, Orth M, Bellosta S, Pitas RE, Mahley RW, Mucke L. Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females. Proc Natl Acad Sci USA. 1998;95:10914&#x2013;10919.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC27995</ArticleId><ArticleId IdType="pubmed">9724804</ArticleId></ArticleIdList></Reference><Reference><Citation>Raber J, Wong D, Yu G-Q, Buttini M, Mahley RW, Pitas RE, Mucke L. Alzheimer's disease: apolipoprotein E and cognitive performance. Nature. 2000;404:352&#x2013;354.</Citation><ArticleIdList><ArticleId IdType="pubmed">10746713</ArticleId></ArticleIdList></Reference><Reference><Citation>Raber J, LeFevour A, Buttini M, Mucke L. Androgens protect against apolipoprotein E4-induced cognitive deficits. J Neurosci. 2002;22:5204&#x2013;5209.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6757715</ArticleId><ArticleId IdType="pubmed">12077215</ArticleId></ArticleIdList></Reference><Reference><Citation>Raffa&#xef; RL, Dong LM, Farese RV, Jr, Weisgraber KH. Introduction of human apolipoprotein E4 &#x201c;domain interaction&#x201d; into mouse apolipoprotein E. Proc Natl Acad Sci USA. 2001;98:11587&#x2013;11591.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC58773</ArticleId><ArticleId IdType="pubmed">11553788</ArticleId></ArticleIdList></Reference><Reference><Citation>Rebeck GW, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron. 1993;11:575&#x2013;580.</Citation><ArticleIdList><ArticleId IdType="pubmed">8398148</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiman EM, Caselli RJ, Chen KW, Alexander GE, Bandy D, Frost J. Declining brain activity in cognitively normal apolipoprotein E C&#x3b5;4 heterozygotes: a foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease. Proc Natl Acad Sci USA. 2001;98:3334&#x2013;3339.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC30654</ArticleId><ArticleId IdType="pubmed">11248079</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabo T, Lomnitski L, Nyska A, Beni S, Maronpot RR, Shohami E, Roses AD, Michaelson DM. Susceptibility of transgenic mice expressing human apolipoprotein E to closed head injury: the allele E3 is neuroprotective whereas E4 increases fatalities. Neuroscience. 2000;101:879&#x2013;884.</Citation><ArticleIdList><ArticleId IdType="pubmed">11113336</ArticleId></ArticleIdList></Reference><Reference><Citation>Salehi A, Dubelaar EJG, Mulder M, Swaab DF. Aggravated decrease in the activity of nucleus basalis neurons in Alzheimer's disease is apolipoprotein E-type dependent. Proc Natl Acad Sci USA. 1998;95:11445&#x2013;11449.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC21662</ArticleId><ArticleId IdType="pubmed">9736756</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuel W, Alford M, Hofstetter CR, Hansen L. Dementia with Lewy bodies versus pure Alzheimer disease: differences in cognition, neuropathology, cholinergic dysfunction, and synapse density. J Neuropathol Exp Neurol. 1997;56:499&#x2013;508.</Citation><ArticleIdList><ArticleId IdType="pubmed">9143263</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses AD. Increased amyloid &#x3b2;-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA. 1993;90:9649&#x2013;9653.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC47627</ArticleId><ArticleId IdType="pubmed">8415756</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt ML, Robinson KA, Lee VM-Y, Trojanowski JQ. Chemical and immunological heterogeneity of fibrillar amyloid in plaques of Alzheimer's disease and Down's syndrome brains revealed by confocal microscopy. Am J Pathol. 1995;147:503&#x2013;515.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1869826</ArticleId><ArticleId IdType="pubmed">7639340</ArticleId></ArticleIdList></Reference><Reference><Citation>Selkoe DJ. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev. 2001;81:741&#x2013;766.</Citation><ArticleIdList><ArticleId IdType="pubmed">11274343</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng HX, Laskowitz DT, Bennett E, Schmechel DE, Bart RD, Saunders AM, Pearlstein RD, Roses AD, Warner DS. Apolipoprotein E isoform-specific differences in outcome from focal ischemia in transgenic mice. J Cereb Blood Flow Metab. 1998;18:361&#x2013;366.</Citation><ArticleIdList><ArticleId IdType="pubmed">9538900</ArticleId></ArticleIdList></Reference><Reference><Citation>Sims NR, Bowen DM, Allen SJ, Smith CCT, Neary D, Thomas DJ, Davison AN. Presynaptic cholinergic dysfunction in patients with dementia. J Neurochem. 1983;40:503&#x2013;509.</Citation><ArticleIdList><ArticleId IdType="pubmed">6822833</ArticleId></ArticleIdList></Reference><Reference><Citation>Sj&#xf6;gren M, Hesse C, Basun H, K&#xf6;l G, Thostrup H, Kilander L, Marcusson J, Edman &#x212b;, Wallin A, Karlsson I, Troell M, Wachtmaister G, Ekdahl A, Olofsson H, Sandstr&#xf6;m A, Andreasen N, Minthon L, Blennow K. Tacrine and rate of progression in Alzheimer's disease. Relation to ApoE allele genotype. J Neural Transm. 2001;108:451&#x2013;458.</Citation><ArticleIdList><ArticleId IdType="pubmed">11475012</ArticleId></ArticleIdList></Reference><Reference><Citation>Small GW, Ercoli LM, Silverman DHS, Huang SC, Komo S, Bookheimer SY, Lavretsky H, Miller K, Siddarth P, Rasgon NL, Mazziotta JC, Saxena S, Wu HM, Mega MS, Cummings JL, Saunders AM, Pericak-Vance MA, Roses AD, Barrio JR, Phelps ME. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci USA. 2000;97:6037&#x2013;6042.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC18554</ArticleId><ArticleId IdType="pubmed">10811879</ArticleId></ArticleIdList></Reference><Reference><Citation>Soininen H, Kosunen O, Helisalmi S, Mannermaa A, Palj&#xd1;rvi L, Talasniemi S, Ryyn&#xd1;nen M, Riekkinen Sr P. A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein &#x3b5;4 allele. Neurosci Lett. 1995;187:79&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">7783963</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone DJ, Rozovsky I, Morgan TE, Anderson CP, Hajian H, Finch CE. Astrocytes and microglia respond to estrogen with increased apoE mRNA in vivo and in vitro. Exp Neurol. 1997;143:313&#x2013;318.</Citation><ArticleIdList><ArticleId IdType="pubmed">9056393</ArticleId></ArticleIdList></Reference><Reference><Citation>Strittmatter WJ, Weisgraber KH, Goedert M, Saunders AM, Huang D, Corder EH, Dong L-M, Jakes R, Alberts MJ, Gilbert JR, Han S-H, Hulette C, Einstein G, Schmechel DE, Pericak-Vance MA, Roses AD. Microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp Neurol. 1994;125:163&#x2013;171.</Citation><ArticleIdList><ArticleId IdType="pubmed">8313935</ArticleId></ArticleIdList></Reference><Reference><Citation>Sze CI, Troncoso JC, Kawas C, Mouton P, Price DL, Martin LJ. Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease. J Neuropathol Exp Neurol. 1997;56:933&#x2013;944.</Citation><ArticleIdList><ArticleId IdType="pubmed">9258263</ArticleId></ArticleIdList></Reference><Reference><Citation>Terry RD. The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis. J Neuropathol Exp Neurol. 1996;55:1023&#x2013;1025.</Citation><ArticleIdList><ArticleId IdType="pubmed">8857998</ArticleId></ArticleIdList></Reference><Reference><Citation>Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991;30:572&#x2013;580.</Citation><ArticleIdList><ArticleId IdType="pubmed">1789684</ArticleId></ArticleIdList></Reference><Reference><Citation>Terry RD, Masliah E, Hansen LA. The neuropathology of Alzheimer disease and the structural basis of its cognitive alterations. In: Terry RD, Katzman R, Bick KL, Sisodia SS, editors. Alzheimer disease, Ed 2. Lippincott Williams and Wilkins; Philadelphia: 1999. pp. 187&#x2013;206.</Citation></Reference><Reference><Citation>Tiraboschi P, Hansen LA, Alford M, Masliah E, Thal LJ, Corey-Bloom J. The decline in synapses and cholinergic activity is asynchronous in Alzheimer's disease. Neurology. 2000;55:1278&#x2013;1283.</Citation><ArticleIdList><ArticleId IdType="pubmed">11087768</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolar M, Keller JN, Chan S, Mattson MP, Marques MA, Crutcher KA. Truncated apolipoprotein E (apoE) causes increased intracellular calcium and may mediate apoE neurotoxicity. J Neurosci. 1999;19:7100&#x2013;7110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6782866</ArticleId><ArticleId IdType="pubmed">10436064</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilcock GK, Esiri MM, Bowen DM, Smith CCT. Alzheimer's disease: correlation of cortical acetyltransferase activity with the severity of dementia and histological abnormalities. J Neurol Sci. 1982;57:407&#x2013;417.</Citation><ArticleIdList><ArticleId IdType="pubmed">7161627</ArticleId></ArticleIdList></Reference><Reference><Citation>Wisniewski T, Frangione B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett. 1992;135:235&#x2013;238.</Citation><ArticleIdList><ArticleId IdType="pubmed">1625800</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu PT, Gilbert JR, Qui H, Ervin J, Rothrock-Christian TR, Hulette C, Schmechel DE. Specific regional transcription of apolipoprotein E in human brain neurons. Am J Pathol. 1999;154:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1850012</ArticleId><ArticleId IdType="pubmed">10027417</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Q, Li Y, Cyras C, Sanan DA, Cordell B. Isolation and characterization of apolipoproteins from murine microglia. Identification of a low density lipoprotein-like apolipoprotein J-rich but E-poor spherical particle. J Biol Chem. 2000;275:31770&#x2013;31777.</Citation><ArticleIdList><ArticleId IdType="pubmed">10918055</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaffe K, Haan M, Byers A, Tangen C, Kuller L. Estrogen use, APOE, and cognitive decline. Evidence of gene-environment interaction. Neurology. 2000;54:1949&#x2013;1953.</Citation><ArticleIdList><ArticleId IdType="pubmed">10822435</ArticleId></ArticleIdList></Reference><Reference><Citation>Yankner BA. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron. 1996;16:921&#x2013;932.</Citation><ArticleIdList><ArticleId IdType="pubmed">8630250</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeo TT, Chua-Couzens J, Butcher LL, Bredesen DE, Cooper JD, Valletta JS, Mobley WC, Longo FM. Absence of p75NTR causes increased basal forebrain cholinergic neuron size, choline acetyltransferase activity, and target innervation. J Neurosci. 1997;17:7594&#x2013;7605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6793892</ArticleId><ArticleId IdType="pubmed">9315882</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12486265</PMID><DateCompleted><Year>2004</Year><Month>11</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>06</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-3050</ISSN><JournalIssue CitedMedium="Print"><Volume>74</Volume><Issue>1</Issue><PubDate><Year>2003</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of neurology, neurosurgery, and psychiatry</Title><ISOAbbreviation>J Neurol Neurosurg Psychiatry</ISOAbbreviation></Journal><ArticleTitle>fMRI studies of associative encoding in young and elderly controls and mild Alzheimer's disease.</ArticleTitle><Pagination><StartPage>44</StartPage><EndPage>50</EndPage><MedlinePgn>44-50</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To examine alterations in patterns of brain activation seen in normal aging and in mild Alzheimer's disease by functional magnetic resonance imaging (fMRI) during an associative encoding task.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">10 young controls, 10 elderly controls, and seven patients with mild Alzheimer's disease were studied using fMRI during a face-name association encoding task. The fMRI paradigm used a block design with three conditions: novel face-name pairs, repeated face-name pairs, and visual fixation.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The young and elderly controls differed primarily in the pattern of activation seen in prefrontal and parietal cortices: elderly controls showed significantly less activation in both superior and inferior prefrontal cortices but greater activation in parietal regions than younger controls during the encoding of novel face-name pairs. Compared with elderly controls, the Alzheimer patients showed significantly less activation in the hippocampal formation but greater activation in the medial parietal and posterior cingulate regions.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The pattern of fMRI activation during the encoding of novel associations is differentially altered in the early stages of Alzheimer's disease compared with normal aging.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sperling</LastName><ForeName>R A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Memory Disorders Unit, Department of Neurology, Brigham and Women's Hospital, 221 Longwood Avenue, Boston, MA 02115, USA. reisa@rics.bwh.harvard.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bates</LastName><ForeName>J F</ForeName><Initials>JF</Initials></Author><Author ValidYN="Y"><LastName>Chua</LastName><ForeName>E F</ForeName><Initials>EF</Initials></Author><Author ValidYN="Y"><LastName>Cocchiarella</LastName><ForeName>A J</ForeName><Initials>AJ</Initials></Author><Author ValidYN="Y"><LastName>Rentz</LastName><ForeName>D M</ForeName><Initials>DM</Initials></Author><Author ValidYN="Y"><LastName>Rosen</LastName><ForeName>B R</ForeName><Initials>BR</Initials></Author><Author ValidYN="Y"><LastName>Schacter</LastName><ForeName>D L</ForeName><Initials>DL</Initials></Author><Author ValidYN="Y"><LastName>Albert</LastName><ForeName>M S</ForeName><Initials>MS</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>AG 08441</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 NS 02189</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MH 60941</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG 04953</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Neurol Neurosurg Psychiatry</MedlineTA><NlmUniqueID>2985191R</NlmUniqueID><ISSNLinking>0022-3050</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001244" MajorTopicYN="Y">Association</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001245" MajorTopicYN="N">Association Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001931" MajorTopicYN="N">Brain Mapping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008569" MajorTopicYN="N">Memory Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010775" MajorTopicYN="N">Photic Stimulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012016" MajorTopicYN="N">Reference Values</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2002</Year><Month>12</Month><Day>18</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>11</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2002</Year><Month>12</Month><Day>18</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2006</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12486265</ArticleId><ArticleId IdType="pmc">PMC1738201</ArticleId><ArticleId IdType="doi">10.1136/jnnp.74.1.44</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):455-60</Citation><ArticleIdList><ArticleId IdType="pubmed">11756667</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychol Aging. 2001 Sep;16(3):371-84</Citation><ArticleIdList><ArticleId IdType="pubmed">11554517</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 1984 Jul;34(7):939-44</Citation><ArticleIdList><ArticleId IdType="pubmed">6610841</ArticleId></ArticleIdList></Reference><Reference><Citation>Psychopharmacol Bull. 1988;24(4):523-9</Citation><ArticleIdList><ArticleId IdType="pubmed">3074313</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Neurol. 1991 Mar;48(3):278-81</Citation><ArticleIdList><ArticleId IdType="pubmed">2001185</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Aging Res. 1990 Autumn;16(3):155-8</Citation><ArticleIdList><ArticleId IdType="pubmed">2090468</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Neuropathol. 1991;82(4):239-59</Citation><ArticleIdList><ArticleId IdType="pubmed">1759558</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 1996 Mar;46(3):692-700</Citation><ArticleIdList><ArticleId IdType="pubmed">8618669</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1997 Jul 18;277(5324):333-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9219684</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 1997 Sep;49(3):786-94</Citation><ArticleIdList><ArticleId IdType="pubmed">9305341</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1997 Oct 17;278(5337):412-9</Citation><ArticleIdList><ArticleId IdType="pubmed">9334292</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Neurol. 1999 Apr;45(4):466-72</Citation><ArticleIdList><ArticleId IdType="pubmed">10211471</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Brain Mapp. 2001 Nov;14(3):129-39</Citation><ArticleIdList><ArticleId IdType="pubmed">11559958</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cogn Neurosci. 2000 Jan;12(1):197-206</Citation><ArticleIdList><ArticleId IdType="pubmed">10769316</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Neurosci. 2000 May;3(5):509-15</Citation><ArticleIdList><ArticleId IdType="pubmed">10769393</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2000 May 23;97(11):6037-42</Citation><ArticleIdList><ArticleId IdType="pubmed">10811879</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2000 Aug 17;343(7):450-6</Citation><ArticleIdList><ArticleId IdType="pubmed">10944562</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci. 2000 Sep 1;20(17):6587-93</Citation><ArticleIdList><ArticleId IdType="pubmed">10964964</ArticleId></ArticleIdList></Reference><Reference><Citation>Brain Res Cogn Brain Res. 2000 Sep;10(1-2):197-206</Citation><ArticleIdList><ArticleId IdType="pubmed">10978709</ArticleId></ArticleIdList></Reference><Reference><Citation>Microsc Res Tech. 2000 Oct 1;51(1):75-84</Citation><ArticleIdList><ArticleId IdType="pubmed">11002355</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2000 Nov 14;55(9):1291-7</Citation><ArticleIdList><ArticleId IdType="pubmed">11087770</ArticleId></ArticleIdList></Reference><Reference><Citation>AJNR Am J Neuroradiol. 2000 Nov-Dec;21(10):1869-75</Citation><ArticleIdList><ArticleId IdType="pubmed">11110539</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3334-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11248079</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2001 Jun 12;56(11):1545-51</Citation><ArticleIdList><ArticleId IdType="pubmed">11402113</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology. 2001 Sep 11;57(5):812-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11552009</ArticleId></ArticleIdList></Reference><Reference><Citation>J Psychiatr Res. 1975 Nov;12(3):189-98</Citation><ArticleIdList><ArticleId IdType="pubmed">1202204</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12490529</PMID><DateCompleted><Year>2003</Year><Month>07</Month><Day>03</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0964-6906</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2003</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>Human molecular genetics</Title><ISOAbbreviation>Hum Mol Genet</ISOAbbreviation></Journal><ArticleTitle>Results of a high-resolution genome screen of 437 Alzheimer's disease families.</ArticleTitle><Pagination><StartPage>23</StartPage><EndPage>32</EndPage><MedlinePgn>23-32</MedlinePgn></Pagination><Abstract><AbstractText>Alzheimer's disease (AD) is a devastating neurodegenerative disorder of late life with complex inheritance. Mutations in three known genes lead to the rare early-onset autosomal dominant form of AD, while a common polymorphism (epsilon 4) in the gene encoding apolipoprotein E (APOE ) is a risk factor for more typical late-onset (&gt;60 years) AD. A recent study concluded that there are up to four additional genes with an equal or greater contribution to the disease. We performed a 9 cM genome screen of 437 families with AD, the full National Institute of Mental Health (NIMH) sample, which has been carefully ascertained, evaluated and followed by our group over the last decade. Performing standard parametric and non-parametric linkage analyses, we observed a 'highly significant' linkage peak by Lander and Kruglyak criteria on chromosome 19q13, which probably represents APOE. Twelve additional locations-on 1q23, 3p26, 4q32, 5p14, 6p21, 6q27, 9q22, 10q24, 11q25, 14q22, 15q26 and 21q22-met criteria for 'suggestive' linkage [i.e. two-point lod score (TLS) &gt;/=1.9 and/or multipoint lod score (MLS) &gt;/=2.2] in at least one of our analyses. Although some of these will surely prove to be false positives, these linkage signals should provide a valuable framework for future studies aimed at identifying additional susceptibility genes for late-onset AD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Blacker</LastName><ForeName>Deborah</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital, Charlestown, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertram</LastName><ForeName>Lars</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Saunders</LastName><ForeName>Aleister J</ForeName><Initials>AJ</Initials></Author><Author ValidYN="Y"><LastName>Moscarillo</LastName><ForeName>Thomas J</ForeName><Initials>TJ</Initials></Author><Author ValidYN="Y"><LastName>Albert</LastName><ForeName>Marilyn S</ForeName><Initials>MS</Initials></Author><Author ValidYN="Y"><LastName>Wiener</LastName><ForeName>Howard</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Perry</LastName><ForeName>Rodney T</ForeName><Initials>RT</Initials></Author><Author ValidYN="Y"><LastName>Collins</LastName><ForeName>Julianne S</ForeName><Initials>JS</Initials></Author><Author ValidYN="Y"><LastName>Harrell</LastName><ForeName>Lindy E</ForeName><Initials>LE</Initials></Author><Author ValidYN="Y"><LastName>Go</LastName><ForeName>Rodney C P</ForeName><Initials>RC</Initials></Author><Author ValidYN="Y"><LastName>Mahoney</LastName><ForeName>Amy</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Beaty</LastName><ForeName>Terri</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Fallin</LastName><ForeName>M Danielle</ForeName><Initials>MD</Initials></Author><Author ValidYN="Y"><LastName>Avramopoulos</LastName><ForeName>Dimitrios</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Chase</LastName><ForeName>Gary A</ForeName><Initials>GA</Initials></Author><Author ValidYN="Y"><LastName>Folstein</LastName><ForeName>Marshal F</ForeName><Initials>MF</Initials></Author><Author ValidYN="Y"><LastName>McInnis</LastName><ForeName>Melvin G</ForeName><Initials>MG</Initials></Author><Author ValidYN="Y"><LastName>Bassett</LastName><ForeName>Susan S</ForeName><Initials>SS</Initials></Author><Author ValidYN="Y"><LastName>Doheny</LastName><ForeName>Kimberly J</ForeName><Initials>KJ</Initials></Author><Author ValidYN="Y"><LastName>Pugh</LastName><ForeName>Elizabeth W</ForeName><Initials>EW</Initials></Author><Author ValidYN="Y"><LastName>Tanzi</LastName><ForeName>Rudolph E</ForeName><Initials>RE</Initials></Author><Author ValidYN="Y"><CollectiveName>NIMH Genetics Initiative Alzheimer's Disease Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>N01-HG-65403</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 MH46281</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 MH46290</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 MH46373</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Hum Mol Genet</MedlineTA><NlmUniqueID>9208958</NlmUniqueID><ISSNLinking>0964-6906</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001057">Apolipoproteins E</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001057" MajorTopicYN="N">Apolipoproteins E</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002874" MajorTopicYN="N">Chromosome Mapping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002877" MajorTopicYN="Y">Chromosomes, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004198" MajorTopicYN="N">Disease Susceptibility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008040" MajorTopicYN="N">Genetic Linkage</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005820" MajorTopicYN="Y">Genetic Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015894" MajorTopicYN="Y">Genome, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2002</Year><Month>12</Month><Day>20</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>7</Month><Day>4</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2002</Year><Month>12</Month><Day>20</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12490529</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddg007</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12490942</PMID><DateCompleted><Year>2003</Year><Month>01</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0028-0836</ISSN><JournalIssue CitedMedium="Print"><Volume>420</Volume><Issue>6917</Issue><PubDate><MedlineDate>2002 Dec 19-26</MedlineDate></PubDate></JournalIssue><Title>Nature</Title><ISOAbbreviation>Nature</ISOAbbreviation></Journal><ArticleTitle>Long-term in vivo imaging of experience-dependent synaptic plasticity in adult cortex.</ArticleTitle><Pagination><StartPage>788</StartPage><EndPage>794</EndPage><MedlinePgn>788-94</MedlinePgn></Pagination><Abstract><AbstractText>Do new synapses form in the adult cortex to support experience-dependent plasticity? To address this question, we repeatedly imaged individual pyramidal neurons in the mouse barrel cortex over periods of weeks. We found that, although dendritic structure is stable, some spines appear and disappear. Spine lifetimes vary greatly: stable spines, about 50% of the population, persist for at least a month, whereas the remainder are present for a few days or less. Serial-section electron microscopy of imaged dendritic segments revealed retrospectively that spine sprouting and retraction are associated with synapse formation and elimination. Experience-dependent plasticity of cortical receptive fields was accompanied by increased synapse turnover. Our measurements suggest that sensory experience drives the formation and elimination of synapses and that these changes might underlie adaptive remodelling of neural circuits.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Trachtenberg</LastName><ForeName>Joshua T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Brian E</ForeName><Initials>BE</Initials></Author><Author ValidYN="Y"><LastName>Knott</LastName><ForeName>Graham W</ForeName><Initials>GW</Initials></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Guoping</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Sanes</LastName><ForeName>Joshua R</ForeName><Initials>JR</Initials></Author><Author ValidYN="Y"><LastName>Welker</LastName><ForeName>Egbert</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Svoboda</LastName><ForeName>Karel</ForeName><Initials>K</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nature</MedlineTA><NlmUniqueID>0410462</NlmUniqueID><ISSNLinking>0028-0836</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nature. 2002 Dec 19-26;420(6917):751-2. doi: 10.1038/420751a.</RefSource><PMID Version="1">12490929</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D015502" MajorTopicYN="N">Absorptiometry, Photon</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002540" MajorTopicYN="N">Cerebral Cortex</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003712" MajorTopicYN="N">Dendrites</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008854" MajorTopicYN="N">Microscopy, Electron</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009473" MajorTopicYN="Y">Neuronal Plasticity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009475" MajorTopicYN="N">Neurons, Afferent</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010465" MajorTopicYN="N">Perception</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017966" MajorTopicYN="N">Pyramidal Cells</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013569" MajorTopicYN="N">Synapses</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2002</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2002</Year><Month>10</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2002</Year><Month>12</Month><Day>20</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>1</Month><Day>24</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2002</Year><Month>12</Month><Day>20</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12490942</ArticleId><ArticleId IdType="doi">10.1038/nature01273</ArticleId><ArticleId IdType="pii">nature01273</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12490949</PMID><DateCompleted><Year>2003</Year><Month>01</Month><Day>23</Day></DateCompleted><DateRevised><Year>2006</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0028-0836</ISSN><JournalIssue CitedMedium="Print"><Volume>420</Volume><Issue>6917</Issue><PubDate><MedlineDate>2002 Dec 19-26</MedlineDate></PubDate></JournalIssue><Title>Nature</Title><ISOAbbreviation>Nature</ISOAbbreviation></Journal><ArticleTitle>Long-term dendritic spine stability in the adult cortex.</ArticleTitle><Pagination><StartPage>812</StartPage><EndPage>816</EndPage><MedlinePgn>812-6</MedlinePgn></Pagination><Abstract><AbstractText>The structural dynamics of synapses probably has a crucial role in the development and plasticity of the nervous system. In the mammalian brain, the vast majority of excitatory axo-dendritic synapses occur on dendritic specializations called 'spines'. However, little is known about their long-term changes in the intact developing or adult animal. To address this question we developed a transcranial two-photon imaging technique to follow identified spines of layer-5 pyramidal neurons in the primary visual cortex of living transgenic mice expressing yellow fluorescent protein. Here we show that filopodia-like dendritic protrusions, extending and retracting over hours, are abundant in young animals but virtually absent from the adult. In young mice, within the 'critical period' for visual cortex development, approximately 73% of spines remain stable over a one-month interval; most changes are associated with spine elimination. In contrast, in adult mice, the overwhelming majority of spines (approximately 96%) remain stable over the same interval with a half-life greater than 13 months. These results indicate that spines, initially plastic during development, become remarkably stable in the adult, providing a potential structural basis for long-term information storage.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Grutzendler</LastName><ForeName>Jaime</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Molecular Neurobiology Program, Skirball Institute, Department of Physiology and Neuroscience, New York University School of Medicine, 540 First Avenue, New York, New York 10016, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kasthuri</LastName><ForeName>Narayanan</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Gan</LastName><ForeName>Wen-Biao</ForeName><Initials>WB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nature</MedlineTA><NlmUniqueID>0410462</NlmUniqueID><ISSNLinking>0028-0836</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nature. 2002 Dec 19-26;420(6917):751-2. doi: 10.1038/420751a.</RefSource><PMID Version="1">12490929</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D015502" MajorTopicYN="N">Absorptiometry, Photon</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003712" MajorTopicYN="N">Dendrites</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006207" MajorTopicYN="N">Half-Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009473" MajorTopicYN="N">Neuronal Plasticity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011554" MajorTopicYN="N">Pseudopodia</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017966" MajorTopicYN="N">Pyramidal Cells</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014793" MajorTopicYN="N">Visual Cortex</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2002</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2002</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2002</Year><Month>12</Month><Day>20</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>1</Month><Day>24</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2002</Year><Month>12</Month><Day>20</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12490949</ArticleId><ArticleId IdType="doi">10.1038/nature01276</ArticleId><ArticleId IdType="pii">nature01276</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12495618</PMID><DateCompleted><Year>2003</Year><Month>01</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0896-6273</ISSN><JournalIssue CitedMedium="Print"><Volume>36</Volume><Issue>6</Issue><PubDate><Year>2002</Year><Month>Dec</Month><Day>19</Day></PubDate></JournalIssue><Title>Neuron</Title><ISOAbbreviation>Neuron</ISOAbbreviation></Journal><ArticleTitle>Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons.</ArticleTitle><Pagination><StartPage>1007</StartPage><EndPage>1019</EndPage><MedlinePgn>1007-19</MedlinePgn></Pagination><Abstract><AbstractText>One hypothesis for the etiology of Parkinson's disease (PD) is that subsets of neurons are vulnerable to a failure in proteasome-mediated protein turnover. Here we show that overexpression of mutant alpha-synuclein increases sensitivity to proteasome inhibitors by decreasing proteasome function. Overexpression of parkin decreases sensitivity to proteasome inhibitors in a manner dependent on parkin's ubiquitin-protein E3 ligase activity, and antisense knockdown of parkin increases sensitivity to proteasome inhibitors. Mutant alpha-synuclein also causes selective toxicity to catecholaminergic neurons in primary midbrain cultures, an effect that can be mimicked by the application of proteasome inhibitors. Parkin is capable of rescuing the toxic effects of mutant alpha-synuclein or proteasome inhibition in these cells. Therefore, parkin and alpha-synuclein are linked by common effects on a pathway associated with selective cell death in catecholaminergic neurons.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Petrucelli</LastName><ForeName>Leonard</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Neurogenetics Laboratory, Mayo Clinic Jacksonville, Jacksonville, FL 32224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Farrell</LastName><ForeName>Casey</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Lockhart</LastName><ForeName>Paul J</ForeName><Initials>PJ</Initials></Author><Author ValidYN="Y"><LastName>Baptista</LastName><ForeName>Melisa</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Kehoe</LastName><ForeName>Kathryn</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Vink</LastName><ForeName>Liselot</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Wolozin</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Farrer</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Hardy</LastName><ForeName>John</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Cookson</LastName><ForeName>Mark R</ForeName><Initials>MR</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P01-NS40256</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01-NS41816-01</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuron</MedlineTA><NlmUniqueID>8809320</NlmUniqueID><ISSNLinking>0896-6273</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002395">Catecholamines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009097">Multienzyme Complexes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C497604">SNCA protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C497605">Snca protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051843">Synucleins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051844">alpha-Synuclein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.16.2</RegistryNumber><NameOfSubstance UI="D014446">Tyrosine 3-Monooxygenase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="D044767">Ubiquitin-Protein Ligases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="C111567">parkin protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D003546">Cysteine Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.25.1</RegistryNumber><NameOfSubstance UI="D046988">Proteasome Endopeptidase Complex</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 6.-</RegistryNumber><NameOfSubstance UI="D008025">Ligases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000831" MajorTopicYN="N">Animals, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002395" MajorTopicYN="N">Catecholamines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002452" MajorTopicYN="N">Cell Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016923" MajorTopicYN="N">Cell Death</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003546" MajorTopicYN="N">Cysteine Endopeptidases</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004791" MajorTopicYN="N">Enzyme Inhibitors</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017930" MajorTopicYN="N">Genes, Reporter</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008025" MajorTopicYN="N">Ligases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009097" MajorTopicYN="N">Multienzyme Complexes</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D046988" MajorTopicYN="N">Proteasome Endopeptidase Complex</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013378" MajorTopicYN="N">Substantia Nigra</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051843" MajorTopicYN="N">Synucleins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014407" MajorTopicYN="N">Tumor Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014446" MajorTopicYN="N">Tyrosine 3-Monooxygenase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044767" MajorTopicYN="Y">Ubiquitin-Protein Ligases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051844" MajorTopicYN="N">alpha-Synuclein</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2002</Year><Month>12</Month><Day>24</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>1</Month><Day>24</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2002</Year><Month>12</Month><Day>24</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12495618</ArticleId><ArticleId IdType="doi">10.1016/s0896-6273(02)01125-x</ArticleId><ArticleId IdType="pii">S089662730201125X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12501252</PMID><DateCompleted><Year>2003</Year><Month>04</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0021-9258</ISSN><JournalIssue CitedMedium="Print"><Volume>278</Volume><Issue>10</Issue><PubDate><Year>2003</Year><Month>Mar</Month><Day>07</Day></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J Biol Chem</ISOAbbreviation></Journal><ArticleTitle>Novel role for apolipoprotein E in the central nervous system. Modulation of sulfatide content.</ArticleTitle><Pagination><StartPage>8043</StartPage><EndPage>8051</EndPage><MedlinePgn>8043-51</MedlinePgn></Pagination><Abstract><AbstractText>It has long been postulated that apolipoprotein E (apoE) may play a role in lipid metabolism in the brain. However, direct evidence that apoE plays such a role is lacking. We investigated whether apoE isoforms influence lipid content in the brain. We compared the brains of wild-type mice to apoE knockout (-/-) and human apoE3 and apoE4 transgenic mice and compared cerebrospinal fluid (CSF) of humans with different apoE isoforms. We found that there was no effect of apoE on the content of multiple phospholipids, sphingolipids, and cholesterol. There was, however, a marked effect of apoE on the sulfatide (ST) content in both the brain and CSF. The sulfatide mass in hippocampus and cortex of apoE knockout mice was found to be 61 and 114 mol% higher than wild-type mice counterparts at 12 months of age. In contrast, the sulfatide content in brain tissues from human apoE4-expressing mice was approximately 60% less than those found in wild-type mice of the same age. The ST mass in human CSF was significantly dependent on the APOE genotypes of the subjects. Examination of potential sulfatide carrier(s) in human CSF demonstrated that sulfatides are specifically associated with apoE-containing high density lipoproteins, suggesting that sulfatide levels in the central nervous system (CNS) are likely to be directly modulated by the same metabolic pathways that regulate levels of apoE-containing CNS lipoproteins. This novel role for apoE in the CNS may provide new insights into the connection of apoE with Alzheimer's disease and poor recovery after brain injury.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Xianlin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Division of Bioorganic Chemistry and Molecular Pharmacology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, USA. xianlin@pcg.wustl.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Hua</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Fryer</LastName><ForeName>John D</ForeName><Initials>JD</Initials></Author><Author ValidYN="Y"><LastName>Fagan</LastName><ForeName>Anne M</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Holtzman</LastName><ForeName>David M</ForeName><Initials>DM</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>AG-13956</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>M01 RR00036</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50-AG05681</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2002</Year><Month>12</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053318">Apolipoprotein E3</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053327">Apolipoprotein E4</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001057">Apolipoproteins E</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013433">Sulfoglycosphingolipids</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053318" MajorTopicYN="N">Apolipoprotein E3</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053327" MajorTopicYN="N">Apolipoprotein E4</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001057" MajorTopicYN="N">Apolipoproteins E</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D021241" MajorTopicYN="N">Spectrometry, Mass, Electrospray Ionization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013433" MajorTopicYN="N">Sulfoglycosphingolipids</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2002</Year><Month>12</Month><Day>27</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>4</Month><Day>24</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2002</Year><Month>12</Month><Day>27</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12501252</ArticleId><ArticleId IdType="doi">10.1074/jbc.M212340200</ArticleId><ArticleId IdType="pii">S0021-9258(20)86418-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12506199</PMID><DateCompleted><Year>2003</Year><Month>02</Month><Day>21</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>100</Volume><Issue>1</Issue><PubDate><Year>2003</Year><Month>Jan</Month><Day>07</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Positive and negative regulation of APP amyloidogenesis by sumoylation.</ArticleTitle><Pagination><StartPage>259</StartPage><EndPage>264</EndPage><MedlinePgn>259-64</MedlinePgn></Pagination><Abstract><AbstractText>Amyloid beta peptide (Abeta) generated from amyloid precursor protein (APP) is central to Alzheimer's disease (AD). Signaling pathways affecting APP amyloidogenesis play critical roles in AD pathogenesis and can be exploited for therapeutic intervention. Here, we show that sumoylation, covalent modification of cellular proteins by small ubiquitin-like modifier (SUMO) proteins, regulates Abeta generation. Increased protein sumoylation resulting from overexpression of SUMO-3 dramatically reduces Abeta production. Conversely, reducing endogenous protein sumoylation with dominant-negative SUMO-3 mutants significantly increases Abeta production. We also show that mutant SUMO-3, K11R, which can only be monomerically conjugated to target proteins, has an opposite effect on Abeta generation to that by SUMO-3, which can form polymeric chains on target proteins. In addition, SUMO-3 immunoreactivity is predominantly detected in neurons in brains from AD, Down's syndrome, and nondemented humans. Therefore, polysumoylation reduces whereas monosumoylation or undersumoylation enhances Abeta generation. These findings provide a regulatory mechanism in APP amyloidogenesis and suggest that components in the sumoylation pathway may be critical in AD onset or progression.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yonghong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Scios, Inc., 820 West Maude Avenue, Sunnyvale, CA 94085, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hui</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Su</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Quon</LastName><ForeName>Diana</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yu-Wang</ForeName><Initials>YW</Initials></Author><Author ValidYN="Y"><LastName>Cordell</LastName><ForeName>Barbara</ForeName><Initials>B</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2002</Year><Month>12</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000075687">NEDD8 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C082860">NEDD8 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D025842">SUMO-1 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C117909">SUMO2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D025841">Small Ubiquitin-Related Modifier Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D025801">Ubiquitin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014452">Ubiquitins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):9102</RefSource></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000196" MajorTopicYN="N">embryology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005333" MajorTopicYN="N">Fetus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005822" MajorTopicYN="N">Genetic Vectors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000075687" MajorTopicYN="N">NEDD8 Protein</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010957" MajorTopicYN="N">Plasmids</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011499" MajorTopicYN="N">Protein Processing, Post-Translational</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D025842" MajorTopicYN="N">SUMO-1 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D025841" MajorTopicYN="N">Small Ubiquitin-Related Modifier Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014162" MajorTopicYN="N">Transfection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014407" MajorTopicYN="N">Tumor Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D025801" MajorTopicYN="N">Ubiquitin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014452" MajorTopicYN="N">Ubiquitins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2002</Year><Month>12</Month><Day>31</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>2</Month><Day>22</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2002</Year><Month>12</Month><Day>31</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2003</Year><Month>7</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12506199</ArticleId><ArticleId IdType="pmc">PMC140945</ArticleId><ArticleId IdType="doi">10.1073/pnas.0235361100</ArticleId><ArticleId IdType="pii">0235361100</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Farzan M, Schnitzler C E, Vasilieva N, Leung D, Choe H. Proc Natl Acad Sci USA. 2000;97:9712&#x2013;9717.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC16930</ArticleId><ArticleId IdType="pubmed">10931940</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain I, Powell D, Howlett D R, Tew D G, Meek T D, Chapman C, Gloger I S, Murphy K E, Southan C D, Ryan D M, et al. Mol Cell Neurosci. 1999;14:419&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pubmed">10656250</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha S, Anderson J P, Barbour R, Basi G S, Caccavello R, Davis D, Doan M, Dovey H F, Frigon N, Hong J, et al. Nature. 1999;402:537&#x2013;540.</Citation><ArticleIdList><ArticleId IdType="pubmed">10591214</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassar R, Bennett B D, Babu-Kahn S, Kahn S, Mendiaz E A, Denis P, Teplow D B, Ross S, Amarante P, Loeloff R, et al. Science. 1999;286:735&#x2013;741.</Citation><ArticleIdList><ArticleId IdType="pubmed">10531052</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan R, Bienkowski M J, Shuck M E, Miao H, Tory M C, Pauley A M, Brashier J R, Stratman N C, Mathews W R, Buhl A E, et al. Nature. 1999;402:533&#x2013;537.</Citation><ArticleIdList><ArticleId IdType="pubmed">10591213</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin X, Koelsch G, Wu S, Downs D, Dashti A, Tang J. Proc Natl Acad Sci USA. 2000;97:1456&#x2013;1460.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC26455</ArticleId><ArticleId IdType="pubmed">10677483</ArticleId></ArticleIdList></Reference><Reference><Citation>Strooper B D, Annaert W. Nat Cell Biol. 2001;3:E221&#x2013;E225.</Citation><ArticleIdList><ArticleId IdType="pubmed">11584280</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfe M S, Haass C. J Biol Chem. 2001;276:5413&#x2013;5416.</Citation><ArticleIdList><ArticleId IdType="pubmed">11134059</ArticleId></ArticleIdList></Reference><Reference><Citation>Buxbaum J D, Liu K N, Luo Y, Slack J L, Stocking K L, Peschon J J, Johnson R S, Castner B J, Cerretti D P, Black R A. J Biol Chem. 1998;273:27765&#x2013;27767.</Citation><ArticleIdList><ArticleId IdType="pubmed">9774383</ArticleId></ArticleIdList></Reference><Reference><Citation>Lammich S, Kojro E, Postina R, Gilbert S, Pfeiffer R, Jasionowski M, Haass C, Fahrenholz F. Proc Natl Acad Sci USA. 1999;96:3922&#x2013;3927.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC22396</ArticleId><ArticleId IdType="pubmed">10097139</ArticleId></ArticleIdList></Reference><Reference><Citation>Selkoe D J. Nature. 1999;399:23&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">10392577</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller S, Hoege C, Pyrowolakis G, Jentsch S. Nat Rev Mol Cell Biol. 2001;2:202&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pubmed">11265250</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh E T, Gong L, Kamitani T. Gene. 2000;248:1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">10806345</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochstrasser M. Cell. 2001;107:5&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">11595179</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N. Nature. 1998;392:605&#x2013;608.</Citation><ArticleIdList><ArticleId IdType="pubmed">9560156</ArticleId></ArticleIdList></Reference><Reference><Citation>Leroy E, Boyer R, Auburger G, Leube B, Ulm G, Mezey E, Harta G, Brownstein M J, Jonnalagada S, Chernova T, et al. Nature. 1998;395:451&#x2013;452.</Citation><ArticleIdList><ArticleId IdType="pubmed">9774100</ArticleId></ArticleIdList></Reference><Reference><Citation>Saigoh K, Wang Y L, Suh J G, Yamanishi T, Sakai Y, Kiyosawa H, Harada T, Ichihara N, Wakana S, Kikuchi T, et al. Nat Genet. 1999;23:47&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">10471497</ArticleId></ArticleIdList></Reference><Reference><Citation>Saitoh H, Hinchey J. J Biol Chem. 2000;275:6252&#x2013;6258.</Citation><ArticleIdList><ArticleId IdType="pubmed">10692421</ArticleId></ArticleIdList></Reference><Reference><Citation>Tatham M H, Jaffray E, Vaughan O A, Desterro J M, Botting C H, Naismith J H, Hay R T. J Biol Chem. 2001;276:35368&#x2013;35374.</Citation><ArticleIdList><ArticleId IdType="pubmed">11451954</ArticleId></ArticleIdList></Reference><Reference><Citation>Matunis M J, Coutavas E, Blobel G. J Cell Biol. 1996;135:1457&#x2013;1470.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2133973</ArticleId><ArticleId IdType="pubmed">8978815</ArticleId></ArticleIdList></Reference><Reference><Citation>Desterro J M, Rodriguez M S, Hay R T. Mol Cell. 1998;2:233&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="pubmed">9734360</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y H, Choi C Y, Kim Y. Proc Natl Acad Sci USA. 1999;96:12350&#x2013;12355.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC22920</ArticleId><ArticleId IdType="pubmed">10535925</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares M B, Bonaldo M F, Jelene P, Su L, Lawton L, Efstratiadis A. Proc Natl Acad Sci USA. 1994;91:9228&#x2013;9232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC44785</ArticleId><ArticleId IdType="pubmed">7937745</ArticleId></ArticleIdList></Reference><Reference><Citation>Buxbaum J D, Gandy S E, Cicchetti P, Erlich M E, Czernik A J, Fracasso R P, Ramabhadran T V, Unterbeck A J, Greengard P. Proc Natl Acad Sci USA. 1990;87:6003&#x2013;6006.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC54458</ArticleId><ArticleId IdType="pubmed">2116015</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson E S, Gupta A A. Cell. 2001;106:735&#x2013;744.</Citation><ArticleIdList><ArticleId IdType="pubmed">11572779</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson E S, Blobel G. J Cell Biol. 1999;147:981&#x2013;994.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2169351</ArticleId><ArticleId IdType="pubmed">10579719</ArticleId></ArticleIdList></Reference><Reference><Citation>Sternsdorf T, Jensen K, Reich B, Will H. J Biol Chem. 1999;274:12555&#x2013;12566.</Citation><ArticleIdList><ArticleId IdType="pubmed">10212234</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofmann H, Floss S, Stamminger T. J Virol. 2000;74:2510&#x2013;2524.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC111739</ArticleId><ArticleId IdType="pubmed">10684265</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu K, Chen A, Pan Z Q. J Biol Chem. 2000;275:32317&#x2013;32324.</Citation><ArticleIdList><ArticleId IdType="pubmed">10921923</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow N, Korenberg J R, Chen X N, Neve R L. J Biol Chem. 1996;271:11339&#x2013;11346.</Citation><ArticleIdList><ArticleId IdType="pubmed">8626687</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong L, Yeh E T. J Biol Chem. 1999;274:12036&#x2013;12042.</Citation><ArticleIdList><ArticleId IdType="pubmed">10207026</ArticleId></ArticleIdList></Reference><Reference><Citation>Osaka F, Kawasaki H, Aida N, Saeki M, Chiba T, Kawashima S, Tanaka K, Kato S. Genes Dev. 1998;12:2263&#x2013;2268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC317039</ArticleId><ArticleId IdType="pubmed">9694792</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickart C M. Mol Cell. 2001;8:499&#x2013;504.</Citation><ArticleIdList><ArticleId IdType="pubmed">11583613</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal A, Almenar-Queralt A, LeBlanc J F, Roberts E A, Goldstein L S. Nature. 2001;414:643&#x2013;648.</Citation><ArticleIdList><ArticleId IdType="pubmed">11740561</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12514198</PMID><DateCompleted><Year>2003</Year><Month>01</Month><Day>27</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1529-2401</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2003</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>The Journal of neuroscience : the official journal of the Society for Neuroscience</Title><ISOAbbreviation>J Neurosci</ISOAbbreviation></Journal><ArticleTitle>Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to beta-amyloid.</ArticleTitle><Pagination><StartPage>29</StartPage><EndPage>33</EndPage><MedlinePgn>29-33</MedlinePgn></Pagination><Abstract><AbstractText>Plaques containing beta-amyloid (Abeta) peptides are one of the pathological features of Alzheimer's disease, and the reduction of Abeta is considered a primary therapeutic target. Amyloid clearance by anti-Abeta antibodies has been reported after immunization, and recent data have shown that the antibodies may act as a peripheral sink for Abeta, thus altering the periphery/brain dynamics. Here we show that peripheral treatment with an agent that has high affinity for Abeta (gelsolin or GM1) but that is unrelated to an antibody or immune modulator reduced the level of Abeta in the brain, most likely because of a peripherally acting effect. We propose that in general, compounds that sequester plasma Abeta could reduce or prevent brain amyloidosis, which would enable the development of new therapeutic agents that are not limited by the need to penetrate the brain or evoke an immune response.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Matsuoka</LastName><ForeName>Yasuji</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The Center for Dementia Research, Nathan Kline Institute, Orangeburg, New York 10962, USA. matsuoka@nki.rfmh.org</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saito</LastName><ForeName>Mitsuo</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>LaFrancois</LastName><ForeName>John</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Saito</LastName><ForeName>Mariko</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Gaynor</LastName><ForeName>Kate</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Olm</LastName><ForeName>Vicki</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Lili</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Casey</LastName><ForeName>Evelyn</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Yifan</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Shiratori</LastName><ForeName>Chiharu</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Lemere</LastName><ForeName>Cynthia</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Duff</LastName><ForeName>Karen</ForeName><Initials>K</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosci</MedlineTA><NlmUniqueID>8102140</NlmUniqueID><ISSNLinking>0270-6474</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018260">Gelsolin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053764">Presenilin-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>37758-47-7</RegistryNumber><NameOfSubstance UI="D005677">G(M1) Ganglioside</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000686" MajorTopicYN="N">Amyloidosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005677" MajorTopicYN="N">G(M1) Ganglioside</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018260" MajorTopicYN="N">Gelsolin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007274" MajorTopicYN="N">Injections, Intraperitoneal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053764" MajorTopicYN="N">Presenilin-1</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>1</Month><Day>7</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>1</Month><Day>28</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>1</Month><Day>7</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2003</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12514198</ArticleId><ArticleId IdType="pmc">PMC6742136</ArticleId><ArticleId IdType="pii">23/1/29</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.23-01-00029.2003</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bacskai BJ, Kajdasz ST, McLellan ME, Games D, Seubert P, Schenk D, Hyman BT. Non-Fc-mediated mechanisms are involved in clearance of amyloid-&#x3b2; in vivo by immunotherapy. J Neurosci. 2002;22:7873&#x2013;7878.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6758112</ArticleId><ArticleId IdType="pubmed">12223540</ArticleId></ArticleIdList></Reference><Reference><Citation>Bard F, Cannon C, Barbour R, Burke RL, Games D, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Lieberburg I, Motter R, Nguyen M, Soriano F, Vasquez N, Weiss K, Welch B. Peripherally administered antibodies against amyloid &#x3b2;-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med. 2000;6:916&#x2013;919.</Citation><ArticleIdList><ArticleId IdType="pubmed">10932230</ArticleId></ArticleIdList></Reference><Reference><Citation>Calhoun ME, Burgermeister P, Phinney AL, Stalder M, Tolnay M, Wiederhold KH, Abramowski D, Sturchler-Pierrat C, Sommer B, Staufenbiel M, Jucker M. Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc Natl Acad Sci USA. 1999;96:14088&#x2013;14093.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC24195</ArticleId><ArticleId IdType="pubmed">10570203</ArticleId></ArticleIdList></Reference><Reference><Citation>Chauhan VP, Ray I, Chauhan A, Wisniewski HM. Binding of gelsolin, a secretory protein, to amyloid &#x3b2;-protein. Biochem Biophys Res Commun. 1999;258:241&#x2013;246.</Citation><ArticleIdList><ArticleId IdType="pubmed">10329371</ArticleId></ArticleIdList></Reference><Reference><Citation>Choo-Smith LP, Garzon-Rodriguez W, Glabe CG, Surewicz WK. Acceleration of amyloid fibril formation by specific binding of A&#x3b2;-(1&#x2013;40) peptide to anglioside-containing membrane vesicles. J Biol Chem. 1997;272:22987&#x2013;22990.</Citation><ArticleIdList><ArticleId IdType="pubmed">9287293</ArticleId></ArticleIdList></Reference><Reference><Citation>Das P, Murphy MP, Younkin LH, Younkin SG, Golde TE. Reduced effectiveness of A&#x3b2;1&#x2013;42 immunization in APP transgenic mice with significant amyloid deposition. Neurobiol Aging. 2001;22:721&#x2013;727.</Citation><ArticleIdList><ArticleId IdType="pubmed">11705631</ArticleId></ArticleIdList></Reference><Reference><Citation>DeMattos RB, Bales KR, Cummins DJ, Dodart JC, Paul SM, Holtzman DM. Peripheral anti-A&#x3b2; antibody alters CNS and plasma A&#x3b2; clearance and decreases brain A&#x3b2; burden in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA. 2001;98:8850&#x2013;8855.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC37524</ArticleId><ArticleId IdType="pubmed">11438712</ArticleId></ArticleIdList></Reference><Reference><Citation>DeMattos RB, Bales KR, Cummins DJ, Paul SM, Holtzman DM. Brain to plasma amyloid-&#x3b2; efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease. Science. 2002;295:2264&#x2013;2267.</Citation><ArticleIdList><ArticleId IdType="pubmed">11910111</ArticleId></ArticleIdList></Reference><Reference><Citation>Duff K, Eckman C, Zehr C, Yu X, Prada CM, Perez-Tur J, Hutton M, Buee L, Harigaya Y, Yager D, Morgan D, Gordon MN, Holcomb L, Refolo L, Zenk B, Hardy J, Younkin S. Increased amyloid-&#x3b2;42(43) in brains of mice expressing mutant presenilin 1. Nature. 1996;383:710&#x2013;713.</Citation><ArticleIdList><ArticleId IdType="pubmed">8878479</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghilardi JR, Catton M, Stimson ER, Rogers S, Walker LC, Maggio JE, Mantyh PW. Intra-arterial infusion of [125I]A&#x3b2; 1&#x2013;40 labels amyloid deposits in the aged primate brain in vivo. NeuroReport. 1996;7:2607&#x2013;2611.</Citation><ArticleIdList><ArticleId IdType="pubmed">8981432</ArticleId></ArticleIdList></Reference><Reference><Citation>Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, Jantzen P, Wright K, Saad I, Mueller R, Morgan D, Sanders S, Zehr C, O'Campo K, Hardy J, Prada CM, Eckman C, Younkin S, Hsiao K, Duff K. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med. 1998;4:97&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">9427614</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G. Correlative memory deficits, A&#x3b2; elevation, and amyloid plaques in transgenic mice. Science. 1996;274:99&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">8810256</ArticleId></ArticleIdList></Reference><Reference><Citation>Janus C, Pearson J, McLaurin J, Mathews PM, Jiang Y, Schmidt SD, Chishti MA, Horne P, Heslin D, French J, Mount HT, Nixon RA, Mercken M, Bergeron C, Fraser PE, George-Hyslop P, Westaway D. A&#x3b2; peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature. 2000;408:979&#x2013;982.</Citation><ArticleIdList><ArticleId IdType="pubmed">11140685</ArticleId></ArticleIdList></Reference><Reference><Citation>Kakio A, Nishimoto SI, Yanagisawa K, Kozutsumi Y, Matsuzaki K. Cholesterol-dependent formation of GM1 ganglioside-bound amyloid &#x3b2;-protein, an endogenous seed for Alzheimer amyloid. J Biol Chem. 2001;276:24985&#x2013;24990.</Citation><ArticleIdList><ArticleId IdType="pubmed">11342534</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawarabayashi T, Younkin LH, Saido TC, Shoji M, Ashe KH, Younkin SG. Age-dependent changes in brain, CSF, and plasma amyloid &#x3b2; protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J Neurosci. 2001;21:372&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6763819</ArticleId><ArticleId IdType="pubmed">11160418</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemere CA, Spooner ET, LaFrancois J, Malester B, Mori C, Leverone JF, Clements JT, Selkoe DJ, Duff KE. A&#x3b2; immunization of PS/APP mice leads to decreased cerebral A&#x3b2; and a corresponding increase in serum A&#x3b2;. Soc Neurosci Abstr. 2002;27:687.10.</Citation></Reference><Reference><Citation>Morgan D, Diamond DM, Gottschall PE, Ugen KE, Dickey C, Hardy J, Duff K, Jantzen P, DiCarlo G, Wilcock D, Connor K, Hatcher J, Hope C, Gordon M, Arendash GW. A&#x3b2; peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature. 2000;408:982&#x2013;985.</Citation><ArticleIdList><ArticleId IdType="pubmed">11140686</ArticleId></ArticleIdList></Reference><Reference><Citation>Peretz D, Williamson RA, Kaneko K, Vergara J, Leclerc E, Schmitt-Ulms G, Mehlhorn IR, Legname G, Wormald MR, Rudd PM, Dwek RA, Burton DR, Prusiner SB. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature. 2001;412:739&#x2013;743.</Citation><ArticleIdList><ArticleId IdType="pubmed">11507642</ArticleId></ArticleIdList></Reference><Reference><Citation>Refolo LM, Malester B, LaFrancois J, Bryant-Thomas T, Wang R, Tint GS, Sambamurti K, Duff K, Pappolla MA. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol Dis. 2000;7:321&#x2013;331.</Citation><ArticleIdList><ArticleId IdType="pubmed">10964604</ArticleId></ArticleIdList></Reference><Reference><Citation>Refolo LM, Pappolla MA, LaFrancois J, Malester B, Schmidt SD, Thomas-Bryant T, Tint GS, Wang R, Mercken M, Petanceska SS, Duff KE. A cholesterol-lowering drug reduces &#x3b2;-amyloid pathology in a transgenic mouse model of Alzheimer's disease. Neurobiol Dis. 2001;8:890&#x2013;899.</Citation><ArticleIdList><ArticleId IdType="pubmed">11592856</ArticleId></ArticleIdList></Reference><Reference><Citation>Rost KL, Brockmoller J, Weber W, Roots I. Multiple-dose pharmacokinetics of ganglioside GM1 after intravenous and intramuscular administration to healthy volunteers. Clin Pharmacol Ther. 1991;50:141&#x2013;149.</Citation><ArticleIdList><ArticleId IdType="pubmed">1868675</ArticleId></ArticleIdList></Reference><Reference><Citation>Saulino MF, Schengrund CL. Differential accumulation of gangliosides by the brains of MPTP-lesioned mice. J Neurosci Res. 1994;37:384&#x2013;391.</Citation><ArticleIdList><ArticleId IdType="pubmed">8176760</ArticleId></ArticleIdList></Reference><Reference><Citation>Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Liao Z, Lieberburg I, Motter R, Mutter L, Soriano F, Shopp G, Vasquez N, Vandevert C. Immunization with amyloid-&#x3b2; attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature. 1999;400:173&#x2013;177.</Citation><ArticleIdList><ArticleId IdType="pubmed">10408445</ArticleId></ArticleIdList></Reference><Reference><Citation>Selkoe DJ. Physiological production of the &#x3b2;-amyloid protein and the mechanism of Alzheimer's disease. Trend Neurosci. 1993;16:403&#x2013;409.</Citation><ArticleIdList><ArticleId IdType="pubmed">7504355</ArticleId></ArticleIdList></Reference><Reference><Citation>Small DH, Mok SS, Bornstein JC. Alzheimer's disease and A&#x3b2; toxicity: from top to bottom. Nat Rev Neurosci. 2001;2:595&#x2013;598.</Citation><ArticleIdList><ArticleId IdType="pubmed">11484003</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiner HL, Lemere CA, Maron R, Spooner ET, Grenfell TJ, Mori C, Issazadeh S, Hancock WW, Selkoe DJ. Nasal administration of amyloid-&#x3b2; peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease. Ann Neurol. 2000;48:567&#x2013;579.</Citation><ArticleIdList><ArticleId IdType="pubmed">11026440</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu GS, Ledeen R. Quantification of gangliotetraose gangliosides with cholera toxin. Anal Biochem. 1988;173:368&#x2013;375.</Citation><ArticleIdList><ArticleId IdType="pubmed">3189815</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12514700</PMID><DateCompleted><Year>2003</Year><Month>03</Month><Day>18</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1078-8956</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2003</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Nature medicine</Title><ISOAbbreviation>Nat Med</ISOAbbreviation></Journal><ArticleTitle>Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease.</ArticleTitle><Pagination><StartPage>3</StartPage><EndPage>4</EndPage><MedlinePgn>3-4</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Li-Bang</ForeName><Initials>LB</Initials></Author><Author ValidYN="Y"><LastName>Lindholm</LastName><ForeName>Kristina</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Riqiang</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Citron</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Weiming</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xiao-Li</ForeName><Initials>XL</Initials></Author><Author ValidYN="Y"><LastName>Beach</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Sue</LastName><ForeName>Lucia</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Philip</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Price</LastName><ForeName>Donald</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Rena</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Yong</ForeName><Initials>Y</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Med</MedlineTA><NlmUniqueID>9502015</NlmUniqueID><ISSNLinking>1078-8956</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D053829">Amyloid Precursor Protein Secretases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010450">Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.-</RegistryNumber><NameOfSubstance UI="D016282">Aspartic Acid Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.45</RegistryNumber><NameOfSubstance UI="C509284">BACE2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.46</RegistryNumber><NameOfSubstance UI="C509280">BACE1 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053829" MajorTopicYN="N">Amyloid Precursor Protein Secretases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016282" MajorTopicYN="N">Aspartic Acid Endopeptidases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010450" MajorTopicYN="N">Endopeptidases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013223" MajorTopicYN="N">Statistics as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013702" MajorTopicYN="N">Temporal Lobe</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014162" MajorTopicYN="N">Transfection</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>1</Month><Day>7</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>3</Month><Day>19</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>1</Month><Day>7</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12514700</ArticleId><ArticleId IdType="doi">10.1038/nm0103-3</ArticleId><ArticleId IdType="pii">nm0103-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12517232</PMID><DateCompleted><Year>2003</Year><Month>01</Month><Day>21</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0098-7484</ISSN><JournalIssue CitedMedium="Print"><Volume>289</Volume><Issue>2</Issue><PubDate><Year>2003</Year><Month>Jan</Month><Day>08</Day></PubDate></JournalIssue><Title>JAMA</Title><ISOAbbreviation>JAMA</ISOAbbreviation></Journal><ArticleTitle>Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis.</ArticleTitle><Pagination><StartPage>210</StartPage><EndPage>216</EndPage><MedlinePgn>210-6</MedlinePgn></Pagination><Abstract><AbstractText Label="CONTEXT" NlmCategory="BACKGROUND">Cholinesterase inhibitors are the primary treatment for the cognitive symptoms of Alzheimer disease (AD). Cholinergic dysfunction is also associated with neuropsychiatric and functional deficits, but results from randomized controlled trials of cholinesterase inhibitors are conflicting.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To conduct a systematic review and meta-analysis to quantify the efficacy of cholinesterase inhibitors for neuropsychiatric and functional outcomes in patients with mild to moderate AD.</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="METHODS">We performed a literature search of trials using MEDLINE (January 1966-December 2001), Dissertations Abstracts On-line, PSYCHINFO, BIOSIS, PubMed, and the Cochrane Controlled Trials Register. We retrieved English- and non-English-language articles for review and collected references from bibliographies of reviews, original research articles, and other articles of interest. We searched for both published and unpublished trials, contacting researchers and pharmaceutical companies.</AbstractText><AbstractText Label="STUDY SELECTION" NlmCategory="METHODS">We included 29 parallel-group or crossover randomized, double-blind, placebo-controlled trials of outpatients who were diagnosed as having mild to moderate probable AD and were treated for at least 1 month with a cholinesterase inhibitor. Sixteen trials included neuropsychiatric and 18 included functional measures.</AbstractText><AbstractText Label="DATA EXTRACTION" NlmCategory="METHODS">Two investigators (N.H.T. and J.H.) independently extracted study methods, sources of bias, and outcomes. Neuropsychiatric outcomes were measured with the Neuropsychiatric Inventory (NPI, 0-120 points) and the Alzheimer Disease Assessment Scale, noncognitive (ADAS-noncog, 0-50 points) and were analyzed with the weighted mean difference method. Functional outcomes were measured with several activities of daily living (ADL) and instrumental activities of daily living (IADL) scales and analyzed with the standardized mean difference method.</AbstractText><AbstractText Label="DATA SYNTHESIS" NlmCategory="RESULTS">For neuropsychiatric outcomes, 10 trials included the ADAS-noncog and 6 included the NPI. Compared with placebo, patients randomized to cholinesterase inhibitors improved 1.72 points on the NPI (95% confidence interval [CI], 0.87-2.57 points), and 0.03 points on the ADAS-noncog (95% CI, 0.00-0.05 points). For functional outcomes, 14 trials used ADL and 13 trials used IADL scales. Compared with placebo, patients randomized to cholinesterase inhibitors improved 0.1 SDs on ADL scales (95% CI, 0.00-0.19 SDs), and 0.09 SDs on IADL scales (95% CI, 0.01 to 0.17 SDs). There was no difference in efficacy among various cholinesterase inhibitors.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These results indicate that cholinesterase inhibitors have a modest beneficial impact on neuropsychiatric and functional outcomes for patients with AD. Future research should focus on how such improvements translate into long-term outcomes such as patient quality of life, institutionalization, and caregiver burden.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Trinh</LastName><ForeName>Nhi-Ha</ForeName><Initials>NH</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Massachusetts General Hospital, Boston, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoblyn</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Mohanty</LastName><ForeName>Subhanjoy</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Yaffe</LastName><ForeName>Kristine</ForeName><Initials>K</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23-AG00888</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA</MedlineTA><NlmUniqueID>7501160</NlmUniqueID><ISSNLinking>0098-7484</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002800">Cholinesterase Inhibitors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2003 May 14;289(18):2359; author reply 2360-1. doi: 10.1001/jama.289.18.2359-a.</RefSource><PMID Version="1">12746352</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2003 May 14;289(18):2359; author reply 2360-1. doi: 10.1001/jama.289.18.2359-b.</RefSource><PMID Version="1">12746353</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2003 May 14;289(18):2359-60; author reply 2360-1. doi: 10.1001/jama.289.18.2359-c.</RefSource><PMID Version="1">12746354</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2003 May 14;289(18):2360; author reply 2360-1. doi: 10.1001/jama.289.18.2360-a.</RefSource><PMID Version="1">12746355</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Evid Based Ment Health. 2003 Aug;6(3):94. doi: 10.1136/ebmh.6.3.94.</RefSource><PMID Version="1">12893805</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000203" MajorTopicYN="N">Activities of Daily Living</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002800" MajorTopicYN="N">Cholinesterase Inhibitors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>66</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>1</Month><Day>9</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>1</Month><Day>22</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>1</Month><Day>9</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12517232</ArticleId><ArticleId IdType="doi">10.1001/jama.289.2.210</ArticleId><ArticleId IdType="pii">jma20041</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12522139</PMID><DateCompleted><Year>2003</Year><Month>04</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0021-9258</ISSN><JournalIssue CitedMedium="Print"><Volume>278</Volume><Issue>10</Issue><PubDate><Year>2003</Year><Month>Mar</Month><Day>07</Day></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J Biol Chem</ISOAbbreviation></Journal><ArticleTitle>PEN-2 and APH-1 coordinately regulate proteolytic processing of presenilin 1.</ArticleTitle><Pagination><StartPage>7850</StartPage><EndPage>7854</EndPage><MedlinePgn>7850-4</MedlinePgn></Pagination><Abstract><AbstractText>Presenilin (PS, PS1/PS2) complexes are known to be responsible for the intramembranous gamma-secretase cleavage of the beta-amyloid precursor protein and signaling receptor Notch. PS holoprotein undergoes endoproteolysis by an unknown enzymatic activity to generate NH(2)- and COOH-terminal fragments, a process that is required for the formation of the active and stable PS/-gamma-secretase complex. Biochemical and genetic studies have recently identified nicastrin, APH-1, and PEN-2 as essential cofactors that physically interact with PS1 and are necessary for the gamma-secretase activity. However, their precise function in regulating the PS complex and gamma-secretase activity remains unknown. Here, we demonstrate that endogenous PEN-2 preferentially interacts with PS1 holoprotein. Down-regulation of PEN-2 expression by small interfering RNA (siRNA) abolishes the endoproteolysis of PS1, whereas overexpression of PEN-2 promotes the production of PS1 fragments, indicating a critical role for PEN-2 in PS1 endoproteolysis. Interestingly, accumulation of full-length PS1 resulting from down-regulation of PEN-2 is alleviated by additional siRNA down-regulation of APH-1. Furthermore, overexpression of APH-1 facilitates PEN-2-mediated PS1 proteolysis, resulting in a significant increase in PS1 fragments. Our data reveal a direct role of PEN-2 in proteolytic cleavage of PS1 and a regulatory function of APH-1, in coordination with PEN-2, in the biogenesis of the PS1 complex.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Wen-jie</ForeName><Initials>WJ</Initials><AffiliationInfo><Affiliation>Fisher Center for Research on Alzheimer's Disease and Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, New York 10021, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hong</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Hongqiao</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Benny S</ForeName><Initials>BS</Initials></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Sanjiv</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Hahn-Jun</ForeName><Initials>HJ</Initials></Author><Author ValidYN="Y"><LastName>Thinakaran</LastName><ForeName>Gopal</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Tae-Wan</ForeName><Initials>TW</Initials></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Gang</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Huaxi</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>F32 AG023432</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG009464</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG09464</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>01</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017931">DNA Primers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508853">PSEN1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C469349">PSENEN protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053764">Presenilin-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="C475154">APH1A protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D053829">Amyloid Precursor Protein Secretases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010450">Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010447">Peptide Hydrolases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D053829" MajorTopicYN="N">Amyloid Precursor Protein Secretases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017931" MajorTopicYN="N">DNA Primers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010450" MajorTopicYN="N">Endopeptidases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006868" MajorTopicYN="N">Hydrolysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010447" MajorTopicYN="N">Peptide Hydrolases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053764" MajorTopicYN="N">Presenilin-1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011499" MajorTopicYN="Y">Protein Processing, Post-Translational</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014407" MajorTopicYN="N">Tumor Cells, Cultured</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>1</Month><Day>11</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>4</Month><Day>24</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>1</Month><Day>11</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12522139</ArticleId><ArticleId IdType="doi">10.1074/jbc.C200648200</ArticleId><ArticleId IdType="pii">S0021-9258(20)86394-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12522269</PMID><DateCompleted><Year>2003</Year><Month>02</Month><Day>24</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>100</Volume><Issue>2</Issue><PubDate><Year>2003</Year><Month>Jan</Month><Day>21</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Chaperones increase association of tau protein with microtubules.</ArticleTitle><Pagination><StartPage>721</StartPage><EndPage>726</EndPage><MedlinePgn>721-6</MedlinePgn></Pagination><Abstract><AbstractText>Molecular chaperones and their functions in protein folding have been implicated in several neurodegenerative diseases, including Parkinson's disease and Huntington's disease, which are characterized by accumulation of protein aggregates (e.g., alpha-synuclein and huntingtin, respectively). These aggregates have been shown in various experimental systems to respond to changes in levels of molecular chaperones suggesting the possibility of therapeutic intervention and a role for chaperones in disease pathogenesis. It remains unclear whether chaperones also play a role in Alzheimer's disease, a neurodegenerative disorder characterized by beta-amyloid and tau protein aggregates. Here, we report an inverse relationship between aggregated tau and the levels of heat shock protein (Hsp)7090 in tau transgenic mouse and Alzheimer's disease brains. In various cellular models, increased levels of Hsp70 and Hsp90 promote tau solubility and tau binding to microtubules, reduce insoluble tau and cause reduced tau phosphorylation. Conversely, lowered levels of Hsp70 and Hsp90 result in the opposite effects. We have also demonstrated a direct association of the chaperones with tau proteins. Our results suggest that up-regulation of molecular chaperones may suppress formation of neurofibrillary tangles by partitioning tau into a productive folding pathway and thereby preventing tau aggregation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dou</LastName><ForeName>Fei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Fisher Center for Research on Alzheimer's Disease, Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, 1230 York Avenue, New York, NY 10021, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Netzer</LastName><ForeName>William J</ForeName><Initials>WJ</Initials></Author><Author ValidYN="Y"><LastName>Tanemura</LastName><ForeName>Kentaro</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Feng</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Hartl</LastName><ForeName>F Ulrich</ForeName><Initials>FU</Initials></Author><Author ValidYN="Y"><LastName>Takashima</LastName><ForeName>Akihiko</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Gouras</LastName><ForeName>Gunnar K</ForeName><Initials>GK</Initials></Author><Author ValidYN="Y"><LastName>Greengard</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Huaxi</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P01 AG009464</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG 09464</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>01</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018840">HSP70 Heat-Shock Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018841">HSP90 Heat-Shock Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016875">tau Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019556" MajorTopicYN="N">COS Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018840" MajorTopicYN="N">HSP70 Heat-Shock Proteins</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018841" MajorTopicYN="N">HSP90 Heat-Shock Proteins</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008870" MajorTopicYN="N">Microtubules</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016874" MajorTopicYN="N">Neurofibrillary Tangles</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017510" MajorTopicYN="Y">Protein Folding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016875" MajorTopicYN="N">tau Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>1</Month><Day>11</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>2</Month><Day>25</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>1</Month><Day>11</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2003</Year><Month>7</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12522269</ArticleId><ArticleId IdType="pmc">PMC141063</ArticleId><ArticleId IdType="doi">10.1073/pnas.242720499</ArticleId><ArticleId IdType="pii">242720499</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Selkoe D J. Nature. 1999;399:A23&#x2013;A31.</Citation><ArticleIdList><ArticleId IdType="pubmed">10392577</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee V M, Goedert M, Trojanowski J Q. Annu Rev Neurosci. 2001;24:1121&#x2013;1159.</Citation><ArticleIdList><ArticleId IdType="pubmed">11520930</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanemura K, Murayama M, Akagi T, Hashikawa T, Tominaga T, Ichikawa M, Yamaguchi H, Takashima A. J Neurosci. 2002;22:133&#x2013;141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6757582</ArticleId><ArticleId IdType="pubmed">11756496</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis J, McGowan E, Rockwood J, Melrose H, Nacharaju P, Van Slegtenhorst M, Gwinn-Hardy K, Paul Murphy M, Baker M, Yu X, et al. Nat Genet. 2000;25:402&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pubmed">10932182</ArticleId></ArticleIdList></Reference><Reference><Citation>von Bergen M, Barghorn S, Li L, Marx A, Biernat J, Mandelkow E M, Mandelkow E. J Biol Chem. 2001;276:48165&#x2013;48174.</Citation><ArticleIdList><ArticleId IdType="pubmed">11606569</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumura N, Yamazaki T, Ihara Y. Am J Pathol. 1999;154:1649&#x2013;1656.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1866642</ArticleId><ArticleId IdType="pubmed">10362789</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartl F U. Nature. 1996;381:571&#x2013;579.</Citation><ArticleIdList><ArticleId IdType="pubmed">8637592</ArticleId></ArticleIdList></Reference><Reference><Citation>Slavotinek A M, Biesecker L G. Trends Genet. 2001;17:528&#x2013;535.</Citation><ArticleIdList><ArticleId IdType="pubmed">11525836</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostrerova N, Petrucelli L, Farrer M, Mehta N, Choi P, Hardy J, Wolozin B. J Neurosci. 1999;19:5782&#x2013;5791.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6783081</ArticleId><ArticleId IdType="pubmed">10407019</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmichael J, Chatellier J, Woolfson A, Milstein C, Fersht A R, Rubinsztein D C. Proc Natl Acad Sci USA. 2000;97:9701&#x2013;9705.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC16928</ArticleId><ArticleId IdType="pubmed">10920207</ArticleId></ArticleIdList></Reference><Reference><Citation>Warrick J M, Chan H Y, Gray-Board G L, Chai Y, Paulson H L, Bonini N M. Nat Genet. 1999;23:425&#x2013;428.</Citation><ArticleIdList><ArticleId IdType="pubmed">10581028</ArticleId></ArticleIdList></Reference><Reference><Citation>Sittler A, Lurz R, Lueder G, Priller J, Lehrach H, Hayer-Hartl M K, Hartl F U, Wanker E E. Hum Mol Genet. 2001;10:1307&#x2013;1315.</Citation><ArticleIdList><ArticleId IdType="pubmed">11406612</ArticleId></ArticleIdList></Reference><Reference><Citation>Auluck P K, Chan H Y, Trojanowski J Q, Lee V M, Bonini N M. Science. 2002;295:865&#x2013;868.</Citation><ArticleIdList><ArticleId IdType="pubmed">11823645</ArticleId></ArticleIdList></Reference><Reference><Citation>Muchowski P J, Schaffar G, Sittler A, Wanker E E, Hayer-Hartl M K, Hartl F U. Proc Natl Acad Sci USA. 2000;97:7841&#x2013;7846.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC16632</ArticleId><ArticleId IdType="pubmed">10859365</ArticleId></ArticleIdList></Reference><Reference><Citation>Gouras G K, Tsai J, Naslund J, Vincent B, Edgar M, Checler F, Greenfield J P, Haroutunian V, Buxbaum J D, Xu H, et al. Am J Pathol. 2000;156:15&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1868613</ArticleId><ArticleId IdType="pubmed">10623648</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H, Gouras G K, Greenfield J P, Vincent B, Naslund J, Mazzarelli L, Fried G, Jovanovic J N, Seeger M, Relkin N R, et al. Nat Med. 1998;4:447&#x2013;451.</Citation><ArticleIdList><ArticleId IdType="pubmed">9546791</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanker E E, Scherzinger E, Heiser V, Sittler A, Eickhoff H, Lehrach H. Methods Enzymol. 1999;309:375&#x2013;386.</Citation><ArticleIdList><ArticleId IdType="pubmed">10507036</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishihara T, Higuchi M, Zhang B, Yoshiyama Y, Hong M, Trojanowski J Q, Lee V M. J Neurosci. 2001;21:6026&#x2013;6035.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6763173</ArticleId><ArticleId IdType="pubmed">11487626</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandt R, Leger J, Lee G. J Cell Biol. 1995;131:1327&#x2013;1340.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2120645</ArticleId><ArticleId IdType="pubmed">8522593</ArticleId></ArticleIdList></Reference><Reference><Citation>Elbashir S M, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Nature. 2001;411:494&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pubmed">11373684</ArticleId></ArticleIdList></Reference><Reference><Citation>Preuss U, Biernat J, Mandelkow E M, Mandelkow E. J Cell Sci. 1997;110:789&#x2013;800.</Citation><ArticleIdList><ArticleId IdType="pubmed">9099953</ArticleId></ArticleIdList></Reference><Reference><Citation>Beckers C J, Balch W E. J Cell Biol. 1989;108:1245&#x2013;1256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2115521</ArticleId><ArticleId IdType="pubmed">2538479</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H, Shields D. J Cell Biol. 1993;122:1169&#x2013;1184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2119863</ArticleId><ArticleId IdType="pubmed">8104189</ArticleId></ArticleIdList></Reference><Reference><Citation>Musch A, Xu H, Shields D, Rodriguez-Boulan E. J Cell Biol. 1996;133:543&#x2013;558.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2120809</ArticleId><ArticleId IdType="pubmed">8636230</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenfield J P, Leung L W, Cai D, Kaasik K, Gross R S, Rodriguez-Boulan E, Greengard P, Xu H. J Biol Chem. 2002;277:12128&#x2013;12136.</Citation><ArticleIdList><ArticleId IdType="pubmed">11823458</ArticleId></ArticleIdList></Reference><Reference><Citation>Oyama F, Murakami N, Ihara Y. Neurosci Res. 1998;31:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">9704973</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohfeld J, Cyr D M, Patterson C. EMBO Rep. 2001;21:885&#x2013;890.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1084084</ArticleId><ArticleId IdType="pubmed">11600451</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou J, Guo Y, Guettouche T, Smith D F, Voellmy R. Cell. 1998;94:471&#x2013;480.</Citation><ArticleIdList><ArticleId IdType="pubmed">9727490</ArticleId></ArticleIdList></Reference><Reference><Citation>Mailliot C, Bussiere T, Caillet-Boudin M L, Delacourte A, Buee L. Neurosci Lett. 1998;255:13&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">9839715</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirby B A, Merril C R, Ghanbari H, Wallace W C. J Neurosci. 1994;14:5687&#x2013;5893.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6577074</ArticleId><ArticleId IdType="pubmed">8083763</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogelsberg-Ragaglia V, Bruce J, Richter-Landsberg C, Zhang B, Hong M, Trojanowski J Q, Lee V M. Mol Biol Cell. 2000;11:4093&#x2013;4104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC15059</ArticleId><ArticleId IdType="pubmed">11102510</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebneth A, Godemann R, Stamer K, Illenberger S, Trinczek B, Mandelkow E. J Cell Biol. 1998;143:777&#x2013;794.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2148132</ArticleId><ArticleId IdType="pubmed">9813097</ArticleId></ArticleIdList></Reference><Reference><Citation>Bramblett G T, Goedert M, Jakes R, Merrick S E, Trojanowski J Q, Lee V M-Y. Neuron. 1993;10:1089&#x2013;1099.</Citation><ArticleIdList><ArticleId IdType="pubmed">8318230</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad S, Ahuja R, Venner T J, Gupta R S. Mol Cell Biol. 1990;10:5160&#x2013;5165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC361191</ArticleId><ArticleId IdType="pubmed">1975944</ArticleId></ArticleIdList></Reference><Reference><Citation>Green L A, Liem R K H. J Biol Chem. 1989;264:15210&#x2013;15215.</Citation><ArticleIdList><ArticleId IdType="pubmed">2527848</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang P, MacRae T H. J Cell Sci. 1997;110:1431&#x2013;1440.</Citation><ArticleIdList><ArticleId IdType="pubmed">9224761</ArticleId></ArticleIdList></Reference><Reference><Citation>Sha B, Lee S, Cyr D M. Struct Fold Des. 2000;8:799&#x2013;807.</Citation><ArticleIdList><ArticleId IdType="pubmed">10997899</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen W J, Cowan N J, Welch W J. J Cell Biol. 1999;145:265&#x2013;277.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2133115</ArticleId><ArticleId IdType="pubmed">10209023</ArticleId></ArticleIdList></Reference><Reference><Citation>Heyrovska N, Frydman J, Hohfeld J, Hartl F U. Biol Chem. 1998;379:301&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pubmed">9563826</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarraberes F A, Dice J F. J Cell Sci. 2001;114:2491&#x2013;2499.</Citation><ArticleIdList><ArticleId IdType="pubmed">11559757</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12522270</PMID><DateCompleted><Year>2003</Year><Month>02</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>100</Volume><Issue>2</Issue><PubDate><Year>2003</Year><Month>Jan</Month><Day>21</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry.</ArticleTitle><Pagination><StartPage>443</StartPage><EndPage>448</EndPage><MedlinePgn>443-8</MedlinePgn></Pagination><Abstract><AbstractText>The reversible phosphorylation of tyrosine residues is an important mechanism for modulating biological processes such as cellular signaling, differentiation, and growth, and if deregulated, can result in various types of cancer. Therefore, an understanding of these dynamic cellular processes at the molecular level requires the ability to assess changes in the sites of tyrosine phosphorylation across numerous proteins simultaneously as well as over time. Here we describe a sensitive approach based on multidimensional liquid chromatography/mass spectrometry that enables the rapid identification of numerous sites of tyrosine phosphorylation on a number of different proteins from human whole cell lysates. We used this methodology to follow changes in tyrosine phosphorylation patterns that occur over time during either the activation of human T cells or the inhibition of the oncogenic BCR-ABL fusion product in chronic myelogenous leukemia cells in response to treatment with STI571 (Gleevec). Together, these experiments rapidly identified 64 unique sites of tyrosine phosphorylation on 32 different proteins. Half of these sites have been documented in the literature, validating the merits of our approach, whereas motif analysis suggests that a number of the undocumented sites are also potentially involved in biological pathways. This methodology should enable the rapid generation of new insights into signaling pathways as they occur in states of health and disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Salomon</LastName><ForeName>Arthur R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Drive, San Diego, CA 92121, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ficarro</LastName><ForeName>Scott B</ForeName><Initials>SB</Initials></Author><Author ValidYN="Y"><LastName>Brill</LastName><ForeName>Laurence M</ForeName><Initials>LM</Initials></Author><Author ValidYN="Y"><LastName>Brinker</LastName><ForeName>Achim</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Phung</LastName><ForeName>Qui T</ForeName><Initials>QT</Initials></Author><Author ValidYN="Y"><LastName>Ericson</LastName><ForeName>Christer</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Sauer</LastName><ForeName>Karsten</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Brock</LastName><ForeName>Ansgar</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Horn</LastName><ForeName>David M</ForeName><Initials>DM</Initials></Author><Author ValidYN="Y"><LastName>Schultz</LastName><ForeName>Peter G</ForeName><Initials>PG</Initials></Author><Author ValidYN="Y"><LastName>Peters</LastName><ForeName>Eric C</ForeName><Initials>EC</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>01</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001549">Benzamides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010879">Piperazines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>42HK56048U</RegistryNumber><NameOfSubstance UI="D014443">Tyrosine</NameOfSubstance></Chemical><Chemical><RegistryNumber>8A1O1M485B</RegistryNumber><NameOfSubstance UI="D000068877">Imatinib Mesylate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="D011505">Protein-Tyrosine Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.2</RegistryNumber><NameOfSubstance UI="D016044">Fusion Proteins, bcr-abl</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.2</RegistryNumber><NameOfSubstance UI="D051746">ZAP-70 Protein-Tyrosine Kinase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.2</RegistryNumber><NameOfSubstance UI="C497261">ZAP70 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001549" MajorTopicYN="N">Benzamides</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002851" MajorTopicYN="N">Chromatography, High Pressure Liquid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016044" MajorTopicYN="N">Fusion Proteins, bcr-abl</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000068877" MajorTopicYN="N">Imatinib Mesylate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019169" MajorTopicYN="N">Jurkat Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013058" MajorTopicYN="Y">Mass Spectrometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010879" MajorTopicYN="N">Piperazines</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011505" MajorTopicYN="N">Protein-Tyrosine Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014443" MajorTopicYN="N">Tyrosine</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051746" MajorTopicYN="N">ZAP-70 Protein-Tyrosine Kinase</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>1</Month><Day>11</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>2</Month><Day>25</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>1</Month><Day>11</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2003</Year><Month>7</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12522270</ArticleId><ArticleId IdType="pmc">PMC141014</ArticleId><ArticleId IdType="doi">10.1073/pnas.2436191100</ArticleId><ArticleId IdType="pii">2436191100</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sickmann A, Meyer H E. Proteomics. 2001;1:200&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pubmed">11680867</ArticleId></ArticleIdList></Reference><Reference><Citation>Gygi S P, Corthals G L, Zhang Y, Rochon Y, Aebersold R. Proc Natl Acad Sci USA. 2000;97:9390&#x2013;9395.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC16874</ArticleId><ArticleId IdType="pubmed">10920198</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyle W J, van der Geer P, Hunter T. Methods Enzymol. 1991;201:110&#x2013;149.</Citation><ArticleIdList><ArticleId IdType="pubmed">1943760</ArticleId></ArticleIdList></Reference><Reference><Citation>Aebersold R H, Leavitt J, Saavedra R A, Hood L E, Kent S B. Proc Natl Acad Sci USA. 1987;84:6970&#x2013;6974.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC299210</ArticleId><ArticleId IdType="pubmed">3313383</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr S A, Huddleston M J, Annan R S. Anal Biochem. 1996;239:180&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pubmed">8811904</ArticleId></ArticleIdList></Reference><Reference><Citation>Posewitz M C, Tempst P. Anal Chem. 1999;71:2883&#x2013;2892.</Citation><ArticleIdList><ArticleId IdType="pubmed">10424175</ArticleId></ArticleIdList></Reference><Reference><Citation>Ficarro S B, McCleland M L, Stukenberg P T, Burke D J, Ross M M, Shabanowitz J, Hunt D F, White F M. Nat Biotechnol. 2002;20:301&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pubmed">11875433</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H, Watts J, Aebersold R. Nat Biotechnol. 2001;19:375&#x2013;378.</Citation><ArticleIdList><ArticleId IdType="pubmed">11283598</ArticleId></ArticleIdList></Reference><Reference><Citation>Goshe M, Conrads T, Panisko E, Angell N, Veenstra T, Smith R. Anal Chem. 2001;73:2578&#x2013;2586.</Citation><ArticleIdList><ArticleId IdType="pubmed">11403303</ArticleId></ArticleIdList></Reference><Reference><Citation>Oda Y, Nagasu T, Chait B. Nat Biotechnol. 2001;19:379&#x2013;382.</Citation><ArticleIdList><ArticleId IdType="pubmed">11283599</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper J A, Sefton B M, Hunter T. Methods Enzymol. 1983;99:387&#x2013;402.</Citation><ArticleIdList><ArticleId IdType="pubmed">6196603</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandey A, Podtelejnikov A V, Blagoev B, Bustelo X R, Mann M, Lodish H F. Proc Natl Acad Sci USA. 2000;97:179&#x2013;184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC26636</ArticleId><ArticleId IdType="pubmed">10618391</ArticleId></ArticleIdList></Reference><Reference><Citation>Heaney C, Kolibaba K, Bhat A, Oda T, Ohno S, Fanning S, Druker B J. Blood. 1997;89:297&#x2013;306.</Citation><ArticleIdList><ArticleId IdType="pubmed">8978305</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauer K, Liou J, Singh S B, Yablonski D, Weiss A, Perlmutter R M. J Biol Chem. 2001;276:45207&#x2013;45216.</Citation><ArticleIdList><ArticleId IdType="pubmed">11487585</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarling A L, Ficarro S B, White F M, Shabanowitz J, Hunt D F, Engelhard V H. J Exp Med. 2000;192:1755&#x2013;1762.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2213507</ArticleId><ArticleId IdType="pubmed">11120772</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin S E, Shabanowitz J, Hunt D F, Marto J A. Anal Chem. 2000;72:4266&#x2013;4274.</Citation><ArticleIdList><ArticleId IdType="pubmed">11008759</ArticleId></ArticleIdList></Reference><Reference><Citation>Eng J, McCormack A, Yates J R. J Am Soc Mass Spectrom. 1994;5:976&#x2013;989.</Citation><ArticleIdList><ArticleId IdType="pubmed">24226387</ArticleId></ArticleIdList></Reference><Reference><Citation>Kane L P, Lin J, Weiss A. Curr Opin Immunol. 2000;12:242&#x2013;249.</Citation><ArticleIdList><ArticleId IdType="pubmed">10781399</ArticleId></ArticleIdList></Reference><Reference><Citation>June C H, Fletcher M C, Ledbetter J A, Samelson L E. J Immunol. 1990;144:1591&#x2013;1599.</Citation><ArticleIdList><ArticleId IdType="pubmed">1689750</ArticleId></ArticleIdList></Reference><Reference><Citation>Watts J D, Affolter M, Krebs D L, Wange R L, Samelson L E, Aebersold R. J Biol Chem. 1994;269:29520&#x2013;29529.</Citation><ArticleIdList><ArticleId IdType="pubmed">7961936</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Bartolo V, Mege D, Germain V, Pelosi M, Dufour E, Michel F, Magistrelli G, Isacchi A, Acuto O. J Biol Chem. 1999;274:6285&#x2013;6294.</Citation><ArticleIdList><ArticleId IdType="pubmed">10037717</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra R, Pu Q Q, Elefanty A G. Blood Rev. 1999;13:211&#x2013;229.</Citation><ArticleIdList><ArticleId IdType="pubmed">10741897</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindler T, Bornmann W, Pellicena P, Miller W T, Clarkson B, Kuriyan J. Science. 2000;289:1938&#x2013;1942.</Citation><ArticleIdList><ArticleId IdType="pubmed">10988075</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaffe M B, Leparc G G, Lai J, Obata T, Volinia S, Cantley L C. Nat Biotechnol. 2001;19:348&#x2013;353.</Citation><ArticleIdList><ArticleId IdType="pubmed">11283593</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanda H, Mimura T, Hamasaki K, Yamamoto K, Yazaki Y, Hirai H, Nojima Y. Immunology. 1999;97:56&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2326814</ArticleId><ArticleId IdType="pubmed">10447714</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutchcroft J E, Slavik J M, Lin H, Watanabe T, Bierer B E. J Immunol. 1998;161:4506&#x2013;4512.</Citation><ArticleIdList><ArticleId IdType="pubmed">9794375</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruzzene M, Brunati A M, Marin O, Donella-Deana A, Pinna L A. Biochemistry. 1996;35:5327&#x2013;5332.</Citation><ArticleIdList><ArticleId IdType="pubmed">8611520</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan A C, Dalton M, Johnson R, Kong G H, Wang T, Thoma R, Kurosaki T. EMBO J. 1995;14:2499&#x2013;2508.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC398363</ArticleId><ArticleId IdType="pubmed">7781602</ArticleId></ArticleIdList></Reference><Reference><Citation>Kersh E N, Shaw A S, Allen P M. Science. 1998;281:572&#x2013;575.</Citation><ArticleIdList><ArticleId IdType="pubmed">9677202</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma G, Lu D, Wu Y, Liu J, Arlinghaus R B. Oncogene. 1997;14:2367&#x2013;2372.</Citation><ArticleIdList><ArticleId IdType="pubmed">9178913</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang G, Kim C N, Perkins C L, Ramadevi N, Winton E, Wittmann S, Bhalla K N. Blood. 2000;96:2246&#x2013;2253.</Citation><ArticleIdList><ArticleId IdType="pubmed">10979973</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrotti D, Cesi V, Trotta R, Guerzoni C, Santilli G, Campbell K, Iervolino A, Condorelli F, Gambacorti-Passerini C, Caligiuri M A, Calabretta B. Nat Genet. 2002;30:48&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">11753385</ArticleId></ArticleIdList></Reference><Reference><Citation>el-Sonbaty S S, Watanabe M, Hochito K, Yamaguchi K, Matsuda I, Tsuchiya H. Int J Hematol. 1995;61:61&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">7537550</ArticleId></ArticleIdList></Reference><Reference><Citation>Maruyama S, Kurosaki T, Sada K, Yamanashi Y, Yamamoto T, Yamamura H. J Biol Chem. 1996;271:6631&#x2013;6635.</Citation><ArticleIdList><ArticleId IdType="pubmed">8636079</ArticleId></ArticleIdList></Reference><Reference><Citation>Grishin A, Sinha S, Roginskaya V, Boyer M J, Gomez-Cambronero J, Zuo S, Kurosaki T, Romero G, Corey S J. Oncogene. 2000;19:97&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pubmed">10644984</ArticleId></ArticleIdList></Reference><Reference><Citation>Corey S J, Burkhardt A L, Bolen J B, Geahlen R L, Tkatch L S, Tweardy D J. Proc Natl Acad Sci USA. 1994;91:4683&#x2013;4687.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC43852</ArticleId><ArticleId IdType="pubmed">8197119</ArticleId></ArticleIdList></Reference><Reference><Citation>Cinek T, Horejsi V. J Immunol. 1992;149:2262&#x2013;2270.</Citation><ArticleIdList><ArticleId IdType="pubmed">1382093</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Trible R P, Samelson L E. Immunity. 1998;9:239&#x2013;246.</Citation><ArticleIdList><ArticleId IdType="pubmed">9729044</ArticleId></ArticleIdList></Reference><Reference><Citation>Steen H, Kuster B, Fernandez M, Pandey A, Mann M. J Biol Chem. 2002;277:1031&#x2013;1039.</Citation><ArticleIdList><ArticleId IdType="pubmed">11687594</ArticleId></ArticleIdList></Reference><Reference><Citation>de Aos I, Metzger M H, Exley M, Dahl C E, Misra S, Zheng D, Varticovski L, Terhorst C, Sancho J. J Biol Chem. 1997;272:25310&#x2013;25318.</Citation><ArticleIdList><ArticleId IdType="pubmed">9312149</ArticleId></ArticleIdList></Reference><Reference><Citation>Vila J M, Gimferrer I, Padilla O, Arman M, Places L, Simarro M, Vives J, Lozano F. Eur J Immunol. 2001;31:1191&#x2013;1198.</Citation><ArticleIdList><ArticleId IdType="pubmed">11298344</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlaepfer D D, Hauck C R, Sieg D J. Prog Biophys Mol Biol. 1999;71:435&#x2013;478.</Citation><ArticleIdList><ArticleId IdType="pubmed">10354709</ArticleId></ArticleIdList></Reference><Reference><Citation>Brasher B B, Van Etten R A. J Biol Chem. 2000;275:35631&#x2013;35637.</Citation><ArticleIdList><ArticleId IdType="pubmed">10964922</ArticleId></ArticleIdList></Reference><Reference><Citation>Konopka J B, Witte O N. Mol Cell Biol. 1985;5:3116&#x2013;3123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC369126</ArticleId><ArticleId IdType="pubmed">3879812</ArticleId></ArticleIdList></Reference><Reference><Citation>Andoniou C E, Thien C B, Langdon W Y. Oncogene. 1996;12:1981&#x2013;1989.</Citation><ArticleIdList><ArticleId IdType="pubmed">8649859</ArticleId></ArticleIdList></Reference><Reference><Citation>Himpel S, Panzer P, Eirmbter K, Czajkowska H, Sayed M, Packman L C, Blundell T, Kentrup H, Grotzinger J, Joost H G, Becker W. Biochem J. 2001;359:497&#x2013;505.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1222170</ArticleId><ArticleId IdType="pubmed">11672423</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogel W, Ullrich A. Cell Growth Differ. 1996;7:1589&#x2013;1597.</Citation><ArticleIdList><ArticleId IdType="pubmed">8959326</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Liu J, Haudenschild C C, Zhan X. J Biol Chem. 1998;273:25770&#x2013;25776.</Citation><ArticleIdList><ArticleId IdType="pubmed">9748248</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Geer P, Wiley S, Lai V K, Olivier J P, Gish G D, Stephens R, Kaplan D, Shoelson S, Pawson T. Curr Biol. 1995;5:404&#x2013;412.</Citation><ArticleIdList><ArticleId IdType="pubmed">7542991</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor V, Wong M, Brandts C, Reilly L, Dean N M, Cowsert L M, Moodie S, Stokoe D. Mol Cell Biol. 2000;20:6860&#x2013;6871.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC86225</ArticleId><ArticleId IdType="pubmed">10958682</ArticleId></ArticleIdList></Reference><Reference><Citation>Furlong M T, Mahrenholz A M, Kim K H, Ashendel C L, Harrison M L, Geahlen R L. Biochim Biophys Acta. 1997;1355:177&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pubmed">9042338</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12529507</PMID><DateCompleted><Year>2003</Year><Month>02</Month><Day>24</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>100</Volume><Issue>2</Issue><PubDate><Year>2003</Year><Month>Jan</Month><Day>21</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics.</ArticleTitle><Pagination><StartPage>605</StartPage><EndPage>610</EndPage><MedlinePgn>605-10</MedlinePgn></Pagination><Abstract><AbstractText>Identifying the genes responsible for human diseases requires combining information about gene position with clues about biological function. The recent availability of whole-genome data sets of RNA and protein expression provides powerful new sources of functional insight. Here we illustrate how such data sets can expedite disease-gene discovery, by using them to identify the gene causing Leigh syndrome, French-Canadian type (LSFC, Online Mendelian Inheritance in Man no. 220111), a human cytochrome c oxidase deficiency that maps to chromosome 2p16-21. Using four public RNA expression data sets, we assigned to all human genes a "score" reflecting their similarity in RNA-expression profiles to known mitochondrial genes. Using a large survey of organellar proteomics, we similarly classified human genes according to the likelihood of their protein product being associated with the mitochondrion. By intersecting this information with the relevant genomic region, we identified a single clear candidate gene, LRPPRC. Resequencing identified two mutations on two independent haplotypes, providing definitive genetic proof that LRPPRC indeed causes LSFC. LRPPRC encodes an mRNA-binding protein likely involved with mtDNA transcript processing, suggesting an additional mechanism of mitochondrial pathophysiology. Similar strategies to integrate diverse genomic information can be applied likewise to other disease pathways and will become increasingly powerful with the growing wealth of diverse, functional genomics data.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mootha</LastName><ForeName>Vamsi K</ForeName><Initials>VK</Initials><AffiliationInfo><Affiliation>Whitehead Institute/Massachusetts Institute of Technology Center for Genome Research, One Kendall Square, Building 300, Cambridge, MA 02139, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lepage</LastName><ForeName>Pierre</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Kathleen</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Bunkenborg</LastName><ForeName>Jakob</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Reich</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Hjerrild</LastName><ForeName>Majbrit</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Delmonte</LastName><ForeName>Terrye</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Villeneuve</LastName><ForeName>Amelie</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Sladek</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Fenghao</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Mitchell</LastName><ForeName>Grant A</ForeName><Initials>GA</Initials></Author><Author ValidYN="Y"><LastName>Morin</LastName><ForeName>Charles</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Mann</LastName><ForeName>Matthias</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Hudson</LastName><ForeName>Thomas J</ForeName><Initials>TJ</Initials></Author><Author ValidYN="Y"><LastName>Robinson</LastName><ForeName>Brian</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Rioux</LastName><ForeName>John D</ForeName><Initials>JD</Initials></Author><Author ValidYN="Y"><LastName>Lander</LastName><ForeName>Eric S</ForeName><Initials>ES</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>01</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C087940">LRPPRC protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009363">Neoplasm Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030401" MajorTopicYN="N">Cytochrome-c Oxidase Deficiency</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D023281" MajorTopicYN="Y">Genomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009363" MajorTopicYN="N">Neoplasm Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="N">Proteomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>1</Month><Day>17</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>2</Month><Day>25</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>1</Month><Day>17</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2003</Year><Month>7</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12529507</ArticleId><ArticleId IdType="pmc">PMC141043</ArticleId><ArticleId IdType="doi">10.1073/pnas.242716699</ArticleId><ArticleId IdType="pii">242716699</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lander E S, Linton L M, Birren B, Nussbaum C, Zody M C, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, et al. Nature. 2001;409:860&#x2013;921.</Citation><ArticleIdList><ArticleId IdType="pubmed">11237011</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoubridge E A. Am J Med Genet. 2001;106:46&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">11579424</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson B H. Pediatr Res. 2000;48:581&#x2013;585.</Citation><ArticleIdList><ArticleId IdType="pubmed">11044474</ArticleId></ArticleIdList></Reference><Reference><Citation>Morin C, Mitchell G, Larochelle J, Lambert M, Ogier H, Robinson B H, De Braekeleer M. Am J Hum Genet. 1993;53:488&#x2013;496.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1682365</ArticleId><ArticleId IdType="pubmed">8392291</ArticleId></ArticleIdList></Reference><Reference><Citation>Merante F, Petrova-Benedict R, MacKay N, Mitchell G, Lambert M, Morin C, De Braekeleer M, Laframboise R, Gagne R, Robinson B H. Am J Hum Genet. 1993;53:481&#x2013;487.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1682348</ArticleId><ArticleId IdType="pubmed">8392290</ArticleId></ArticleIdList></Reference><Reference><Citation>De Braekeleer M, Dao T N. Hum Biol. 1994;66:205&#x2013;223.</Citation><ArticleIdList><ArticleId IdType="pubmed">8194844</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee N, Daly M J, Delmonte T, Lander E S, Xu F, Hudson T J, Mitchell G A, Morin C C, Robinson B H, Rioux J D. Am J Hum Genet. 2001;68:397&#x2013;409.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1235273</ArticleId><ArticleId IdType="pubmed">11156535</ArticleId></ArticleIdList></Reference><Reference><Citation>Kent W J. Genome Res. 2002;12:656&#x2013;664.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC187518</ArticleId><ArticleId IdType="pubmed">11932250</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramaswamy S, Tamayo P, Rifkin R, Mukherjee S, Yeang C H, Angelo M, Ladd C, Reich M, Latulippe E, Mesirov J P, et al. Proc Natl Acad Sci USA. 2001;98:15149&#x2013;15154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC64998</ArticleId><ArticleId IdType="pubmed">11742071</ArticleId></ArticleIdList></Reference><Reference><Citation>Miki R, Kadota K, Bono H, Mizuno Y, Tomaru Y, Carninci P, Itoh M, Shibata K, Kawai J, Konno H, et al. Proc Natl Acad Sci USA. 2001;98:2199&#x2013;2204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC30115</ArticleId><ArticleId IdType="pubmed">11226216</ArticleId></ArticleIdList></Reference><Reference><Citation>Su A I, Cooke M P, Ching K A, Hakak Y, Walker J R, Wiltshire T, Orth A P, Vega R G, Sapinoso L M, Moqrich A, et al. Proc Natl Acad Sci USA. 2002;99:4465&#x2013;4470.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC123671</ArticleId><ArticleId IdType="pubmed">11904358</ArticleId></ArticleIdList></Reference><Reference><Citation>Scharfe C, Zaccaria P, Hoertnagel K, Jaksch M, Klopstock T, Lill R, Prokisch H, Gerbitz K D, Mewes H W, Meitinger T. Nucleic Acids Res. 1999;27:153&#x2013;155.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC148118</ArticleId><ArticleId IdType="pubmed">9847163</ArticleId></ArticleIdList></Reference><Reference><Citation>Mootha V K, Wei M C, Buttle K F, Scorrano L, Panoutsakopoulou V, Mannella C A, Korsmeyer S J. EMBO J. 2001;20:661&#x2013;671.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC145422</ArticleId><ArticleId IdType="pubmed">11179211</ArticleId></ArticleIdList></Reference><Reference><Citation>Parvari R, Brodyansky I, Elpeleg O, Moses S, Landau D, Hershkovitz E. Am J Hum Genet. 2001;69:869&#x2013;875.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1226072</ArticleId><ArticleId IdType="pubmed">11524703</ArticleId></ArticleIdList></Reference><Reference><Citation>Burge C, Karlin S. J Mol Biol. 1997;268:78&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">9149143</ArticleId></ArticleIdList></Reference><Reference><Citation>DeRisi J L, Iyer V R, Brown P O. Science. 1997;278:680&#x2013;686.</Citation><ArticleIdList><ArticleId IdType="pubmed">9381177</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandey A, Mann M. Nature. 2000;405:837&#x2013;846.</Citation><ArticleIdList><ArticleId IdType="pubmed">10866210</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou J, Wang F, McKeehan W L. In Vitro Cell Dev Biol Anim. 1994;30:111&#x2013;114.</Citation><ArticleIdList><ArticleId IdType="pubmed">8012652</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, McKeehan W L. Genomics. 2002;79:124&#x2013;136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3241999</ArticleId><ArticleId IdType="pubmed">11827465</ArticleId></ArticleIdList></Reference><Reference><Citation>Mili S, Shu H J, Zhao Y, Pinol-Roma S. Mol Cell Biol. 2001;21:7307&#x2013;7319.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC99905</ArticleId><ArticleId IdType="pubmed">11585913</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostrowski J, Wyrwicz L, Rychlewski L, Bomsztyk K. J Biol Chem. 2002;277:6303&#x2013;6310.</Citation><ArticleIdList><ArticleId IdType="pubmed">11741984</ArticleId></ArticleIdList></Reference><Reference><Citation>Manthey G M, Przybyla-Zawislak B, McEwen J E. Eur J Biochem. 1998;255:156&#x2013;161.</Citation><ArticleIdList><ArticleId IdType="pubmed">9692914</ArticleId></ArticleIdList></Reference><Reference><Citation>Manthey G M, McEwen J E. EMBO J. 1995;14:4031&#x2013;4043.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC394481</ArticleId><ArticleId IdType="pubmed">7664742</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12540902</PMID><DateCompleted><Year>2003</Year><Month>03</Month><Day>07</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0028-0836</ISSN><JournalIssue CitedMedium="Print"><Volume>421</Volume><Issue>6921</Issue><PubDate><Year>2003</Year><Month>Jan</Month><Day>23</Day></PubDate></JournalIssue><Title>Nature</Title><ISOAbbreviation>Nature</ISOAbbreviation></Journal><ArticleTitle>Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders.</ArticleTitle><Pagination><StartPage>373</StartPage><EndPage>379</EndPage><MedlinePgn>373-9</MedlinePgn></Pagination><Abstract><AbstractText>The expansion of a CAG repeat coding for polyglutamine in otherwise unrelated gene products is central to eight neurodegenerative disorders including Huntington's disease. It has been well documented that expanded polyglutamine fragments, cleaved from their respective full-length proteins, form microscopically visible aggregates in affected individuals and in transgenic mice. The contribution of polyglutamine oligomers to neurodegeneration, however, is controversial. The azo-dye Congo red binds preferentially to beta-sheets containing amyloid fibrils and can specifically inhibit oligomerization and disrupt preformed oligomers. Here we show that inhibition of polyglutamine oligomerization by Congo red prevents ATP depletion and caspase activation, preserves normal cellular protein synthesis and degradation functions, and promotes the clearance of expanded polyglutamine repeats in vivo and in vitro. Infusion of Congo red into a transgenic mouse model of Huntington's disease, well after the onset of symptoms, promotes the clearance of expanded repeats in vivo and exerts marked protective effects on survival, weight loss and motor function. We conclude that oligomerization is a crucial determinant in the biochemical properties of expanded polyglutamine that are central to their chronic cytotoxicity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>S&#xe1;nchez</LastName><ForeName>Ivelisse</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahlke</LastName><ForeName>Christian</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Junying</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>DP1 OD000580</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nature</MedlineTA><NlmUniqueID>0410462</NlmUniqueID><ISSNLinking>0028-0836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011993">Recombinant Fusion Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>26700-71-0</RegistryNumber><NameOfSubstance UI="C097188">polyglutamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>3U05FHG59S</RegistryNumber><NameOfSubstance UI="D003224">Congo Red</NameOfSubstance></Chemical><Chemical><RegistryNumber>8L70Q75FXE</RegistryNumber><NameOfSubstance UI="D000255">Adenosine Triphosphate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D020169">Caspases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000255" MajorTopicYN="N">Adenosine Triphosphate</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020169" MajorTopicYN="N">Caspases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016923" MajorTopicYN="N">Cell Death</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003224" MajorTopicYN="N">Congo Red</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004789" MajorTopicYN="N">Enzyme Activation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006816" MajorTopicYN="N">Huntington Disease</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020836" MajorTopicYN="N">Protein Structure, Quaternary</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011993" MajorTopicYN="N">Recombinant Fusion Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019680" MajorTopicYN="N">Trinucleotide Repeat Expansion</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015431" MajorTopicYN="N">Weight Loss</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2002</Year><Month>8</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2002</Year><Month>11</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>1</Month><Day>24</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>3</Month><Day>8</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>1</Month><Day>24</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12540902</ArticleId><ArticleId IdType="doi">10.1038/nature01301</ArticleId><ArticleId IdType="pii">nature01301</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12551931</PMID><DateCompleted><Year>2003</Year><Month>04</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0021-9258</ISSN><JournalIssue CitedMedium="Print"><Volume>278</Volume><Issue>10</Issue><PubDate><Year>2003</Year><Month>Mar</Month><Day>07</Day></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J Biol Chem</ISOAbbreviation></Journal><ArticleTitle>The Notch ligands, Delta1 and Jagged2, are substrates for presenilin-dependent "gamma-secretase" cleavage.</ArticleTitle><Pagination><StartPage>7751</StartPage><EndPage>7754</EndPage><MedlinePgn>7751-4</MedlinePgn></Pagination><Abstract><AbstractText>The evolutionary conserved Notch signaling pathway is involved in cell fate specification and mediated by molecular interactions between the Notch receptors and the Notch ligands, Delta, Serrate, and Jagged. In this report, we demonstrate that like Notch, Delta1 and Jagged2 are subject to presenilin (PS)-dependent, intramembranous "gamma-secretase" processing, resulting in the production of soluble intracellular derivatives. Moreover, and paralleling the observation that expression of familial Alzheimer's disease-linked mutant PS1 compromises production of Notch S3/NICD, we show that the PS-dependent production of Delta1 cytoplasmic derivatives are also reduced in cells expressing mutant PS1. These studies led us to conclude that a similar molecular apparatus is responsible for intramembranous processing of Notch and it's ligands. To assess the potential role of the cytoplasmic derivative on nuclear transcriptional events, we expressed a Delta1-Gal4VP16 chimera and demonstrated marked transcriptional stimulation of a luciferase-based reporter. Our findings offer the proposal that Delta1 and Jagged2 play dual roles as activators of Notch receptor signaling and as receptors that mediate nuclear signaling events via gamma-secretase-generated cytoplasmic domains.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ikeuchi</LastName><ForeName>Takeshi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurobiology, Pharmacology, and Physiology, The University of Chicago, Illinois 60637, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sisodia</LastName><ForeName>Sangram S</ForeName><Initials>SS</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>AG021494</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>01</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002352">Carrier Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017931">DNA Primers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036341">Intercellular Signaling Peptides and Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047908">Intracellular Signaling Peptides and Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C490504">JAG2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C490503">Jag2 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000072101">Jagged-2 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008024">Ligands</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508853">PSEN1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053764">Presenilin-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C064045">delta protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D053829">Amyloid Precursor Protein Secretases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010450">Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.-</RegistryNumber><NameOfSubstance UI="D016282">Aspartic Acid Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.46</RegistryNumber><NameOfSubstance UI="C509280">BACE1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.46</RegistryNumber><NameOfSubstance UI="C509282">Bace1 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053829" MajorTopicYN="N">Amyloid Precursor Protein Secretases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016282" MajorTopicYN="N">Aspartic Acid Endopeptidases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002352" MajorTopicYN="N">Carrier Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017931" MajorTopicYN="N">DNA Primers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010450" MajorTopicYN="N">Endopeptidases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006868" MajorTopicYN="N">Hydrolysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036341" MajorTopicYN="N">Intercellular Signaling Peptides and Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047908" MajorTopicYN="N">Intracellular Signaling Peptides and Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072101" MajorTopicYN="N">Jagged-2 Protein</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008024" MajorTopicYN="N">Ligands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053764" MajorTopicYN="N">Presenilin-1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017386" MajorTopicYN="N">Sequence Homology, Amino Acid</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>1</Month><Day>29</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>4</Month><Day>24</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>1</Month><Day>29</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12551931</ArticleId><ArticleId IdType="doi">10.1074/jbc.C200711200</ArticleId><ArticleId IdType="pii">S0021-9258(20)86382-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12552040</PMID><DateCompleted><Year>2003</Year><Month>02</Month><Day>05</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-632X</ISSN><JournalIssue CitedMedium="Internet"><Volume>60</Volume><Issue>2</Issue><PubDate><Year>2003</Year><Month>Jan</Month><Day>28</Day></PubDate></JournalIssue><Title>Neurology</Title><ISOAbbreviation>Neurology</ISOAbbreviation></Journal><ArticleTitle>MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD.</ArticleTitle><Pagination><StartPage>253</StartPage><EndPage>260</EndPage><MedlinePgn>253-60</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To assess the feasibility of using MRI measurements as a surrogate endpoint for disease progression in a therapeutic trial for AD.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A total of 362 patients with probable AD from 38 different centers participated in the MRI portion of a 52-week randomized placebo-controlled trial of milameline, a muscarinic receptor agonist. The therapeutic trial itself was not completed due to projected lack of efficacy on interim analysis; however, the MRI arm of the study was continued. Of the 362 subjects who underwent a baseline MRI study, 192 subjects underwent a second MRI 1 year later. Hippocampal volume and temporal horn volume were measured from the MRI scans.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The annualized percent changes in hippocampal volume (-4.9%) and temporal horn volume (16.1%) in the study patients were consistent with data from prior single-site studies. Correlations between the rate of MRI volumetric change and change in behavioral/cognitive measures were greater for the temporal horn than for the hippocampus. Decline over time was more consistently seen with imaging measures, 99% of the time for the hippocampus, than behavioral/cognitive measures (p &lt; 0.001). Greater consistency in MRI than behavioral/clinical measures resulted in markedly lower estimated sample size requirements for clinical trials. The estimated number of subjects per arm required to detect a 50% reduction in the rate of decline over 1 year are: AD Assessment Scale-cognitive subscale 320; Mini-Mental Status Examination 241; hippocampal volume 21; temporal horn volume 54.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The consistency of MRI measurements obtained across sites, and the consistency between the multisite milameline data and that obtained in prior single-site studies, demonstrate the technical feasibility of using structural MRI measures as a surrogate endpoint of disease progression in therapeutic trials. However, validation of imaging as a biomarker of therapeutic efficacy in AD awaits a positive trial.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jack</LastName><ForeName>C R</ForeName><Initials>CR</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Department of Diagnostic Radiology, Mayo Clinic and Foundation, Rochester, MN, USA. jack.clifford@mayo.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slomkowski</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Gracon</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Hoover</LastName><ForeName>T M</ForeName><Initials>TM</Initials></Author><Author ValidYN="Y"><LastName>Felmlee</LastName><ForeName>J P</ForeName><Initials>JP</Initials></Author><Author ValidYN="Y"><LastName>Stewart</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Shiung</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>O'Brien</LastName><ForeName>P C</ForeName><Initials>PC</Initials></Author><Author ValidYN="Y"><LastName>Cha</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Knopman</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Petersen</LastName><ForeName>R C</ForeName><Initials>RC</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG011378</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurology</MedlineTA><NlmUniqueID>0401060</NlmUniqueID><ISSNLinking>0028-3878</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004095">Dihydropyridines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018721">Muscarinic Agonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018696">Neuroprotective Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010091">Oximes</NameOfSubstance></Chemical><Chemical><RegistryNumber>R9X77R42FN</RegistryNumber><NameOfSubstance UI="C084978">milameline</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004095" MajorTopicYN="N">Dihydropyridines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="N">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="Y">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018721" MajorTopicYN="N">Muscarinic Agonists</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018696" MajorTopicYN="N">Neuroprotective Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010091" MajorTopicYN="N">Oximes</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012016" MajorTopicYN="N">Reference Values</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018401" MajorTopicYN="N">Sample Size</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017678" MajorTopicYN="N">Sex Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>1</Month><Day>29</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>2</Month><Day>6</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>1</Month><Day>29</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2009</Year><Month>9</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12552040</ArticleId><ArticleId IdType="mid">NIHMS136225</ArticleId><ArticleId IdType="pmc">PMC2745302</ArticleId><ArticleId IdType="doi">10.1212/01.wnl.0000042480.86872.03</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fox NC, Freeborough PA. Brain atrophy progression measured from registered serial MRI: validation and application to Alzheimer's disease. Journal of Magnetic Resonance Imaging. 1997;7:1069&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">9400851</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox NC, Scahill RI, Crum WR, Rossor MN. Correlation between rates of brain atrophy and cognitive decline in AD. Neurology. 1999;52:1687&#x2013;1689.</Citation><ArticleIdList><ArticleId IdType="pubmed">10331700</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox NC, Freeborough PA, Rossor MN. Visualization and quantification of rates of atrophy in Alzheimer's disease. The Lancet. 1996;348:94&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">8676724</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox NC, Cousens S, Scahill R, et al. Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease. Arch Neurol. 2000;57:339&#x2013;443.</Citation><ArticleIdList><ArticleId IdType="pubmed">10714659</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeborough PA, Fox NC. The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI. IEEE Trans on Medical Imaging. 1997;15:623&#x2013;629.</Citation><ArticleIdList><ArticleId IdType="pubmed">9368118</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR, Jr., Petersen RC, Xu Y, et al. The rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology. 1998;51:993&#x2013;999.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2768817</ArticleId><ArticleId IdType="pubmed">9781519</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR, Jr., Petersen RC, Xu Y, O'Brien PC, Smith Ge, Ivnik RJ, et al. Rates of Hippocampal Atrophy in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease. Neurology. 2000;55:484&#x2013;489.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2724764</ArticleId><ArticleId IdType="pubmed">10953178</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry E, Tomlinson B, Blessed G, Bergmann K, Givson P, Perry R. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. BMJ. 1978;2:1457&#x2013;1459.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1608703</ArticleId><ArticleId IdType="pubmed">719462</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitehouse PJ, Price DL, Strubel RG, Clark AW, Coyle JT, DeLong MR. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science. 1982;215:1237&#x2013;1239.</Citation><ArticleIdList><ArticleId IdType="pubmed">7058341</ArticleId></ArticleIdList></Reference><Reference><Citation>Folstein MF, Folstein SE, McHugh PR. Mini Mental State&#x201d;: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research. 1975;12:189&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="pubmed">1202204</ArticleId></ArticleIdList></Reference><Reference><Citation>Felmlee JP, Lanners DM, Rettman DW, Hangiandreou NJ, Jack CRJ. MR imaging quality control measurements taken as part of a Multi-center trial: Initial results. Radiology. 1997;205:619.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR, Jr., Petersen RC, O'Brien PC, et al. MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease. Neurology. 1992;42:183&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">1734300</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR, Jr., Petersen RC, Xu YC, et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology. 1997;49:786&#x2013;794.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2730601</ArticleId><ArticleId IdType="pubmed">9305341</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR, Jr., Twomey CK, Zinsmeister AR, et al. Anterior temporal lobes and hippocampal formations: normative volumetric measurements for MR images in young adults. Radiology. 1989;172:549&#x2013;554.</Citation><ArticleIdList><ArticleId IdType="pubmed">2748838</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR, Jr., Sharbrough FW, Twomey CK, Cascino GD, Hirschorn KA, Marsh WR, et al. Temporal Lobe Seizures: Lateralization with MR volume measurements of hippocampal formation. Radiology. 1990;175:423&#x2013;429.</Citation><ArticleIdList><ArticleId IdType="pubmed">2183282</ArticleId></ArticleIdList></Reference><Reference><Citation>Killiany RJ, Moss MB, Albert MS, et al. Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. Arch Neurol. 1993;50:949&#x2013;954.</Citation><ArticleIdList><ArticleId IdType="pubmed">8363449</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasuski JS, Alexander GE, Horwitz B, Daly EM, Murphy DG, Rapoport SI, et al. Volumes of medial temporal lobe structures in patients with Alzheimer's disease and mild cognitive impairment (and in healthy controls). Biological Psychiatry. 1998;43:60&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">9442345</ArticleId></ArticleIdList></Reference><Reference><Citation>Laakso MP, Soininen H, Partanen K, et al. Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: correlation with memory functions. J of Neural Transmission. 1995;9:73&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">7605591</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehericy S, Baulac M, Chiras J, et al. Amygdalohippocampal MR volume measurements in the early stages of Alzheimer disease. AJNR. 1994;15:927&#x2013;937.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8332162</ArticleId><ArticleId IdType="pubmed">8059663</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearlson GD, Harris GJ, Powers RE, et al. Quantitative changes in mesial temporal volume, regional cerebral blood flow, and cognition in Alzheimer's disease. Arch Gen Psychiatry. 1992;49:402&#x2013;408.</Citation><ArticleIdList><ArticleId IdType="pubmed">1586276</ArticleId></ArticleIdList></Reference><Reference><Citation>Laakso MP, Lehtovirta M, Partanen K, Riekkinen PJ, Soininen H. Hippocampus in Alzheimer's disease: A 3-year followup MRI study. Biol Psychiatry. 2000;47:557&#x2013;561.</Citation><ArticleIdList><ArticleId IdType="pubmed">10715362</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox NC, Warrington EK, Freeborough PA, et al. Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study. Brain. 1996;119:2001&#x2013;2007.</Citation><ArticleIdList><ArticleId IdType="pubmed">9010004</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen RC, Jack CR, Jr., Xu YC, Waring SC, O'Brien PC, Smith GE, et al. Memory and MRI-based hippocampal volumes in aging and Alzheimer's disease. Neurology. 2000;54:581&#x2013;587.</Citation><ArticleIdList><ArticleId IdType="pubmed">10680786</ArticleId></ArticleIdList></Reference><Reference><Citation>DeCarli C, Haxby JV, Gillette JA, et al. Longitudinal changes in lateral ventricular volume in patients with dementia of the Alzheimer type. Neurology. 1993;42:2029&#x2013;2036.</Citation><ArticleIdList><ArticleId IdType="pubmed">1407587</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12552120</PMID><DateCompleted><Year>2003</Year><Month>03</Month><Day>18</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>100</Volume><Issue>3</Issue><PubDate><Year>2003</Year><Month>Feb</Month><Day>04</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: a magnetic resonance microscopy and stereologic analysis.</ArticleTitle><Pagination><StartPage>1381</StartPage><EndPage>1386</EndPage><MedlinePgn>1381-6</MedlinePgn></Pagination><Abstract><AbstractText>High-resolution magnetic resonance microscopy (MRM) was used to determine regional brain volumetric changes in a mouse model of Alzheimer's disease. These transgenic (Tg) mice overexpress human mutant amyloid precursor protein (APP) V717F under control of platelet-derived growth factor promoter (PDAPP mice), and cortical and hippocampal beta-amyloid (Abeta) deposits accumulate in heterozygotes after 8-10 mos. We used MRM to obtain 3D volumetric data on mouse brains imaged in their skulls to define genotype- and age-related changes. Hippocampal, cerebellar, and brain volumes and corpus callosum length were quantified in 40-, 100-, 365-, and 630-day-old mice. Measurements taken at age 100 days, before Abeta deposition, revealed a 12.3% reduction of hippocampus volume in Tg mice compared with WT controls. This reduction persisted without progression to age 21 mos. A significant 18% increase in hippocampal volume occurred between 40 and 630 days in WT mice, and no corresponding significant increase occurred in Tg mice. Cavalieri volume estimates of hippocampal subfields from 100-day-old Tg mice further localized a 28% volume deficit in the dentate gyrus. In addition, corpus callosum length was reduced by approximately 25% in Tg mice at all ages analyzed. In summary, reduced hippocampal volume and corpus callosum length can be detected by MRM before Abeta deposition. We conclude that overexpression of APP and amyloid may initiate pathologic changes before the appearance of plaques, suggesting novel targets for the treatment of Alzheimer's disease and further reinforcing the need for early diagnosis and treatment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Redwine</LastName><ForeName>Jeffrey M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Neurome, Incorporated, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kosofsky</LastName><ForeName>Barry</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Jacobs</LastName><ForeName>Russell E</ForeName><Initials>RE</Initials></Author><Author ValidYN="Y"><LastName>Games</LastName><ForeName>Dora</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Reilly</LastName><ForeName>John F</ForeName><Initials>JF</Initials></Author><Author ValidYN="Y"><LastName>Morrison</LastName><ForeName>John H</ForeName><Initials>JH</Initials></Author><Author ValidYN="Y"><LastName>Young</LastName><ForeName>Warren G</ForeName><Initials>WG</Initials></Author><Author ValidYN="Y"><LastName>Bloom</LastName><ForeName>Floyd E</ForeName><Initials>FE</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>01</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020574">Proto-Oncogene Proteins c-sis</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003337" MajorTopicYN="N">Corpus Callosum</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018891" MajorTopicYN="N">Dentate Gyrus</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006579" MajorTopicYN="N">Heterozygote</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020574" MajorTopicYN="N">Proto-Oncogene Proteins c-sis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014018" MajorTopicYN="N">Tissue Distribution</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>1</Month><Day>29</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>3</Month><Day>19</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>1</Month><Day>29</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2003</Year><Month>8</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12552120</ArticleId><ArticleId IdType="pmc">PMC298781</ArticleId><ArticleId IdType="doi">10.1073/pnas.242746599</ArticleId><ArticleId IdType="pii">242746599</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hardy J, Selkoe D. Science. 2002;297:353&#x2013;356.</Citation><ArticleIdList><ArticleId IdType="pubmed">12130773</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J, Hardy J, Fischbeck K. Science. 2002;296:1991&#x2013;1995.</Citation><ArticleIdList><ArticleId IdType="pubmed">12065827</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo Y M, Emmerling M R, Vigo-Pelfrey C, Kasunic T C, Kirkpatrick J B, Murdoch G H, Ball M J, Roher A E. J Biol Chem. 1996;271:4077&#x2013;4081.</Citation><ArticleIdList><ArticleId IdType="pubmed">8626743</ArticleId></ArticleIdList></Reference><Reference><Citation>Lue L F, Kuo Y M, Roher A E, Brachova L, Shen Y, Sue L, Beach T, Kurth J H, Rydel R E, Rogers J. Am J Pathol. 1999;155:853&#x2013;862.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1866907</ArticleId><ArticleId IdType="pubmed">10487842</ArticleId></ArticleIdList></Reference><Reference><Citation>Borchelt D R, Thinakaran G, Eckman C B, Lee M K, Davenport F, Ratovitsky T, Prada C M, Kim G, Seekins S, Yager D, et al. Neuron. 1996;17:1005&#x2013;1013.</Citation><ArticleIdList><ArticleId IdType="pubmed">8938131</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemere C A, Lopera F, Kosik K S, Lendon C L, Ossa J, Saido T C, Yamaguchi H, Ruiz A, Martinez A, Madrigal L, et al. Nat Med. 1996;2:1146&#x2013;1150.</Citation><ArticleIdList><ArticleId IdType="pubmed">8837617</ArticleId></ArticleIdList></Reference><Reference><Citation>Citron M, Oltersdorf T, Haass C, McConlogue L, Hung A Y, Seubert P, Vigo-Pelfrey C, Lieberburg I, Selkoe D J. Nature. 1992;360:672&#x2013;674.</Citation><ArticleIdList><ArticleId IdType="pubmed">1465129</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai X D, Golde T E, Younkin S G. Science. 1993;259:514&#x2013;516.</Citation><ArticleIdList><ArticleId IdType="pubmed">8424174</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki N, Cheung T T, Cai X D, Odaka A, Otvos L, Eckman C, Golde T E, Younkin S G. Science. 1994;264:1336&#x2013;1340.</Citation><ArticleIdList><ArticleId IdType="pubmed">8191290</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, Bird T D, Hardy J, Hutton M, Kukull W, et al. Nat Med. 1996;2:864&#x2013;870.</Citation><ArticleIdList><ArticleId IdType="pubmed">8705854</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami K, Irie K, Morimoto A, Ohigashi H, Shindo M, Nagao M, Shimizu T, Shirasawa T. Biochem Biophys Res Commun. 2002;294:5&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">12054732</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins L S, Rodems J M, Catalano R, Quon D, Cordell B. Proc Natl Acad Sci USA. 1995;92:4402&#x2013;4406.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC41952</ArticleId><ArticleId IdType="pubmed">7753818</ArticleId></ArticleIdList></Reference><Reference><Citation>Mucke L, Masliah E, Yu G Q, Mallory M, Rockenstein E M, Tatsuno G, Hu K, Kholodenko D, Johnson-Wood K, McConlogue L. J Neurosci. 2000;20:4050&#x2013;4058.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772621</ArticleId><ArticleId IdType="pubmed">10818140</ArticleId></ArticleIdList></Reference><Reference><Citation>Sturchler-Pierrat C, Abramowski D, Duke M, Wiederhold K H, Mistl C, Rothacher S, Ledermann B, Burki K, Frey P, Paganetti P A, et al. Proc Natl Acad Sci USA. 1997;94:13287&#x2013;13292.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC24301</ArticleId><ArticleId IdType="pubmed">9371838</ArticleId></ArticleIdList></Reference><Reference><Citation>Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F, et al. Nature. 1995;373:523&#x2013;527.</Citation><ArticleIdList><ArticleId IdType="pubmed">7845465</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodart J C, Mathis C, Saura J, Bales K R, Paul S M, Ungerer A. Neurobiol Dis. 2000;7:71&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">10783292</ArticleId></ArticleIdList></Reference><Reference><Citation>Moechars D, Dewachter I, Lorent K, Reverse D, Baekelandt V, Naidu A, Tesseur I, Spittaels K, Haute C V, Checler F, et al. J Biol Chem. 1999;274:6483&#x2013;6492.</Citation><ArticleIdList><ArticleId IdType="pubmed">10037741</ArticleId></ArticleIdList></Reference><Reference><Citation>Chui D H, Tanahashi H, Ozawa K, Ikeda S, Checler F, Ueda O, Suzuki H, Araki W, Inoue H, Shirotani K, et al. Nat Med. 1999;5:560&#x2013;564.</Citation><ArticleIdList><ArticleId IdType="pubmed">10229234</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsia A Y, Masliah E, McConlogue L, Yu G Q, Tatsuno G, Hu K, Kholodenko D, Malenka R C, Nicoll R A, Mucke L. Proc Natl Acad Sci USA. 1999;96:3228&#x2013;3233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC15924</ArticleId><ArticleId IdType="pubmed">10077666</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar-Singh S, Dewachter I, Moechars D, Lubke U, De Jonghe C, Ceuterick C, Checler F, Naidu A, Cordell B, Cras P, et al. Neurobiol Dis. 2000;7:9&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">10671319</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzjohn S M, Morton R A, Kuenzi F, Rosahl T W, Shearman M, Lewis H, Smith D, Reynolds D S, Davies C H, Collingridge G L, et al. J Neurosci. 2001;21:4691&#x2013;4698.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6762352</ArticleId><ArticleId IdType="pubmed">11425896</ArticleId></ArticleIdList></Reference><Reference><Citation>Murrell J, Farlow M, Ghetti B, Benson M D. Science. 1991;254:97&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">1925564</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G, Chen K, Knox J, Inglis J, Bernard A, Martin S, Justice A, McConlogue L, Games D, Freedman S, et al. Nature. 2000;408:975&#x2013;979.</Citation><ArticleIdList><ArticleId IdType="pubmed">11140684</ArticleId></ArticleIdList></Reference><Reference><Citation>Bard F, Cannon C, Barbour R, Burke R, Games D, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, et al. Nat Med. 2000;6:916&#x2013;919.</Citation><ArticleIdList><ArticleId IdType="pubmed">10932230</ArticleId></ArticleIdList></Reference><Reference><Citation>Hennig J, Nauerth A, Friedburg H. Magn Reson Med. 1986;3:823&#x2013;833.</Citation><ArticleIdList><ArticleId IdType="pubmed">3821461</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu L, Airey D C, Williams R W. J Neurosci. 2001;21:3503&#x2013;3514.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6762463</ArticleId><ArticleId IdType="pubmed">11331379</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyman B T, Van Horsen G W, Damasio A R, Barnes C L. Science. 1984;225:1168&#x2013;1170.</Citation><ArticleIdList><ArticleId IdType="pubmed">6474172</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison J H, Hof P R. Science. 1997;278:412&#x2013;419.</Citation><ArticleIdList><ArticleId IdType="pubmed">9334292</ArticleId></ArticleIdList></Reference><Reference><Citation>Bussi&#xe8;re T, Friend P D, Sadeghi N, Wicinski B, Lin G I, Bouras C, Giannakopoulos P, Robakis N K, Morrison J H, Perl D P, Hof P R. Neuroscience. 2002;112:75&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">12044473</ArticleId></ArticleIdList></Reference><Reference><Citation>Killiany R J, Hyman B T, Gomez-Isla T, Moss M B, Kikinis R, Jolesz F, Tanzi R, Jones K, Albert M S. Neurology. 2002;58:1188&#x2013;1196.</Citation><ArticleIdList><ArticleId IdType="pubmed">11971085</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacchino J, Criado J R, Games D, Henriksen S. Brain Res. 2000;876:185&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pubmed">10973607</ArticleId></ArticleIdList></Reference><Reference><Citation>Huitron-Resendiz S, Sanchez-Alavez M, Gallegos R, Berg G, Crawford E, Giacchino J L, Games D, Henriksen S J, Criado J R. Brain Res. 2002;928:126&#x2013;137.</Citation><ArticleIdList><ArticleId IdType="pubmed">11844479</ArticleId></ArticleIdList></Reference><Reference><Citation>Larson J, Lynch G, Games D, Seubert P. Brain Res. 1999;840:23&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">10517949</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Alavez M, Gallegos R A, Kalafut M A, Games D, Henriksen S J, Criado J R. Neurosci Lett. 2002;330:45&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">12213631</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodart J C, Mathis C, Bales K R, Paul S M, Ungerer A. Neurosci Lett. 1999;277:49&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">10643895</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack C R, Petersen R C, Xu Y C, Waring S C, O'Brien P C, Tangalos E G, Smith G E, Ivnik R J, Kokmen E. Neurology. 1997;49:786&#x2013;794.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2730601</ArticleId><ArticleId IdType="pubmed">9305341</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack C, Petersen R, Xu Y, O'Brien P, Smith G, Ivnik R, Boeve B, Waring S, Tangalos E, Kokmen E. Neurology. 1999;52:1397&#x2013;1403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2730146</ArticleId><ArticleId IdType="pubmed">10227624</ArticleId></ArticleIdList></Reference><Reference><Citation>Killiany R J, Gomez-Isla T, Moss M, Kikinis R, Sandor T, Jolesz F, Tanzi R, Jones K, Hyman B T, Albert M S. Ann Neurol. 2000;47:430&#x2013;439.</Citation><ArticleIdList><ArticleId IdType="pubmed">10762153</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox N, Crum W, Scahill R, Stevens J, Janssen J, Rossor M. Lancet. 2001;358:201&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pubmed">11476837</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez-Isla T, Price J L, McKeel D W, Morris J C, Growdon J H, Hyman B T. J Neurosci. 1996;16:4491&#x2013;4500.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6578866</ArticleId><ArticleId IdType="pubmed">8699259</ArticleId></ArticleIdList></Reference><Reference><Citation>Convit A, De L M, Tarshish C, De S S, Tsui W, Rusinek H, George A. Neurobiol Aging. 1997;18:131&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pubmed">9258889</ArticleId></ArticleIdList></Reference><Reference><Citation>Price J L, Ko A I, Wade M J, Tsou S K, McKeel D W, Morris J C. Arch Neurol. 2001;58:1395&#x2013;1402.</Citation><ArticleIdList><ArticleId IdType="pubmed">11559310</ArticleId></ArticleIdList></Reference><Reference><Citation>Masliah E, Mallory M, Alford M, De Teresa R, Hansen L A, McKeel D W, Morris J C. Neurology. 2001;56:127&#x2013;129.</Citation><ArticleIdList><ArticleId IdType="pubmed">11148253</ArticleId></ArticleIdList></Reference><Reference><Citation>Hof, P. R., Bussiere, T., Gold, G., Kovari, E., Giannakopoulos, P., Bouras, C., Perl, D. P. &amp; Morrison, J. H. (2003) J. Neuropathol. Exp. Neurol. 62, in press.</Citation><ArticleIdList><ArticleId IdType="pubmed">12528818</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H Y, Lee D H, D'Andrea M R, Peterson P A, Shank R P, Reitz A B. J Biol Chem. 2000;275:5626&#x2013;5632.</Citation><ArticleIdList><ArticleId IdType="pubmed">10681545</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H Y, Lee D H, Davis C B, Shank R P. J Neurochem. 2000;75:1155&#x2013;1161.</Citation><ArticleIdList><ArticleId IdType="pubmed">10936198</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaar M, Zhai S, Fine R E, Eisenhauer P B, Arble B L, Stewart K B, Gilchrest B A. J Biol Chem. 2002;277:7720&#x2013;7725.</Citation><ArticleIdList><ArticleId IdType="pubmed">11756426</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh D M, Klyubin I, Fadeeva J V, Cullen W K, Anwyl R, Wolfe M S, Rowan M J, Selkoe D J. Nature. 2002;416:535&#x2013;539.</Citation><ArticleIdList><ArticleId IdType="pubmed">11932745</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H W, Pasternak J F, Kuo H, Ristic H, Lambert M P, Chromy B, Viola K L, Klein W L, Stine W B, Krafft G A, et al. Brain Res. 2002;924:133&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pubmed">11750898</ArticleId></ArticleIdList></Reference><Reference><Citation>Berzin T M, Zipser B D, Rafii M S, Kuo-Leblanc V, Yancopoulos G D, Glass D J, Fallon J R, Stopa E G. Neurobiol Aging. 2000;21:349&#x2013;355.</Citation><ArticleIdList><ArticleId IdType="pubmed">10867220</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotman S L, Halfter W, Cole G J. Mol Cell Neurosci. 2000;15:183&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="pubmed">10673326</ArticleId></ArticleIdList></Reference><Reference><Citation>Verbeek M M, Otte-Holler I, van den Born J, van den Heuvel L P, David G, Wesseling P, de Waal R M. Am J Pathol. 1999;155:2115&#x2013;2125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1866925</ArticleId><ArticleId IdType="pubmed">10595940</ArticleId></ArticleIdList></Reference><Reference><Citation>Bose C M, Qiu D, Bergamaschi A, Gravante B, Bossi M, Villa A, Rupp F, Malgaroli A. J Neurosci. 2000;20:9086&#x2013;9095.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6773041</ArticleId><ArticleId IdType="pubmed">11124985</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira A. J Cell Sci. 1999;112:4729&#x2013;4738.</Citation><ArticleIdList><ArticleId IdType="pubmed">10574720</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantych K B, Ferreira A. J Neurosci. 2001;21:6802&#x2013;6809.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6763100</ArticleId><ArticleId IdType="pubmed">11517268</ArticleId></ArticleIdList></Reference><Reference><Citation>Allinquant B, Hantraye P, Mailleux P, Moya K, Bouillot C, Prochiantz A. J Cell Biol. 1995;128:919&#x2013;927.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2120404</ArticleId><ArticleId IdType="pubmed">7876315</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattson M P. J Neurobiol. 1994;25:439&#x2013;450.</Citation><ArticleIdList><ArticleId IdType="pubmed">7915758</ArticleId></ArticleIdList></Reference><Reference><Citation>Mucke L, Abraham C R, Masliah E. Ann NY Acad Sci. 1996;777:82&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">8624131</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez R G, Zheng H, Van der Ploeg L H, Koo E H. J Neurosci. 1997;17:9407&#x2013;9414.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6573428</ArticleId><ArticleId IdType="pubmed">9390996</ArticleId></ArticleIdList></Reference><Reference><Citation>Phinney A L, Calhoun M E, Wolfer D P, Lipp H P, Zheng H, Jucker M. Neuroscience. 1999;90:1207&#x2013;1216.</Citation><ArticleIdList><ArticleId IdType="pubmed">10338291</ArticleId></ArticleIdList></Reference><Reference><Citation>Magara F, Muller U, Li Z W, Lipp H P, Weissmann C, Stagljar M, Wolfer D P. Proc Natl Acad Sci USA. 1999;96:4656&#x2013;4661.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC16388</ArticleId><ArticleId IdType="pubmed">10200318</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampel H, Teipel S J, Alexander G E, Horwitz B, Teichberg D, Schapiro M B, Rapoport S I. Arch Neurol. 1998;55:193&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="pubmed">9482361</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampel H, Teipel S J, Alexander G E, Pogarell O, Rapoport S I, Moller H J. J Neural Transm. 2002;109:837&#x2013;855.</Citation><ArticleIdList><ArticleId IdType="pubmed">12111472</ArticleId></ArticleIdList></Reference><Reference><Citation>Pantel J, Schroder J, Jauss M, Essig M, Minakaran R, Schonknecht P, Schneider G, Schad L R, Knopp M V. Psychiatry Res. 1999;90:181&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pubmed">10466737</ArticleId></ArticleIdList></Reference><Reference><Citation>Teipel S J, Hampel H, Pietrini P, Alexander G E, Horwitz B, Daley E, Moller H J, Schapiro M B, Rapoport S I. Arch Neurol. 1999;56:467&#x2013;473.</Citation><ArticleIdList><ArticleId IdType="pubmed">10199337</ArticleId></ArticleIdList></Reference><Reference><Citation>Teipel S J, Bayer W, Alexander G E, Zebuhr Y, Teichberg D, Kulic L, Schapiro M B, Moller H J, Rapoport S I, Hampel H. Arch Neurol. 2002;59:243&#x2013;248.</Citation><ArticleIdList><ArticleId IdType="pubmed">11843695</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12553913</PMID><DateCompleted><Year>2003</Year><Month>02</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0092-8674</ISSN><JournalIssue CitedMedium="Print"><Volume>112</Volume><Issue>2</Issue><PubDate><Year>2003</Year><Month>Jan</Month><Day>24</Day></PubDate></JournalIssue><Title>Cell</Title><ISOAbbreviation>Cell</ISOAbbreviation></Journal><ArticleTitle>The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function.</ArticleTitle><Pagination><StartPage>257</StartPage><EndPage>269</EndPage><MedlinePgn>257-69</MedlinePgn></Pagination><Abstract><AbstractText>Brain-derived neurotrophic factor (BDNF) modulates hippocampal plasticity and hippocampal-dependent memory in cell models and in animals. We examined the effects of a valine (val) to methionine (met) substitution in the 5' pro-region of the human BDNF protein. In human subjects, the met allele was associated with poorer episodic memory, abnormal hippocampal activation assayed with fMRI, and lower hippocampal n-acetyl aspartate (NAA), assayed with MRI spectroscopy. Neurons transfected with met-BDNF-GFP showed lower depolarization-induced secretion, while constitutive secretion was unchanged. Furthermore, met-BDNF-GFP failed to localize to secretory granules or synapses. These results demonstrate a role for BDNF and its val/met polymorphism in human memory and hippocampal function and suggest val/met exerts these effects by impacting intracellular trafficking and activity-dependent secretion of BDNF.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Egan</LastName><ForeName>Michael F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Clinical Brain Disorders Branch, National Institute of Mental Health, Room 4s-235, 10 Center Drive, Bethesda, MD 20892, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kojima</LastName><ForeName>Masami</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Callicott</LastName><ForeName>Joseph H</ForeName><Initials>JH</Initials></Author><Author ValidYN="Y"><LastName>Goldberg</LastName><ForeName>Terry E</ForeName><Initials>TE</Initials></Author><Author ValidYN="Y"><LastName>Kolachana</LastName><ForeName>Bhaskar S</ForeName><Initials>BS</Initials></Author><Author ValidYN="Y"><LastName>Bertolino</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Zaitsev</LastName><ForeName>Eugene</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Gold</LastName><ForeName>Bert</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Goldman</LastName><ForeName>David</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Dean</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Bai</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Weinberger</LastName><ForeName>Daniel R</ForeName><Initials>DR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell</MedlineTA><NlmUniqueID>0413066</NlmUniqueID><ISSNLinking>0092-8674</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019208">Brain-Derived Neurotrophic Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>30KYC7MIAI</RegistryNumber><NameOfSubstance UI="D001224">Aspartic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>997-55-7</RegistryNumber><NameOfSubstance UI="C000179">N-acetylaspartate</NameOfSubstance></Chemical><Chemical><RegistryNumber>AE28F7PNPL</RegistryNumber><NameOfSubstance UI="D008715">Methionine</NameOfSubstance></Chemical><Chemical><RegistryNumber>HG18B9YRS7</RegistryNumber><NameOfSubstance UI="D014633">Valine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Cell. 2003 Jan 24;112(2):144-5. doi: 10.1016/s0092-8674(03)00039-4.</RefSource><PMID Version="1">12553902</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001224" MajorTopicYN="N">Aspartic Acid</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019208" MajorTopicYN="N">Brain-Derived Neurotrophic Factor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003712" MajorTopicYN="N">Dendrites</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008568" MajorTopicYN="N">Memory</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008715" MajorTopicYN="N">Methionine</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008856" MajorTopicYN="N">Microscopy, Fluorescence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017354" MajorTopicYN="N">Point Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D021381" MajorTopicYN="N">Protein Transport</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D022142" MajorTopicYN="N">Secretory Vesicles</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013569" MajorTopicYN="N">Synapses</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014633" MajorTopicYN="N">Valine</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>1</Month><Day>30</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>2</Month><Day>15</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>1</Month><Day>30</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12553913</ArticleId><ArticleId IdType="doi">10.1016/s0092-8674(03)00035-7</ArticleId><ArticleId IdType="pii">S0092867403000357</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12554684</PMID><DateCompleted><Year>2003</Year><Month>09</Month><Day>24</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0964-6906</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>3</Issue><PubDate><Year>2003</Year><Month>Feb</Month><Day>01</Day></PubDate></JournalIssue><Title>Human molecular genetics</Title><ISOAbbreviation>Hum Mol Genet</ISOAbbreviation></Journal><ArticleTitle>Suppression of polyglutamine-induced protein aggregation in Caenorhabditis elegans by torsin proteins.</ArticleTitle><Pagination><StartPage>307</StartPage><EndPage>319</EndPage><MedlinePgn>307-19</MedlinePgn></Pagination><Abstract><AbstractText>Torsion dystonia is an autosomal dominant movement disorder characterized by involuntary, repetitive muscle contractions and twisted postures. The most severe early-onset form of dystonia has been linked to mutations in the human DYT1 (TOR1A) gene encoding a protein termed torsinA. While causative genetic alterations have been identified, the function of torsin proteins and the molecular mechanism underlying dystonia remain unknown. Phylogenetic analysis of the torsin protein family indicates these proteins share distant sequence similarity with the large and diverse family of AAA+ proteins. We have established the nematode, Caenorhabditis elegans, as a model system for examining torsin activity. Using an in vivo assay for polyglutamine repeat-induced protein aggregation in living animals, we have determined that ectopic overexpression of both human and C. elegans torsin proteins results in a dramatic reduction of polyglutamine-dependent protein aggregation in a manner similar to that previously reported for molecular chaperones. The suppressive effects of torsin overexpression persisted as animals aged, whereas a mutant nematode torsin protein was incapable of ameliorating aggregate formation. Antibody staining of transgenic animals indicated that both the C. elegans torsin-related protein TOR-2 and ubiquitin were localized to sites of protein aggregation. These data represent the first functional evidence of a role for torsins in effectively managing protein folding and suggest that possible breakdown in a neuroprotective mechanism that is, in part, mediated by torsins may be responsible for the neuronal dysfunction associated with dystonia.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Caldwell</LastName><ForeName>Guy A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>The University of Alabama, Department of Biological Sciences, Tuscaloosa, AL 35487, USA. gcaldwel@bama.ua.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Songsong</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Sexton</LastName><ForeName>Elaina G</ForeName><Initials>EG</Initials></Author><Author ValidYN="Y"><LastName>Gelwix</LastName><ForeName>Christopher C</ForeName><Initials>CC</Initials></Author><Author ValidYN="Y"><LastName>Bevel</LastName><ForeName>John Paul</ForeName><Initials>JP</Initials></Author><Author ValidYN="Y"><LastName>Caldwell</LastName><ForeName>Kim A</ForeName><Initials>KA</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R15 NS043176</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Hum Mol Genet</MedlineTA><NlmUniqueID>9208958</NlmUniqueID><ISSNLinking>0964-6906</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D029742">Caenorhabditis elegans Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018832">Molecular Chaperones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011506">Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>26700-71-0</RegistryNumber><NameOfSubstance UI="C097188">polyglutamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.1.-</RegistryNumber><NameOfSubstance UI="D017853">Phosphotransferases (Alcohol Group Acceptor)</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.1.-</RegistryNumber><NameOfSubstance UI="C472494">let-363 protein, C elegans</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017173" MajorTopicYN="N">Caenorhabditis elegans</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029742" MajorTopicYN="N">Caenorhabditis elegans Proteins</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004421" MajorTopicYN="N">Dystonia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018832" MajorTopicYN="N">Molecular Chaperones</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017853" MajorTopicYN="N">Phosphotransferases (Alcohol Group Acceptor)</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011506" MajorTopicYN="N">Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016415" MajorTopicYN="N">Sequence Alignment</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>1</Month><Day>30</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>9</Month><Day>25</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>1</Month><Day>30</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12554684</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddg027</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12560553</PMID><DateCompleted><Year>2003</Year><Month>02</Month><Day>21</Day></DateCompleted><DateRevised><Year>2007</Year><Month>11</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1095-9203</ISSN><JournalIssue CitedMedium="Internet"><Volume>299</Volume><Issue>5607</Issue><PubDate><Year>2003</Year><Month>Jan</Month><Day>31</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>Prevention of transthyretin amyloid disease by changing protein misfolding energetics.</ArticleTitle><Pagination><StartPage>713</StartPage><EndPage>716</EndPage><MedlinePgn>713-6</MedlinePgn></Pagination><Abstract><AbstractText>Genetic evidence suggests that inhibition of amyloid fibril formation by small molecules should be effective against amyloid diseases. Known amyloid inhibitors appear to function by shifting the aggregation equilibrium away from the amyloid state. Here, we describe a series of transthyretin amyloidosis inhibitors that functioned by increasing the kinetic barrier associated with misfolding, preventing amyloidogenesis by stabilizing the native state. The trans-suppressor mutation, threonine 119 --&gt; methionine 119, which is known to ameliorate familial amyloid disease, also functioned through kinetic stabilization, implying that this small-molecule strategy should be effective in treating amyloid diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hammarstr&#xf6;m</LastName><ForeName>Per</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Chemistry and The Skaggs Institute of Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiseman</LastName><ForeName>R Luke</ForeName><Initials>RL</Initials></Author><Author ValidYN="Y"><LastName>Powers</LastName><ForeName>Evan T</ForeName><Initials>ET</Initials></Author><Author ValidYN="Y"><LastName>Kelly</LastName><ForeName>Jeffery W</ForeName><Initials>JW</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>DK 46335</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011228">Prealbumin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D021122">Protein Subunits</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000686" MajorTopicYN="N">Amyloidosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011228" MajorTopicYN="N">Prealbumin</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011489" MajorTopicYN="N">Protein Denaturation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017510" MajorTopicYN="Y">Protein Folding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020836" MajorTopicYN="N">Protein Structure, Quaternary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D021122" MajorTopicYN="N">Protein Subunits</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013489" MajorTopicYN="N">Suppression, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013816" MajorTopicYN="N">Thermodynamics</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>2</Month><Day>1</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>2</Month><Day>22</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>2</Month><Day>1</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12560553</ArticleId><ArticleId IdType="doi">10.1126/science.1079589</ArticleId><ArticleId IdType="pii">299/5607/713</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12563035</PMID><DateCompleted><Year>2003</Year><Month>04</Month><Day>01</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>100</Volume><Issue>4</Issue><PubDate><Year>2003</Year><Month>Feb</Month><Day>18</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>JNK-interacting protein-1 promotes transcription of A beta protein precursor but not A beta precursor-like proteins, mechanistically different than Fe65.</ArticleTitle><Pagination><StartPage>1729</StartPage><EndPage>1734</EndPage><MedlinePgn>1729-34</MedlinePgn></Pagination><Abstract><AbstractText>Processing of the amyloid beta protein precursor (A beta PP) by the beta and gamma secretases leads to the production of two small peptides, amyloid beta and the A beta PP intracellular domain (AID, or called elsewhere AICD). Whereas the role of amyloid beta in the pathogenesis of Alzheimer's disease has been studied extensively, only recently has information begun to accumulate as to the role of AID. Functions identified for AID include its ability to trigger apoptosis and a role in regulating gene transcription, particularly in combination with the A beta PP binding protein Fe65. Here, we report that AID in combination with Janus kinase interacting protein-1 (JIP-1) can activate gene expression. We demonstrate that the mechanism is different from activation in combination with Fe65 by first showing that although Fe65 enters the nucleus in the absence of full-length A beta PP, JIP-1 does not. Additionally, JIP-1-induced activation is Tip60 independent, whereas a complex with AID, Fe65, and Tip60 is formed for Fe65-induced activation. Finally, and probably most interestingly, we show that although the A beta PP family members APLP1 and APLP2 (for amyloid beta precursor-like protein) can cause activation in combination with Fe65, APLP1 and APLP2 show little or no activation in combination with JIP-1. This activity for the AID fragment may help explain the unique functions of A beta PP relative to its other family members, and changes in gene expression found in Alzheimer's disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Scheinfeld</LastName><ForeName>Meir H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsuda</LastName><ForeName>Shuji</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>D'Adamio</LastName><ForeName>Luciano</ForeName><Initials>L</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 GM007288</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32GM07288</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>01</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C091042">APBB1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D048868">Adaptor Proteins, Signal Transducing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002352">Carrier Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C490666">MAPK8IP1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009687">Nuclear Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D048868" MajorTopicYN="Y">Adaptor Proteins, Signal Transducing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002352" MajorTopicYN="N">Carrier Proteins</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009687" MajorTopicYN="N">Nuclear Proteins</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014158" MajorTopicYN="N">Transcription, Genetic</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>2</Month><Day>4</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>4</Month><Day>2</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>2</Month><Day>4</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2003</Year><Month>8</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12563035</ArticleId><ArticleId IdType="pmc">PMC149901</ArticleId><ArticleId IdType="doi">10.1073/pnas.0437908100</ArticleId><ArticleId IdType="pii">0437908100</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sisodia S S, St. George-Hyslop P H. Nat Rev Neurosci. 2002;3:281&#x2013;290.</Citation><ArticleIdList><ArticleId IdType="pubmed">11967558</ArticleId></ArticleIdList></Reference><Reference><Citation>Koo E H. Traffic. 2002;3:763&#x2013;770.</Citation><ArticleIdList><ArticleId IdType="pubmed">12383342</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy J, Selkoe D J. Science. 2002;297:353&#x2013;356.</Citation><ArticleIdList><ArticleId IdType="pubmed">12130773</ArticleId></ArticleIdList></Reference><Reference><Citation>Obrenovich M E, Joseph J A, Atwood C S, Perry G, Smith M A. Neurobiol Aging. 2002;23:1097&#x2013;1099.</Citation><ArticleIdList><ArticleId IdType="pubmed">12470809</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith M A, Casadesus G, Joseph J A, Perry G. Free Radical Biol Med. 2002;33:1194&#x2013;1199.</Citation><ArticleIdList><ArticleId IdType="pubmed">12398927</ArticleId></ArticleIdList></Reference><Reference><Citation>Passer B, Pellegrini L, Russo C, Siegel R M, Lenardo M J, Schettini G, Bachmann M, Tabaton M, D'Adamio L. J Alzheimer's Dis. 2000;2:289&#x2013;301.</Citation><ArticleIdList><ArticleId IdType="pubmed">12214090</ArticleId></ArticleIdList></Reference><Reference><Citation>Cupers P, Orlans I, Craessaerts K, Annaert W, De Strooper B. J Neurochem. 2001;78:1168&#x2013;1178.</Citation><ArticleIdList><ArticleId IdType="pubmed">11553691</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown M S, Ye J, Rawson R B, Goldstein J L. Cell. 2000;100:391&#x2013;398.</Citation><ArticleIdList><ArticleId IdType="pubmed">10693756</ArticleId></ArticleIdList></Reference><Reference><Citation>Artavanis-Tsakonas S, Rand M, Lake R J. Science. 1999;284:770&#x2013;776.</Citation><ArticleIdList><ArticleId IdType="pubmed">10221902</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopan R, Goate A. Neuron. 2002;33:321&#x2013;324.</Citation><ArticleIdList><ArticleId IdType="pubmed">11832221</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao X, Sudhof T C. Science. 2001;293:115&#x2013;120.</Citation><ArticleIdList><ArticleId IdType="pubmed">11441186</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y, Pimplikar S W. Proc Natl Acad Sci USA. 2001;98:14979&#x2013;14984.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC64969</ArticleId><ArticleId IdType="pubmed">11742091</ArticleId></ArticleIdList></Reference><Reference><Citation>Spana E P, Doe C Q. Neuron. 1996;17:21&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">8755475</ArticleId></ArticleIdList></Reference><Reference><Citation>Roncarati R, Sestan N, Scheinfeld M H, Berechid B E, Lopez P A, McGlade J C, Meucci O, Rakic P, D'Adamio L. Proc Natl Acad Sci USA. 2002;99:7102&#x2013;7707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC124535</ArticleId><ArticleId IdType="pubmed">12011466</ArticleId></ArticleIdList></Reference><Reference><Citation>Baek S H, Ohgi K A, Rose D W, Koo E H, Glass C K, Rosenfeld M G. Cell. 2002;110:55&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">12150997</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayer T A, Cappai R, Masters C L, Beyreuther K, Multhaup G. Mol Psychiatry. 1999;4:524&#x2013;528.</Citation><ArticleIdList><ArticleId IdType="pubmed">10578233</ArticleId></ArticleIdList></Reference><Reference><Citation>Paliga K, Peraus G, Kreger S, Durrwang U, Hesse L, Multhaup G, Masters C L, Beyreuther K, Weidemann A. Eur J Biochem. 1997;250:354&#x2013;363.</Citation><ArticleIdList><ArticleId IdType="pubmed">9428684</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu K P, Zoukhri D, Zieske J D, Dartt D A, Sergheraert C, Loing E, Yu F S. Am J Physiol. 2001;281:C603&#x2013;C614.</Citation><ArticleIdList><ArticleId IdType="pubmed">11443060</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo A C, Thinakaran G, Slunt H H, Sisodia S S. J Biol Chem. 1995;270:12641&#x2013;12645.</Citation><ArticleIdList><ArticleId IdType="pubmed">7759513</ArticleId></ArticleIdList></Reference><Reference><Citation>Galvan V, Chen S, Lu D, Logvinova A, Goldsmith P, Koo E H, Bredesen D E. J Neurochem. 2002;82:283&#x2013;294.</Citation><ArticleIdList><ArticleId IdType="pubmed">12124429</ArticleId></ArticleIdList></Reference><Reference><Citation>Cowan C M, Thai J, Krajewski S, Reed J C, Nicholson D W, Kaufmann S H, Roskams A J. J Neurosci. 2001;21:7099&#x2013;7109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6763014</ArticleId><ArticleId IdType="pubmed">11549720</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheinfeld M H, Ghersi E, Laky K, Fowlkes B J, D'Adamio L. J Biol Chem. 2002;277:44195&#x2013;44201.</Citation><ArticleIdList><ArticleId IdType="pubmed">12228233</ArticleId></ArticleIdList></Reference><Reference><Citation>Borg J P, Ooi J, Levy E, Margolis B. Mol Cell Biol. 1996;16:6229&#x2013;6241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC231626</ArticleId><ArticleId IdType="pubmed">8887653</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiore F, Zambrano N, Minopoli G, Donini V, Duilio A, Russo T. J Biol Chem. 1995;270:30853&#x2013;30856.</Citation><ArticleIdList><ArticleId IdType="pubmed">8537337</ArticleId></ArticleIdList></Reference><Reference><Citation>Trommsdorff M, Borg J P, Margolis B, Herz J. J Biol Chem. 1998;273:33556&#x2013;33560.</Citation><ArticleIdList><ArticleId IdType="pubmed">9837937</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarr P E, Roncarati R, Pelicci G, Pelicci P G, D'Adamio L. J Biol Chem. 2002;277:16798&#x2013;16804.</Citation><ArticleIdList><ArticleId IdType="pubmed">11877420</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuda S, Yasukawa T, Humma Y, Ito Y, Niikura T, Hiraki T, Hirai S, Ohno S, Kita Y, Kawasumi M, et al. J Neurosci. 2001;21:6597&#x2013;6607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6763068</ArticleId><ArticleId IdType="pubmed">11517249</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheinfeld M H, Roncarati R, Vito P, Lopez P A, Abdallah M, D'Adamio L. J Biol Chem. 2002;277:3767&#x2013;3775.</Citation><ArticleIdList><ArticleId IdType="pubmed">11724784</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickens M, Rogers J S, Cavanagh J, Raitano A, Xia Z, Halpern J R, Greenberg M E, Sawyers C L, Davis R J. Science. 1997;277:693&#x2013;696.</Citation><ArticleIdList><ArticleId IdType="pubmed">9235893</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitmarsh A J, Cavanagh J, Tournier C, Yasuda J, Davis R J. Science. 1998;281:1671&#x2013;1674.</Citation><ArticleIdList><ArticleId IdType="pubmed">9733513</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu X, Raina A K, Rottkamp C A, Aliev G, Perry G, Boux H, Smith M A. J Neurochem. 2001;76:435&#x2013;441.</Citation><ArticleIdList><ArticleId IdType="pubmed">11208906</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoji M, Iwakami N, Takeuchi S, Waragai M, Suzuki M, Kanazawa I, Lippa C F, Ono S, Okazawa H. Mol Brain Res. 2000;85:221&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pubmed">11146125</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds C H, Utton M A, Gibb G M, Yates A, Anderton B H. J Neurochem. 1997;68:1736&#x2013;1744.</Citation><ArticleIdList><ArticleId IdType="pubmed">9084448</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu X, Castellani R J, Takeda A, Nunomura A, Atwood C S, Perry G, Smith M A. Mech Aging Dev. 2001;123:39&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">11640950</ArticleId></ArticleIdList></Reference><Reference><Citation>Seiffert D, Bradley J D, Rominger C M, Rominger D H, Yang F, Meredith J E, Jr, Wang Q, Roach A H, Thompson L A, Spitz S M, et al. J Biol Chem. 2000;275:34086&#x2013;34091.</Citation><ArticleIdList><ArticleId IdType="pubmed">10915801</ArticleId></ArticleIdList></Reference><Reference><Citation>Dovey H F, John V, Anderson J P, Chen L Z, de Saint Andrieu P, Fang L Y, Freedman S B, Folmer B, Goldbach E, Holsztynska E J, et al. J Neurochem. 2001;76:173&#x2013;181.</Citation><ArticleIdList><ArticleId IdType="pubmed">11145990</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfe M S, Xia W, Ostaszewski B L, Diehl T S, Kimberly W T, Selkoe D J. Nature. 1999;398:513&#x2013;517.</Citation><ArticleIdList><ArticleId IdType="pubmed">10206644</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S H, Leem J Y, Lah J J, Slunt H H, Levey A I, Thinakaran G, Sisodia S S. J Biol Chem. 2001;276:43343&#x2013;43350.</Citation><ArticleIdList><ArticleId IdType="pubmed">11564743</ArticleId></ArticleIdList></Reference><Reference><Citation>Minopoli G, de Candia P, Bonetti A, Faraonio R, Zambrano N, Russo T. J Biol Chem. 2001;276:6545&#x2013;6550.</Citation><ArticleIdList><ArticleId IdType="pubmed">11085987</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikura T, Ogryzko V V, Grigoriev M, Groisman R, Wang J, Horikoshi M, Scully R, Qin J, Nakatani Y. Cell. 2000;102:463&#x2013;473.</Citation><ArticleIdList><ArticleId IdType="pubmed">10966108</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroeter E H, Kisslinger J A, Kopan R. Nature. 1998;393:382&#x2013;386.</Citation><ArticleIdList><ArticleId IdType="pubmed">9620803</ArticleId></ArticleIdList></Reference><Reference><Citation>Sestan N, Artavanis-Tsakonas S, Rakic P. Science. 1999;286:741&#x2013;746.</Citation><ArticleIdList><ArticleId IdType="pubmed">10531053</ArticleId></ArticleIdList></Reference><Reference><Citation>von Koch C S, Zheng H, Chen H, Trumbauer M, Thinakaran G, van der Ploeg L H, Price D L, Sisodia S S. Neurobiol Aging. 1997;18:661&#x2013;669.</Citation><ArticleIdList><ArticleId IdType="pubmed">9461064</ArticleId></ArticleIdList></Reference><Reference><Citation>Heber S, Herms S, Gajic V, Hainfellner J, Aguzzi A, Rulicke T, von Kretzschmar H, von Koch C, Sisodia S, Tremml P, et al. J Neurosci. 2000;20:7951&#x2013;7963.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772747</ArticleId><ArticleId IdType="pubmed">11050115</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12566568</PMID><DateCompleted><Year>2003</Year><Month>04</Month><Day>01</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>100</Volume><Issue>4</Issue><PubDate><Year>2003</Year><Month>Feb</Month><Day>18</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology.</ArticleTitle><Pagination><StartPage>2023</StartPage><EndPage>2028</EndPage><MedlinePgn>2023-8</MedlinePgn></Pagination><Abstract><AbstractText>Transgenic PDAPP mice, which express a disease-linked isoform of the human amyloid precursor protein, exhibit CNS pathology that is similar to Alzheimer's disease. In an age-dependent fashion, the mice develop plaques containing beta-amyloid peptide (Abeta) and exhibit neuronal dystrophy and synaptic loss. It has been shown in previous studies that pathology can be prevented and even reversed by immunization of the mice with the Abeta peptide. Similar protection could be achieved by passive administration of some but not all monoclonal antibodies against Abeta. In the current studies we sought to define the optimal antibody response for reducing neuropathology. Immune sera with reactivity against different Abeta epitopes and monoclonal antibodies with different isotypes were examined for efficacy both ex vivo and in vivo. The studies showed that: (i) of the purified or elicited antibodies tested, only antibodies against the N-terminal regions of Abeta were able to invoke plaque clearance; (ii) plaque binding correlated with a clearance response and neuronal protection, whereas the ability of antibodies to capture soluble Abeta was not necessarily correlated with efficacy; (iii) the isotype of the antibody dramatically influenced the degree of plaque clearance and neuronal protection; (iv) high affinity of the antibody for Fc receptors on microglial cells seemed more important than high affinity for Abeta itself; and (v) complement activation was not required for plaque clearance. These results indicate that antibody Fc-mediated plaque clearance is a highly efficient and effective process for protection against neuropathology in an animal model of Alzheimer's disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bard</LastName><ForeName>Fr&#xe9;d&#xe9;rique</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Elan Pharmaceuticals, 800 Gateway Boulevard, South San Francisco, CA 94080, USA. frederique.bard@elan.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbour</LastName><ForeName>Robin</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Cannon</LastName><ForeName>Catherine</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Carretto</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Fox</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Games</LastName><ForeName>Dora</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Guido</LastName><ForeName>Teresa</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Hoenow</LastName><ForeName>Kathleen</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Kang</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Johnson-Wood</LastName><ForeName>Kelly</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Karen</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Kholodenko</LastName><ForeName>Dora</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Celeste</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Mike</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Motter</LastName><ForeName>Ruth</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Minh</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Reed</LastName><ForeName>Amanda</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Schenk</LastName><ForeName>Dale</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Pearl</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Vasquez</LastName><ForeName>Nicki</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Seubert</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Yednock</LastName><ForeName>Ted</ForeName><Initials>T</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>02</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000939">Epitopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Proc Natl Acad Sci U S A. 2004 Aug 3;101(3):11526</RefSource></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000918" MajorTopicYN="Y">Antibody Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018604" MajorTopicYN="N">Epitope Mapping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000939" MajorTopicYN="N">Epitopes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>2</Month><Day>5</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>4</Month><Day>2</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>2</Month><Day>5</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2003</Year><Month>8</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12566568</ArticleId><ArticleId IdType="pmc">PMC149952</ArticleId><ArticleId IdType="doi">10.1073/pnas.0436286100</ArticleId><ArticleId IdType="pii">0436286100</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, et al. Nature. 1999;400:173&#x2013;177.</Citation><ArticleIdList><ArticleId IdType="pubmed">10408445</ArticleId></ArticleIdList></Reference><Reference><Citation>Janus C, Pearson J, McLaurin J A, Mathews P M, Jiang Y, Schmidt S D, Chishti M A, Horne P, Heslin D, French J, et al. Nature. 2000;408:979&#x2013;982.</Citation><ArticleIdList><ArticleId IdType="pubmed">11140685</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan D, Diamond D M, Gottschall P E, Ugen K E, Dickey C, Hardy J, Duff K, Jantzen P, DiCarlo G, Wilcock D, et al. Nature. 2000;408:982&#x2013;985.</Citation><ArticleIdList><ArticleId IdType="pubmed">11140686</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigurdsson E M, Scholtzova H, Mehta P D, Frangione B, Wisniewski T. Am J Pathol. 2001;159:439&#x2013;447.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1850561</ArticleId><ArticleId IdType="pubmed">11485902</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon B, Koppel R, Frenkel D, Hanan-Aharon E. Proc Natl Acad Sci USA. 1997;94:4109&#x2013;4112.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC20576</ArticleId><ArticleId IdType="pubmed">9108113</ArticleId></ArticleIdList></Reference><Reference><Citation>DeMattos R B, Bales K R, Cummins D J, Dodart J C, Paul S M, Holtzman D M. Proc Natl Acad Sci USA. 2001;98:8850&#x2013;8855.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC37524</ArticleId><ArticleId IdType="pubmed">11438712</ArticleId></ArticleIdList></Reference><Reference><Citation>Bard F, Cannon C, Barbour R, Burke R L, Games D, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, et al. Nat Med. 2000;6:916&#x2013;919.</Citation><ArticleIdList><ArticleId IdType="pubmed">10932230</ArticleId></ArticleIdList></Reference><Reference><Citation>Bacskai B J, Kajdasz S T, McLellan M E, Games D, Seubert P, Schenk D, Hyman B T. J Neurosci. 2002;22:7873&#x2013;7878.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6758112</ArticleId><ArticleId IdType="pubmed">12223540</ArticleId></ArticleIdList></Reference><Reference><Citation>Dodart J C, Bales K R, Gannon K S, Greene S J, DeMattos R B, Mathis C, DeLong C A, Wu S, Wu X, Holtzman D M, Paul S. Nat Neurosci. 2002;5:452&#x2013;457.</Citation><ArticleIdList><ArticleId IdType="pubmed">11941374</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam J P. Proc Natl Acad Sci USA. 1988;85:5409&#x2013;5413.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC281766</ArticleId><ArticleId IdType="pubmed">3399498</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson J P, Esch F S, Keim P S, Sambamurti K, Lieberburg I, Robakis N K. Neurosci Lett. 1991;128:126&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pubmed">1922940</ArticleId></ArticleIdList></Reference><Reference><Citation>Seubert P, Vigo-Pelfrey C, Esch F, Lee M, Dovey H, Davis D, Sinha S, Schlossmacher M, Whaley J, Swindlehurst C, et al. Nature. 1992;359:325&#x2013;327.</Citation><ArticleIdList><ArticleId IdType="pubmed">1406936</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson-Wood K, Lee M, Motter R, Hu K, Gordon G, Barbour R, Khan K, Gordon M, Tan H, Games D, et al. Proc Natl Acad Sci USA. 1997;94:1550&#x2013;1555.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC19829</ArticleId><ArticleId IdType="pubmed">9037091</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravetch J V, Kinet J-P. Annu Rev Immunol. 1991;9:457&#x2013;492.</Citation><ArticleIdList><ArticleId IdType="pubmed">1910686</ArticleId></ArticleIdList></Reference><Reference><Citation>Takai T, Li M, Sylvestre D, Clynes R, Ravetch J V. Cell. 1994;76:519&#x2013;529.</Citation><ArticleIdList><ArticleId IdType="pubmed">8313472</ArticleId></ArticleIdList></Reference><Reference><Citation>Fossati-Jimack L, Ioan-Facsinay A, Reininger L, Chicheportiche Y, Watanabe N, Saito T, Hofhuis F M A, Engelbert Gessner J, Schiller C, Schmidt R E, et al. J Exp Med. 2000;191:1293&#x2013;1302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2193130</ArticleId><ArticleId IdType="pubmed">10770797</ArticleId></ArticleIdList></Reference><Reference><Citation>Azeredo da Silveira S, Kikuchi S, Fossati-Jimack L, Moll T, Saito T, Verbeek J S, Botto M, Walport M J, Carroll M, Izui S. J Exp Med. 2002;195:665&#x2013;672.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2193744</ArticleId><ArticleId IdType="pubmed">11901193</ArticleId></ArticleIdList></Reference><Reference><Citation>Arulanandam B P, O'Toole M, Metzger D W. J Infect Dis. 1999;180:940&#x2013;949.</Citation><ArticleIdList><ArticleId IdType="pubmed">10479116</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerhard W, Mozdzanowska K, Furchner M, Washko G, Maiese K. Immunol Rev. 1997;159:95&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pubmed">9416505</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson J A, Hevey M, Bakken R, Guest S, Bray M, Schmaljohn A L, Hart M K. Science. 2000;287:1664&#x2013;1666.</Citation><ArticleIdList><ArticleId IdType="pubmed">10698744</ArticleId></ArticleIdList></Reference><Reference><Citation>Frenkel D, Balass M, Solomon B. J Neuroimmunol. 1998;88:85&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">9688328</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson C F, Mosser D M. J Immunol. 2002;168:3697&#x2013;3701.</Citation><ArticleIdList><ArticleId IdType="pubmed">11937518</ArticleId></ArticleIdList></Reference><Reference><Citation>Senior K. Lancet Neurol. 2002;1:3.</Citation><ArticleIdList><ArticleId IdType="pubmed">12849527</ArticleId></ArticleIdList></Reference><Reference><Citation>Schenk D. Nat Rev Neurosci. 2002;3:824&#x2013;828.</Citation><ArticleIdList><ArticleId IdType="pubmed">12360327</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12574416</PMID><DateCompleted><Year>2003</Year><Month>02</Month><Day>21</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1529-2401</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>3</Issue><PubDate><Year>2003</Year><Month>Feb</Month><Day>01</Day></PubDate></JournalIssue><Title>The Journal of neuroscience : the official journal of the Society for Neuroscience</Title><ISOAbbreviation>J Neurosci</ISOAbbreviation></Journal><ArticleTitle>Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits.</ArticleTitle><Pagination><StartPage>876</StartPage><EndPage>882</EndPage><MedlinePgn>876-82</MedlinePgn></Pagination><Abstract><AbstractText>Recently it was demonstrated that exposure of the developing brain during the period of synaptogenesis to drugs that block NMDA glutamate receptors or drugs that potentiate GABA(A) receptors can trigger widespread apoptotic neurodegeneration. All currently used general anesthetic agents have either NMDA receptor-blocking or GABA(A) receptor-enhancing properties. To induce or maintain a surgical plane of anesthesia, it is common practice in pediatric or obstetrical medicine to use agents from these two classes in combination. Therefore, the question arises whether this practice entails significant risk of inducing apoptotic neurodegeneration in the developing human brain. To begin to address this problem, we have administered to 7-d-old infant rats a combination of drugs commonly used in pediatric anesthesia (midazolam, nitrous oxide, and isoflurane) in doses sufficient to maintain a surgical plane of anesthesia for 6 hr, and have observed that this causes widespread apoptotic neurodegeneration in the developing brain, deficits in hippocampal synaptic function, and persistent memory/learning impairments.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jevtovic-Todorovic</LastName><ForeName>Vesna</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Virginia Health System, Charlottesville, Virginia 22908, USA. vj3w@virginia.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hartman</LastName><ForeName>Richard E</ForeName><Initials>RE</Initials></Author><Author ValidYN="Y"><LastName>Izumi</LastName><ForeName>Yukitoshi</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Benshoff</LastName><ForeName>Nicholas D</ForeName><Initials>ND</Initials></Author><Author ValidYN="Y"><LastName>Dikranian</LastName><ForeName>Krikor</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Zorumski</LastName><ForeName>Charles F</ForeName><Initials>CF</Initials></Author><Author ValidYN="Y"><LastName>Olney</LastName><ForeName>John W</ForeName><Initials>JW</Initials></Author><Author ValidYN="Y"><LastName>Wozniak</LastName><ForeName>David F</ForeName><Initials>DF</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>AG 11355</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG011355</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>Z01 DA000406</GrantID><Acronym>ImNIH</Acronym><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HD037100</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MH 45493</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG018434</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HD 37100</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AA012951</GrantID><Acronym>AA</Acronym><Agency>NIAAA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG 18434</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>DA 05072</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K08 DA 00406</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AA 12951</GrantID><Acronym>AA</Acronym><Agency>NIAAA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH045493</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R37 HD037100</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DA005072</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosci</MedlineTA><NlmUniqueID>8102140</NlmUniqueID><ISSNLinking>0270-6474</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000777">Anesthetics</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004338">Drug Combinations</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018691">Excitatory Amino Acid Antagonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018755">GABA Agonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016194">Receptors, N-Methyl-D-Aspartate</NameOfSubstance></Chemical><Chemical><RegistryNumber>CYS9AKD70P</RegistryNumber><NameOfSubstance UI="D007530">Isoflurane</NameOfSubstance></Chemical><Chemical><RegistryNumber>K50XQU1029</RegistryNumber><NameOfSubstance UI="D009609">Nitrous Oxide</NameOfSubstance></Chemical><Chemical><RegistryNumber>R60L0SM5BC</RegistryNumber><NameOfSubstance UI="D008874">Midazolam</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000777" MajorTopicYN="N">Anesthetics</DescriptorName><QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000831" MajorTopicYN="N">Animals, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001522" MajorTopicYN="N">Behavior, Animal</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000254" MajorTopicYN="N">growth &amp; development</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004338" MajorTopicYN="N">Drug Combinations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018691" MajorTopicYN="N">Excitatory Amino Acid Antagonists</DescriptorName><QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018755" MajorTopicYN="N">GABA Agonists</DescriptorName><QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007530" MajorTopicYN="N">Isoflurane</DescriptorName><QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007859" MajorTopicYN="N">Learning Disabilities</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017774" MajorTopicYN="N">Long-Term Potentiation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018782" MajorTopicYN="N">Maze Learning</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008569" MajorTopicYN="N">Memory Disorders</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008874" MajorTopicYN="N">Midazolam</DescriptorName><QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009609" MajorTopicYN="N">Nitrous Oxide</DescriptorName><QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016194" MajorTopicYN="N">Receptors, N-Methyl-D-Aspartate</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009435" MajorTopicYN="N">Synaptic Transmission</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>2</Month><Day>8</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>2</Month><Day>22</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>2</Month><Day>8</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2003</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12574416</ArticleId><ArticleId IdType="pmc">PMC6741934</ArticleId><ArticleId IdType="pii">23/3/876</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.23-03-00876.2003</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aggleton JP, Brown MW. Episodic memory, amnesia, and the hippocampal-anterior thalamic axis. Behav Brain Sci. 1999;22:425&#x2013;489.</Citation><ArticleIdList><ArticleId IdType="pubmed">11301518</ArticleId></ArticleIdList></Reference><Reference><Citation>Corso TD, Sesma MA, Tenkova TI, Der TC, Wozniak DF, Farber NB, Olney JW. Multifocal brain damage induced by phencyclidine is augmented by pilocarpine. Brain Res. 1997;33:533&#x2013;541.</Citation><ArticleIdList><ArticleId IdType="pubmed">9106435</ArticleId></ArticleIdList></Reference><Reference><Citation>DeOlmos JS, Ingram WR. An improved cupric-silver method for impregnation of axonal and terminal degeneration. Brain Res. 1971;33:523&#x2013;529.</Citation><ArticleIdList><ArticleId IdType="pubmed">4109198</ArticleId></ArticleIdList></Reference><Reference><Citation>Dikranian K, Ishimaru MJ, Tenkova T, Labruyere J, Qin YQ, Ikonomidou C, Olney JW. Apoptosis in the in vivo mammalian forebrain. Neurobiol Dis. 2001;8:359&#x2013;379.</Citation><ArticleIdList><ArticleId IdType="pubmed">11447994</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobbing J, Sands J. The brain growth spurt in various mammalian species. Early Hum Dev. 1979;3:79&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">118862</ArticleId></ArticleIdList></Reference><Reference><Citation>Franks NP, Lieb WR. Molecular and cellular mechanism of general anesthesia. Nature. 1994;367:607&#x2013;614.</Citation><ArticleIdList><ArticleId IdType="pubmed">7509043</ArticleId></ArticleIdList></Reference><Reference><Citation>Franks NP, Dickinson R, deSousa SLM, Hall AC, Lieb WR. How does xenon produce anesthesia? Nature. 1998;396:324.</Citation><ArticleIdList><ArticleId IdType="pubmed">9845069</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonsowski CT, Eger EI., II Nitrous oxide minimum alveolar anesthetic concentration in rats is greater than previously reported. Anesth Analg. 1994;79:710&#x2013;712.</Citation><ArticleIdList><ArticleId IdType="pubmed">7943780</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartman RE, Wozniak DF, Nardi A, Olney JW, Sartorious L, Holtzman DM. (2002) Behavioral phenotyping of GFAP-apoE3 and -apoE4 transgenic mice: ApoE4 mice show profound working memory impairments in the absence of Alzheimer's-like neuropathology. Exp Neurol. 2001;170:326&#x2013;344.</Citation><ArticleIdList><ArticleId IdType="pubmed">11476599</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho N, Liauw JA, Blaeser F, Wei F, Hanissian S, Muglia LM, Wozniak DF, Nardi A, Linden DJ, Zhuo M, Muglia LJ, Chatila TA. Impaired synaptic plasticity and CREB activation in CaMKIV/Gr-deficient mice. J Neurosci. 2000;20:6459&#x2013;6472.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772951</ArticleId><ArticleId IdType="pubmed">10964952</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornbein TF, Eger EI, II, Winter PM, Smith G, Wetstone D, Smith KH. The minimum alveolar concentration of nitrous oxide in man. Anesth Analg. 1982;61:553&#x2013;556.</Citation><ArticleIdList><ArticleId IdType="pubmed">7201254</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vockler J, Dikranian K, Tenkova TI, Stefovska V, Turski L, Olney JW. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science. 1999;283:70&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">9872743</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikonomidou C, Bittigau P, Ishimaru MJ, Wozniak DF, Koch C, Genz K, Price MT, Stefovska V, Horster F, Tenkova T, Dikranian K, Olney JW. Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science. 2000;287:1056&#x2013;1060.</Citation><ArticleIdList><ArticleId IdType="pubmed">10669420</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishimaru MJ, Ikonomidou C, Tenkova TI, Der TC, Dikranian K, Sesma MA, Olney JW. Distinguishing excitotoxic from apoptotic neurodegeneration in the developing rat brain. J Comp Neurol. 1999;408:461&#x2013;476.</Citation><ArticleIdList><ArticleId IdType="pubmed">10340498</ArticleId></ArticleIdList></Reference><Reference><Citation>Jevtovic-Todorovic V, Todorovic SM, Mennerick S, Powell S, Dikranian K, Benshoff N, Zorumski CF, Olney JW. Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant, and neurotoxin. Nat Med. 1998;4:460&#x2013;463.</Citation><ArticleIdList><ArticleId IdType="pubmed">9546794</ArticleId></ArticleIdList></Reference><Reference><Citation>Kissin I, Brown PT, Bradley EL. (1990) Sedative and hypnotic midazolam-morphine interactions in rats. Anesth Analg. 1990;71:137&#x2013;143.</Citation><ArticleIdList><ArticleId IdType="pubmed">2375515</ArticleId></ArticleIdList></Reference><Reference><Citation>Lodge D, Anis NA. Effects of phencyclidine on excitatory amino acid activation of spinal interneurons in the cat. Eur J Pharmacol. 1982;77:203&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pubmed">7037432</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoudi NW, Cole DJ, Shapiro HM. Insufficient anesthetic potency of nitrous oxide in the rat. Anesthesiology. 1989;70:345&#x2013;349.</Citation><ArticleIdList><ArticleId IdType="pubmed">2913868</ArticleId></ArticleIdList></Reference><Reference><Citation>Mennerick S, Jevtovic-Todorovic V, Todorovic SM, Shen W, Olney JW, Zorumski CF. Effect of nitrous oxide on excitatory and inhibitory synaptic transmission in hippocampal cultures. J Neurosci. 1998;18:9716&#x2013;9726.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6793274</ArticleId><ArticleId IdType="pubmed">9822732</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell AS, Dalrymple-Alford JC, Christie MA. Spatial working memory and the brainstem cholinergic innervation to the anterior thalamus. J Neurosci. 2002;22:1922&#x2013;1928.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6758859</ArticleId><ArticleId IdType="pubmed">11880522</ArticleId></ArticleIdList></Reference><Reference><Citation>Olney JW, Tenkova TI, Dikranian K, Muglia LJ, Jermakowicz WJ, D'Sa C, Roth KA. Ethanol-induced apoptotic neurodegeneration in the developing C57BL/6 mouse brain. Brain Res Dev Brain Res. 2002a;133:115&#x2013;126.</Citation><ArticleIdList><ArticleId IdType="pubmed">11882342</ArticleId></ArticleIdList></Reference><Reference><Citation>Olney JW, Tenkova TI, Dikranian K, Qin YQ, Labruyere J, Ikonomidou C. Ethanol-induced caspase-3 activation in the in vivo developing mouse brain. Neurobiol Dis. 2002b;9:205&#x2013;219.</Citation><ArticleIdList><ArticleId IdType="pubmed">11895372</ArticleId></ArticleIdList></Reference><Reference><Citation>Orliaguet G, Vivien B, Langeron O, Bouhemad B, Coriat P, Riou B. Minimum alveolar concentration of volatile anesthetics in rats during postnatal maturation. Anesthesiology. 2001;95:734&#x2013;739.</Citation><ArticleIdList><ArticleId IdType="pubmed">11575548</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens WC, Kingston HGG. Inhalation anesthesia. In: Barash PG, Cullen BF, Stoelting RK, editors. Clinical anesthesia. Lippincott; Philadelphia: 1992. pp. 385&#x2013;412.</Citation></Reference><Reference><Citation>Streissguth AP, O'Malley K. Neuropsychiatric implications and long-term consequences of fetal alcohol spectrum disorders. Semin Clin Neuropsychiatry. 2000;5:177&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pubmed">11291013</ArticleId></ArticleIdList></Reference><Reference><Citation>West MJ. Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias. Trends Neurosci. 1999;22:51&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">10092043</ArticleId></ArticleIdList></Reference><Reference><Citation>Wozniak DF, Stewart GR, Finger S, Olney JW. Comparison of behavioral effects of nucleus basalis magnocellularis lesions and somatosensory cortex ablation in the rat. Neuroscience. 1989;32:685&#x2013;700.</Citation><ArticleIdList><ArticleId IdType="pubmed">2689907</ArticleId></ArticleIdList></Reference><Reference><Citation>Wozniak DF, Olney JW, Kettinger L, III, Price M, Miller JP. Behavioral effects of MK-801 in the rat. Psychopharmacology. 1990;101:47&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">2188277</ArticleId></ArticleIdList></Reference><Reference><Citation>Wozniak DF, Cicero TJ, Kettinger L, III, Meyer ER. Paternal alcohol consumption in the rat impairs spatial learning performance in male offspring. Psychopharmacology. 1991;105:289&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pubmed">1796134</ArticleId></ArticleIdList></Reference><Reference><Citation>Zorumski CF, Mennerick S, Izumi Y. Assessment of synaptic effects of nitric oxide in hippocampal neurons. Methods Neurosci. 1996;31:283&#x2013;299.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12574428</PMID><DateCompleted><Year>2003</Year><Month>02</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1529-2401</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>3</Issue><PubDate><Year>2003</Year><Month>Feb</Month><Day>01</Day></PubDate></JournalIssue><Title>The Journal of neuroscience : the official journal of the Society for Neuroscience</Title><ISOAbbreviation>J Neurosci</ISOAbbreviation></Journal><ArticleTitle>Evidence from functional neuroimaging of a compensatory prefrontal network in Alzheimer's disease.</ArticleTitle><Pagination><StartPage>986</StartPage><EndPage>993</EndPage><MedlinePgn>986-93</MedlinePgn></Pagination><Abstract><AbstractText>Previous experiments have found that individuals with Alzheimer's disease (AD) show increased activity in prefrontal regions compared with healthy age-matched controls during cognitive tasks. This has been interpreted as compensatory reallocation of cognitive resources, but direct evidence for a facilitating effect on performance has been lacking. To address this we measured neural activity during semantic and episodic memory tasks in mildly demented AD patients and healthy elderly controls. Controls recruited a left hemisphere network of regions, including prefrontal and temporal cortices in both the semantic and episodic tasks. Patients engaged a unique network involving bilateral dorsolateral prefrontal and posterior cortices. Critically, activity in this network of regions was correlated with better performance on both the semantic and episodic tasks in the patients. This provides the most direct evidence to date that AD patients can use additional neural resources in prefrontal cortex, presumably those mediating executive functions, to compensate for losses attributable to the degenerative process of the disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Grady</LastName><ForeName>Cheryl L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Rotman Research Institute, Baycrest Center for Geriatric Care, Toronto, Ontario, Canada M6A 2E1. cgrady@rotman-baycrest.on.ca</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McIntosh</LastName><ForeName>Anthony R</ForeName><Initials>AR</Initials></Author><Author ValidYN="Y"><LastName>Beig</LastName><ForeName>Sania</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Keightley</LastName><ForeName>Michelle L</ForeName><Initials>ML</Initials></Author><Author ValidYN="Y"><LastName>Burian</LastName><ForeName>Hana</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Black</LastName><ForeName>Sandra E</ForeName><Initials>SE</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D018848">Controlled Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosci</MedlineTA><NlmUniqueID>8102140</NlmUniqueID><ISSNLinking>0270-6474</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000222" MajorTopicYN="Y">Adaptation, Physiological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001931" MajorTopicYN="N">Brain Mapping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009415" MajorTopicYN="N">Nerve Net</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017397" MajorTopicYN="N">Prefrontal Cortex</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012016" MajorTopicYN="N">Reference Values</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013702" MajorTopicYN="N">Temporal Lobe</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014055" MajorTopicYN="N">Tomography, Emission-Computed</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>2</Month><Day>8</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>2</Month><Day>22</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>2</Month><Day>8</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2003</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12574428</ArticleId><ArticleId IdType="pmc">PMC6741917</ArticleId><ArticleId IdType="pii">23/3/986</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.23-03-00986.2003</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Backman L, Andersson JLR, Nyberg L, Winblad B, Nordberg A, Almkvist O. Brain regions associated with episodic retrieval in normal aging and Alzheimer's disease. Neurology. 1999;52:1861&#x2013;1870.</Citation><ArticleIdList><ArticleId IdType="pubmed">10371535</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker JT, Mintun MA, Aleva K, Wiseman MB, Nichols T, DeKosky ST. Compensatory reallocation of brain resources supporting verbal episodic memory in Alzheimer's disease. Neurology. 1996;46:692&#x2013;700.</Citation><ArticleIdList><ArticleId IdType="pubmed">8618669</ArticleId></ArticleIdList></Reference><Reference><Citation>Binetti G, Magni E, Cappa SF, Padovani A, Bianchetti A, Trabucchi M. Semantic memory in Alzheimer's disease: an analysis of category fluency. J Clin Exp Neuropsychol. 1995;17:82&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">7608305</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun AR, Guillemin A, Hosey L, Varga M. The neural organization of discourse: an H2 15O-PET study of narrative production in English and American sign language. Brain. 2001;124:2028&#x2013;2044.</Citation><ArticleIdList><ArticleId IdType="pubmed">11571220</ArticleId></ArticleIdList></Reference><Reference><Citation>Braver TS, Cohen JD, Nystrom LE, Jonides J, Smith EE, Noll DC. A parametric study of prefrontal cortex involvement in human working memory. NeuroImage. 1997;5:49&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">9038284</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckner RL, Wheeler ME, Sheridan MA. Encoding processes during retrieval tasks. J Cognit Neurosci. 2001;13:406&#x2013;415.</Citation><ArticleIdList><ArticleId IdType="pubmed">11371316</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabeza R, Nyberg L. Imaging cognition II: an empirical review of 275 PET and fMRI studies. J Cognit Neurosci. 2000;12:1&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">10769304</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabeza R, Grady CL, Nyberg L, McIntosh AR, Tulving E, Kapur S, Jennings JM, Houle S, Craik FIM. Age-related differences in neural activity during memory encoding and retrieval: a positron emission tomography study. J Neurosci. 1997;17:391&#x2013;400.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6793692</ArticleId><ArticleId IdType="pubmed">8987764</ArticleId></ArticleIdList></Reference><Reference><Citation>Della-Maggiore V, Sekuler AB, Grady CL, Bennett PJ, Sekuler R, McIntosh AR. Corticolimbic interactions associated with performance on a short-term memory task are modified by age. J Neurosci. 2000;20:8410&#x2013;8416.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6773167</ArticleId><ArticleId IdType="pubmed">11069948</ArticleId></ArticleIdList></Reference><Reference><Citation>Desgranges B, Baron JC, de la Sayette V, Petit-Taboue MC, Benali K, Landeau B, Lechevalier B, Eustache F. The neural substrates of memory systems impairment in Alzheimer's disease. A PET study of resting brain glucose utilization. Brain. 1998;121:611&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pubmed">9577389</ArticleId></ArticleIdList></Reference><Reference><Citation>Desgranges B, Baron JC, Lalevee C, Giffard B, Viader F, de La Sayette V, Eustache F. The neural substrates of episodic memory impairment in Alzheimer's disease as revealed by FDG-PET: relationship to degree of deterioration. Brain. 2002;125:1116&#x2013;1124.</Citation><ArticleIdList><ArticleId IdType="pubmed">11960900</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Esposito M, Detre JA, Alsop DC, Shin RK, Atlas S, Grossman M. The neural basis of the central executive system of working memory. Nature. 1995;378:279&#x2013;281.</Citation><ArticleIdList><ArticleId IdType="pubmed">7477346</ArticleId></ArticleIdList></Reference><Reference><Citation>Duzel E, Cabeza R, Picton TW, Yonelinas AP, Scheich H, Heinze HJ, Tulving E. Task-related and item-related brain processes of memory retrieval. Proc Natl Acad Sci USA. 1999;96:1794&#x2013;1799.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC15598</ArticleId><ArticleId IdType="pubmed">9990104</ArticleId></ArticleIdList></Reference><Reference><Citation>Edgington ES. Randomization tests. Marcel Dekker; New York: 1980.</Citation></Reference><Reference><Citation>Efron B, Tibshirani R. Bootstrap methods for standard errors, confidence intervals and other measures of statistical accuracy. Stat Sci. 1986;1:54&#x2013;77.</Citation></Reference><Reference><Citation>Eustache F, Desgranges B, Giffard B, de la Sayette V, Baron JC. Entorhinal cortex disruption causes memory deficit in early Alzheimer's disease as shown by PET. NeuroReport. 2001;12:683&#x2013;685.</Citation><ArticleIdList><ArticleId IdType="pubmed">11277563</ArticleId></ArticleIdList></Reference><Reference><Citation>Frackowiak RS, Friston KJ. Functional neuroanatomy of the human brain: positron emission tomography&#x2014;a new neuroanatomical technique. J Anat. 1994;184:211&#x2013;225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1259983</ArticleId><ArticleId IdType="pubmed">8014115</ArticleId></ArticleIdList></Reference><Reference><Citation>Friston KJ, Frith CD, Liddle PF, Frackowiak RSJ. Functional connectivity: the principal-component analysis of large (PET) data sets. J Cereb Blood Flow Metab. 1993;13:5&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">8417010</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuster JM. Executive frontal functions. Exp Brain Res. 2000;133:66&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">10933211</ArticleId></ArticleIdList></Reference><Reference><Citation>Giffard B, Desgranges B, Nore-Mary F, Lalevee C, de la Sayette V, Pasquier F, Eustache F. The nature of semantic memory deficits in Alzheimer's disease: new insights from hyperpriming effects. Brain. 2001;124:1522&#x2013;1532.</Citation><ArticleIdList><ArticleId IdType="pubmed">11459744</ArticleId></ArticleIdList></Reference><Reference><Citation>Grady CL, Haxby JV, Horwitz B, Sundaram M, Berg G, Schapiro MB, Friedland RP, Rapoport SI. Longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer type. J Clin Exp Neuropsychol. 1988;10:576&#x2013;596.</Citation><ArticleIdList><ArticleId IdType="pubmed">3265710</ArticleId></ArticleIdList></Reference><Reference><Citation>Grady CL, Horwitz B, Pietrini P, Mentis MJ, Ungerleider LG, Rapoport SI, Haxby JV. The effect of task difficulty on cerebral blood flow during perceptual matching of faces. Hum Brain Mapp. 1996;4:227&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="pubmed">20408201</ArticleId></ArticleIdList></Reference><Reference><Citation>Grady CL, McIntosh AR, Beig S, Craik FIM. An examination of the effects of stimulus type, encoding strategy, and functional connectivity on the role of right prefrontal cortex in recognition memory. NeuroImage. 2001a;14:556&#x2013;571.</Citation><ArticleIdList><ArticleId IdType="pubmed">11506530</ArticleId></ArticleIdList></Reference><Reference><Citation>Grady CL, Furey ML, Pietrini P, Horwitz B, Rapoport SI. Altered brain functional connectivity and impaired short term memory in Alzheimer's disease. Brain. 2001b;124:739&#x2013;756.</Citation><ArticleIdList><ArticleId IdType="pubmed">11287374</ArticleId></ArticleIdList></Reference><Reference><Citation>Grady CL, Bernstein L, Siegenthaler A, Beig S. The effects of encoding task on age-related differences in the functional neuroanatomy of face memory. Psychol Aging. 2002;17:7&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">11931288</ArticleId></ArticleIdList></Reference><Reference><Citation>Grady CL, McIntosh AR, Craik FI (2003) Age-related differences in the functional connectivity of the hippocampus during memory encoding. Hippocampus, in press.</Citation><ArticleIdList><ArticleId IdType="pubmed">12921348</ArticleId></ArticleIdList></Reference><Reference><Citation>Greene JD, Hodges JR. The fractionation of remote memory. Evidence from a longitudinal study of dementia of Alzheimer type. Brain. 1996;119:129&#x2013;142.</Citation><ArticleIdList><ArticleId IdType="pubmed">8624676</ArticleId></ArticleIdList></Reference><Reference><Citation>Grossman M, Payer F, Onishi K, White-Devine T, Morrison D, D'Esposito M, Robinson K, Alavi A. Constraints on the cerebral basis for semantic processing from neuroimaging studies of Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1997;63:152&#x2013;158.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2169652</ArticleId><ArticleId IdType="pubmed">9285450</ArticleId></ArticleIdList></Reference><Reference><Citation>Herscovitch P, Markham J, Raichle ME. Brain blood flow measured with intravenous O-15 water: I. Theory and error analysis. J Nucl Med. 1983;24:782&#x2013;789.</Citation><ArticleIdList><ArticleId IdType="pubmed">6604139</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodges JR, Salmon DP, Butters N. Semantic memory impairment in Alzheimer's disease: failure of access or degraded knowledge? Neuropsychologia. 1992;30:301&#x2013;314.</Citation><ArticleIdList><ArticleId IdType="pubmed">1603295</ArticleId></ArticleIdList></Reference><Reference><Citation>Horwitz B. Data analysis paradigms for metabolic-flow data: combining neural modeling and functional neuroimaging. Hum Brain Mapp. 1994;2:112&#x2013;122.</Citation><ArticleIdList><ArticleId IdType="pubmed">24591196</ArticleId></ArticleIdList></Reference><Reference><Citation>Horwitz B, McIntosh AR, Haxby JV, Furey M, Salerno J, Schapiro MB, Rapoport SI, Grady CL. Network analysis of PET-mapped visual pathways in Alzheimer type dementia. NeuroReport. 1995;6:2287&#x2013;2292.</Citation><ArticleIdList><ArticleId IdType="pubmed">8747138</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagust WJ, Friedland RP, Budinger TF, Koss E, Ober B. Longitudinal studies of regional cerebral metabolism in Alzheimer's disease. Neurol. 1988;38:909&#x2013;912.</Citation><ArticleIdList><ArticleId IdType="pubmed">3259296</ArticleId></ArticleIdList></Reference><Reference><Citation>Madden DJ, Turkington TG, Provenzale JM, Denny LL, Hawk TC, Gottlob LR, Coleman RE. Adult age differences in the functional neuroanatomy of verbal recognition memory. Hum Brain Mapp. 1999;7:115&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6873331</ArticleId><ArticleId IdType="pubmed">9950069</ArticleId></ArticleIdList></Reference><Reference><Citation>Maril A, Wagner AD, Schacter DL. On the tip of the tongue: an event-related fMRI study of semantic retrieval failure and cognitive conflict. Neuron. 2001;31:653&#x2013;660.</Citation><ArticleIdList><ArticleId IdType="pubmed">11545723</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntosh AR. Mapping cognition to the brain through neural interactions. Memory. 1999;7:523&#x2013;548.</Citation><ArticleIdList><ArticleId IdType="pubmed">10659085</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntosh AR, Bookstein FL, Haxby JV, Grady CL. Spatial pattern analysis of functional brain images using partial least squares. NeuroImage. 1996;3:143&#x2013;157.</Citation><ArticleIdList><ArticleId IdType="pubmed">9345485</ArticleId></ArticleIdList></Reference><Reference><Citation>McIntosh AR, Rajah MN, Lobaugh NJ. Interactions of prefrontal cortex in relation to awareness in sensory learning. Science. 1999;284:1531&#x2013;1533.</Citation><ArticleIdList><ArticleId IdType="pubmed">10348741</ArticleId></ArticleIdList></Reference><Reference><Citation>Meltzer CC, Leal JP, Mayberg HS, Wagner HN, Jr, Frost JJ. Correction of PET data for partial volume effects in human cerebral cortex by MR imaging. J Comput Assist Tomogr. 1990;14:561&#x2013;570.</Citation><ArticleIdList><ArticleId IdType="pubmed">2370355</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakano S, Asada T, Matsuda H, Uno M, Takasaki M. Donepezil hydrochloride preserves regional cerebral blood flow in patients with Alzheimer's disease. J Nucl Med. 2001;42:1441&#x2013;1445.</Citation><ArticleIdList><ArticleId IdType="pubmed">11585854</ArticleId></ArticleIdList></Reference><Reference><Citation>Nobili F, Koulibaly M, Vitali P, Migneco O, Mariani G, Ebmeier K, Pupi A, Robert PH, Rodriguez G, Darcourt J. Brain perfusion follow-up in Alzheimer's patients during treatment with acetylcholinesterase inhibitors. J Nucl Med. 2002;43:983&#x2013;990.</Citation><ArticleIdList><ArticleId IdType="pubmed">12163621</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyberg L, Tulving E, Habib R, Nilsson L-G, Kapur S, Houle S, Cabeza R, McIntosh AR. Functional brain maps of retrieval mode and recovery of episodic information. NeuroReport. 1995;7:249&#x2013;252.</Citation><ArticleIdList><ArticleId IdType="pubmed">8742463</ArticleId></ArticleIdList></Reference><Reference><Citation>Ober BA, Shenaut GK. Well-organized conceptual domains in Alzheimer's disease. J Int Neuropsychol Soc. 1999;5:676&#x2013;684.</Citation><ArticleIdList><ArticleId IdType="pubmed">10645709</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry RJ, Hodges JR. Fate of patients with questionable (very mild) Alzheimer's disease: longitudinal profiles of individual subjects' decline. Dem Geriatr Cognit Dis. 2000;11:342&#x2013;349.</Citation><ArticleIdList><ArticleId IdType="pubmed">11044780</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuter-Lorenz PA, Jonides J, Smith EE, Hartley A, Miller A, Marshuetz C, Koeppe RA. Age differences in the frontal lateralization of verbal and spatial working memory revealed by PET. J Cognit Neurosci. 2000;12:174&#x2013;187.</Citation><ArticleIdList><ArticleId IdType="pubmed">10769314</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampson PD, Streissguth AP, Barr HM, Bookstein FL. Neurobehavioral effects of prenatal alcohol: Part II. Partial least squares analysis. Neurotox Teratol. 1989;11:477&#x2013;491.</Citation><ArticleIdList><ArticleId IdType="pubmed">2593987</ArticleId></ArticleIdList></Reference><Reference><Citation>Saykin AJ, Flashman LA, Frutiger SA, Johnson SC, Mamourian AC, Moritz CH, O'Jile JR, Riordan HJ, Santulli RB, Smith CA, Weaver JB. Neuroanatomic substrates of semantic memory impairment in Alzheimer's disease: patterns of functional MRI activation. J Int Neuropsychol Soc. 1999;5:377&#x2013;392.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4443687</ArticleId><ArticleId IdType="pubmed">10439584</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreurs BG, McIntosh AR, Bahro M, Herscovitch P, Sunderland T, Molchan SE. Lateralization and behavioral correlation of changes in regional cerebral blood flow with classical conditioning of the human eyeblink response. J Neurophysiol. 1997;77:2153&#x2013;2163.</Citation><ArticleIdList><ArticleId IdType="pubmed">9114262</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith EE, Jonides J. Neuroimaging analyses of human working memory. Proc Natl Acad Sci USA. 1998;95:12061&#x2013;12068.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC21765</ArticleId><ArticleId IdType="pubmed">9751790</ArticleId></ArticleIdList></Reference><Reference><Citation>Snodgrass JG, Vanderwart M. A standardized set of 260 pictures: norms for name agreement, image agreement, familiarity and visual complexity. J Exp Psychol Hum Learn. 1980;6:174&#x2013;215.</Citation><ArticleIdList><ArticleId IdType="pubmed">7373248</ArticleId></ArticleIdList></Reference><Reference><Citation>Staff RT, Gemmell HG, Shanks MF, Murray AD, Venneri A. Changes in the rCBF images of patients with Alzheimer's disease receiving Donepezil therapy. Nucl Med Commun. 2000;21:37&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">10717900</ArticleId></ArticleIdList></Reference><Reference><Citation>Stern Y, Moeller JR, Anderson KE, Luber B, Zubin NR, DiMauro AA, Park A, Campbell CE, Marder K, Bell K, Van Heertum R, Sackeim HA. Different brain networks mediate task performance in normal aging and AD: defining compensation. Neurology. 2000;55:1291&#x2013;1297.</Citation><ArticleIdList><ArticleId IdType="pubmed">11087770</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuss DT, Benson DF. Neuropsychological studies of the frontal lobes. Psychol Bull. 1984;95:3&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">6544432</ArticleId></ArticleIdList></Reference><Reference><Citation>Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain. Thieme; New York: 1988.</Citation></Reference><Reference><Citation>Tulving E, Kapur S, Craik FIM, Moscovitch M, Houle S. Hemispheric encoding/retrieval asymmetry in episodic memory: positron emission tomography findings. Proc Natl Acad Sci USA. 1994;91:2016&#x2013;2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC43300</ArticleId><ArticleId IdType="pubmed">8134342</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandenberghe R, Price C, Wise R, Josephs O, Frackowiak RSJ. Functional anatomy of a common semantic system for words and pictures. Nature. 1996;383:254&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pubmed">8805700</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner AD, Pare-Blagoev EJ, Clark J, Poldrack RA. Recovering meaning: left prefrontal cortex guides controlled semantic retrieval. Neuron. 2001;31:329&#x2013;338.</Citation><ArticleIdList><ArticleId IdType="pubmed">11502262</ArticleId></ArticleIdList></Reference><Reference><Citation>Weingartner HJ, Kawas C, Rawlings R, Shapiro M. Changes in semantic memory in early stage Alzheimer's disease patients. Gerontologist. 1993;33:637&#x2013;643.</Citation><ArticleIdList><ArticleId IdType="pubmed">8225008</ArticleId></ArticleIdList></Reference><Reference><Citation>Welsh K, Butters N, Hughes J, Mohs R, Heyman A. Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Arch Neurol. 1991;48:278&#x2013;281.</Citation><ArticleIdList><ArticleId IdType="pubmed">2001185</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiggs CL, Weisberg J, Martin A. Neural correlates of semantic and episodic memory retrieval. Neuropsychologia. 1999;37:103&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pubmed">9920476</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilding EL, Rugg MD. An event-related potential study of recognition memory with and without retrieval of source. Brain Cognit. 1996;119:889&#x2013;906.</Citation><ArticleIdList><ArticleId IdType="pubmed">8673500</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodard JL, Grafton ST, Votaw JR, Green RC, Dobraski ME, Hoffman JM. Compensatory recruitment of neural resources during overt rehearsal of word lists in Alzheimer's disease. Neuropsychology. 1998;12:491&#x2013;504.</Citation><ArticleIdList><ArticleId IdType="pubmed">9805319</ArticleId></ArticleIdList></Reference><Reference><Citation>Woods RP, Cherry SR, Mazziotta JC. Rapid automated algorithm for aligning and reslicing PET images. J Comput Assist Tomogr. 1992;16:620&#x2013;633.</Citation><ArticleIdList><ArticleId IdType="pubmed">1629424</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12574429</PMID><DateCompleted><Year>2003</Year><Month>02</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1529-2401</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>3</Issue><PubDate><Year>2003</Year><Month>Feb</Month><Day>01</Day></PubDate></JournalIssue><Title>The Journal of neuroscience : the official journal of the Society for Neuroscience</Title><ISOAbbreviation>J Neurosci</ISOAbbreviation></Journal><ArticleTitle>Dynamics of gray matter loss in Alzheimer's disease.</ArticleTitle><Pagination><StartPage>994</StartPage><EndPage>1005</EndPage><MedlinePgn>994-1005</MedlinePgn></Pagination><Abstract><AbstractText>We detected and mapped a dynamically spreading wave of gray matter loss in the brains of patients with Alzheimer's disease (AD). The loss pattern was visualized in four dimensions as it spread over time from temporal and limbic cortices into frontal and occipital brain regions, sparing sensorimotor cortices. The shifting deficits were asymmetric (left hemisphere &gt; right hemisphere) and correlated with progressively declining cognitive status (p &lt; 0.0006). Novel brain mapping methods allowed us to visualize dynamic patterns of atrophy in 52 high-resolution magnetic resonance image scans of 12 patients with AD (age 68.4 +/- 1.9 years) and 14 elderly matched controls (age 71.4 +/- 0.9 years) scanned longitudinally (two scans; interscan interval 2.1 +/- 0.4 years). A cortical pattern matching technique encoded changes in brain shape and tissue distribution across subjects and time. Cortical atrophy occurred in a well defined sequence as the disease progressed, mirroring the sequence of neurofibrillary tangle accumulation observed in cross sections at autopsy. Advancing deficits were visualized as dynamic maps that change over time. Frontal regions, spared early in the disease, showed pervasive deficits later (&gt;15% loss). The maps distinguished different phases of AD and differentiated AD from normal aging. Local gray matter loss rates (5.3 +/- 2.3% per year in AD v 0.9 +/- 0.9% per year in controls) were faster in the left hemisphere (p &lt; 0.029) than the right. Transient barriers to disease progression appeared at limbic/frontal boundaries. This degenerative sequence, observed in vivo as it developed, provides the first quantitative, dynamic visualization of cortical atrophic rates in normal elderly populations and in those with dementia.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Paul M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Laboratory of Neuro Imaging, Brain Mapping Division, Department of Neurology, University of California Los Angeles School of Medicine, Los Angeles, California 90095-1769, USA. thompson@loni.ucla.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayashi</LastName><ForeName>Kiralee M</ForeName><Initials>KM</Initials></Author><Author ValidYN="Y"><LastName>de Zubicaray</LastName><ForeName>Greig</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Janke</LastName><ForeName>Andrew L</ForeName><Initials>AL</Initials></Author><Author ValidYN="Y"><LastName>Rose</LastName><ForeName>Stephen E</ForeName><Initials>SE</Initials></Author><Author ValidYN="Y"><LastName>Semple</LastName><ForeName>James</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Herman</LastName><ForeName>David</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Michael S</ForeName><Initials>MS</Initials></Author><Author ValidYN="Y"><LastName>Dittmer</LastName><ForeName>Stephanie S</ForeName><Initials>SS</Initials></Author><Author ValidYN="Y"><LastName>Doddrell</LastName><ForeName>David M</ForeName><Initials>DM</Initials></Author><Author ValidYN="Y"><LastName>Toga</LastName><ForeName>Arthur W</ForeName><Initials>AW</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 LM05639</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P41 RR13642</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 MH52176</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>M01 RR000865</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 LM005639</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>M01 RR00865</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P41 RR013642</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D018848">Controlled Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosci</MedlineTA><NlmUniqueID>8102140</NlmUniqueID><ISSNLinking>0270-6474</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001284" MajorTopicYN="N">Atrophy</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001931" MajorTopicYN="Y">Brain Mapping</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="N">Cognition Disorders</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007091" MajorTopicYN="N">Image Processing, Computer-Assisted</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020407" MajorTopicYN="N">Internet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="Y">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012016" MajorTopicYN="N">Reference Values</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013995" MajorTopicYN="N">Time</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>2</Month><Day>8</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>2</Month><Day>22</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>2</Month><Day>8</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2003</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12574429</ArticleId><ArticleId IdType="pmc">PMC6741905</ArticleId><ArticleId IdType="pii">23/3/994</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.23-03-00994.2003</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>American Psychiatric Association. Diagnostic and statistical manual of mental disorders, Ed 4 (DSM-IV). American Psychiatric Association; Washington, DC: 2000.</Citation></Reference><Reference><Citation>Arnold SE, Hyman BT, Flory J, Damasio AR, Van Hoesen GW. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex. 1991;1:103&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pubmed">1822725</ArticleId></ArticleIdList></Reference><Reference><Citation>Arriagada P, Growdon JH, Hedley-Whyte ET, Hyman BT. Neurofibrillary tangles, but not plaques parallel duration and severity of Alzheimer's disease. Neurology. 1992;42:631&#x2013;639.</Citation><ArticleIdList><ArticleId IdType="pubmed">1549228</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashburner J, Friston KJ. Voxel-based morphometry&#x2014;the methods. NeuroImage. 2000;11:805&#x2013;821.</Citation><ArticleIdList><ArticleId IdType="pubmed">10860804</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashburner J, Friston KJ. Why voxel-based morphometry should be used. NeuroImage. 2001;14:1238&#x2013;1243.</Citation><ArticleIdList><ArticleId IdType="pubmed">11707080</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashburner J, Csernansky J, Davatzikos C, Fox NC, Frisoni G, Thompson PM (2003) Computational neuroanatomy: towards a computer-assisted diagnosis of degenerative brain diseases based on magnetic resonance imaging. Lancet Neurol, in press.</Citation><ArticleIdList><ArticleId IdType="pubmed">12849264</ArticleId></ArticleIdList></Reference><Reference><Citation>Baron JC, Chetelat G, Desgranges B, Perchey G, Landeau B, de la Sayette V, Eustache F. In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease. NeuroImage. 2001;14:298&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pubmed">11467904</ArticleId></ArticleIdList></Reference><Reference><Citation>Bookstein FL. Voxel-based morphometry should not be used with imperfectly registered images. NeuroImage. 2001;14:1454&#x2013;1462.</Citation><ArticleIdList><ArticleId IdType="pubmed">11707101</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Braak E. Neuropathological staging of Alzheimer related changes. Acta Neuropathol. 1991;82:239&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pubmed">1759558</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Braak E. Staging of Alzheimer-related cortical destruction. Int Psychogeriatr 9[Suppl 1] 1997. 257 261; discussion 269&#x2013;272.</Citation><ArticleIdList><ArticleId IdType="pubmed">9447446</ArticleId></ArticleIdList></Reference><Reference><Citation>Brion JP, Octave JN, Couck AM. Distribution of the phosphorylated microtubule-associated protein tau in developing cortical neurons. Neuroscience. 1994;63:895&#x2013;909.</Citation><ArticleIdList><ArticleId IdType="pubmed">7898684</ArticleId></ArticleIdList></Reference><Reference><Citation>Brun A, Englund E. Regional pattern of degeneration in Alzheimer's disease: neuronal loss and histopathologic grading. Histopathology. 1981;5:549&#x2013;564.</Citation><ArticleIdList><ArticleId IdType="pubmed">7286917</ArticleId></ArticleIdList></Reference><Reference><Citation>Bullmore ET, Suckling J, Overmeyer S, Rabe-Hesketh S, Taylor E, Brammer MJ. Global, voxel, and cluster tests, by theory and permutation, for a difference between two groups of structural MR images of the brain. IEEE Trans Med Imaging. 1999;18:32&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">10193695</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannon TD, Thompson PM, van Erp T, Toga AW, Poutanen V-P, Huttunen M, L&#xf6;nnqvist J, Standertskj&#xf6;ld-Nordenstam C-G, Narr KL, Khaledy M, Zoumalan CI, Dail R, Kaprio J. Cortex mapping reveals regionally specific patterns of genetic and disease-specific gray-matter deficits in twins discordant for schizophrenia. Proc Natl Acad Sci USA. 2002;99:3228&#x2013;3233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC122501</ArticleId><ArticleId IdType="pubmed">11867725</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinton J, Blackman SEA, Royston MC, Robert GW. Differential synaptic loss in the cortex in AD: a study using archival material. NeuroReport. 1994;5:497&#x2013;500.</Citation><ArticleIdList><ArticleId IdType="pubmed">8003683</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins DL, Neelin P, Peters T, Evans AC. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr. 1994;18:192&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pubmed">8126267</ArticleId></ArticleIdList></Reference><Reference><Citation>de Brabander JM, Kramers RJ, Uylings HB. Layer-specific dendritic regression of pyramidal cells with aging in the human prefrontal cortex. Eur J Neurosci. 1998;10:1261&#x2013;1269.</Citation><ArticleIdList><ArticleId IdType="pubmed">9749780</ArticleId></ArticleIdList></Reference><Reference><Citation>DeCarli C. Part IV. Neuroimaging in dementing disorders. Dis Mon. 2000;46:706&#x2013;724.</Citation><ArticleIdList><ArticleId IdType="pubmed">11078011</ArticleId></ArticleIdList></Reference><Reference><Citation>Delacourte A, David JP, Sergeant N, Buee L, Wattez A, Vermersch P, Ghozali F, Fallet-Bianco C, Pasquier F, Lebert F, Petit H, Di Menza C. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology. 1999;52:1158&#x2013;1165.</Citation><ArticleIdList><ArticleId IdType="pubmed">10214737</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Torre JC. Alzheimer disease as a vascular disorder: nosological evidence. Stroke. 2002;33:1152&#x2013;1162.</Citation><ArticleIdList><ArticleId IdType="pubmed">11935076</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans AC, Collins DL, Neelin P, MacDonald D, Kamber M, Marrett TS. Three-dimensional correlative imaging: applications in human brain mapping. In: Thatcher RW, Hallett M, Zeffiro T, John ER, Huerta M, editors. Functional neuroimaging: technical foundations. Academic; San Diego: 1994. pp. 145&#x2013;162.</Citation></Reference><Reference><Citation>Fischl B, Sereno MI, Tootell RBH, Dale AM. High-resolution inter-subject averaging and a coordinate system for the cortical surface. Hum Brain Mapp. 1999;8:272&#x2013;284.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6873338</ArticleId><ArticleId IdType="pubmed">10619420</ArticleId></ArticleIdList></Reference><Reference><Citation>Flood DG, Buell SJ, Horwitz GJ, Coleman PD. Dendritic extent in human dentate gyrus granule cells in normal aging and senile dementia. Brain Res. 1987;402:205&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">3828793</ArticleId></ArticleIdList></Reference><Reference><Citation>Folstein MF, Folstein SE, McHugh PR. &#x201c;Mini mental state&#x201d;: a practical method of grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="pubmed">1202204</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox NC, Freeborough PA, Rossor MN. Visualisation and quantification of rates of atrophy in AD. Lancet. 1996;348:94&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">8676724</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox NC, Scahill RI, Crum WR, Rossor MN. Correlation between rates of brain atrophy and cognitive decline in AD. Neurology. 1999;52:1687&#x2013;1689.</Citation><ArticleIdList><ArticleId IdType="pubmed">10331700</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox NC, Cousens S, Scahill R, Harvey RJ, Rossor MN. Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects. Arch Neurol. 2000;57:339&#x2013;344.</Citation><ArticleIdList><ArticleId IdType="pubmed">10714659</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeborough PA, Fox NC. Modeling brain deformations in Alzheimer disease by fluid registration of serial 3D MR images. J Comput Assist Tomogr. 1998;22:838&#x2013;843.</Citation><ArticleIdList><ArticleId IdType="pubmed">9754126</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedland RP, Luxenberg J. Neuroimaging and dementia. In: Theodore WH, editor. Clinical neuroimaging: frontiers in clinical neuroscience, Vol 4. Allan Liss; New York: 1988. pp. 139&#x2013;163.</Citation></Reference><Reference><Citation>Friston KJ, Holmes A, Poline JB, Price CJ, Frith CD. Detecting activations in PET and fMRI: levels of inference and power. NeuroImage. 1996;4:223&#x2013;235.</Citation><ArticleIdList><ArticleId IdType="pubmed">9345513</ArticleId></ArticleIdList></Reference><Reference><Citation>Geschwind N, Levitsky W. Human brain: left-right asymmetries in temporal speech region. Science. 1968;161:186&#x2013;187.</Citation><ArticleIdList><ArticleId IdType="pubmed">5657070</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez-Isla T, Hollister R, West H, Mui S, Growdon JH, Petersen RC, Parisi JE, Hyman BT. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol. 1997;41:17&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">9005861</ArticleId></ArticleIdList></Reference><Reference><Citation>Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RSJ. A voxel-based morphometric study of aging in 465 normal adult human brains. NeuroImage. 2001;14:21&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">11525331</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampel H, Teipel SJ, Alexander GE, Pogarell O, Rapoport SI, Moller HJ. In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease: perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and PET. J Neural Transm. 2002;109:837&#x2013;855.</Citation><ArticleIdList><ArticleId IdType="pubmed">12111472</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanks SD, Flood DG. Region-specific stability of dendritic extent in normal human aging and regression in Alzheimer's disease. I. CA1 of hippocampus. Brain Res. 1991;540:63&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">2054634</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi KM, Thompson PM, Mega MS, Zoumalan CI (2002) Medial hemispheric surface gyral pattern delineation in 3D: surface curve protocol. Available at:http://www.loni.ucla.edu/&#x223c;khayashi/Public/medial_surface/ MedialLinesProtocol.</Citation></Reference><Reference><Citation>Hof PR, Morrison JH. The cellular basis of cortical disconnection in Alzheimer disease and related dementing conditions. In: Terry RD, Katzman R, Bick KL, editors. Alzheimer disease. Raven; New York: 1994. pp. 197&#x2013;229.</Citation></Reference><Reference><Citation>Holmes AP, Blair RC, Watson JD, Ford I. Nonparametric analysis of statistic images from functional mapping experiments. J Cereb Blood Flow Metab. 1996;16:7&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">8530558</ArticleId></ArticleIdList></Reference><Reference><Citation>Hubbard BM, Anderson JM. A quantitative study of cerebral atrophy in old age and senile dementia. J Neurol Sci. 1981;50:135&#x2013;145.</Citation><ArticleIdList><ArticleId IdType="pubmed">7229656</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulstaert F, Blennow K, Ivanoiu A, Schoonderwaldt HC, Riemenschneider M, De Deyn PP, Bancher C, Cras P, Wiltfang J, Mehta PD, Iqbal K, Pottel H, Vanmechelen E, Vanderstichele H. Improved discrimination of AD patients using beta-amyloid(1&#x2013;42) and tau levels in CSF. Neurology. 1999;52:1555&#x2013;1562.</Citation><ArticleIdList><ArticleId IdType="pubmed">10331678</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack CR, Jr, Petersen RC, Xu Y, O'Brien PC, Smith GE, Ivnik RJ, Tangalos EG, Kokmen E. Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology. 1998;51:993&#x2013;999.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2768817</ArticleId><ArticleId IdType="pubmed">9781519</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagust WJ, Haan MN, Eberling JL, Wolfe N, Reed BR. Functional imaging predicts cognitive decline in Alzheimer's disease. J Neuroimaging. 1996;6:156&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pubmed">8704290</ArticleId></ArticleIdList></Reference><Reference><Citation>Janke AL, de Zubicaray GI, Rose SE, Griffin M, Chalk JB, Galloway GJ. 4D deformation modeling of cortical disease progression in Alzheimer's dementia. Magn Reson Med. 2001;46:661&#x2013;666.</Citation><ArticleIdList><ArticleId IdType="pubmed">11590641</ArticleId></ArticleIdList></Reference><Reference><Citation>Jernigan TL, Salmon D, Butters N, Hesselink JR. Cerebral structure on MRI, part II: specific changes in Alzheimer's and Huntington's diseases. Biol Psychiatry. 1991;29:68&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">1825793</ArticleId></ArticleIdList></Reference><Reference><Citation>Jobst KA, Smith AD, Szatmari M, Esiri MM, Jaskowski A, Hindley N, McDonald B, Molyneux AJ. Rapidly progressing atrophy of medial temporal lobe in Alzheimer's disease. Lancet. 1994;343:829&#x2013;830.</Citation><ArticleIdList><ArticleId IdType="pubmed">7908080</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson KA, Jones K, Holman BL, Becker JA, Spiers PA, Satlin A, Albert MS. Preclinical prediction of Alzheimer's disease using SPECT. Neurology. 1998;50:1563&#x2013;1571.</Citation><ArticleIdList><ArticleId IdType="pubmed">9633695</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaye J, Moore M, Kerr D. The rate of brain volume loss accelerates as Alzheimer's disease progresses from a presymptomatic phase to frank dementia. Neurology. 1999;52[Suppl]:A569&#x2013;A570.</Citation></Reference><Reference><Citation>Kaye JA, Swihart T, Howieson D, Dame A, Moore MM, Karnos T, Camicioli R, Ball M, Oken B, Sexton G. Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia. Neurology. 1997;48:1297&#x2013;1304.</Citation><ArticleIdList><ArticleId IdType="pubmed">9153461</ArticleId></ArticleIdList></Reference><Reference><Citation>Laakso MP, Lehtovirta M, Partanen K, Riekkinen PJ, Soininen H. Hippocampus in AD: a 3-year follow-up MRI study. Biol Psychiatry. 2000;47:557&#x2013;561.</Citation><ArticleIdList><ArticleId IdType="pubmed">10715362</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehtovirta M, Laakso MP, Frisoni GB, Soininen H. How does the apolipoprotein E genotype modulate the brain in aging and in Alzheimer's disease? A review of neuroimaging studies. Neurobiol Aging. 2000;21:293&#x2013;300.</Citation><ArticleIdList><ArticleId IdType="pubmed">10867214</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonard CM. Structural variation in the developing and mature cerebral cortex: noise or signal? In: Thatcher RW, Reid Lyon G, Rumsey J, Krasnegor N, editors. Developmental neuroimaging: mapping the development of brain and behavior. Academic; New York: 1996. pp. 207&#x2013;231.</Citation></Reference><Reference><Citation>Loewenstein DA, Barker WW, Chang JY, Apicella A, Yoshii F, Kothari P, Levin B, Duara R. Predominant left hemisphere metabolic dysfunction in dementia. Arch Neurol. 1989;46:146&#x2013;152.</Citation><ArticleIdList><ArticleId IdType="pubmed">2783845</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDonald D, Kabani N, Avis D, Evans AC. Automated 3-D extraction of inner and outer surfaces of cerebral cortex from MRI. NeuroImage. 2000;12:340&#x2013;356.</Citation><ArticleIdList><ArticleId IdType="pubmed">10944416</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazziotta JC, Frackowiak RS, Phelps ME. The use of positron emission tomography in the clinical assessment of dementia. Semin Nucl Med. 1992;22:233&#x2013;246.</Citation><ArticleIdList><ArticleId IdType="pubmed">1439869</ArticleId></ArticleIdList></Reference><Reference><Citation>McEwen BS. Possible mechanisms for atrophy of the human hippocampus. Mol Psychiatry. 1997;2:255&#x2013;262.</Citation><ArticleIdList><ArticleId IdType="pubmed">9152991</ArticleId></ArticleIdList></Reference><Reference><Citation>McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadian EM. Clinical diagnosis of AD: report of the NINCDS-ARDRA Work Group under the auspices of the Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939&#x2013;944.</Citation><ArticleIdList><ArticleId IdType="pubmed">6610841</ArticleId></ArticleIdList></Reference><Reference><Citation>Mega MS, Chen S, Thompson PM, Woods RP, Karaca TJ, Tiwari A, Vinters H, Small GW, Toga AW. Mapping pathology to metabolism: coregistration of stained whole brain sections to PET in AD. NeuroImage. 1997;5:147&#x2013;153.</Citation><ArticleIdList><ArticleId IdType="pubmed">9345544</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesulam MM. A plasticity-based theory of the pathogenesis of Alzheimer's disease. Ann NY Acad Sci. 2000;924:42&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">11193801</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison JH, Hof PR. Life and death of neurons in the aging brain. Science. 1997;278:412&#x2013;419.</Citation><ArticleIdList><ArticleId IdType="pubmed">9334292</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison JH, Hof PR. Selective vulnerability of corticocortical and hippocampal circuits in aging and Alzheimer's disease. Prog Brain Res. 2002;136:467&#x2013;486.</Citation><ArticleIdList><ArticleId IdType="pubmed">12143403</ArticleId></ArticleIdList></Reference><Reference><Citation>Mummery CJ, Patterson K, Price CJ, Ashburner J, Frackowiak RS, Hodges JR. A voxel-based morphometry study of semantic dementia: relationship between temporal lobe atrophy and semantic memory. Ann Neurol. 2000;47:36&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">10632099</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy DGM, DeCarli CD, Daly E, Gillette JA, McIntosh AR, Haxby JV, Teichberg D, Schapiro MB, Rapoport SI, Horwitz B. Volumetric magnetic resonance imaging in men with dementia of the Alzheimer type: correlations with disease severity. Biol Psychiatry. 1993;34:612&#x2013;621.</Citation><ArticleIdList><ArticleId IdType="pubmed">8292690</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura S, Akiguchi I, Kameyama M, Kudo M, Mizuno N. Senile changes in the basal dendrites of the pyramidal cells in the human motor cortex: a quantitative Golgi study. Rinsho Shinkeigaku. 1984;24:85&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">6205808</ArticleId></ArticleIdList></Reference><Reference><Citation>Nichols TE, Holmes AP. Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum Brain Mapp. 2002;15:1&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6871862</ArticleId><ArticleId IdType="pubmed">11747097</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Brien JT, Paling S, Barber R, Williams ED, Ballard C, McKeith IG, Gholkar A, Crum WR, Rossor MN, Fox NC. Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia. Neurology. 2001;56:1386&#x2013;1388.</Citation><ArticleIdList><ArticleId IdType="pubmed">11376193</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono M, Kubik S, Abernathey CD. Atlas of the cerebral sulci. Thieme; Stuttgart, Germany: 1990.</Citation></Reference><Reference><Citation>Pearson RCA, Esiri MM, Hiorns RW, Wilcock GK, Powell TPS. Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer's disease. Proc Natl Acad Sci USA. 1985;82:4531&#x2013;4534.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC391136</ArticleId><ArticleId IdType="pubmed">3859874</ArticleId></ArticleIdList></Reference><Reference><Citation>Price JL, Morris JC. Tangles and plaques in nondemented aging and &#x201c;preclinical&#x201d; Alzheimer's disease. Ann Neurol. 1999;45:358&#x2013;368.</Citation><ArticleIdList><ArticleId IdType="pubmed">10072051</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiman EM, Caselli RJ, Chen K, Alexander GE, Bandy D, Frost J. Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: a foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease. Proc Natl Acad Sci USA. 2001;98:3334&#x2013;3339.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC30654</ArticleId><ArticleId IdType="pubmed">11248079</ArticleId></ArticleIdList></Reference><Reference><Citation>Rombouts SA, Barkhof F, Witter MP, Scheltens P. Unbiased whole-brain analysis of gray matter loss in Alzheimer's disease. Neurosci Lett. 2000;285:231&#x2013;233.</Citation><ArticleIdList><ArticleId IdType="pubmed">10806328</ArticleId></ArticleIdList></Reference><Reference><Citation>Scahill RI, Schott JM, Stevens JM, Rossor MN, Fox NC. Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI. Proc Natl Acad Sci USA. 2002;99:4703&#x2013;4707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC123711</ArticleId><ArticleId IdType="pubmed">11930016</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimada A. Age-dependent cerebral atrophy and cognitive dysfunction in SAMP10 mice. Neurobiol Aging. 1999;20:125&#x2013;136.</Citation><ArticleIdList><ArticleId IdType="pubmed">10537022</ArticleId></ArticleIdList></Reference><Reference><Citation>Simic G, Kostovic I, Winblad B, Bogdanovic N. Volume and number of neurons of the human hippocampal formation in normal aging and Alzheimer's disease. J Comp Neurol. 1997;379:482&#x2013;494.</Citation><ArticleIdList><ArticleId IdType="pubmed">9067838</ArticleId></ArticleIdList></Reference><Reference><Citation>Sled JG, Zijdenbos AP, Evans AC. A non-parametric method for automatic correction of intensity non-uniformity in MRI data. IEEE Trans Med Imaging. 1998;17:87&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">9617910</ArticleId></ArticleIdList></Reference><Reference><Citation>Small GW, Ercoli LM, Silverman DH, Huang SC, Komo S, Bookheimer SY, Lavretsky H, Miller K, Siddarth P, Rasgon NL, Mazziotta JC, Saxena S, Wu HM, Mega MS, Cummings JL, Saunders AM, Pericak-Vance MA, Roses AD, Barrio JR, Phelps ME. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci USA. 2000;97:6037&#x2013;6042.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC18554</ArticleId><ArticleId IdType="pubmed">10811879</ArticleId></ArticleIdList></Reference><Reference><Citation>Sowell ER, Thompson PM, Holmes CJ, Jernigan TL, Toga AW. Progression of structural changes in the human brain during the first three decades of life: in vivo evidence for post-adolescent frontal and striatal maturation. Nat Neurosci. 1999;2:859&#x2013;861.</Citation><ArticleIdList><ArticleId IdType="pubmed">10491602</ArticleId></ArticleIdList></Reference><Reference><Citation>Sowell ER, Thompson PM, Mega MS, Zoumalan CI, Lindshield C, Rex DE (2000) Gyral pattern delineation in 3D: surface curve protocol. Available at: http://www.loni.ucla. edu/&#x223c;esowell/new_sulcvar.html</Citation></Reference><Reference><Citation>Sowell ER, Thompson PM, Tessner KD, Toga AW. Accelerated brain growth and cortical gray matter thinning are inversely related during post-adolescent frontal lobe maturation. J Neurosci. 2001;21:8819&#x2013;8829.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6762261</ArticleId><ArticleId IdType="pubmed">11698594</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinmetz H, Furst G, Freund H-J. Variation of perisylvian and calcarine anatomic landmarks within stereotaxic proportional coordinates. Am J Neuroradiol. 1990;11:1123&#x2013;1130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8332148</ArticleId><ArticleId IdType="pubmed">2124038</ArticleId></ArticleIdList></Reference><Reference><Citation>Studholme C, Cardenas V, Schuff N, Rosen H, Miller B, Weiner MW. Detecting spatially consistent structural differences in Alzheimer's and frontotemporal dementia using deformation morphometry. Proceedings of the Third International Conference on Medical Image Computing and Computer Assisted Intervention (MICCAI). Springer; Berlin: 2001.</Citation></Reference><Reference><Citation>Subsol G, Roberts N, Doran M, Thirion JP, Whitehouse GH. Automatic analysis of cerebral atrophy. Magn Reson Imaging. 1997;15:917&#x2013;927.</Citation><ArticleIdList><ArticleId IdType="pubmed">9322211</ArticleId></ArticleIdList></Reference><Reference><Citation>Terry RD, DeTeresa R, Hansen LA. Neocortical cell counts in normal human adult aging. Ann Neurol. 1987;21:530&#x2013;539.</Citation><ArticleIdList><ArticleId IdType="pubmed">3606042</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson PM, Mega MS, Narr KL, Sowell ER, Blanton RE, Toga AW. Brain image analysis and atlas construction. In: Fitzpatrick M, Sonka M, editors. Handbook on medical image analysis. SPIE; Bellingham, WA: 2000.</Citation></Reference><Reference><Citation>Thompson PM, Toga AW. Detection, visualization and animation of abnormal anatomic structure with a deformable probabilistic brain atlas based on random vector field transformations. Med Image Anal. 1997;1:271&#x2013;294.</Citation><ArticleIdList><ArticleId IdType="pubmed">9873911</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson PM, Toga AW. A framework for computational anatomy. Comput Vis Sci. 2002;5:1&#x2013;12.</Citation></Reference><Reference><Citation>Thompson PM, MacDonald D, Mega MS, Holmes CJ, Evans AC, Toga AW. Detection and mapping of abnormal brain structure with a probabilistic atlas of cortical surfaces. J Comp Assist Tomogr. 1997;21:567&#x2013;581.</Citation><ArticleIdList><ArticleId IdType="pubmed">9216760</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson PM, Moussai J, Khan AA, Zohoori S, Goldkorn A, Mega MS, Small GW, Cummings JL, Toga AW. Cortical variability and asymmetry in normal aging and Alzheimer's disease. Cereb Cortex. 1998;8:492&#x2013;509.</Citation><ArticleIdList><ArticleId IdType="pubmed">9758213</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson PM, Giedd JN, Woods RP, MacDonald D, Evans A, Toga AW. Growth patterns in the developing brain detected by using continuum-mechanical tensor maps. Nature. 2000a;404:190&#x2013;193.</Citation><ArticleIdList><ArticleId IdType="pubmed">10724172</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson PM, Woods RP, Mega MS, Toga AW. Mathematical/computational challenges in creating deformable and probabilistic atlases of the human brain. Hum Brain Mapp. 2000b;9:81&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6871833</ArticleId><ArticleId IdType="pubmed">10680765</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson PM, Cannon TD, Narr KL, van Erp T, Khaledy M, Poutanen V-P, Huttunen M, L&#xf6;nnqvist J, Standertskj&#xf6;ld-Nordenstam C-G, Kaprio J, Dail R, Zoumalan CI, Toga AW. Genetic influences on brain structure. Nat Neurosci. 2001a;4:1253&#x2013;1258.</Citation><ArticleIdList><ArticleId IdType="pubmed">11694885</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson PM, Mega RS, Woods RP, Zoumalan CI, Lindshield CJ, Blanton RE, Moussai J, Holmes CJ, Cummings JL, Toga AW. Cortical change in Alzheimer's disease detected with a disease-specific population-based brain atlas. Cereb Cortex. 2001b;11:1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">11113031</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson PM, Mega MS, Vidal C, Rapoport JL, Toga AW. Detecting disease-specific patterns of brain structure using cortical pattern matching and a population-based probabilistic brain atlas. IEEE Conference on Information Processing in Medical Imaging, Davis, CA. In: Insana M, Leahy R, editors. Lecture notes in computer science 2082. Springer; New York: 2001c. pp. 488&#x2013;501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3016014</ArticleId><ArticleId IdType="pubmed">21218175</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson PM, Vidal CN, Giedd JN, Gochman P, Blumenthal J, Nicolson R, Toga AW, Rapoport JL. Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proc Natl Acad Sci USA. 2001d;98:11650&#x2013;11655.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC58784</ArticleId><ArticleId IdType="pubmed">11573002</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson PM, Cannon TD, Toga AW (2003) Mapping genetic influences on human brain structure. Ann Med, in press.</Citation><ArticleIdList><ArticleId IdType="pubmed">12553492</ArticleId></ArticleIdList></Reference><Reference><Citation>Uylings HB, de Brabander JM. Neuronal changes in normal human aging and Alzheimer's disease. Brain Cogn. 2002;49:268&#x2013;276.</Citation><ArticleIdList><ArticleId IdType="pubmed">12139954</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Chalk JB, Rose SE, de Zubicaray GI, Cowin G, Galloway GJ, Barnes D, Spooner D, Doddrell DM, Semple J. MR image-based measurement of rates of change in volumes of brain structures. Part II: application to a study of Alzheimer's disease and normal aging. Magn Reson Imaging. 2002;20:41&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">11973028</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinberger DR, McClure RK. Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain? Arch Gen Psychiatry. 2002;59:553&#x2013;558.</Citation><ArticleIdList><ArticleId IdType="pubmed">12044198</ArticleId></ArticleIdList></Reference><Reference><Citation>Woods RP, Mazziotta JC, Cherry SR. MRI-PET registration with automated algorithm. J Comput Assist Tomogr. 1993;17:536&#x2013;546.</Citation><ArticleIdList><ArticleId IdType="pubmed">8331222</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright IC, McGuire PK, Poline JB, Travere JM, Murray RM, Frith CD, Frackowiak RS, Friston KJ. A voxel-based method for the statistical analysis of gray and white matter density applied to schizophrenia. NeuroImage. 1995;2:244&#x2013;252.</Citation><ArticleIdList><ArticleId IdType="pubmed">9343609</ArticleId></ArticleIdList></Reference><Reference><Citation>Yesavage JA. Geriatric depression scale. Psychopharmacol Bull. 1988;24:709&#x2013;711.</Citation><ArticleIdList><ArticleId IdType="pubmed">3249773</ArticleId></ArticleIdList></Reference><Reference><Citation>Zijdenbos AP, Dawant BM. Brain segmentation and white matter lesion detection in MR images. Crit Rev Biomed Eng. 1994;22:401&#x2013;465.</Citation><ArticleIdList><ArticleId IdType="pubmed">8631195</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12575948</PMID><DateCompleted><Year>2003</Year><Month>04</Month><Day>04</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0896-6273</ISSN><JournalIssue CitedMedium="Print"><Volume>37</Volume><Issue>3</Issue><PubDate><Year>2003</Year><Month>Feb</Month><Day>06</Day></PubDate></JournalIssue><Title>Neuron</Title><ISOAbbreviation>Neuron</ISOAbbreviation></Journal><ArticleTitle>SCA7 knockin mice model human SCA7 and reveal gradual accumulation of mutant ataxin-7 in neurons and abnormalities in short-term plasticity.</ArticleTitle><Pagination><StartPage>383</StartPage><EndPage>401</EndPage><MedlinePgn>383-401</MedlinePgn></Pagination><Abstract><AbstractText>We targeted 266 CAG repeats (a number that causes infantile-onset disease) into the mouse Sca7 locus to generate an authentic model of spinocerebellar ataxia type 7 (SCA7). These mice reproduced features of infantile SCA7 (ataxia, visual impairments, and premature death) and showed impaired short-term synaptic potentiation; downregulation of photoreceptor-specific genes, despite apparently normal CRX activity, led to shortening of photoreceptor outer segments. Wild-type ataxin-7 was barely detectable, as was mutant ataxin-7 in young animals; with increasing age, however, ataxin-7 staining became more pronounced. Neurons that appeared most vulnerable had relatively high levels of mutant ataxin-7; it is interesting, however, that marked dysfunction occurred in these neurons weeks prior to the appearance of nuclear inclusions. These data demonstrate that glutamine expansion stabilizes mutant ataxin-7, provide an explanation for selective neuronal vulnerability, and show that mutant ataxin-7 impairs posttetanic potentiation (PTP).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yoo</LastName><ForeName>Seung Yun</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Division of Neuroscience, Baylor College of Medicine, Houston, TX 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pennesi</LastName><ForeName>Mark E</ForeName><Initials>ME</Initials></Author><Author ValidYN="Y"><LastName>Weeber</LastName><ForeName>Edwin J</ForeName><Initials>EJ</Initials></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Bisong</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Atkinson</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Shiming</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Armstrong</LastName><ForeName>Dawna L</ForeName><Initials>DL</Initials></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Samuel M</ForeName><Initials>SM</Initials></Author><Author ValidYN="Y"><LastName>Sweatt</LastName><ForeName>J David</ForeName><Initials>JD</Initials></Author><Author ValidYN="Y"><LastName>Zoghbi</LastName><ForeName>Huda Y</ForeName><Initials>HY</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>EY02520</GrantID><Acronym>EY</Acronym><Agency>NEI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>EY04446</GrantID><Acronym>EY</Acronym><Agency>NEI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>EY12543</GrantID><Acronym>EY</Acronym><Agency>NEI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 EY012543</GrantID><Acronym>EY</Acronym><Agency>NEI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS27699</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HD24064</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuron</MedlineTA><NlmUniqueID>8809320</NlmUniqueID><ISSNLinking>0896-6273</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000593829">ATXN7 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000067719">Ataxin-7</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000593831">Atxn7 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018398">Homeodomain Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015534">Trans-Activators</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C109288">cone rod homeobox protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067719" MajorTopicYN="N">Ataxin-7</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002531" MajorTopicYN="N">Cerebellum</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018398" MajorTopicYN="N">Homeodomain Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017774" MajorTopicYN="N">Long-Term Potentiation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009473" MajorTopicYN="N">Neuronal Plasticity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017949" MajorTopicYN="N">Retinal Cone Photoreceptor Cells</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017948" MajorTopicYN="N">Retinal Rod Photoreceptor Cells</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012174" MajorTopicYN="N">Retinitis Pigmentosa</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012995" MajorTopicYN="N">Solubility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020754" MajorTopicYN="N">Spinocerebellar Ataxias</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015534" MajorTopicYN="N">Trans-Activators</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>2</Month><Day>11</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>4</Month><Day>5</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>2</Month><Day>11</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12575948</ArticleId><ArticleId IdType="doi">10.1016/s0896-6273(02)01190-x</ArticleId><ArticleId IdType="pii">S089662730201190X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12580705</PMID><DateCompleted><Year>2003</Year><Month>03</Month><Day>11</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0003-9942</ISSN><JournalIssue CitedMedium="Print"><Volume>60</Volume><Issue>2</Issue><PubDate><Year>2003</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Archives of neurology</Title><ISOAbbreviation>Arch Neurol</ISOAbbreviation></Journal><ArticleTitle>Estrogen levels do not correlate with improvement in cognition.</ArticleTitle><Pagination><StartPage>209</StartPage><EndPage>212</EndPage><MedlinePgn>209-12</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To investigate whether an association exists between estradiol and estrone levels and measures of cognitive functioning in women with Alzheimer disease (AD) treated with conjugated equine estrogen (Premarin; Wyeth-Ayerst, Philadelphia, Pa).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We studied 120 postmenopausal women who underwent hysterectomy and who had AD treated with Premarin for 1 year. Plasma estradiol and estrone levels were determined at multiple points during the 1-year treatment trial. The change from baseline level at 2 and 12 months was associated with the change score on 7 different assessments of cognitive functioning.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">At baseline, estradiol levels were low and there were no associations between the estradiol level and the 7 neuropsychological measures. A similar pattern was observed for estrone treatment. During treatment with 0.625 mg/d of Premarin, estradiol levels increased about 4-fold; while receiving 1.25 mg/d of Premarin, estradiol levels increased about 8-fold. A similar pattern was seen with estrone treatment. For both estradiol and estrone levels, there were no significant associations between the change in plasma level and the change in neuropsychological test scores at either 2 or 12 months.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Although Premarin elevated estradiol and estrone levels, there was no association between hormone levels and cognitive functioning after either 2 or 12 months of treatment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Thal</LastName><ForeName>Leon J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, University of California, San Diego, School of Medicine, 9500 Gilman Dr, La Jolla, CA 92093, USA. lthal@ucsd.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Ronald G</ForeName><Initials>RG</Initials></Author><Author ValidYN="Y"><LastName>Mulnard</LastName><ForeName>Ruth</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Sano</LastName><ForeName>Mary</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Grundman</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Schneider</LastName><ForeName>Lon</ForeName><Initials>L</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>AG0 10483</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Arch Neurol</MedlineTA><NlmUniqueID>0372436</NlmUniqueID><ISSNLinking>0003-9942</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004966">Estrogens, Conjugated (USP)</NameOfSubstance></Chemical><Chemical><RegistryNumber>2DI9HA706A</RegistryNumber><NameOfSubstance UI="D004970">Estrone</NameOfSubstance></Chemical><Chemical><RegistryNumber>4TI98Z838E</RegistryNumber><NameOfSubstance UI="D004958">Estradiol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="N">Cognition Disorders</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004958" MajorTopicYN="N">Estradiol</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004966" MajorTopicYN="N">Estrogens, Conjugated (USP)</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004970" MajorTopicYN="N">Estrone</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017698" MajorTopicYN="N">Postmenopause</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>2</Month><Day>13</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>3</Month><Day>12</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>2</Month><Day>13</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12580705</ArticleId><ArticleId IdType="doi">10.1001/archneur.60.2.209</ArticleId><ArticleId IdType="pii">noc20239</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12584433</PMID><DateCompleted><Year>2003</Year><Month>07</Month><Day>03</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1420-8008</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>3</Issue><PubDate><Year>2003</Year></PubDate></JournalIssue><Title>Dementia and geriatric cognitive disorders</Title><ISOAbbreviation>Dement Geriatr Cogn Disord</ISOAbbreviation></Journal><ArticleTitle>Cerebrospinal fluid beta-amyloid 42 is reduced before the onset of sporadic dementia: a population-based study in 85-year-olds.</ArticleTitle><Pagination><StartPage>169</StartPage><EndPage>176</EndPage><MedlinePgn>169-76</MedlinePgn></Pagination><Abstract><AbstractText>Deposition of beta-amyloid (Abeta) is an early pathogenic event in Alzheimer's disease (AD). We measured Abeta42 and Abeta40 in cerebrospinal fluid (CSF) in a population-based sample of 85-year-olds, 27 demented and 35 non-demented. During the following 3 years, 7 of the 35 non-demented individuals had developed dementia, while 28 remained non-demented. Reduced CSF levels of both Abeta42 (p = 0.001) and Abeta40 (p = 0.0001) were found in patients with manifest AD and vascular dementia at the age of 85. Non-demented individuals who developed dementia during follow-up had lower levels of CSF- Abeta42 (p = 0.003), but not CSF-Abeta40 (p = 0.96), than those who remained non-demented. The odds ratio for development of dementia was 8.2 (p = 0.027) for individuals in the lower 50th percentile of CSF-Abeta42, while none of those in the highest 33rd percentile of CSF-Abeta42 developed dementia during follow-up. There were no significant differences between carriers and non-carriers of the apolipoprotein E epsilon4 allele regarding CSF-Abeta42 or CSF-Abeta40. Our study suggests that low CSF-Abeta42 is found also in an unselected population-based sample of old demented patients and provides the first evidence of a disturbance in the metabolism of Abeta, specifically involving Abeta42, before the onset of clinical symptoms in AD.</AbstractText><CopyrightInformation>Copyright 2003 S. Karger AG, Basel</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Skoog</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Institute of Clinical Neuroscience, Unit of Neuropsychiatric Epidemiology, University of G&#xf6;teborg, Sahlgrenska University Hospital, G&#xf6;teborg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davidsson</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Aevarsson</LastName><ForeName>O</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Vanderstichele</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Vanmechelen</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Blennow</LastName><ForeName>K</ForeName><Initials>K</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Dement Geriatr Cogn Disord</MedlineTA><NlmUniqueID>9705200</NlmUniqueID><ISSNLinking>1420-8008</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001057">Apolipoproteins E</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020033">Protein Isoforms</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C078592">amyloid beta-protein (1-40)</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C075222">amyloid beta-protein (1-42)</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="Y">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001057" MajorTopicYN="N">Apolipoproteins E</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="N">Dementia</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="Y">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="Y">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020033" MajorTopicYN="N">Protein Isoforms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012494" MajorTopicYN="N">Sampling Studies</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2002</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>2</Month><Day>14</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>7</Month><Day>4</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>2</Month><Day>14</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12584433</ArticleId><ArticleId IdType="doi">10.1159/000068478</ArticleId><ArticleId IdType="pii">68478</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12586942</PMID><DateCompleted><Year>2003</Year><Month>03</Month><Day>03</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1095-9203</ISSN><JournalIssue CitedMedium="Internet"><Volume>299</Volume><Issue>5609</Issue><PubDate><Year>2003</Year><Month>Feb</Month><Day>14</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>Single-neuron activity and tissue oxygenation in the cerebral cortex.</ArticleTitle><Pagination><StartPage>1070</StartPage><EndPage>1072</EndPage><MedlinePgn>1070-2</MedlinePgn></Pagination><Abstract><AbstractText>Blood oxygen level-dependent functional magnetic resonance imaging uses alterations in brain hemodynamics to infer changes in neural activity. Are these hemodynamic changes regulated at a spatial scale capable of resolving functional columns within the cerebral cortex? To address this question, we made simultaneous measurements of tissue oxygenation and single-cell neural activity within the visual cortex. Results showed that increases in neuronal spike rate were accompanied by immediate decreases in tissue oxygenation. We used this decrease in tissue oxygenation to predict the orientation selectivity and ocular dominance of neighboring neurons. Our results establish a coupling between neural activity and oxidative metabolism and suggest that high-resolution functional magnetic resonance imaging may be used to localize neural activity at a columnar level.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Jeffrey K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Group in Vision Science, School of Optometry, Helen Willis Neuroscience Institute, University of California, Berkeley, CA 94720-2020, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peterson</LastName><ForeName>Matthew R</ForeName><Initials>MR</Initials></Author><Author ValidYN="Y"><LastName>Freeman</LastName><ForeName>Ralph D</ForeName><Initials>RD</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>EY01175</GrantID><Acronym>EY</Acronym><Agency>NEI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>EY03176</GrantID><Acronym>EY</Acronym><Agency>NEI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 EY 07043-24</GrantID><Acronym>EY</Acronym><Agency>NEI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006454">Hemoglobins</NameOfSubstance></Chemical><Chemical><RegistryNumber>9008-02-0</RegistryNumber><NameOfSubstance UI="C100003">deoxyhemoglobin</NameOfSubstance></Chemical><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Science. 2003 Feb 14;299(5609):1023-4. doi: 10.1126/science.1082403.</RefSource><PMID Version="1">12586929</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000200" MajorTopicYN="N">Action Potentials</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002415" MajorTopicYN="N">Cats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002560" MajorTopicYN="N">Cerebrovascular Circulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D023882" MajorTopicYN="N">Dominance, Ocular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004567" MajorTopicYN="N">Electrodes, Implanted</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006454" MajorTopicYN="N">Hemoglobins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008839" MajorTopicYN="N">Microelectrodes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010101" MajorTopicYN="Y">Oxygen Consumption</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010775" MajorTopicYN="N">Photic Stimulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014793" MajorTopicYN="N">Visual Cortex</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>2</Month><Day>15</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>3</Month><Day>4</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>2</Month><Day>15</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12586942</ArticleId><ArticleId IdType="doi">10.1126/science.1079220</ArticleId><ArticleId IdType="pii">299/5609/1070</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12589027</PMID><DateCompleted><Year>2003</Year><Month>05</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>100</Volume><Issue>5</Issue><PubDate><Year>2003</Year><Month>Mar</Month><Day>04</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice.</ArticleTitle><Pagination><StartPage>2911</StartPage><EndPage>2916</EndPage><MedlinePgn>2911-6</MedlinePgn></Pagination><Abstract><AbstractText>In addition to neurological deficits, Huntington's disease (HD) patients and transgenic mice expressing mutant human huntingtin exhibit reduced levels of brain-derived neurotrophic factor, hyperglycemia, and tissue wasting. We show that the progression of neuropathological (formation of huntingtin inclusions and apoptotic protease activation), behavioral (motor dysfunction), and metabolic (glucose intolerance and tissue wasting) abnormalities in huntingtin mutant mice, an animal model of HD, are retarded when the mice are maintained on a dietary restriction (DR) feeding regimen resulting in an extension of their life span. DR increases levels of brain-derived neurotrophic factor and the protein chaperone heat-shock protein-70 in the striatum and cortex, which are depleted in HD mice fed a normal diet. The suppression of the pathogenic processes by DR in HD mice suggests that mutant huntingtin promotes neuronal degeneration by impairing cellular stress resistance, and that the body wasting in HD is driven by the neurodegenerative process. Our findings suggest a dietary intervention that may suppress the disease process and increase the life span of humans that carry the mutant huntingtin gene.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Duan</LastName><ForeName>Wenzhen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Laboratory of Neurosciences, National Institute on Aging, National Institutes of Health, 5600 Nathan Shock Drive, Baltimore, MD 21224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Zhihong</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Haiyang</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Ware</LastName><ForeName>Melvin</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiao-Jiang</ForeName><Initials>XJ</Initials></Author><Author ValidYN="Y"><LastName>Mattson</LastName><ForeName>Mark P</ForeName><Initials>MP</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>02</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019208">Brain-Derived Neurotrophic Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C506812">Htt protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071058">Huntingtin Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020738">Leptin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009687">Nuclear Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D020169">Caspases</NameOfSubstance></Chemical><Chemical><RegistryNumber>IY9XDZ35W2</RegistryNumber><NameOfSubstance UI="D005947">Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001522" MajorTopicYN="N">Behavior, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019208" MajorTopicYN="N">Brain-Derived Neurotrophic Factor</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020169" MajorTopicYN="N">Caspases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004789" MajorTopicYN="N">Enzyme Activation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005947" MajorTopicYN="N">Glucose</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071058" MajorTopicYN="N">Huntingtin Protein</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015151" MajorTopicYN="N">Immunoblotting</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020738" MajorTopicYN="N">Leptin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009687" MajorTopicYN="N">Nuclear Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>2</Month><Day>18</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>5</Month><Day>14</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>2</Month><Day>18</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2003</Year><Month>9</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12589027</ArticleId><ArticleId IdType="pmc">PMC151440</ArticleId><ArticleId IdType="doi">10.1073/pnas.0536856100</ArticleId><ArticleId IdType="pii">0536856100</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Reiner A, Albin R L, Anderson K D, D'Amato C J, Penney J B, Young A B. Proc Natl Acad Sci USA. 1988;85:5733&#x2013;5737.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC281835</ArticleId><ArticleId IdType="pubmed">2456581</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrew S E, Goldberg Y P, Kremer B, Telenius H, Theilmann J, Adam S, Starr E, Squitieri F, Lin B, Kalchman M A, et al. Nat Genet. 1993;7:513&#x2013;519.</Citation><ArticleIdList><ArticleId IdType="pubmed">8401589</ArticleId></ArticleIdList></Reference><Reference><Citation>Benitez J, Fernandez E, Garcia Ruiz P, Robledo M, Ramos C, Yebenes J. Hum Genet. 1994;94:563&#x2013;564.</Citation><ArticleIdList><ArticleId IdType="pubmed">7959696</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandt J, Bylsma F W, Gross R, Stine O C, Ranen N, Ross C A. Neurology. 1996;46:527&#x2013;531.</Citation><ArticleIdList><ArticleId IdType="pubmed">8614526</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu M, Gash M T, Mann V M, Javoy-Agid F, Cooper M, Schapira H V. Ann Neurol. 1996;39:385&#x2013;389.</Citation><ArticleIdList><ArticleId IdType="pubmed">8602759</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkins B G, Koroshetz W J, Beal M F, Rosen BR. Neurology. 1993;43:2689&#x2013;2695.</Citation><ArticleIdList><ArticleId IdType="pubmed">8255479</ArticleId></ArticleIdList></Reference><Reference><Citation>Beal M F, Kowall N W, Ellison D W, Mazurek M F, Swartz K J, Martin J B. Nature. 1986;321:168&#x2013;171.</Citation><ArticleIdList><ArticleId IdType="pubmed">2422561</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakao N, Brundin P. Neuroscience. 1997;76:749&#x2013;761.</Citation><ArticleIdList><ArticleId IdType="pubmed">9135048</ArticleId></ArticleIdList></Reference><Reference><Citation>Cha J H. Trends Neurosci. 2000;23:387&#x2013;392.</Citation><ArticleIdList><ArticleId IdType="pubmed">10941183</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies S W, Turmaine M, Cozens B A, DiFiglia M, Sharp A H, Ross C A, Scherzinger E, Wanker E E, Mangiarini L, Bates G P. Cell. 1997;90:537&#x2013;548.</Citation><ArticleIdList><ArticleId IdType="pubmed">9267033</ArticleId></ArticleIdList></Reference><Reference><Citation>Schilling G, Becher M W, Sharp A H, Jinnah H A, Duan K, Kotzuki J A, Slunt H H, Ratovitski T, Cooper J K, Jenkins N A, et al. Hum Mol Genet. 1999;8:397&#x2013;407.</Citation><ArticleIdList><ArticleId IdType="pubmed">9949199</ArticleId></ArticleIdList></Reference><Reference><Citation>Schilling G, Coonfield M L, Ross C A, Borchelt D R. Neurosci Lett. 2001;315:149&#x2013;153.</Citation><ArticleIdList><ArticleId IdType="pubmed">11716985</ArticleId></ArticleIdList></Reference><Reference><Citation>Ona V O, Li M, Vonsattel J P, Andrews L J, Khan S Q, Chung W M, Frey A S, Menon A S, Li X J, Stieg P E, et al. Nature. 1999;399:263&#x2013;267.</Citation><ArticleIdList><ArticleId IdType="pubmed">10353249</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonini A, Leenders K L, Spiegel R, Meier D, Vontobel P, Weigell-Weber M, Sanchez-Pernaute R, de Yebenez J G, Boesiger P, Weindl A, Maguire R P. Brain. 1996;119:2085&#x2013;2095.</Citation><ArticleIdList><ArticleId IdType="pubmed">9010012</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuwert T. J Neurol. 1993;241:31&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">8138819</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin W R, Clark C, Ammann W, Stoessl A J, Shtybel W, Hayden M R. Neurology. 1992;42:223&#x2013;229.</Citation><ArticleIdList><ArticleId IdType="pubmed">1531155</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrer L. Clin Genet. 1985;27:62&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">3156696</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurlbert M S, Zhou W, Wasmeier C, Kaddis F G, Hutton J C, Freed C R. Diabetes. 1999;48:649&#x2013;651.</Citation><ArticleIdList><ArticleId IdType="pubmed">10078572</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreassen O A, Dedeoglu A, Ferrante R J, Jenkins B G, Ferrante K L, Thomas M, Friedlich A, Browne S E, Schilling G, Borchelt D R, et al. Neurobiol Dis. 2001;8:479&#x2013;491.</Citation><ArticleIdList><ArticleId IdType="pubmed">11447996</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrer I, Goutan E, Marin C, Rey M J, Ribalta T. Brain Res. 2000;866:257&#x2013;261.</Citation><ArticleIdList><ArticleId IdType="pubmed">10825501</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuccato C, Ciammola A, Rigamonti D, Leavitt B R, Goffredo D, Conti L, MacDonald M E, Friedlander R M, Silani V, Hayden M R, et al. Science. 2001;293:493&#x2013;498.</Citation><ArticleIdList><ArticleId IdType="pubmed">11408619</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng B, Mattson M P. Brain Res. 1994;640:56&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">7911729</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan W, Guo Z, Mattson M P. J Neurochem. 2001;76:619&#x2013;626.</Citation><ArticleIdList><ArticleId IdType="pubmed">11208925</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakao N, Kokaia Z, Odin P, Lindvall O. Exp Neurol. 1995;131:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">7895804</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Navarro E, Canudas A M, Akerund P, Alberch J, Arenas E. J Neurochem. 2000;75:2190&#x2013;2199.</Citation><ArticleIdList><ArticleId IdType="pubmed">11183872</ArticleId></ArticleIdList></Reference><Reference><Citation>Bemelmans A P, Horellou P, Pradier L, Brunet I, Colin P, Mallet J. Hum Gene Ther. 1999;10:2987&#x2013;2997.</Citation><ArticleIdList><ArticleId IdType="pubmed">10609659</ArticleId></ArticleIdList></Reference><Reference><Citation>Weindruch R, Sohal R S. N Engl J Med. 1997;337:986&#x2013;994.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2851235</ArticleId><ArticleId IdType="pubmed">9309105</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanagat J, Allison D B, Weindruch R. Toxicol Sci. 1999;52:S35&#x2013;S40.</Citation><ArticleIdList><ArticleId IdType="pubmed">10630588</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubey A, Forster M J, Lal H, Sohal R S. Arch Biochem Biophys. 1996;333:189&#x2013;197.</Citation><ArticleIdList><ArticleId IdType="pubmed">8806770</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Z, Ersoz A, Butterfield D A, Mattson M P. J Neurochem. 2000;75:314&#x2013;320.</Citation><ArticleIdList><ArticleId IdType="pubmed">10854276</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu B P, Chung H Y. Ann NY Acad Sci. 2001;928:39&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">11795526</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruce-Keller A J, Umberger G, McFall R, Mattson M P. Ann Neurol. 1999;45:8&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">9894871</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan W, Mattson M P. J Neurosci Res. 1999;57:195&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pubmed">10398297</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z F, Mattson M P. J Neurosci Res. 1999;57:830&#x2013;839.</Citation><ArticleIdList><ArticleId IdType="pubmed">10467254</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Seroogy K B, Mattson M P. J Neurochem. 2000;80:539&#x2013;547.</Citation><ArticleIdList><ArticleId IdType="pubmed">11905999</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan W, Ladenheim B, Cutler R G, Kruman I I, Cadet J L, Mattson M P. J Neurochem. 2002;80:101&#x2013;110.</Citation><ArticleIdList><ArticleId IdType="pubmed">11796748</ArticleId></ArticleIdList></Reference><Reference><Citation>Hengemihle J M, Long J M, Betkey J, Jucker M, Ingram D K. Neurobiol Aging. 1999;20:9&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">10466889</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodrick C L, Ingram D K, Reynolds M A, Freeman J R, Cider N. Mech Ageing Dev. 1990;55:69&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">2402168</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattson M P. Nature. 2002;415:377&#x2013;379.</Citation><ArticleIdList><ArticleId IdType="pubmed">11807533</ArticleId></ArticleIdList></Reference><Reference><Citation>Heydari A R, Conrad C C, Richardson A. J Nutr. 1995;125:410&#x2013;418.</Citation><ArticleIdList><ArticleId IdType="pubmed">7876915</ArticleId></ArticleIdList></Reference><Reference><Citation>Dedeoglu A, Ferrante R J, Andreassen O A, Dillmann W H, Beal M F. Exp Neurol. 2002;176:262&#x2013;265.</Citation><ArticleIdList><ArticleId IdType="pubmed">12093104</ArticleId></ArticleIdList></Reference><Reference><Citation>Jana N R, Tanaka M, Wang G, Nukina N. Hum Mol Genet. 2000;9:2009&#x2013;2018.</Citation><ArticleIdList><ArticleId IdType="pubmed">10942430</ArticleId></ArticleIdList></Reference><Reference><Citation>Schabitz W R, Sommer C, Zoder W, Kiessling M, Schwaninger M, Schwab S. Stroke. 2000;31:2212&#x2013;2217.</Citation><ArticleIdList><ArticleId IdType="pubmed">10978054</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattson M P, Lovell M A, Furukawa K, Markesbery W R. J Neurochem. 1995;65:1740&#x2013;1751.</Citation><ArticleIdList><ArticleId IdType="pubmed">7561872</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Duan W, Mattson M P. J Neurochem. 2002;82:1367&#x2013;1375.</Citation><ArticleIdList><ArticleId IdType="pubmed">12354284</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H, Li S H, Li X J. J Biol Chem. 2001;276:48417&#x2013;48424.</Citation><ArticleIdList><ArticleId IdType="pubmed">11606565</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakagawa T. Diabetes. 2000;49:436&#x2013;444.</Citation><ArticleIdList><ArticleId IdType="pubmed">10868966</ArticleId></ArticleIdList></Reference><Reference><Citation>Rios M, Fan G, Fekete C, Kelly J, Bates B, Kuehn R, Lechan R M, Jaenisch R. Mol Endocrinol. 2001;15:1748&#x2013;1757.</Citation><ArticleIdList><ArticleId IdType="pubmed">11579207</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters A, Schweiger U, Fruhwald-Schultes B, Born J, Fehm H L. Exp Clin Endocrinol Diabetes. 2002;110:199&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pubmed">12148083</ArticleId></ArticleIdList></Reference><Reference><Citation>Schober A, Wolf N, Huber K, Hertel R, Krieglstein K, Minichiello L, Kahane N, Widenfalk J, Kalcheim C, Olson L. J Neurosci. 1998;18:7272&#x2013;7284.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6793231</ArticleId><ArticleId IdType="pubmed">9736648</ArticleId></ArticleIdList></Reference><Reference><Citation>Kernie S G, Liebl D J, Parada L F. EMBO J. 2000;19:1290&#x2013;1300.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC305670</ArticleId><ArticleId IdType="pubmed">10716929</ArticleId></ArticleIdList></Reference><Reference><Citation>Pratley R E, Salbe A D, Ravussin E, Caviness J N. Ann Neurol. 2000;47:64&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">10632102</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanberg P R, Fibiger H C, Mark R F. Med J Aust. 1981;1:407&#x2013;409.</Citation><ArticleIdList><ArticleId IdType="pubmed">6454826</ArticleId></ArticleIdList></Reference><Reference><Citation>Luesse H G, Schiefer J, Spruenken A, Puls C, Block F, Kosinski C M. Behav Brain Res. 2001;126:185&#x2013;195.</Citation><ArticleIdList><ArticleId IdType="pubmed">11704263</ArticleId></ArticleIdList></Reference><Reference><Citation>Hockly E, Cordery P M, Woodman B, Mahal A, van Dellen A, Blakemore C, Lewis C M, Hannan A J, Bates G P. Ann Neurol. 2002;51:235&#x2013;242.</Citation><ArticleIdList><ArticleId IdType="pubmed">11835380</ArticleId></ArticleIdList></Reference><Reference><Citation>Beilby J, Chin C Y, Porter I, Walpole I R, Goldblatt J. Med J Aust. 1994;161:356&#x2013;360.</Citation><ArticleIdList><ArticleId IdType="pubmed">8090111</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12591949</PMID><DateCompleted><Year>2003</Year><Month>05</Month><Day>13</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>100</Volume><Issue>5</Issue><PubDate><Year>2003</Year><Month>Mar</Month><Day>04</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>The integrity of a cholesterol-binding pocket in Niemann-Pick C2 protein is necessary to control lysosome cholesterol levels.</ArticleTitle><Pagination><StartPage>2518</StartPage><EndPage>2525</EndPage><MedlinePgn>2518-25</MedlinePgn></Pagination><Abstract><AbstractText>The neurodegenerative disease Niemann-Pick Type C2 (NPC2) results from mutations in the NPC2 (HE1) gene that cause abnormally high cholesterol accumulation in cells. We find that purified NPC2, a secreted soluble protein, binds cholesterol specifically with a much higher affinity (K(d) = 30-50 nM) than previously reported. Genetic and biochemical studies identified single amino acid changes that prevent both cholesterol binding and the restoration of normal cholesterol levels in mutant cells. The amino acids that affect cholesterol binding surround a hydrophobic pocket in the NPC2 protein structure, identifying a candidate sterol-binding location. On the basis of evolutionary analysis and mutagenesis, three other regions of the NPC2 protein emerged as important, including one required for efficient secretion.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ko</LastName><ForeName>Dennis C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Department of Developmental Biology, Beckman Center B300, 279 Campus Drive, Stanford University School of Medicine, Stanford, CA 94305-5329, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Binkley</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Sidow</LastName><ForeName>Arend</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Scott</LastName><ForeName>Matthew P</ForeName><Initials>MP</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>HHMI</Acronym><Agency>Howard Hughes Medical Institute</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>02</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000596">Amino Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002352">Carrier Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017077">Culture Media, Conditioned</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018076">DNA, Complementary</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006023">Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C104585">NPC2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D033921">Vesicular Transport Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>87Z59R7D14</RegistryNumber><NameOfSubstance UI="D005372">Filipin</NameOfSubstance></Chemical><Chemical><RegistryNumber>97C5T2UQ7J</RegistryNumber><NameOfSubstance UI="D002784">Cholesterol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000596" MajorTopicYN="N">Amino Acids</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016466" MajorTopicYN="N">CHO Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002352" MajorTopicYN="Y">Carrier Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002784" MajorTopicYN="N">Cholesterol</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002850" MajorTopicYN="N">Chromatography, Gel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017077" MajorTopicYN="N">Culture Media, Conditioned</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018076" MajorTopicYN="N">DNA, Complementary</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019143" MajorTopicYN="N">Evolution, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005372" MajorTopicYN="N">Filipin</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006023" MajorTopicYN="N">Glycoproteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016297" MajorTopicYN="N">Mutagenesis, Site-Directed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010957" MajorTopicYN="N">Plasmids</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017434" MajorTopicYN="N">Protein Structure, Tertiary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017386" MajorTopicYN="N">Sequence Homology, Amino Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012984" MajorTopicYN="N">Software</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033921" MajorTopicYN="N">Vesicular Transport Proteins</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>2</Month><Day>20</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>5</Month><Day>14</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>2</Month><Day>20</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2003</Year><Month>9</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12591949</ArticleId><ArticleId IdType="pmc">PMC151373</ArticleId><ArticleId IdType="doi">10.1073/pnas.0530027100</ArticleId><ArticleId IdType="pii">0530027100</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Patterson M C, Vanier M T, Suzuki K, Morris J A, Carstea E D, Neufeld E, Blanchette-Mackie E J, Pentchev P G. In: The Metabolic and Molecular Bases of Inherited Disease. Scriver C R, Beaudet A L, Sly W S, Valle D, editors. New York: McGraw&#x2013;Hill; 2001. pp. 3611&#x2013;3633.</Citation></Reference><Reference><Citation>Liscum L, Faust J R. J Biol Chem. 1987;262:17002&#x2013;17008.</Citation><ArticleIdList><ArticleId IdType="pubmed">3680287</ArticleId></ArticleIdList></Reference><Reference><Citation>Pentchev P G, Comly M E, Kruth H S, Tokoro T, Butler J, Sokol J, Filling-Katz M, Quirk J M, Marshall D C, Patel S, et al. FASEB J. 1987;1:40&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">3609608</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi T, Beuchat M H, Lindsay M, Frias S, Palmiter R D, Sakuraba H, Parton R G, Gruenberg J. Nat Cell Biol. 1999;1:113&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pubmed">10559883</ArticleId></ArticleIdList></Reference><Reference><Citation>Carstea E D, Morris J A, Coleman K G, Loftus S K, Zhang D, Cummings C, Gu J, Rosenfeld M A, Pavan W J, Krizman D B, et al. Science. 1997;277:228&#x2013;231.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Loftus S K, Morris J A, Carstea E D, Gu J Z, Cummings C, Brown A, Ellison J, Ohno K, Rosenfeld M A, Tagle D A, et al. Science. 1997;277:232&#x2013;235.</Citation><ArticleIdList><ArticleId IdType="pubmed">9211850</ArticleId></ArticleIdList></Reference><Reference><Citation>Naureckiene S, Sleat D E, Lackland H, Fensom A, Vanier M T, Wattiaux R, Jadot M, Lobel P. Science. 2000;290:2298&#x2013;2301.</Citation><ArticleIdList><ArticleId IdType="pubmed">11125141</ArticleId></ArticleIdList></Reference><Reference><Citation>Millat G, Chikh K, Naureckiene S, Sleat D E, Fensom A H, Higaki K, Elleder M, Lobel P, Vanier M T. Am J Hum Genet. 2001;69:1013&#x2013;1021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1274348</ArticleId><ArticleId IdType="pubmed">11567215</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirchhoff C, Osterhoff C, Habben I, Ivell R, Kirchloff C. Int J Androl. 1990;13:155&#x2013;167.</Citation><ArticleIdList><ArticleId IdType="pubmed">1693137</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamura N, Kiuchi S, Tamba M, Kashima T, Hiramoto S, Baba T, Dacheux F, Dacheux J L, Sugita Y, Jin Y Z. Biochim Biophys Acta. 1999;1438:377&#x2013;387.</Citation><ArticleIdList><ArticleId IdType="pubmed">10366780</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedland N, Liou H-L, Lobel P, Stock A M. Proc Natl Acad Sci USA. 2003;100:2512&#x2013;2517.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC151372</ArticleId><ArticleId IdType="pubmed">12591954</ArticleId></ArticleIdList></Reference><Reference><Citation>Cadigan K M, Spillane D M, Chang T Y. J Cell Biol. 1990;110:295&#x2013;308.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2116012</ArticleId><ArticleId IdType="pubmed">2404988</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon A L, Stone E A, Sidow A. Proc Natl Acad Sci USA. 2002;99:2912&#x2013;2917.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC122447</ArticleId><ArticleId IdType="pubmed">11880638</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson J D, Higgins D G, Gibson T J. Nucleic Acids Res. 1994;22:4673&#x2013;4680.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC308517</ArticleId><ArticleId IdType="pubmed">7984417</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman N, Ninio M, Pe'er I, Pupko T. J Comput Biol. 2002;9:331&#x2013;353.</Citation><ArticleIdList><ArticleId IdType="pubmed">12015885</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelley L A, MacCallum R M, Sternberg M J. J Mol Biol. 2000;299:499&#x2013;520.</Citation><ArticleIdList><ArticleId IdType="pubmed">10860755</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer D, Barret C, Bryson K, Elofsson A, Godzik A, Jones D, Karplus K J, Kelley L A, MacCallum R M, Pawowski K, et al. Proteins. 1999;Suppl. 3:209&#x2013;217.</Citation><ArticleIdList><ArticleId IdType="pubmed">10526371</ArticleId></ArticleIdList></Reference><Reference><Citation>Guex N, Peitsch M C. Electrophoresis. 1997;18:2714&#x2013;2723.</Citation><ArticleIdList><ArticleId IdType="pubmed">9504803</ArticleId></ArticleIdList></Reference><Reference><Citation>Lange Y, Swaisgood M H, Ramos B V, Steck T L. J Biol Chem. 1989;264:3786&#x2013;3793.</Citation><ArticleIdList><ArticleId IdType="pubmed">2917977</ArticleId></ArticleIdList></Reference><Reference><Citation>Lange Y, Ye J, Steck T L. J Biol Chem. 1998;273:18915&#x2013;18922.</Citation><ArticleIdList><ArticleId IdType="pubmed">9668068</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies J P, Chen F W, Ioannou Y A. Science. 2000;290:2295&#x2013;2298.</Citation><ArticleIdList><ArticleId IdType="pubmed">11125140</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossjohn J, Feil S C, McKinstry W J, Tweten R K, Parker M W. Cell. 1997;89:685&#x2013;692.</Citation><ArticleIdList><ArticleId IdType="pubmed">9182756</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsujishita Y, Hurley J H. Nat Struct Biol. 2000;7:408&#x2013;414.</Citation><ArticleIdList><ArticleId IdType="pubmed">10802740</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller G A, Benjamin D C, Rule G S. Biochemistry. 1998;37:12707&#x2013;12714.</Citation><ArticleIdList><ArticleId IdType="pubmed">9737847</ArticleId></ArticleIdList></Reference><Reference><Citation>Storch J, Thumser A E. Biochim Biophys Acta. 2000;1486:28&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">10856711</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurley J H, Misra S. Annu Rev Biophys Biomol Struct. 2000;29:49&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4781318</ArticleId><ArticleId IdType="pubmed">10940243</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahuran D J. Biochim Biophys Acta. 1998;1393:1&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">9714704</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright C S, Li S C, Rastinejad F. J Mol Biol. 2000;304:411&#x2013;422.</Citation><ArticleIdList><ArticleId IdType="pubmed">11090283</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12591954</PMID><DateCompleted><Year>2003</Year><Month>05</Month><Day>13</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>100</Volume><Issue>5</Issue><PubDate><Year>2003</Year><Month>Mar</Month><Day>04</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Structure of a cholesterol-binding protein deficient in Niemann-Pick type C2 disease.</ArticleTitle><Pagination><StartPage>2512</StartPage><EndPage>2517</EndPage><MedlinePgn>2512-7</MedlinePgn></Pagination><Abstract><AbstractText>Niemann-Pick disease type C2 (NP-C2) is a fatal hereditary disease characterized by accumulation of low-density lipoprotein-derived cholesterol in lysosomes. Here we report the 1.7-A resolution crystal structure of the cholesterol-binding protein deficient in this disease, NPC2, and the characterization of its ligand binding properties. Human NPC2 binds the cholesterol analog dehydroergosterol with submicromolar affinity at both acidic and neutral pH. NPC2 has an Ig-like fold stabilized by three disulfide bonds. The structure of the bovine protein reveals a loosely packed region penetrating from the surface into the hydrophobic core that forms adjacent small cavities with a total volume of approximately 160 A(3). We propose that this region represents the incipient cholesterol-binding site that dilates to accommodate an approximately 740-A(3) cholesterol molecule.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Friedland</LastName><ForeName>Natalia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Center for Advanced Biotechnology and Medicine, Howard Hughes Medical Institute, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, 679 Hoes Lane, Piscataway, NJ 08854, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liou</LastName><ForeName>Heng-Ling</ForeName><Initials>HL</Initials></Author><Author ValidYN="Y"><LastName>Lobel</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Stock</LastName><ForeName>Ann M</ForeName><Initials>AM</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>PDB</DataBankName><AccessionNumberList><AccessionNumber>1NEP</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><Acronym>HHMI</Acronym><Agency>Howard Hughes Medical Institute</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK054317</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>DK54317</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>02</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002352">Carrier Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004220">Disulfides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006023">Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008024">Ligands</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008894">Milk Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C104585">NPC2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013261">Sterols</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D033921">Vesicular Transport Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>97C5T2UQ7J</RegistryNumber><NameOfSubstance UI="D002784">Cholesterol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002352" MajorTopicYN="Y">Carrier Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002417" MajorTopicYN="N">Cattle</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002784" MajorTopicYN="N">Cholesterol</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018360" MajorTopicYN="N">Crystallography, X-Ray</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004220" MajorTopicYN="N">Disulfides</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006023" MajorTopicYN="N">Glycoproteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008024" MajorTopicYN="N">Ligands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008894" MajorTopicYN="N">Milk Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008925" MajorTopicYN="N">Mites</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009542" MajorTopicYN="N">Niemann-Pick Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017510" MajorTopicYN="N">Protein Folding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017433" MajorTopicYN="N">Protein Structure, Secondary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017434" MajorTopicYN="N">Protein Structure, Tertiary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017386" MajorTopicYN="N">Sequence Homology, Amino Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013261" MajorTopicYN="N">Sterols</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D033921" MajorTopicYN="N">Vesicular Transport Proteins</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>2</Month><Day>20</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>5</Month><Day>14</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>2</Month><Day>20</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2003</Year><Month>9</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12591954</ArticleId><ArticleId IdType="pmc">PMC151372</ArticleId><ArticleId IdType="doi">10.1073/pnas.0437840100</ArticleId><ArticleId IdType="pii">0437840100</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Goldstein J L, Hobbs H H, Brown M S. In: The Metabolic and Molecular Bases of Inherited Disease. Scriver C R, Beaudet A L, Sly W S, Valle D, editors. III. New York: McGraw&#x2013;Hill; 2001. pp. 2863&#x2013;2913.</Citation></Reference><Reference><Citation>Patterson M C, Vanier M T, Suzuki K, Morris J A, Carstea E, Neufeld E B, Blanchette-Mackie J E, Pentchev P G. In: The Metabolic and Molecular Bases of Inherited Disease. Scriver C R, Beaudet A L, Sly W S, Valle D, editors. III. New York: McGraw&#x2013;Hill; 2001. pp. 3611&#x2013;3633.</Citation></Reference><Reference><Citation>Carstea E D, Morris J A, Coleman K G, Loftus S K, Zhang D, Cummings C, Gu J, Rosenfeld M A, Pavan W J, Krizman D B, et al. Science. 1997;277:228&#x2013;231.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannou Y A. Nat Rev Mol Cell Biol. 2001;2:657&#x2013;668.</Citation><ArticleIdList><ArticleId IdType="pubmed">11533723</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies J P, Chen F W, Ioannou Y A. Science. 2000;290:2295&#x2013;2298.</Citation><ArticleIdList><ArticleId IdType="pubmed">11125140</ArticleId></ArticleIdList></Reference><Reference><Citation>Naureckiene S, Sleat D E, Lackland H, Fensom A, Vanier M T, Wattiaux R, Jadot M, Lobel P. Science. 2000;290:2298&#x2013;2301.</Citation><ArticleIdList><ArticleId IdType="pubmed">11125141</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirchhoff C, Osterhoff C, Young L. Biol Reprod. 1996;54:847&#x2013;856.</Citation><ArticleIdList><ArticleId IdType="pubmed">8924505</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamura N, Kiuchi S, Tamba M, Kashima T, Hiramoto S, Baba T, Dacheux F, Dacheux J L, Sugita Y, Jin Y Z. Biochim Biophys Acta. 1999;1438:377&#x2013;387.</Citation><ArticleIdList><ArticleId IdType="pubmed">10366780</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko D C, Binkley J, Sidow A, Scott M P. Proc Natl Acad Sci USA. 2003;100:2518&#x2013;2525.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC151373</ArticleId><ArticleId IdType="pubmed">12591949</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen L B, Ravn P, Boisen A, Berglund L, Petersen T E. Eur J Biochem. 1997;243:437&#x2013;441.</Citation><ArticleIdList><ArticleId IdType="pubmed">9030770</ArticleId></ArticleIdList></Reference><Reference><Citation>Otwinowski Z. In: Proceedings of the CCP4 Study Weekend: Data Collection and Processing. Sawyer L, Isaacs N, Bayley S, editors. Daresbury Laboratory, Warrington, U.K.: Science and Engineering Research Council; 1993. pp. 56&#x2013;62.</Citation></Reference><Reference><Citation>Br&#xfc;nger A T, Adams P D, Clore G M, DeLano W L, Gros P, Grosse-Kunstleve R W, Jiang J S, Kuszewski J, Nilges M, Pannu N S, et al. Acta Crystallogr D. 1998;54:905&#x2013;921.</Citation><ArticleIdList><ArticleId IdType="pubmed">9757107</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrakis A, Morris R, Lamzin V S. Nat Struct Biol. 1999;6:458&#x2013;463.</Citation><ArticleIdList><ArticleId IdType="pubmed">10331874</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones T A, Zou J Y, Cowan S W, Kjeldgaard M. Acta Crystallogr A. 1991;47:110&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pubmed">2025413</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroeder F, Butko P, Nemecz G, Scallen T J. J Biol Chem. 1990;265:151&#x2013;157.</Citation><ArticleIdList><ArticleId IdType="pubmed">2294101</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandwar R P, Jia Y, Stano N M, Patel S S. Biochemistry. 2002;41:3586&#x2013;3595.</Citation><ArticleIdList><ArticleId IdType="pubmed">11888274</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraulis P J. J Appl Crystallogr. 1991;24:946&#x2013;950.</Citation></Reference><Reference><Citation>Merritt E A, Bacon D J. Methods Enzymol. 1997;277:505&#x2013;524.</Citation><ArticleIdList><ArticleId IdType="pubmed">18488322</ArticleId></ArticleIdList></Reference><Reference><Citation>Lascombe M B, Ponchet M, Venard P, Milat M L, Blein J P, Prange T. Acta Crystallogr D. 2002;58:1442&#x2013;1447.</Citation><ArticleIdList><ArticleId IdType="pubmed">12198300</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J C, Miercke L J, Krucinski J, Starr J R, Saenz G, Wang X, Spilburg C A, Lange L G, Ellsworth J L, Stroud R M. Biochemistry. 1998;37:5107&#x2013;5117.</Citation><ArticleIdList><ArticleId IdType="pubmed">9548741</ArticleId></ArticleIdList></Reference><Reference><Citation>Yue Q K, Kass I J, Sampson N S, Vrielink A. Biochemistry. 1999;38:4277&#x2013;4286.</Citation><ArticleIdList><ArticleId IdType="pubmed">10194345</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsujishita Y, Hurley J H. Nat Struct Biol. 2000;7:408&#x2013;414.</Citation><ArticleIdList><ArticleId IdType="pubmed">10802740</ArticleId></ArticleIdList></Reference><Reference><Citation>Glatz J F, Storch J. Curr Opin Lipidol. 2001;12:267&#x2013;274.</Citation><ArticleIdList><ArticleId IdType="pubmed">11353329</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodsdon M E, Cistola D P. Biochemistry. 1997;36:1450&#x2013;1460.</Citation><ArticleIdList><ArticleId IdType="pubmed">9063893</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang J, Edelsbrunner H, Woodward C. Protein Sci. 1998;7:1884&#x2013;1897.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2144175</ArticleId><ArticleId IdType="pubmed">9761470</ArticleId></ArticleIdList></Reference><Reference><Citation>Millat G, Chikh K, Naureckiene S, Sleat D E, Fensom A H, Higaki K, Elleder M, Lobel P, Vanier M T. Am J Hum Genet. 2001;69:1013&#x2013;1021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1274348</ArticleId><ArticleId IdType="pubmed">11567215</ArticleId></ArticleIdList></Reference><Reference><Citation>Kl&#xfc;nemann H H, Elleder M, Kaminski W E, Snow K, Peyser J M, O'Brien J F, Munoz D, Schmitz G, Klein H E, Pendlebury W W. Ann Neurol. 2002;52:743&#x2013;749.</Citation><ArticleIdList><ArticleId IdType="pubmed">12447927</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller G A, Benjamin D C, Rule G S. Biochemistry. 1998;37:12707&#x2013;12714.</Citation><ArticleIdList><ArticleId IdType="pubmed">9737847</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichikawa S, Hatanaka H, Yuuki T, Iwamoto N, Kojima S, Nishiyama C, Ogura K, Okumura Y, Inagaki F. J Biol Chem. 1998;273:356&#x2013;360.</Citation><ArticleIdList><ArticleId IdType="pubmed">9417088</ArticleId></ArticleIdList></Reference><Reference><Citation>Derewenda U, Li J, Derewenda Z, Dauter Z, Mueller G A, Rule G S, Benjamin D C. J Mol Biol. 2002;318:189&#x2013;197.</Citation><ArticleIdList><ArticleId IdType="pubmed">12054778</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright C S, Li S C, Rastinejad F. J Mol Biol. 2000;304:411&#x2013;422.</Citation><ArticleIdList><ArticleId IdType="pubmed">11090283</ArticleId></ArticleIdList></Reference><Reference><Citation>Inohara N, Nu&#xf1;ez G. Trends Biochem Sci. 2002;27:219&#x2013;221.</Citation><ArticleIdList><ArticleId IdType="pubmed">12076526</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12594315</PMID><DateCompleted><Year>2003</Year><Month>02</Month><Day>28</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1533-4406</ISSN><JournalIssue CitedMedium="Internet"><Volume>348</Volume><Issue>8</Issue><PubDate><Year>2003</Year><Month>Feb</Month><Day>20</Day></PubDate></JournalIssue><Title>The New England journal of medicine</Title><ISOAbbreviation>N Engl J Med</ISOAbbreviation></Journal><ArticleTitle>Detection of pathologic prion protein in the olfactory epithelium in sporadic Creutzfeldt-Jakob disease.</ArticleTitle><Pagination><StartPage>711</StartPage><EndPage>719</EndPage><MedlinePgn>711-9</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Olfactory cortexes and the olfactory tracts are involved in sporadic Creutzfeldt-Jakob disease. We examined peripheral regions of the olfactory sensory pathway, including the olfactory mucosa, to assess whether pathologic infectious prion protein (PrPSc) is deposited in the epithelium lining the nasal cavity.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We studied nine patients with neuropathologically confirmed sporadic Creutzfeldt-Jakob disease. We obtained the brain, the cribriform plate with the attached olfactory mucosa, and the surrounding respiratory epithelium at autopsy. Control samples of nasal mucosa were obtained post mortem or at biopsy from age-matched control subjects and from control patients with other neurodegenerative diseases. The olfactory and respiratory mucosa and the intracranial olfactory system were analyzed by light microscopy, immunohistochemistry, and Western blotting for pathological changes and for deposition of PrPSc.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In all nine patients with sporadic Creutzfeldt-Jakob disease, PrPSc was found in the olfactory cilia and central olfactory pathway but not in the respiratory mucosa. No PrPSc was detected in any of the tissue samples from the 11 controls.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our pathological and biochemical studies show that PrPSc is deposited in the neuroepithelium of the olfactory mucosa in patients with sporadic Creutzfeldt-Jakob disease, indicating that olfactory biopsy may provide diagnostic information in living patients. The olfactory pathway may represent a route of infection and a means of spreading prions.</AbstractText><CopyrightInformation>Copyright 2003 Massachusetts Medical Society</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zanusso</LastName><ForeName>Gianluigi</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurologic and Visual Sciences, University of Verona, Verona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrari</LastName><ForeName>Sergio</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Cardone</LastName><ForeName>Franco</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Zampieri</LastName><ForeName>Paolo</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Gelati</LastName><ForeName>Matteo</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Fiorini</LastName><ForeName>Michele</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Farinazzo</LastName><ForeName>Alessia</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Gardiman</LastName><ForeName>Marina</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Cavallaro</LastName><ForeName>Tiziana</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Bentivoglio</LastName><ForeName>Marina</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Righetti</LastName><ForeName>Pier Giorgio</ForeName><Initials>PG</Initials></Author><Author ValidYN="Y"><LastName>Pocchiari</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Rizzuto</LastName><ForeName>Nicola</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Monaco</LastName><ForeName>Salvatore</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>N Engl J Med</MedlineTA><NlmUniqueID>0255562</NlmUniqueID><ISSNLinking>0028-4793</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018620">PrPSc Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>N Engl J Med. 2003 Feb 20;348(8):681-2. doi: 10.1056/NEJMp020187.</RefSource><PMID Version="1">12594311</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001923" MajorTopicYN="N">Brain Chemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007562" MajorTopicYN="N">Creutzfeldt-Jakob Syndrome</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004848" MajorTopicYN="N">Epithelium</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009831" MajorTopicYN="N">Olfactory Mucosa</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018620" MajorTopicYN="N">PrPSc Proteins</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>2</Month><Day>21</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>3</Month><Day>1</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>2</Month><Day>21</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12594315</ArticleId><ArticleId IdType="doi">10.1056/NEJMoa022043</ArticleId><ArticleId IdType="pii">348/8/711</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12597857</PMID><DateCompleted><Year>2003</Year><Month>03</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0896-6273</ISSN><JournalIssue CitedMedium="Print"><Volume>37</Volume><Issue>4</Issue><PubDate><Year>2003</Year><Month>Feb</Month><Day>20</Day></PubDate></JournalIssue><Title>Neuron</Title><ISOAbbreviation>Neuron</ISOAbbreviation></Journal><ArticleTitle>The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson's disease.</ArticleTitle><Pagination><StartPage>583</StartPage><EndPage>595</EndPage><MedlinePgn>583-95</MedlinePgn></Pagination><Abstract><AbstractText>Accumulation of misfolded proteins as insoluble aggregates occurs in several neurodegenerative diseases. In Parkinson's disease (PD) and dementia with Lewy bodies (DLB), alpha-synuclein (alpha S) accumulates in insoluble inclusions. To identify soluble alpha S oligomers that precede insoluble aggregates, we probed the cytosols of mesencephalic neuronal (MES) cells, normal and alpha S-transgenic mouse brains, and normal, PD, and DLB human brains. All contained highly soluble oligomers of alpha S whose detection was enhanced by delipidation. Exposure of living MES neurons to polyunsaturated fatty acids (PUFAs) increased alpha S oligomer levels, whereas saturated FAs decreased them. PUFAs directly promoted oligomerization of recombinant alphaS. Transgenic mice accumulated soluble oligomers with age. PD and DLB brains had elevated amounts of the soluble, lipid-dependent oligomers. We conclude that alpha S interacts with PUFAs in vivo to promote the formation of highly soluble oligomers that precede the insoluble alpha S aggregates associated with neurodegeneration.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sharon</LastName><ForeName>Ronit</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Center for Neurologic Diseases, Harvard Medical School, Brigham and Women's Hospital, Boston, MA 02215, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bar-Joseph</LastName><ForeName>Ifat</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Frosch</LastName><ForeName>Matthew P</ForeName><Initials>MP</Initials></Author><Author ValidYN="Y"><LastName>Walsh</LastName><ForeName>Dominic M</ForeName><Initials>DM</Initials></Author><Author ValidYN="Y"><LastName>Hamilton</LastName><ForeName>James A</ForeName><Initials>JA</Initials></Author><Author ValidYN="Y"><LastName>Selkoe</LastName><ForeName>Dennis J</ForeName><Initials>DJ</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NS 38375</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuron</MedlineTA><NlmUniqueID>8809320</NlmUniqueID><ISSNLinking>0896-6273</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005227">Fatty Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005231">Fatty Acids, Unsaturated</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D046911">Macromolecular Substances</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C497604">SNCA protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C497605">Snca protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051843">Synucleins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051844">alpha-Synuclein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019943" MajorTopicYN="N">Amino Acid Substitution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001923" MajorTopicYN="N">Brain Chemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003600" MajorTopicYN="N">Cytosol</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005227" MajorTopicYN="N">Fatty Acids</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005231" MajorTopicYN="N">Fatty Acids, Unsaturated</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020961" MajorTopicYN="N">Lewy Body Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D046911" MajorTopicYN="N">Macromolecular Substances</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008636" MajorTopicYN="N">Mesencephalon</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012995" MajorTopicYN="N">Solubility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051843" MajorTopicYN="N">Synucleins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051844" MajorTopicYN="N">alpha-Synuclein</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>2</Month><Day>25</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>3</Month><Day>8</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>2</Month><Day>25</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12597857</ArticleId><ArticleId IdType="doi">10.1016/s0896-6273(03)00024-2</ArticleId><ArticleId IdType="pii">S0896627303000242</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12598614</PMID><DateCompleted><Year>2003</Year><Month>03</Month><Day>24</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1529-2401</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>4</Issue><PubDate><Year>2003</Year><Month>Feb</Month><Day>15</Day></PubDate></JournalIssue><Title>The Journal of neuroscience : the official journal of the Society for Neuroscience</Title><ISOAbbreviation>J Neurosci</ISOAbbreviation></Journal><ArticleTitle>blue cheese mutations define a novel, conserved gene involved in progressive neural degeneration.</ArticleTitle><Pagination><StartPage>1254</StartPage><EndPage>1264</EndPage><MedlinePgn>1254-64</MedlinePgn></Pagination><Abstract><AbstractText>A common feature of many human neurodegenerative diseases is the accumulation of insoluble ubiquitin-containing protein aggregates in the CNS. Although Drosophila has been helpful in understanding several human neurodegenerative disorders, a loss-of-function mutation has not been identified that leads to insoluble CNS protein aggregates. The study of Drosophila mutations may identify unique components that are associated with human degenerative diseases. The Drosophila blue cheese (bchs) gene defines such a novel degenerative pathway. bchs mutants have a reduced adult life span with the age-dependent formation of protein aggregates throughout the neuropil of the CNS. These inclusions contain insoluble ubiquitinated proteins and amyloid precursor-like protein. Progressive loss of CNS size and morphology along with extensive neuronal apoptosis occurs in aged bchs mutants. BCHS protein is widely expressed in the cytoplasm of CNS neurons and is present over the entire length of axonal projections. BCHS is nearly 3500 amino acids in size, with the last 1000 amino acids consisting of three functional protein motifs implicated in vesicle transport and protein processing. This region along with previously unidentified proteins encoded in the human, mouse, and nematode genomes shows striking homology along the full length of the BCHS protein. The high degree of conservation between Drosophila and human bchs suggests that study of the functional pathway of BCHS and associated mutant phenotype may provide useful insights into human neurodegenerative disorders.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Finley</LastName><ForeName>Kim D</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>Molecular and Cellular Biology Laboratory and Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, California 92037-1099, USA. finley@salk.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Edeen</LastName><ForeName>Philip T</ForeName><Initials>PT</Initials></Author><Author ValidYN="Y"><LastName>Cumming</LastName><ForeName>Robert C</ForeName><Initials>RC</Initials></Author><Author ValidYN="Y"><LastName>Mardahl-Dumesnil</LastName><ForeName>Michelle D</ForeName><Initials>MD</Initials></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>Barbara J</ForeName><Initials>BJ</Initials></Author><Author ValidYN="Y"><LastName>Rodriguez</LastName><ForeName>Maria H</ForeName><Initials>MH</Initials></Author><Author ValidYN="Y"><LastName>Hwang</LastName><ForeName>Calvin E</ForeName><Initials>CE</Initials></Author><Author ValidYN="Y"><LastName>Benedetti</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>McKeown</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS09658</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS009658</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM56920A</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R03 AG19614</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 MH57460</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosci</MedlineTA><NlmUniqueID>8102140</NlmUniqueID><ISSNLinking>0270-6474</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C066839">Appl protein, Drosophila</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D029721">Drosophila Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D025801">Ubiquitin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C472019">bchs protein, Drosophila</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017124" MajorTopicYN="N">Conserved Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004330" MajorTopicYN="N">Drosophila</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000254" MajorTopicYN="N">growth &amp; development</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029721" MajorTopicYN="N">Drosophila Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017344" MajorTopicYN="N">Genes, Insect</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015151" MajorTopicYN="N">Immunoblotting</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002479" MajorTopicYN="N">Inclusion Bodies</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="Y">Membrane Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009410" MajorTopicYN="N">Nerve Degeneration</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017386" MajorTopicYN="N">Sequence Homology, Amino Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D025801" MajorTopicYN="N">Ubiquitin</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>2</Month><Day>25</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>3</Month><Day>26</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>2</Month><Day>25</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2003</Year><Month>8</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12598614</ArticleId><ArticleId IdType="mid">NIHMS23051</ArticleId><ArticleId IdType="pmc">PMC1975817</ArticleId><ArticleId IdType="pii">23/4/1254</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.23-04-01254.2003</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abrams JM. An emerging blueprint for apoptosis in Drosophila. Trends Cell Biol. 1999;9:435&#x2013;440.</Citation><ArticleIdList><ArticleId IdType="pubmed">10511707</ArticleId></ArticleIdList></Reference><Reference><Citation>Alloway PG, Howard L, Dolph PJ. The formation of stable rhodopsin&#x2013;arrestin complexes induces apoptosis and photoreceptor cell degeneration. Neuron. 2000;28:129&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pubmed">11086989</ArticleId></ArticleIdList></Reference><Reference><Citation>Auluck PK, Chan HY, Trojanowski JQ, Lee VM, Bonini NM. Chaperone suppression of &#x3b1;-synuclein toxicity in a Drosophila model for Parkinson's disease. Science. 2002;295:865&#x2013;868.</Citation><ArticleIdList><ArticleId IdType="pubmed">11823645</ArticleId></ArticleIdList></Reference><Reference><Citation>Bacskai BJ, Kajdasz ST, Christie RH, Carter C, Games D, Seubert P, Schenk D, Hyman BT. Imaging of amyloid-&#x3b2; deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy. Nat Med. 2001;7:369&#x2013;372.</Citation><ArticleIdList><ArticleId IdType="pubmed">11231639</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbosa MD, Nguyen QA, Tchernev VT, Ashley JA, Detter JC, Blaydes SM, Brandt SJ, Chotai D, Hodgman C, Solari RC, Lovett M, Kingsmore SF. Identification of the homologous beige and Chediak&#x2013;Higashi syndrome genes. Nature. 1996;382:262&#x2013;265.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2893578</ArticleId><ArticleId IdType="pubmed">8717042</ArticleId></ArticleIdList></Reference><Reference><Citation>Bence NF, Sampat RM, Kopito RR. Impairment of the ubiquitin&#x2013;proteasome system by protein aggregation. Science. 2001;292:1552&#x2013;1555.</Citation><ArticleIdList><ArticleId IdType="pubmed">11375494</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchanan RL, Benzer S. Defective glia in the Drosophila brain degeneration mutant drop-dead. Neuron. 1993;10:839&#x2013;850.</Citation><ArticleIdList><ArticleId IdType="pubmed">8494644</ArticleId></ArticleIdList></Reference><Reference><Citation>Burd CG, Emr SD. Phosphatidylinositol 3-phosphate signaling mediated by specific binding to RING FYVE domains. Mol Cell. 1998;2:157&#x2013;162.</Citation><ArticleIdList><ArticleId IdType="pubmed">9702203</ArticleId></ArticleIdList></Reference><Reference><Citation>Cataldo AM, Hamilton DJ, Barnett JL, Paskevich PA, Nixon RA. Properties of the endosomal&#x2013;lysosomal system in the human CNS: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease. J Neurosci. 1996;16:186&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6578706</ArticleId><ArticleId IdType="pubmed">8613784</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan HY, Bonini NM. Drosophila models of human neurodegenerative disease. Cell Death Differ. 2000;7:1075&#x2013;1080.</Citation><ArticleIdList><ArticleId IdType="pubmed">11139281</ArticleId></ArticleIdList></Reference><Reference><Citation>Cormont M, Mari M, Galmiche A, Hofman P, Le Marchand-Brustel Y. A FYVE-finger-containing protein, Rabip4, is a Rab4 effector involved in early endosomal traffic. Proc Natl Acad Sci USA. 2001;98:1637&#x2013;1642.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC29309</ArticleId><ArticleId IdType="pubmed">11172003</ArticleId></ArticleIdList></Reference><Reference><Citation>Corvera S, D'Arrigo A, Stenmark H. Phosphoinositides in membrane traffic. Curr Opin Cell Biol. 1999;11:460&#x2013;465.</Citation><ArticleIdList><ArticleId IdType="pubmed">10449332</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson FF, Steller H. Blocking apoptosis prevents blindness in Drosophila retinal degeneration mutants. Nature. 1998;391:587&#x2013;591.</Citation><ArticleIdList><ArticleId IdType="pubmed">9468136</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Q, Lewis JJ, Strum KM, Dimayuga E, Bruce-Keller AJ, Dunn JC, Keller JN. Polyglutamine expansion, protein aggregation, proteasome activity, and neural survival. J Biol Chem. 2002;277:13935&#x2013;13942.</Citation><ArticleIdList><ArticleId IdType="pubmed">11782460</ArticleId></ArticleIdList></Reference><Reference><Citation>Faigle W, Raposo G, Tenza D, Pinet V, Vogt AB, Kropshofer H, Fischer A, de Saint-Basile G, Amigorena S. Deficient peptide loading and MHC class II endosomal sorting in a human genetic immunodeficiency disease: the Chediak&#x2013;Higashi syndrome. J Cell Biol. 1998;141:1121&#x2013;1134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2137185</ArticleId><ArticleId IdType="pubmed">9606205</ArticleId></ArticleIdList></Reference><Reference><Citation>Feany MB, Bender W. A Drosophila model of Parkinson's disease. Nature. 2000;204:394&#x2013;398.</Citation><ArticleIdList><ArticleId IdType="pubmed">10746727</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Funez P, Nino-Rosales ML, de Gouyon B, She WC, Luchak JM, Martinez P, Turiegano E, Benito J, Capovilla M, Skinner PJ, McCall A, Canal I, Orr HT, Zoghbi HY, Botas J. Identification of genes that modify ataxin-1-induced neurodegeneration. Nature. 2000;408:101&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pubmed">11081516</ArticleId></ArticleIdList></Reference><Reference><Citation>Finley KD, Edeen PT, Foss M, Gross E, Ghbeish N, Palmer RH, Taylor BJ, McKeown M. dissatisfaction encodes a Tailless-like nuclear receptor expressed in a subset of CNS neurons controlling Drosophila sexual behavior. Neuron. 1998;21:1363&#x2013;1374.</Citation><ArticleIdList><ArticleId IdType="pubmed">9883729</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandy S, Petanceska S. Regulation of Alzheimer &#x3b2;-amyloid precursor trafficking and metabolism. Biochim Biophys Acta. 2000;1502:44&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">10899430</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunawardena S, Goldstein LS. Disruption of axonal transport and neuronal viability by amyloid precursor protein mutations in Drosophila. Neuron. 2001;32:389&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pubmed">11709151</ArticleId></ArticleIdList></Reference><Reference><Citation>Hay BA, Maile R, Rubin GM. P-element insertion-dependent gene activation in the Drosophila eye. Proc Natl Acad Sci USA. 1997;94:5195&#x2013;5200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC24655</ArticleId><ArticleId IdType="pubmed">9144214</ArticleId></ArticleIdList></Reference><Reference><Citation>Hicke L. A new ticket for entry into budding vesicles&#x2014;ubiquitin. Cell. 2001;106:527&#x2013;530.</Citation><ArticleIdList><ArticleId IdType="pubmed">11551499</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson MD. Anti-apoptosis therapy: a way of treating neural degeneration? Curr Biol. 1998;8:R418&#x2013;R421.</Citation><ArticleIdList><ArticleId IdType="pubmed">9637913</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo E, McLaurin J, Yip CM, St. George-Hyslop P, Fraser PE. &#x3b1;-Synuclein membrane interactions and lipid specificity. J Biol Chem. 2000;275:34328&#x2013;34334.</Citation><ArticleIdList><ArticleId IdType="pubmed">10915790</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston JA, Ward CL, Kopito RR. Aggresomes: a cellular response to misfolded proteins. J Cell Biol. 1998;143:1883&#x2013;1898.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2175217</ArticleId><ArticleId IdType="pubmed">9864362</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazantsev A, Walker HA, Slepko N, Bear JE, Preisinger E, Steffan JS, Zhu YZ, Gertler FB, Housman DE, Marsh JL, Thompson LM. A bivalent huntingtin binding peptide suppresses polyglutamine aggregation and pathogenesis in Drosophila. Nat Genet. 2002;30:367&#x2013;376.</Citation><ArticleIdList><ArticleId IdType="pubmed">11925563</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazemi-Esfarjani P, Benzer S. Genetic suppression of polyglutamine toxicity in Drosophila. Science. 2000;287:1837&#x2013;1840.</Citation><ArticleIdList><ArticleId IdType="pubmed">10710314</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiselev A, Socolich M, Vinos J, Hardy RW, Zuker CS, Ranganathan R. A molecular pathway for light-dependent photoreceptor apoptosis in Drosophila. Neuron. 2000;28:139&#x2013;152.</Citation><ArticleIdList><ArticleId IdType="pubmed">11086990</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraut R, Menon K, Zinn K. A gain-of-function screen for genes controlling motor axon guidance and synaptogenesis in Drosophila. Curr Biol. 2001;11:417&#x2013;430.</Citation><ArticleIdList><ArticleId IdType="pubmed">11301252</ArticleId></ArticleIdList></Reference><Reference><Citation>Kretzschmar D, Hasan G, Sharma S, Heisenberg M, Benzer S. The swiss cheese mutant causes glial hyperwrapping and brain degeneration in Drosophila. J Neurosci. 1997;17:7425&#x2013;7432.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6573436</ArticleId><ArticleId IdType="pubmed">9295388</ArticleId></ArticleIdList></Reference><Reference><Citation>Kutateladze TG, Ogburn KD, Watson WT, de Beer T, Emr SD, Burd CG, Overduin M. Phosphatidylinositol 3-phosphate recognition by the FYVE domain. Mol Cell. 1999;3:805&#x2013;811.</Citation><ArticleIdList><ArticleId IdType="pubmed">10394369</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai EC, Deblandre GA, Kintner C, Rubin GM. Drosophila neuralized is a ubiquitin ligase that promotes the internalization and degradation of delta. Dev Cell. 2001;1:783&#x2013;794.</Citation><ArticleIdList><ArticleId IdType="pubmed">11740940</ArticleId></ArticleIdList></Reference><Reference><Citation>Lloyd TE, Atkinson R, Wu MN, Zhou Y, Pennetta G, Bellen HJ. Hrs regulates endosome membrane invagination and tyrosine kinase receptor signaling in Drosophila. Cell. 2002;108:261&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pubmed">11832215</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsh JL, Walker H, Theisen H, Zhu YZ, Fielder T, Purcell J, Thompson LM. Expanded polyglutamine peptides alone are intrinsically cytotoxic and cause neurodegeneration in Drosophila. Hum Mol Genet. 2000;9:13&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">10587574</ArticleId></ArticleIdList></Reference><Reference><Citation>Min KT, Benzer S. spongecake and eggroll: two hereditary diseases in Drosophila resemble patterns of human brain degeneration. Curr Biol. 1997;7:885&#x2013;888.</Citation><ArticleIdList><ArticleId IdType="pubmed">9382801</ArticleId></ArticleIdList></Reference><Reference><Citation>Min KT, Benzer S. Preventing neurodegeneration in the Drosophila mutant bubblegum. Science. 1999;284:1985&#x2013;1988.</Citation><ArticleIdList><ArticleId IdType="pubmed">10373116</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohtashami M, Stewart BA, Boulianne GL, Trimble WS. Analysis of the mutant Drosophila N-ethylmaleimide sensitive fusion-1 protein in comatose reveals molecular correlates of the behavioural paralysis. J Neurochem. 2001;77:1407&#x2013;1417.</Citation><ArticleIdList><ArticleId IdType="pubmed">11389191</ArticleId></ArticleIdList></Reference><Reference><Citation>Muqit MM, Feany MB. Modeling neurodegenerative diseases in Drosophila: a fruitful approach? Nat Rev Neurosci. 2002;3:237&#x2013;243.</Citation><ArticleIdList><ArticleId IdType="pubmed">11994755</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutsuddi M, Nambu JR. Neural disease: Drosophila degenerates for a good cause. Curr Biol. 1998;8:R809&#x2013;R811.</Citation><ArticleIdList><ArticleId IdType="pubmed">9811597</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagle DL, Karim MA, Woolf EA, Holmgren L, Bork P, Misumi DJ, McGrail SH, Dussault BJ, Jr, Perou CM, Boissy RE, Duyk GM, Spritz RA, Moore KJ. Identification and mutation analysis of the complete gene for Chediak&#x2013;Higashi syndrome. Nat Genet. 1996;14:307&#x2013;311.</Citation><ArticleIdList><ArticleId IdType="pubmed">8896560</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakano Y, Fujitani K, Kurihara J, Ragan J, Usui-Aoki K, Shimoda L, Lukacsovich T, Suzuki K, Sezaki M, Sano Y, Ueda R, Awano W, Kaneda M, Umeda M, Yamamoto D. Mutations in the novel membrane protein Spinster interfere with programmed cell death and cause neural degeneration in Drosophila melanogaster. Mol Cell Biol. 2001;21:3775&#x2013;3788.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC87027</ArticleId><ArticleId IdType="pubmed">11340170</ArticleId></ArticleIdList></Reference><Reference><Citation>Neer EJ, Schmidt CJ, Nambudripad R, Smith TF. The ancient regulatory-protein family of WD-repeat proteins. Nature. 1994;371:297&#x2013;300.</Citation><ArticleIdList><ArticleId IdType="pubmed">8090199</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostrerova-Golts N, Petrucelli L, Hardy J, Lee JM, Farer M, Wolozin B. The A53T &#x3b1;-synuclein mutation increases iron-dependent aggregation and toxicity. J Neurosci. 2000;20:6048&#x2013;6054.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772599</ArticleId><ArticleId IdType="pubmed">10934254</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips JP, Campbell SD, Michaud D, Charbonneau M, Hilliker AJ. Null mutation of copper/zinc superoxide dismutase in Drosophila confers hypersensitivity to paraquat and reduced longevity. Proc Natl Acad Sci USA. 1989;86:2761&#x2013;2765.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC286998</ArticleId><ArticleId IdType="pubmed">2539600</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickart CM. Ubiquitin enters the new millennium. Mol Cell. 2001;8:499&#x2013;504.</Citation><ArticleIdList><ArticleId IdType="pubmed">11583613</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiter LT, Potocki L, Chien S, Gribskov M, Bier E. A systematic analysis of human disease-associated gene sequences in Drosophila melanogaster. Genome Res. 2001;11:1114&#x2013;1125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC311089</ArticleId><ArticleId IdType="pubmed">11381037</ArticleId></ArticleIdList></Reference><Reference><Citation>Rio DC. Regulation of Drosophila P-element transposition. Trends Genet. 1991;7:282&#x2013;287.</Citation><ArticleIdList><ArticleId IdType="pubmed">1662417</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinow S, White K. The locus elav of Drosophila melanogaster is expressed in neurons at all developmental stages. Dev Biol. 1988;126:294&#x2013;303.</Citation><ArticleIdList><ArticleId IdType="pubmed">3127258</ArticleId></ArticleIdList></Reference><Reference><Citation>Rorth P. A modular misexpression screen in Drosophila detecting tissue-specific phenotypes. Proc Natl Acad Sci USA. 1996;93:12418&#x2013;12422.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC38006</ArticleId><ArticleId IdType="pubmed">8901596</ArticleId></ArticleIdList></Reference><Reference><Citation>Seugnet L, Simpson P, Haenlin M. Requirement for dynamin during Notch signaling in Drosophila neurogenesis. Dev Biol. 1997;192:585&#x2013;598.</Citation><ArticleIdList><ArticleId IdType="pubmed">9441691</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharon R, Goldberg MS, Bar-Josef I, Betensky RA, Shen J, Selkoe DJ. &#x3b1;-Synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins. Proc Natl Acad Sci USA. 2001;98:9110&#x2013;9115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC55381</ArticleId><ArticleId IdType="pubmed">11481478</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherman MY, Goldberg AL. Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. Neuron. 2001;29:15&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">11182078</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoelson SE. SH2 and PTB domain interactions in tyrosine kinase signal transduction. Curr Opin Chem Biol. 1997;1:227&#x2013;234.</Citation><ArticleIdList><ArticleId IdType="pubmed">9667855</ArticleId></ArticleIdList></Reference><Reference><Citation>Steffan JS, Bodai L, Pallos J, Poelman M, McCampbell A, Apostol BL, Kazantsev A, Schmidt E, Zhu YZ, Greenwald M, Kurokawa R, Housman DE, Jackson GR, Marsh JL, Thompson LM. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature. 2001;413:739&#x2013;743.</Citation><ArticleIdList><ArticleId IdType="pubmed">11607033</ArticleId></ArticleIdList></Reference><Reference><Citation>Stenmark H, Aasland R. FYVE-finger proteins&#x2014;effectors of an inositol lipid. J Cell Sci. 1999;112:4175&#x2013;4183.</Citation><ArticleIdList><ArticleId IdType="pubmed">10564636</ArticleId></ArticleIdList></Reference><Reference><Citation>Suhr ST, Senut MC, Whitelegge JP, Faull KF, Cuizon DB, Gage FH. Identities of sequestered proteins in aggregates from cells with induced polyglutamine expression. J Cell Biol. 2001;153:283&#x2013;294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2169460</ArticleId><ArticleId IdType="pubmed">11309410</ArticleId></ArticleIdList></Reference><Reference><Citation>Tchernev VT, Mansfield TA, Giot L, Kumar AM, Nandabalan K, Li Y, Mishra VS, Detter JC, Rothberg JM, Wallace MR, Southwick FS, Kingsmore SF. The Chediak&#x2013;Higashi protein interacts with SNARE complex and signal transduction proteins. Mol Med. 2002;8:56&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2039936</ArticleId><ArticleId IdType="pubmed">11984006</ArticleId></ArticleIdList></Reference><Reference><Citation>Torroja L, Luo L, White K. APPL, the Drosophila member of the APP family, exhibits differential trafficking and processing in CNS neurons. J Neurosci. 1996;16:4638&#x2013;4650.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6579020</ArticleId><ArticleId IdType="pubmed">8764652</ArticleId></ArticleIdList></Reference><Reference><Citation>Waelter S, Scherzinger E, Hasenbank R, Nordhoff E, Lurz R, Goehler H, Gauss C, Sathasivam K, Bates GP, Lehrach H, Wanker EE. The huntingtin interacting protein HIP1 is a clathrin and &#x3b1;-adaptin-binding protein involved in receptor-mediated endocytosis. Hum Mol Genet. 2001;10:1807&#x2013;1817.</Citation><ArticleIdList><ArticleId IdType="pubmed">11532990</ArticleId></ArticleIdList></Reference><Reference><Citation>Warrick JM, Chan HY, Gray-Board GL, Chai Y, Paulson HL, Bonini NM. Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nat Genet. 1999;23:425&#x2013;428.</Citation><ArticleIdList><ArticleId IdType="pubmed">10581028</ArticleId></ArticleIdList></Reference><Reference><Citation>Wittmann CW, Wszolek MF, Shulman JM, Salvaterra PM, Lewis J, Hutton M, Feany MB. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science. 2001;293:711&#x2013;714.</Citation><ArticleIdList><ArticleId IdType="pubmed">11408621</ArticleId></ArticleIdList></Reference><Reference><Citation>Wurmser AE, Gary JD, Emr SD. Phosphoinositide 3-kinases and their FYVE domain-containing effectors as regulators of vacuolar/lysosomal membrane trafficking pathways. J Biol Chem. 1999;274:9129&#x2013;9132.</Citation><ArticleIdList><ArticleId IdType="pubmed">10092582</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong WC, Montell C. Defective glia induce neuronal apoptosis in the repo visual system of Drosophila. Neuron. 1995;14:581&#x2013;590.</Citation><ArticleIdList><ArticleId IdType="pubmed">7695904</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12598899</PMID><DateCompleted><Year>2003</Year><Month>06</Month><Day>10</Day></DateCompleted><DateRevised><Year>2010</Year><Month>11</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1097-6256</ISSN><JournalIssue CitedMedium="Print"><Volume>6</Volume><Issue>4</Issue><PubDate><Year>2003</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Nature neuroscience</Title><ISOAbbreviation>Nat Neurosci</ISOAbbreviation></Journal><ArticleTitle>Extracellular amyloid formation and associated pathology in neural grafts.</ArticleTitle><Pagination><StartPage>370</StartPage><EndPage>377</EndPage><MedlinePgn>370-7</MedlinePgn></Pagination><Abstract><AbstractText>Amyloid precursor protein (APP) processing and the generation of beta-amyloid peptide (Abeta) are important in the pathogenesis of Alzheimer's disease. Although this has been studied extensively at the molecular and cellular levels, much less is known about the mechanisms of amyloid accumulation in vivo. We transplanted transgenic APP23 and wild-type B6 embryonic neural cells into the neocortex and hippocampus of both B6 and APP23 mice. APP23 grafts into wild-type hosts did not develop amyloid deposits up to 20 months after grafting. In contrast, both transgenic and wild-type grafts into young transgenic hosts developed amyloid plaques as early as 3 months after grafting. Although largely diffuse in nature, some of the amyloid deposits in wild-type grafts were congophilic and were surrounded by neuritic changes and gliosis, similar to the amyloid-associated pathology previously described in APP23 mice. Our results indicate that diffusion of soluble Abeta in the extracellular space is involved in the spread of Abeta pathology, and that extracellular amyloid formation can lead to neurodegeneration.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Meyer-Luehmann</LastName><ForeName>Melanie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neuropathology, Institute of Pathology, University of Basel, Sch&#xf6;nbeinstrasse 40, CH-4003 Basel, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stalder</LastName><ForeName>Martina</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Herzig</LastName><ForeName>Martin C</ForeName><Initials>MC</Initials></Author><Author ValidYN="Y"><LastName>Kaeser</LastName><ForeName>Stephan A</ForeName><Initials>SA</Initials></Author><Author ValidYN="Y"><LastName>Kohler</LastName><ForeName>Esther</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Pfeifer</LastName><ForeName>Michelle</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Boncristiano</LastName><ForeName>Sonia</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Mathews</LastName><ForeName>Paul M</ForeName><Initials>PM</Initials></Author><Author ValidYN="Y"><LastName>Mercken</LastName><ForeName>Marc</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Abramowski</LastName><ForeName>Dorothee</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Staufenbiel</LastName><ForeName>Matthias</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Jucker</LastName><ForeName>Mathias</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Neurosci</MedlineTA><NlmUniqueID>9809671</NlmUniqueID><ISSNLinking>1097-6256</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nat Neurosci. 2003 Apr;6(4):328-30. doi: 10.1038/nn0403-328.</RefSource><PMID Version="1">12658277</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016380" MajorTopicYN="N">Brain Tissue Transplantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004058" MajorTopicYN="N">Diffusion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005110" MajorTopicYN="N">Extracellular Space</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005911" MajorTopicYN="N">Gliosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006085" MajorTopicYN="N">Graft Survival</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000637" MajorTopicYN="N">transplantation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058225" MajorTopicYN="N">Plaque, Amyloid</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D021381" MajorTopicYN="N">Protein Transport</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011930" MajorTopicYN="N">Reaction Time</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012995" MajorTopicYN="N">Solubility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2002</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2003</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>2</Month><Day>25</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>6</Month><Day>11</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>2</Month><Day>25</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12598899</ArticleId><ArticleId IdType="doi">10.1038/nn1022</ArticleId><ArticleId IdType="pii">nn1022</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12601150</PMID><DateCompleted><Year>2003</Year><Month>05</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>100</Volume><Issue>5</Issue><PubDate><Year>2003</Year><Month>Mar</Month><Day>04</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson's disease.</ArticleTitle><Pagination><StartPage>2884</StartPage><EndPage>2889</EndPage><MedlinePgn>2884-9</MedlinePgn></Pagination><Abstract><AbstractText>We used a high-titer recombinant adeno-associated virus (rAAV) vector to express WT or mutant human alpha-synuclein in the substantia nigra of adult marmosets. The alpha-synuclein protein was expressed in 90-95% of all nigral dopamine neurons and distributed by anterograde transport throughout their axonal and dendritic projections. The transduced neurons developed severe neuronal pathology, including alpha-synuclein-positive cytoplasmic inclusions and granular deposits; swollen, dystrophic, and fragmented neuritis; and shrunken and pyknotic, densely alpha-synuclein-positive perikarya. By 16 wk posttransduction, 30-60% of the tyrosine hydroxylase-positive neurons were lost, and the tyrosine hydroxylase-positive innervation of the caudate nucleus and putamen was reduced to a similar extent. The rAAV-alpha-synuclein-treated monkeys developed a type of motor impairment, i.e., head position bias, compatible with this magnitude of nigrostriatal damage. rAAV vector-mediated alpha-synuclein gene transfer provides a transgenic primate model of nigrostriatal alpha-synucleinopathy that is of particular interest because it develops slowly over time, like human Parkinson's disease (PD), and expresses neuropathological features (alpha-synuclein-positive inclusions and dystrophic neurites, in particular) that are similar to those seen in idiopathic PD. This model offers new opportunities for the study of pathogenetic mechanisms and exploration of new therapeutic targets of particular relevance to human PD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kirik</LastName><ForeName>Deniz</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Wallenberg Neuroscience Center, Department of Physiological Sciences, Division of Neurobiology, Lund University, BMC A11, 221 84 Lund, Sweden. deniz.kirik@mphy.lu.se</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Annett</LastName><ForeName>Lucy E</ForeName><Initials>LE</Initials></Author><Author ValidYN="Y"><LastName>Burger</LastName><ForeName>Corinna</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Muzyczka</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Mandel</LastName><ForeName>Ronald J</ForeName><Initials>RJ</Initials></Author><Author ValidYN="Y"><LastName>Bj&#xf6;rklund</LastName><ForeName>Anders</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>P01 NS036302</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 NS36302</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>02</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000662">Amphetamines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C497604">SNCA protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051843">Synucleins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051844">alpha-Synuclein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.16.2</RegistryNumber><NameOfSubstance UI="D014446">Tyrosine 3-Monooxygenase</NameOfSubstance></Chemical><Chemical><RegistryNumber>VTD58H1Z2X</RegistryNumber><NameOfSubstance UI="D004298">Dopamine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000662" MajorTopicYN="N">Amphetamines</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002144" MajorTopicYN="N">Callithrix</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000229" MajorTopicYN="N">Dependovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004298" MajorTopicYN="N">Dopamine</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005822" MajorTopicYN="N">Genetic Vectors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013378" MajorTopicYN="N">Substantia Nigra</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051843" MajorTopicYN="N">Synucleins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014446" MajorTopicYN="N">Tyrosine 3-Monooxygenase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051844" MajorTopicYN="N">alpha-Synuclein</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>2</Month><Day>26</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>5</Month><Day>14</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>2</Month><Day>26</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2003</Year><Month>9</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12601150</ArticleId><ArticleId IdType="pmc">PMC151435</ArticleId><ArticleId IdType="doi">10.1073/pnas.0536383100</ArticleId><ArticleId IdType="pii">0536383100</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Beal M F. Nat Rev Neurosci. 2001;2:325&#x2013;334.</Citation><ArticleIdList><ArticleId IdType="pubmed">11331916</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawson T, Mandir A, Lee M. Neuron. 2002;35:219&#x2013;222.</Citation><ArticleIdList><ArticleId IdType="pubmed">12160740</ArticleId></ArticleIdList></Reference><Reference><Citation>Spillantini M G, Schmidt M L, Lee V M, Trojanowski J Q, Jakes R, Goedert M. Nature. 1997;388:839&#x2013;840.</Citation><ArticleIdList><ArticleId IdType="pubmed">9278044</ArticleId></ArticleIdList></Reference><Reference><Citation>Goedert M. Nat Rev Neurosci. 2001;2:492&#x2013;501.</Citation><ArticleIdList><ArticleId IdType="pubmed">11433374</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymeropoulos M H, Lavedan C, Leroy E, Ide S E, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, et al. Science. 1997;276:2045&#x2013;2047.</Citation><ArticleIdList><ArticleId IdType="pubmed">9197268</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, Przuntek H, Epplen J T, Schols L, Riess O. Nat Genet. 1998;18:106&#x2013;108.</Citation><ArticleIdList><ArticleId IdType="pubmed">9462735</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway K A, Rochet J C, Bieganski R M, Lansbury P T., Jr Science. 2001;294:1346&#x2013;1349.</Citation><ArticleIdList><ArticleId IdType="pubmed">11701929</ArticleId></ArticleIdList></Reference><Reference><Citation>McNaught K S, Olanow C W, Halliwell B, Isacson O, Jenner P. Nat Rev Neurosci. 2001;2:589&#x2013;594.</Citation><ArticleIdList><ArticleId IdType="pubmed">11484002</ArticleId></ArticleIdList></Reference><Reference><Citation>Przedborski S, Chen Q, Vila M, Giasson B I, Djaldatti R, Vukosavic S, Souza J M, Jackson-Lewis V V, Lee V M, Ischiropoulos H. J Neurochem. 2001;76:637&#x2013;640.</Citation><ArticleIdList><ArticleId IdType="pubmed">11208927</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J, Kao S Y, Lee F J, Song W, Jin L W, Yankner B A. Nat Med. 2002;8:600&#x2013;606.</Citation><ArticleIdList><ArticleId IdType="pubmed">12042811</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabrizi S J, Orth M, Wilkinson J M, Taanman J W, Warner T T, Cooper J M, Schapira A H. Hum Mol Genet. 2000;9:2683&#x2013;2689.</Citation><ArticleIdList><ArticleId IdType="pubmed">11063727</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou W, Hurlbert M S, Schaack J, Prasad K N, Freed C R. Brain Res. 2000;866:33&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">10825478</ArticleId></ArticleIdList></Reference><Reference><Citation>Junn E, Mouradian M M. Neurosci Lett. 2002;320:146&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pubmed">11852183</ArticleId></ArticleIdList></Reference><Reference><Citation>Feany M B, Bender W W. Nature. 2000;404:394&#x2013;398.</Citation><ArticleIdList><ArticleId IdType="pubmed">10746727</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M K, Stirling W, Xu Y, Xu X, Qui D, Mandir A S, Dawson T M, Copeland N G, Jenkins N A, Price D L. Proc Natl Acad Sci USA. 2002;99:8968&#x2013;8973.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC124407</ArticleId><ArticleId IdType="pubmed">12084935</ArticleId></ArticleIdList></Reference><Reference><Citation>Giasson B I, Duda J E, Quinn S M, Zhang B, Trojanowski J Q, Lee V M. Neuron. 2002;34:521&#x2013;533.</Citation><ArticleIdList><ArticleId IdType="pubmed">12062037</ArticleId></ArticleIdList></Reference><Reference><Citation>Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A, Sagara Y, Sisk A, Mucke L. Science. 2000;287:1265&#x2013;1269.</Citation><ArticleIdList><ArticleId IdType="pubmed">10678833</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuoka Y, Vila M, Lincoln S, McCormack A, Picciano M, LaFrancois J, Yu X, Dickson D, Langston W J, McGowan E, et al. Neurobiol Dis. 2001;8:535&#x2013;539.</Citation><ArticleIdList><ArticleId IdType="pubmed">11442360</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahle P J, Neumann M, Ozmen L, Muller V, Jacobsen H, Schindzielorz A, Okochi M, Leimer U, van Der Putten H, Probst A, et al. J Neurosci. 2000;20:6365&#x2013;6373.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772969</ArticleId><ArticleId IdType="pubmed">10964942</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Putten H, Wiederhold K H, Probst A, Barbieri S, Mistl C, Danner S, Kauffmann S, Hofele K, Spooren W P, Ruegg M A, et al. J Neurosci. 2000;20:6021&#x2013;6029.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772584</ArticleId><ArticleId IdType="pubmed">10934251</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathke-Hartlieb S, Kahle P J, Neumann M, Ozmen L, Haid S, Okochi M, Haass C, Schulz J B. J Neurochem. 2001;77:1181&#x2013;1184.</Citation><ArticleIdList><ArticleId IdType="pubmed">11359883</ArticleId></ArticleIdList></Reference><Reference><Citation>Samulski R J, Sally M, Muzyczka N. In: The Development of Human Gene Therapy. Friedmann T, editor. Plainview, NY: Cold Spring Harbor Lab. Press; 1999. pp. 131&#x2013;170.</Citation></Reference><Reference><Citation>Naldini L, Verma I M. In: The Development of Human Gene Therapy. Friedmann T, editor. Plainview, NY: Cold Spring Harbor Lab. Press; 1999. pp. 47&#x2013;60.</Citation></Reference><Reference><Citation>Kirik D, Rosenblad C, Burger C, Lundberg C, Johansen T E, Muzyczka N, Mandel R J, Bjorklund A. J Neurosci. 2002;22:2780&#x2013;2791.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6758323</ArticleId><ArticleId IdType="pubmed">11923443</ArticleId></ArticleIdList></Reference><Reference><Citation>Hauswirth W W, Lewin A S, Zolotukhin S, Muzyczka N. Methods Enzymol. 2000;316:743&#x2013;761.</Citation><ArticleIdList><ArticleId IdType="pubmed">10800712</ArticleId></ArticleIdList></Reference><Reference><Citation>Zolotukhin S, Byrne B J, Mason E, Zolotukhin I, Potter M, Chesnut K, Summerford C, Samulski R J, Muzyczka N. Gene Ther. 1999;6:973&#x2013;985.</Citation><ArticleIdList><ArticleId IdType="pubmed">10455399</ArticleId></ArticleIdList></Reference><Reference><Citation>McLaughlin S K, Collis P, Hermonat P L, Muzyczka N. J Virol. 1988;62:1963&#x2013;1973.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC253280</ArticleId><ArticleId IdType="pubmed">2835501</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L, Daly T, Gao C, Flotte T R, Song S, Byrne B J, Sands M S, Ponder K P. Hum Gene Ther. 2001;12:563&#x2013;573.</Citation><ArticleIdList><ArticleId IdType="pubmed">11268288</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephan, H., Baron, G. &amp; Schwerdtfeger, W. K. (1980) (Springer, Berlin).</Citation></Reference><Reference><Citation>Annett L E, Rogers D C, Hernandez T D, Dunnett S B. Brain. 1992;115:825&#x2013;856.</Citation><ArticleIdList><ArticleId IdType="pubmed">1352726</ArticleId></ArticleIdList></Reference><Reference><Citation>Annett L E, Smyly R E, Henderson J M, Cummings R A, Kendall A L, Dunnett S B. In: Innovative Animal Models of Central Nervous System Disease: From Molecule to Therapy. Emerich D F, Dean R L, Sandberg P, editors. Totowa, NJ: Humana; 2000. pp. 171&#x2013;186.</Citation></Reference><Reference><Citation>West M J. Trends Neurosci. 1999;22:51&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">10092043</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandel R J, Rendahl K G, Snyder R O, Leff S E. Exp Neurol. 1999;159:47&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">10486174</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandel R J, Snyder R O, Leff S E. Exp Neurol. 1999;160:205&#x2013;214.</Citation><ArticleIdList><ArticleId IdType="pubmed">10630205</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo W D, Qu G, Sferra T J, Clark R, Chen R, Johnson P R. Hum Gene Ther. 1999;10:201&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pubmed">10022545</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari F K, Samulski T, Shenk T, Samulski R J. J Virol. 1996;70:3227&#x2013;3234.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC190186</ArticleId><ArticleId IdType="pubmed">8627803</ArticleId></ArticleIdList></Reference><Reference><Citation>Giasson B I, Jakes R, Goedert M, Duda J E, Leight S, Trojanowski J Q, Lee V M. J Neurosci Res. 2000;59:528&#x2013;533.</Citation><ArticleIdList><ArticleId IdType="pubmed">10679792</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanda S, Bishop J F, Eglitis M A, Yang Y, Mouradian M M. Neuroscience. 2000;97:279&#x2013;284.</Citation><ArticleIdList><ArticleId IdType="pubmed">10799759</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostrerova N, Petrucelli L, Farrer M, Mehta N, Choi P, Hardy J, Wolozin B. J Neurosci. 1999;19:5782&#x2013;5791.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6783081</ArticleId><ArticleId IdType="pubmed">10407019</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo Bianco C, Ridet J L, Schneider B L, Deglon N, Aebischer P. Proc Natl Acad Sci USA. 2002;99:10813&#x2013;10818.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC125054</ArticleId><ArticleId IdType="pubmed">12122208</ArticleId></ArticleIdList></Reference><Reference><Citation>Betarbet R, Sherer T B, MacKenzie G, Garcia-Osuna M, Panov A V, Greenamyre J T. Nat Neurosci. 2000;3:1301&#x2013;1306.</Citation><ArticleIdList><ArticleId IdType="pubmed">11100151</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12604778</PMID><DateCompleted><Year>2003</Year><Month>05</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>100</Volume><Issue>5</Issue><PubDate><Year>2003</Year><Month>Mar</Month><Day>04</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Cdc42-interacting protein 4 binds to huntingtin: neuropathologic and biological evidence for a role in Huntington's disease.</ArticleTitle><Pagination><StartPage>2712</StartPage><EndPage>2717</EndPage><MedlinePgn>2712-7</MedlinePgn></Pagination><Abstract><AbstractText>Huntington's disease (HD) is a neurodegenerative disease caused by polyglutamine (polyQ) expansion in the protein huntingtin (htt). Pathogenesis in HD seems to involve the formation of neuronal intranuclear inclusions and the abnormal regulation of transcription and signal transduction. To identify previously uncharacterized htt-interacting proteins in a simple model system, we used a yeast two-hybrid screen with a Caenorhabditis elegans activation domain library. We found a predicted SH3 domain protein (K08E3.3b) that interacts with N-terminal htt in two-hybrid tests. A human homolog of K08E3.3b is the Cdc42-interacting protein 4 (CIP4), a protein involved in Cdc42 and Wiskott-Aldrich syndrome protein-dependent signal transduction. CIP4 interacted in vitro with full-length htt from lymphoblastoid cells. Neuronal CIP4 immunoreactivity increased with neuropathological severity in the neostriatum of HD patients and partially colocalized to ubiquitin-positive aggregates. Marked CIP4 overexpression also was observed in Western blot from human HD brain striatum. The overexpression of CIP4 induced the death of striatal neurons. Our data suggest that CIP4 accumulation and cellular toxicity may have a role in HD pathogenesis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Holbert</LastName><ForeName>S&#xe9;bastien</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratory of Genomic Biology, Institut National de la Sant&#xe9; et de la Recherche M&#xe9;dicale-Avenir Group and Fondation Jean Dausset-Centre d'Etude du Polymorphisme Humain, 75010 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dedeoglu</LastName><ForeName>Alpaslan</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Humbert</LastName><ForeName>Sandrine</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Saudou</LastName><ForeName>Fr&#xe9;d&#xe9;ric</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Ferrante</LastName><ForeName>Robert J</ForeName><Initials>RJ</Initials></Author><Author ValidYN="Y"><LastName>N&#xe9;ri</LastName><ForeName>Christian</ForeName><Initials>C</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U01 AT000613</GrantID><Acronym>AT</Acronym><Agency>NCCIH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AT000613</GrantID><Acronym>AT</Acronym><Agency>NCCIH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MH/NS 31862</GrantID><Acronym>MH</Acronym><Agency>NIMH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG013846</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG012992</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG13846</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG12992</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AT00613</GrantID><Acronym>AT</Acronym><Agency>NCCIH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS35255</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>02</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C086055">HTT protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C499524">Htt protein, rat</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071058">Huntingtin Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008869">Microtubule-Associated Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015778">Minor Histocompatibility Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009687">Nuclear Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C406285">TRIP10 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C498640">Trip10 protein, rat</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D025801">Ubiquitin</NameOfSubstance></Chemical><Chemical><RegistryNumber>26700-71-0</RegistryNumber><NameOfSubstance UI="C097188">polyglutamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.5.2</RegistryNumber><NameOfSubstance UI="D020741">rho GTP-Binding Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017173" MajorTopicYN="N">Caenorhabditis elegans</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016923" MajorTopicYN="N">Cell Death</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004591" MajorTopicYN="N">Electrophoresis, Polyacrylamide Gel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015723" MajorTopicYN="N">Gene Library</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071058" MajorTopicYN="N">Huntingtin Protein</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006816" MajorTopicYN="N">Huntington Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008214" MajorTopicYN="N">Lymphocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008869" MajorTopicYN="N">Microtubule-Associated Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015778" MajorTopicYN="N">Minor Histocompatibility Antigens</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009687" MajorTopicYN="N">Nuclear Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017434" MajorTopicYN="N">Protein Structure, Tertiary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020798" MajorTopicYN="N">Two-Hybrid System Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D025801" MajorTopicYN="N">Ubiquitin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020741" MajorTopicYN="N">rho GTP-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>2</Month><Day>27</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>5</Month><Day>14</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>2</Month><Day>27</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2003</Year><Month>9</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12604778</ArticleId><ArticleId IdType="pmc">PMC151406</ArticleId><ArticleId IdType="doi">10.1073/pnas.0437967100</ArticleId><ArticleId IdType="pii">0437967100</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>The Huntington's Disease Research Collaborative Group. Cell. 1993;72:971&#x2013;983.</Citation><ArticleIdList><ArticleId IdType="pubmed">8458085</ArticleId></ArticleIdList></Reference><Reference><Citation>DiFiglia M, Sapp E, Chase K, Schwarz C, Meloni A, Young C, Martin E, Vonsattel J P, Carraway R, Reeves S A, et al. Neuron. 1995;14:1075&#x2013;1081.</Citation><ArticleIdList><ArticleId IdType="pubmed">7748555</ArticleId></ArticleIdList></Reference><Reference><Citation>Vonsattel J P, Myers R H, Stevens T J, Ferrante R J, Bird E D, Richardson E P., Jr J Neuropathol Exp Neurol. 1985;44:559&#x2013;577.</Citation><ArticleIdList><ArticleId IdType="pubmed">2932539</ArticleId></ArticleIdList></Reference><Reference><Citation>Harper P S. Hum Genet. 1992;89:365&#x2013;376.</Citation><ArticleIdList><ArticleId IdType="pubmed">1535611</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross C A. Neuron. 2002;35:819&#x2013;822.</Citation><ArticleIdList><ArticleId IdType="pubmed">12372277</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies S W, Turmaine M, Cozens B A, DiFiglia M, Sharp A H, Ross C A, Scherzinger E, Wanker E E, Mangiarini L, Bates G P. Cell. 1997;90:537&#x2013;548.</Citation><ArticleIdList><ArticleId IdType="pubmed">9267033</ArticleId></ArticleIdList></Reference><Reference><Citation>Saudou F, Finkbeiner S, Devys D, Greenberg M E. Cell. 1998;95:55&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">9778247</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy P H, Charles V, Williams M, Miller G, Whetsell W O, Jr, Tagle D A. Philos Trans R Soc London B. 1999;354:1035&#x2013;1045.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1692609</ArticleId><ArticleId IdType="pubmed">10434303</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodgson J G, Agopyan N, Gutekunst C A, Leavitt B R, LePiane F, Singaraja R, Smith D J, Bissada N, McCutcheon K, Nasir J, et al. Neuron. 1999;23:181&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pubmed">10402204</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuemmerle S, Gutekunst C A, Klein A M, Li X J, Li S H, Beal M F, Hersch S M, Ferrante R J. Ann Neurol. 1999;46:842&#x2013;849.</Citation><ArticleIdList><ArticleId IdType="pubmed">10589536</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Li S H, Yu Z X, Shelbourne P, Li X J. J Neurosci. 2001;21:8473&#x2013;8481.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6762783</ArticleId><ArticleId IdType="pubmed">11606636</ArticleId></ArticleIdList></Reference><Reference><Citation>Sisodia S S. Cell. 1998;95:1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">9778239</ArticleId></ArticleIdList></Reference><Reference><Citation>Cha J H. Trends Neurosci. 2000;23:387&#x2013;392.</Citation><ArticleIdList><ArticleId IdType="pubmed">10941183</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucifora F C, Jr, Sasaki M, Peters M F, Huang H, Cooper J K, Yamada M, Takahashi H, Tsuji S, Troncoso J, Dawson V L, et al. Science. 2001;291:2423&#x2013;2428.</Citation><ArticleIdList><ArticleId IdType="pubmed">11264541</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z X, Li S H, Nguyen H P, Li X J. Hum Mol Genet. 2002;11:905&#x2013;914.</Citation><ArticleIdList><ArticleId IdType="pubmed">11971872</ArticleId></ArticleIdList></Reference><Reference><Citation>Steffan J S, Bodai L, Pallos J, Poelman M, McCampbell A, Apostol B L, Kazantsev A, Schmidt E, Zhu Y Z, Greenwald M, et al. Nature. 2001;413:739&#x2013;743.</Citation><ArticleIdList><ArticleId IdType="pubmed">11607033</ArticleId></ArticleIdList></Reference><Reference><Citation>Orr H T. Hum Mol Genet. 2002;11:1909&#x2013;1910.</Citation><ArticleIdList><ArticleId IdType="pubmed">12165553</ArticleId></ArticleIdList></Reference><Reference><Citation>Colomer V, Engelender S, Sharp A H, Duan K, Cooper J K, Lanahan A, Lyford G, Worley P, Ross C A. Hum Mol Genet. 1997;6:1519&#x2013;1525.</Citation><ArticleIdList><ArticleId IdType="pubmed">9285789</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y F, Deth R C, Devys D. J Biol Chem. 1997;272:8121&#x2013;8124.</Citation><ArticleIdList><ArticleId IdType="pubmed">9079622</ArticleId></ArticleIdList></Reference><Reference><Citation>Song C, Perides G, Liu Y F. J Biol Chem. 2002;277:6703&#x2013;6707.</Citation><ArticleIdList><ArticleId IdType="pubmed">11733534</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y F, Dorow D, Marshall J. J Biol Chem. 2000;275:19035&#x2013;19040.</Citation><ArticleIdList><ArticleId IdType="pubmed">10801775</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Savanenin A, Reddy P H, Liu Y F. J Biol Chem. 2001;276:24713&#x2013;24718.</Citation><ArticleIdList><ArticleId IdType="pubmed">11319238</ArticleId></ArticleIdList></Reference><Reference><Citation>Aspenstr&#xf6;m P. Curr Biol. 1997;7:479&#x2013;487.</Citation><ArticleIdList><ArticleId IdType="pubmed">9210375</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian L, Nelson D L, Stewart D M. J Biol Chem. 2000;275:7854&#x2013;7861.</Citation><ArticleIdList><ArticleId IdType="pubmed">10713100</ArticleId></ArticleIdList></Reference><Reference><Citation>Fromont-Racine M, Rain J C, Legrain P. Nat Genet. 1997;16:277&#x2013;282.</Citation><ArticleIdList><ArticleId IdType="pubmed">9207794</ArticleId></ArticleIdList></Reference><Reference><Citation>Neri C, Albanese V, Lebre A S, Holbert S, Saada C, Bougueleret L, Meier-Ewert S, Le Gall I, Millasseau P, Bui H, et al. Hum Mol Genet. 1996;5:1001&#x2013;1009.</Citation><ArticleIdList><ArticleId IdType="pubmed">8817338</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalchman M A, Koide H B, McCutcheon K, Graham R K, Nichol K, Nishiyama K, Kazemi-Esfarjani P, Lynn F C, Wellington C, Metzler M, et al. Nat Genet. 1997;16:44&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">9140394</ArticleId></ArticleIdList></Reference><Reference><Citation>Holbert S, Denghien I, Kiechle T, Rosenblatt A, Wellington C, Hayden M R, Margolis R L, Ross C A, Dausset J, Ferrante R J, Neri C. Proc Natl Acad Sci USA. 2001;98:1811&#x2013;1816.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC29339</ArticleId><ArticleId IdType="pubmed">11172033</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrante R J, Gutekunst C A, Persichetti F, McNeil S M, Kowall N W, Gusella J F, MacDonald M E, Beal M F, Hersch S M. J Neurosci. 1997;17:3052&#x2013;3063.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6573626</ArticleId><ArticleId IdType="pubmed">9096140</ArticleId></ArticleIdList></Reference><Reference><Citation>Faber P W, Barnes G T, Srinidhi J, Chen J, Gusella J F, MacDonald M E. Hum Mol Genet. 1998;7:1463&#x2013;1474.</Citation><ArticleIdList><ArticleId IdType="pubmed">9700202</ArticleId></ArticleIdList></Reference><Reference><Citation>Passani L A, Bedford M T, Faber P W, McGinnis K M, Sharp A H, Gusella J F, Vonsattel J P, MacDonald M E. Hum Mol Genet. 2000;9:2175&#x2013;2182.</Citation><ArticleIdList><ArticleId IdType="pubmed">10958656</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan E Y, Luthi-Carter R, Strand A, Solano S M, Hanson S A, DeJohn M M, Kooperberg C, Chase K O, DiFiglia M, Young A B, et al. Hum Mol Genet. 2002;11:1939&#x2013;1951.</Citation><ArticleIdList><ArticleId IdType="pubmed">12165556</ArticleId></ArticleIdList></Reference><Reference><Citation>Richnau N, Aspenstr&#xf6;m P. J Biol Chem. 2001;276:35060&#x2013;35070.</Citation><ArticleIdList><ArticleId IdType="pubmed">11431473</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo L. Nat Rev Neurosci. 2000;1:173&#x2013;180.</Citation><ArticleIdList><ArticleId IdType="pubmed">11257905</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker J A, Connolly J B, Wellington C, Hayden M, Dausset J, Neri C. Proc Natl Acad Sci USA. 2001;98:13318&#x2013;13323.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC60868</ArticleId><ArticleId IdType="pubmed">11687635</ArticleId></ArticleIdList></Reference><Reference><Citation>The C. elegans Sequencing Consortium. Science. 1998;282:2012&#x2013;2018.</Citation><ArticleIdList><ArticleId IdType="pubmed">9851916</ArticleId></ArticleIdList></Reference><Reference><Citation>Faber P W, Alter J R, MacDonald M E, Hart A C. Proc Natl Acad Sci USA. 1999;96:179&#x2013;184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC15113</ArticleId><ArticleId IdType="pubmed">9874792</ArticleId></ArticleIdList></Reference><Reference><Citation>Satyal S H, Schmidt E, Kitagawa K, Sondheimer N, Lindquist S, Kramer J M, Morimoto R I. Proc Natl Acad Sci USA. 2000;97:5750&#x2013;5755.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC18505</ArticleId><ArticleId IdType="pubmed">10811890</ArticleId></ArticleIdList></Reference><Reference><Citation>Morley J F, Brignull H R, Weyers J J, Morimoto R I. Proc Natl Acad Sci USA. 2002;99:10417&#x2013;10422.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC124929</ArticleId><ArticleId IdType="pubmed">12122205</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutekunst C A, Li S H, Yi H, Mulroy J S, Kuemmerle S, Jones R, Rye D, Ferrante R J, Hersch S M, Li X J. J Neurosci. 1999;19:2522&#x2013;2534.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6786077</ArticleId><ArticleId IdType="pubmed">10087066</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlier M F, Nioche P, Broutin-L'Hermite I, Boujemaa R, Le Clainche C, Egile C, Garbay C, Ducruix A, Sansonetti P, Pantaloni D. J Biol Chem. 2000;275:21946&#x2013;21952.</Citation><ArticleIdList><ArticleId IdType="pubmed">10781580</ArticleId></ArticleIdList></Reference><Reference><Citation>Otsuki, M., Itoh, T. &amp; Takenawa, T. T. (December 10, 2002) J. Biol. Chem., 10.1074/jbc.M207433200.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Velier J, Kim M, Schwarz C, Kim T W, Sapp E, Chase K, Aronin N, DiFiglia M. Exp Neurol. 1998;152:34&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">9682010</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L, Adams R D, Saltiel A R. Proc Natl Acad Sci USA. 2002;99:12835&#x2013;21840.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC130546</ArticleId><ArticleId IdType="pubmed">12242347</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Z Y, Chawla A, Bose A, Way M, Czech M P. J Biol Chem. 2002;277:509&#x2013;515.</Citation><ArticleIdList><ArticleId IdType="pubmed">11694514</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrer L A. Clin Genet. 1985;27:62&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">3156696</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurlbert M S, Zhou W, Wasmeier C, Kaddis F G, Hutton J C, Freed C R. Diabetes. 1999;48:649&#x2013;651.</Citation><ArticleIdList><ArticleId IdType="pubmed">10078572</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12612547</PMID><DateCompleted><Year>2003</Year><Month>05</Month><Day>30</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1078-8956</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>4</Issue><PubDate><Year>2003</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Nature medicine</Title><ISOAbbreviation>Nat Med</ISOAbbreviation></Journal><ArticleTitle>Adult mouse astrocytes degrade amyloid-beta in vitro and in situ.</ArticleTitle><Pagination><StartPage>453</StartPage><EndPage>457</EndPage><MedlinePgn>453-7</MedlinePgn></Pagination><Abstract><AbstractText>Alzheimer disease (AD) is a progressive neurodegenerative disorder characterized by excessive deposition of amyloid-beta (Abeta) peptides in the brain. One of the earliest neuropathological changes in AD is the accumulation of astrocytes at sites of Abeta deposition, but the cause or significance of this cellular response is unclear. Here we show that cultured adult mouse astrocytes migrate in response to monocyte chemoattractant protein-1 (MCP-1), a chemokine present in AD lesions, and cease migration upon interaction with immobilized Abeta(1-42). We also show that astrocytes bind and degrade Abeta(1-42). Astrocytes plated on Abeta-laden brain sections from a mouse model of AD associate with the Abeta deposits and reduce overall Abeta levels in these sections. Our results suggest a novel mechanism for the accumulation of astrocytes around Abeta deposits, indicate a direct role for astrocytes in degradation of Abeta and implicate deficits in astroglial clearance of Abeta in the pathogenesis of AD. Treatments that increase removal of Abeta by astrocytes may therefore be a critical mechanism to reduce the neurodegeneration associated with AD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wyss-Coray</LastName><ForeName>Tony</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Geriatric Research, Education and Clinical Center, VA Palo Alto Health Care System, Palo Alto, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loike</LastName><ForeName>John D</ForeName><Initials>JD</Initials></Author><Author ValidYN="Y"><LastName>Brionne</LastName><ForeName>Thomas C</ForeName><Initials>TC</Initials></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Emily</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Anankov</LastName><ForeName>Roman</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Fengrong</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Silverstein</LastName><ForeName>Samuel C</ForeName><Initials>SC</Initials></Author><Author ValidYN="Y"><LastName>Husemann</LastName><ForeName>Jens</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>AG-08702</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG-15871</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG-19772</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>03</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Med</MedlineTA><NlmUniqueID>9502015</NlmUniqueID><ISSNLinking>1078-8956</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018932">Chemokine CCL2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C092862">amyloid beta-protein (10-43)</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Trends Mol Med. 2003 Jul;9(7):279-80. doi: 10.1016/s1471-4914(03)00112-6.</RefSource><PMID Version="1">12900212</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Trends Mol Med. 2003 Jul;9(7):281-2. doi: 10.1016/s1471-4914(03)00109-6.</RefSource><PMID Version="1">12900213</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002465" MajorTopicYN="N">Cell Movement</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018932" MajorTopicYN="N">Chemokine CCL2</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2002</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2003</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>3</Month><Day>4</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>5</Month><Day>31</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>3</Month><Day>4</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12612547</ArticleId><ArticleId IdType="doi">10.1038/nm838</ArticleId><ArticleId IdType="pii">nm838</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12618962</PMID><DateCompleted><Year>2003</Year><Month>05</Month><Day>05</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0002-9297</ISSN><JournalIssue CitedMedium="Print"><Volume>72</Volume><Issue>4</Issue><PubDate><Year>2003</Year><Month>Apr</Month></PubDate></JournalIssue><Title>American journal of human genetics</Title><ISOAbbreviation>Am J Hum Genet</ISOAbbreviation></Journal><ArticleTitle>Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease.</ArticleTitle><Pagination><StartPage>804</StartPage><EndPage>811</EndPage><MedlinePgn>804-11</MedlinePgn></Pagination><Abstract><AbstractText>Mitochondrial (mt) impairment, particularly within complex I of the electron transport system, has been implicated in the pathogenesis of Parkinson disease (PD). More than half of mitochondrially encoded polypeptides form part of the reduced nicotinamide adenine dinucleotide dehydrogenase (NADH) complex I enzyme. To test the hypothesis that mtDNA variation contributes to PD expression, we genotyped 10 single-nucleotide polymorphisms (SNPs) that define the European mtDNA haplogroups in 609 white patients with PD and 340 unaffected white control subjects. Overall, individuals classified as haplogroup J (odds ratio [OR] 0.55; 95% confidence interval [CI] 0.34-0.91; P=.02) or K (OR 0.52; 95% CI 0.30-0.90; P=.02) demonstrated a significant decrease in risk of PD versus individuals carrying the most common haplogroup, H. Furthermore, a specific SNP that defines these two haplogroups, 10398G, is strongly associated with this protective effect (OR 0.53; 95% CI 0.39-0.73; P=.0001). SNP 10398G causes a nonconservative amino acid change from threonine to alanine within the NADH dehydrogenase 3 (ND3) of complex I. After stratification by sex, this decrease in risk appeared stronger in women than in men (OR 0.43; 95% CI 0.27-0.71; P=.0009). In addition, SNP 9055A of ATP6 demonstrated a protective effect for women (OR 0.45; 95% CI 0.22-0.93; P=.03). Our results suggest that ND3 is an important factor in PD susceptibility among white individuals and could help explain the role of complex I in PD expression.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>van der Walt</LastName><ForeName>Joelle M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Medicine, and Center for Human Genetics, Institute for Genome Sciences and Policy, Duke University Medical Center, Durham, NC 27710, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicodemus</LastName><ForeName>Kristin K</ForeName><Initials>KK</Initials></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Eden R</ForeName><Initials>ER</Initials></Author><Author ValidYN="Y"><LastName>Scott</LastName><ForeName>William K</ForeName><Initials>WK</Initials></Author><Author ValidYN="Y"><LastName>Nance</LastName><ForeName>Martha A</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Watts</LastName><ForeName>Ray L</ForeName><Initials>RL</Initials></Author><Author ValidYN="Y"><LastName>Hubble</LastName><ForeName>Jean P</ForeName><Initials>JP</Initials></Author><Author ValidYN="Y"><LastName>Haines</LastName><ForeName>Jonathan L</ForeName><Initials>JL</Initials></Author><Author ValidYN="Y"><LastName>Koller</LastName><ForeName>William C</ForeName><Initials>WC</Initials></Author><Author ValidYN="Y"><LastName>Lyons</LastName><ForeName>Kelly</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Pahwa</LastName><ForeName>Rajesh</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Stern</LastName><ForeName>Matthew B</ForeName><Initials>MB</Initials></Author><Author ValidYN="Y"><LastName>Colcher</LastName><ForeName>Amy</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Hiner</LastName><ForeName>Bradley C</ForeName><Initials>BC</Initials></Author><Author ValidYN="Y"><LastName>Jankovic</LastName><ForeName>Joseph</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Ondo</LastName><ForeName>William G</ForeName><Initials>WG</Initials></Author><Author ValidYN="Y"><LastName>Allen</LastName><ForeName>Fred H</ForeName><Initials>FH</Initials><Suffix>Jr</Suffix></Author><Author ValidYN="Y"><LastName>Goetz</LastName><ForeName>Christopher G</ForeName><Initials>CG</Initials></Author><Author ValidYN="Y"><LastName>Small</LastName><ForeName>Gary W</ForeName><Initials>GW</Initials></Author><Author ValidYN="Y"><LastName>Mastaglia</LastName><ForeName>Frank</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Stajich</LastName><ForeName>Jeffrey M</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>McLaurin</LastName><ForeName>Adam C</ForeName><Initials>AC</Initials></Author><Author ValidYN="Y"><LastName>Middleton</LastName><ForeName>Lefkos T</ForeName><Initials>LT</Initials></Author><Author ValidYN="Y"><LastName>Scott</LastName><ForeName>Burton L</ForeName><Initials>BL</Initials></Author><Author ValidYN="Y"><LastName>Schmechel</LastName><ForeName>Donald E</ForeName><Initials>DE</Initials></Author><Author ValidYN="Y"><LastName>Pericak-Vance</LastName><ForeName>Margaret A</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Vance</LastName><ForeName>Jeffery M</ForeName><Initials>JM</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>GENBANK</DataBankName><AccessionNumberList><AccessionNumber>AB055387</AccessionNumber><AccessionNumber>D38112</AccessionNumber><AccessionNumber>J01415</AccessionNumber><AccessionNumber>X93334</AccessionNumber></AccessionNumberList></DataBank><DataBank><DataBankName>RefSeq</DataBankName><AccessionNumberList><AccessionNumber>NC_001807</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>P01 NS026630</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 NS26630</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 NS039764</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>2 P50 NS39764-02</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG020135</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1R01-AG-20135-01</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>02</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Hum Genet</MedlineTA><NlmUniqueID>0370475</NlmUniqueID><ISSNLinking>0002-9297</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004272">DNA, Mitochondrial</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D004272" MajorTopicYN="N">DNA, Mitochondrial</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName><QualifierName UI="Q000208" MajorTopicYN="N">ethnology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006239" MajorTopicYN="N">Haplotypes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011110" MajorTopicYN="Y">Polymorphism, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="Y">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012016" MajorTopicYN="N">Reference Values</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044465" MajorTopicYN="N">White People</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2002</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2002</Year><Month>12</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>3</Month><Day>6</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>5</Month><Day>6</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>3</Month><Day>6</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2003</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12618962</ArticleId><ArticleId IdType="pmc">PMC1180345</ArticleId><ArticleId IdType="doi">10.1086/373937</ArticleId><ArticleId IdType="pii">S0002-9297(07)60604-1</ArticleId></ArticleIdList><ReferenceList><Title>Electronic-Database Information</Title><Reference><Citation>GenBank, http://www.ncbi.nlm.nih.gov/Genbank/ (for mt reference sequences: Cambridge [accession number NC001807], revised Cambridge [accession number J01415], Japanese [accession number AB055387], Swedish [accession number X93334], and African [accession number D38112])</Citation></Reference><Reference><Citation>Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.nlm.nih.gov/Omim/</Citation></Reference><Reference><Citation>Primer3 Web site, http://www-genome.wi.mit.edu/cgi-bin/primer/primer3_www.cgi</Citation></Reference></ReferenceList><ReferenceList><Reference><Citation>Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drouin J, Eperon IC, Nierlich DP, Roe BA, Sanger F, Schreier PH, Smith AJ, Staden R, Young IG (1981) Sequence and organization of the human mitochondrial genome. Nature 290:457&#x2013;465</Citation><ArticleIdList><ArticleId IdType="pubmed">7219534</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews RM, Kubacka I, Chinnery PF, Lightowlers RN, Turnbull DM, Howell N (1999) Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet 23:147</Citation><ArticleIdList><ArticleId IdType="pubmed">10508508</ArticleId></ArticleIdList></Reference><Reference><Citation>Ardlie KG, Lunetta KL, Seielstad M (2002) Testing for population subdivision and association in four case-control studies. Am J Hum Genet 71:304&#x2013;311</Citation><ArticleIdList><ArticleId IdType="pmc">PMC379163</ArticleId><ArticleId IdType="pubmed">12096349</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnason U, Xu X, Gullberg A (1996) Comparison between the complete mitochondrial DNA sequences of Homo and the common chimpanzee based on nonchimeric sequences. J Mol Evol 42:145&#x2013;152</Citation><ArticleIdList><ArticleId IdType="pubmed">8919866</ArticleId></ArticleIdList></Reference><Reference><Citation>Betarbet R, Sherer TB, Greenamyre JT (2002) Animal models of Parkinson&#x2019;s disease. Bioessays 24:308&#x2013;318</Citation><ArticleIdList><ArticleId IdType="pubmed">11948617</ArticleId></ArticleIdList></Reference><Reference><Citation>Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT (2000) Chronic systemic pesticide exposure reproduces features of Parkinson&#x2019;s disease. Nat Neurosci 3:1301&#x2013;1306</Citation><ArticleIdList><ArticleId IdType="pubmed">11100151</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown MD, Starikovskaya E, Derbeneva O, Hosseini S, Allen JC, Mikhailovskaya IE, Sukernik RI, Wallace DC (2002) The role of mtDNA background in disease expression: a new primary LHON mutation associated with western eurasian haplogroup J. Hum Genet 110:130&#x2013;138</Citation><ArticleIdList><ArticleId IdType="pubmed">11935318</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassarino DS, Fall CP, Swerdlow RH, Smith TS, Halvorsen EM, Miller SW, Parks JP, Parker WD Jr, Bennett JP Jr (1997) Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson&#x2019;s disease. Biochim Biophys Acta 1362:77&#x2013;86</Citation><ArticleIdList><ArticleId IdType="pubmed">9434102</ArticleId></ArticleIdList></Reference><Reference><Citation>De Benedictis G, Carrieri G, Garasto S, Rose G, Varcasia O, Bonafe M, Franceschi C, Jazwinski SM (2000) Does a retrograde response in human aging and longevity exist? Exp Gerontol 35:795&#x2013;801</Citation><ArticleIdList><ArticleId IdType="pubmed">11053670</ArticleId></ArticleIdList></Reference><Reference><Citation>De Benedictis G, Rose G, Carrieri G, De Luca M, Falcone E, Passarino G, Bonafe M, Monti D, Baggio G, Bertolini S, Mari D, Mattace R, Franceschi C (1999) Mitochondrial DNA inherited variants are associated with successful aging and longevity in humans. FASEB J 13:1532&#x2013;1536</Citation><ArticleIdList><ArticleId IdType="pubmed">10463944</ArticleId></ArticleIdList></Reference><Reference><Citation>Finnila S, Hassinen IE, Ala-Kokko L, Majamaa K (2000) Phylogenetic network of the mtDNA haplogroup U in northern Finland based on sequence analysis of the complete coding region by conformation-sensitive gel electrophoresis. Am J Hum Genet 66:1017&#x2013;1026</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1288139</ArticleId><ArticleId IdType="pubmed">10712215</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenamyre JT, MacKenzie G, Peng TI, Stephans SE (1999) Mitochondrial dysfunction in Parkinson&#x2019;s disease. Biochem Soc Symp 66:85&#x2013;97</Citation><ArticleIdList><ArticleId IdType="pubmed">10989660</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenamyre JT, Sherer TB, Betarbet R, Panov AV (2001) Complex I and Parkinson&#x2019;s disease. IUBMB Life 52:135&#x2013;141</Citation><ArticleIdList><ArticleId IdType="pubmed">11798025</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu M, Cooper JM, Taanman JW, Schapira AHV (1998) Mitochondrial DNA transmission of the mitochondrial defect in Parkinson&#x2019;s disease. Ann Neurol 44:177&#x2013;186</Citation><ArticleIdList><ArticleId IdType="pubmed">9708539</ArticleId></ArticleIdList></Reference><Reference><Citation>Haynes C, Speer MC, Peedin M, Roses AD, Haines JL, Vance JM, Pericak-Vance MA (1995) PEDIGENE: a comprehensive data management system to facilitate efficient and rapid disease gene mapping. Am J Hum Genet Suppl 57:A193</Citation></Reference><Reference><Citation>Herrnstadt C, Elson JL, Fahy E, Preston G, Turnbull DM, Anderson C, Ghosh SS, Olefsky JM, Beal MF, Davis RE, Howell N (2002) Reduced-median-network analysis of complete mitochondrial DNA coding-region sequences for the major African, Asian, and European haplogroups. Am J Hum Genet 70:1152&#x2013;1171</Citation><ArticleIdList><ArticleId IdType="pmc">PMC447592</ArticleId><ArticleId IdType="pubmed">11938495</ArticleId></ArticleIdList></Reference><Reference><Citation>Horai S, Hayasaka K, Kondo R, Tsugane K, Takahata N (1995) Recent African origin of modern humans revealed by complete sequences of hominoid mitochondrial DNAs. Proc Natl Acad Sci USA 92:532&#x2013;536</Citation><ArticleIdList><ArticleId IdType="pmc">PMC42775</ArticleId><ArticleId IdType="pubmed">7530363</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenner P, Olanow CW (1998) Understanding cell death in Parkinson&#x2019;s disease. Ann Neurol 44:S72-S84</Citation><ArticleIdList><ArticleId IdType="pubmed">9749577</ArticleId></ArticleIdList></Reference><Reference><Citation>Muthane U, Jain S, Gururaj G (2001) Hunting genes in Parkinson&#x2019;s disease from the roots. Med Hypotheses 57:51&#x2013;55</Citation><ArticleIdList><ArticleId IdType="pubmed">11421624</ArticleId></ArticleIdList></Reference><Reference><Citation>Orth M, Schapira AH (2002) Mitochondrial involvement in Parkinson&#x2019;s disease. Neurochem Int 40:533&#x2013;541</Citation><ArticleIdList><ArticleId IdType="pubmed">11850110</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker WD Jr, Boyson SJ, Parks JK (1989) Abnormalities of the electron transport chain in idiopathic Parkinson&#x2019;s disease. Ann Neurol 26:719&#x2013;723</Citation><ArticleIdList><ArticleId IdType="pubmed">2557792</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards M, Macaulay V, Hickey E, Vega E, Sykes B, Guida V, Rengo C, et al (2000) Tracing European founder lineages in the Near Eastern mtDNA pool. Am J Hum Genet 67:1251&#x2013;1276</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1288566</ArticleId><ArticleId IdType="pubmed">11032788</ArticleId></ArticleIdList></Reference><Reference><Citation>Schapira AH, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD (1990) Mitochondrial complex I deficiency in Parkinson&#x2019;s disease. J Neurochem 54:823&#x2013;827</Citation><ArticleIdList><ArticleId IdType="pubmed">2154550</ArticleId></ArticleIdList></Reference><Reference><Citation>Schapira AH, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD (1989) Mitochondrial complex I deficiency in Parkinson&#x2019;s disease. Lancet 1:1269</Citation><ArticleIdList><ArticleId IdType="pubmed">2566813</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherer TB, Betarbet R, Stout AK, Lund S, Baptista M, Panov AV, Cookson MR, Greenamyre JT (2002) An in vitro model of Parkinson&#x2019;s disease: linking mitochondrial impairment to altered &#x3b1;-synuclein metabolism and oxidative damage. J Neurosci 22:7006&#x2013;7015</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6757862</ArticleId><ArticleId IdType="pubmed">12177198</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon DK, Mayeux R, Marder K, Kowall NW, Beal MF, Johns DR (2000) Mitochondrial DNA mutations in complex I and tRNA genes in Parkinson&#x2019;s disease. Neurology 54:703&#x2013;709</Citation><ArticleIdList><ArticleId IdType="pubmed">10680807</ArticleId></ArticleIdList></Reference><Reference><Citation>Swerdlow RH, Parker WD, Currie LJ, Bennett JP, Harrison MB, Trugman JM, Wooten GF (2001) Gender ratio differences between Parkinson&#x2019;s disease patients and their affected relatives. Parkinsonism Relat Disord 7:129&#x2013;133</Citation><ArticleIdList><ArticleId IdType="pubmed">11248594</ArticleId></ArticleIdList></Reference><Reference><Citation>Swerdlow RH, Parks JK, Miller SW, Tuttle JB, Trimmer PA, Sheehan JP, Bennett JPJ, Davis RE, Parker WD (1996) Origin and functional consequences of the complex I defect in Parkinson&#x2019;s disease. Ann Neurol 40:663&#x2013;671</Citation><ArticleIdList><ArticleId IdType="pubmed">8871587</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanner CM, Goldman SM (1996) Epidemiology of Parkinson&#x2019;s disease. Neurol Clin 14:317&#x2013;335</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7173037</ArticleId><ArticleId IdType="pubmed">8827174</ArticleId></ArticleIdList></Reference><Reference><Citation>Torroni A, Huoponen K, Francalacci P, Petrozzi M, Morelli L, Scozzari R, Obinu D, Savontaus M-L, Wallace DC (1996) Classification of European mtDNAs from an analysis of three European populations. Genetics 144:1835&#x2013;1850</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1207732</ArticleId><ArticleId IdType="pubmed">8978068</ArticleId></ArticleIdList></Reference><Reference><Citation>Torroni A, Lott MT, Cabell MF, Chen YS, Lavergne L, Wallace DC (1994) mtDNA and the origin of Caucasians: identification of ancient Caucasian-specific haplogroups, one of which is prone to a recurrent somatic duplication in the D-loop region. Am J Hum Genet 55:760&#x2013;776</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1918284</ArticleId><ArticleId IdType="pubmed">7942855</ArticleId></ArticleIdList></Reference><Reference><Citation>Torroni A, Wallace DC (1994) Mitochondrial DNA variation in human populations and implications for detection of mitochondrial DNA mutations of pathological significance. J Bioenerg Biomembr 26:261&#x2013;271</Citation><ArticleIdList><ArticleId IdType="pubmed">7521328</ArticleId></ArticleIdList></Reference><Reference><Citation>Trimmer PA, Swerdlow RH, Parks JK, Keeney P, Bennett JP Jr, Miller SW, Davis RE, Parker WD Jr (2000) Abnormal mitochondrial morphology in sporadic Parkinson&#x2019;s and Alzheimer&#x2019;s disease cybrid cell lines. Exp Neurol 162:37&#x2013;50</Citation><ArticleIdList><ArticleId IdType="pubmed">10716887</ArticleId></ArticleIdList></Reference><Reference><Citation>Veech GA, Dennis J, Keeney PM, Fall CP, Swerdlow RH, Parker WD Jr, Bennett JP Jr (2000) Disrupted mitochondrial electron transport function increases expression of anti-apoptotic bcl-2 and bcl-XL proteins in SH-SY5Y neuroblastoma and in Parkinson disease cybrid cells through oxidative stress. J Neurosci Res 61: 693&#x2013;700</Citation><ArticleIdList><ArticleId IdType="pubmed">10972966</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace DC, Brown MD, Lott MT (1999) Mitochondrial DNA variation in human evolution and disease. Gene 238:211&#x2013;230</Citation><ArticleIdList><ArticleId IdType="pubmed">10570998</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12621436</PMID><DateCompleted><Year>2003</Year><Month>04</Month><Day>09</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0028-0836</ISSN><JournalIssue CitedMedium="Print"><Volume>422</Volume><Issue>6927</Issue><PubDate><Year>2003</Year><Month>Mar</Month><Day>06</Day></PubDate></JournalIssue><Title>Nature</Title><ISOAbbreviation>Nature</ISOAbbreviation></Journal><ArticleTitle>Monoclonal antibodies inhibit prion replication and delay the development of prion disease.</ArticleTitle><Pagination><StartPage>80</StartPage><EndPage>83</EndPage><MedlinePgn>80-3</MedlinePgn></Pagination><Abstract><AbstractText>Prion diseases such as Creutzfeldt-Jakob disease (CJD) are fatal, neuro-degenerative disorders with no known therapy. A proportion of the UK population has been exposed to a bovine spongiform encephalopathy-like prion strain and are at risk of developing variant CJD. A hallmark of prion disease is the transformation of normal cellular prion protein (PrP(C)) into an infectious disease-associated isoform, PrP(Sc). Recent in vitro studies indicate that anti-PrP monoclonal antibodies with little or no affinity for PrP(Sc) can prevent the incorporation of PrP(C) into propagating prions. We therefore investigated in a murine scrapie model whether anti-PrP monoclonal antibodies show similar inhibitory effects on prion replication in vivo. We found that peripheral PrP(Sc) levels and prion infectivity were markedly reduced, even when the antibodies were first administered at the point of near maximal accumulation of PrP(Sc) in the spleen. Furthermore, animals in which the treatment was continued remained healthy for over 300 days after equivalent untreated animals had succumbed to the disease. These findings indicate that immunotherapeutic strategies for human prion diseases are worth pursuing.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>White</LastName><ForeName>Anthony R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>CNS Infection and Immunity Group, Department of Neurogenetics, Division of Neurosciences and Psychological Medicine, Faculty of Medicine, Imperial College, Norfolk Place, London W2 1PG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Enever</LastName><ForeName>Perry</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Tayebi</LastName><ForeName>Mourad</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Mushens</LastName><ForeName>Rosey</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Linehan</LastName><ForeName>Jackie</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Brandner</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Anstee</LastName><ForeName>David</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Collinge</LastName><ForeName>John</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Hawke</LastName><ForeName>Simon</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nature</MedlineTA><NlmUniqueID>0410462</NlmUniqueID><ISSNLinking>0028-0836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018620">PrPSc Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007116" MajorTopicYN="Y">Immunization, Passive</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018620" MajorTopicYN="N">PrPSc Proteins</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017096" MajorTopicYN="N">Prion Diseases</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012608" MajorTopicYN="N">Scrapie</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2002</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2003</Year><Month>1</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>3</Month><Day>7</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>4</Month><Day>10</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>3</Month><Day>7</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12621436</ArticleId><ArticleId IdType="doi">10.1038/nature01457</ArticleId><ArticleId IdType="pii">nature01457</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12627226</PMID><DateCompleted><Year>2003</Year><Month>05</Month><Day>30</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1078-8956</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>4</Issue><PubDate><Year>2003</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Nature medicine</Title><ISOAbbreviation>Nat Med</ISOAbbreviation></Journal><ArticleTitle>Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain.</ArticleTitle><Pagination><StartPage>439</StartPage><EndPage>447</EndPage><MedlinePgn>439-47</MedlinePgn></Pagination><Abstract><AbstractText>The subcortical white matter of the adult human brain harbors a pool of glial progenitor cells. These cells can be isolated by fluorescence-activated cell sorting (FACS) after either transfection with green fluorescent protein (GFP) under the control of the CNP2 promoter, or A2B5-targeted immunotagging. Although these cells give rise largely to oligodendrocytes, in low-density culture we observed that some also generated neurons. We thus asked whether these nominally glial progenitors might include multipotential progenitor cells capable of neurogenesis. We found that adult human white-matter progenitor cells (WMPCs) could be passaged as neurospheres in vitro and that these cells generated functionally competent neurons and glia both in vitro and after xenograft to the fetal rat brain. WMPCs were able to produce neurons after their initial isolation and did not require in vitro expansion or reprogramming to do so. These experiments indicate that an abundant pool of mitotically competent neurogenic progenitor cells resides in the adult human white matter.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nunes</LastName><ForeName>Marta C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Neurology and Neuroscience, Cornell University Medical College, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roy</LastName><ForeName>Neeta Singh</ForeName><Initials>NS</Initials></Author><Author ValidYN="Y"><LastName>Keyoung</LastName><ForeName>H Michael</ForeName><Initials>HM</Initials></Author><Author ValidYN="Y"><LastName>Goodman</LastName><ForeName>Robert R</ForeName><Initials>RR</Initials></Author><Author ValidYN="Y"><LastName>McKhann</LastName><ForeName>Guy</ForeName><Initials>G</Initials><Suffix>2nd</Suffix></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Li</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Jian</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Nedergaard</LastName><ForeName>Maiken</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Goldman</LastName><ForeName>Steven A</ForeName><Initials>SA</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01NS33106</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01NS39559</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R37/R01NS29813</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>03</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Med</MedlineTA><NlmUniqueID>9502015</NlmUniqueID><ISSNLinking>1078-8956</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName><QualifierName UI="Q000196" MajorTopicYN="N">embryology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016380" MajorTopicYN="N">Brain Tissue Transplantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002469" MajorTopicYN="N">Cell Separation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005434" MajorTopicYN="N">Flow Cytometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009457" MajorTopicYN="N">Neuroglia</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName><QualifierName UI="Q000637" MajorTopicYN="N">transplantation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName><QualifierName UI="Q000637" MajorTopicYN="N">transplantation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D033581" MajorTopicYN="N">Stem Cell Transplantation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013234" MajorTopicYN="N">Stem Cells</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2002</Year><Month>12</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2003</Year><Month>2</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>3</Month><Day>11</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>5</Month><Day>31</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>3</Month><Day>11</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12627226</ArticleId><ArticleId IdType="doi">10.1038/nm837</ArticleId><ArticleId IdType="pii">nm837</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12628165</PMID><DateCompleted><Year>2003</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0896-6273</ISSN><JournalIssue CitedMedium="Print"><Volume>37</Volume><Issue>5</Issue><PubDate><Year>2003</Year><Month>Mar</Month><Day>06</Day></PubDate></JournalIssue><Title>Neuron</Title><ISOAbbreviation>Neuron</ISOAbbreviation></Journal><ArticleTitle>Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity.</ArticleTitle><Pagination><StartPage>735</StartPage><EndPage>749</EndPage><MedlinePgn>735-49</MedlinePgn></Pagination><Abstract><AbstractText>Mutations in parkin, which encodes a RING domain protein associated with ubiquitin ligase activity, lead to autosomal recessive Parkinson's disease characterized by midbrain dopamine neuron loss. Here we show that parkin functions in a multiprotein ubiquitin ligase complex that includes the F-box/WD repeat protein hSel-10 and Cullin-1. HSel-10 serves to target the parkin ubiquitin ligase activity to cyclin E, an hSel-10-interacting protein previously implicated in the regulation of neuronal apoptosis. Consistent with the notion that cyclin E is a substrate of the parkin ubiquitin ligase complex, parkin deficiency potentiates the accumulation of cyclin E in cultured postmitotic neurons exposed to the glutamatergic excitotoxin kainate and promotes their apoptosis. Furthermore, parkin overexpression attenuates the accumulation of cyclin E in toxin-treated primary neurons, including midbrain dopamine neurons, and protects them from apoptosis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Staropoli</LastName><ForeName>John F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Department of Pathology, Center for Neurobiology and Behavior, Taub Institute, College of Physicians and Surgeons, Columbia University, 15-403, 630 West 168th Street, New York, NY 10032, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McDermott</LastName><ForeName>Caroline</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Martinat</LastName><ForeName>C&#xe9;cile</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Schulman</LastName><ForeName>Brenda</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Demireva</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Abeliovich</LastName><ForeName>Asa</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuron</MedlineTA><NlmUniqueID>8809320</NlmUniqueID><ISSNLinking>0896-6273</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="D044843">SKP Cullin F-Box Protein Ligases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="D044767">Ubiquitin-Protein Ligases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="C111567">parkin protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 6.-</RegistryNumber><NameOfSubstance UI="D008025">Ligases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 6.3.2.-</RegistryNumber><NameOfSubstance UI="D010453">Peptide Synthases</NameOfSubstance></Chemical><Chemical><RegistryNumber>SIV03811UC</RegistryNumber><NameOfSubstance UI="D007608">Kainic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007608" MajorTopicYN="N">Kainic Acid</DescriptorName><QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008025" MajorTopicYN="N">Ligases</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008938" MajorTopicYN="N">Mitosis</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010453" MajorTopicYN="N">Peptide Synthases</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044843" MajorTopicYN="N">SKP Cullin F-Box Protein Ligases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044767" MajorTopicYN="Y">Ubiquitin-Protein Ligases</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>3</Month><Day>12</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>4</Month><Day>8</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>3</Month><Day>12</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12628165</ArticleId><ArticleId IdType="doi">10.1016/s0896-6273(03)00084-9</ArticleId><ArticleId IdType="pii">S0896627303000849</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12629183</PMID><DateCompleted><Year>2003</Year><Month>03</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1529-2401</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>5</Issue><PubDate><Year>2003</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>The Journal of neuroscience : the official journal of the Society for Neuroscience</Title><ISOAbbreviation>J Neurosci</ISOAbbreviation></Journal><ArticleTitle>Leukemia inhibitory factor is a key signal for injury-induced neurogenesis in the adult mouse olfactory epithelium.</ArticleTitle><Pagination><StartPage>1792</StartPage><EndPage>1803</EndPage><MedlinePgn>1792-803</MedlinePgn></Pagination><Abstract><AbstractText>The mammalian olfactory epithelium (OE) is composed of primary olfactory sensory neurons (OSNs) that are renewed throughout adulthood by local, restricted neuronal progenitor cells. The molecular signals that control this neurogenesis in vivo are unknown. Using olfactory bulb ablation (OBX) in adult mice to trigger synchronous mitotic stimulation of neuronal progenitors in the OE, we show the in vivo involvement of a cytokine in the cellular events leading to the regeneration of the OE. We find that, of many potential mitogenic signals, only leukemia inhibitory factor (LIF) is induced before the onset of neuronal progenitor proliferation. The rise in LIF mRNA expression peaks at 8 hr after OBX, and in situ RT-PCR and immunocytochemistry indicate that LIF is upregulated, in part, in the injured neurons themselves. This rise in LIF is necessary for injury-induced neurogenesis, as OBX in the LIF knock-out mouse fails to stimulate cell proliferation in the OE. Moreover, delivery of exogenous LIF to the intact adult OE using an adenoviral vector stimulates BrdU labeling in the apical OE. Taken together, these results suggest that injured OSNs release LIF as a stimulus to initiate their own replacement.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bauer</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Unit&#xe9; Mixte de Recherche 5020 Centre National de la Recherche Scientifique, Universit&#xe9; Lyon I, 69622 Villeurbanne, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasika</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Jing</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Mauduit</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Raccurt</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Morel</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Jourdan</LastName><ForeName>F</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Benahmed</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Moyse</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Patterson</LastName><ForeName>P H</ForeName><Initials>PH</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosci</MedlineTA><NlmUniqueID>8102140</NlmUniqueID><ISSNLinking>0270-6474</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019208">Brain-Derived Neurotrophic Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006131">Growth Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006133">Growth Substances</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053605">Leukemia Inhibitory Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C507838">Lif protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008222">Lymphokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>G34N38R2N1</RegistryNumber><NameOfSubstance UI="D001973">Bromodeoxyuridine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019208" MajorTopicYN="N">Brain-Derived Neurotrophic Factor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001973" MajorTopicYN="N">Bromodeoxyuridine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016923" MajorTopicYN="N">Cell Death</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018014" MajorTopicYN="N">Gene Transfer Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006131" MajorTopicYN="N">Growth Inhibitors</DescriptorName><QualifierName UI="Q000172" MajorTopicYN="Y">deficiency</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006133" MajorTopicYN="N">Growth Substances</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="Y">Interleukin-6</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053605" MajorTopicYN="N">Leukemia Inhibitory Factor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008222" MajorTopicYN="N">Lymphokines</DescriptorName><QualifierName UI="Q000172" MajorTopicYN="Y">deficiency</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019635" MajorTopicYN="N">Neurosurgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009830" MajorTopicYN="N">Olfactory Bulb</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009831" MajorTopicYN="N">Olfactory Mucosa</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000293" MajorTopicYN="N">injuries</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>3</Month><Day>12</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>3</Month><Day>26</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>3</Month><Day>12</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2003</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12629183</ArticleId><ArticleId IdType="pmc">PMC6741956</ArticleId><ArticleId IdType="pii">23/5/1792</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.23-05-01792.2003</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Banner LR, Patterson PH. Major changes in the expression of the mRNAs for cholinergic differentiation factor/leukemia inhibitory factor and its receptor after injury to adult peripheral nerves and ganglia. Proc Natl Acad Sci USA. 1994;91:7109&#x2013;7113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC44348</ArticleId><ArticleId IdType="pubmed">8041754</ArticleId></ArticleIdList></Reference><Reference><Citation>Banner LR, Moayeri NN, Patterson PH. Leukemia inhibitory factor is expressed in astrocytes following cortical brain injury. Exp Neurol. 1997;147:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">9294397</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer S, Mauduit C, Jourdan F, Benahmed M, Moyse E. In vivo involvement of the cytokine LIF during lesion-induced renewal of olfactory sensory neurons in adult mouse. In: Patterson PH, Kordon C, Christen Y, editors. Neuro-immune interactions in neurologic and psychiatric disorders. Springer; Fondation IPSEN. Berlin: 2000. pp. 153&#x2013;160.</Citation></Reference><Reference><Citation>Blesch A, Uy HS, Grill RJ, Cheng JG, Patterson PH, Tuszynski MH. Leukemia inhibitory factor augments neurotrophin expression and corticospinal axon growth after adult CNS injury. J Neurosci. 1999;19:3556&#x2013;3566.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6782234</ArticleId><ArticleId IdType="pubmed">10212315</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckland ME, Cunningham AM. Alterations in expression of the neurotrophic factors glial cell line-derived neurotrophic factor, ciliary neurotrophic factor and brain-derived neurotrophic factor, in the target-deprived olfactory neuroepithelium. Neuroscience. 1999;90:333&#x2013;347.</Citation><ArticleIdList><ArticleId IdType="pubmed">10188958</ArticleId></ArticleIdList></Reference><Reference><Citation>Bugga L, Gadient RA, Kwan K, Stewart CL, Patterson PH. Analysis of neuronal and glial phenotypes in brains of mice deficient in leukemia inhibitory factor. J Neurobiol. 1998;36:509&#x2013;524.</Citation><ArticleIdList><ArticleId IdType="pubmed">9740023</ArticleId></ArticleIdList></Reference><Reference><Citation>Caggiano M, Kauer JS, Hunter DD. Globose basal cells are neuronal progenitors in the olfactory epithelium: a lineage analysis using replication-incompetent retrovirus. Neuron. 1994;13:339&#x2013;352.</Citation><ArticleIdList><ArticleId IdType="pubmed">8060615</ArticleId></ArticleIdList></Reference><Reference><Citation>Calof AL, Mumm JS, Rim PC, Shou J. The neuronal stem cell of the olfactory epithelium. J Neurobiol. 1998;36:190&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pubmed">9712304</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlson CD, Bai Y, Ding M, Jonakait GM, Hart RP. Interleukin-1 involvement in the induction of leukemia inhibitory factor mRNA expression following axotomy of sympathetic ganglia. J Neuroimmunol. 1996;70:181&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pubmed">8898726</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng J-G, Patterson PH. LIF is an autocrine factor for sympathetic neurons. Mol Cell Neurosci. 1997;9:372&#x2013;380.</Citation><ArticleIdList><ArticleId IdType="pubmed">9361275</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciccolini F, Svendsen CN. Fibroblast growth factor 2 (FGF2) promotes acquisition of epidermal growth factor (EGF) responsiveness in mouse striatal precursor cells: identification of neural precursors responding to both EGF and FGF-2. J Neurosci. 1998;18:7869&#x2013;7880.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6792996</ArticleId><ArticleId IdType="pubmed">9742155</ArticleId></ArticleIdList></Reference><Reference><Citation>Corness J, Shi T-J, Xu Z-Q, Brulet P, Hokfelt T. Influence of leukemia inhibitory factor on galanin/GMAP and neuropeptide Y expression in mouse primary sensory neurons after axotomy. Exp Brain Res. 1996;112:79&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">8951409</ArticleId></ArticleIdList></Reference><Reference><Citation>Craig CG, Tropepe V, Morshead CM, Reynolds BA, Weiss S, Van Der Kooy D. In vivo growth factor expansion of endogenous subependymal neural precursor cell populations in the adult mouse brain. J Neurosci. 1996;16:2649&#x2013;2658.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6578757</ArticleId><ArticleId IdType="pubmed">8786441</ArticleId></ArticleIdList></Reference><Reference><Citation>Crews L, Hunter D. Neurogenesis in the olfactory epithelium. Perspect Dev Neurobiol. 1994;2:151&#x2013;161.</Citation><ArticleIdList><ArticleId IdType="pubmed">7728499</ArticleId></ArticleIdList></Reference><Reference><Citation>Curtis R, Scherer SS, Somogyi R, Adryan KM, Ip NY, Zhu Y, Lindsay RM, DiStefano PS. Retrograde axonal transport of LIF is increased by peripheral nerve injury: correlation with increased LIF expression in distal nerve. Neuron. 1994;12:191&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pubmed">7507340</ArticleId></ArticleIdList></Reference><Reference><Citation>Deckner ML, Frisen J, Verge VM, Hokfelt T, Risling M. Localization of neurotrophin receptors in olfactory epithelium and bulb. NeuroReport. 1993;5:301&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pubmed">8298092</ArticleId></ArticleIdList></Reference><Reference><Citation>Deckner ML, Risling M, Frisen J. Apoptotic death of olfactory sensory neurons in the adult rat. Exp Neurol. 1997;143:132&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pubmed">9000452</ArticleId></ArticleIdList></Reference><Reference><Citation>DeHamer MK, Guevara JL, Hannon K, Olwin BB, Calof AL. Genesis of olfactory receptor neurons in vitro: regulation of progenitor cell divisions by fibroblast growth factors. Neuron. 1994;13:1083&#x2013;1097.</Citation><ArticleIdList><ArticleId IdType="pubmed">7946347</ArticleId></ArticleIdList></Reference><Reference><Citation>Ensoli F, Fiorelli V, Vannelli B, Barni T, De Cristofaro M, Ensoli B, Thiele CJ. Basic fibroblast growth factor supports human olfactory neurogenesis by autocrine/paracrine mechanisms. Neuroscience. 1998;86:881&#x2013;893.</Citation><ArticleIdList><ArticleId IdType="pubmed">9692724</ArticleId></ArticleIdList></Reference><Reference><Citation>Estus S, Zacks WJ, Freeman RS, Gruda M, Bravo R, Johnson EM. Altered gene expression in neurons during programmed cell death: identification of c-jun as necessary for neuronal apoptosis. J Cell Biol. 1994;127:1717&#x2013;1727.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2120296</ArticleId><ArticleId IdType="pubmed">7798322</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezeh PI, Farbman AI. Differential activation of ErbB receptors in the rat olfactory mucosa by transforming growth factor-alpha and epidermal growth factor in vivo. J Neurobiol. 1998;37:199&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pubmed">9805267</ArticleId></ArticleIdList></Reference><Reference><Citation>Fann M-J, Patterson PH. Depolarization differentially regulates the effects of bone morphogenetic protein (BMP)-2, BMP-6, and activin A on sympathetic neuronal phenotype. J Neurochem. 1994a;63:2074&#x2013;2079.</Citation><ArticleIdList><ArticleId IdType="pubmed">7964725</ArticleId></ArticleIdList></Reference><Reference><Citation>Fann M-J, Patterson PH. Neuropoietic cytokines and activin A differentially regulate the phenotype of cultured sympathetic neurons. Proc Natl Acad Sci USA. 1994b;91:43&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC42882</ArticleId><ArticleId IdType="pubmed">7904069</ArticleId></ArticleIdList></Reference><Reference><Citation>Farbman AI, Buchholz JA. Transforming growth factor-&#x3b1; and other growth factors stimulate cell division in olfactory epithelium in vitro. J Neurobiol. 1996;30:267&#x2013;280.</Citation><ArticleIdList><ArticleId IdType="pubmed">8738755</ArticleId></ArticleIdList></Reference><Reference><Citation>Farbman AI, Buchholz JA, Suzuki Y, Coines A, Speert D. A molecular basis of cell death in olfactory epithelium. J Comp Neurol. 1999;414:306&#x2013;314.</Citation><ArticleIdList><ArticleId IdType="pubmed">10516598</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992;119:493&#x2013;501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2289665</ArticleId><ArticleId IdType="pubmed">1400587</ArticleId></ArticleIdList></Reference><Reference><Citation>Getchell TV, Shah DS, Partin JV, Subhedar NK, Getchell ML. Leukemia inhibitory factor mRNA expression is upregulated in macrophages and olfactory receptor neurons after target ablation. J Neurosci Res. 2002;67:246&#x2013;254.</Citation><ArticleIdList><ArticleId IdType="pubmed">11782968</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein BJ, Wolozin BL, Schwob JE. FGF2 suppresses neurogenesis of a cell line derived from rat olfactory epithelium. J Neurobiol. 1997;33:411&#x2013;428.</Citation><ArticleIdList><ArticleId IdType="pubmed">9322158</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatta T, Moriyama K, Nakashima K, Taga T, Otani H. The role of gp130 in cerebral cortical development: in vivo functional analysis in a mouse exo utero system. J Neurosci. 2002;22:5516&#x2013;5524.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6758239</ArticleId><ArticleId IdType="pubmed">12097503</ArticleId></ArticleIdList></Reference><Reference><Citation>Herzog C, Otto T. Regeneration of olfactory receptor neurons following chemical lesion: time course and enhancement with growth factor administration. Brain Res. 1999;849:155&#x2013;161.</Citation><ArticleIdList><ArticleId IdType="pubmed">10592297</ArticleId></ArticleIdList></Reference><Reference><Citation>Holcomb JD, Mumm JS, Calof AL. Apoptosis in the neuronal lineage of the mouse olfactory epithelium: regulation in vivo and in vitro. Dev Biol. 1995;172:307&#x2013;323.</Citation><ArticleIdList><ArticleId IdType="pubmed">7589810</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu P, Yu F, Feron F, Pickles JO, Sneesby K, Mackay-Sim A. Basic fibroblast growth factor and fibroblast growth factor receptors in adult olfactory epithelium. Brain Res. 2001;896:188&#x2013;197.</Citation><ArticleIdList><ArticleId IdType="pubmed">11277992</ArticleId></ArticleIdList></Reference><Reference><Citation>Huard JM, Schwob JE. Cell cycle of globose basal cells in rat olfactory epithelium. Dev Dyn. 1995;203:17&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">7647371</ArticleId></ArticleIdList></Reference><Reference><Citation>Huard JM, Youngentob SL, Goldstein BJ, Luskin MB, Schwob JE. Adult olfactory epithelium contains multipotent progenitors that give rise to neurons and non-neural cells. J Comp Neurol. 1998;400:469&#x2013;486.</Citation><ArticleIdList><ArticleId IdType="pubmed">9786409</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunter DD, Caggiano M, Kauer JS. Lineage analysis of the olfactory epithelium using a replication-incompetent retrovirus. Chem Senses. 1994;19:683&#x2013;693.</Citation><ArticleIdList><ArticleId IdType="pubmed">7735847</ArticleId></ArticleIdList></Reference><Reference><Citation>Jankowsky JL, Patterson PH. Differential regulation of cytokine expression following pilocarpine-induced seizure. Exp Neurol. 1999;159:333&#x2013;346.</Citation><ArticleIdList><ArticleId IdType="pubmed">10506506</ArticleId></ArticleIdList></Reference><Reference><Citation>Kastner A, Moyse E, Bauer S, Jourdan F, Brun G. Unusual regulation of cyclin-dependent kinases cdk2 and cdk4 during in vivo mitotic stimulation of olfactory neuron progenitors in adult mouse. J Neurochem. 2000;74:2343&#x2013;2349.</Citation><ArticleIdList><ArticleId IdType="pubmed">10820194</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerr BJ, Han J, Patterson PH. Adenoviral delivery of LIF induces significant proliferation in neurogenic areas of adult mouse brain. Soc Neurosci Abstr. 2002;28:23.6.</Citation></Reference><Reference><Citation>Krishna NSR, Little SS, Getchell TV. Epidermal growth factor receptor mRNA and protein are expressed in progenitor cells of olfactory epithelium. J Comp Neurol. 1996;373:297&#x2013;307.</Citation><ArticleIdList><ArticleId IdType="pubmed">8889929</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn HG, Palmer TD, Fuchs E. Adult neurogenesis: a compensatory mechanism for neuronal damage. Eur Arch Psychiatry Clin Neurosci. 2001;251:152&#x2013;158.</Citation><ArticleIdList><ArticleId IdType="pubmed">11697579</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurek JB, Austin L, Cheema SS, Bartlett PF, Murphy M. Up-regulation of leukaemia inhibitory factor and interleukin-6 in transected sciatic nerve and muscle following denervation. Neuromuscul Disord. 1996;6:105&#x2013;114.</Citation><ArticleIdList><ArticleId IdType="pubmed">8664561</ArticleId></ArticleIdList></Reference><Reference><Citation>Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680&#x2013;685.</Citation><ArticleIdList><ArticleId IdType="pubmed">5432063</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavoie JN, Rivard N, L'Allemain G, Pouyssegur J. A temporal and biochemical link between growth factor-activated MAP kinases, cyclin D1 induction and cell cycle entry. Prog Cell Cycle Res. 1996;2:49&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">9552382</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemke R, Gadient RA, Schliebs R, Bigl V, Patterson PH. Neuronal expression of leukemia inhibitory factor (LIF) in the rat brain. Neurosci Lett. 1996;215:205&#x2013;208.</Citation><ArticleIdList><ArticleId IdType="pubmed">8899749</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemke R, Gadient RA, Patterson PH, Bigl V, Schliebs R. Leukemia inhibitory factor (LIF) mRNA-expressing neuronal subpopulations in adult rat basal forebrain. Neurosci Lett. 1997;229:69&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">9224804</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim DA, Tramontin AD, Trevejo JM, Herrera DG, Garcia-Verdugo JM, Alvarez-Buylla A. Noggin antagonizes BMP signaling to create a niche for adult neurogenesis. Neuron. 2000;28:713&#x2013;726.</Citation><ArticleIdList><ArticleId IdType="pubmed">11163261</ArticleId></ArticleIdList></Reference><Reference><Citation>MacDonald KPA, Murrell WG, Bartlett PF, Bushell GR, Mackay-Sim A. FGF2 promotes neuronal differentiation in explant cultures of adult and embryonic mouse olfactory epithelium. J Neurosci Res. 1996;44:27&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">8926627</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackay-Sim A, Chuah MI. Neurotrophic factors in the primary olfactory pathway. Prog Neurobiol. 2000;62:527&#x2013;559.</Citation><ArticleIdList><ArticleId IdType="pubmed">10869782</ArticleId></ArticleIdList></Reference><Reference><Citation>Magavi SS, Macklis JD. Manipulation of neural precursors in situ: induction of neurogenesis in the neocortex of adult mice. Neuropsychopharmacology. 2001;25:816&#x2013;835.</Citation><ArticleIdList><ArticleId IdType="pubmed">11750176</ArticleId></ArticleIdList></Reference><Reference><Citation>Magavi SS, Leavitt BR, Macklis JD. Induction of neurogenesis in the neocortex of adult mice. Nature. 2000;405:951&#x2013;955.</Citation><ArticleIdList><ArticleId IdType="pubmed">10879536</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahalik TJ. Apparent apoptotic cell death in the olfactory epithelium of adult rodents: death occurs at different developmental stages. J Comp Neurol. 1996;372:457&#x2013;464.</Citation><ArticleIdList><ArticleId IdType="pubmed">8873871</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahanthappa NK, Schwarting GA. Peptide growth control of olfactory neurogenesis and neuron survival in vitro: roles of EGF and TGF-&#x3b2;s. Neuron. 1993;10:293&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pubmed">7679915</ArticleId></ArticleIdList></Reference><Reference><Citation>Margolis FL. Olfactory marker protein (OMP). Scand J Immunol. 1982;9:181&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pubmed">6963760</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin-Villalba A, Herr I, Jeremias I, Hahne M, Brandt R, Vogel J, Schenkel J, Herdegen T, Debatin KM. CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons. J Neurosci. 1999;19:3809&#x2013;3817.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6782733</ArticleId><ArticleId IdType="pubmed">10234013</ArticleId></ArticleIdList></Reference><Reference><Citation>Michel D, Moyse E, Brun G, Jourdan F. Induction of apoptosis in mouse olfactory neuroepithelium by synaptic target ablation. NeuroReport. 1994;5:1329&#x2013;1332.</Citation><ArticleIdList><ArticleId IdType="pubmed">7919191</ArticleId></ArticleIdList></Reference><Reference><Citation>Michel D, Chatelain G, Mauduit C, Benahmed M, Brun G. Recent evolutionary acquisition of alternative pre-mRNA splicing and 3&#x2032; processing regulations induced by intronic B2 SINE insertion. Nucleic Acids Res. 1997a;25:3228&#x2013;3234.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC146886</ArticleId><ArticleId IdType="pubmed">9241235</ArticleId></ArticleIdList></Reference><Reference><Citation>Michel D, Moyse E, Trembleau A, Brun G, Jourdan F. Clusterin/Apo J expression is associated with neuronal apoptosis in the olfactory mucosa of the adult mouse. J Cell Sci. 1997b;110:1635&#x2013;1645.</Citation><ArticleIdList><ArticleId IdType="pubmed">9247197</ArticleId></ArticleIdList></Reference><Reference><Citation>Minami M, Kuraishi Y, Satoh M. Effects of kainic acid on messenger RNA levels of IL-1 beta, IL-6, TNF alpha and LIF in the rat brain. Biochem Biophys Res Commun. 1991;176:593&#x2013;598.</Citation><ArticleIdList><ArticleId IdType="pubmed">1709015</ArticleId></ArticleIdList></Reference><Reference><Citation>Monti-Graziadei AG, Graziadei PPC. Studies on neuronal plasticity and regeneration in the olfactory system: morphologic and functional characteristics of the olfactory sensory neurons. In: Meisami A, Brazier MAB, editors. Neural growth and differentiation. Raven; New York: 1979. pp. 373&#x2013;396.</Citation></Reference><Reference><Citation>Mowla SJ, Pareek S, Farhadi HF, Petrecca K, Fawcett JP, Seidah NG, Morris SJ, Sossin WS, Murphy RA. Differential sorting of nerve growth factor and brain-derived neurotrophic factor in hippocampal neurons. J Neurosci. 1999;19:2069&#x2013;2080.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6782557</ArticleId><ArticleId IdType="pubmed">10066260</ArticleId></ArticleIdList></Reference><Reference><Citation>Nan B, Getchell ML, Partin JV, Getchell TV. Leukemia inhibitory factor, interleukin-6, and their receptors are expressed transiently in the olfactory mucosa after target ablation. J Comp Neurol. 2001;435:60&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">11370011</ArticleId></ArticleIdList></Reference><Reference><Citation>Newman MP, Feron F, Mackay-Sim A. Growth factor regulation of neurogenesis in adult olfactory epithelium. Neuroscience. 2000;99:343&#x2013;350.</Citation><ArticleIdList><ArticleId IdType="pubmed">10938440</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohta Y, Ichimura K. Immunohistochemical localization of epidermal growth factors in mouse olfactory epithelium. Am J Rhinol. 1999;13:225&#x2013;228.</Citation><ArticleIdList><ArticleId IdType="pubmed">10392243</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozawa K, Seo M, Imamura T. A quantitative method for evaluation of FGF family and FGF receptor family gene expression by RT-PCR. Brain Res Protoc. 1997;1:211&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">9385055</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao MS, Sun Y, Escary JL, Perreau J, Tresser S, Patterson PH, Zigmond RE, Brulet P, Landis SC. Leukemia inhibitory factor mediates an injury response but not a target-directed developmental transmitter switch in sympathetic neurons. Neuron. 1993;11:1175&#x2013;1185.</Citation><ArticleIdList><ArticleId IdType="pubmed">7506046</ArticleId></ArticleIdList></Reference><Reference><Citation>Recher S, Raccurt M, Lambert A, Lobie PE, Mertani HC, Morel G. Prenatal and adult growth hormone gene expression in rat lymphoid organs. J Histochem Cytochem. 2001;49:347&#x2013;354.</Citation><ArticleIdList><ArticleId IdType="pubmed">11181738</ArticleId></ArticleIdList></Reference><Reference><Citation>Roskams AJ, Bethel MA, Hurt KJ, Ronnett GV. Sequential expression of Trks A, B, and C in the regenerating olfactory neuroepithelium. J Neurosci. 1996;16:1294&#x2013;1307.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6578567</ArticleId><ArticleId IdType="pubmed">8778281</ArticleId></ArticleIdList></Reference><Reference><Citation>Salehi-Ashtiani K, Farbman AI. Expression of neu and neu differentiation factor in the olfactory mucosa of rat. Int J Dev Neurosci. 1996;14:801&#x2013;811.</Citation><ArticleIdList><ArticleId IdType="pubmed">9010726</ArticleId></ArticleIdList></Reference><Reference><Citation>Satoh M, Yoshida T. Enhancement of neuronal progenitor cell divisions by fibroblast growth factor-2 and leukemia inhibitory factor in organ culture of murine olfactory epithelium. IFO Res Commun. 1997a;18:13&#x2013;19.</Citation></Reference><Reference><Citation>Satoh M, Yoshida T. Promotion of neurogenesis in mouse olfactory neuronal progenitor cells by leukemia inhibitory factor in vitro. Neurosci Lett. 1997b;225:165&#x2013;168.</Citation><ArticleIdList><ArticleId IdType="pubmed">9147396</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheffler B, Horn M, Blumcke I, Laywell ED, Coomes D, Kukekov VG, Steindler DA. Marrow-mindedness: a perspective on neuropoiesis. Trends Neurosci. 1999;22:348&#x2013;357.</Citation><ArticleIdList><ArticleId IdType="pubmed">10407420</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz-Levey M, Chikaraishi DM, Kauer JS. Characterization of potential precursor populations in the mouse olfactory epithelium using immunocytochemistry and autoradiography. J Neurosci. 1991;11:3556&#x2013;3564.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6575532</ArticleId><ArticleId IdType="pubmed">1719164</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwob JE. Neural regeneration and the peripheral olfactory system. Anat Rec. 2002;269:33&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">11891623</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwob JE, Huard JM, Luskin MB, Youngentob SL. Retroviral lineage studies of the rat olfactory epithelium. Chem Senses. 1994;19(6):671&#x2013;682.</Citation><ArticleIdList><ArticleId IdType="pubmed">7735846</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwob JE, Youngentob SL, Mezza RC. Reconstitution of the rat olfactory epithelium after methyl bromide-induced lesion. J Comp Neurol. 1995;359:15&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">8557844</ArticleId></ArticleIdList></Reference><Reference><Citation>Sendtner M, Gotz R, Holtmann B, Escary JL, Masu Y, Carroll P, Wolf E, Brem G, Brulet P, Thoenen H. Cryptic physiological trophic support of motoneurons by LIF revealed by double gene targeting of CNTF and LIF. Curr Biol. 1996;6:686&#x2013;694.</Citation><ArticleIdList><ArticleId IdType="pubmed">8793295</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherr CJ. Cancer cell cycles. Science. 1996;274:1672&#x2013;1677.</Citation><ArticleIdList><ArticleId IdType="pubmed">8939849</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherr CJ. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res. 2000;60:3689&#x2013;3695.</Citation><ArticleIdList><ArticleId IdType="pubmed">10919634</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimazaki T, Shingo T, Weiss S. The ciliary neurotrophic factor/leukemia inhibitory factor/gp130 receptor complex operates in the maintenance of mammalian forebrain neural stem cells. J Neurosci. 2001;21:7642&#x2013;7653.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6762896</ArticleId><ArticleId IdType="pubmed">11567054</ArticleId></ArticleIdList></Reference><Reference><Citation>Shou J, Rim PC, Calof AL. BMPs inhibit neurogenesis by a mechanism involving degradation of a transcription factor. Nat Neurosci. 1999;2:339&#x2013;345.</Citation><ArticleIdList><ArticleId IdType="pubmed">10204540</ArticleId></ArticleIdList></Reference><Reference><Citation>Shou J, Murray RC, Rim PC, Calof AL. Opposing effects of bone morphogenetic proteins on neuron production and survival in the olfactory receptor neuron lineage. Development. 2000;127:5403&#x2013;5413.</Citation><ArticleIdList><ArticleId IdType="pubmed">11076761</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugiura S, Lahav R, Han J, Kou S-Y, Banner LR, de Pablo F, Patterson PH. Leukaemia inhibitory factor is required for normal inflammatory responses to injury in the peripheral and central nervous systems in vivo and is chemotactic for macrophages in vitro. Eur J Neurosci. 2000;12:457&#x2013;466.</Citation><ArticleIdList><ArticleId IdType="pubmed">10712626</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Zigmond RE. Leukaemia inhibitory factor induced in the sciatic nerve after axotomy is involved in the induction of galanin in sensory neurons. Eur J Neurosci. 1996;8:2213&#x2013;2220.</Citation><ArticleIdList><ArticleId IdType="pubmed">8921314</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Rao MS, Zigmond RE, Landis SC. Regulation of vasoactive intestinal peptide expression in sympathetic neurons in culture and after axotomy: the role of cholinergic differentiation factor/leukemia inhibitory factor. J Neurobiol. 1994;25:415&#x2013;430.</Citation><ArticleIdList><ArticleId IdType="pubmed">8077967</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki Y, Farbman AI. Tumor necrosis factor-alpha-induced apoptosis in olfactory epithelium in vitro: possible roles of caspase 1 (ICE), caspase 2 (ICH-1), and caspase 3 (CPP32). Exp Neurol. 2000;165:35&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">10964483</ArticleId></ArticleIdList></Reference><Reference><Citation>Tropepe V, Hitoshi S, Sirard C, Mak TW, Rossant J, van der Kooy D. Direct neural fate specification from embryonic stem cells: a primitive mammalian neural stem cell stage acquired through a default mechanism. Neuron. 2001;30:65&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">11343645</ArticleId></ArticleIdList></Reference><Reference><Citation>Turnley AM, Bartlett PF. Cytokines that signal through the leukemia inhibitory factor receptor-beta complex in the nervous system. J Neurochem. 2000;74:889&#x2013;899.</Citation><ArticleIdList><ArticleId IdType="pubmed">10693919</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiler E, Farbman AI. Supporting cell proliferation in the olfactory epithelium decreases postnatally. Glia. 1998;22:315&#x2013;328.</Citation><ArticleIdList><ArticleId IdType="pubmed">9517564</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasuno H, Fukazawa K, Fukuoka T, Kondo E, Sakagami M, Noguchi K. Nerve growth factor applied onto the olfactory epithelium alleviates degenerative changes of the olfactory receptor neurons following axotomy. Brain Res. 2000;887:53&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">11134589</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu M, Oishi K, Lee SC, Patterson PH. Studies using LIF knockout mice and a LIF adenoviral vector demonstrate a key anti-inflammatory role for this cytokine in cutaneous inflammation. J Immunol. 2001;166:2049&#x2013;2054.</Citation><ArticleIdList><ArticleId IdType="pubmed">11160255</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12634421</PMID><DateCompleted><Year>2003</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>100</Volume><Issue>7</Issue><PubDate><Year>2003</Year><Month>Apr</Month><Day>01</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.</ArticleTitle><Pagination><StartPage>4162</StartPage><EndPage>4167</EndPage><MedlinePgn>4162-7</MedlinePgn></Pagination><Abstract><AbstractText>Two substrates of insulin-degrading enzyme (IDE), amyloid beta-protein (Abeta) and insulin, are critically important in the pathogenesis of Alzheimer's disease (AD) and type 2 diabetes mellitus (DM2), respectively. We previously identified IDE as a principal regulator of Abeta levels in neuronal and microglial cells. A small chromosomal region containing a mutant IDE allele has been associated with hyperinsulinemia and glucose intolerance in a rat model of DM2. Human genetic studies have implicated the IDE region of chromosome 10 in both AD and DM2. To establish whether IDE hypofunction decreases Abeta and insulin degradation in vivo and chronically increases their levels, we characterized mice with homozygous deletions of the IDE gene (IDE --). IDE deficiency resulted in a &gt;50% decrease in Abeta degradation in both brain membrane fractions and primary neuronal cultures and a similar deficit in insulin degradation in liver. The IDE -- mice showed increased cerebral accumulation of endogenous Abeta, a hallmark of AD, and had hyperinsulinemia and glucose intolerance, hallmarks of DM2. Moreover, the mice had elevated levels of the intracellular signaling domain of the beta-amyloid precursor protein, which was recently found to be degraded by IDE in vitro. Together with emerging genetic evidence, our in vivo findings suggest that IDE hypofunction may underlie or contribute to some forms of AD and DM2 and provide a mechanism for the recently recognized association among hyperinsulinemia, diabetes, and AD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Farris</LastName><ForeName>Wesley</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mansourian</LastName><ForeName>Stefan</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Yang</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Lindsley</LastName><ForeName>Loren</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Eckman</LastName><ForeName>Elizabeth A</ForeName><Initials>EA</Initials></Author><Author ValidYN="Y"><LastName>Frosch</LastName><ForeName>Matthew P</ForeName><Initials>MP</Initials></Author><Author ValidYN="Y"><LastName>Eckman</LastName><ForeName>Christopher B</ForeName><Initials>CB</Initials></Author><Author ValidYN="Y"><LastName>Tanzi</LastName><ForeName>Rudolph E</ForeName><Initials>RE</Initials></Author><Author ValidYN="Y"><LastName>Selkoe</LastName><ForeName>Dennis J</ForeName><Initials>DJ</Initials></Author><Author ValidYN="Y"><LastName>Guenette</LastName><ForeName>Suzanne</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P01 AG015379</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG15379</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG015903</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG15903</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG1247</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>03</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.24.56</RegistryNumber><NameOfSubstance UI="D007339">Insulysin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018149" MajorTopicYN="N">Glucose Intolerance</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005951" MajorTopicYN="N">Glucose Tolerance Test</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007339" MajorTopicYN="N">Insulysin</DescriptorName><QualifierName UI="Q000172" MajorTopicYN="N">deficiency</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016133" MajorTopicYN="N">Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>3</Month><Day>14</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>5</Month><Day>23</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>3</Month><Day>14</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2003</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12634421</ArticleId><ArticleId IdType="pmc">PMC153065</ArticleId><ArticleId IdType="doi">10.1073/pnas.0230450100</ArticleId><ArticleId IdType="pii">0230450100</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Duckworth W C, Bennett R G, Hamel F G. Endocr Rev. 1998;19:608&#x2013;624.</Citation><ArticleIdList><ArticleId IdType="pubmed">9793760</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldfine I D, Williams J A, Bailey A C, Wong K Y, Iwamoto Y, Yokono K, Baba S, Roth R A. Diabetes. 1984;33:64&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">6360769</ArticleId></ArticleIdList></Reference><Reference><Citation>Seta K A, Roth R A. Biochem Biophys Res Commun. 1997;231:167&#x2013;171.</Citation><ArticleIdList><ArticleId IdType="pubmed">9070242</ArticleId></ArticleIdList></Reference><Reference><Citation>Vekrellis K, Ye Z, Qiu W Q, Walsh D, Hartley D, Chesneau V, Rosner M R, Selkoe D J. J Neurosci. 2000;20:1657&#x2013;1665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772918</ArticleId><ArticleId IdType="pubmed">10684867</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett R G, Duckworth W C, Hamel F G. J Biol Chem. 2000;275:36621&#x2013;36625.</Citation><ArticleIdList><ArticleId IdType="pubmed">10973971</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurochkin I V. Trends Biochem Sci. 2001;26:421&#x2013;425.</Citation><ArticleIdList><ArticleId IdType="pubmed">11440853</ArticleId></ArticleIdList></Reference><Reference><Citation>Authier F, Posner B I, Bergeron J J M. Clin Invest Med. 1996;19:149&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pubmed">8724818</ArticleId></ArticleIdList></Reference><Reference><Citation>Fakhrai-Rad H, Nikoshkov A, Kamel A, Fernstrom M, Zierath J R, Norgren S, Luthman H, Galli J. Hum Mol Genet. 2000;9:2149&#x2013;2158.</Citation><ArticleIdList><ArticleId IdType="pubmed">10958757</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh S, Watanabe R M, Valle T T, Hauser E R, Magnuson V L, Langefeld C D, Ally D S, Mohlke K L, Silander K, Kohtamaki K, et al. Am J Hum Genet. 2000;67:1174&#x2013;1185.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1288560</ArticleId><ArticleId IdType="pubmed">11032783</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiltshire S, Hattersley A T, Hitman G A, Walker M, Levy J C, Sampson M, O'Rahilly S, Frayling T M, Bell J I, Lathrop G M, et al. Am J Hum Genet. 2001;69:553&#x2013;569.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1235485</ArticleId><ArticleId IdType="pubmed">11484155</ArticleId></ArticleIdList></Reference><Reference><Citation>Meigs J B, Panhuysen C I, Myers R H, Wilson P W, Cupples L A. Diabetes. 2002;51:833&#x2013;840.</Citation><ArticleIdList><ArticleId IdType="pubmed">11872688</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu W Q, Ye Z, Kholodenko D, Seubert P, Selkoe D J. J Biol Chem. 1997;272:6641&#x2013;6646.</Citation><ArticleIdList><ArticleId IdType="pubmed">9045694</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu W Q, Walsh D M, Ye Z, Vekrellis K, Zhang J, Podlisny M, Rosner M R, Safavi A, Hersh L B, Selkoe D J. J Biol Chem. 1998;273:32730&#x2013;32738.</Citation><ArticleIdList><ArticleId IdType="pubmed">9830016</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudoh S, Frosch M P, Wolf B A. Biochemistry. 2002;41:1091&#x2013;1099.</Citation><ArticleIdList><ArticleId IdType="pubmed">11802707</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee A, Song E, Kihiko-Ehmann M, Goodman J P, Jr, Pyrek J S, Estus S, Hersh L B. J Neurosci. 2000;20:8745&#x2013;8749.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6773064</ArticleId><ArticleId IdType="pubmed">11102481</ArticleId></ArticleIdList></Reference><Reference><Citation>Savage M J, Trusko S P, Howland D S, Pinsker L R, Mistretta S, Reaume A G, Greenberg B D, Siman R, Scott R W. J Neurosci. 1998;18:1743&#x2013;1752.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6792617</ArticleId><ArticleId IdType="pubmed">9464999</ArticleId></ArticleIdList></Reference><Reference><Citation>Dovey H F, John V, Anderson J P, Chen L Z, de Saint Andrieu P, Fang L Y, Freedman S B, Folmer B, Goldbach E, Holsztynska E J, et al. J Neurochem. 2001;76:173&#x2013;181.</Citation><ArticleIdList><ArticleId IdType="pubmed">11145990</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwata N, Tsubuki S, Takaki Y, Shirotani K, Lu B, Gerard N P, Gerard C, Hama E, Lee H J, Saido T C. Science. 2001;292:1550&#x2013;1552.</Citation><ArticleIdList><ArticleId IdType="pubmed">11375493</ArticleId></ArticleIdList></Reference><Reference><Citation>Eckman E A, Watson M, Marlow L, Sambamurti K, Eckman C B. J Biol Chem. 2003;278:2081&#x2013;2084.</Citation><ArticleIdList><ArticleId IdType="pubmed">12464614</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertram L, Blacker D, Mullin K, Keeney D, Jones J, Basu S, Yhu S, McInnis M G, Go R C, Vekrellis K, et al. Science. 2000;290:2302&#x2013;2303.</Citation><ArticleIdList><ArticleId IdType="pubmed">11125142</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y J, Scott W K, Hedges D J, Zhang F, Gaskell P C, Nance M A, Watts R L, Hubble J P, Koller W C, Pahwa R, et al. Am J Hum Genet. 2002;70:985&#x2013;993.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC379130</ArticleId><ArticleId IdType="pubmed">11875758</ArticleId></ArticleIdList></Reference><Reference><Citation>Ait-Ghezala G, Abdullah L, Crescentini R, Crawford F, Town T, Singh S, Richards D, Duara R, Mullan M. Neurosci Lett. 2002;325:87&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">12044628</ArticleId></ArticleIdList></Reference><Reference><Citation>Abraham R, Myers A, Wavrant-DeVrieze F, Hamshere M L, Thomas H V, Marshall H, Compton D, Spurlock G, Turic D, Hoogendoorn B, et al. Hum Genet. 2001;109:646&#x2013;652.</Citation><ArticleIdList><ArticleId IdType="pubmed">11810277</ArticleId></ArticleIdList></Reference><Reference><Citation>Boussaha M, Hannequin D, Verpillat P, Brice A, Frebourg T, Campion D. Neurosci Lett. 2002;329:121&#x2013;123.</Citation><ArticleIdList><ArticleId IdType="pubmed">12161276</ArticleId></ArticleIdList></Reference><Reference><Citation>Myers A, Holmans P, Marshall H, Kwon J, Meyer D, Ramic D, Shears S, Booth J, DeVrieze F W, Crook R, et al. Science. 2000;290:2304&#x2013;2305.</Citation><ArticleIdList><ArticleId IdType="pubmed">11125144</ArticleId></ArticleIdList></Reference><Reference><Citation>Ertekin-Taner N, Graff-Radford N, Younkin L H, Eckman C, Baker M, Adamson J, Ronald J, Blangero J, Hutton M, Younkin S G. Science. 2000;290:2303&#x2013;2304.</Citation><ArticleIdList><ArticleId IdType="pubmed">11125143</ArticleId></ArticleIdList></Reference><Reference><Citation>Edbauer D, Willem M, Lammich S, Steiner H, Haass C. J Biol Chem. 2002;277:13389&#x2013;13393.</Citation><ArticleIdList><ArticleId IdType="pubmed">11809755</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimberly W T, Zheng J B, Guenette S Y, Selkoe D J. J Biol Chem. 2001;276:40288&#x2013;40292.</Citation><ArticleIdList><ArticleId IdType="pubmed">11544248</ArticleId></ArticleIdList></Reference><Reference><Citation>Cupers P, Orlans I, Craessaerts K, Annaert W, De Strooper B. J Neurochem. 2001;78:1168&#x2013;1178.</Citation><ArticleIdList><ArticleId IdType="pubmed">11553691</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao X, Sudhof T C. Science. 2001;293:115&#x2013;120.</Citation><ArticleIdList><ArticleId IdType="pubmed">11441186</ArticleId></ArticleIdList></Reference><Reference><Citation>Baek S H, Ohgi K A, Rose D W, Koo E H, Glass C K, Rosenfeld M G. Cell. 2002;110:55&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">12150997</ArticleId></ArticleIdList></Reference><Reference><Citation>Zambrowicz B P, Friedrich G A, Buxton E C, Lilleberg S L, Person C, Sands A T. Nature. 1998;392:608&#x2013;611.</Citation><ArticleIdList><ArticleId IdType="pubmed">9560157</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujiki Y, Hubbard A L, Fowler S, Lazarow P B. J Cell Biol. 1982;93:97&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2112113</ArticleId><ArticleId IdType="pubmed">7068762</ArticleId></ArticleIdList></Reference><Reference><Citation>Podlisny M B, Tolan D, Selkoe D J. Am J Pathol. 1991;138:1423&#x2013;1435.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1886384</ArticleId><ArticleId IdType="pubmed">1905108</ArticleId></ArticleIdList></Reference><Reference><Citation>Podlisny M B, Citron M, Amarante P, Sherrington R, Xia W, Zhang J, Diehl T, Levesque G, Fraser P, Haass C, et al. Neurobiol Dis. 1997;3:325&#x2013;337.</Citation><ArticleIdList><ArticleId IdType="pubmed">9173929</ArticleId></ArticleIdList></Reference><Reference><Citation>Duff K, Eckman C, Zehr C, Yu X, Prada C-M, Perez-Tur J, Hutton M, Buee L, Harigaya Y, Yager D, et al. Nature. 1996;383:710&#x2013;713.</Citation><ArticleIdList><ArticleId IdType="pubmed">8878479</ArticleId></ArticleIdList></Reference><Reference><Citation>Petanceska S S, Nagy V, Frail D, Gandy S. Exp Gerontol. 2000;35:1317&#x2013;1325.</Citation><ArticleIdList><ArticleId IdType="pubmed">11113610</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia W, Ray W J, Ostaszewski B L, Rahmati T, Kimberly W T, Wolfe M S, Zhange J, Goate A M, Selkoe D J. Proc Natl Acad Sci USA. 2000;97:9299&#x2013;9304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC16862</ArticleId><ArticleId IdType="pubmed">10922078</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu B, Gerard N P, Kolakowski L F, Jr, Bozza M, Zurakowski D, Finco O, Carroll M C, Gerard C. J Exp Med. 1995;181:2271&#x2013;2275.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2192063</ArticleId><ArticleId IdType="pubmed">7760013</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng H, Jiang M, Trumbauer M E, Sirinathsinghji D J S, Hopkins R, Smith D W, Heavesn R P, Dawson G R, Boyce S, Conner M W, et al. Cell. 1995;81:525&#x2013;531.</Citation><ArticleIdList><ArticleId IdType="pubmed">7758106</ArticleId></ArticleIdList></Reference><Reference><Citation>Mucke L, Masliah E, Yu G Q, Mallory M, Rockenstein E M, Tatsuno G, Hu K, Kholodenko D, Johnson-Wood K, McConlogue L. J Neurosci. 2000;20:4050&#x2013;4058.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772621</ArticleId><ArticleId IdType="pubmed">10818140</ArticleId></ArticleIdList></Reference><Reference><Citation>Duckworth W C, Kitabchi A E. Diabetes. 1974;23:536&#x2013;543.</Citation><ArticleIdList><ArticleId IdType="pubmed">4834293</ArticleId></ArticleIdList></Reference><Reference><Citation>Lue L F, Kuo Y M, Roher A E, Brachova L, Shen Y, Sue L, Beach T, Kurth J H, Rydel R E, Rogers J. Am J Pathol. 1999;155:853&#x2013;862.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1866907</ArticleId><ArticleId IdType="pubmed">10487842</ArticleId></ArticleIdList></Reference><Reference><Citation>McLean C A, Cherny R A, Fraser F W, Fuller S J, Smith M J, Beyreuther K, Bush A I, Masters C L. Ann Neurol. 1999;46:860&#x2013;866.</Citation><ArticleIdList><ArticleId IdType="pubmed">10589538</ArticleId></ArticleIdList></Reference><Reference><Citation>Weyer C, Hanson R L, Tataranni P A, Bogardus C, Pratley R E. Diabetes. 2000;49:2094&#x2013;2101.</Citation><ArticleIdList><ArticleId IdType="pubmed">11118012</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G. J Clin Invest. 1997;100:1166&#x2013;1173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC508292</ArticleId><ArticleId IdType="pubmed">9303923</ArticleId></ArticleIdList></Reference><Reference><Citation>Weyer C, Salbe A D, Lindsay R S, Pratley R E, Bogardus C, Tataranni P A. Metabolism. 2001;50:223&#x2013;230.</Citation><ArticleIdList><ArticleId IdType="pubmed">11229433</ArticleId></ArticleIdList></Reference><Reference><Citation>Backer J M, Kahn C R, White M F. J Biol Chem. 1990;265:14828&#x2013;14835.</Citation><ArticleIdList><ArticleId IdType="pubmed">2203763</ArticleId></ArticleIdList></Reference><Reference><Citation>Pratley R E, Weyer C. Diabetologia. 2001;44:929&#x2013;945.</Citation><ArticleIdList><ArticleId IdType="pubmed">11484070</ArticleId></ArticleIdList></Reference><Reference><Citation>Ott A, Stolk R P, van Harskamp F, Pols H A, Hofman A, Breteler M M. Neurology. 1999;53:1937&#x2013;1942.</Citation><ArticleIdList><ArticleId IdType="pubmed">10599761</ArticleId></ArticleIdList></Reference><Reference><Citation>Leibson C L, Rocca W A, Hanson V A, Cha R, Kokmen E, O'Brien P C, Palumbo P J. Am J Epidemiol. 1997;145:301&#x2013;308.</Citation><ArticleIdList><ArticleId IdType="pubmed">9054233</ArticleId></ArticleIdList></Reference><Reference><Citation>Curb J D, Rodriguez B L, Abbott R D, Petrovitch H, Ross G W, Masaki K H, Foley D, Blanchette P L, Harris T, Chen R, et al. Neurology. 1999;52:971&#x2013;975.</Citation><ArticleIdList><ArticleId IdType="pubmed">10102414</ArticleId></ArticleIdList></Reference><Reference><Citation>Stolk R P, Breteler M M, Ott A, Pols H A, Lamberts S W, Grobbee D E, Hofman A. Diabetes Care. 1997;20:792&#x2013;795.</Citation><ArticleIdList><ArticleId IdType="pubmed">9135944</ArticleId></ArticleIdList></Reference><Reference><Citation>Razay G, Wilcock G K. Age Ageing. 1994;23:396&#x2013;399.</Citation><ArticleIdList><ArticleId IdType="pubmed">7825486</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujisawa Y, Sasaki K, Akiyama K. Biol Psychiatry. 1991;30:1219&#x2013;1228.</Citation><ArticleIdList><ArticleId IdType="pubmed">1790263</ArticleId></ArticleIdList></Reference><Reference><Citation>Craft S, Newcomer J, Kanne S, Dagogo-Jack S, Cryer P, Sheline Y, Luby J, Dagogo-Jack A, Alderson A. Neurobiol Aging. 1996;17:123&#x2013;130.</Citation><ArticleIdList><ArticleId IdType="pubmed">8786794</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki N, Fukatsu R, Tsuzuki K, Hayashi Y, Yoshida T, Fujii N, Koike T, Wakayama I, Yanagihara R, Garruto R, et al. Am J Pathol. 1998;153:1149&#x2013;1155.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1853056</ArticleId><ArticleId IdType="pubmed">9777946</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitek M P, Bhattacharya K, Glendening J M, Stopa E, Vlassara H, Bucala R, Manogue K, Cerami A. Proc Natl Acad Sci USA. 1994;91:4766&#x2013;4770.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC43869</ArticleId><ArticleId IdType="pubmed">8197133</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12640146</PMID><DateCompleted><Year>2003</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>100</Volume><Issue>7</Issue><PubDate><Year>2003</Year><Month>Apr</Month><Day>01</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway.</ArticleTitle><Pagination><StartPage>4281</StartPage><EndPage>4286</EndPage><MedlinePgn>4281-6</MedlinePgn></Pagination><Abstract><AbstractText>Oxidative stress is believed to be an important mediator of neurodegeneration. However, the transcriptional pathways induced in neurons by oxidative stress that activate protective gene responses have yet to be fully delineated. We report that the transcription factor Sp1 is acetylated in response to oxidative stress in neurons. Histone deacetylase (HDAC) inhibitors augment Sp1 acetylation, Sp1 DNA binding, and Sp1-dependent gene expression and confer resistance to oxidative stress-induced death in vitro and in vivo. Sp1 activation is necessary for the protective effects of HDAC inhibitors. Together, these results demonstrate that HDAC inhibitors inhibit oxidative death independent of polyglutamine expansions by activating an Sp1-dependent adaptive response.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ryu</LastName><ForeName>Hoon</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology and Program in Neuroscience, Harvard Medical School and Beth Israel Deaconess Medical Center, Harvard Institutes of Medicine, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Junghee</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Olofsson</LastName><ForeName>Beatrix A</ForeName><Initials>BA</Initials></Author><Author ValidYN="Y"><LastName>Mwidau</LastName><ForeName>Aziza</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Dedeoglu</LastName><ForeName>Alpaslan</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Escudero</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Flemington</LastName><ForeName>Erik</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Azizkhan-Clifford</LastName><ForeName>Jane</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Ferrante</LastName><ForeName>Robert J</ForeName><Initials>RJ</Initials></Author><Author ValidYN="Y"><LastName>Ratan</LastName><ForeName>Rajiv R</ForeName><Initials>RR</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS045242</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 NS045242</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS37102</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS39170</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS35255</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA71019</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>03</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D056572">Histone Deacetylase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020319">Oligodeoxyribonucleotides, Antisense</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016329">Sp1 Transcription Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>26700-71-0</RegistryNumber><NameOfSubstance UI="C097188">polyglutamine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Proc Natl Acad Sci U S A. 2003 May 27;100(11):6890</RefSource><Note>Deodoglu, A [corrected to Dedeoglu, A]</Note></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000107" MajorTopicYN="N">Acetylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016923" MajorTopicYN="N">Cell Death</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002540" MajorTopicYN="N">Cerebral Cortex</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004791" MajorTopicYN="N">Enzyme Inhibitors</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056572" MajorTopicYN="Y">Histone Deacetylase Inhibitors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020319" MajorTopicYN="N">Oligodeoxyribonucleotides, Antisense</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016329" MajorTopicYN="N">Sp1 Transcription Factor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>3</Month><Day>18</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>5</Month><Day>23</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>3</Month><Day>18</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2003</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12640146</ArticleId><ArticleId IdType="pmc">PMC153084</ArticleId><ArticleId IdType="doi">10.1073/pnas.0737363100</ArticleId><ArticleId IdType="pii">0737363100</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sagara Y, Dargusch R, Chambers D, Davis J, Schubert D, Maher P. Free Radical Biol Med. 1998;24:1375&#x2013;1389.</Citation><ArticleIdList><ArticleId IdType="pubmed">9641255</ArticleId></ArticleIdList></Reference><Reference><Citation>Atwood C S, Huang X, Moir R D, Tanzi R E, Bush A I. Met Ions Biol Syst. 1999;36:309&#x2013;364.</Citation><ArticleIdList><ArticleId IdType="pubmed">10093929</ArticleId></ArticleIdList></Reference><Reference><Citation>Browne S E, Ferrante R J, Beal M F. Brain Pathol. 1999;9:147&#x2013;163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8098260</ArticleId><ArticleId IdType="pubmed">9989457</ArticleId></ArticleIdList></Reference><Reference><Citation>Castagne V, Gautschi M, Lefevre K, Posada A, Clarke P G. Prog Neurobiol. 1999;59:397&#x2013;423.</Citation><ArticleIdList><ArticleId IdType="pubmed">10501635</ArticleId></ArticleIdList></Reference><Reference><Citation>Estevez A G, Crow J P, Sampson J B, Reiter C, Zhuang Y, Richardson G J, Tarpey M M, Barveito L, Beckman J S. Science. 1999;286:2498&#x2013;2500.</Citation><ArticleIdList><ArticleId IdType="pubmed">10617463</ArticleId></ArticleIdList></Reference><Reference><Citation>Floyd R A. Proc Soc Exp Biol Med. 1999;222:236&#x2013;245.</Citation><ArticleIdList><ArticleId IdType="pubmed">10601882</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattson M P, Pedersen W A, Duan W, Culmsee C, Camandolsa S. Ann NY Acad Sci. 1999;893:154&#x2013;175.</Citation><ArticleIdList><ArticleId IdType="pubmed">10672236</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratan R R. In: Cell Death and Disease of the Nervous System. Koliatsos V E, Ratan R R, editors. Totowa, NJ: Humana; 1999. pp. 649&#x2013;666.</Citation></Reference><Reference><Citation>Albers D S, Beal M F. J Neural Transm. 2000;59,Suppl.:133&#x2013;154.</Citation><ArticleIdList><ArticleId IdType="pubmed">10961426</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoulson I. Ann Neurol. 1998;44:S160&#x2013;S166.</Citation><ArticleIdList><ArticleId IdType="pubmed">9749589</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J M, Zipfel G J, Choi D W. Nature. 1999;399:A7&#x2013;A14.</Citation><ArticleIdList><ArticleId IdType="pubmed">10392575</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickenbottom S L, Grotta J. Semin Neurol. 1998;18:485&#x2013;492.</Citation><ArticleIdList><ArticleId IdType="pubmed">9932619</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy T H, Miyamoto M, Sastre A, Schnaar R L, Coyle J T. Neuron. 1989;2:1547&#x2013;1558.</Citation><ArticleIdList><ArticleId IdType="pubmed">2576375</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy T H, Schnaar R L, Coyle J T. FASEB J. 1990;4:1624&#x2013;1633.</Citation><ArticleIdList><ArticleId IdType="pubmed">2180770</ArticleId></ArticleIdList></Reference><Reference><Citation>Crack P J, Taylor J M, Flentjar N J, de Haan J, Hertzog P, Ianello R C, Kola I. J Neurochem. 2001;78:1389&#x2013;1399.</Citation><ArticleIdList><ArticleId IdType="pubmed">11579147</ArticleId></ArticleIdList></Reference><Reference><Citation>Tkac I, Keene C D, Pfeuuffer J, Low W C, Gruetter R. J Neurosci Res. 2001;66:891&#x2013;898.</Citation><ArticleIdList><ArticleId IdType="pubmed">11746416</ArticleId></ArticleIdList></Reference><Reference><Citation>Klivenyi P, Andreassen O A, Ferrante R J, Dedeoglu A, Mueller G, Lancelot E, Bodgonav M, Andersen J K, Jiang D, Beal M F. J Neurosci. 2000;20:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6774090</ArticleId><ArticleId IdType="pubmed">10627575</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry T L, Godin D V, Hansen S. Neurosci Lett. 1982;33:305&#x2013;310.</Citation><ArticleIdList><ArticleId IdType="pubmed">7162692</ArticleId></ArticleIdList></Reference><Reference><Citation>Dexter D T, Sian J, Rose S, Hindmarsh J G, Mann V M, Copper F R, Wells S E, Daniel A J, Lee A H, Schapira A H. Anal Neurol. 1994;35:38&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">8285590</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenner P, Olanow J P. Neurology. 1996;47:S161&#x2013;S170.</Citation><ArticleIdList><ArticleId IdType="pubmed">8959985</ArticleId></ArticleIdList></Reference><Reference><Citation>Jha N, Kumar M J, Boonplueang R, Andersen J K. J Neurochem. 2002;80:555&#x2013;561.</Citation><ArticleIdList><ArticleId IdType="pubmed">11841562</ArticleId></ArticleIdList></Reference><Reference><Citation>Nenoi M, Ichimura S, Mita K, Yukawa O, Cartwright I L. Cancer Res. 2001;61:5885&#x2013;5894.</Citation><ArticleIdList><ArticleId IdType="pubmed">11479230</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratan R R, Murphy T H, Baraban J M. J Neurochem. 1994;62:376&#x2013;379.</Citation><ArticleIdList><ArticleId IdType="pubmed">7903353</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan S, Sagara Y, Liu Y, Maher P, Schubert D. J Cell Biol. 1998;141:1423&#x2013;1432.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2132785</ArticleId><ArticleId IdType="pubmed">9628898</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaman K, Ryu H, Hall D, O'Donovan K, Lin K, Miller M P, Marquis J C, Baraban J M, Semenza G L, Ratan R R. J Neurosci. 1999;19:9821&#x2013;9830.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6782985</ArticleId><ArticleId IdType="pubmed">10559391</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratan R R, Murphy T H, Baraban J M. J Neurosci. 1994b;14:4385&#x2013;4392.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6577015</ArticleId><ArticleId IdType="pubmed">8027786</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa K, Estus S, Fu W, Mark R J, Mattson M P. J Cell Biol. 1997;136:1137&#x2013;1149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2132476</ArticleId><ArticleId IdType="pubmed">9060477</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Maher P, Schubert D. J Cell Biol. 1997a;139:1317&#x2013;1324.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2140210</ArticleId><ArticleId IdType="pubmed">9382876</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Maher P, Schubert D. Neuron. 1997b;19:453&#x2013;463.</Citation><ArticleIdList><ArticleId IdType="pubmed">9292733</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowe S W, Ruley H E, Jacks T, Housman D E. Cell. 1993;74:957&#x2013;967.</Citation><ArticleIdList><ArticleId IdType="pubmed">8402885</ArticleId></ArticleIdList></Reference><Reference><Citation>Estus S, Zaks W J, Freeman R S, Gruda M, Bravo R, Johnson EM., Jr J Cell Biol. 1994;127:1717&#x2013;1727.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2120296</ArticleId><ArticleId IdType="pubmed">7798322</ArticleId></ArticleIdList></Reference><Reference><Citation>Ham J, Babij C, Whitfield J, Pfarr C M, Lallemand D, Yaniv M, Rubin L L. Neuron. 1995;14:927&#x2013;939.</Citation><ArticleIdList><ArticleId IdType="pubmed">7748560</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia Z, Dickens M, Raingeaud J, Davis R J, Greenberg M E. Science. 1995;270:1326&#x2013;1331.</Citation><ArticleIdList><ArticleId IdType="pubmed">7481820</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Hare M J, Hou S T, Morris E J, Cregan S P, Xu Q, Slack R S, Park D S. J Biol Chem. 2000;275:25358&#x2013;25364.</Citation><ArticleIdList><ArticleId IdType="pubmed">10851232</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D X, Greene L A. Neuron. 2001;32:425&#x2013;438.</Citation><ArticleIdList><ArticleId IdType="pubmed">11709154</ArticleId></ArticleIdList></Reference><Reference><Citation>Walton M, Woodgate A M, Muravlev A, Xu R, During M J, Dragunow M. J Neurochem. 1999;73:1836&#x2013;1842.</Citation><ArticleIdList><ArticleId IdType="pubmed">10537041</ArticleId></ArticleIdList></Reference><Reference><Citation>Riccio A, Ahn S, Davenport C M, Blendy J A, Ginty D D. Science. 1999;286:2358&#x2013;2361.</Citation><ArticleIdList><ArticleId IdType="pubmed">10600750</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmeliet P, Dor Y, Herbert J M, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, et al. Nature. 1998;394:485&#x2013;490.</Citation><ArticleIdList><ArticleId IdType="pubmed">9697772</ArticleId></ArticleIdList></Reference><Reference><Citation>Beg A A, Baltimore D. Science. 1996;274:782&#x2013;784.</Citation><ArticleIdList><ArticleId IdType="pubmed">8864118</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin K I, DiDonato J, Hoffman A, Hardwick J M, Ratan R R. J Cell Biol. 1998;141:1479&#x2013;1487.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2133010</ArticleId><ArticleId IdType="pubmed">9647642</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattson M P, Culmsee C, Yu Z F. Cell Tissue Res. 2000;301:173&#x2013;187.</Citation><ArticleIdList><ArticleId IdType="pubmed">10928290</ArticleId></ArticleIdList></Reference><Reference><Citation>Digicaylioglu M, Lipton S A. Nature. 2001;412:641&#x2013;647.</Citation><ArticleIdList><ArticleId IdType="pubmed">11493922</ArticleId></ArticleIdList></Reference><Reference><Citation>Briggs M R, Kadonaga J T, Bell S P, Tjian R. Science. 1986;234:47&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">3529394</ArticleId></ArticleIdList></Reference><Reference><Citation>Suske G. Gene. 1999;238:291&#x2013;300.</Citation><ArticleIdList><ArticleId IdType="pubmed">10570957</ArticleId></ArticleIdList></Reference><Reference><Citation>Leggett R W, Armstrong S A, Barry D, Mueller C R. J Biol Chem. 1995;270:25879&#x2013;25884.</Citation><ArticleIdList><ArticleId IdType="pubmed">7592774</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan G Z, Ziff E B. J Neurosci. 1997;17:6122&#x2013;6132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6568361</ArticleId><ArticleId IdType="pubmed">9236224</ArticleId></ArticleIdList></Reference><Reference><Citation>Krainc D, Bai G, Okamoto S, Carles M, Kusiak J W, Brent R N, Lipton S A. J Biol Chem. 1998;273:26218&#x2013;26224.</Citation><ArticleIdList><ArticleId IdType="pubmed">9748305</ArticleId></ArticleIdList></Reference><Reference><Citation>Black A R, Jensen D, Lin S Y, Azizkhan J C. J Biol Chem. 1999;274:1207&#x2013;1215.</Citation><ArticleIdList><ArticleId IdType="pubmed">9880488</ArticleId></ArticleIdList></Reference><Reference><Citation>Lania L, Majello B, De Luca P. Int J Biochem Cell Biol. 1997;29:1313&#x2013;1323.</Citation><ArticleIdList><ArticleId IdType="pubmed">9570130</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Hwang C K, Junn E, Lee G, Mouradian M M. J Biol Chem. 2000;275:38863&#x2013;38869.</Citation><ArticleIdList><ArticleId IdType="pubmed">10984499</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunah, A. W., Jeong, H., Griffin, A., Kim, Y. M., Standaert, D. G., Hersch, S. M., Mouradian, M. M., Young, A. B., Tanese, N. &amp; Krainc, D. (2002) 296, 2238&#x2013;2243.</Citation><ArticleIdList><ArticleId IdType="pubmed">11988536</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S H, Cheng A L, Zhou H, Lam S, Rao M, Li H, Li X J. Mol Cell Biol. 2002;22:1277&#x2013;1287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC134707</ArticleId><ArticleId IdType="pubmed">11839795</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyttenbach A, Sauvageot O, Carmichael J, Diaz-Latoud C, Arrigo A P, Rubinsztein D C. Hum Mol Genet. 2002;11:1137&#x2013;1151.</Citation><ArticleIdList><ArticleId IdType="pubmed">11978772</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogdanov M B, Andreassen O A, Dedeoglu A, Ferrante R J, Beal M F. J Neurochem. 2001;79:1246&#x2013;1249.</Citation><ArticleIdList><ArticleId IdType="pubmed">11752065</ArticleId></ArticleIdList></Reference><Reference><Citation>Patzel V, Steidl U, Kronenwett R, Haas R, Sczakiel G. Nucleic Acids Res. 1999;27:4328&#x2013;4334.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC148713</ArticleId><ArticleId IdType="pubmed">10536139</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee S, Zaman K, Ryu H, Conforto A, Ratan R R. Anal Neurol. 2001;49:345&#x2013;354.</Citation><ArticleIdList><ArticleId IdType="pubmed">11261509</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsiao M, Tse V, Carmel J, Tsai Y, Felgner P L, Haas M, Silverberg G D. Biochem Biophys Res Commun. 1997;233:359&#x2013;364.</Citation><ArticleIdList><ArticleId IdType="pubmed">9144539</ArticleId></ArticleIdList></Reference><Reference><Citation>Doetzlhofer A, Rotheneder H, Lagger G, Koranda M, Kurtev V, Brosch G, Wintersberger E, Seiser C. Mol Cell Biol. 1999;19:5504&#x2013;5511.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC84392</ArticleId><ArticleId IdType="pubmed">10409740</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu W, Roeder R G. Cell. 1997;90:595&#x2013;606.</Citation><ArticleIdList><ArticleId IdType="pubmed">9288740</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Bieker J J. Proc Natl Acad Sci USA. 1998;95:9855&#x2013;9860.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC21426</ArticleId><ArticleId IdType="pubmed">9707565</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C J, Deng Z, Kim A Y, Blobel G A, Lieberman P M. Mol Cell Biol. 2001;21:476&#x2013;487.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC86604</ArticleId><ArticleId IdType="pubmed">11134336</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin K I, Pasinelli P, Brown R H, Hardwick J M, Ratan R R. J Biol Chem. 1999;274:13650&#x2013;13655.</Citation><ArticleIdList><ArticleId IdType="pubmed">10224137</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki T, Kimura A, Nagai R, Horikoshi M. Genes Cells. 2000;5:29&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">10651903</ArticleId></ArticleIdList></Reference><Reference><Citation>Braun H, Koop R, Ertmer A, Nacht S, Suske G. Nucleic Acids Res. 2001;29:4994&#x2013;5000.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC97549</ArticleId><ArticleId IdType="pubmed">11812829</ArticleId></ArticleIdList></Reference><Reference><Citation>Prives C, Manley J L. Cell. 2001;107:815&#x2013;818.</Citation><ArticleIdList><ArticleId IdType="pubmed">11779456</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo M H, Allis C D. BioEssays. 1998;20:615&#x2013;626.</Citation><ArticleIdList><ArticleId IdType="pubmed">9780836</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida M, Kijima M, Akita M, Beppu T. J Biol Chem. 1990;265:17174&#x2013;17179.</Citation><ArticleIdList><ArticleId IdType="pubmed">2211619</ArticleId></ArticleIdList></Reference><Reference><Citation>Sternson S M, Wong J C, Grozinger C M, Schreiber S L. Org Lett. 2001;3:4239&#x2013;4242.</Citation><ArticleIdList><ArticleId IdType="pubmed">11784187</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Lint C, Emiliani S, Verdin E. Gene Expression. 1996;5:245&#x2013;253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6138027</ArticleId><ArticleId IdType="pubmed">8723390</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Y-C, Illenye S, Heintz N H. Mol Cell Biol. 2001;21:1121&#x2013;1131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC99566</ArticleId><ArticleId IdType="pubmed">11158299</ArticleId></ArticleIdList></Reference><Reference><Citation>Richon V M, Sandhoff T W, Rifkind R A, Marks P, A. Proc Natl Acad Sci USA. 2000;97:10014&#x2013;10019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC27656</ArticleId><ArticleId IdType="pubmed">10954755</ArticleId></ArticleIdList></Reference><Reference><Citation>Steffan J S, Kazantsev A, Spasic-Boskovic O, Greenwald M, Zhu Y Z, Gohler H, Wanker E E, Bates G P, Housman D E, Thompson L M. Proc Natl Acad Sci USA. 2000;97:6763&#x2013;6768.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC18731</ArticleId><ArticleId IdType="pubmed">10823891</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz J B, Henshaw D R, MacGarvey U, Beal M F. Neurochem Int. 1996;29:167&#x2013;171.</Citation><ArticleIdList><ArticleId IdType="pubmed">8837046</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim G W, Chan P H. J Cereb Blood Flow Metab. 2002;22:798&#x2013;809.</Citation><ArticleIdList><ArticleId IdType="pubmed">12142565</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoghbi H Y, Orr H T. Annu Rev Neurosci. 2000;23:217&#x2013;247.</Citation><ArticleIdList><ArticleId IdType="pubmed">10845064</ArticleId></ArticleIdList></Reference><Reference><Citation>McCampbell A, Fischbeck K H. Nat Med. 2001;7:528&#x2013;530.</Citation><ArticleIdList><ArticleId IdType="pubmed">11329046</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucifora F C, Jr, Sasaki M, Peters M F, Huang H, Cooper J K, Yamada M, Takahashi H, Tsuji S, Troncoso J, Dawson V L, et al. Science. 2001;291:2423&#x2013;2428.</Citation><ArticleIdList><ArticleId IdType="pubmed">11264541</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold D B, Heintz N. Proc Natl Acad Sci USA. 1997;94:8842&#x2013;8847.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC23159</ArticleId><ArticleId IdType="pubmed">9238065</ArticleId></ArticleIdList></Reference><Reference><Citation>Dressel U, Renkawitz R, Baniahmad A. Anticancer Res. 2000;20:1017&#x2013;1022.</Citation><ArticleIdList><ArticleId IdType="pubmed">10810390</ArticleId></ArticleIdList></Reference><Reference><Citation>Takakura M, Kyo S, Sowa Y, Wang Z, Yatabe N, Maida Y, Tanaka M, Inoue M. Nucleic Acids Res. 2001;29:3006&#x2013;3011.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC55810</ArticleId><ArticleId IdType="pubmed">11452025</ArticleId></ArticleIdList></Reference><Reference><Citation>Maehara K, Uekawa N, Isobe K. Biochem Biophys Res Commun. 2002;295:187&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pubmed">12083788</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Sowa Y, Sakai T, Pardee A B. Oncogene. 2000;19:5712&#x2013;5719.</Citation><ArticleIdList><ArticleId IdType="pubmed">11126357</ArticleId></ArticleIdList></Reference><Reference><Citation>McCampbell A, Taye A A, Whitty L, Penney E, Steffan J S, Fischbeck K H. Proc Natl Acad Sci USA. 2001;98:15179&#x2013;15184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC65003</ArticleId><ArticleId IdType="pubmed">11742087</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes R E, Olson J M. Nat Med. 2001;7:419&#x2013;423.</Citation><ArticleIdList><ArticleId IdType="pubmed">11283667</ArticleId></ArticleIdList></Reference><Reference><Citation>Steffan J S, Bodai L, Pallos J, Poelman M, McCampbell A, Apostol B L, Kazantsev A, Schmidt E, Zhu Y Z, Greenwald M, et al. Nature. 2001;413:739&#x2013;743.</Citation><ArticleIdList><ArticleId IdType="pubmed">11607033</ArticleId></ArticleIdList></Reference><Reference><Citation>McGuinness M C, Lu J-F, Zhang H-P, Dong G-X, Heinzer A K, Watkins P A, Powers J, Smith K D. Mol Cell Biol. 2003;23:744&#x2013;753.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC151532</ArticleId><ArticleId IdType="pubmed">12509471</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12641446</PMID><DateCompleted><Year>2003</Year><Month>04</Month><Day>17</Day></DateCompleted><DateRevised><Year>2003</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0006-2960</ISSN><JournalIssue CitedMedium="Print"><Volume>42</Volume><Issue>11</Issue><PubDate><Year>2003</Year><Month>Mar</Month><Day>25</Day></PubDate></JournalIssue><Title>Biochemistry</Title><ISOAbbreviation>Biochemistry</ISOAbbreviation></Journal><ArticleTitle>Insights into the amyloid folding problem from solid-state NMR.</ArticleTitle><Pagination><StartPage>3151</StartPage><EndPage>3159</EndPage><MedlinePgn>3151-9</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tycko</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Laboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892-0520, USA. tycko@helix.nih.gov</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biochemistry</MedlineTA><NlmUniqueID>0370623</NlmUniqueID><ISSNLinking>0006-2960</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000682">Amyloid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000682" MajorTopicYN="N">Amyloid</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008854" MajorTopicYN="N">Microscopy, Electron</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019906" MajorTopicYN="N">Nuclear Magnetic Resonance, Biomolecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017510" MajorTopicYN="Y">Protein Folding</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>3</Month><Day>19</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>4</Month><Day>18</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>3</Month><Day>19</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12641446</ArticleId><ArticleId IdType="doi">10.1021/bi027378p</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12641729</PMID><DateCompleted><Year>2003</Year><Month>04</Month><Day>23</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-3042</ISSN><JournalIssue CitedMedium="Print"><Volume>85</Volume><Issue>1</Issue><PubDate><Year>2003</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of neurochemistry</Title><ISOAbbreviation>J Neurochem</ISOAbbreviation></Journal><ArticleTitle>Effects of L-dopa and other amino acids against paraquat-induced nigrostriatal degeneration.</ArticleTitle><Pagination><StartPage>82</StartPage><EndPage>86</EndPage><MedlinePgn>82-6</MedlinePgn></Pagination><Abstract><AbstractText>Exposure to the herbicide paraquat causes selective nigrostriatal degeneration and aggregation of alpha-synuclein in the mouse brain. The purpose of this study was to assess mechanisms of paraquat entry into the CNS and, in particular, the effects of substrates of the blood-brain barrier (BBB) neutral amino acid transporter (System L carrier) on paraquat accumulation and neurotoxicity. Using a paraquat antibody, robust immunoreactivity was observed in the midbrain of mice injected with the herbicide. This immunoreactivity was abolished by administration of l-valine or l-phenylalanine, two System L substrates, immediately before paraquat exposure. Pre-treatment with these amino acids completely protected against paraquat-induced loss of nigrostriatal dopaminergic cells and formation of thioflavine S-positive intracellular deposits. Interestingly, the anti-parkinsonian drug l-dopa, which is transported across the BBB through the same neutral amino acid carrier, was also neuroprotective when administered 30 min prior to paraquat. In contrast, paraquat-induced toxicity was unaffected if animals (i) were pre-treated with d-valine, the biologically inactive d-isomer of l-valine, or with l-lysine, a substrate of the basic rather than the neutral amino acid carrier, or (ii) were injected with l-dopa 24 h after paraquat exposure. Data are consistent with a critical role of uptake across the BBB in paraquat neurotoxicity, and suggest that dietary elements (e.g. amino acids) or therapeutic agents (e.g. l-dopa) may modify the effects of toxicants targeting the nigrostriatal system.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McCormack</LastName><ForeName>Alison L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>The Parkinson's Institute, Sunnyvale, California 94089, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Monte</LastName><ForeName>Donato A</ForeName><Initials>DA</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>ES10442</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>ES10806</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>ES12077</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Neurochem</MedlineTA><NlmUniqueID>2985190R</NlmUniqueID><ISSNLinking>0022-3042</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000596">Amino Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018696">Neuroprotective Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>46627O600J</RegistryNumber><NameOfSubstance UI="D007980">Levodopa</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.16.2</RegistryNumber><NameOfSubstance UI="D014446">Tyrosine 3-Monooxygenase</NameOfSubstance></Chemical><Chemical><RegistryNumber>PLG39H7695</RegistryNumber><NameOfSubstance UI="D010269">Paraquat</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000596" MajorTopicYN="N">Amino Acids</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003342" MajorTopicYN="N">Corpus Striatum</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007980" MajorTopicYN="N">Levodopa</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018696" MajorTopicYN="N">Neuroprotective Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010269" MajorTopicYN="N">Paraquat</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010302" MajorTopicYN="N">Parkinson Disease, Secondary</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013378" MajorTopicYN="N">Substantia Nigra</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014446" MajorTopicYN="N">Tyrosine 3-Monooxygenase</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>3</Month><Day>19</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>4</Month><Day>24</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>3</Month><Day>19</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12641729</ArticleId><ArticleId IdType="doi">10.1046/j.1471-4159.2003.01621.x</ArticleId><ArticleId IdType="pii">1621</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12642658</PMID><DateCompleted><Year>2003</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>100</Volume><Issue>7</Issue><PubDate><Year>2003</Year><Month>Apr</Month><Day>01</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants.</ArticleTitle><Pagination><StartPage>4078</StartPage><EndPage>4083</EndPage><MedlinePgn>4078-83</MedlinePgn></Pagination><Abstract><AbstractText>Parkinson's disease (PD) is a common neurodegenerative disorder characterized by loss of dopaminergic neurons in the substantia nigra. Several lines of evidence strongly implicate mitochondrial dysfunction as a major causative factor in PD, although the molecular mechanisms responsible for mitochondrial dysfunction are poorly understood. Recently, loss-of-function mutations in the parkin gene, which encodes a ubiquitin-protein ligase, were found to underlie a familial form of PD known as autosomal recessive juvenile parkinsonism (AR-JP). To gain insight into the molecular mechanism responsible for selective cell death in AR-JP, we have created a Drosophila model of this disorder. Drosophila parkin null mutants exhibit reduced lifespan, locomotor defects, and male sterility. The locomotor defects derive from apoptotic cell death of muscle subsets, whereas the male sterile phenotype derives from a spermatid individualization defect at a late stage of spermatogenesis. Mitochondrial pathology is the earliest manifestation of muscle degeneration and a prominent characteristic of individualizing spermatids in parkin mutants. These results indicate that the tissue-specific phenotypes observed in Drosophila parkin mutants result from mitochondrial dysfunction and raise the possibility that similar mitochondrial impairment triggers the selective cell loss observed in AR-JP.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Greene</LastName><ForeName>Jessica C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Genome Sciences, University of Washington, P.O. Box 357730, Seattle, WA 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whitworth</LastName><ForeName>Alexander J</ForeName><Initials>AJ</Initials></Author><Author ValidYN="Y"><LastName>Kuo</LastName><ForeName>Isabella</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Andrews</LastName><ForeName>Laurie A</ForeName><Initials>LA</Initials></Author><Author ValidYN="Y"><LastName>Feany</LastName><ForeName>Mel B</ForeName><Initials>MB</Initials></Author><Author ValidYN="Y"><LastName>Pallanck</LastName><ForeName>Leo J</ForeName><Initials>LJ</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS041536</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS041780</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1R01NS41536-01</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1R01NS41780-01</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>03</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="D044767">Ubiquitin-Protein Ligases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.3.2.27</RegistryNumber><NameOfSubstance UI="C111567">parkin protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 6.-</RegistryNumber><NameOfSubstance UI="D008025">Ligases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003001" MajorTopicYN="N">Cloning, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004330" MajorTopicYN="N">Drosophila</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000254" MajorTopicYN="N">growth &amp; development</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008025" MajorTopicYN="N">Ligases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008136" MajorTopicYN="N">Longevity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016296" MajorTopicYN="Y">Mutagenesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009410" MajorTopicYN="N">Nerve Degeneration</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016415" MajorTopicYN="N">Sequence Alignment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017386" MajorTopicYN="N">Sequence Homology, Amino Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013087" MajorTopicYN="N">Spermatids</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044767" MajorTopicYN="Y">Ubiquitin-Protein Ligases</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>3</Month><Day>19</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>5</Month><Day>23</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>3</Month><Day>19</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2003</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12642658</ArticleId><ArticleId IdType="pmc">PMC153051</ArticleId><ArticleId IdType="doi">10.1073/pnas.0737556100</ArticleId><ArticleId IdType="pii">0737556100</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vaughan J R, Davis M B, Wood N W. Ann Hum Genet. 2001;65:111&#x2013;126.</Citation><ArticleIdList><ArticleId IdType="pubmed">11427172</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorell J, Johnson C, Rybicki B, Peterson E, Richardson R. Neurology. 1998;50:1346&#x2013;1350.</Citation><ArticleIdList><ArticleId IdType="pubmed">9595985</ArticleId></ArticleIdList></Reference><Reference><Citation>Gwinn-Hardy K A. Movement Disorders. 2002;14:645&#x2013;656.</Citation><ArticleIdList><ArticleId IdType="pubmed">12210852</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuno Y, Saitoh T, Sone N. Biochem Biophys Res Commun. 1987;143:294&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">3103619</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicklas W, Vyas I, Heikkila R. Life Sci. 1985;36:2503&#x2013;2508.</Citation><ArticleIdList><ArticleId IdType="pubmed">2861548</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramsay R, Salach J, Dadgar J, Singer T. Biochem Biophys Res Commun. 1986;135:269&#x2013;275.</Citation><ArticleIdList><ArticleId IdType="pubmed">3485428</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks A, Chadwick C, Gelbard H, Cory-Slechta D, Federoff H. Brain Res. 1999;823:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">10095006</ArticleId></ArticleIdList></Reference><Reference><Citation>Betarbet R, Sherer T B, MacKenzie G, Garcia-Osuna M, Panov A V, Greenamyre J T. Nat Neurosci. 2000;3:1301&#x2013;1306.</Citation><ArticleIdList><ArticleId IdType="pubmed">11100151</ArticleId></ArticleIdList></Reference><Reference><Citation>Janetzky B, Hauck S, Youdim M, Riederer P, Jellinger K, Pantucek F, Zochling R, Boissl K, Reichmann H. Neurosci Lett. 1994;169:126&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pubmed">8047266</ArticleId></ArticleIdList></Reference><Reference><Citation>Schapira A, Cooper J, Dexter D, Clark J, Jenner P, Marsden C. Lancet. 1989;1:1269.</Citation><ArticleIdList><ArticleId IdType="pubmed">2566813</ArticleId></ArticleIdList></Reference><Reference><Citation>Schapira A, Cooper J, Dexter D, Clark J, Jenner P, Marsden C. J Neurochem. 1990;54:823&#x2013;827.</Citation><ArticleIdList><ArticleId IdType="pubmed">2154550</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuno Y, Ohta S, Tanaka M, Takamiya S, Suzuki K, Sato T, Oya H, Ozawa T, Kagawa Y. Biochem Biophys Res Commun. 1989;163:1450&#x2013;1455.</Citation><ArticleIdList><ArticleId IdType="pubmed">2551290</ArticleId></ArticleIdList></Reference><Reference><Citation>Hattori N, Tanaka M, Ozawa T, Mizuno Y. Ann Neurol. 1991;30:563&#x2013;571.</Citation><ArticleIdList><ArticleId IdType="pubmed">1665052</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N. Nature. 1998;392:605&#x2013;608.</Citation><ArticleIdList><ArticleId IdType="pubmed">9560156</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai Y, Soda M, Takahashi R. J Biol Chem. 2000;275:35661&#x2013;35664.</Citation><ArticleIdList><ArticleId IdType="pubmed">10973942</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimura H, Hattori N, Kubo S-I, Mizuno Y, Asakawa S, Minoshima S, Shimizu N, Iwai K, Chiba T, Tanaka K, Suzuki T. Nat Genet. 2000;25:302&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pubmed">10888878</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Gao J, Chung K K K, Huang H, Dawson V L, Dawson T M. Proc Natl Acad Sci USA. 2000;97:13354&#x2013;13359.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC27228</ArticleId><ArticleId IdType="pubmed">11078524</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimura H, Schlossmacher M G, Hattori N, Frosch M P, Trockenbacher A, Schneider R, Mizuno Y, Kosik K S, Selkoe D J. Science. 2001;293:263&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pubmed">11431533</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai Y, Soda M, Inoue H, Hattori N, Mizuno Y, Takahashi R. Cell. 2001;105:891&#x2013;902.</Citation><ArticleIdList><ArticleId IdType="pubmed">11439185</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung K K K, Zhang Y, Lim K L, Tanaka Y, Huang H, Gao J, Ross C A, Dawson V L, Dawson T M. Nat Med. 2001;7:1144&#x2013;1150.</Citation><ArticleIdList><ArticleId IdType="pubmed">11590439</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranganayakulu G, Schulz R A, Olson E N. Dev Biol. 1996;176:143&#x2013;148.</Citation><ArticleIdList><ArticleId IdType="pubmed">8654890</ArticleId></ArticleIdList></Reference><Reference><Citation>Engels W R, Johnson-Schlitz D M, Eggleston W B, Sved J. Cell. 1990;62:515&#x2013;525.</Citation><ArticleIdList><ArticleId IdType="pubmed">2165865</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsunoda S, Sierralta J, Sun Y, Bodner R, Suzuki E, Becker A, Socolich M, Zuker C S. Nature. 1997;388:243&#x2013;249.</Citation><ArticleIdList><ArticleId IdType="pubmed">9230432</ArticleId></ArticleIdList></Reference><Reference><Citation>Brand A, Perrimon N. Development (Cambridge, UK) 1993;118:401&#x2013;415.</Citation><ArticleIdList><ArticleId IdType="pubmed">8223268</ArticleId></ArticleIdList></Reference><Reference><Citation>Benzer S. Sci Am. 1973;229:24&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">4202065</ArticleId></ArticleIdList></Reference><Reference><Citation>Benzer S. Proc Natl Acad Sci USA. 1967;58:1112&#x2013;1119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC335755</ArticleId><ArticleId IdType="pubmed">16578662</ArticleId></ArticleIdList></Reference><Reference><Citation>Feany M B, Bender W W. Nature. 2000;404:394&#x2013;398.</Citation><ArticleIdList><ArticleId IdType="pubmed">10746727</ArticleId></ArticleIdList></Reference><Reference><Citation>Bortner C D, Oldenburg B E N, Cidlowski J A. Trends Cell Biol. 1995;5:21&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">14731429</ArticleId></ArticleIdList></Reference><Reference><Citation>Auluck P, Chan H, Trojanowski J, Lee V, Bonini N M. Science. 2002;295:809&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pubmed">11823645</ArticleId></ArticleIdList></Reference><Reference><Citation>Orth M, Schapira A. Neurochem Int. 2002;40:533&#x2013;541.</Citation><ArticleIdList><ArticleId IdType="pubmed">11850110</ArticleId></ArticleIdList></Reference><Reference><Citation>Betarbet R, Sherer T B, Di Monte D, Greenamyre J T. Brain Pathol. 2002;12:499&#x2013;510.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8095781</ArticleId><ArticleId IdType="pubmed">12408237</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen J K. BioEssays. 2001;23:640&#x2013;646.</Citation><ArticleIdList><ArticleId IdType="pubmed">11462217</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12649271</PMID><DateCompleted><Year>2003</Year><Month>07</Month><Day>10</Day></DateCompleted><DateRevised><Year>2022</Year><Month>08</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0021-9258</ISSN><JournalIssue CitedMedium="Print"><Volume>278</Volume><Issue>22</Issue><PubDate><Year>2003</Year><Month>May</Month><Day>30</Day></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J Biol Chem</ISOAbbreviation></Journal><ArticleTitle>Ceramide stabilizes beta-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid beta-peptide biogenesis.</ArticleTitle><Pagination><StartPage>19777</StartPage><EndPage>19783</EndPage><MedlinePgn>19777-83</MedlinePgn></Pagination><Abstract><AbstractText>The lipid second messenger ceramide regulates several biochemical events that occur during aging. In addition, its level is highly elevated in the amyloid-burdened brains of Alzheimer's disease patients. Here, we analyzed the impact of aberrant ceramide levels on amyloid beta-peptide (Abeta) generation by using a cell-permeable analog of ceramide, C6-ceramide, and several biochemical inhibitors of the sphingomyelin/glycosphingolipid biosynthetic pathway. We found that C6-ceramide increased the biogenesis of Abeta by affecting beta-but not gamma-cleavage of the amyloid precursor protein. Similarly to C6-ceramide, increased levels of endogenous ceramide induced by neutral sphingomyelinase treatment also promoted the biogenesis of Abeta. Conversely, fumonisin B1, which inhibits the biosynthesis of endogenous ceramide, reduced Abeta production. Exogenous C6-ceramide restored both intracellular ceramide levels and Abeta generation in fumonisin B1-treated cells. These events were specific for amyloid precursor protein and were not associated with apoptotic cell death. Pulse-chase and time-course degradation experiments showed that ceramide post-translationally stabilizes the beta-secretase BACE1. Taken together, these data indicate that the lipid second messenger ceramide, which is elevated in the brains of Alzheimer's disease patients, increases the half-life of BACE1 and thereby promotes Abeta biogenesis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Puglielli</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Neurobiology of Disease Laboratory, Massachusetts General Hospital, Harvard Medical School, Charlestown 02129, USA. pugliell@helix.mgh.harvard.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellis</LastName><ForeName>Blake C</ForeName><Initials>BC</Initials></Author><Author ValidYN="Y"><LastName>Saunders</LastName><ForeName>Aleister J</ForeName><Initials>AJ</Initials></Author><Author ValidYN="Y"><LastName>Kovacs</LastName><ForeName>Dora M</ForeName><Initials>DM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType><PublicationType UI="D016441">Retracted Publication</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>03</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002518">Ceramides</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D053829">Amyloid Precursor Protein Secretases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010450">Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.-</RegistryNumber><NameOfSubstance UI="D016282">Aspartic Acid Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.46</RegistryNumber><NameOfSubstance UI="C509280">BACE1 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="RetractionIn"><RefSource>J Biol Chem. 2022 Jun;298(6):102052. doi: 10.1016/j.jbc.2022.102052.</RefSource><PMID Version="1">35635926</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D053829" MajorTopicYN="N">Amyloid Precursor Protein Secretases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016282" MajorTopicYN="N">Aspartic Acid Endopeptidases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016466" MajorTopicYN="N">CHO Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002518" MajorTopicYN="N">Ceramides</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010450" MajorTopicYN="N">Endopeptidases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014407" MajorTopicYN="N">Tumor Cells, Cultured</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>3</Month><Day>22</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>7</Month><Day>11</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>3</Month><Day>22</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12649271</ArticleId><ArticleId IdType="doi">10.1074/jbc.M300466200</ArticleId><ArticleId IdType="pii">S0021-9258(20)79996-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12657655</PMID><DateCompleted><Year>2003</Year><Month>04</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1529-2401</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>6</Issue><PubDate><Year>2003</Year><Month>Mar</Month><Day>15</Day></PubDate></JournalIssue><Title>The Journal of neuroscience : the official journal of the Society for Neuroscience</Title><ISOAbbreviation>J Neurosci</ISOAbbreviation></Journal><ArticleTitle>Neprilysin gene transfer reduces human amyloid pathology in transgenic mice.</ArticleTitle><Pagination><StartPage>1992</StartPage><EndPage>1996</EndPage><MedlinePgn>1992-6</MedlinePgn></Pagination><Abstract><AbstractText>The degenerative process of Alzheimer's disease is linked to a shift in the balance between amyloid-beta (Abeta) production, clearance, and degradation. Neprilysin has recently been implicated as a major extracellular Abeta degrading enzyme in the brain. However, there has been no direct demonstration that neprilysin antagonizes the deposition of amyloid-beta in vivo. To address this issue, a lentiviral vector expressing human neprilysin (Lenti-Nep) was tested in transgenic mouse models of amyloidosis. We show that unilateral intracerebral injection of Lenti-Nep reduced amyloid-beta deposits by half relative to the untreated side. Furthermore, Lenti-Nep ameliorated neurodegenerative alterations in the frontal cortex and hippocampus of these transgenic mice. These data further support a role for neprilysin in regulating cerebral amyloid deposition and suggest that gene transfer approaches might have potential for the development of alternative therapies for Alzheimer's disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Marr</LastName><ForeName>Robert A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, California 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rockenstein</LastName><ForeName>Edward</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Mukherjee</LastName><ForeName>Atish</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Kindy</LastName><ForeName>Mark S</ForeName><Initials>MS</Initials></Author><Author ValidYN="Y"><LastName>Hersh</LastName><ForeName>Louis B</ForeName><Initials>LB</Initials></Author><Author ValidYN="Y"><LastName>Gage</LastName><ForeName>Fred H</ForeName><Initials>FH</Initials></Author><Author ValidYN="Y"><LastName>Verma</LastName><ForeName>Inder M</ForeName><Initials>IM</Initials></Author><Author ValidYN="Y"><LastName>Masliah</LastName><ForeName>Eliezer</ForeName><Initials>E</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>AG 19323</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG018440</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG18440</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 AG005131</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG5131</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG019323</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R37 AG018440</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG10689</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG08514</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R37 AG008514</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG008514</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosci</MedlineTA><NlmUniqueID>8102140</NlmUniqueID><ISSNLinking>0270-6474</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C075222">amyloid beta-protein (1-42)</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.24.11</RegistryNumber><NameOfSubstance UI="D015260">Neprilysin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000686" MajorTopicYN="N">Amyloidosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004333" MajorTopicYN="N">Drug Administration Routes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005625" MajorTopicYN="N">Frontal Lobe</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018014" MajorTopicYN="N">Gene Transfer Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017930" MajorTopicYN="N">Genes, Reporter</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015316" MajorTopicYN="N">Genetic Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005822" MajorTopicYN="N">Genetic Vectors</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016086" MajorTopicYN="N">Lentivirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015260" MajorTopicYN="N">Neprilysin</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058225" MajorTopicYN="N">Plaque, Amyloid</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013234" MajorTopicYN="N">Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>3</Month><Day>27</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>4</Month><Day>18</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>3</Month><Day>27</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2003</Year><Month>9</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12657655</ArticleId><ArticleId IdType="pmc">PMC6742010</ArticleId><ArticleId IdType="pii">23/6/1992</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.23-06-01992.2003</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Akiyama H, Kondo H, Ikeda K, Kato M, McGeer PL. Immunohistochemical localization of neprilysin in the human cerebral cortex: inverse association with vulnerability to amyloid beta-protein (Abeta) deposition. Brain Res. 2001;902:277&#x2013;281.</Citation><ArticleIdList><ArticleId IdType="pubmed">11384622</ArticleId></ArticleIdList></Reference><Reference><Citation>Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L. A third-generation lentivirus vector with a conditional packaging system. J Virol. 1998;72:8463&#x2013;8471.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC110254</ArticleId><ArticleId IdType="pubmed">9765382</ArticleId></ArticleIdList></Reference><Reference><Citation>Follenzi A, Ailles LE, Bakovic S, Geuna M, Naldini L. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat Genet. 2000;25:217&#x2013;222.</Citation><ArticleIdList><ArticleId IdType="pubmed">10835641</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukami S, Watanabe K, Iwata N, Haraoka J, Lu B, Gerard NP, Gerard C, Fraser P, Westaway D, George-Hyslop PS, Saido TC. Abeta-degrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with Abeta pathology. Neurosci Res. 2002;43:39&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">12074840</ArticleId></ArticleIdList></Reference><Reference><Citation>Glabe C. Does Alzheimer disease tilt the scales of amyloid degradation versus accumulation? Nat Med. 2000;6:133&#x2013;134.</Citation><ArticleIdList><ArticleId IdType="pubmed">10655093</ArticleId></ArticleIdList></Reference><Reference><Citation>Hama E, Shirotani K, Masumoto H, Sekine-Aizawa Y, Aizawa H, Saido TC. Clearance of extracellular and cell-associated amyloid beta peptide through viral expression of neprilysin in primary neurons. J Biochem (Tokyo) 2001;130:721&#x2013;726.</Citation><ArticleIdList><ArticleId IdType="pubmed">11726269</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwata N, Tsubuki S, Takaki Y, Watanabe K, Sekiguchi M, Hosoki E, Kawashima-Morishima M, Lee HJ, Hama E, Sekine-Aizawa Y, Saido TC. Identification of the major Abeta1&#x2013;42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat Med. 2000;6:143&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pubmed">10655101</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwata N, Tsubuki S, Takaki Y, Shirotani K, Lu B, Gerard NP, Gerard C, Hama E, Lee HJ, Saido TC. Metabolic regulation of brain Abeta by neprilysin. Science. 2001;292:1550&#x2013;1552.</Citation><ArticleIdList><ArticleId IdType="pubmed">11375493</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C, Hersh LB. Neprilysin: assay methods, purification, and characterization. Methods Enzymol. 1995;248:253&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pubmed">7674925</ArticleId></ArticleIdList></Reference><Reference><Citation>Masliah E, Sisk A, Mallory M, Mucke L, Schenk D, Games D. Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F &#x3b2;-amyloid precursor protein and Alzheimer's disease. J Neurosci. 1996;16:5795&#x2013;5811.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6578961</ArticleId><ArticleId IdType="pubmed">8795633</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyoshi H, Blomer U, Takahashi M, Gage FH, Verma IM. Development of a self-inactivating lentivirus vector. J Virol. 1998;72:8150&#x2013;8157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC110156</ArticleId><ArticleId IdType="pubmed">9733856</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohajeri MH, Wollmer MA, Nitsch RM. A&#x3b2;42-induced increase in neprilysin is associated with prevention of amyloid plaque formation in vivo. J Biol Chem. 2002;277:35460&#x2013;35465.</Citation><ArticleIdList><ArticleId IdType="pubmed">12105192</ArticleId></ArticleIdList></Reference><Reference><Citation>Mucke L, Masliah E, Yu GQ, Mallory M, Rockenstein EM, Tatsuno G, Hu K, Kholodenko D, Johnson-Wood K, McConlogue L. High-level neuronal expression of A&#x3b2;1&#x2013;42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci. 2000;20:4050&#x2013;4058.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772621</ArticleId><ArticleId IdType="pubmed">10818140</ArticleId></ArticleIdList></Reference><Reference><Citation>Naldini L, Blomer U, Gage F, Trono D, Verma I. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA. 1996;93:11382&#x2013;11388.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC38066</ArticleId><ArticleId IdType="pubmed">8876144</ArticleId></ArticleIdList></Reference><Reference><Citation>Oda M, Morino H, Maruyama H, Terasawa H, Izumi Y, Torii T, Sasaki K, Nakamura S, Kawakami H. Dinucleotide repeat polymorphisms in the neprilysin gene are not associated with sporadic Alzheimer's disease. Neurosci Lett. 2002;320:105&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">11849775</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray J, Raymon HK, Gage FH. Generation and culturing of precursor cells and neuroblasts from embryonic and adult central nervous system. Methods Enzymol. 1995;254:20&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">8531687</ArticleId></ArticleIdList></Reference><Reference><Citation>Reilly CE. Neprilysin content is reduced in Alzheimer brain areas. J Neurol. 2001;248:159&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pubmed">11284139</ArticleId></ArticleIdList></Reference><Reference><Citation>Rockenstein E, Mallory M, Mante M, Sisk A, Masliaha E. Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1&#x2013;42). J Neurosci Res. 2001;66:573&#x2013;582.</Citation><ArticleIdList><ArticleId IdType="pubmed">11746377</ArticleId></ArticleIdList></Reference><Reference><Citation>Sodeyama N, Mizusawa H, Yamada M, Itoh Y, Otomo E, Matsushita M. Lack of association of neprilysin polymorphism with Alzheimer's disease and Alzheimer's disease-type neuropathological changes. J Neurol Neurosurg Psychiatry. 2001;71:817&#x2013;818.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1737626</ArticleId><ArticleId IdType="pubmed">11762318</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner AJ, Isaac RE, Coates D. The neprilysin (NEP) family of zinc metalloendopeptidases: genomics and function. BioEssays. 2001;23:261&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pubmed">11223883</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 2002;416:535&#x2013;539.</Citation><ArticleIdList><ArticleId IdType="pubmed">11932745</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasojima K, McGeer EG, McGeer PL. Relationship between beta amyloid peptide generating molecules and neprilysin in Alzheimer disease and normal brain. Brain Res. 2001a;919:115&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="pubmed">11689168</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasojima K, Akiyama H, McGeer EG, McGeer PL. Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of beta-amyloid peptide. Neurosci Lett. 2001b;297:97&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">11121879</ArticleId></ArticleIdList></Reference><Reference><Citation>Zerovnik E. Amyloid-fibril formation. Eur J Biochem. 2002;269:3362&#x2013;3371.</Citation><ArticleIdList><ArticleId IdType="pubmed">12135474</ArticleId></ArticleIdList></Reference><Reference><Citation>Zufferey R, Donello JE, Trono D, Hope TJ. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol. 1999;73:2886&#x2013;2892.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC104046</ArticleId><ArticleId IdType="pubmed">10074136</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12658818</PMID><DateCompleted><Year>2003</Year><Month>11</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1672-0733</ISSN><JournalIssue CitedMedium="Print"><Volume>22</Volume><Issue>3</Issue><PubDate><Year>2002</Year></PubDate></JournalIssue><Title>Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban</Title><ISOAbbreviation>J Huazhong Univ Sci Technolog Med Sci</ISOAbbreviation></Journal><ArticleTitle>The effect of beta-amyloid on neurons and the influence of glucocorticoid and age on such effect.</ArticleTitle><Pagination><StartPage>250</StartPage><EndPage>252</EndPage><MedlinePgn>250-2</MedlinePgn></Pagination><Abstract><AbstractText>To explore the relationship between beta-amyloid (A beta) and the pathogenesis of Alzheimer disease (AD), after injection of beta-amyloid into the rat brain, the apoptosis of nerve cells and acetylcholine (Ach) content in rat hippocampus were examined by employing TUNEL technique and base hydroxylamine colorimetry respectively. The influence of age and glucocorticoid on the neurotoxic effect of A beta was also analyzed. A beta peptide could strongly induce the apoptosis of neurons in hippocampus, cortex and striate body (P &lt; 0.05 or P &lt; 0.01). In addition, the senility and glucocorticoid pre-treatment could enhance the toxic effect of A beta (P &lt; 0.05 or P &lt; 0.01). It is concluded that A beta may play an important role in the pathogenesis of Alzheimer disease via its induction of apoptosis of neurons and by decreasing the content of the Ach.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Honghui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Geriatrics, Wuhan Psychiatric Hospital, University of Science and Technology, Wuhan 430030.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Shenggang</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Mei</LastName><ForeName>Yuanwu</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Changqin</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Anqiu</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Tong</LastName><ForeName>Etang</ForeName><Initials>E</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>J Huazhong Univ Sci Technolog Med Sci</MedlineTA><NlmUniqueID>101169627</NlmUniqueID><ISSNLinking>1672-0733</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>7S5I7G3JQL</RegistryNumber><NameOfSubstance UI="D003907">Dexamethasone</NameOfSubstance></Chemical><Chemical><RegistryNumber>N9YNS0M02X</RegistryNumber><NameOfSubstance UI="D000109">Acetylcholine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000109" MajorTopicYN="N">Acetylcholine</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003907" MajorTopicYN="N">Dexamethasone</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004357" MajorTopicYN="N">Drug Synergism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007276" MajorTopicYN="N">Injections, Intraventricular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>3</Month><Day>28</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>12</Month><Day>3</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>3</Month><Day>28</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12658818</ArticleId><ArticleId IdType="doi">10.1007/BF02828194</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Neurosci. 2001 Aug 1;21(15):5703-14</Citation><ArticleIdList><ArticleId IdType="pubmed">11466442</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroscience. 1998 Nov;87(2):349-57</Citation><ArticleIdList><ArticleId IdType="pubmed">9740397</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Gerontol. 1998 Nov-Dec;33(7-8):689-96</Citation><ArticleIdList><ArticleId IdType="pubmed">9951616</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12660385</PMID><DateCompleted><Year>2003</Year><Month>04</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1533-4406</ISSN><JournalIssue CitedMedium="Internet"><Volume>348</Volume><Issue>13</Issue><PubDate><Year>2003</Year><Month>Mar</Month><Day>27</Day></PubDate></JournalIssue><Title>The New England journal of medicine</Title><ISOAbbreviation>N Engl J Med</ISOAbbreviation></Journal><ArticleTitle>Silent brain infarcts and the risk of dementia and cognitive decline.</ArticleTitle><Pagination><StartPage>1215</StartPage><EndPage>1222</EndPage><MedlinePgn>1215-22</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Silent brain infarcts are frequently seen on magnetic resonance imaging (MRI) in healthy elderly people and may be associated with dementia and cognitive decline.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We studied the association between silent brain infarcts and the risk of dementia and cognitive decline in 1015 participants of the prospective, population-based Rotterdam Scan Study, who were 60 to 90 years of age and free of dementia and stroke at base line. Participants underwent neuropsychological testing and cerebral MRI at base line in 1995 to 1996 and again in 1999 to 2000 and were monitored for dementia throughout the study period. We performed Cox proportional-hazards and multiple linear-regression analyses, adjusted for age, sex, and level of education and for the presence or absence of subcortical atrophy and white-matter lesions.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">During 3697 person-years of follow-up (mean per person, 3.6 years), dementia developed in 30 of the 1015 participants. The presence of silent brain infarcts at base line more than doubled the risk of dementia (hazard ratio, 2.26; 95 percent confidence interval, 1.09 to 4.70). The presence of silent brain infarcts on the base-line MRI was associated with worse performance on neuropsychological tests and a steeper decline in global cognitive function. Silent thalamic infarcts were associated with a decline in memory performance, and nonthalamic infarcts with a decline in psychomotor speed. When participants with silent brain infarcts at base line were subdivided into those with and those without additional infarcts at follow-up, the decline in cognitive function was restricted to those with additional silent infarcts.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Elderly people with silent brain infarcts have an increased risk of dementia and a steeper decline in cognitive function than those without such lesions.</AbstractText><CopyrightInformation>Copyright 2003 Massachusetts Medical Society</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vermeer</LastName><ForeName>Sarah E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, Erasmus Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prins</LastName><ForeName>Niels D</ForeName><Initials>ND</Initials></Author><Author ValidYN="Y"><LastName>den Heijer</LastName><ForeName>Tom</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Hofman</LastName><ForeName>Albert</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Koudstaal</LastName><ForeName>Peter J</ForeName><Initials>PJ</Initials></Author><Author ValidYN="Y"><LastName>Breteler</LastName><ForeName>Monique M B</ForeName><Initials>MM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>N Engl J Med</MedlineTA><NlmUniqueID>0255562</NlmUniqueID><ISSNLinking>0028-4793</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>N Engl J Med. 2003 Mar 27;348(13):1277-8. doi: 10.1056/NEJMe030017.</RefSource><PMID Version="1">12660392</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>N Engl J Med. 2003 Jul 3;349(1):96; author reply 96. doi: 10.1056/NEJMc031035.</RefSource><PMID Version="1">12840103</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020520" MajorTopicYN="N">Brain Infarction</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="N">Cognition Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="N">Dementia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016014" MajorTopicYN="N">Linear Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011569" MajorTopicYN="N">Psychiatric Status Rating Scales</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>3</Month><Day>28</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>4</Month><Day>5</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>3</Month><Day>28</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12660385</ArticleId><ArticleId IdType="doi">10.1056/NEJMoa022066</ArticleId><ArticleId IdType="pii">348/13/1215</ArticleId></ArticleIdList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12660785</PMID><DateCompleted><Year>2003</Year><Month>04</Month><Day>30</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0028-0836</ISSN><JournalIssue CitedMedium="Print"><Volume>422</Volume><Issue>6930</Issue><PubDate><Year>2003</Year><Month>Mar</Month><Day>27</Day></PubDate></JournalIssue><Title>Nature</Title><ISOAbbreviation>Nature</ISOAbbreviation></Journal><ArticleTitle>The role of presenilin cofactors in the gamma-secretase complex.</ArticleTitle><Pagination><StartPage>438</StartPage><EndPage>441</EndPage><MedlinePgn>438-41</MedlinePgn></Pagination><Abstract><AbstractText>Mutations in presenilin genes account for the majority of the cases of the familial form of Alzheimer's disease (FAD). Presenilin is essential for gamma-secretase activity, a proteolytic activity involved in intramembrane cleavage of Notch and beta-amyloid precursor protein (betaAPP). Cleavage of betaAPP by FAD mutant presenilin results in the overproduction of highly amyloidogenic amyloid beta42 peptides. gamma-Secretase activity requires the formation of a stable, high-molecular-mass protein complex that, in addition to the endoproteolysed fragmented form of presenilin, contains essential cofactors including nicastrin, APH-1 (refs 15-18) and PEN-2 (refs 16, 19). However, the role of each protein in complex formation and the generation of enzymatic activity is unclear. Here we show that Drosophila APH-1 (Aph-1) increases the stability of Drosophila presenilin (Psn) holoprotein in the complex. Depletion of PEN-2 by RNA interference prevents endoproteolysis of presenilin and promotes stabilization of the holoprotein in both Drosophila and mammalian cells, including primary neurons. Co-expression of Drosophila Pen-2 with Aph-1 and nicastrin increases the formation of Psn fragments as well as gamma-secretase activity. Thus, APH-1 stabilizes the presenilin holoprotein in the complex, whereas PEN-2 is required for endoproteolytic processing of presenilin and conferring gamma-secretase activity to the complex.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Takasugi</LastName><ForeName>Nobumasa</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neuropathology and Neuroscience, Graduate School of Pharmaceutical Sciences, University of Tokyo, 7-3-1 Hongo, Bunkyoku, Tokyo 113-0033, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomita</LastName><ForeName>Taisuke</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Hayashi</LastName><ForeName>Ikuo</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Tsuruoka</LastName><ForeName>Makiko</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Niimura</LastName><ForeName>Manabu</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Takahashi</LastName><ForeName>Yasuko</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Thinakaran</LastName><ForeName>Gopal</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Iwatsubo</LastName><ForeName>Takeshi</ForeName><Initials>T</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>03</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nature</MedlineTA><NlmUniqueID>0410462</NlmUniqueID><ISSNLinking>0028-0836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D029721">Drosophila Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D046911">Macromolecular Substances</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508853">PSEN1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C469349">PSENEN protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C473290">Pen-2 protein, Drosophila</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053764">Presenilin-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C413604">nicastrin protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="C475154">APH1A protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D053829">Amyloid Precursor Protein Secretases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010450">Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010447">Peptide Hydrolases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.-</RegistryNumber><NameOfSubstance UI="D016282">Aspartic Acid Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.46</RegistryNumber><NameOfSubstance UI="C509280">BACE1 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nature. 2003 Mar 27;422(6930):385, 387. doi: 10.1038/422385a.</RefSource><PMID Version="1">12660764</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053829" MajorTopicYN="N">Amyloid Precursor Protein Secretases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016282" MajorTopicYN="N">Aspartic Acid Endopeptidases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029721" MajorTopicYN="N">Drosophila Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004331" MajorTopicYN="N">Drosophila melanogaster</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010450" MajorTopicYN="N">Endopeptidases</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D046911" MajorTopicYN="N">Macromolecular Substances</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010447" MajorTopicYN="N">Peptide Hydrolases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053764" MajorTopicYN="N">Presenilin-1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011499" MajorTopicYN="N">Protein Processing, Post-Translational</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034622" MajorTopicYN="N">RNA Interference</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2002</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2003</Year><Month>2</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>3</Month><Day>28</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>5</Month><Day>6</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>3</Month><Day>28</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12660785</ArticleId><ArticleId IdType="doi">10.1038/nature01506</ArticleId><ArticleId IdType="pii">nature01506</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12665571</PMID><DateCompleted><Year>2003</Year><Month>05</Month><Day>02</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0270-7306</ISSN><JournalIssue CitedMedium="Print"><Volume>23</Volume><Issue>8</Issue><PubDate><Year>2003</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Molecular and cellular biology</Title><ISOAbbreviation>Mol Cell Biol</ISOAbbreviation></Journal><ArticleTitle>From calcium to NF-kappa B signaling pathways in neurons.</ArticleTitle><Pagination><StartPage>2680</StartPage><EndPage>2698</EndPage><MedlinePgn>2680-98</MedlinePgn></Pagination><Abstract><AbstractText>NF-kappa B plays crucial roles in the nervous system, including potential roles in long-term responses to synaptic plasticity, pro- or antiapoptotic effects during developmental cell death, and neurodegenerative disorders. We report here the characterization of signaling pathways leading to the constitutive activation of NF-kappa B in primary cultures of neonatal cerebellar granule neurons, consecutive to calcium entry into the cytosol. We found that opening of calcium channels at the plasma membrane and at intracellular stores is indispensable for the basal NF-kappa B activity. We demonstrated further that three cellular sensors of the cytosolic Ca(2+) levels, calmodulin, protein kinases C (PKCs), and the p21(ras)/phosphatidylinositol 3-kinase (PI3K)/Akt pathway are simultaneously involved in the steps linking the Ca(2+) second messenger to NF-kappa B activity. Calmodulin triggers the activity of calcineurin, a phosphatase which plays a role in the basal NF-kappa B activity, while stimulation of both the calmodulin kinase II and Akt kinase pathways results in the up-regulation of the transcriptional potential of the p65 subunit of NF-kappa B. Finally, using pharmacological and molecular approaches, we analyze interactions between these three pathways at different levels and demonstrate a connection between PKCs and PI3K. All three components converge towards NF-kappa B, at the level of both nuclear translocation and transcriptional activity. These results stand in contrast to the situation in nonneuronal cells, which either do not respond to Ca(2+) or do not simultaneously activate all three cascades. By using a global approach in studying signaling pathways in neurons, these results provide further evidence to validate the concept of networks of transducing cascades, specific to cells and to physiological situations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lilienbaum</LastName><ForeName>Alain</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Unit&#xe9; de Biologie Mol&#xe9;culaire de l'Expression G&#xe9;nique, URA 2582 CNRS, Institut Pasteur, 75724 Paris Cedex 15, France. lilienba@ext.jussieu.fr</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Isra&#xeb;l</LastName><ForeName>Alain</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Cell Biol</MedlineTA><NlmUniqueID>8109087</NlmUniqueID><ISSNLinking>0270-7306</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002147">Calmodulin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011518">Proto-Oncogene Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D017346">Protein Serine-Threonine Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.11</RegistryNumber><NameOfSubstance UI="D017868">Cyclic AMP-Dependent Protein Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.5.2</RegistryNumber><NameOfSubstance UI="D016283">Proto-Oncogene Proteins p21(ras)</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D021581" MajorTopicYN="N">Active Transport, Cell Nucleus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020013" MajorTopicYN="Y">Calcium Signaling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002147" MajorTopicYN="N">Calmodulin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002531" MajorTopicYN="N">Cerebellum</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017868" MajorTopicYN="N">Cyclic AMP-Dependent Protein Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019869" MajorTopicYN="N">Phosphatidylinositol 3-Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017346" MajorTopicYN="Y">Protein Serine-Threonine Kinases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011518" MajorTopicYN="N">Proto-Oncogene Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051057" MajorTopicYN="N">Proto-Oncogene Proteins c-akt</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016283" MajorTopicYN="N">Proto-Oncogene Proteins p21(ras)</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014158" MajorTopicYN="N">Transcription, Genetic</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>4</Month><Day>1</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>5</Month><Day>3</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>4</Month><Day>1</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2003</Year><Month>4</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12665571</ArticleId><ArticleId IdType="pmc">PMC152563</ArticleId><ArticleId IdType="doi">10.1128/MCB.23.8.2680-2698.2003</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arenzana-Seisdedos, F., J. Thompson, M. S. Rodriguez, F. Bachelerie, D. Thomas, and R. T. Hay. 1995. Inducible nuclear expression of newly synthesized I&#x3ba;B&#x3b1; negatively regulates DNA-binding and transcriptional activities of NF-&#x3ba;B. Mol. Cell. Biol. 15:2689-2696.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC230499</ArticleId><ArticleId IdType="pubmed">7739549</ArticleId></ArticleIdList></Reference><Reference><Citation>Barger, S. W., and M. P. Mattson. 1996. Induction of neuroprotective &#x3ba;B-dependent transcription by secreted forms of the Alzheimer's beta-amyloid precursor. Brain Res. Mol. Brain Res. 40:116-126.</Citation><ArticleIdList><ArticleId IdType="pubmed">8840019</ArticleId></ArticleIdList></Reference><Reference><Citation>Barkett, M., and T. D. Gilmore. 1999. Control of apoptosis by Rel/NF-kB transcription factors. Oncogene 18:6910-6924.</Citation><ArticleIdList><ArticleId IdType="pubmed">10602466</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer, B., and G. Baier. 2002. Protein kinase C and AKT/protein kinase B in CD4+ T-lymphocytes: new partners in TCR/CD28 signal integration. Mol. Immunol. 38:1087-1099.</Citation><ArticleIdList><ArticleId IdType="pubmed">12044776</ArticleId></ArticleIdList></Reference><Reference><Citation>Beraud, C., W. J. Henzel, and P. A. Baeuerle. 1999. Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-&#x3ba;B activation. Proc. Natl. Acad. Sci. USA 96:429-434.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC15153</ArticleId><ArticleId IdType="pubmed">9892650</ArticleId></ArticleIdList></Reference><Reference><Citation>Bird, T. A., K. Schooley, S. K. Dower, H. Hagen, and G. D. Virca. 1997. Activation of nuclear transcription factor NF-&#x3ba;B by interleukin-1 is accompanied by casein kinase II-mediated phosphorylation of the p65 subunit. J. Biol. Chem. 272:32606-32612.</Citation><ArticleIdList><ArticleId IdType="pubmed">9405476</ArticleId></ArticleIdList></Reference><Reference><Citation>Biswas, D. K., A. P. Cruz, E. Gansberger, and A. B. Pardee. 2000. Epidermal growth factor-induced nuclear factor &#x3ba;B activation: a major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells. Proc. Natl. Acad. Sci. USA 97:8542-8547.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC26984</ArticleId><ArticleId IdType="pubmed">10900013</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonizzi, G., J. Piette, S. Schoonbroodt, M. P. Merville, and V. Bours. 1999. Role of the protein kinase C lambda/iota isoform in nuclear factor-&#x3ba;B activation by interleukin-1&#x3b1; or tumor necrosis factor-alpha: cell type specificities. Biochem. Pharmacol. 57:713-720.</Citation><ArticleIdList><ArticleId IdType="pubmed">10037458</ArticleId></ArticleIdList></Reference><Reference><Citation>Bren, G. D., K. N. Pennington, and C. V. Paya. 2000. PKC-zeta-associated CK2 participates in the turnover of free I&#x3ba;B&#x3b1;. J. Mol. Biol. 297:1245-1258.</Citation><ArticleIdList><ArticleId IdType="pubmed">10764587</ArticleId></ArticleIdList></Reference><Reference><Citation>Cambray-Deakin, M. A. 1996. Cerebellar granule cells, p. 3-13. In J. Cohen and G. P. Wilkin (ed.), Neural cell culture. IRL Press, Oxford, United Kingdom.</Citation></Reference><Reference><Citation>Carmichael, J., W. G. DeGraff, A. F. Gazdar, J. D. Minna, and J. B. Mitchell. 1987. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. Cancer Res. 47:943-946.</Citation><ArticleIdList><ArticleId IdType="pubmed">3802101</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpenter, C. L., and L. C. Cantley. 1996. Phosphoinositide kinases. Curr. Opin. Cell Biol. 8:153-158.</Citation><ArticleIdList><ArticleId IdType="pubmed">8791418</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll, J. E., E. F. Howard, D. C. Hess, C. G. Wakade, Q. Chen, and C. Cheng. 1998. Nuclear factor-&#x3ba;B activation during cerebral reperfusion: effect of attenuation with N-acetylcysteine treatment. Brain Res. Mol. Brain Res. 56:186-191.</Citation><ArticleIdList><ArticleId IdType="pubmed">9602121</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng, B., S. Christakos, and M. P. Mattson. 1994. Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron 12:139-153.</Citation><ArticleIdList><ArticleId IdType="pubmed">7507336</ArticleId></ArticleIdList></Reference><Reference><Citation>Clemens, J. A., D. T. Stephenson, E. P. Dixon, E. B. Smalstig, R. E. Mincy, K. S. Rash, and S. P. Little. 1997. Global cerebral ischemia activates nuclear factor-&#x3ba;B prior to evidence of DNA fragmentation. Brain Res. Mol. Brain Res. 48:187-196.</Citation><ArticleIdList><ArticleId IdType="pubmed">9332715</ArticleId></ArticleIdList></Reference><Reference><Citation>Courtney, M. J., K. E. Akerman, and E. T. Coffey. 1997. Neurotrophins protect cultured cerebellar granule neurons against the early phase of cell death by a two-component mechanism. J. Neurosci. 17:4201-4211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6573533</ArticleId><ArticleId IdType="pubmed">9151737</ArticleId></ArticleIdList></Reference><Reference><Citation>Crowder, R. J., and R. S. Freeman. 1998. Phosphatidylinositol 3-kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factor-dependent sympathetic neurons. J. Neurosci. 18:2933-2943.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6792598</ArticleId><ArticleId IdType="pubmed">9526010</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta, S. R., A. Brunet, and M. E. Greenberg. 1999. Cellular survival: a play in three Akts. Genes Dev. 13:2905-2927.</Citation><ArticleIdList><ArticleId IdType="pubmed">10579998</ArticleId></ArticleIdList></Reference><Reference><Citation>Delhase, M., N. Li, and M. Karin. 2000. Kinase regulation in inflammatory response. Nature 406:367-368.</Citation><ArticleIdList><ArticleId IdType="pubmed">10935625</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Mello, S. R., K. Borodezt, and S. P. Soltoff. 1997. Insulin-like growth factor and potassium depolarization maintain neuronal survival by distinct pathways: possible involvement of PI 3-kinase in IGF-1 signaling. J. Neurosci. 17:1548-1560.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6573379</ArticleId><ArticleId IdType="pubmed">9030615</ArticleId></ArticleIdList></Reference><Reference><Citation>Downward, J. 1998. Mechanisms and consequences of activation of protein kinase B/Akt. Curr. Opin. Cell Biol. 10:262-267.</Citation><ArticleIdList><ArticleId IdType="pubmed">9561851</ArticleId></ArticleIdList></Reference><Reference><Citation>Faux, M. C., E. N. Rollins, A. S. Edwards, L. K. Langeberg, A. C. Newton, and J. D. Scott. 1999. Mechanism of A-kinase-anchoring protein 79 (AKAP79) and protein kinase C interaction. Biochem. J. 343:443-452.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1220573</ArticleId><ArticleId IdType="pubmed">10510312</ArticleId></ArticleIdList></Reference><Reference><Citation>Finkbeiner, S., and M. E. Greenberg. 1996. Ca2+-dependent routes to Ras: mechanisms for neuronal survival, differentiation, and plasticity? Neuron 16:233-236.</Citation><ArticleIdList><ArticleId IdType="pubmed">8789937</ArticleId></ArticleIdList></Reference><Reference><Citation>Franke, T. F., D. R. Kaplan, and L. C. Cantley. 1997. PI3K: downstream AKTion blocks apoptosis. Cell 88:435-437.</Citation><ArticleIdList><ArticleId IdType="pubmed">9038334</ArticleId></ArticleIdList></Reference><Reference><Citation>Franklin, J. L., and E. M. Johnson, Jr. 1992. Suppression of programmed neuronal death by sustained elevation of cytoplasmic calcium. Trends Neurosci. 15:501-508.</Citation><ArticleIdList><ArticleId IdType="pubmed">1282751</ArticleId></ArticleIdList></Reference><Reference><Citation>Frantz, B., E. C. Nordby, G. Bren, N. Steffan, C. V. Paya, R. L. Kincaid, M. J. Tocci, S. J. O'Keefe, and E. A. O'Neill. 1994. Calcineurin acts in synergy with PMA to inactivate I&#x3ba;B/MAD3, an inhibitor of NF-&#x3ba;B. EMBO J. 13:861-870.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC394885</ArticleId><ArticleId IdType="pubmed">8112299</ArticleId></ArticleIdList></Reference><Reference><Citation>Gewirtz, A. T., A. S. Rao, P. O. Simon, Jr., D. Merlin, D. Carnes, J. L. Madara, and A. S. Neish. 2000. Salmonella typhimurium induces epithelial IL-8 expression via Ca2+-mediated activation of the NF-&#x3ba;B pathway. J. Clin. Investig. 105:79-92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC382586</ArticleId><ArticleId IdType="pubmed">10619864</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh, A., and M. E. Greenberg. 1995. Calcium signaling in neurons: molecular mechanisms and cellular consequences. Science 268:239-247.</Citation><ArticleIdList><ArticleId IdType="pubmed">7716515</ArticleId></ArticleIdList></Reference><Reference><Citation>Grilli, M., J. J. S. Chiu, and M. Lenardo. 1993. NF-&#x3ba;-B and rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143:1-62.</Citation><ArticleIdList><ArticleId IdType="pubmed">8449662</ArticleId></ArticleIdList></Reference><Reference><Citation>Grilli, M., F. Goffi, M. Memo, and P. Spano. 1996. Interleukin-1&#x3b1; and glutamate activate the NF-&#x3ba;B/Rel binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal cultures. J. Biol. Chem. 271:15002-15007.</Citation><ArticleIdList><ArticleId IdType="pubmed">8663145</ArticleId></ArticleIdList></Reference><Reference><Citation>Grilli, M., M. Pizzi, M. Memo, and P. Spano. 1996. Neuroprotection by aspirin and sodium salicylate through blockade of NF-&#x3ba;B activation. Science 274:1383-1385.</Citation><ArticleIdList><ArticleId IdType="pubmed">8910280</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrini, L., F. Blasi, and S. Denis-Donini. 1995. Synaptic activation of NF-&#x3ba;B by glutamate in cerebellar granule neurons in vitro. Proc. Natl. Acad. Sci. USA 92:9077-9081.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC40927</ArticleId><ArticleId IdType="pubmed">7568076</ArticleId></ArticleIdList></Reference><Reference><Citation>Han, B., and C. D. Logsdon. 2000. CCK stimulates mob-1 expression and NF-&#x3ba;B activation via protein kinase C and intracellular Ca2+. Am. J. Physiol. Cell Physiol. 278:C344-C351.</Citation><ArticleIdList><ArticleId IdType="pubmed">10666030</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsuan, S. L., M. S. Kannan, S. Jeyaseelan, Y. S. Prakash, C. Malazdrewich, M. S. Abrahamsen, G. C. Sieck, and S. K. Maheswaran. 1999. Pasteurella haemolytica leukotoxin and endotoxin induced cytokine gene expression in bovine alveolar macrophages requires NF-&#x3ba;B activation and calcium elevation. Microb. Pathog. 26:263-273.</Citation><ArticleIdList><ArticleId IdType="pubmed">10222211</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes, K., S. Edin, A. Antonsson, and T. Grundstrom. 2001. Calmodulin-dependent kinase II mediates T cell receptor/CD3- and phorbol ester-induced activation of I&#x3ba;B kinase. J. Biol. Chem. 276:36008-36013.</Citation><ArticleIdList><ArticleId IdType="pubmed">11470799</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunot, S., B. Brugg, D. Ricard, P. P. Michel, M. P. Muriel, M. Ruberg, B. A. Faucheux, Y. Agid, and E. C. Hirsch. 1997. Nuclear translocation of NF-&#x3ba;B is increased in dopaminergic neurons of patients with Parkinson disease. Proc. Natl. Acad. Sci. USA 94:7531-7536.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC23856</ArticleId><ArticleId IdType="pubmed">9207126</ArticleId></ArticleIdList></Reference><Reference><Citation>Israel, A. 2000. The IKK complex: an integrator of all signals that activate NF-&#x3ba;B? Trends Cell Biol. 10:129-133.</Citation><ArticleIdList><ArticleId IdType="pubmed">10740266</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaken, S. 1996. Protein kinase C isozymes and substrates. Curr. Opin. Cell Biol. 8:168-173.</Citation><ArticleIdList><ArticleId IdType="pubmed">8791416</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang, M. K., Y. H. Goo, Y. C. Sohn, Y. S. Kim, S.-K. Lee, H. Kang, J. Cheong, and J. W. Lee. 2001. Ca2+/Calmodulin-dependant protein kinase IV stimulates nuclear factor-&#x3ba;B transactivation via phosphorylation of the p65 subunit. J. Biol. Chem. 8:20005-20010.</Citation><ArticleIdList><ArticleId IdType="pubmed">11274168</ArticleId></ArticleIdList></Reference><Reference><Citation>Jefferson, K. K., M. F. Smith, Jr., and D. A. Bobak. 1999. Roles of intracellular calcium and NF-&#x3ba;B in the Clostridium difficile toxin A-induced up-regulation and secretion of IL-8 from human monocytes. J. Immunol. 163:5183-5191.</Citation><ArticleIdList><ArticleId IdType="pubmed">10553038</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaltschmidt, B., M. Uherek, B. Volk, P. A. Baeuerle, and C. Kaltschmidt. 1997. Transcription factor NF-&#x3ba;B is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc. Natl. Acad. Sci. USA 94:2642-2647.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC20142</ArticleId><ArticleId IdType="pubmed">9122249</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaltschmidt, C., B. Kaltschmidt, and P. A. Baeuerle. 1993. Brain synapses contain inducible forms of the transcription factor NF-&#x3ba;B. Mech. Dev. 43:135-147.</Citation><ArticleIdList><ArticleId IdType="pubmed">8297787</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaltschmidt, C., B. Kaltschmidt, and P. A. Baeuerle. 1995. Stimulation of ionotropic glutamate receptors activates transcription factor NF-&#x3ba;B in primary neurons. Proc. Natl. Acad. Sci. USA 92:9618-9622.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC40853</ArticleId><ArticleId IdType="pubmed">7568184</ArticleId></ArticleIdList></Reference><Reference><Citation>Kane, L. P., V. S. Shapiro, D. Stokoe, and A. Weiss. 1999. Induction of NF-&#x3ba;B by the Akt/PKB kinase. Curr. Biol. 9:601-604.</Citation><ArticleIdList><ArticleId IdType="pubmed">10359702</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopp, E. B., and S. Ghosh. 1995. NF-&#x3ba;B and rel proteins in innate immunity. Adv. Immunol. 58:1-27.</Citation><ArticleIdList><ArticleId IdType="pubmed">7741027</ArticleId></ArticleIdList></Reference><Reference><Citation>Koulich, E., T. Nguyen, K. Johnson, C. A. Giardina, and S. R. D'Mello. 2001. NF-&#x3ba;B is involved in the survival of cerebellar granule neurons: association of I&#x3ba;B phosphorylation with cell survival. J. Neurochem. 76:1188-1198.</Citation><ArticleIdList><ArticleId IdType="pubmed">11181838</ArticleId></ArticleIdList></Reference><Reference><Citation>Lallena, M. J., M. T. Diaz-Meco, G. Bren, C. V. Paya, and J. Moscat. 1999. Activation of I&#x3ba;B kinase beta by protein kinase C isoforms. Mol. Cell. Biol. 19:2180-2188.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC84010</ArticleId><ArticleId IdType="pubmed">10022904</ArticleId></ArticleIdList></Reference><Reference><Citation>Leevers, S. J., B. Vanhaesebroeck, and M. D. Waterfield. 1999. Signalling through phosphoinositide 3-kinases: the lipids take centre stage. Curr. Opin. Cell Biol. 11:219-225.</Citation><ArticleIdList><ArticleId IdType="pubmed">10209156</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin, C. H., S. Y. Sheu, H. M. Lee, Y. S. Ho, W. S. Lee, W. C. Ko, and J. R. Sheu. 2000. Involvement of protein kinase C-gamma in IL-1&#x3b2;-induced cyclooxygenase-2 expression in human pulmonary epithelial cells. Mol. Pharmacol. 57:36-43.</Citation><ArticleIdList><ArticleId IdType="pubmed">10617676</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin, X., A. O'Mahony, Y. Mu, R. Geleziunas, and W. C. Greene. 2000. Protein kinase C-theta participates in NF-&#x3ba;B activation induced by CD3-CD28 costimulation through selective activation of I&#x3ba;B kinase beta. Mol. Cell. Biol. 20:2933-2940.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC85537</ArticleId><ArticleId IdType="pubmed">10733597</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipton, S. A. 1997. Janus faces of NF-&#x3ba;B: neurodestruction versus neuroprotection. Nat. Med. 3:20-22.</Citation><ArticleIdList><ArticleId IdType="pubmed">8986730</ArticleId></ArticleIdList></Reference><Reference><Citation>Madrid, L. V., C. Y. Wang, D. C. Guttridge, A. J. Schottelius, A. S. Baldwin, Jr., and M. W. Mayo. 2000. Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-&#x3ba;B. Mol. Cell. Biol. 20:1626-1638.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC85346</ArticleId><ArticleId IdType="pubmed">10669740</ArticleId></ArticleIdList></Reference><Reference><Citation>Martiny-Baron, G., M. G. Kazanietz, H. Mischak, P. M. Blumberg, G. Kochs, H. Hug, D. Marme, and C. Schachtele. 1993. Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J. Biol. Chem. 268:9194-9197.</Citation><ArticleIdList><ArticleId IdType="pubmed">8486620</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto, A., Y. Deyama, A. Deyama, M. Okitsu, Y. Yoshimura, and K. Suzuki. 1998. Epidermal growth factor receptor-mediated expression of NF-&#x3ba;B transcription factor in osteoblastic MC3T3-E1 cells cultured under a low-calcium environment. Life Sci. 62:1623-1627.</Citation><ArticleIdList><ArticleId IdType="pubmed">9585147</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuoka, Y., Y. Kitamura, M. Okazaki, K. Terai, and T. Taniguchi. 1999. Kainic acid-induced activation of nuclear factor-&#x3ba;B in rat hippocampus. Exp. Brain Res. 124:215-222.</Citation><ArticleIdList><ArticleId IdType="pubmed">9928844</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattson, M. P., C. Culmsee, Z. Yu, and S. Camandola. 2000. Roles of nuclear factor &#x3ba;B in neuronal survival and plasticity. J. Neurochem. 74:443-456.</Citation><ArticleIdList><ArticleId IdType="pubmed">10646495</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattson, M. P., Y. Goodman, H. Luo, W. Fu, and K. Furukawa. 1997. Activation of NF-&#x3ba;B protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. J. Neurosci. Res. 49:681-697.</Citation><ArticleIdList><ArticleId IdType="pubmed">9335256</ArticleId></ArticleIdList></Reference><Reference><Citation>Meberg, P. J., W. R. Kinney, E. G. Valcourt, and A. Routtenberg. 1996. Gene expression of the transcription factor NF-&#x3ba;B in hippocampus: regulation by synaptic activity. Brain Res. Mol. Brain Res. 38:179-190.</Citation><ArticleIdList><ArticleId IdType="pubmed">8793106</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercurio, F., and A. M. Manning. 1999. Multiple signals converging on NF-&#x3ba;B. Curr. Opin. Cell Biol. 11:226-232.</Citation><ArticleIdList><ArticleId IdType="pubmed">10209157</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller, T. M., M. G. Tansey, E. M. Johnson, Jr., and D. J. Creedon. 1997. Inhibition of phosphatidylinositol 3-kinase activity blocks depolarization- and insulin-like growth factor I-mediated survival of cerebellar granule cells. J. Biol. Chem. 272:9847-9853.</Citation><ArticleIdList><ArticleId IdType="pubmed">9092520</ArticleId></ArticleIdList></Reference><Reference><Citation>New, L., Y. Jiang, M. Zhao, K. Liu, W. Zhu, L. J. Flood, Y. Kato, G. C. N. Parry, and J. Han. 1998. PRAK, a novel protein kinase regulated by the p38 MAP kinase. EMBO J. 17:3372-3384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1170675</ArticleId><ArticleId IdType="pubmed">9628874</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Neill, L. A., and C. Kaltschmidt. 1997. NF-&#x3ba;B: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 20:252-258.</Citation><ArticleIdList><ArticleId IdType="pubmed">9185306</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozes, O. N., L. D. Mayo, J. A. Gustin, S. R. Pfeffer, L. M. Pfeffer, and D. B. Donner. 1999. NF-&#x3ba;B activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401:82-85.</Citation><ArticleIdList><ArticleId IdType="pubmed">10485710</ArticleId></ArticleIdList></Reference><Reference><Citation>Pahl, H. L., and P. A. Baeuerle. 1996. Activation of NF-&#x3ba;B by ER stress requires both Ca2+ and reactive oxygen intermediates as messengers. FEBS Lett. 392:129-136.</Citation><ArticleIdList><ArticleId IdType="pubmed">8772190</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel, R., M. Holt, R. Philipova, S. Moss, H. Schulman, H. Hidaka, and M. Whitaker. 1999. Calcium/calmodulin-dependent phosphorylation and activation of human Cdc25-C at the G2/M phase transition in HeLa cells. J. Biol. Chem. 274:7958-7968.</Citation><ArticleIdList><ArticleId IdType="pubmed">10075693</ArticleId></ArticleIdList></Reference><Reference><Citation>Philpott, K. L., M. J. McCarthy, A. Klippel, and L. L. Rubin. 1997. Activated phosphatidylinositol 3-kinase and Akt kinase promote survival of superior cervical neurons. J. Cell Biol. 139:809-815.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2141707</ArticleId><ArticleId IdType="pubmed">9348296</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccioli, P., C. Porcile, S. Stanzione, M. Bisaglia, A. Bajetto, R. Bonavia, T. Florio, and G. Schettini. 2001. Inhibition of nuclear factor-&#x3ba;B activation induces apoptosis in cerebellar granule cells. J. Neurosci. Res. 66:1064-1073.</Citation><ArticleIdList><ArticleId IdType="pubmed">11746438</ArticleId></ArticleIdList></Reference><Reference><Citation>Pieper, G. M., and Riaz-ul-Haq. 1997. Activation of nuclear factor-&#x3ba;B in cultured endothelial cells by increased glucose concentration: prevention by calphostin C. J. Cardiovasc. Pharmacol. 30:528-532.</Citation><ArticleIdList><ArticleId IdType="pubmed">9335415</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad, A. V., W. H. Pilcher, and S. A. Joseph. 1994. Nuclear factor-&#x3ba;B in rat brain: enhanced DNA-binding activity following convulsant-induced seizures. Neurosci. Lett. 170:145-148.</Citation><ArticleIdList><ArticleId IdType="pubmed">8041493</ArticleId></ArticleIdList></Reference><Reference><Citation>Pugazhenthi, S., A. Nesterova, C. Sable, K. A. Heidenreich, L. M. Boxer, L. E. Heasley, and J. E.-B. Reusch. 2000. Akt/protein kinase B up-regulates bcl2 expression through cAMP-response element-binding protein. J. Biol. Chem. 275:10761-10766.</Citation><ArticleIdList><ArticleId IdType="pubmed">10753867</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinlan, K. L., S. M. Naik, G. Cannon, C. A. Armstrong, N. W. Bunnett, J. C. Ansel, and S. W. Caughman. 1999. Substance P activates coincident NF-AT- and NF-&#x3ba;B-dependent adhesion molecule gene expression in microvascular endothelial cells through intracellular calcium mobilization. J. Immunol. 163:5656-5665.</Citation><ArticleIdList><ArticleId IdType="pubmed">10553096</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao, A., C. Luo, and P. G. Hogan. 1997. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15:707-747.</Citation><ArticleIdList><ArticleId IdType="pubmed">9143705</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy, S. A., J. H. Huang, and W. S. Liao. 1997. Phosphatidylinositol 3-kinase in interleukin 1 signaling. Physical interaction with the interleukin 1 receptor and requirement in NF&#x3ba;B and AP-1 activation. J. Biol. Chem. 272:29167-29173.</Citation><ArticleIdList><ArticleId IdType="pubmed">9360994</ArticleId></ArticleIdList></Reference><Reference><Citation>Romashkova, J. A., and S. S. Makarov. 1999. NF-&#x3ba;B is a target of AKT in anti-apoptotic PDGF signalling. Nature 401:86-90.</Citation><ArticleIdList><ArticleId IdType="pubmed">10485711</ArticleId></ArticleIdList></Reference><Reference><Citation>Rong, Y., and M. Baudry. 1996. Seizure activity results in a rapid induction of nuclear factor-&#x3ba;B in adult but not juvenile rat limbic structures. J. Neurochem. 67:662-668.</Citation><ArticleIdList><ArticleId IdType="pubmed">8764593</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakurai, H., H. Chiba, H. Miyoshi, T. Sugita, and W. Toriumi. 1999. IkB kinases phosphorylate NF-kB p65 subunit on serine 536 in the transactivation domain. J. Biol. Chem. 274:30353-30356.</Citation><ArticleIdList><ArticleId IdType="pubmed">10521409</ArticleId></ArticleIdList></Reference><Reference><Citation>Salminen, A., P. K. Liu, and C. Y. Hsu. 1995. Alteration of transcription factor binding activities in the ischemic rat brain. Biochem. Biophys. Res. Commun. 212:939-944.</Citation><ArticleIdList><ArticleId IdType="pubmed">7626134</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt-Ullrich, R., S. M&#xe9;met, A. Lilienbaum, J. Feuillard, M. Raphael, and A. Isra&#xeb;l. 1996. NF-&#x3ba;B activity in transgenic mice: developmental regulation and tissue specificity. Development 122:2117-2128.</Citation><ArticleIdList><ArticleId IdType="pubmed">8681793</ArticleId></ArticleIdList></Reference><Reference><Citation>Shatrov, V. A., V. Lehmann, and S. Chouaib. 1997. Sphingosine-1-phosphate mobilizes intracellular calcium and activates transcription factor NF-&#x3ba;B in U937 cells. Biochem. Biophys. Res. Commun. 234:121-124.</Citation><ArticleIdList><ArticleId IdType="pubmed">9168973</ArticleId></ArticleIdList></Reference><Reference><Citation>Sizemore, N., S. Leung, and G. R. Stark. 1999. Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-&#x3ba;B p65/RelA subunit. Mol. Cell. Biol. 19:4798-4805.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC84278</ArticleId><ArticleId IdType="pubmed">10373529</ArticleId></ArticleIdList></Reference><Reference><Citation>Soler, R. M., J. Egea, G. M. Mintenig, C. Sanz-Rodriguez, M. Iglesias, and J. X. Comella. 1998. Calmodulin is involved in membrane depolarization-mediated survival of motoneurons by phosphatidylinositol-3 kinase- and MAPK-independent pathways. J. Neurosci. 18:1230-1239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6792726</ArticleId><ArticleId IdType="pubmed">9454833</ArticleId></ArticleIdList></Reference><Reference><Citation>Steffan, N. M., G. D. Bren, B. Frantz, M. J. Tocci, E. A. O'Neill, and C. V. Paya. 1995. Regulation of IkB alpha phosphorylation by PKC- and Ca2+-dependent signal transduction pathways. J. Immunol. 155:4685-4691.</Citation><ArticleIdList><ArticleId IdType="pubmed">7594468</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun, L., and G. Carpenter. 1998. Epidermal growth factor activation of NF-&#x3ba;B is mediated through I&#x3ba;B&#x3b1; degradation and intracellular free calcium. Oncogene 16:2095-2102.</Citation><ArticleIdList><ArticleId IdType="pubmed">9572490</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun, P., H. Enslen, P. S. Myung, and R. A. Maurer. 1994. Differential activation of CREB by Ca2+/calmodulin-dependent protein kinases type II and type IV involves phosphorylation of a site that negatively regulates activity. Genes Dev. 8:2527-2539.</Citation><ArticleIdList><ArticleId IdType="pubmed">7958915</ArticleId></ArticleIdList></Reference><Reference><Citation>Tando, Y., H. Algul, M. Wagner, H. Weidenbach, G. Adler, and R. M. Schmid. 1999. Caerulein-induced NF-&#x3ba;B/Rel activation requires both Ca2+ and protein kinase C as messengers. Am. J. Physiol. 277:G678-G686.</Citation><ArticleIdList><ArticleId IdType="pubmed">10484394</ArticleId></ArticleIdList></Reference><Reference><Citation>Trushin, S. A., K. N. Pennington, A. Algeciras-Schimnich, and C. V. Paya. 1999. Protein kinase C and calcineurin synergize to activate I&#x3ba;B kinase and NF-&#x3ba;B in T lymphocytes. J. Biol. Chem. 274:22923-22931.</Citation><ArticleIdList><ArticleId IdType="pubmed">10438457</ArticleId></ArticleIdList></Reference><Reference><Citation>Usachev, Y. M., and S. A. Thayer. 1999. Controlling the urge for a Ca2+ surge: all-or-none Ca2+ release in neurons. Bioessays 21:743-750.</Citation><ArticleIdList><ArticleId IdType="pubmed">10462414</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma, I. M., J. K. Stevenson, E. M. Schwarz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-&#x3ba;B/I&#x3ba;B family: intimate tales of association and dissociation. Genes Dev. 9:2723-2735.</Citation><ArticleIdList><ArticleId IdType="pubmed">7590248</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, D., and A. S. Baldwin, Jr. 1998. Activation of nuclear factor-&#x3ba;B-dependent transcription by tumor necrosis factor-alpha is mediated through phosphorylation of RelA/p65 on serine 529. J. Biol. Chem. 273:29411-29416.</Citation><ArticleIdList><ArticleId IdType="pubmed">9792644</ArticleId></ArticleIdList></Reference><Reference><Citation>Weil, R., C. Laurent-Winter, and A. Israel. 1997. Regulation of I&#x3ba;B&#x3b2; degradation. Similarities to and differences from I&#x3ba;B&#x3b1;. J. Biol. Chem. 272:9942-9949.</Citation><ArticleIdList><ArticleId IdType="pubmed">9092533</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiteside, S. T., J. C. Epinat, N. R. Rice, and A. Israel. 1997. I&#x3ba;B epsilon, a novel member of the I&#x3ba;B family, controls RelA and cRel NF-&#x3ba;B activity. EMBO J. 16:1413-1426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1169738</ArticleId><ArticleId IdType="pubmed">9135156</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiteside, S. T., M. K. Ernst, O. LeBail, C. Laurent-Winter, N. Rice, and A. Israel. 1995. N- and C-terminal sequences control degradation of MAD3/I&#x3ba;B&#x3b1; in response to inducers of NF-&#x3ba;B activity. Mol. Cell. Biol. 15:5339-5345.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC230782</ArticleId><ArticleId IdType="pubmed">7565683</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiteside, S. T., and A. Israel. 1997. I &#x3ba;B proteins: structure, function and regulation. Semin. Cancer Biol. 8:75-82.</Citation><ArticleIdList><ArticleId IdType="pubmed">9299585</ArticleId></ArticleIdList></Reference><Reference><Citation>Wooten, M. W., M. L. Seibenhener, G. Zhou, M. L. Vandenplas, and T. H. Tan. 1999. Overexpression of atypical PKC in PC12 cells enhances NGF-responsiveness and survival through an NF-&#x3ba;B dependent pathway. Cell Death Differ. 6:753-764.</Citation><ArticleIdList><ArticleId IdType="pubmed">10467349</ArticleId></ArticleIdList></Reference><Reference><Citation>Yabe, T., D. Wilson, and J. P. Schwartz. 2001. NF&#x3ba;B activation is required for the neuroprotective effects of pigment epithelium-derived factor (PEDF) on cerebellar granule neurons. J. Biol. Chem. 276:43313-43319.</Citation><ArticleIdList><ArticleId IdType="pubmed">11553640</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, K., X. S. Mu, and R. L. Hayes. 1995. Increased cortical nuclear factor-&#x3ba;B (NF-&#x3ba;B) DNA binding activity after traumatic brain injury in rats. Neurosci. Lett. 197:101-104.</Citation><ArticleIdList><ArticleId IdType="pubmed">8552270</ArticleId></ArticleIdList></Reference><Reference><Citation>Yano, S., H. Tokumitsu, and T. R. Soderling. 1998. Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway. Nature 396:584-587.</Citation><ArticleIdList><ArticleId IdType="pubmed">9859994</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu, Z., D. Zhou, A. J. Bruce-Keller, M. S. Kindy, and M. P. Mattson. 1999. Lack of the p50 subunit of nuclear factor-&#x3ba;B increases the vulnerability of hippocampal neurons to excitotoxic injury. J. Neurosci. 19:8856-8865.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6782758</ArticleId><ArticleId IdType="pubmed">10516305</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, S., T. Tobaru, J. A. Zivin, and D. A. Shackelford. 1998. Activation of nuclear factor-&#x3ba;B in the rabbit spinal cord following ischemia and reperfusion. Brain Res. Mol. Brain Res. 63:121-132.</Citation><ArticleIdList><ArticleId IdType="pubmed">9838076</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12669033</PMID><DateCompleted><Year>2003</Year><Month>06</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1078-8956</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><Issue>5</Issue><PubDate><Year>2003</Year><Month>May</Month></PubDate></JournalIssue><Title>Nature medicine</Title><ISOAbbreviation>Nat Med</ISOAbbreviation></Journal><ArticleTitle>Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease.</ArticleTitle><Pagination><StartPage>589</StartPage><EndPage>595</EndPage><MedlinePgn>589-95</MedlinePgn></Pagination><Abstract><AbstractText>Glial cell line-derived neurotrophic factor (GDNF) is a potent neurotrophic factor with restorative effects in a wide variety of rodent and primate models of Parkinson disease, but penetration into brain tissue from either the blood or the cerebro-spinal fluid is limited. Here we delivered GDNF directly into the putamen of five Parkinson patients in a phase 1 safety trial. One catheter needed to be repositioned and there were changes in the magnetic resonance images that disappeared after lowering the concentration of GDNF. After one year, there were no serious clinical side effects, a 39% improvement in the off-medication motor sub-score of the Unified Parkinson's Disease Rating Scale (UPDRS) and a 61% improvement in the activities of daily living sub-score. Medication-induced dyskinesias were reduced by 64% and were not observed off medication during chronic GDNF delivery. Positron emission tomography (PET) scans of [(18)F]dopamine uptake showed a significant 28% increase in putamen dopamine storage after 18 months, suggesting a direct effect of GDNF on dopamine function. This study warrants careful examination of GDNF as a treatment for Parkinson disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gill</LastName><ForeName>Steven S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Frenchay Hospital, Institute of Neurosciences, Bristol, UK. steven.gill@north-bristol.swest.nhs.uk</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Nikunj K</ForeName><Initials>NK</Initials></Author><Author ValidYN="Y"><LastName>Hotton</LastName><ForeName>Gary R</ForeName><Initials>GR</Initials></Author><Author ValidYN="Y"><LastName>O'Sullivan</LastName><ForeName>Karen</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>McCarter</LastName><ForeName>Ren&#xe9;e</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Bunnage</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Brooks</LastName><ForeName>David J</ForeName><Initials>DJ</Initials></Author><Author ValidYN="Y"><LastName>Svendsen</LastName><ForeName>Clive N</ForeName><Initials>CN</Initials></Author><Author ValidYN="Y"><LastName>Heywood</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>03</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Med</MedlineTA><NlmUniqueID>9502015</NlmUniqueID><ISSNLinking>1078-8956</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005462">Fluorine Radioisotopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495039">GDNF protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051100">Glial Cell Line-Derived Neurotrophic Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009414">Nerve Growth Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>63-84-3</RegistryNumber><NameOfSubstance UI="D004295">Dihydroxyphenylalanine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D004295" MajorTopicYN="N">Dihydroxyphenylalanine</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005462" MajorTopicYN="N">Fluorine Radioisotopes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051100" MajorTopicYN="N">Glial Cell Line-Derived Neurotrophic Factor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009414" MajorTopicYN="N">Nerve Growth Factors</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011699" MajorTopicYN="N">Putamen</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="N">Research Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014055" MajorTopicYN="N">Tomography, Emission-Computed</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2002</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2003</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>4</Month><Day>2</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>6</Month><Day>27</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>4</Month><Day>2</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12669033</ArticleId><ArticleId IdType="doi">10.1038/nm850</ArticleId><ArticleId IdType="pii">nm850</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12670422</PMID><DateCompleted><Year>2003</Year><Month>05</Month><Day>01</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0896-6273</ISSN><JournalIssue CitedMedium="Print"><Volume>37</Volume><Issue>6</Issue><PubDate><Year>2003</Year><Month>Mar</Month><Day>27</Day></PubDate></JournalIssue><Title>Neuron</Title><ISOAbbreviation>Neuron</ISOAbbreviation></Journal><ArticleTitle>APP processing and synaptic function.</ArticleTitle><Pagination><StartPage>925</StartPage><EndPage>937</EndPage><MedlinePgn>925-37</MedlinePgn></Pagination><Abstract><AbstractText>A large body of evidence has implicated Abeta peptides and other derivatives of the amyloid precursor protein (APP) as central to the pathogenesis of Alzheimer's disease (AD). However, the functional relationship of APP and its proteolytic derivatives to neuronal electrophysiology is not known. Here, we show that neuronal activity modulates the formation and secretion of Abeta peptides in hippocampal slice neurons that overexpress APP. In turn, Abeta selectively depresses excitatory synaptic transmission onto neurons that overexpress APP, as well as nearby neurons that do not. This depression depends on NMDA-R activity and can be reversed by blockade of neuronal activity. Synaptic depression from excessive Abeta could contribute to cognitive decline during early AD. In addition, we propose that activity-dependent modulation of endogenous Abeta production may normally participate in a negative feedback that could keep neuronal hyperactivity in check. Disruption of this feedback system could contribute to disease progression in AD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kamenetz</LastName><ForeName>Flavio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomita</LastName><ForeName>Taisuke</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Hsieh</LastName><ForeName>Helen</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Seabrook</LastName><ForeName>Guy</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Borchelt</LastName><ForeName>David</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Iwatsubo</LastName><ForeName>Takeshi</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Sisodia</LastName><ForeName>Sangram</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Malinow</LastName><ForeName>Roberto</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 GM008444</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuron</MedlineTA><NlmUniqueID>8809320</NlmUniqueID><ISSNLinking>0896-6273</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D025461" MajorTopicYN="N">Feedback, Physiological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013569" MajorTopicYN="N">Synapses</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009435" MajorTopicYN="N">Synaptic Transmission</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>4</Month><Day>3</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>5</Month><Day>2</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>4</Month><Day>3</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12670422</ArticleId><ArticleId IdType="doi">10.1016/s0896-6273(03)00124-7</ArticleId><ArticleId IdType="pii">S0896627303001247</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12672860</PMID><DateCompleted><Year>2003</Year><Month>04</Month><Day>09</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1533-4406</ISSN><JournalIssue CitedMedium="Internet"><Volume>348</Volume><Issue>14</Issue><PubDate><Year>2003</Year><Month>Apr</Month><Day>03</Day></PubDate></JournalIssue><Title>The New England journal of medicine</Title><ISOAbbreviation>N Engl J Med</ISOAbbreviation></Journal><ArticleTitle>Memantine in moderate-to-severe Alzheimer's disease.</ArticleTitle><Pagination><StartPage>1333</StartPage><EndPage>1341</EndPage><MedlinePgn>1333-41</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Overstimulation of the N-methyl-D-aspartate (NMDA) receptor by glutamate is implicated in neurodegenerative disorders. Accordingly, we investigated memantine, an NMDA antagonist, for the treatment of Alzheimer's disease.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patients with moderate-to-severe Alzheimer's disease were randomly assigned to receive placebo or 20 mg of memantine daily for 28 weeks. The primary efficacy variables were the Clinician's Interview-Based Impression of Change Plus Caregiver Input (CIBIC-Plus) and the Alzheimer's Disease Cooperative Study Activities of Daily Living Inventory modified for severe dementia (ADCS-ADLsev). The secondary efficacy end points included the Severe Impairment Battery and other measures of cognition, function, and behavior. Treatment differences between base line and the end point were assessed. Missing observations were imputed by using the most recent previous observation (the last observation carried forward). The results were also analyzed with only the observed values included, without replacing the missing values (observed-cases analysis).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Two hundred fifty-two patients (67 percent women; mean age, 76 years) from 32 U.S. centers were enrolled. Of these, 181 (72 percent) completed the study and were evaluated at week 28. Seventy-one patients discontinued treatment prematurely (42 taking placebo and 29 taking memantine). Patients receiving memantine had a better outcome than those receiving placebo, according to the results of the CIBIC-Plus (P=0.06 with the last observation carried forward, P=0.03 for observed cases), the ADCS-ADLsev (P=0.02 with the last observation carried forward, P=0.003 for observed cases), and the Severe Impairment Battery (P&lt;0.001 with the last observation carried forward, P=0.002 for observed cases). Memantine was not associated with a significant frequency of adverse events.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Antiglutamatergic treatment reduced clinical deterioration in moderate-to-severe Alzheimer's disease, a phase associated with distress for patients and burden on caregivers, for which other treatments are not available.</AbstractText><CopyrightInformation>Copyright 2003 Massachusetts Medical Society</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reisberg</LastName><ForeName>Barry</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, New York University School of Medicine, New York 10016, USA. barry.reisberg@med.nyu.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doody</LastName><ForeName>Rachelle</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>St&#xf6;ffler</LastName><ForeName>Albrecht</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Schmitt</LastName><ForeName>Frederick</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Ferris</LastName><ForeName>Steven</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>M&#xf6;bius</LastName><ForeName>Hans J&#xf6;rg</ForeName><Initials>HJ</Initials></Author><Author ValidYN="Y"><CollectiveName>Memantine Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>1-U01 AG-10483</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG-03051</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG-08051</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>N Engl J Med</MedlineTA><NlmUniqueID>0255562</NlmUniqueID><ISSNLinking>0028-4793</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018691">Excitatory Amino Acid Antagonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>6384-92-5</RegistryNumber><NameOfSubstance UI="D016202">N-Methylaspartate</NameOfSubstance></Chemical><Chemical><RegistryNumber>W8O17SJF3T</RegistryNumber><NameOfSubstance UI="D008559">Memantine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>N Engl J Med. 2003 Aug 7;349(6):609-10; author reply 609-10. doi: 10.1056/NEJM200308073490616.</RefSource><PMID Version="1">12904528</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Curr Neurol Neurosci Rep. 2003 Nov;3(6):485-6. doi: 10.1007/s11910-003-0051-8.</RefSource><PMID Version="1">14565902</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Alzheimer Dis Assoc Disord. 2004 Jan-Mar;18(1):47-8; author reply 48. doi: 10.1097/00002093-200401000-00010.</RefSource><PMID Version="1">15195464</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000203" MajorTopicYN="N">Activities of Daily Living</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001519" MajorTopicYN="N">Behavior</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018691" MajorTopicYN="N">Excitatory Amino Acid Antagonists</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008559" MajorTopicYN="N">Memantine</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016202" MajorTopicYN="N">N-Methylaspartate</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>4</Month><Day>4</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>4</Month><Day>10</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>4</Month><Day>4</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12672860</ArticleId><ArticleId IdType="doi">10.1056/NEJMoa013128</ArticleId><ArticleId IdType="pii">348/14/1333</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12679784</PMID><DateCompleted><Year>2003</Year><Month>06</Month><Day>18</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1465-7392</ISSN><JournalIssue CitedMedium="Print"><Volume>5</Volume><Issue>5</Issue><PubDate><Year>2003</Year><Month>May</Month></PubDate></JournalIssue><Title>Nature cell biology</Title><ISOAbbreviation>Nat Cell Biol</ISOAbbreviation></Journal><ArticleTitle>Reconstitution of gamma-secretase activity.</ArticleTitle><Pagination><StartPage>486</StartPage><EndPage>488</EndPage><MedlinePgn>486-8</MedlinePgn></Pagination><Abstract><AbstractText>gamma-Secretase is a membrane protein complex with an unusual aspartyl protease activity that catalyses the regulated intramembranous cleavage of the beta-amyloid precursor protein (APP) to release the Alzheimer's disease (AD)-associated amyloid beta-peptide (Abeta) and the APP intracellular domain (AICD). Here we show the reconstitution of gamma-secretase activity in the yeast Saccharomyces cerevisiae, which lacks endogenous gamma-secretase activity. Reconstituted gamma-secretase activity depends on the presence of four complex components including presenilin (PS), nicastrin (Nct), APH-1 (refs 3-6) and PEN-2 (refs 4, 7), is associated with endoproteolysis of PS, and produces Abeta and AICD in vitro. Thus, the biological activity of gamma-secretase is reconstituted by the co-expression of human PS, Nct, APH-1 and PEN-2 in yeast.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Edbauer</LastName><ForeName>Dieter</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Adolf-Butenandt-Institute, Department of Biochemistry, Laboratory for Alzheimer's and Parkinson's Disease Research, Ludwig-Maximilians-University, 80336 Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winkler</LastName><ForeName>Edith</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Regula</LastName><ForeName>Joerg T</ForeName><Initials>JT</Initials></Author><Author ValidYN="Y"><LastName>Pesold</LastName><ForeName>Brigitte</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Steiner</LastName><ForeName>Harald</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Haass</LastName><ForeName>Christian</ForeName><Initials>C</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Cell Biol</MedlineTA><NlmUniqueID>100890575</NlmUniqueID><ISSNLinking>1465-7392</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D046911">Macromolecular Substances</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508853">PSEN1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C469349">PSENEN protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053764">Presenilin-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011993">Recombinant Fusion Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C413604">nicastrin protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="C475154">APH1A protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D053829">Amyloid Precursor Protein Secretases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010450">Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010447">Peptide Hydrolases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.-</RegistryNumber><NameOfSubstance UI="D016282">Aspartic Acid Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.46</RegistryNumber><NameOfSubstance UI="C509280">BACE1 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053829" MajorTopicYN="N">Amyloid Precursor Protein Secretases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016282" MajorTopicYN="N">Aspartic Acid Endopeptidases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002462" MajorTopicYN="N">Cell Membrane</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010450" MajorTopicYN="N">Endopeptidases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005057" MajorTopicYN="N">Eukaryotic Cells</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015971" MajorTopicYN="N">Gene Expression Regulation, Enzymologic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015966" MajorTopicYN="N">Gene Expression Regulation, Fungal</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017930" MajorTopicYN="N">Genes, Reporter</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D046911" MajorTopicYN="N">Macromolecular Substances</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010447" MajorTopicYN="N">Peptide Hydrolases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053764" MajorTopicYN="N">Presenilin-1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011993" MajorTopicYN="N">Recombinant Fusion Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012441" MajorTopicYN="N">Saccharomyces cerevisiae</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2003</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2003</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>4</Month><Day>8</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>6</Month><Day>19</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>4</Month><Day>8</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12679784</ArticleId><ArticleId IdType="doi">10.1038/ncb960</ArticleId><ArticleId IdType="pii">ncb960</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12682308</PMID><DateCompleted><Year>2003</Year><Month>04</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-632X</ISSN><JournalIssue CitedMedium="Internet"><Volume>60</Volume><Issue>7</Issue><PubDate><Year>2003</Year><Month>Apr</Month><Day>08</Day></PubDate></JournalIssue><Title>Neurology</Title><ISOAbbreviation>Neurology</ISOAbbreviation></Journal><ArticleTitle>DHEA treatment of Alzheimer's disease: a randomized, double-blind, placebo-controlled study.</ArticleTitle><Pagination><StartPage>1071</StartPage><EndPage>1076</EndPage><MedlinePgn>1071-6</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To compare the efficacy and tolerability of dehydroepiandrosterone (DHEA) vs placebo in AD.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">Fifty-eight subjects with AD were randomized to 6 month's treatment with DHEA (50 mg per os twice a day; n = 28) or placebo (n = 30) in a multi-site, double-blind pilot trial. Primary efficacy measures assessed cognitive functioning (the AD Assessment Scale-Cognitive [ADAS-Cog]) and observer-based ratings of overall changes in severity (the Clinician's Interview-Based Impression of Change with Caregiver Input [CIBIC-Plus]). At baseline, 3 months, and 6 months, the ADAS-Cog was administered, and at 3 and 6 months, the CIBIC-Plus was administered. The 6-month time point was the primary endpoint.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Nineteen DHEA-treated subjects and 14 placebo-treated subjects completed the trial. DHEA was relatively well-tolerated. DHEA treatment, relative to placebo, was not associated with improvement in ADAS-Cog scores at month 6 (last observation carried forward; p = 0.10); transient improvement was noted at month 3 (p = 0.014; cutoff for Bonferroni significance = 0.0125). No difference between treatments was seen on the CIBIC-Plus at either the 6-month or the 3-month time points.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">DHEA did not significantly improve cognitive performance or overall ratings of change in severity in this small-scale pilot study. A transient effect on cognitive performance may have been seen at month 3, but narrowly missed significance.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wolkowitz</LastName><ForeName>O M</ForeName><Initials>OM</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Center for Neurobiology and Psychiatry, University of California San Francisco (UCSF) School of Medicine, USA. owenw@itsa.ucsf.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kramer</LastName><ForeName>J H</ForeName><Initials>JH</Initials></Author><Author ValidYN="Y"><LastName>Reus</LastName><ForeName>V I</ForeName><Initials>VI</Initials></Author><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>M M</ForeName><Initials>MM</Initials></Author><Author ValidYN="Y"><LastName>Yaffe</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Walton</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Raskind</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Peskind</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Newhouse</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Sack</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>De Souza</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Sadowsky</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Roberts</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><CollectiveName>DHEA-Alzheimer's Disease Collaborative Research</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>1R4 1AG NS13334-01</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurology</MedlineTA><NlmUniqueID>0401060</NlmUniqueID><ISSNLinking>0028-3878</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018696">Neuroprotective Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018697">Nootropic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>459AG36T1B</RegistryNumber><NameOfSubstance UI="D003687">Dehydroepiandrosterone</NameOfSubstance></Chemical><Chemical><RegistryNumber>57B09Q7FJR</RegistryNumber><NameOfSubstance UI="D019314">Dehydroepiandrosterone Sulfate</NameOfSubstance></Chemical><Chemical><RegistryNumber>WI4X0X7BPJ</RegistryNumber><NameOfSubstance UI="D006854">Hydrocortisone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Neurology. 2003 Apr 8;60(7):1060-1. doi: 10.1212/01.wnl.0000059944.48810.3a.</RefSource><PMID Version="1">12682305</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Neurology. 2004 Mar 23;62(6):1030. doi: 10.1212/wnl.62.6.1030.</RefSource><PMID Version="1">15037728</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017109" MajorTopicYN="N">Akathisia, Drug-Induced</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003221" MajorTopicYN="N">Confusion</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003687" MajorTopicYN="N">Dehydroepiandrosterone</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019314" MajorTopicYN="N">Dehydroepiandrosterone Sulfate</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006854" MajorTopicYN="N">Hydrocortisone</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018696" MajorTopicYN="N">Neuroprotective Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018697" MajorTopicYN="N">Nootropic Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010259" MajorTopicYN="N">Paranoid Disorders</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010352" MajorTopicYN="N">Patient Dropouts</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>4</Month><Day>12</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>4</Month><Day>24</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>4</Month><Day>12</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12682308</ArticleId><ArticleId IdType="doi">10.1212/01.wnl.0000052994.54660.58</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12684440</PMID><DateCompleted><Year>2003</Year><Month>05</Month><Day>30</Day></DateCompleted><DateRevised><Year>2020</Year><Month>02</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1529-2401</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>7</Issue><PubDate><Year>2003</Year><Month>Apr</Month><Day>01</Day></PubDate></JournalIssue><Title>The Journal of neuroscience : the official journal of the Society for Neuroscience</Title><ISOAbbreviation>J Neurosci</ISOAbbreviation></Journal><ArticleTitle>Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer's disease.</ArticleTitle><Pagination><StartPage>2557</StartPage><EndPage>2563</EndPage><MedlinePgn>2557-63</MedlinePgn></Pagination><Abstract><AbstractText>Cell cycle events play a major role in the loss of neurons in advanced Alzheimer's disease (AD). It is currently unknown, however, whether the same is true for the neuronal losses in early disease stages. To explore this issue we analyzed brain autopsy material from individuals clinically categorized with mild cognitive impairment (MCI), many if not most of whom will progress to AD. Immunocytochemistry for three cell cycle-related proteins, proliferating cell nuclear antigen, cyclin D, and cyclin B, was performed on sections from hippocampus, basal nucleus of Meynert, and entorhinal cortex. The results obtained from MCI cases were compared with material from individuals diagnosed with AD and those without cognitive impairment. In both hippocampus and basal nucleus, there was a significant percentage of cell cycle immunopositive neurons in the MCI cases. These percentages were similar to those found in the AD cases but significantly higher than non-cognitively impaired controls. In entorhinal cortex, the density of cell cycle-positive neurons was greater in MCI than in AD. However, we observed large variations in the percentages of immunopositive neurons from individual to individual. These findings lend support to the hypothesis that both the mechanism of cell loss (a cell cycle-induced death) and the rate of cell loss (a slow atrophy over several months) are identical at all stages of the AD disease process. The implication of the findings for human clinical trials is discussed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Alzheimer Research Laboratory, University Hospitals of Cleveland and Department of Neurosciences, Case Western Reserve University, School of Medicine, Cleveland, Ohio 44106, USA. yxy33@po.cwru.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mufson</LastName><ForeName>Elliott J</ForeName><Initials>EJ</Initials></Author><Author ValidYN="Y"><LastName>Herrup</LastName><ForeName>Karl</ForeName><Initials>K</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>A 09446</GrantID><Agency>PHS HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG14449</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG010161</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 AG008012</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS020591</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS20591</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG08012</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG10161</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG014449</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>A16668</GrantID><Agency>PHS HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosci</MedlineTA><NlmUniqueID>8102140</NlmUniqueID><ISSNLinking>0270-6474</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019926">Cyclin B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D056741">Cyclin D</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016213">Cyclins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018809">Proliferating Cell Nuclear Antigen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020532" MajorTopicYN="N">Basal Nucleus of Meynert</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002452" MajorTopicYN="N">Cell Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002453" MajorTopicYN="N">Cell Cycle</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016923" MajorTopicYN="N">Cell Death</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="N">Cognition Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019926" MajorTopicYN="N">Cyclin B</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056741" MajorTopicYN="N">Cyclin D</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016213" MajorTopicYN="N">Cyclins</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018728" MajorTopicYN="N">Entorhinal Cortex</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018809" MajorTopicYN="N">Proliferating Cell Nuclear Antigen</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>4</Month><Day>10</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>5</Month><Day>31</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>4</Month><Day>10</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2003</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12684440</ArticleId><ArticleId IdType="pmc">PMC6742098</ArticleId><ArticleId IdType="pii">23/7/2557</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.23-07-02557.2003</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>al-Ubaidi MR, Hollyfield JG, Overbeek PA, Baehr W. Photoreceptor degeneration induced by the expression of simian virus 40 large tumor antigen in the retina of transgenic mice. Proc Natl Acad Sci USA. 1992;89:1194&#x2013;1198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC48415</ArticleId><ArticleId IdType="pubmed">1311085</ArticleId></ArticleIdList></Reference><Reference><Citation>Arendt T, Rodel L, Gartner U, Holzer M. Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer's disease. NeuroReport. 1996;7:3047&#x2013;3049.</Citation><ArticleIdList><ArticleId IdType="pubmed">9116237</ArticleId></ArticleIdList></Reference><Reference><Citation>Arendt T, Holzer M, Gartner U. Neuronal expression of cyclin dependent kinase inhibitors of the INK4 family in Alzheimer's disease. J Neural Transm. 1998;105:949&#x2013;960.</Citation><ArticleIdList><ArticleId IdType="pubmed">9869328</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold S, Hyman B, J F. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in cerebral cortex of patients with Alzheimer's disease. Cereb Cortex. 1991;1:103&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pubmed">1822725</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 1993;7:812&#x2013;821.</Citation><ArticleIdList><ArticleId IdType="pubmed">8491378</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumann K, Mandelkow EM, Biernat J, Piwnica-Worms H, Mandelkow E. Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5. FEBS Lett. 1993;336:417&#x2013;424.</Citation><ArticleIdList><ArticleId IdType="pubmed">8282104</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett DA, Wilson RS, Schneider JA, Evans DA, Beckett LA, Aggarwal NT, Barnes LL, Fox JH, Bach J. Natural history of mild cognitive impairment in older persons. Neurology. 2002;59:198&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pubmed">12136057</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 1991;82:239&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pubmed">1759558</ArticleId></ArticleIdList></Reference><Reference><Citation>Busser J, Geldmacher DS, Herrup K. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain. J Neurosci. 1998;18:2801&#x2013;2807.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6792587</ArticleId><ArticleId IdType="pubmed">9525997</ArticleId></ArticleIdList></Reference><Reference><Citation>Feddersen RM, Ehlenfeldt R, Yunis WS, Clark HB, Orr HT. Disrupted cerebellar cortical development and progressive degeneration of Purkinje cells in SV40 T antigen transgenic mice. Neuron. 1992;9:955&#x2013;966.</Citation><ArticleIdList><ArticleId IdType="pubmed">1419002</ArticleId></ArticleIdList></Reference><Reference><Citation>Feddersen RM, Clark HB, Yunis WS, Orr HT. In vivo viability of postmitotic Purkinje neurons requires pRb family member function. Mol Cell Neurosci. 1995;6:153&#x2013;167.</Citation><ArticleIdList><ArticleId IdType="pubmed">7551567</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukutani Y, Kobayashi K, Nakamura I. Neurons, intracellular and extracellular neurofibrillary tangles in subdivisions of the hippocampal cortex in normal ageing and Alzheimer's disease. Neurosci Lett. 1995;200:57&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">8584267</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilmor ML, Erickson JD, Varoqui H, Hersh LB, Bennett DA, Cochran EJ, Mufson EJ, Levey AI. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol. 1999;411:693&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pubmed">10421878</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez-Isla T, Price JL, McKeel DW, Jr, Morris JC, Growdon JH, Hyman BT. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci. 1996;16:4491&#x2013;4500.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6578866</ArticleId><ArticleId IdType="pubmed">8699259</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillery RW, Herrup K. Quantification without pontification: choosing a method for counting objects in sectioned tissues. J Comp Neurol. 1997;386:2&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">9303520</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrup K, Busser JC. The induction of multiple cell cycle events precedes target-related neuronal death. Development. 1995;121:2385&#x2013;2395.</Citation><ArticleIdList><ArticleId IdType="pubmed">7671804</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoozemans JJ, Bruckner MK, Rozemuller AJ, Veerhuis R, Eikelenboom P, Arendt T. Cyclin D1 and cyclin E are co-localized with cyclo-oxygenase 2 (COX-2) in pyramidal neurons in Alzheimer disease temporal cortex. J Neuropathol Exp Neurol. 2002;61:678&#x2013;688.</Citation><ArticleIdList><ArticleId IdType="pubmed">12152783</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyman B, Van Hoesen G, Damasio A, Barnes C. Alzheimer's disease: cell specific pathology isolates the hippocampal formation in Alzheimer's disease. Science. 1984;225:1168&#x2013;1170.</Citation><ArticleIdList><ArticleId IdType="pubmed">6474172</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyman B, Van Hoesen G, Kromer L, Damasio A. Perforant pathway changes and the memory impairment of Alzheimer's disease. Ann Neurol. 1986;20:472&#x2013;481.</Citation><ArticleIdList><ArticleId IdType="pubmed">3789663</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacks T, Fazeli A, Schmitt E, Bronson R, Goodell M, Weinberg R. Effects of an Rb mutation in the mouse. Nature. 1992;359:295&#x2013;300.</Citation><ArticleIdList><ArticleId IdType="pubmed">1406933</ArticleId></ArticleIdList></Reference><Reference><Citation>Kordower JH, Chu Y, Stebbins GT, DeKosky ST, Cochran EJ, Bennett D, Mufson EJ. Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann Neurol. 2001;49:202&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pubmed">11220740</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EY-HP, Chang C-Y, Hu N, Wang Y-CJ, Lai C-C, Herrup K, Lee W-H, Bradley A. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature. 1992;359:288&#x2013;294.</Citation><ArticleIdList><ArticleId IdType="pubmed">1406932</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EY-HP, Hu N, Yuan S-SF, Cox LA, Bradley A, Lee W-H, Herrup K. Dual roles of the RB protein in cell cycle regulation and neuron differentiation. Genes Dev. 1994;8:2008&#x2013;2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">7958874</ArticleId></ArticleIdList></Reference><Reference><Citation>Lew J, Wang JH. Neuronal cdc2-like kinase. Trends Biochem Sci. 1995;20:33&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">7878742</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippa C, Hamos J, Pulaski-Salo D. Alzheimer's disease and aging: effects on perforant pathway perikarya and synapses. Neurobiol Aging. 1992;13:405&#x2013;411.</Citation><ArticleIdList><ArticleId IdType="pubmed">1625770</ArticleId></ArticleIdList></Reference><Reference><Citation>McShea A, Harris PL, Webster KR, Wahl AF, Smith MA. Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. Am J Pathol. 1997;150:1933&#x2013;1939.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1858317</ArticleId><ArticleId IdType="pubmed">9176387</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer JS, Xu G, Thornby J, Chowdhury MH, Quach M. Is mild cognitive impairment prodromal for vascular dementia like Alzheimer's disease? Stroke. 2002;33:1981&#x2013;1985.</Citation><ArticleIdList><ArticleId IdType="pubmed">12154249</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell TW, Mufson EJ, Schneider JA, Cochran EJ, Nissanov J, Han LY, Bienias JL, Lee VM, Trojanowski JQ, Bennett DA, Arnold SE. Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease. Ann Neurol. 2002;51:182&#x2013;189.</Citation><ArticleIdList><ArticleId IdType="pubmed">11835374</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, Berg L. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol. 2001;58:397&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pubmed">11255443</ArticleId></ArticleIdList></Reference><Reference><Citation>Mufson EJ, Chen EY, Cochran EJ, Beckett LA, Bennett DA, Kordower JH. Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment. Exp Neurol. 1999;158:469&#x2013;490.</Citation><ArticleIdList><ArticleId IdType="pubmed">10415154</ArticleId></ArticleIdList></Reference><Reference><Citation>Mufson EJ, Ma SY, Cochran EJ, Bennett DA, Beckett LA, Jaffar S, Saragovi HU, Kordower JH. Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol. 2000;427:19&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">11042589</ArticleId></ArticleIdList></Reference><Reference><Citation>Mufson EJ, Ma SY, Dills J, Cochran EJ, Leurgans S, Wuu J, Bennett DA, Jaffar S, Gilmor ML, Levey AI, Kordower JH. Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. J Comp Neurol. 2002;443:136&#x2013;153.</Citation><ArticleIdList><ArticleId IdType="pubmed">11793352</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy Z, Esiri M, Cato A, Smith A. Cell cycle markers in the hippocampus in Alzheimer's disease. Acta Neuropathol (Berl) 1997;94:6&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">9224524</ArticleId></ArticleIdList></Reference><Reference><Citation>Park DS, Morris EJ, Greene LA, Geller HM. G1/S cell cycle blockers and inhibitors of cyclin-dependent kinases suppress camptothecin-induced neuronal apoptosis. J Neurosci. 1997;17:1256&#x2013;1270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6793728</ArticleId><ArticleId IdType="pubmed">9006970</ArticleId></ArticleIdList></Reference><Reference><Citation>Park DS, Morris EJ, Padmanabhan J, Shelanski ML, Geller HM, Greene LA. Cyclin-dependent kinases participate in death of neurons evoked by DNA-damaging agents. J Cell Biol. 1998;143:457&#x2013;467.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2132832</ArticleId><ArticleId IdType="pubmed">9786955</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen RC. Aging, mild cognitive impairment, and Alzheimer's disease. Neurol Clin. 2000a;18:789&#x2013;806.</Citation><ArticleIdList><ArticleId IdType="pubmed">11072261</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen RC. Mild cognitive impairment: transition between aging and Alzheimer's disease. Neurologia. 2000b;15:93&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pubmed">10846869</ArticleId></ArticleIdList></Reference><Reference><Citation>Price J, Davis P, Morris J, White D. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol Aging. 1991;12:295&#x2013;312.</Citation><ArticleIdList><ArticleId IdType="pubmed">1961359</ArticleId></ArticleIdList></Reference><Reference><Citation>Prosperi E. Multiple roles of the proliferating cell nuclear antigen: DNA replication, repair and cell cycle control. Prog Cell Cycle Res. 1997;3:193&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pubmed">9552415</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossler M, Zarski R, Bohl J, Ohm TG. Stage-dependent and sector-specific neuronal loss in hippocampus during Alzheimer's disease. Acta Neuropathol (Berl) 2002;103:363&#x2013;369.</Citation><ArticleIdList><ArticleId IdType="pubmed">11904756</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent I, Rosado M, Davies P. Mitotic mechanisms in Alzheimer's disease? J Cell Biol. 1996;132:413&#x2013;425.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2120731</ArticleId><ArticleId IdType="pubmed">8636218</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent I, Jicha G, Rosado M, Dickson D. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J Neurosci. 1997;17:3588&#x2013;3598.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6573674</ArticleId><ArticleId IdType="pubmed">9133382</ArticleId></ArticleIdList></Reference><Reference><Citation>West M, Coleman P, Flood D, JC T. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet. 1994;344:769&#x2013;772.</Citation><ArticleIdList><ArticleId IdType="pubmed">7916070</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitehouse P, Price D, Struble R, Clark A, Coyle J, DeLong M. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science. 1982;215:1237&#x2013;1239.</Citation><ArticleIdList><ArticleId IdType="pubmed">7058341</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q, Combs C, Cannady SB, Geldmacher DS, Herrup K. Beta-amyloid activated microglia induce cell cycling and cell death in cultured cortical neurons. Neurobiol Aging. 2000;21:797&#x2013;806.</Citation><ArticleIdList><ArticleId IdType="pubmed">11124423</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Geldmacher DS, Herrup K. DNA replication precedes neuronal cell death in Alzheimer's disease. J Neurosci. 2001;21:2661&#x2013;2668.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6762514</ArticleId><ArticleId IdType="pubmed">11306619</ArticleId></ArticleIdList></Reference><Reference><Citation>Zweig R, Ross C, Hedreen J, Steele C, Cardillo J, Whitehouse P, Folstein M, Price D. The neuropathology of aminergic nuclei in Alzheimer's disease. Ann Neurol. 1988;24:233&#x2013;242.</Citation><ArticleIdList><ArticleId IdType="pubmed">3178178</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12686070</PMID><DateCompleted><Year>2003</Year><Month>04</Month><Day>22</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0140-6736</ISSN><JournalIssue CitedMedium="Print"><Volume>361</Volume><Issue>9364</Issue><PubDate><Year>2003</Year><Month>Apr</Month><Day>05</Day></PubDate></JournalIssue><Title>Lancet (London, England)</Title><ISOAbbreviation>Lancet</ISOAbbreviation></Journal><ArticleTitle>Classification of dementias.</ArticleTitle><Pagination><StartPage>1227</StartPage><EndPage>1228</EndPage><MedlinePgn>1227-8</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Arai</LastName><ForeName>Hiroyuki</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Matsui</LastName><ForeName>Toshifumi</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Maruyama</LastName><ForeName>Masahiro</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Okamura</LastName><ForeName>Nobuyuki</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Sasaki</LastName><ForeName>Hidetada</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016420">Comment</PublicationType><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet</MedlineTA><NlmUniqueID>2985213R</NlmUniqueID><ISSNLinking>0140-6736</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016875">tau Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Lancet. 2002 Dec 14;360(9349):1963-5. doi: 10.1016/S0140-6736(02)11920-9.</RefSource><PMID Version="1">12493278</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="N">Cognition Disorders</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016875" MajorTopicYN="N">tau Proteins</DescriptorName><QualifierName UI="Q000134" MajorTopicYN="Y">cerebrospinal fluid</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>4</Month><Day>11</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>4</Month><Day>23</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>4</Month><Day>11</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12686070</ArticleId><ArticleId IdType="doi">10.1016/s0140-6736(03)12938-8</ArticleId><ArticleId IdType="pii">S0140673603129388</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12690204</PMID><DateCompleted><Year>2003</Year><Month>05</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-9203</ISSN><JournalIssue CitedMedium="Internet"><Volume>300</Volume><Issue>5619</Issue><PubDate><Year>2003</Year><Month>Apr</Month><Day>25</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics.</ArticleTitle><Pagination><StartPage>640</StartPage><EndPage>643</EndPage><MedlinePgn>640-3</MedlinePgn></Pagination><Abstract><AbstractText>Kuru is an acquired prion disease largely restricted to the Fore linguistic group of the Papua New Guinea Highlands, which was transmitted during endocannibalistic feasts. Heterozygosity for a common polymorphism in the human prion protein gene (PRNP) confers relative resistance to prion diseases. Elderly survivors of the kuru epidemic, who had multiple exposures at mortuary feasts, are, in marked contrast to younger unexposed Fore, predominantly PRNP 129 heterozygotes. Kuru imposed strong balancing selection on the Fore, essentially eliminating PRNP 129 homozygotes. Worldwide PRNP haplotype diversity and coding allele frequencies suggest that strong balancing selection at this locus occurred during the evolution of modern humans.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mead</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Medical Research Council Prion Unit, and Department of Neurodegenerative Disease, Institute of Neurology, University College, Queen Square, London WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stumpf</LastName><ForeName>Michael P H</ForeName><Initials>MP</Initials></Author><Author ValidYN="Y"><LastName>Whitfield</LastName><ForeName>Jerome</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Beck</LastName><ForeName>Jonathan A</ForeName><Initials>JA</Initials></Author><Author ValidYN="Y"><LastName>Poulter</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Campbell</LastName><ForeName>Tracy</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Uphill</LastName><ForeName>James B</ForeName><Initials>JB</Initials></Author><Author ValidYN="Y"><LastName>Goldstein</LastName><ForeName>David</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Alpers</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Fisher</LastName><ForeName>Elizabeth M C</ForeName><Initials>EM</Initials></Author><Author ValidYN="Y"><LastName>Collinge</LastName><ForeName>John</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016456">Historical Article</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>04</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003062">Codon</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018621">PrPC Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>AE28F7PNPL</RegistryNumber><NameOfSubstance UI="D008715">Methionine</NameOfSubstance></Chemical><Chemical><RegistryNumber>HG18B9YRS7</RegistryNumber><NameOfSubstance UI="D014633">Valine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Science. 2003 Oct 3;302(5642):57. doi: 10.1126/science.302.5642.57.</RefSource><PMID Version="1">14526061</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Science. 2004 Jul 16;305(5682):342-3. doi: 10.1126/science.305.5682.342.</RefSource><PMID Version="1">15256657</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002190" MajorTopicYN="N">Cannibalism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003062" MajorTopicYN="N">Codon</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007562" MajorTopicYN="N">Creutzfeldt-Jakob Syndrome</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName><QualifierName UI="Q000266" MajorTopicYN="Y">history</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005006" MajorTopicYN="N">Ethnicity</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005787" MajorTopicYN="N">Gene Frequency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006239" MajorTopicYN="N">Haplotypes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006579" MajorTopicYN="N">Heterozygote</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049672" MajorTopicYN="N">History, 19th Century</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049673" MajorTopicYN="N">History, 20th Century</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049690" MajorTopicYN="N">History, Ancient</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006720" MajorTopicYN="N">Homozygote</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007729" MajorTopicYN="N">Kuru</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000266" MajorTopicYN="Y">history</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015810" MajorTopicYN="N">Linkage Disequilibrium</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008715" MajorTopicYN="N">Methionine</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010219" MajorTopicYN="N" Type="Geographic">Papua New Guinea</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011110" MajorTopicYN="Y">Polymorphism, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018621" MajorTopicYN="N">PrPC Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012641" MajorTopicYN="Y">Selection, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014633" MajorTopicYN="N">Valine</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>4</Month><Day>12</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>5</Month><Day>24</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>4</Month><Day>12</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12690204</ArticleId><ArticleId IdType="doi">10.1126/science.1083320</ArticleId><ArticleId IdType="pii">1083320</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12691659</PMID><DateCompleted><Year>2003</Year><Month>06</Month><Day>12</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0896-6273</ISSN><JournalIssue CitedMedium="Print"><Volume>38</Volume><Issue>1</Issue><PubDate><Year>2003</Year><Month>Apr</Month><Day>10</Day></PubDate></JournalIssue><Title>Neuron</Title><ISOAbbreviation>Neuron</ISOAbbreviation></Journal><ArticleTitle>Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-Secretase complex.</ArticleTitle><Pagination><StartPage>9</StartPage><EndPage>12</EndPage><MedlinePgn>9-12</MedlinePgn></Pagination><Abstract><AbstractText>Gamma-Secretase cleaves the Amyloid Precursor Protein (APP) in its transmembrane domain, releasing the amyloid peptide Abeta. Abeta is the main constituent of the amyloid plaques in the brains of patients suffering from Alzheimer's disease. Several other type I integral membrane proteins are also cleaved by this protease. Recent work indicates that gamma-Secretase is a multiprotein complex consisting of Presenilin, Nicastrin, Aph-1, and Pen-2 and that all four proteins are necessary for full proteolytic activity. Since several paralogs and alternatively spliced variants of at least Presenilin and Aph-1 have been identified as well, it is anticipated that gamma-Secretase is not a homogeneous activity. Gamma-Secretase is an interesting but complex drug target that challenges classical thinking about proteolytic processing and intracellular signaling.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>De Strooper</LastName><ForeName>Bart</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Neuronal Cell Biology and Gene Transfer Laboratory, Center for Human Genetics, K.U. Leuven and Flanders Interuniversitary Institute for Biotechnology, VIB4, Leuven, Belgium. bart.destrooper@med.kuleuven.ac.be</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuron</MedlineTA><NlmUniqueID>8809320</NlmUniqueID><ISSNLinking>0896-6273</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508853">PSEN1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508861">PSEN2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C469349">PSENEN protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053764">Presenilin-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053766">Presenilin-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C413604">nicastrin protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="C475154">APH1A protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D053829">Amyloid Precursor Protein Secretases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010450">Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010447">Peptide Hydrolases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.-</RegistryNumber><NameOfSubstance UI="D016282">Aspartic Acid Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.46</RegistryNumber><NameOfSubstance UI="C509280">BACE1 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D053829" MajorTopicYN="N">Amyloid Precursor Protein Secretases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016282" MajorTopicYN="N">Aspartic Acid Endopeptidases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010450" MajorTopicYN="N">Endopeptidases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010447" MajorTopicYN="N">Peptide Hydrolases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053764" MajorTopicYN="N">Presenilin-1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053766" MajorTopicYN="N">Presenilin-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>22</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>4</Month><Day>15</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>6</Month><Day>13</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>4</Month><Day>15</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12691659</ArticleId><ArticleId IdType="doi">10.1016/s0896-6273(03)00205-8</ArticleId><ArticleId IdType="pii">S0896627303002058</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12695498</PMID><DateCompleted><Year>2003</Year><Month>05</Month><Day>30</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0021-9525</ISSN><JournalIssue CitedMedium="Print"><Volume>161</Volume><Issue>1</Issue><PubDate><Year>2003</Year><Month>Apr</Month><Day>14</Day></PubDate></JournalIssue><Title>The Journal of cell biology</Title><ISOAbbreviation>J Cell Biol</ISOAbbreviation></Journal><ArticleTitle>Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells.</ArticleTitle><Pagination><StartPage>41</StartPage><EndPage>54</EndPage><MedlinePgn>41-54</MedlinePgn></Pagination><Abstract><AbstractText>Alzheimer's amyloid precursor protein 695 (APP) is a plasma membrane protein, which is known to be the source of the toxic amyloid beta (Abeta) peptide associated with the pathogenesis of Alzheimer's disease (AD). Here we demonstrate that by virtue of its chimeric NH2-terminal signal, APP is also targeted to mitochondria of cortical neuronal cells and select regions of the brain of a transgenic mouse model for AD. The positively charged residues at 40, 44, and 51 of APP are critical components of the mitochondrial-targeting signal. Chemical cross-linking together with immunoelectron microscopy show that the mitochondrial APP exists in NH2-terminal inside transmembrane orientation and in contact with mitochondrial translocase proteins. Mutational studies show that the acidic domain, which spans sequence 220-290 of APP, causes the transmembrane arrest with the COOH-terminal 73-kD portion of the protein facing the cytoplasmic side. Accumulation of full-length APP in the mitochondrial compartment in a transmembrane-arrested form, but not lacking the acidic domain, caused mitochondrial dysfunction and impaired energy metabolism. These results show, for the first time, that APP is targeted to neuronal mitochondria under some physiological and pathological conditions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Anandatheerthavarada</LastName><ForeName>Hindupur K</ForeName><Initials>HK</Initials><AffiliationInfo><Affiliation>Department of Animal Biology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biswas</LastName><ForeName>Gopa</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Robin</LastName><ForeName>Marie-Anne</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Avadhani</LastName><ForeName>Narayan G</ForeName><Initials>NG</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>GM34483</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cell Biol</MedlineTA><NlmUniqueID>0375356</NlmUniqueID><ISSNLinking>0021-9525</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011993">Recombinant Fusion Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002451" MajorTopicYN="N">Cell Compartmentation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030401" MajorTopicYN="N">Cytochrome-c Oxidase Deficiency</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004734" MajorTopicYN="N">Energy Metabolism</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007425" MajorTopicYN="N">Intracellular Membranes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008854" MajorTopicYN="N">Microscopy, Electron</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008968" MajorTopicYN="N">Molecular Conformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017434" MajorTopicYN="N">Protein Structure, Tertiary</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D021381" MajorTopicYN="N">Protein Transport</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011993" MajorTopicYN="N">Recombinant Fusion Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>4</Month><Day>16</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>5</Month><Day>31</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>4</Month><Day>16</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2003</Year><Month>10</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12695498</ArticleId><ArticleId IdType="pmc">PMC2172865</ArticleId><ArticleId IdType="doi">10.1083/jcb.200207030</ArticleId><ArticleId IdType="pii">jcb.200207030</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Addya, S., H.K. Anandatheerthavarada, G. Biswas, S.V. Bhagwat, J. Mullick, and N.G. Avadhani. 1997. Targeting of NH2-terminal&#x2013;processed microsomal protein to mitochondria: a novel pathway for the biogenesis of hepatic mitochondrial P450MT2. J. Cell Biol. 139:589&#x2013;599.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2141697</ArticleId><ArticleId IdType="pubmed">9348277</ArticleId></ArticleIdList></Reference><Reference><Citation>Amuthan, G., G. Biswas, H.K. Anandatheerthavarada, C. Vijayasarathy, H.M. Shephard, and N.G. Avadhani. 2002. Mitochondrial stress-induced calcium signaling, phenotypic changes and invasive behavior in human lung carcinoma A549 cells. Oncogene. 21:7839&#x2013;7849.</Citation><ArticleIdList><ArticleId IdType="pubmed">12420221</ArticleId></ArticleIdList></Reference><Reference><Citation>Anandatheerthavarada, H.K., G. Biswas, J. Mullick, N.B. Sepuri, L. Otvos, D. Pain, and N.G. Avadhani. 1999. Dual targeting of cytochrome P4502B1 to endoplasmic reticulum and mitochondria involves a novel signal activation by cyclic AMP-dependent phosphorylation at ser128. EMBO J. 18:5494&#x2013;5504.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1171618</ArticleId><ArticleId IdType="pubmed">10523294</ArticleId></ArticleIdList></Reference><Reference><Citation>Beal, M.F. 1998. Mitochondrial dysfunction in neurodegenerative diseases. Biochim. Biophys. Acta. 1366:211&#x2013;223.</Citation><ArticleIdList><ArticleId IdType="pubmed">9714810</ArticleId></ArticleIdList></Reference><Reference><Citation>Busciglio, J., A. Pelsman, C. Wong, G. Pigino, M. Yuan, H. Mori, and B.A. Yankner. 2002. Altered metabolism of the amyloid &#x3b2; precursor protein is associated with mitochondrial dysfunction in Down's syndrome. Neuron. 33:677&#x2013;688.</Citation><ArticleIdList><ArticleId IdType="pubmed">11879646</ArticleId></ArticleIdList></Reference><Reference><Citation>Campard, P.K., B. Tasiaux, and J.N. Octave. 2000. The processing and biological function of the human amyloid precursor protein (APP): lessons from different cellular models. Exp. Gerontol. 35:843&#x2013;850.</Citation><ArticleIdList><ArticleId IdType="pubmed">11053675</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen, M.L., T.E. Golde, M.F. Usiak, L.H. Younkin, and S.G. Younkin. 1988. In situ hybridization of nucleus basalis neurons shows increased &#x3b2;-amyloid mRNA in Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 85:1227&#x2013;1231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC279740</ArticleId><ArticleId IdType="pubmed">3277188</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasso, M. 1998. In vitro reconstitution. Current Protocols in Cell Biology. Vol. 1. J.S. Bonifacino, M. Dasso, J.B. Harford, J. Lippincot-Schawartz, and K.M. Yamada, editors. John Wiley &amp; Sons Inc., New York. 11.0.1&#x2013;11.0.2.</Citation></Reference><Reference><Citation>De La Monte, S.M., T. Luong, T.R. Neely, D. Robinson, and J.R. Wands. 2000. Mitochondrial DNA damage as a mechanism of cell loss in Alzheimer's disease. Lab. Invest. 80:1323&#x2013;1335.</Citation><ArticleIdList><ArticleId IdType="pubmed">10950123</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan, W., V.M. Rangnekar, and M.P. Mattson. 1999. Prostate apoptosis response-4 production in synaptic compartments following apoptotic and excitotoxic insults: evidence for a pivotal role in mitochondrial dysfunction and neuronal degeneration. J. Neurochem. 72:2312&#x2013;2322.</Citation><ArticleIdList><ArticleId IdType="pubmed">10349840</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunn, K.J., J.R. Perez-Polo, and T.G. Wood. 1996. Rapid neurite formation in a human cortical neuronal cell line. Int. J. Dev. Neurosci. 14:61&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">8779309</ArticleId></ArticleIdList></Reference><Reference><Citation>Eilers, M., and G. Schatz. 1986. Binding of a specific ligand inhibits import of a purified precursor protein into mitochondria. Nature. 322:228&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pubmed">3016548</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant, S.M., S.L. Shankar, R.M. Chalmers-Redman, W.G. Tatton, M. Szyf, and A.C. Cuello. 1999. Mitochondrial abnormalities in neuroectodermal cells stably expressing human amyloid precursor protein (hAPP751). Neuroreport. 10:41&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">10094130</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenfield, J.P., J. Tsai, G.K. Gouras, B. Hai, G. Thinakaran, F. Checler, S.S. Sisodia, P. Greengard, and H. Xu. 1999. Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer &#x3b2;-amyloid peptides. Proc. Natl. Acad. Sci. USA. 96:742&#x2013;747.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC15207</ArticleId><ArticleId IdType="pubmed">9892704</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasimoto, Y., T. Niikura, Y. Ito, and I. Nishimoto. 2000. Multiple mechanisms underlie neurotoxicity by different types of Alzheimer's disease mutations of amyloid precursor protein. J. Biol. Chem. 275:34541&#x2013;34551.</Citation><ArticleIdList><ArticleId IdType="pubmed">10934205</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatanpaa, K., K. Chandrasekaran, D.R. Brady, and S.I. Rapoport. 1998. No association between Alzheimer plaques and decreased levels of cytochrome oxidase subunit mRNA, a marker of neuronal energy metabolism. Brain Res. Mol. Brain. Res. 59:13&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">9729244</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugon, J., F. Esclaire, M. Lesort, G. Kisby, and P. Spencer. 1999. Toxic neuronal apoptosis and modifications of Tau and APP gene and protein expressions. Drug Metab. Rev. 31:635&#x2013;647.</Citation><ArticleIdList><ArticleId IdType="pubmed">10461544</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobsen, J.S., A.J. Blume, and M.P. Vitek. 1991. Quantitative measurement of alternatively spliced amyloid precursor protein mRNA expression in Alzheimer's disease and normal brain by S1 nuclease protection analysis. Neurobiol. Aging. 12:585&#x2013;592.</Citation><ArticleIdList><ArticleId IdType="pubmed">1722874</ArticleId></ArticleIdList></Reference><Reference><Citation>Janus, C., and D. Westaway. 2001. Transgenic mouse models of Alzheimer's disease. Physiol. Behav. 73:873&#x2013;886.</Citation><ArticleIdList><ArticleId IdType="pubmed">11566220</ArticleId></ArticleIdList></Reference><Reference><Citation>Maltese, W.A., S. Wilson, Y. Tan, S. Suomensaari, S. Sinha, R. Barbour, and L. McConlogue. 2001. Retention of the Alzheimer's amyloid precursor fragment C99 in the endoplasmic reticulum prevents formation of amyloid &#x3b2;-peptide. J. Biol. Chem. 276:20267&#x2013;20279.</Citation><ArticleIdList><ArticleId IdType="pubmed">11278337</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurer, I., S. Zierz, and H.J. Moller. 2000. A selective defect of cytochrome c oxidase is present in brain of Alzheimer's disease patients. Neurobiol. Aging. 21:455&#x2013;462.</Citation><ArticleIdList><ArticleId IdType="pubmed">10858595</ArticleId></ArticleIdList></Reference><Reference><Citation>Mecocci, P., A. Cherubini, M.F. Beal, R. Cecchetti, F. Chionne, M.C. Polidori, G. Romano, and U. Senin. 1996. Altered mitochondrial membrane fluidity in AD brain. Neurosci. Lett. 207:129&#x2013;132.</Citation><ArticleIdList><ArticleId IdType="pubmed">8731438</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura, I., T. Uetsuki, S.U. Dani, Y. Ohsawa, I. Saito, H. Okamura, Y. Uchiyama, and K. Yoshikawa. 1998. Degeneration in vivo of rat hippocampal neurons by wild-type Alzheimer amyloid precursor protein overexpressed by adenovirus-mediated gene transfer. J. Neurosci. 18:2387&#x2013;2398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6793123</ArticleId><ArticleId IdType="pubmed">9502800</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunan, J., and D.H. Small. 2000. Regulation of APP cleavage by &#x3b1;-, &#x3b2;-, and &#x3b3;-secretases. FEBS Lett. 483:6&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">11033346</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmert, M.R., T.E. Golde, M.L. Cohen, D.M. Kovacs, R.E. Tanzi, J.F. Gusella, M.F. Usiak, L.H. Younkin, and S.G. Younkin. 1988. Amyloid protein precursor messenger RNAs: differential expression in Alzheimer's disease. Science. 241:1080&#x2013;1084.</Citation><ArticleIdList><ArticleId IdType="pubmed">2457949</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker, W.D., Jr. 1991. Cytochrome oxidase deficiency in Alzheimer's disease. Ann. NY Acad. Sci. 640:59&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">1663716</ArticleId></ArticleIdList></Reference><Reference><Citation>Price, D.L., and S.S. Sisodia. 1998. Mutant genes in familial Alzheimer's disease and transgenic models. Annu. Rev. Neurosci. 21:479&#x2013;505.</Citation><ArticleIdList><ArticleId IdType="pubmed">9530504</ArticleId></ArticleIdList></Reference><Reference><Citation>Ringheim, G.E., A.M. Szcepanik, K.L. Burgher, W. Petko, J.A. Heroux, and F. Cavalieri. 1996. Transcriptional inhibition of the &#x3b2;-amyloid precursor protein by interferon-&#x3b3;. Biochem. Biophys. Res. Commun. 224:246&#x2013;251.</Citation><ArticleIdList><ArticleId IdType="pubmed">8694821</ArticleId></ArticleIdList></Reference><Reference><Citation>Rockenstein, E.M., L. McConlogue, H. Tan, M. Power, E. Masliah, and L. Mucke. 1995. Levels and alternative splicing of amyloid &#x3b2; protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer's disease. J. Biol. Chem. 270:28257&#x2013;28267.</Citation><ArticleIdList><ArticleId IdType="pubmed">7499323</ArticleId></ArticleIdList></Reference><Reference><Citation>Robin, M.A., H.K. Anandatheerthavarada, G. Biswas, N.B. Sepuri, D.M. Gordon, D. Pain, and N.G. Avadhani. 2002. Bimodal targeting of microsomal CYP2E1 to mitochondria through activation of an N-terminal chimeric signal by cAMP-mediated phosphorylation. J. Biol. Chem. 277:40583&#x2013;40593.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3800117</ArticleId><ArticleId IdType="pubmed">12191992</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronnett, G.V., L.D. Hester, J.F. Nye, K. Conners, and S.H. Snyder. 1990. Human cortical neuronal cell line: establishment from a patient with unilateral megalencephaly. Science. 248:603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pubmed">1692158</ArticleId></ArticleIdList></Reference><Reference><Citation>Selkoe, D.J. 1999. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature. 399:A23&#x2013;A31.</Citation><ArticleIdList><ArticleId IdType="pubmed">10392577</ArticleId></ArticleIdList></Reference><Reference><Citation>Shepherd, C.E., S. Bowes, D. Parkinson, M. Cambray-Deakin, and R.C. Pearson. 2000. Expression of amyloid precursor protein in human astrocytes in vitro: isoform-specific increases following heat shock. Neuroscience. 99:317&#x2013;325.</Citation><ArticleIdList><ArticleId IdType="pubmed">10938437</ArticleId></ArticleIdList></Reference><Reference><Citation>Sims, N.R. 1996. Energy metabolism, oxidative stress and neuronal degeneration in Alzheimer's disease. Neurodegeneration. 5:435&#x2013;440.</Citation><ArticleIdList><ArticleId IdType="pubmed">9117559</ArticleId></ArticleIdList></Reference><Reference><Citation>Sisodia, S.S., and P.H. St George-Hyslop. 2002. &#x3b3;-Secretase, Notch, A&#x3b2; and Alzheimer's disease: where do the presenilins fit in? Nat. Rev. Neurosci. 3:281&#x2013;290.</Citation><ArticleIdList><ArticleId IdType="pubmed">11967558</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson, D.T., K. Rash, and J.A. Clemens. 1992. Amyloid precursor protein accumulates in regions of neurodegeneration following focal cerebral ischemia in the rat. Brain Res. 593:128&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pubmed">1458315</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi, M., S. Dore, C.D. Ferris, T. Tomita, A. Sawa, H. Wolosker, D.R. Borchelt, T. Iwatsubo, S.H. Kim, G. Thinakaran, et al. 2000. Amyloid precursor proteins inhibit heme oxygenase activity and augment neurotoxicity in Alzheimer's disease. Neuron. 28:461&#x2013;473.</Citation><ArticleIdList><ArticleId IdType="pubmed">11144356</ArticleId></ArticleIdList></Reference><Reference><Citation>Teller, J.K., C. Russo, L.M. DeBusk, G. Angelini, D. Zaccheo, F. Dagna-Bricarelli, P. Scartezzini, S. Bertolini, D.M. Mann, M. Tabaton, and P. Gambetti. 1996. Presence of soluble amyloid &#x3b2;-peptide precedes amyloid plaque formation in Down's syndrome. Nat. Med. 2:93&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">8564851</ArticleId></ArticleIdList></Reference><Reference><Citation>Truscott, K.N., N. Pfanner, and W. Voos. 2001. Transport of proteins into mitochondria. Rev. Physiol. Biochem. Pharmacol. 143:81&#x2013;136.</Citation><ArticleIdList><ArticleId IdType="pubmed">11428265</ArticleId></ArticleIdList></Reference><Reference><Citation>Uetsuki, T., K. Takemoto, I. Nishimura, M. Okamoto, M. Niinobe, T. Momoi, M. Miura, and K. Yoshikawa. 1999. Activation of neuronal caspase-3 by intracellular accumulation of wild-type Alzheimer amyloid precursor protein. J. Neurosci. 19:6955&#x2013;6964.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6782871</ArticleId><ArticleId IdType="pubmed">10436052</ArticleId></ArticleIdList></Reference><Reference><Citation>Valla, J., J.D. Berndt, and F. Gonzalez-Lima. 2001. Energy hypo metabolism in posterior cingulate cortex of Alzheimer's patients: superficial laminar cytochrome oxidase associated with disease duration. J. Neurosci. 21:4923&#x2013;4930.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6762373</ArticleId><ArticleId IdType="pubmed">11425920</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayasarathy, C., S. Damle, N. Lenka, and N.G. Avadhani. 1999. Tissue variant effects of heme inhibitors on the mouse cytochrome c oxidase gene expression and catalytic activity of the enzyme complex. Eur. J. Biochem. 266:191&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pubmed">10542064</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster, M.T., B.R. Pearce, D.M. Bowen, and P.T. Francis. 1998. The effects of perturbed energy metabolism on the processing of amyloid precursor protein in PC12 cells. J. Neural Transm. 105:839&#x2013;853.</Citation><ArticleIdList><ArticleId IdType="pubmed">9869322</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamaguchi, H., T. Yamazaki, K. Ishiguro, M. Shoji, Y. Nakazato, and S. Hirai. 1992. Ultrastructural localization of Alzheimer amyloid b/A4 protein precursor in the cytoplasm of neurons and senile plaque-associated astrocytes. Acta. Neuropathol. (Berl). 85:15&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">1363016</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12704391</PMID><DateCompleted><Year>2003</Year><Month>07</Month><Day>01</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1097-6256</ISSN><JournalIssue CitedMedium="Print"><Volume>6</Volume><Issue>5</Issue><PubDate><Year>2003</Year><Month>May</Month></PubDate></JournalIssue><Title>Nature neuroscience</Title><ISOAbbreviation>Nat Neurosci</ISOAbbreviation></Journal><ArticleTitle>Becoming a new neuron in the adult olfactory bulb.</ArticleTitle><Pagination><StartPage>507</StartPage><EndPage>518</EndPage><MedlinePgn>507-18</MedlinePgn></Pagination><Abstract><AbstractText>New neurons are continually recruited throughout adulthood in certain regions of the adult mammalian brain. How these cells mature and integrate into preexisting functional circuits remains unknown. Here we describe the physiological properties of newborn olfactory bulb interneurons at five different stages of their maturation in adult mice. Patch-clamp recordings were obtained from tangentially and radially migrating young neurons and from neurons in three subsequent maturation stages. Tangentially migrating neurons expressed extrasynaptic GABA(A) receptors and then AMPA receptors, before NMDA receptors appeared in radially migrating neurons. Spontaneous synaptic activity emerged soon after migration was complete, and spiking activity was the last characteristic to be acquired. This delayed excitability is unique to cells born in the adult and may protect circuits from uncontrolled neurotransmitter release and neural network disruption. Our results show that newly born cells recruited into the olfactory bulb become neurons, and a unique sequence of events leads to their functional integration.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Carleton</LastName><ForeName>Alan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pasteur Institute, Laboratory of Perception and Memory, CNRS UMR 2182, 25 Rue du Dr Roux, 75015 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petreanu</LastName><ForeName>Leopoldo T</ForeName><Initials>LT</Initials></Author><Author ValidYN="Y"><LastName>Lansford</LastName><ForeName>Rusty</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Alvarez-Buylla</LastName><ForeName>Arturo</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Lledo</LastName><ForeName>Pierre-Marie</ForeName><Initials>PM</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>HD32116</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Nat Neurosci</MedlineTA><NlmUniqueID>9809671</NlmUniqueID><ISSNLinking>1097-6256</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nat Neurosci. 2003 May;6(5):442. doi: 10.1038/nn0503-442.</RefSource><PMID Version="1">12715009</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000831" MajorTopicYN="N">Animals, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002465" MajorTopicYN="N">Cell Movement</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009830" MajorTopicYN="N">Olfactory Bulb</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000254" MajorTopicYN="Y">growth &amp; development</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009435" MajorTopicYN="N">Synaptic Transmission</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2003</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2003</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>4</Month><Day>22</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>7</Month><Day>2</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>4</Month><Day>22</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12704391</ArticleId><ArticleId IdType="doi">10.1038/nn1048</ArticleId><ArticleId IdType="pii">nn1048</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12707067</PMID><DateCompleted><Year>2003</Year><Month>05</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0003-9942</ISSN><JournalIssue CitedMedium="Print"><Volume>60</Volume><Issue>4</Issue><PubDate><Year>2003</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Archives of neurology</Title><ISOAbbreviation>Arch Neurol</ISOAbbreviation></Journal><ArticleTitle>Parkinsonianlike signs and risk of incident Alzheimer disease in older persons.</ArticleTitle><Pagination><StartPage>539</StartPage><EndPage>544</EndPage><MedlinePgn>539-44</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Parkinsonianlike signs are common in older persons, but little is known about how their severity or rate of progression is related to the development of Alzheimer disease (AD) or decline in cognition.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To examine the association of progression of parkinsonianlike signs with incident AD and cognitive decline.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Longitudinal cohort study.</AbstractText><AbstractText Label="PARTICIPANTS AND SETTING" NlmCategory="METHODS">For up to 8 years, 824 older Catholic clergy members without clinical evidence of AD or Parkinson disease at baseline underwent annual clinical evaluations that included a modified version of the Unified Parkinson's Disease Rating Scale (UPDRS), detailed cognitive function testing, and clinical classification of AD.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">Clinically diagnosed AD and change in global and specific measures of cognitive function.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">During an average of 4.6 years of observation, 114 persons developed AD. The global UPDRS score increased in 79% of participants, who were divided into tertiles with the least, moderate, or most rapid progression. We examined the relationship of progression to disease risk in a proportional hazards model that controlled for baseline global UPDRS and demographic variables. Compared with the 21% without progression, risk of AD more than doubled in the subgroup with the least progression (P =.08), more than tripled in the moderate subgroup (P =.02), and increased more than 8-fold in the subgroup with the most rapid progression (P&lt;.001). This effect was mainly due to worsening gait and rigidity. Rate of change on the global UPDRS measure was inversely correlated with rate of change on a global measure of cognitive function (r = -0.64).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Progression of parkinsonianlike signs in old age is associated with decline in cognitive function and the development of AD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Robert S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Rush Alzheimer's Disease Center and Rush Institute for Healthy Aging and the Department of Neurological Sciences, Rush-Presbyterian-St Luke's Medical Center, Chicago, IL 60612, USA. rwilson@rush.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schneider</LastName><ForeName>Julie A</ForeName><Initials>JA</Initials></Author><Author ValidYN="Y"><LastName>Bienias</LastName><ForeName>Julia L</ForeName><Initials>JL</Initials></Author><Author ValidYN="Y"><LastName>Evans</LastName><ForeName>Denis A</ForeName><Initials>DA</Initials></Author><Author ValidYN="Y"><LastName>Bennett</LastName><ForeName>David A</ForeName><Initials>DA</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K08 AG00849</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG10161</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG15819</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Arch Neurol</MedlineTA><NlmUniqueID>0372436</NlmUniqueID><ISSNLinking>0003-9942</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001057">Apolipoproteins E</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001057" MajorTopicYN="N">Apolipoproteins E</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>4</Month><Day>23</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>5</Month><Day>8</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>4</Month><Day>23</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12707067</ArticleId><ArticleId IdType="doi">10.1001/archneur.60.4.539</ArticleId><ArticleId IdType="pii">60/4/539</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12707064</PMID><DateCompleted><Year>2003</Year><Month>05</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0003-9942</ISSN><JournalIssue CitedMedium="Print"><Volume>60</Volume><Issue>4</Issue><PubDate><Year>2003</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Archives of neurology</Title><ISOAbbreviation>Arch Neurol</ISOAbbreviation></Journal><ArticleTitle>Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease.</ArticleTitle><Pagination><StartPage>510</StartPage><EndPage>515</EndPage><MedlinePgn>510-5</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The statin treatment of dyslipidemia is associated with a reduced risk of development of Alzheimer disease (AD). The effect may be mediated by a reduction in cholesterol biosynthesis in the brain, by lowering levels of apolipoprotein E (apo E)-containing lipoproteins, or by pleitropic effects such as reduction in beta-amyloid production. In the brain, cholesterol from damaged or dying neurons is converted to 24S-hydroxycholesterol by cholesterol 24-hydroxylase (CYP46). The oxysterol is subsequently transferred across the blood-brain barrier, transported to the liver by low-density lipoproteins (LDLs), and excreted as bile acids. Most of plasma 24S-hydroxycholesterol is derived from brain cholesterol; consequently, plasma levels of the oxysterol reflect brain cholesterol catabolism.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To examine the effect of 3 statins and a nonstatin hypolipidemic agent on plasma levels of 24S-hydroxycholesterol and apo E in patients with AD.</AbstractText><AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">The study had a sequential parallel design. It was open-labeled and involved lipoprotein and 24S-hydroxycholesterol evaluations at baseline and at 6 weeks of treatment with 40 mg of lovastatin, simvastatin, or pravastatin sodium per day, or 1 g of extended-release niacin per day. Blood samples were drawn after a 12-hour fast for measurement of plasma sterols, oxysterols, lipoprotein cholesterol, and levels of apo E, plasma transaminases, and glucose. Measurements were made at baseline and during treatment.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Statin treatment reduced levels of plasma lathosterol by 49.5%, 24S-hydroxycholesterol by 21.4%, LDL cholesterol by 34.9%, and total cholesterol by 25%. The ratios of lathosterol-campesterol and 24S-hydroxycholesterol-LDL cholesterol were reduced significantly, but the ratio of 24S-hydroxycholesterol-total cholesterol was unchanged. Extended-release niacin also significantly reduced levels of 24S-hydroxycholesterol by 10% and LDL cholesterol by 18.1%. None of the agents lowered plasma concentration of apo E.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Statins lowered levels of plasma 24S-hydroxycholesterol without affecting levels of apo E. The LDL lowering was more pronounced than 24S-hydroxycholesterol reductions. The effect of statins on LDL partially explains the reduction of plasma oxysterol level.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vega</LastName><ForeName>Gloria Lena</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Department of Clinical Nutrition, the Center for Human Nutrition, University of Texas Southwestern Medical Center and Nutrition and Metabolism Laboratory, Veterans Affairs Medical Center, Dallas 75390, USA. Gloria.Vega@utsouthwestern.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weiner</LastName><ForeName>Myron F</ForeName><Initials>MF</Initials></Author><Author ValidYN="Y"><LastName>Lipton</LastName><ForeName>Anne M</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Von Bergmann</LastName><ForeName>Klaus</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Lutjohann</LastName><ForeName>Dieter</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>Carol</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Svetlik</LastName><ForeName>Doris</ForeName><Initials>D</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>M01-RR00633</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P-30-AG-12300</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Arch Neurol</MedlineTA><NlmUniqueID>0372436</NlmUniqueID><ISSNLinking>0003-9942</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006888">Hydroxycholesterols</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019161">Hydroxymethylglutaryl-CoA Reductase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>2679MF687A</RegistryNumber><NameOfSubstance UI="D009525">Niacin</NameOfSubstance></Chemical><Chemical><RegistryNumber>47IMW63S3F</RegistryNumber><NameOfSubstance UI="C044563">24-hydroxycholesterol</NameOfSubstance></Chemical><Chemical><RegistryNumber>9LHU78OQFD</RegistryNumber><NameOfSubstance UI="D008148">Lovastatin</NameOfSubstance></Chemical><Chemical><RegistryNumber>AGG2FN16EV</RegistryNumber><NameOfSubstance UI="D019821">Simvastatin</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.-</RegistryNumber><NameOfSubstance UI="D013250">Steroid Hydroxylases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.14.25</RegistryNumber><NameOfSubstance UI="D000072556">Cholesterol 24-Hydroxylase</NameOfSubstance></Chemical><Chemical><RegistryNumber>KXO2KT9N0G</RegistryNumber><NameOfSubstance UI="D017035">Pravastatin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072556" MajorTopicYN="N">Cholesterol 24-Hydroxylase</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006888" MajorTopicYN="N">Hydroxycholesterols</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019161" MajorTopicYN="N">Hydroxymethylglutaryl-CoA Reductase Inhibitors</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008148" MajorTopicYN="N">Lovastatin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009525" MajorTopicYN="N">Niacin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017035" MajorTopicYN="N">Pravastatin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019821" MajorTopicYN="N">Simvastatin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013250" MajorTopicYN="N">Steroid Hydroxylases</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>4</Month><Day>23</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>5</Month><Day>8</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>4</Month><Day>23</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12707064</ArticleId><ArticleId IdType="doi">10.1001/archneur.60.4.510</ArticleId><ArticleId IdType="pii">60/4/510</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12730604</PMID><DateCompleted><Year>2003</Year><Month>05</Month><Day>27</Day></DateCompleted><DateRevised><Year>2009</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1095-9203</ISSN><JournalIssue CitedMedium="Internet"><Volume>300</Volume><Issue>5620</Issue><PubDate><Year>2003</Year><Month>May</Month><Day>02</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>Mutations in dynein link motor neuron degeneration to defects in retrograde transport.</ArticleTitle><Pagination><StartPage>808</StartPage><EndPage>812</EndPage><MedlinePgn>808-12</MedlinePgn></Pagination><Abstract><AbstractText>Degenerative disorders of motor neurons include a range of progressive fatal diseases such as amyotrophic lateral sclerosis (ALS), spinal-bulbar muscular atrophy (SBMA), and spinal muscular atrophy (SMA). Although the causative genetic alterations are known for some cases, the molecular basis of many SMA and SBMA-like syndromes and most ALS cases is unknown. Here we show that missense point mutations in the cytoplasmic dynein heavy chain result in progressive motor neuron degeneration in heterozygous mice, and in homozygotes this is accompanied by the formation of Lewy-like inclusion bodies, thus resembling key features of human pathology. These mutations exclusively perturb neuron-specific functions of dynein.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hafezparast</LastName><ForeName>Majid</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurodegenerative Disease, Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klocke</LastName><ForeName>Rainer</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Ruhrberg</LastName><ForeName>Christiana</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Marquardt</LastName><ForeName>Andreas</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Ahmad-Annuar</LastName><ForeName>Azlina</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Bowen</LastName><ForeName>Samantha</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Lalli</LastName><ForeName>Giovanna</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Witherden</LastName><ForeName>Abi S</ForeName><Initials>AS</Initials></Author><Author ValidYN="Y"><LastName>Hummerich</LastName><ForeName>Holger</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Nicholson</LastName><ForeName>Sharon</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Morgan</LastName><ForeName>P Jeffrey</ForeName><Initials>PJ</Initials></Author><Author ValidYN="Y"><LastName>Oozageer</LastName><ForeName>Ravi</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Priestley</LastName><ForeName>John V</ForeName><Initials>JV</Initials></Author><Author ValidYN="Y"><LastName>Averill</LastName><ForeName>Sharon</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>King</LastName><ForeName>Von R</ForeName><Initials>VR</Initials></Author><Author ValidYN="Y"><LastName>Ball</LastName><ForeName>Simon</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Peters</LastName><ForeName>Jo</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Toda</LastName><ForeName>Takashi</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Yamamoto</LastName><ForeName>Ayumu</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Hiraoka</LastName><ForeName>Yasushi</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Augustin</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Korthaus</LastName><ForeName>Dirk</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Wattler</LastName><ForeName>Sigrid</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Wabnitz</LastName><ForeName>Philipp</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Dickneite</LastName><ForeName>Carmen</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Lampel</LastName><ForeName>Stefan</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Boehme</LastName><ForeName>Florian</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Peraus</LastName><ForeName>Gisela</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Popp</LastName><ForeName>Andreas</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Rudelius</LastName><ForeName>Martina</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Schlegel</LastName><ForeName>Juergen</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Fuchs</LastName><ForeName>Helmut</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Hrabe de Angelis</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Schiavo</LastName><ForeName>Giampietro</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Shima</LastName><ForeName>David T</ForeName><Initials>DT</Initials></Author><Author ValidYN="Y"><LastName>Russ</LastName><ForeName>Andreas P</ForeName><Initials>AP</Initials></Author><Author ValidYN="Y"><LastName>Stumm</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Joanne E</ForeName><Initials>JE</Initials></Author><Author ValidYN="Y"><LastName>Fisher</LastName><ForeName>Elizabeth M C</ForeName><Initials>EM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013744">Tetanus Toxin</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.2</RegistryNumber><NameOfSubstance UI="D004398">Dyneins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000870" MajorTopicYN="N">Anterior Horn Cells</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001370" MajorTopicYN="Y">Axonal Transport</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002465" MajorTopicYN="N">Cell Movement</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002490" MajorTopicYN="N">Central Nervous System</DescriptorName><QualifierName UI="Q000196" MajorTopicYN="N">embryology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002874" MajorTopicYN="N">Chromosome Mapping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019281" MajorTopicYN="N">Dimerization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004398" MajorTopicYN="N">Dyneins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005727" MajorTopicYN="N">Ganglia, Spinal</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006056" MajorTopicYN="N">Golgi Apparatus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006579" MajorTopicYN="N">Heterozygote</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006720" MajorTopicYN="N">Homozygote</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016631" MajorTopicYN="N">Lewy Bodies</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008809" MajorTopicYN="N">Mice, Inbred C3H</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016472" MajorTopicYN="N">Motor Neuron Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020125" MajorTopicYN="N">Mutation, Missense</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009410" MajorTopicYN="Y">Nerve Degeneration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017354" MajorTopicYN="N">Point Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013127" MajorTopicYN="N">Spinal Nerves</DescriptorName><QualifierName UI="Q000254" MajorTopicYN="N">growth &amp; development</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013744" MajorTopicYN="N">Tetanus Toxin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>5</Month><Day>6</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>5</Month><Day>28</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>5</Month><Day>6</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12730604</ArticleId><ArticleId IdType="doi">10.1126/science.1083129</ArticleId><ArticleId IdType="pii">300/5620/808</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12730962</PMID><DateCompleted><Year>2003</Year><Month>08</Month><Day>04</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0894-1491</ISSN><JournalIssue CitedMedium="Print"><Volume>42</Volume><Issue>4</Issue><PubDate><Year>2003</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Glia</Title><ISOAbbreviation>Glia</ISOAbbreviation></Journal><ArticleTitle>Expression of complement messenger RNAs and proteins by human oligodendroglial cells.</ArticleTitle><Pagination><StartPage>417</StartPage><EndPage>423</EndPage><MedlinePgn>417-23</MedlinePgn></Pagination><Abstract><AbstractText>Neurons, astrocytes, microglia, and endothelial cells are capable of synthesizing most, if not all, of the complement proteins. Little is known, however, about the capacity of oligodendroglial cells to generate complement components. This study evaluated expression of complement mRNAs and their protein products by human oligodendrocytes. Cells were isolated and cultured from white matter of seven adult cases that had undergone surgical temporal lobe resection for epilepsy. Oligodendroglial cultures were characterized by the expression of such cell type-specific mRNAs as myelin proteolipid protein (PLP), oligodendrocyte-specific protein (OSP), and 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNPase) and were further characterized by immunostaining for such differentiation markers as myelin basic protein (MBP), PLP, CNPase, and O4. RT-PCR analysis showed that the oligodendroglial cells expressed detectable levels of complement mRNAs for the C1q B-chain, C1r, C1s, C2, C3, C4, C5, C6, C7, C8 gamma subunit, and C9. Immunostaining was positive for C1q, C1s, C2, C3, C4, C5, C6, C7, C8, and C9. Double immunostaining for the oligodendrocyte marker O4 and the complement protein C3 demonstrated that all O4-positive cells were also positive for C3, indicating constitutive C3 expression. These results indicate that oligodendroglial cells may be a source of complement proteins in human brain and thus could contribute to the pathogenesis of several neurodegenerative and inflammatory diseases of the CNS, such as Alzheimer's disease, multiple sclerosis, and progressive supranuclear palsy, where complement-activated oligodendrocytes are abundant.</AbstractText><CopyrightInformation>Copyright 2003 Wiley-Liss, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hosokawa</LastName><ForeName>Masato</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klegeris</LastName><ForeName>Andis</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Maguire</LastName><ForeName>John</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>McGeer</LastName><ForeName>Patrick L</ForeName><Initials>PL</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Glia</MedlineTA><NlmUniqueID>8806785</NlmUniqueID><ISSNLinking>0894-1491</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-36-7</RegistryNumber><NameOfSubstance UI="D003165">Complement System Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003165" MajorTopicYN="N">Complement System Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009836" MajorTopicYN="N">Oligodendroglia</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014158" MajorTopicYN="N">Transcription, Genetic</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>5</Month><Day>6</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>8</Month><Day>5</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>5</Month><Day>6</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12730962</ArticleId><ArticleId IdType="doi">10.1002/glia.10234</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12732730</PMID><DateCompleted><Year>2003</Year><Month>07</Month><Day>01</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>100</Volume><Issue>10</Issue><PubDate><Year>2003</Year><Month>May</Month><Day>13</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo.</ArticleTitle><Pagination><StartPage>6221</StartPage><EndPage>6226</EndPage><MedlinePgn>6221-6</MedlinePgn></Pagination><Abstract><AbstractText>Factors that elevate amyloid-beta (Abeta) peptide levels are associated with an increased risk for Alzheimer's disease. Insulysin has been identified as one of several proteases potentially involved in Abeta degradation based on its hydrolysis of Abeta peptides in vitro. In this study, in vivo levels of brain Abeta40 and Abeta42 peptides were found to be increased significantly (1.6- and 1.4-fold, respectively) in an insulysin-deficient gene-trap mouse model. A 6-fold increase in the level of the gamma-secretase-generated C-terminal fragment of the Abeta precursor protein in the insulysin-deficient mouse also was found. In mice heterozygous for the insulysin gene trap, in which insulysin activity levels were decreased approximately 50%, brain Abeta peptides were increased to levels intermediate between those in wild-type mice and homozygous insulysin gene-trap mice that had no detectable insulysin activity. These findings indicate that there is an inverse correlation between in vivo insulysin activity levels and brain Abeta peptide levels and suggest that modulation of insulysin activity may alter the risk for Alzheimer's disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Bonnie C</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, University of Texas Southwestern Medical School, Dallas 75390-9151, USA. bonnie.miller@utsouthwestern.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eckman</LastName><ForeName>Elizabeth A</ForeName><Initials>EA</Initials></Author><Author ValidYN="Y"><LastName>Sambamurti</LastName><ForeName>Kumar</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Dobbs</LastName><ForeName>Nicole</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Chow</LastName><ForeName>K Martin</ForeName><Initials>KM</Initials></Author><Author ValidYN="Y"><LastName>Eckman</LastName><ForeName>Christopher B</ForeName><Initials>CB</Initials></Author><Author ValidYN="Y"><LastName>Hersh</LastName><ForeName>Louis B</ForeName><Initials>LB</Initials></Author><Author ValidYN="Y"><LastName>Thiele</LastName><ForeName>Dwain L</ForeName><Initials>DL</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>N01 DA008801</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>05</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017931">DNA Primers</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.24.56</RegistryNumber><NameOfSubstance UI="D007339">Insulysin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000704" MajorTopicYN="N">Analysis of Variance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017931" MajorTopicYN="N">DNA Primers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007339" MajorTopicYN="N">Insulysin</DescriptorName><QualifierName UI="Q000172" MajorTopicYN="N">deficiency</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008815" MajorTopicYN="N">Mice, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>5</Month><Day>7</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>7</Month><Day>2</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>5</Month><Day>7</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2003</Year><Month>11</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12732730</ArticleId><ArticleId IdType="pmc">PMC156353</ArticleId><ArticleId IdType="doi">10.1073/pnas.1031520100</ArticleId><ArticleId IdType="pii">1031520100</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hardy J, Selkoe D J. Science. 2002;297:353&#x2013;356.</Citation><ArticleIdList><ArticleId IdType="pubmed">12130773</ArticleId></ArticleIdList></Reference><Reference><Citation>Sambamurti K, Greig N H, Lahiri D K. Neuromol Med. 2002;1:1&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">12025813</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal A, Almenar-Queralt A, LeBlanc J F, Roberts E A, Goldstein L S. Nature. 2001;414:643&#x2013;648.</Citation><ArticleIdList><ArticleId IdType="pubmed">11740561</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunan J, Small D H. FEBS Lett. 2000;483:6&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">11033346</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurochkin I V, Goto S. FEBS Lett. 1994;345:33&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">8194595</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu W Q, Ye Z, Kholodenko D, Seubert P, Selkoe D J. J Biol Chem. 1997;272:6641&#x2013;6646.</Citation><ArticleIdList><ArticleId IdType="pubmed">9045694</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu W Q, Walsh D M, Ye Z, Vekrellis K, Zhang J, Podlisny M B, Rosner M R, Safavi A, Hersh L B, Selkoe D J. J Biol Chem. 1998;273:32730&#x2013;32738.</Citation><ArticleIdList><ArticleId IdType="pubmed">9830016</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirsky I A. Recent Prog Horm Res. 1957;13:429&#x2013;435.</Citation><ArticleIdList><ArticleId IdType="pubmed">13477814</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker A B, Roth R A. Methods Enzymol. 1995;248:693&#x2013;703.</Citation><ArticleIdList><ArticleId IdType="pubmed">7674956</ArticleId></ArticleIdList></Reference><Reference><Citation>Safavi A, Miller B C, Cottam L, Hersh L B. Biochemistry. 1996;35:14318&#x2013;14325.</Citation><ArticleIdList><ArticleId IdType="pubmed">8916918</ArticleId></ArticleIdList></Reference><Reference><Citation>Zambrowicz B P, Friedrich G A, Buxton E C, Lilleberg S L, Person C, Sands A T. Nature. 1998;392:608&#x2013;611.</Citation><ArticleIdList><ArticleId IdType="pubmed">9560157</ArticleId></ArticleIdList></Reference><Reference><Citation>Chomczynski P, Saachi N. Anal Biochem. 1987;162:156&#x2013;159.</Citation><ArticleIdList><ArticleId IdType="pubmed">2440339</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen K, Miller B C. J Immunol. 2002;168:4440&#x2013;4445.</Citation><ArticleIdList><ArticleId IdType="pubmed">11970987</ArticleId></ArticleIdList></Reference><Reference><Citation>Duff K, Eckman C, Zehr C, Yu X, Prada C M, Perez-tur J, Hutton M, Buee L, Harigaya Y, Yager D, et al. Nature. 1996;383:710&#x2013;713.</Citation><ArticleIdList><ArticleId IdType="pubmed">8878479</ArticleId></ArticleIdList></Reference><Reference><Citation>Haugabook S J, Le T, Yager D, Zenk B, Healy B M, Eckman E A, Prada C, Younkin L, Murphy P, Pinnix I, et al. FASEB J. 2001;15:16&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">11099491</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinnix I, Musunuru U, Tun H, Sridharan A, Golde T, Eckman C, Ziani-Cherif C, Onstead L, Sambamurti K. J Biol Chem. 2001;276:481&#x2013;487.</Citation><ArticleIdList><ArticleId IdType="pubmed">11035007</ArticleId></ArticleIdList></Reference><Reference><Citation>Affholter J A, Fried V A, Roth R A. Science. 1988;242:1415&#x2013;1418.</Citation><ArticleIdList><ArticleId IdType="pubmed">3059494</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumeister H, Muller D, Rehbein M, Richter D. FEBS Lett. 1993;317:250&#x2013;254.</Citation><ArticleIdList><ArticleId IdType="pubmed">8425612</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakano Y, Kondoh G, Kudo T, Imaizumi K, Kato M, Miyazaki J I, Tohyama M, Takeda J, Takeda M. Eur J Neurosci. 1999;11:2577&#x2013;2581.</Citation><ArticleIdList><ArticleId IdType="pubmed">10383647</ArticleId></ArticleIdList></Reference><Reference><Citation>Holcomb L, Gordon M N, McGowan E, Yu X, Benkovic S, Jantzen P, Wright K, Saad I, Mueller R, Morgan D, et al. Nat Med. 1998;4:97&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">9427614</ArticleId></ArticleIdList></Reference><Reference><Citation>Borchelt D R, Thinakaran G, Eckman C B, Lee M K, Davenport F, Ratovitsky T, Prada C M, Kim G, Seekins S, Yager D, et al. Neuron. 1996;17:1005&#x2013;1013.</Citation><ArticleIdList><ArticleId IdType="pubmed">8938131</ArticleId></ArticleIdList></Reference><Reference><Citation>Citron M, Westaway D, Xia W, Carlson G, Diehl T, Levesque G, Johnson-Wood K, Lee M, Seubert P, Davis A, et al. Nat Med. 1997;3:67&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">8986743</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwata N, Tsubuki S, Takaki Y, Shirotani K, Lu B, Gerard N P, Gerard C, Hama E, Lee H J, Saido T C. Science. 2001;292:1550&#x2013;1552.</Citation><ArticleIdList><ArticleId IdType="pubmed">11375493</ArticleId></ArticleIdList></Reference><Reference><Citation>Eckman E A, Watson M, Marlow L, Sambamurti K, Eckman C B. J Biol Chem. 2003;278:2081&#x2013;2084.</Citation><ArticleIdList><ArticleId IdType="pubmed">12464614</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwata N, Tsubuki S, Takaki Y, Watanabe K, Sekiguchi M, Hosoki E, Kawashima-Morishima M, Lee H J, Hama E, Sekine-Aizawa Y, et al. Nat Med. 2000;6:143&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pubmed">10655101</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukami S, Watanabe K, Iwata N, Haraoka J, Lu B, Gerard N P, Gerard C, Fraser P, Westaway D, St. George-Hyslop P, et al. Neurosci Res. 2002;43:39&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">12074840</ArticleId></ArticleIdList></Reference><Reference><Citation>Seta K A, Roth R A. Biochem Biophys Res Commun. 1997;231:167&#x2013;171.</Citation><ArticleIdList><ArticleId IdType="pubmed">9070242</ArticleId></ArticleIdList></Reference><Reference><Citation>Vekrellis K, Ye Z, Qiu W Q, Walsh D, Hartley D, Chesneau V, Rosner M R, Selkoe D J. J Neurosci. 2000;20:1657&#x2013;1665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772918</ArticleId><ArticleId IdType="pubmed">10684867</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller B C, Thiele D, Hersh L B, Cottam G L. Immunopharmacology. 1996;31:151&#x2013;161.</Citation><ArticleIdList><ArticleId IdType="pubmed">8861741</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudoh S, Frosch M, Wolf B. Biochemistry. 2002;41:1091&#x2013;1099.</Citation><ArticleIdList><ArticleId IdType="pubmed">11802707</ArticleId></ArticleIdList></Reference><Reference><Citation>Edbauer D, Willem M, Lammich S, Steiner H, Haass C. J Biol Chem. 2002;277:13389&#x2013;13393.</Citation><ArticleIdList><ArticleId IdType="pubmed">11809755</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao X, Sudhof T C. Science. 2001;293:115&#x2013;120.</Citation><ArticleIdList><ArticleId IdType="pubmed">11441186</ArticleId></ArticleIdList></Reference><Reference><Citation>Passer B, Pellegrini L, Russo C, Siegel R M, Lenardo M J, Schettini G, Bachmann M, Tabaton M, D'Adamio L. J Alzheimers Dis. 2000;2:289&#x2013;301.</Citation><ArticleIdList><ArticleId IdType="pubmed">12214090</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu D C, Rabizadeh S, Chandra S, Shayya R F, Ellerby L M, Ye X, Salvesen G S, Koo E H, Bredesen D E. Nat Med. 2000;6:397&#x2013;404.</Citation><ArticleIdList><ArticleId IdType="pubmed">10742146</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertrand E, Brouillet E, Caille I, Bouillot C, Cole G, Prochiantz A, Allinquant B. Mol Cell Neurosci. 2001;18:503&#x2013;511.</Citation><ArticleIdList><ArticleId IdType="pubmed">11922141</ArticleId></ArticleIdList></Reference><Reference><Citation>Selkoe D J. Neuron. 2001;32:177&#x2013;180.</Citation><ArticleIdList><ArticleId IdType="pubmed">11683988</ArticleId></ArticleIdList></Reference><Reference><Citation>Carson J A, Turner A J. J Neurochem. 2002;81:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">12067222</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee A, Hersh L B. J Alzheimers Dis. 2002;4:341&#x2013;348.</Citation><ArticleIdList><ArticleId IdType="pubmed">12446966</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12740439</PMID><DateCompleted><Year>2003</Year><Month>07</Month><Day>16</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>100</Volume><Issue>11</Issue><PubDate><Year>2003</Year><Month>May</Month><Day>27</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Gamma-secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2.</ArticleTitle><Pagination><StartPage>6382</StartPage><EndPage>6387</EndPage><MedlinePgn>6382-7</MedlinePgn></Pagination><Abstract><AbstractText>gamma-Secretase catalyzes the intramembrane proteolysis of Notch, beta-amyloid precursor protein, and other substrates as part of a new signaling paradigm and as a key step in the pathogenesis of Alzheimer's disease. This unusual protease has eluded identification, though evidence suggests that the presenilin heterodimer comprises the catalytic site and that a highly glycosylated form of nicastrin associates with it. The formation of presenilin heterodimers from the holoprotein is tightly gated by unknown limiting cellular factors. Here we show that Aph-1 and Pen-2, two recently identified membrane proteins genetically linked to gamma-secretase, associate directly with presenilin and nicastrin in the active protease complex. Coexpression of all four proteins leads to marked increases in presenilin heterodimers, full glycosylation of nicastrin, and enhanced gamma-secretase activity. These findings suggest that the four membrane proteins comprise the limiting components of gamma-secretase and coassemble to form the active enzyme in mammalian cells.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kimberly</LastName><ForeName>W Taylor</ForeName><Initials>WT</Initials><AffiliationInfo><Affiliation>Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>LaVoie</LastName><ForeName>Matthew J</ForeName><Initials>MJ</Initials></Author><Author ValidYN="Y"><LastName>Ostaszewski</LastName><ForeName>Beth L</ForeName><Initials>BL</Initials></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Wenjuan</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Wolfe</LastName><ForeName>Michael S</ForeName><Initials>MS</Initials></Author><Author ValidYN="Y"><LastName>Selkoe</LastName><ForeName>Dennis J</ForeName><Initials>DJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>05</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C405066">APH-1 protein, C elegans</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D029742">Caenorhabditis elegans Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018398">Homeodomain Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008562">Membrane Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C413604">nicastrin protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D053829">Amyloid Precursor Protein Secretases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010450">Endopeptidases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D053829" MajorTopicYN="N">Amyloid Precursor Protein Secretases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029742" MajorTopicYN="Y">Caenorhabditis elegans Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003412" MajorTopicYN="N">Cricetulus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010450" MajorTopicYN="N">Endopeptidases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018398" MajorTopicYN="N">Homeodomain Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008562" MajorTopicYN="N">Membrane Glycoproteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>5</Month><Day>13</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>7</Month><Day>17</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>5</Month><Day>13</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2003</Year><Month>11</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12740439</ArticleId><ArticleId IdType="pmc">PMC164455</ArticleId><ArticleId IdType="doi">10.1073/pnas.1037392100</ArticleId><ArticleId IdType="pii">1037392100</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown, M. S., Ye, J., Rawson, R. B. &amp; Goldstein, J. L. (2000) Cell 100, 391&#x2013;398.</Citation><ArticleIdList><ArticleId IdType="pubmed">10693756</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfe, M. S. &amp; Selkoe, D. J. (2002) Science 296, 2156&#x2013;2157.</Citation><ArticleIdList><ArticleId IdType="pubmed">12077393</ArticleId></ArticleIdList></Reference><Reference><Citation>Selkoe, D. J. (2001) Physiol. Rev. 81, 741&#x2013;766.</Citation><ArticleIdList><ArticleId IdType="pubmed">11274343</ArticleId></ArticleIdList></Reference><Reference><Citation>Thinakaran, G., Borchelt, D. R., Lee, M. K., Slunt, H. H., Spitzer, L., Kim, G., Ratovitsky, T., Davenport, F., Nordstedt, C., Seeger, M., et al. (1996) Neuron 17, 181&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pubmed">8755489</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, Y. M., Xu, M., Lai, M. T., Huang, Q., Castro, J. L., DiMuzio-Mower, J., Harrison, T., Lellis, C., Nadin, A., Neduvelil, J. G., et al. (2000) Nature 405, 689&#x2013;694.</Citation><ArticleIdList><ArticleId IdType="pubmed">10864326</ArticleId></ArticleIdList></Reference><Reference><Citation>Esler, W. P., Kimberly, W. T., Ostaszewski, B. L., Diehl, T. S., Moore, C. L., Tsai, J. Y., Rahmati, T., Xia, W., Selkoe, D. J. &amp; Wolfe, M. S. (2000) Nat. Cell Biol. 2, 428&#x2013;434.</Citation><ArticleIdList><ArticleId IdType="pubmed">10878808</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfe, M. S., Xia, W., Ostaszewski, B. L., Diehl, T. S., Kimberly, W. T. &amp; Selkoe, D. J. (1999) Nature 398, 513&#x2013;517.</Citation><ArticleIdList><ArticleId IdType="pubmed">10206644</ArticleId></ArticleIdList></Reference><Reference><Citation>De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Gundula, G., Annaert, W., Von Figura, K. &amp; Van Leuven, F. (1998) Nature 391, 387&#x2013;390.</Citation><ArticleIdList><ArticleId IdType="pubmed">9450754</ArticleId></ArticleIdList></Reference><Reference><Citation>Steiner, H., Kostka, M., Romig, H., Basset, G., Pesold, B., Hardy, J., Capell, A., Meyn, L., Grim, M. L., Baumeister, R., et al. (2000) Nat. Cell Biol. 2, 848&#x2013;851.</Citation><ArticleIdList><ArticleId IdType="pubmed">11056541</ArticleId></ArticleIdList></Reference><Reference><Citation>Thinakaran, G., Harris, C. L., Ratovitski, T., Davenport, F., Slunt, H. H., Price, D. L., Borchelt, D. R. &amp; Sisodia, S. S. (1997) J. Biol. Chem. 272, 28415&#x2013;28422.</Citation><ArticleIdList><ArticleId IdType="pubmed">9353300</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu, G., Nishimura, M., Arawaka, S., Levitan, D., Zhang, L., Tandon, A., Song, Y. Q., Rogaeva, E., Chen, F., Kawarai, T., et al. (2000) Nature 407, 48&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">10993067</ArticleId></ArticleIdList></Reference><Reference><Citation>Levitan, D., Yu, G., St George Hyslop, P. &amp; Goutte, C. (2001) Dev. Biol. 240, 654&#x2013;661.</Citation><ArticleIdList><ArticleId IdType="pubmed">11784090</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung, H. M. &amp; Struhl, G. (2001) Nat. Cell Biol. 3, 1129&#x2013;1132.</Citation><ArticleIdList><ArticleId IdType="pubmed">11781576</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Schier, H. &amp; St. Johnston, D. (2002) Dev. Cell 2, 79&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">11782316</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu, Y., Ye, Y. &amp; Fortini, M. E. (2002) Dev. Cell 2, 69&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">11782315</ArticleId></ArticleIdList></Reference><Reference><Citation>Edbauer, D., Winkler, E., Haass, C. &amp; Steiner, H. (2002) Proc. Natl. Acad. Sci. USA 99, 8666&#x2013;8671.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC124353</ArticleId><ArticleId IdType="pubmed">12048259</ArticleId></ArticleIdList></Reference><Reference><Citation>Leem, J. Y., Vijayan, S., Han, P., Cai, D., Machura, M., Lopes, K. O., Veselits, M. L., Xu, H. &amp; Thinakaran, G. (2002) J. Biol. Chem. 277, 19236&#x2013;19240.</Citation><ArticleIdList><ArticleId IdType="pubmed">11943765</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomita, T., Katayama, R., Takikawa, R. &amp; Iwatsubo, T. (2002) FEBS Lett. 520, 117&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="pubmed">12044882</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimberly, W. T., LaVoie, M. J., Ostaszewski, B. L., Ye, W., Wolfe, M. S. &amp; Selkoe, D. J. (2002) J. Biol. Chem. 277, 35113&#x2013;35117.</Citation><ArticleIdList><ArticleId IdType="pubmed">12130643</ArticleId></ArticleIdList></Reference><Reference><Citation>Esler, W. P., Kimberly, W. T., Ostaszewski, B. L., Ye, W., Diehl, T. S., Selkoe, D. J. &amp; Wolfe, M. S. (2002) Proc. Natl. Acad. Sci. USA 99, 2720&#x2013;2725.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC122414</ArticleId><ArticleId IdType="pubmed">11867728</ArticleId></ArticleIdList></Reference><Reference><Citation>Goutte, C., Tsunozaki, M., Hale, V. A. &amp; Priess, J. R. (2002) Proc. Natl. Acad. Sci. USA 99, 775&#x2013;779.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC117381</ArticleId><ArticleId IdType="pubmed">11792846</ArticleId></ArticleIdList></Reference><Reference><Citation>Francis, R., McGrath, G., Zhang, J., Ruddy, D. A., Sym, M., Apfeld, J., Nicoll, M., Maxwell, M., Hai, B., Ellis, M. C., et al. (2002) Dev. Cell 3, 85&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">12110170</ArticleId></ArticleIdList></Reference><Reference><Citation>Schagger, H. &amp; von Jagow, G. (1991) Anal. Biochem. 199, 223&#x2013;231.</Citation><ArticleIdList><ArticleId IdType="pubmed">1812789</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia, W., Zhang, J., Kholodenko, D., Citron, M, Podlisny, M. B., Teplow, D. B., Haass, C., Seubert, P., Koo, E. H. &amp; Selkoe, D. J. (1997) J. Biol. Chem. 272, 7977&#x2013;7982.</Citation><ArticleIdList><ArticleId IdType="pubmed">9065468</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, D. S., Tandon, A., Chen, F., Yu, G., Yu, H., Arawaka, S., Hasegawa, H., Duthie, M., Schmidt, S. D., Ramabhadran, T. V., et al. (2002) J. Biol. Chem. 277, 28135&#x2013;28142.</Citation><ArticleIdList><ArticleId IdType="pubmed">12032140</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, Y.-M., Lai, M.-T., Xu, M., Huang, Q., DiMuzio-Mower, J., Sardana, M. K., Shi, X.-P., Yin, K.-C., Shafer, J. A. &amp; Gardell, S. J. (2000) Proc. Natl. Acad. Sci. USA 97, 6138&#x2013;6143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC18571</ArticleId><ArticleId IdType="pubmed">10801983</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu, G., Chen, F., Levesque, G., Nishimura, M., Zhang, D. M., Levesque, L., Rogaeva, E., Xu, D., Liang, Y., Duthie, M., et al. (1998) J. Biol. Chem. 273, 16470&#x2013;16475.</Citation><ArticleIdList><ArticleId IdType="pubmed">9632714</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimberly, W. T., Esler, W. P., Ye, W., Ostaszewski, B. L., Gao, J., Diehl, T., Selkoe, D. J. &amp; Wolfe, M. S. (2003) Biochemistry 42, 137&#x2013;144.</Citation><ArticleIdList><ArticleId IdType="pubmed">12515548</ArticleId></ArticleIdList></Reference><Reference><Citation>Steiner, H., Winkler, E., Edbauer, D., Prokop, S., Basset, G., Yamasaki, A., Kostka, M. &amp; Haass, C. (2002) J. Biol. Chem. 277, 39062&#x2013;39065.</Citation><ArticleIdList><ArticleId IdType="pubmed">12198112</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12741986</PMID><DateCompleted><Year>2003</Year><Month>06</Month><Day>10</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0896-6273</ISSN><JournalIssue CitedMedium="Print"><Volume>38</Volume><Issue>3</Issue><PubDate><Year>2003</Year><Month>May</Month><Day>08</Day></PubDate></JournalIssue><Title>Neuron</Title><ISOAbbreviation>Neuron</ISOAbbreviation></Journal><ArticleTitle>Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice.</ArticleTitle><Pagination><StartPage>375</StartPage><EndPage>387</EndPage><MedlinePgn>375-87</MedlinePgn></Pagination><Abstract><AbstractText>Polyglutamine-induced neurodegeneration in transgenic mice carrying the spinocerebellar ataxia type 1 (SCA1) gene is modulated by subcellular distribution of ataxin-1 and by components of the protein folding/degradation machinery. Since phosphorylation is a prominent mechanism by which these processes are regulated, we examined phosphorylation of ataxin-1 and found that serine 776 (S776) was phosphorylated. Residue 776 appeared to affect cellular deposition of ataxin-1[82Q] in that ataxin-1[82Q]-A776 failed to form nuclear inclusions in tissue culture cells. The importance of S776 for polyglutamine-induced pathogenesis was examined by generating ataxin-1[82Q]-A776 transgenic mice. These mice expressed ataxin-1[82Q]-A776 within Purkinje cell nuclei, yet the ability of ataxin-1[82Q]-A776 to induce disease was substantially reduced. These studies demonstrate that polyglutamine tract expansion and localization of ataxin-1 to the nucleus of Purkinje cells are not sufficient to induce disease. We suggest that S776 of ataxin-1 also has a critical role in SCA1 pathogenesis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Emamian</LastName><ForeName>Effat S</ForeName><Initials>ES</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine and Pathology, University of Minnesota, Mayo Mail Code 206, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaytor</LastName><ForeName>Michael D</ForeName><Initials>MD</Initials></Author><Author ValidYN="Y"><LastName>Duvick</LastName><ForeName>Lisa A</ForeName><Initials>LA</Initials></Author><Author ValidYN="Y"><LastName>Zu</LastName><ForeName>Tao</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Tousey</LastName><ForeName>Susan K</ForeName><Initials>SK</Initials></Author><Author ValidYN="Y"><LastName>Zoghbi</LastName><ForeName>Huda Y</ForeName><Initials>HY</Initials></Author><Author ValidYN="Y"><LastName>Clark</LastName><ForeName>H Brent</ForeName><Initials>HB</Initials></Author><Author ValidYN="Y"><LastName>Orr</LastName><ForeName>Harry T</ForeName><Initials>HT</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NS22920</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS27699</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuron</MedlineTA><NlmUniqueID>8809320</NlmUniqueID><ISSNLinking>0896-6273</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000067696">Ataxin-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000067528">Ataxins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000593750">Atxn1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009687">Nuclear Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>26700-71-0</RegistryNumber><NameOfSubstance UI="C097188">polyglutamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>452VLY9402</RegistryNumber><NameOfSubstance UI="D012694">Serine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067696" MajorTopicYN="N">Ataxin-1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067528" MajorTopicYN="N">Ataxins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016466" MajorTopicYN="N">CHO Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019556" MajorTopicYN="N">COS Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002467" MajorTopicYN="N">Cell Nucleus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002479" MajorTopicYN="N">Inclusion Bodies</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009687" MajorTopicYN="N">Nuclear Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011689" MajorTopicYN="N">Purkinje Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012694" MajorTopicYN="N">Serine</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020754" MajorTopicYN="N">Spinocerebellar Ataxias</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019680" MajorTopicYN="N">Trinucleotide Repeat Expansion</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>5</Month><Day>14</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>6</Month><Day>11</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>5</Month><Day>14</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12741986</ArticleId><ArticleId IdType="doi">10.1016/s0896-6273(03)00258-7</ArticleId><ArticleId IdType="pii">S0896627303002587</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12748381</PMID><DateCompleted><Year>2003</Year><Month>07</Month><Day>16</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>100</Volume><Issue>11</Issue><PubDate><Year>2003</Year><Month>May</Month><Day>27</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Mice lacking methyl-CpG binding protein 1 have deficits in adult neurogenesis and hippocampal function.</ArticleTitle><Pagination><StartPage>6777</StartPage><EndPage>6782</EndPage><MedlinePgn>6777-82</MedlinePgn></Pagination><Abstract><AbstractText>DNA methylation-mediated epigenetic regulation plays critical roles in regulating mammalian gene expression, but its role in normal brain function is not clear. Methyl-CpG binding protein 1 (MBD1), a member of the methylated DNA-binding protein family, has been shown to bind methylated gene promoters and facilitate transcriptional repression in vitro. Here we report the generation and analysis of MBD1-/- mice. MBD1-/- mice had no detectable developmental defects and appeared healthy throughout life. However, we found that MBD1-/- neural stem cells exhibited reduced neuronal differentiation and increased genomic instability. Furthermore, adult MBD1-/- mice had decreased neurogenesis, impaired spatial learning, and a significant reduction in long-term potentiation in the dentate gyrus of the hippocampus. Our findings indicate that DNA methylation is important in maintaining cellular genomic stability and is crucial for normal neural stem cell and brain functions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Xinyu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ueba</LastName><ForeName>Tetsuya</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Christie</LastName><ForeName>Brian R</ForeName><Initials>BR</Initials></Author><Author ValidYN="Y"><LastName>Barkho</LastName><ForeName>Basam</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>McConnell</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials></Author><Author ValidYN="Y"><LastName>Nakashima</LastName><ForeName>Kinichi</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Lein</LastName><ForeName>Edward S</ForeName><Initials>ES</Initials></Author><Author ValidYN="Y"><LastName>Eadie</LastName><ForeName>Brennan D</ForeName><Initials>BD</Initials></Author><Author ValidYN="Y"><LastName>Willhoite</LastName><ForeName>Andrew R</ForeName><Initials>AR</Initials></Author><Author ValidYN="Y"><LastName>Muotri</LastName><ForeName>Alysson R</ForeName><Initials>AR</Initials></Author><Author ValidYN="Y"><LastName>Summers</LastName><ForeName>Robert G</ForeName><Initials>RG</Initials></Author><Author ValidYN="Y"><LastName>Chun</LastName><ForeName>Jerold</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Kuo-Fen</ForeName><Initials>KF</Initials></Author><Author ValidYN="Y"><LastName>Gage</LastName><ForeName>Fred H</ForeName><Initials>FH</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>F32 NS010826</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>05</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018899" MajorTopicYN="Y">CpG Islands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>5</Month><Day>16</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>7</Month><Day>17</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>5</Month><Day>16</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2003</Year><Month>11</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12748381</ArticleId><ArticleId IdType="pmc">PMC164523</ArticleId><ArticleId IdType="doi">10.1073/pnas.1131928100</ArticleId><ArticleId IdType="pii">1131928100</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bird, A. (2002) Genes Dev. 16, 6-21.</Citation><ArticleIdList><ArticleId IdType="pubmed">11782440</ArticleId></ArticleIdList></Reference><Reference><Citation>Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U. &amp; Zoghbi, H. Y. (1999) Nat. Genet. 23, 185-188.</Citation><ArticleIdList><ArticleId IdType="pubmed">10508514</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahbazian, M., Young, J., Yuva-Paylor, L., Spencer, C., Antalffy, B., Noebels, J., Armstrong, D., Paylor, R. &amp; Zoghbi, H. (2002) Neuron 35, 243-254.</Citation><ArticleIdList><ArticleId IdType="pubmed">12160743</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, R. Z., Akbarian, S., Tudor, M. &amp; Jaenisch, R. (2001) Nat. Genet. 27, 327-331.</Citation><ArticleIdList><ArticleId IdType="pubmed">11242118</ArticleId></ArticleIdList></Reference><Reference><Citation>Guy, J., Hendrich, B., Holmes, M., Martin, J. E. &amp; Bird, A. (2001) Nat. Genet. 27, 322-326.</Citation><ArticleIdList><ArticleId IdType="pubmed">11242117</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendrich, B., Guy, J., Ramsahoye, B., Wilson, V. A. &amp; Bird, A. (2001) Genes Dev. 15, 710-723.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC312657</ArticleId><ArticleId IdType="pubmed">11274056</ArticleId></ArticleIdList></Reference><Reference><Citation>Millar, C. B., Guy, J., Sansom, O. J., Selfridge, J., MacDougall, E., Hendrich, B., Keightley, P. D., Bishop, S. M., Clarke, A. R. &amp; Bird, A. (2002) Science 297, 403-405.</Citation><ArticleIdList><ArticleId IdType="pubmed">12130785</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohki, I., Shimotake, N., Fujita, N., Jee, J., Ikegami, T., Nakao, M. &amp; Shirakawa, M. (2001) Cell 105, 487-497.</Citation><ArticleIdList><ArticleId IdType="pubmed">11371345</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujita, N., Shimotake, N., Ohki, I., Chiba, T., Saya, H., Shirakawa, M. &amp; Nakao, M. (2000) Mol. Cell. Biol. 20, 5107-5118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC85960</ArticleId><ArticleId IdType="pubmed">10866667</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng, H. H., Jeppesen, P. &amp; Bird, A. (2000) Mol. Cell. Biol. 20, 1394-1406.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC85293</ArticleId><ArticleId IdType="pubmed">10648624</ArticleId></ArticleIdList></Reference><Reference><Citation>Bestor, T. H. &amp; Verdine, G. L. (1994) Curr. Opin. Cell Biol. 6, 380-389.</Citation><ArticleIdList><ArticleId IdType="pubmed">7917329</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeleznik-Le, N. J., Harden, A. M. &amp; Rowley, J. D. (1994) Proc. Natl. Acad. Sci. USA 91, 10610-10614.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC45071</ArticleId><ArticleId IdType="pubmed">7938000</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu, Y., Nakamura, T., Alder, H., Prasad, R., Canaani, O., Cimino, G., Croce, C. M. &amp; Canaani, E. (1992) Cell 71, 701-708.</Citation><ArticleIdList><ArticleId IdType="pubmed">1423625</ArticleId></ArticleIdList></Reference><Reference><Citation>Voo, K. S., Carlone, D. L., Jacobsen, B. M., Flodin, A. &amp; Skalnik, D. G. (2000) Mol. Cell. Biol. 20, 2108-2121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC110827</ArticleId><ArticleId IdType="pubmed">10688657</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujita, N., Takebayashi, S., Okumura, K., Kudo, S., Chiba, T., Saya, H. &amp; Nakao, M. (1999) Mol. Cell. Biol. 19, 6415-6426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC84611</ArticleId><ArticleId IdType="pubmed">10454587</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendrich, B., Abbott, C., McQueen, H., Chambers, D., Cross, S. &amp; Bird, A. (1999) Mamm. Genome 10, 906-912.</Citation><ArticleIdList><ArticleId IdType="pubmed">10441743</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, E., Bestor, T. H. &amp; Jaenisch, R. (1992) Cell 69, 915-926.</Citation><ArticleIdList><ArticleId IdType="pubmed">1606615</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan, K. M., Norwood, T., Gimelli, G., Gartler, S. M. &amp; Hansen, R. S. (2001) Hum. Genet. 109, 452-462.</Citation><ArticleIdList><ArticleId IdType="pubmed">11702227</ArticleId></ArticleIdList></Reference><Reference><Citation>Tucker, K. L. (2001) Neuron 30, 649-652.</Citation><ArticleIdList><ArticleId IdType="pubmed">11430798</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan, G., Beard, C., Chen, R. Z., Csankovszki, G., Sun, Y., Siniaia, M., Biniszkiewicz, D., Bates, B., Lee, P. P., Kuhn, R., et al. (2001) J. Neurosci. 21, 788-797.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6762314</ArticleId><ArticleId IdType="pubmed">11157065</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson-Grusby, L., Beard, C., Possemato, R., Tudor, M., Fambrough, D., Csankovszki, G., Dausman, J., Lee, P., Wilson, C., Lander, E. &amp; Jaenisch, R. (2001) Nat. Genet. 27, 31-39.</Citation><ArticleIdList><ArticleId IdType="pubmed">11137995</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh, C. P., Chaillet, J. R. &amp; Bestor, T. H. (1998) Nat. Genet. 20, 116-117.</Citation><ArticleIdList><ArticleId IdType="pubmed">9771701</ArticleId></ArticleIdList></Reference><Reference><Citation>Gage, F. H. (2000) Science 287, 1433-1438.</Citation><ArticleIdList><ArticleId IdType="pubmed">10688783</ArticleId></ArticleIdList></Reference><Reference><Citation>van Praag, H., Christie, B. R., Sejnowski, T. J. &amp; Gage, F. H. (1999) Proc. Natl. Acad. Sci. USA 96, 13427-13431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC23964</ArticleId><ArticleId IdType="pubmed">10557337</ArticleId></ArticleIdList></Reference><Reference><Citation>Lein, E. S., Hohn, A. &amp; Shatz, C. J. (2000) J. Comp. Neurol. 420, 1-18.</Citation><ArticleIdList><ArticleId IdType="pubmed">10745216</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao, X., Lein, E. S., He, A., Smith, S. C., Aston, C. &amp; Gage, F. H. (2001) J. Comp. Neurol. 441, 187-196.</Citation><ArticleIdList><ArticleId IdType="pubmed">11745644</ArticleId></ArticleIdList></Reference><Reference><Citation>Barch, M. J., Knutsen, T. &amp; Spurbeck, J. L. (1997) The AGT Cytogenetics Laboratory Manual (Lippincott, Philadelphia).</Citation></Reference><Reference><Citation>Rehen, S. K., McConnell, M. J., Kaushal, D., Kingsbury, M. A., Yang, A. H. &amp; Chun, J. (2001) Proc. Natl. Acad. Sci. USA 98, 13361-13366.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC60876</ArticleId><ArticleId IdType="pubmed">11698687</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen, D. M., van Praag, H., Ray, J., Weaver, Z., Winrow, C. J., Carter, T. A., Braquet, R., Harrington, E., Ried, T., Brown, K. D., et al. (2001) Genes Dev. 15, 554-566.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC312645</ArticleId><ArticleId IdType="pubmed">11238376</ArticleId></ArticleIdList></Reference><Reference><Citation>Crawley, J. N. (1999) Brain Res. 835, 18-26.</Citation><ArticleIdList><ArticleId IdType="pubmed">10448192</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempermann, G., Brandon, E. P. &amp; Gage, F. H. (1998) Curr. Biol. 8, 939-942.</Citation><ArticleIdList><ArticleId IdType="pubmed">9707406</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoder, J. A., Walsh, C. P. &amp; Bestor, T. H. (1997) Trends Genet. 13, 335-340.</Citation><ArticleIdList><ArticleId IdType="pubmed">9260521</ArticleId></ArticleIdList></Reference><Reference><Citation>van Gent, D. C., Hoeijmakers, J. H. &amp; Kanaar, R. (2001) Nat. Rev. Genet. 2, 196-206.</Citation><ArticleIdList><ArticleId IdType="pubmed">11256071</ArticleId></ArticleIdList></Reference><Reference><Citation>Laird, P. W. &amp; Jaenisch, R. (1996) Annu. Rev. Genet. 30, 441-464.</Citation><ArticleIdList><ArticleId IdType="pubmed">8982461</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, R. Z., Pettersson, U., Beard, C., Jackson-Grusby, L. &amp; Jaenisch, R. (1998) Nature 395, 89-93.</Citation><ArticleIdList><ArticleId IdType="pubmed">9738504</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandel, E. R. (2001) Science 294, 1030-1038.</Citation><ArticleIdList><ArticleId IdType="pubmed">11691980</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorincz, M. C., Schubeler, D. &amp; Groudine, M. (2001) Mol. Cell. Biol. 21, 7913-7922.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC99960</ArticleId><ArticleId IdType="pubmed">11689684</ArticleId></ArticleIdList></Reference><Reference><Citation>Esteller, M. &amp; Herman, J. G. (2002) J. Pathol. 196, 1-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">11748635</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12750520</PMID><DateCompleted><Year>2003</Year><Month>06</Month><Day>23</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1095-9203</ISSN><JournalIssue CitedMedium="Internet"><Volume>300</Volume><Issue>5622</Issue><PubDate><Year>2003</Year><Month>May</Month><Day>16</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>Mitochondrial dysfunction in the elderly: possible role in insulin resistance.</ArticleTitle><Pagination><StartPage>1140</StartPage><EndPage>1142</EndPage><MedlinePgn>1140-2</MedlinePgn></Pagination><Abstract><AbstractText>Insulin resistance is a major factor in the pathogenesis of type 2 diabetes in the elderly. To investigate how insulin resistance arises, we studied healthy, lean, elderly and young participants matched for lean body mass and fat mass. Elderly study participants were markedly insulin-resistant as compared with young controls, and this resistance was attributable to reduced insulin-stimulated muscle glucose metabolism. These changes were associated with increased fat accumulation in muscle and liver tissue assessed by 1H nuclear magnetic resonance (NMR) spectroscopy, and with a approximately 40% reduction in mitochondrial oxidative and phosphorylation activity, as assessed by in vivo 13C/31P NMR spectroscopy. These data support the hypothesis that an age-associated decline in mitochondrial function contributes to insulin resistance in the elderly.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Petersen</LastName><ForeName>Kitt Falk</ForeName><Initials>KF</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Befroy</LastName><ForeName>Douglas</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Dufour</LastName><ForeName>Sylvie</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Dziura</LastName><ForeName>James</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Ariyan</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Rothman</LastName><ForeName>Douglas L</ForeName><Initials>DL</Initials></Author><Author ValidYN="Y"><LastName>DiPietro</LastName><ForeName>Loretta</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Cline</LastName><ForeName>Gary W</ForeName><Initials>GW</Initials></Author><Author ValidYN="Y"><LastName>Shulman</LastName><ForeName>Gerald I</ForeName><Initials>GI</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 DK049230</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P60 AG-10469</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K-23 DK-02347</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG-09872</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 DK-45735</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG023686</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 DK-49230</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>M01 RR-00125</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>M01 RR000125</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 DK045735</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 DK002734</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014280">Triglycerides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000273" MajorTopicYN="N">Adipose Tissue</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="N">Blood Glucose</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007333" MajorTopicYN="Y">Insulin Resistance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D028361" MajorTopicYN="N">Mitochondrial Diseases</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019906" MajorTopicYN="N">Nuclear Magnetic Resonance, Biomolecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010101" MajorTopicYN="N">Oxygen Consumption</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014280" MajorTopicYN="N">Triglycerides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>5</Month><Day>17</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>6</Month><Day>24</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>5</Month><Day>17</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2010</Year><Month>12</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12750520</ArticleId><ArticleId IdType="mid">NIHMS251032</ArticleId><ArticleId IdType="pmc">PMC3004429</ArticleId><ArticleId IdType="doi">10.1126/science.1082889</ArticleId><ArticleId IdType="pii">300/5622/1140</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>King H, Aubert RE, Herman WH. Diabetes Care. 1998;21:1414.</Citation><ArticleIdList><ArticleId IdType="pubmed">9727886</ArticleId></ArticleIdList></Reference><Reference><Citation>Huse DM, Oster G, Killen AR, Lacey MJ, Colditz GA. JAMA. 1989;262:2708.</Citation><ArticleIdList><ArticleId IdType="pubmed">2509743</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki A, Suzuki T, Horiuchi N. Diabetologia. 1982;22:154.</Citation><ArticleIdList><ArticleId IdType="pubmed">7075915</ArticleId></ArticleIdList></Reference><Reference><Citation>Saad MF, et al. Lancet. 1989;1:1356.</Citation><ArticleIdList><ArticleId IdType="pubmed">2567374</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe JW, Minaker KL, Pallotta JA, Flier JS. J Clin Invest. 1983;71:1581.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC370364</ArticleId><ArticleId IdType="pubmed">6345585</ArticleId></ArticleIdList></Reference><Reference><Citation>Reaven GM. Physiol Rev. 1995;75:473.</Citation><ArticleIdList><ArticleId IdType="pubmed">7624391</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson AB, et al. Clin Sci (London) 1992;82:219.</Citation><ArticleIdList><ArticleId IdType="pubmed">1311661</ArticleId></ArticleIdList></Reference><Reference><Citation>Krssak M, et al. Diabetologia. 1999;42:113.</Citation><ArticleIdList><ArticleId IdType="pubmed">10027589</ArticleId></ArticleIdList></Reference><Reference><Citation>Perseghin G, et al. Diabetes. 1999;48:1600.</Citation><ArticleIdList><ArticleId IdType="pubmed">10426379</ArticleId></ArticleIdList></Reference><Reference><Citation>Szczepaniak LS, et al. Am J Physiol. 1999;276:E977.</Citation><ArticleIdList><ArticleId IdType="pubmed">10329993</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen KF, et al. J Clin Invest. 2002;109:1345.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC150981</ArticleId><ArticleId IdType="pubmed">12021250</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraegen EW, et al. Diabetes. 1991;40:1397.</Citation><ArticleIdList><ArticleId IdType="pubmed">1936601</ArticleId></ArticleIdList></Reference><Reference><Citation>Seppala-Lindroos A, et al. J Clin Endocrinol Metab. 2002;87:3023.</Citation><ArticleIdList><ArticleId IdType="pubmed">12107194</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin ME, et al. Diabetes. 1999;48:1270.</Citation><ArticleIdList><ArticleId IdType="pubmed">10342815</ArticleId></ArticleIdList></Reference><Reference><Citation>Dresner A, et al. J Clin Invest. 1999;103:253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC407880</ArticleId><ArticleId IdType="pubmed">9916137</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu C, et al. J Biol Chem. 2002;277:50230.</Citation><ArticleIdList><ArticleId IdType="pubmed">12006582</ArticleId></ArticleIdList></Reference><Reference><Citation>Itani SI, Ruderman NB, Schmieder F, Boden G. Diabetes. 2002;51:2005.</Citation><ArticleIdList><ArticleId IdType="pubmed">12086926</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JK, et al. Proc Natl Acad Sci USA. 2001;98:7522.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Boden G, Chen X, Ruiz J, White JV, Rossetti L. J Clin Invest. 1994;93:2438.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC294452</ArticleId><ArticleId IdType="pubmed">8200979</ArticleId></ArticleIdList></Reference><Reference><Citation>Roden M, et al. J Clin Invest. 1996;97:2859.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC507380</ArticleId><ArticleId IdType="pubmed">8675698</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen KF, et al. Diabetes. 1998;47:381.</Citation><ArticleIdList><ArticleId IdType="pubmed">9519743</ArticleId></ArticleIdList></Reference><Reference><Citation>Baecke JA, Burema J, Frijters JE. Am J Clin Nutr. 1982;36:936.</Citation><ArticleIdList><ArticleId IdType="pubmed">7137077</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelley DE, He J, Menshikova EV, Ritov VB. Diabetes. 2002;51:2944.</Citation><ArticleIdList><ArticleId IdType="pubmed">12351431</ArticleId></ArticleIdList></Reference><Reference><Citation>Shulman GI. J Clin Invest. 2000;106:171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC314317</ArticleId><ArticleId IdType="pubmed">10903330</ArticleId></ArticleIdList></Reference><Reference><Citation>Lebon V, et al. J Clin Invest. 2001;108:733.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC209375</ArticleId><ArticleId IdType="pubmed">11544279</ArticleId></ArticleIdList></Reference><Reference><Citation>Trounce I, Byrne E, Marzuki S. Lancet. 1989;1:637.</Citation><ArticleIdList><ArticleId IdType="pubmed">2564459</ArticleId></ArticleIdList></Reference><Reference><Citation>Michikawa Y, Mazzucchelli F, Bresolin N, Scarlato G, Attardi G. Science. 1999;286:774.</Citation><ArticleIdList><ArticleId IdType="pubmed">10531063</ArticleId></ArticleIdList></Reference><Reference><Citation>Harman D. J Am Geriatr Soc. 1972;20:145.</Citation><ArticleIdList><ArticleId IdType="pubmed">5016631</ArticleId></ArticleIdList></Reference><Reference><Citation>Linnane AW, Marzuki S, Ozawa T, Tanaka M. Lancet. 1989;1:642.</Citation><ArticleIdList><ArticleId IdType="pubmed">2564461</ArticleId></ArticleIdList></Reference><Reference><Citation>Luft R, Luthman H. Lakartidningen. 1993;90:2770.</Citation><ArticleIdList><ArticleId IdType="pubmed">8366714</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12750521</PMID><DateCompleted><Year>2003</Year><Month>06</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1095-9203</ISSN><JournalIssue CitedMedium="Internet"><Volume>300</Volume><Issue>5622</Issue><PubDate><Year>2003</Year><Month>May</Month><Day>16</Day></PubDate></JournalIssue><Title>Science (New York, N.Y.)</Title><ISOAbbreviation>Science</ISOAbbreviation></Journal><ArticleTitle>Regulation of aging and age-related disease by DAF-16 and heat-shock factor.</ArticleTitle><Pagination><StartPage>1142</StartPage><EndPage>1145</EndPage><MedlinePgn>1142-5</MedlinePgn></Pagination><Abstract><AbstractText>The Caenorhabditis elegans transcription factor HSF-1, which regulates the heat-shock response, also influences aging. Reducing hsf-1 activity accelerates tissue aging and shortens life-span, and we show that hsf-1 overexpression extends lifespan. We find that HSF-1, like the transcription factor DAF-16, is required for daf-2-insulin/IGF-1 receptor mutations to extend life-span. Our findings suggest this is because HSF-1 and DAF-16 together activate expression of specific genes, including genes encoding small heat-shock proteins, which in turn promote longevity. The small heat-shock proteins also delay the onset of polyglutamine-expansion protein aggregation, suggesting that these proteins couple the normal aging process to this type of age-related disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hsu</LastName><ForeName>Ao-Lin</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Biophysics, University of California, San Francisco, CA 94143-2200, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murphy</LastName><ForeName>Coleen T</ForeName><Initials>CT</Initials></Author><Author ValidYN="Y"><LastName>Kenyon</LastName><ForeName>Cynthia</ForeName><Initials>C</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Science</MedlineTA><NlmUniqueID>0404511</NlmUniqueID><ISSNLinking>0036-8075</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D029742">Caenorhabditis elegans Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051858">Forkhead Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C108831">daf-16 protein, C elegans</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C474710">heat shock factor-1, C elegans</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="C107483">DAF-2 protein, C elegans</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="D017526">Receptor, IGF Type 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="D011972">Receptor, Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Science. 2003 Jun 27;300(5628):2033</RefSource></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="N">Aging</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017173" MajorTopicYN="N">Caenorhabditis elegans</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029742" MajorTopicYN="N">Caenorhabditis elegans Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051858" MajorTopicYN="N">Forkhead Transcription Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018869" MajorTopicYN="N">Heat-Shock Response</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008136" MajorTopicYN="N">Longevity</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017526" MajorTopicYN="N">Receptor, IGF Type 1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011972" MajorTopicYN="N">Receptor, Insulin</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>5</Month><Day>17</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>6</Month><Day>24</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>5</Month><Day>17</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12750521</ArticleId><ArticleId IdType="doi">10.1126/science.1083701</ArticleId><ArticleId IdType="pii">300/5622/1142</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12757707</PMID><DateCompleted><Year>2003</Year><Month>06</Month><Day>25</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0092-8674</ISSN><JournalIssue CitedMedium="Print"><Volume>113</Volume><Issue>4</Issue><PubDate><Year>2003</Year><Month>May</Month><Day>16</Day></PubDate></JournalIssue><Title>Cell</Title><ISOAbbreviation>Cell</ISOAbbreviation></Journal><ArticleTitle>Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1.</ArticleTitle><Pagination><StartPage>457</StartPage><EndPage>468</EndPage><MedlinePgn>457-68</MedlinePgn></Pagination><Abstract><AbstractText>Spinocerebellar ataxia type 1 (SCA1) is one of several neurological disorders caused by a CAG repeat expansion. In SCA1, this expansion produces an abnormally long polyglutamine tract in the protein ataxin-1. Mutant polyglutamine proteins accumulate in neurons, inducing neurodegeneration, but the mechanism underlying this accumulation has been unclear. We have discovered that the 14-3-3 protein, a multifunctional regulatory molecule, mediates the neurotoxicity of ataxin-1 by binding to and stabilizing ataxin-1, thereby slowing its normal degradation. The association of ataxin-1 with 14-3-3 is regulated by Akt phosphorylation, and in a Drosophila model of SCA1, both 14-3-3 and Akt modulate neurodegeneration. Our finding that phosphatidylinositol 3-kinase/Akt signaling and 14-3-3 cooperate to modulate the neurotoxicity of ataxin-1 provides insight into SCA1 pathogenesis and identifies potential targets for therapeutic intervention.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Hung-Kai</ForeName><Initials>HK</Initials><AffiliationInfo><Affiliation>Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernandez-Funez</LastName><ForeName>Pedro</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Acevedo</LastName><ForeName>Summer F</ForeName><Initials>SF</Initials></Author><Author ValidYN="Y"><LastName>Lam</LastName><ForeName>Yung C</ForeName><Initials>YC</Initials></Author><Author ValidYN="Y"><LastName>Kaytor</LastName><ForeName>Michael D</ForeName><Initials>MD</Initials></Author><Author ValidYN="Y"><LastName>Fernandez</LastName><ForeName>Michael H</ForeName><Initials>MH</Initials></Author><Author ValidYN="Y"><LastName>Aitken</LastName><ForeName>Alastair</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Skoulakis</LastName><ForeName>Efthimios M C</ForeName><Initials>EM</Initials></Author><Author ValidYN="Y"><LastName>Orr</LastName><ForeName>Harry T</ForeName><Initials>HT</Initials></Author><Author ValidYN="Y"><LastName>Botas</LastName><ForeName>Juan</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Zoghbi</LastName><ForeName>Huda Y</ForeName><Initials>HY</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>HD24064</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS22920</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS27699</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NS42179</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell</MedlineTA><NlmUniqueID>0413066</NlmUniqueID><ISSNLinking>0092-8674</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D048948">14-3-3 Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000593749">ATXN1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000067696">Ataxin-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000067528">Ataxins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D029721">Drosophila Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009687">Nuclear Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011518">Proto-Oncogene Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>26700-71-0</RegistryNumber><NameOfSubstance UI="C097188">polyglutamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>452VLY9402</RegistryNumber><NameOfSubstance UI="D012694">Serine</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.16.2</RegistryNumber><NameOfSubstance UI="D014446">Tyrosine 3-Monooxygenase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C494918">AKT1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C494917">Akt1 protein, Drosophila</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D017346">Protein Serine-Threonine Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D048948" MajorTopicYN="N">14-3-3 Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020816" MajorTopicYN="N">Amino Acid Motifs</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067696" MajorTopicYN="N">Ataxin-1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067528" MajorTopicYN="N">Ataxins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019556" MajorTopicYN="N">COS Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002467" MajorTopicYN="N">Cell Nucleus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029721" MajorTopicYN="N">Drosophila Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004331" MajorTopicYN="N">Drosophila melanogaster</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002479" MajorTopicYN="N">Inclusion Bodies</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009410" MajorTopicYN="N">Nerve Degeneration</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009687" MajorTopicYN="N">Nuclear Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019869" MajorTopicYN="N">Phosphatidylinositol 3-Kinases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017346" MajorTopicYN="N">Protein Serine-Threonine Kinases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011518" MajorTopicYN="Y">Proto-Oncogene Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051057" MajorTopicYN="N">Proto-Oncogene Proteins c-akt</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012694" MajorTopicYN="N">Serine</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020754" MajorTopicYN="N">Spinocerebellar Ataxias</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019680" MajorTopicYN="N">Trinucleotide Repeat Expansion</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014446" MajorTopicYN="N">Tyrosine 3-Monooxygenase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>5</Month><Day>22</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>6</Month><Day>26</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>5</Month><Day>22</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12757707</ArticleId><ArticleId IdType="doi">10.1016/s0092-8674(03)00349-0</ArticleId><ArticleId IdType="pii">S0092867403003490</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12761214</PMID><DateCompleted><Year>2003</Year><Month>11</Month><Day>10</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0021-9258</ISSN><JournalIssue CitedMedium="Print"><Volume>278</Volume><Issue>33</Issue><PubDate><Year>2003</Year><Month>Aug</Month><Day>15</Day></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J Biol Chem</ISOAbbreviation></Journal><ArticleTitle>Crystal structure of human DJ-1, a protein associated with early onset Parkinson's disease.</ArticleTitle><Pagination><StartPage>31372</StartPage><EndPage>31379</EndPage><MedlinePgn>31372-9</MedlinePgn></Pagination><Abstract><AbstractText>We report the crystal structure at 1.8-A resolution of human DJ-1, which has been linked to early onset Parkinson's disease. The monomer of DJ-1 contains the alpha/beta-fold that is conserved among members of the DJ-1/ThiJ/PfpI superfamily. However, the structure also contains an extra helix at the C terminus, which mediates a novel mode of dimerization for the DJ-1 proteins. A putative active site has been identified near the dimer interface, and the residues Cys-106, His-126, and Glu-18 may play important roles in the catalysis by this protein. Studies with the disease-causing L166P mutant suggest that the mutation has disrupted the C-terminal region and the dimerization of the protein. The DJ-1 proteins may function only as dimers. The Lys to Arg mutation at residue 130, the site of sumoylation of DJ-1, has minimal impact on the structure of the protein.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tao</LastName><ForeName>Xiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, Columbia University, New York, New York 10027, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tong</LastName><ForeName>Liang</ForeName><Initials>L</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>PDB</DataBankName><AccessionNumberList><AccessionNumber>1PDV</AccessionNumber><AccessionNumber>1PDW</AccessionNumber><AccessionNumber>1PE0</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>AI49475</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>05</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047908">Intracellular Signaling Peptides and Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015513">Oncogene Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D025842">SUMO-1 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.2.-</RegistryNumber><NameOfSubstance UI="C105131">PARK7 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.2.-</RegistryNumber><NameOfSubstance UI="D000071617">Protein Deglycase DJ-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D017668" MajorTopicYN="N">Age of Onset</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002384" MajorTopicYN="N">Catalysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003461" MajorTopicYN="N">Crystallography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019281" MajorTopicYN="N">Dimerization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D047908" MajorTopicYN="N">Intracellular Signaling Peptides and Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015513" MajorTopicYN="N">Oncogene Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017354" MajorTopicYN="N">Point Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071617" MajorTopicYN="N">Protein Deglycase DJ-1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017433" MajorTopicYN="N">Protein Structure, Secondary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017434" MajorTopicYN="N">Protein Structure, Tertiary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D025842" MajorTopicYN="N">SUMO-1 Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017386" MajorTopicYN="N">Sequence Homology, Amino Acid</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>5</Month><Day>23</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>11</Month><Day>11</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>5</Month><Day>23</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12761214</ArticleId><ArticleId IdType="doi">10.1074/jbc.M304221200</ArticleId><ArticleId IdType="pii">S0021-9258(20)84183-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12761548</PMID><DateCompleted><Year>2003</Year><Month>06</Month><Day>18</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0028-0836</ISSN><JournalIssue CitedMedium="Print"><Volume>423</Volume><Issue>6938</Issue><PubDate><Year>2003</Year><Month>May</Month><Day>22</Day></PubDate></JournalIssue><Title>Nature</Title><ISOAbbreviation>Nature</ISOAbbreviation></Journal><ArticleTitle>GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides.</ArticleTitle><Pagination><StartPage>435</StartPage><EndPage>439</EndPage><MedlinePgn>435-9</MedlinePgn></Pagination><Abstract><AbstractText>Alzheimer's disease is associated with increased production and aggregation of amyloid-beta (Abeta) peptides. Abeta peptides are derived from the amyloid precursor protein (APP) by sequential proteolysis, catalysed by the aspartyl protease BACE, followed by presenilin-dependent gamma-secretase cleavage. Presenilin interacts with nicastrin, APH-1 and PEN-2 (ref. 6), all of which are required for gamma-secretase function. Presenilins also interact with alpha-catenin, beta-catenin and glycogen synthase kinase-3beta (GSK-3beta), but a functional role for these proteins in gamma-secretase activity has not been established. Here we show that therapeutic concentrations of lithium, a GSK-3 inhibitor, block the production of Abeta peptides by interfering with APP cleavage at the gamma-secretase step, but do not inhibit Notch processing. Importantly, lithium also blocks the accumulation of Abeta peptides in the brains of mice that overproduce APP. The target of lithium in this setting is GSK-3alpha, which is required for maximal processing of APP. Since GSK-3 also phosphorylates tau protein, the principal component of neurofibrillary tangles, inhibition of GSK-3alpha offers a new approach to reduce the formation of both amyloid plaques and neurofibrillary tangles, two pathological hallmarks of Alzheimer's disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Phiel</LastName><ForeName>Christopher J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Hematology-Oncology and Howard Hughes Medical Institute, University of Pennsylvania School of Medicine, Philadelphia, Philadelphia 19104-6148, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Christina A</ForeName><Initials>CA</Initials></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Virginia M-Y</ForeName><Initials>VM</Initials></Author><Author ValidYN="Y"><LastName>Klein</LastName><ForeName>Peter S</ForeName><Initials>PS</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nature</MedlineTA><NlmUniqueID>0410462</NlmUniqueID><ISSNLinking>0028-0836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051880">Receptors, Notch</NameOfSubstance></Chemical><Chemical><RegistryNumber>9FN79X2M3F</RegistryNumber><NameOfSubstance UI="D008094">Lithium</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.26</RegistryNumber><NameOfSubstance UI="D038362">Glycogen Synthase Kinase 3</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.26</RegistryNumber><NameOfSubstance UI="C448021">glycogen synthase kinase 3 alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D053829">Amyloid Precursor Protein Secretases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010450">Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.-</RegistryNumber><NameOfSubstance UI="D016282">Aspartic Acid Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.46</RegistryNumber><NameOfSubstance UI="C509282">Bace1 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Nature. 2003 May 22;423(6938):392-3. doi: 10.1038/423392a.</RefSource><PMID Version="1">12761533</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Nature. 2011 Dec 07;480(7376):E4-5; discussion E6. doi: 10.1038/nature10615.</RefSource><PMID Version="1">22158250</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053829" MajorTopicYN="N">Amyloid Precursor Protein Secretases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016282" MajorTopicYN="N">Aspartic Acid Endopeptidases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016466" MajorTopicYN="N">CHO Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010450" MajorTopicYN="N">Endopeptidases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D038362" MajorTopicYN="N">Glycogen Synthase Kinase 3</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008094" MajorTopicYN="N">Lithium</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051880" MajorTopicYN="N">Receptors, Notch</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2003</Year><Month>1</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2003</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>5</Month><Day>23</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>6</Month><Day>19</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>5</Month><Day>23</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12761548</ArticleId><ArticleId IdType="doi">10.1038/nature01640</ArticleId><ArticleId IdType="pii">nature01640</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12761533</PMID><DateCompleted><Year>2003</Year><Month>06</Month><Day>18</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0028-0836</ISSN><JournalIssue CitedMedium="Print"><Volume>423</Volume><Issue>6938</Issue><PubDate><Year>2003</Year><Month>May</Month><Day>22</Day></PubDate></JournalIssue><Title>Nature</Title><ISOAbbreviation>Nature</ISOAbbreviation></Journal><ArticleTitle>Alzheimer's disease: Mental plaque removal.</ArticleTitle><Pagination><StartPage>392</StartPage><EndPage>393</EndPage><MedlinePgn>392-3</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>De Strooper</LastName><ForeName>Bart</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Woodgett</LastName><ForeName>James</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016433">News</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nature</MedlineTA><NlmUniqueID>0410462</NlmUniqueID><ISSNLinking>0028-0836</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>9FN79X2M3F</RegistryNumber><NameOfSubstance UI="D008094">Lithium</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D000071679">Glycogen Synthase Kinase 3 beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.26</RegistryNumber><NameOfSubstance UI="D038362">Glycogen Synthase Kinase 3</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.26</RegistryNumber><NameOfSubstance UI="C448021">glycogen synthase kinase 3 alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D053829">Amyloid Precursor Protein Secretases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.-</RegistryNumber><NameOfSubstance UI="D010450">Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.-</RegistryNumber><NameOfSubstance UI="D016282">Aspartic Acid Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.46</RegistryNumber><NameOfSubstance UI="C509282">Bace1 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Nature. 2003 May 22;423(6938):435-9. doi: 10.1038/nature01640.</RefSource><PMID Version="1">12761548</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053829" MajorTopicYN="N">Amyloid Precursor Protein Secretases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016282" MajorTopicYN="N">Aspartic Acid Endopeptidases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010450" MajorTopicYN="N">Endopeptidases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D038362" MajorTopicYN="N">Glycogen Synthase Kinase 3</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071679" MajorTopicYN="N">Glycogen Synthase Kinase 3 beta</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008094" MajorTopicYN="N">Lithium</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016874" MajorTopicYN="N">Neurofibrillary Tangles</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058225" MajorTopicYN="N">Plaque, Amyloid</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>5</Month><Day>23</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>6</Month><Day>19</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>5</Month><Day>23</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12761533</ArticleId><ArticleId IdType="doi">10.1038/423392a</ArticleId><ArticleId IdType="pii">423392a</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12765607</PMID><DateCompleted><Year>2003</Year><Month>06</Month><Day>25</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0896-6273</ISSN><JournalIssue CitedMedium="Print"><Volume>38</Volume><Issue>4</Issue><PubDate><Year>2003</Year><Month>May</Month><Day>22</Day></PubDate></JournalIssue><Title>Neuron</Title><ISOAbbreviation>Neuron</ISOAbbreviation></Journal><ArticleTitle>Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease.</ArticleTitle><Pagination><StartPage>547</StartPage><EndPage>554</EndPage><MedlinePgn>547-54</MedlinePgn></Pagination><Abstract><AbstractText>To test whether antibodies against beta-amyloid are effective in slowing progression of Alzheimer's disease, we assessed cognitive functions in 30 patients who received a prime and a booster immunization of aggregated Abeta(42) over a 1 year period in a placebo-controlled, randomized trial. Twenty patients generated antibodies against beta-amyloid, as determined by tissue amyloid plaque immunoreactivity assay. Patients who generated such antibodies showed significantly slower rates of decline of cognitive functions and activities of daily living, as indicated by the Mini Mental State Examination, the Disability Assessment for Dementia, and the Visual Paired Associates Test of delayed recall from the Wechsler Memory Scale, as compared to patients without such antibodies. These beneficial clinical effects were also present in two of three patients who had experienced transient episodes of immunization-related aseptic meningoencephalitis. Our results establish that antibodies against beta-amyloid plaques can slow cognitive decline in patients with Alzheimer's disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hock</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Psychiatry Research, University of Zurich, August Forel Strasse 1, 8008 Zurich, Switzerland. chock@bli.unizh.ch</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konietzko</LastName><ForeName>Uwe</ForeName><Initials>U</Initials></Author><Author ValidYN="Y"><LastName>Streffer</LastName><ForeName>Johannes R</ForeName><Initials>JR</Initials></Author><Author ValidYN="Y"><LastName>Tracy</LastName><ForeName>Jay</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Signorell</LastName><ForeName>Andri</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>M&#xfc;ller-Tillmanns</LastName><ForeName>Britta</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Lemke</LastName><ForeName>Ulrike</ForeName><Initials>U</Initials></Author><Author ValidYN="Y"><LastName>Henke</LastName><ForeName>Katharina</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Moritz</LastName><ForeName>Eva</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Garcia</LastName><ForeName>Esmeralda</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Wollmer</LastName><ForeName>M Axel</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Umbricht</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>de Quervain</LastName><ForeName>Dominique J F</ForeName><Initials>DJ</Initials></Author><Author ValidYN="Y"><LastName>Hofmann</LastName><ForeName>Marc</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Maddalena</LastName><ForeName>Alessia</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Papassotiropoulos</LastName><ForeName>Andreas</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Nitsch</LastName><ForeName>Roger M</ForeName><Initials>RM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuron</MedlineTA><NlmUniqueID>8809320</NlmUniqueID><ISSNLinking>0896-6273</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000906">Antibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C075222">amyloid beta-protein (1-42)</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Neuron. 2003 May 22;38(4):517-8. doi: 10.1016/s0896-6273(03)00297-6.</RefSource><PMID Version="1">12765602</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000203" MajorTopicYN="N">Activities of Daily Living</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000906" MajorTopicYN="N">Antibodies</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="N">Cognition Disorders</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006624" MajorTopicYN="N">Hippocampus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016233" MajorTopicYN="Y">Immunotherapy, Active</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010352" MajorTopicYN="N">Patient Dropouts</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058225" MajorTopicYN="N">Plaque, Amyloid</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>5</Month><Day>27</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>6</Month><Day>26</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>5</Month><Day>27</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12765607</ArticleId><ArticleId IdType="doi">10.1016/s0896-6273(03)00294-0</ArticleId><ArticleId IdType="pii">S0896627303002940</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12765608</PMID><DateCompleted><Year>2003</Year><Month>06</Month><Day>25</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0896-6273</ISSN><JournalIssue CitedMedium="Print"><Volume>38</Volume><Issue>4</Issue><PubDate><Year>2003</Year><Month>May</Month><Day>22</Day></PubDate></JournalIssue><Title>Neuron</Title><ISOAbbreviation>Neuron</ISOAbbreviation></Journal><ArticleTitle>Cdk5 is a key factor in tau aggregation and tangle formation in vivo.</ArticleTitle><Pagination><StartPage>555</StartPage><EndPage>565</EndPage><MedlinePgn>555-65</MedlinePgn></Pagination><Abstract><AbstractText>Tau aggregation is a common feature of neurodegenerative diseases such as Alzheimer's disease, and hyperphosphorylation of tau has been implicated as a fundamental pathogenic mechanism in this process. To examine the impact of cdk5 in tau aggregation and tangle formation, we crossed transgenic mice overexpressing the cdk5 activator p25, with transgenic mice overexpressing mutant (P301L) human tau. Tau was hyperphosphorylated at several sites in the double transgenics, and there was a highly significant accumulation of aggregated tau in brainstem and cortex. This was accompanied by increased numbers of silver-stained neurofibrillary tangles (NFTs). Insoluble tau was also associated with active GSK. Thus, cdk5 can initiate a major impact on tau pathology progression that probably involves several kinases. Kinase inhibitors may thus be beneficial therapeutically.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Noble</LastName><ForeName>Wendy</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Center for Dementia Research, Nathan S. Kline Institute, New York University, 140 Old Orangeburg Road, Orangeburg, NY 10962, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olm</LastName><ForeName>Vicki</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Takata</LastName><ForeName>Kazuyuki</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Casey</LastName><ForeName>Evelyn</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Mary</LastName><ForeName>O</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Meyerson</LastName><ForeName>Jordana</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Gaynor</LastName><ForeName>Kate</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>LaFrancois</LastName><ForeName>John</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Lili</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Kondo</LastName><ForeName>Takayuki</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Davies</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Burns</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Veeranna</LastName></Author><Author ValidYN="Y"><LastName>Nixon</LastName><ForeName>Ralph</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Dickson</LastName><ForeName>Dennis</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Matsuoka</LastName><ForeName>Yasuji</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Ahlijanian</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Lau</LastName><ForeName>Lit-Fui</ForeName><Initials>LF</Initials></Author><Author ValidYN="Y"><LastName>Duff</LastName><ForeName>Karen</ForeName><Initials>K</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>AG 172116</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neuron</MedlineTA><NlmUniqueID>8809320</NlmUniqueID><ISSNLinking>0896-6273</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016875">tau Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D051360">Cyclin-Dependent Kinase 5</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.22</RegistryNumber><NameOfSubstance UI="C495905">CDK5 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.22</RegistryNumber><NameOfSubstance UI="C495906">Cdk5 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.22</RegistryNumber><NameOfSubstance UI="D018844">Cyclin-Dependent Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.26</RegistryNumber><NameOfSubstance UI="D038362">Glycogen Synthase Kinase 3</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001933" MajorTopicYN="N">Brain Stem</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002540" MajorTopicYN="N">Cerebral Cortex</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051360" MajorTopicYN="N">Cyclin-Dependent Kinase 5</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018844" MajorTopicYN="N">Cyclin-Dependent Kinases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004790" MajorTopicYN="N">Enzyme Induction</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015971" MajorTopicYN="N">Gene Expression Regulation, Enzymologic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D038362" MajorTopicYN="N">Glycogen Synthase Kinase 3</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016874" MajorTopicYN="N">Neurofibrillary Tangles</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016875" MajorTopicYN="N">tau Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>5</Month><Day>27</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>6</Month><Day>26</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>5</Month><Day>27</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12765608</ArticleId><ArticleId IdType="doi">10.1016/s0896-6273(03)00259-9</ArticleId><ArticleId IdType="pii">S0896627303002599</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12771112</PMID><DateCompleted><Year>2003</Year><Month>06</Month><Day>12</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0098-7484</ISSN><JournalIssue CitedMedium="Print"><Volume>289</Volume><Issue>20</Issue><PubDate><Year>2003</Year><Month>May</Month><Day>28</Day></PubDate></JournalIssue><Title>JAMA</Title><ISOAbbreviation>JAMA</ISOAbbreviation></Journal><ArticleTitle>Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.</ArticleTitle><Pagination><StartPage>2651</StartPage><EndPage>2662</EndPage><MedlinePgn>2651-62</MedlinePgn></Pagination><Abstract><AbstractText Label="CONTEXT" NlmCategory="BACKGROUND">Postmenopausal women have a greater risk than men of developing Alzheimer disease, but studies of the effects of estrogen therapy on Alzheimer disease have been inconsistent. On July 8, 2002, the study drugs, estrogen plus progestin, in the Women's Health Initiative (WHI) trial were discontinued because of certain increased health risks in women receiving combined hormone therapy.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate the effect of estrogen plus progestin on the incidence of dementia and mild cognitive impairment compared with placebo.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS" NlmCategory="METHODS">The Women's Health Initiative Memory Study (WHIMS), a randomized, double-blind, placebo-controlled clinical trial, began enrolling participants from the Women's Health Initiative (WHI) estrogen plus progestin trial in May 1996. Of the 4894 eligible participants of the WHI study, 4532 (92.6%) postmenopausal women free of probable dementia, aged 65 years or older, and recruited from 39 of 40 WHI clinical centers were enrolled in the WHIMS.</AbstractText><AbstractText Label="INTERVENTION" NlmCategory="METHODS">Participants received either 1 daily tablet of 0.625 mg of conjugated equine estrogen plus 2.5 mg of medroxyprogesterone acetate (n = 2229), or a matching placebo (n = 2303).</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">Incidence of probable dementia (primary outcome) and mild cognitive impairment (secondary outcome) were identified through a structured clinical assessment.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The mean (SD) time between the date of randomization into WHI and the last Modified Mini-Mental State Examination (3MSE) for all WHIMS participants was 4.05 (1.19) years. Overall, 61 women were diagnosed with probable dementia, 40 (66%) in the estrogen plus progestin group compared with 21 (34%) in the placebo group. The hazard ratio (HR) for probable dementia was 2.05 (95% confidence interval [CI], 1.21-3.48; 45 vs 22 per 10 000 person-years; P =.01). This increased risk would result in an additional 23 cases of dementia per 10 000 women per year. Alzheimer disease was the most common classification of dementia in both study groups. Treatment effects on mild cognitive impairment did not differ between groups (HR, 1.07; 95% CI, 0.74-1.55; 63 vs 59 cases per 10 000 person-years; P =.72).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Estrogen plus progestin therapy increased the risk for probable dementia in postmenopausal women aged 65 years or older. In addition, estrogen plus progestin therapy did not prevent mild cognitive impairment in these women. These findings, coupled with previously reported WHI data, support the conclusion that the risks of estrogen plus progestin outweigh the benefits.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shumaker</LastName><ForeName>Sally A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Public Health Sciences, Wake Forest University Health Sciences, Winston-Salem, NC 27104, USA. sshumake@wfubmc.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Legault</LastName><ForeName>Claudine</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Rapp</LastName><ForeName>Stephen R</ForeName><Initials>SR</Initials></Author><Author ValidYN="Y"><LastName>Thal</LastName><ForeName>Leon</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Wallace</LastName><ForeName>Robert B</ForeName><Initials>RB</Initials></Author><Author ValidYN="Y"><LastName>Ockene</LastName><ForeName>Judith K</ForeName><Initials>JK</Initials></Author><Author ValidYN="Y"><LastName>Hendrix</LastName><ForeName>Susan L</ForeName><Initials>SL</Initials></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Beverly N</ForeName><Initials>BN</Initials><Suffix>3rd</Suffix></Author><Author ValidYN="Y"><LastName>Assaf</LastName><ForeName>Annlouise R</ForeName><Initials>AR</Initials></Author><Author ValidYN="Y"><LastName>Jackson</LastName><ForeName>Rebecca D</ForeName><Initials>RD</Initials></Author><Author ValidYN="Y"><LastName>Kotchen</LastName><ForeName>Jane Morley</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Wassertheil-Smoller</LastName><ForeName>Sylvia</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Wactawski-Wende</LastName><ForeName>Jean</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><CollectiveName>WHIMS Investigators</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA</MedlineTA><NlmUniqueID>7501160</NlmUniqueID><ISSNLinking>0098-7484</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004966">Estrogens, Conjugated (USP)</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D045167">Progesterone Congeners</NameOfSubstance></Chemical><Chemical><RegistryNumber>C2QI4IOI2G</RegistryNumber><NameOfSubstance UI="D017258">Medroxyprogesterone Acetate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2003 May 28;289(20):2717-9. doi: 10.1001/jama.289.20.2717.</RefSource><PMID Version="1">12771119</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2003 Oct 1;290(13):1706-7; author reply 1707-8. doi: 10.1001/jama.290.13.1706-b.</RefSource><PMID Version="1">14519698</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2003 Oct 1;290(13):1706; author reply 1707-8. doi: 10.1001/jama.290.13.1706-a.</RefSource><PMID Version="1">14519699</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2003 Oct 1;290(13):1707; author reply 1707-8. doi: 10.1001/jama.290.13.1707-b.</RefSource><PMID Version="1">14519700</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2003 Oct 1;290(13):1707; author reply 1707-8. doi: 10.1001/jama.290.13.1707-a.</RefSource><PMID Version="1">14519701</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Evid Based Ment Health. 2003 Nov;6(4):111. doi: 10.1136/ebmh.6.4.111.</RefSource><PMID Version="1">14585784</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Can Fam Physician. 2004 Feb;50:235-7.</RefSource><PMID Version="1">15000334</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Menopause Int. 2013 Sep;19(3):105-6.</RefSource><PMID Version="1">24195130</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="N">Cognition Disorders</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="N">Dementia</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015914" MajorTopicYN="Y">Estrogen Replacement Therapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004966" MajorTopicYN="N">Estrogens, Conjugated (USP)</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017258" MajorTopicYN="N">Medroxyprogesterone Acetate</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017698" MajorTopicYN="N">Postmenopause</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045167" MajorTopicYN="N">Progesterone Congeners</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>5</Month><Day>29</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>6</Month><Day>13</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>5</Month><Day>29</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12771112</ArticleId><ArticleId IdType="doi">10.1001/jama.289.20.2651</ArticleId><ArticleId IdType="pii">289/20/2651</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12771113</PMID><DateCompleted><Year>2003</Year><Month>06</Month><Day>12</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0098-7484</ISSN><JournalIssue CitedMedium="Print"><Volume>289</Volume><Issue>20</Issue><PubDate><Year>2003</Year><Month>May</Month><Day>28</Day></PubDate></JournalIssue><Title>JAMA</Title><ISOAbbreviation>JAMA</ISOAbbreviation></Journal><ArticleTitle>Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.</ArticleTitle><Pagination><StartPage>2663</StartPage><EndPage>2672</EndPage><MedlinePgn>2663-72</MedlinePgn></Pagination><Abstract><AbstractText Label="CONTEXT" NlmCategory="BACKGROUND">Observational studies have suggested that postmenopausal hormone treatment may improve cognitive function, but data from randomized clinical trials have been sparse and inconclusive. The Women's Health Initiative Memory Study (WHIMS) is an ancillary study of the Women's Health Initiative (WHI) hormone therapy trials. On July 8, 2002, the estrogen plus progestin therapy in the WHI trial was discontinued because of certain increased health risks for women.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To determine whether estrogen plus progestin therapy protects global cognitive function in older postmenopausal women.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS" NlmCategory="METHODS">A randomized, double-blind, placebo-controlled clinical trial, WHIMS is an ancillary study of geographically diverse, community-dwelling women aged 65 years or older from 39 of 40 clinical centers within the WHI estrogen plus progestin trial that started in June 1995. Of 4894 eligible postmenopausal women aged 65 years or older and free of probable dementia at baseline, 4532 (92.6%) were enrolled in the estrogen plus progestin component of WHIMS. A total of 4381 participants (96.7%) provided at least 1 valid cognitive function score between June 1995 and July 8, 2002.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Participants received either 1 daily tablet containing 0.625 mg of conjugated equine estrogen with 2.5 mg of medroxyprogesterone acetate (n = 2145) or matching placebo (n = 2236).</AbstractText><AbstractText Label="MAIN OUTCOME MEASURE" NlmCategory="METHODS">Global cognitive function measured annually with the Modified Mini-Mental State Examination.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The Modified Mini-Mental State Examination mean total scores in both groups increased slightly over time (mean follow-up of 4.2 years). Women in the estrogen plus progestin group had smaller average increases in total scores compared with women receiving placebo (P =.03), but these differences were not clinically important. Removing women by censoring them after adjudicated dementia, mild cognitive impairment, or stroke, and nonadherence to study protocol, did not alter the findings. Prior hormone therapy use and duration of prior use did not affect the interpretation of the results, nor did timing of prior hormone therapy initiation with respect to the final menstrual period. More women in the estrogen plus progestin group had a substantial and clinically important decline (&gt; or =2 SDs) in Modified Mini-Mental State Examination total score (6.7%) compared with the placebo group (4.8%) (P =.008).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Among postmenopausal women aged 65 years or older, estrogen plus progestin did not improve cognitive function when compared with placebo. While most women receiving estrogen plus progestin did not experience clinically relevant adverse effects on cognition compared with placebo, a small increased risk of clinically meaningful cognitive decline occurred in the estrogen plus progestin group.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rapp</LastName><ForeName>Stephen R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Behavioral Medicine, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA. srapp@wfubmc.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Espeland</LastName><ForeName>Mark A</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Shumaker</LastName><ForeName>Sally A</ForeName><Initials>SA</Initials></Author><Author ValidYN="Y"><LastName>Henderson</LastName><ForeName>Victor W</ForeName><Initials>VW</Initials></Author><Author ValidYN="Y"><LastName>Brunner</LastName><ForeName>Robert L</ForeName><Initials>RL</Initials></Author><Author ValidYN="Y"><LastName>Manson</LastName><ForeName>JoAnn E</ForeName><Initials>JE</Initials></Author><Author ValidYN="Y"><LastName>Gass</LastName><ForeName>Margery L S</ForeName><Initials>ML</Initials></Author><Author ValidYN="Y"><LastName>Stefanick</LastName><ForeName>Marcia L</ForeName><Initials>ML</Initials></Author><Author ValidYN="Y"><LastName>Lane</LastName><ForeName>Dorothy S</ForeName><Initials>DS</Initials></Author><Author ValidYN="Y"><LastName>Hays</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Karen C</ForeName><Initials>KC</Initials></Author><Author ValidYN="Y"><LastName>Coker</LastName><ForeName>Laura H</ForeName><Initials>LH</Initials></Author><Author ValidYN="Y"><LastName>Dailey</LastName><ForeName>Maggie</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Bowen</LastName><ForeName>Deborah</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><CollectiveName>WHIMS Investigators</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA</MedlineTA><NlmUniqueID>7501160</NlmUniqueID><ISSNLinking>0098-7484</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004966">Estrogens, Conjugated (USP)</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D045167">Progesterone Congeners</NameOfSubstance></Chemical><Chemical><RegistryNumber>C2QI4IOI2G</RegistryNumber><NameOfSubstance UI="D017258">Medroxyprogesterone Acetate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2003 May 28;289(20):2717-9. doi: 10.1001/jama.289.20.2717.</RefSource><PMID Version="1">12771119</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003072" MajorTopicYN="N">Cognition Disorders</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015914" MajorTopicYN="Y">Estrogen Replacement Therapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004966" MajorTopicYN="N">Estrogens, Conjugated (USP)</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017258" MajorTopicYN="N">Medroxyprogesterone Acetate</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017698" MajorTopicYN="N">Postmenopause</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045167" MajorTopicYN="N">Progesterone Congeners</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>5</Month><Day>29</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>6</Month><Day>13</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>5</Month><Day>29</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12771113</ArticleId><ArticleId IdType="doi">10.1001/jama.289.20.2663</ArticleId><ArticleId IdType="pii">289/20/2663</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12783420</PMID><DateCompleted><Year>2003</Year><Month>07</Month><Day>09</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0364-5134</ISSN><JournalIssue CitedMedium="Print"><Volume>53</Volume><Issue>6</Issue><PubDate><Year>2003</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Annals of neurology</Title><ISOAbbreviation>Ann Neurol</ISOAbbreviation></Journal><ArticleTitle>Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke.</ArticleTitle><Pagination><StartPage>743</StartPage><EndPage>751</EndPage><MedlinePgn>743-51</MedlinePgn></Pagination><Abstract><AbstractText>We demonstrate that the 3-hydroxy-3-methyl-glutaryl-coenzyme A (HMG-CoA) reductase inhibitors atorvastatin and simvastatin enhance functional outcome and induce brain plasticity when administered after stroke to rats. With atorvastatin treatment initiated 1 day after stroke, animals exhibited significant increases in vascular endothelial growth factor, cyclic guanosine monophosphate, angiogenesis, endogenous cell proliferation and neurogenesis, and an increase in the synaptic protein, synaptophysin. Atorvastatin-induced angiogenesis in a tube formation assay was reduced by an antibody against the vascular endothelial growth factor receptor 2 (FIK-1) and by the nitric oxide synthase inhibitor, N-mono-methyl-L-arginine (L-NAME). Atorvastatin also induced phosphorylation of Akt and Erk in cultured primary cortical neurons. These data indicate that atorvastatin induced brain plasticity and has neurorestorative activity after experimental stroke.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jieli</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Henry Ford Health Sciences Center, Detroit, MI 48202, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Zheng Gang</ForeName><Initials>ZG</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yi</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ying</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Lei</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Hao</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Chenling</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Mei</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Katakowski</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Feldkamp</LastName><ForeName>Carolyn S</ForeName><Initials>CS</Initials></Author><Author ValidYN="Y"><LastName>Chopp</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P01 NS23393</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS35504</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01HL64766</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Neurol</MedlineTA><NlmUniqueID>7707449</NlmUniqueID><ISSNLinking>0364-5134</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000906">Antibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006538">Heptanoic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019161">Hydroxymethylglutaryl-CoA Reductase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011518">Proto-Oncogene Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011758">Pyrroles</NameOfSubstance></Chemical><Chemical><RegistryNumber>A0JWA85V8F</RegistryNumber><NameOfSubstance UI="D000069059">Atorvastatin</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.13.39</RegistryNumber><NameOfSubstance UI="D019001">Nitric Oxide Synthase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.10.1</RegistryNumber><NameOfSubstance UI="D040301">Vascular Endothelial Growth Factor Receptor-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C494920">Akt1 protein, rat</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D017346">Protein Serine-Threonine Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.24</RegistryNumber><NameOfSubstance UI="D020928">Mitogen-Activated Protein Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>V55S2QJN2X</RegistryNumber><NameOfSubstance UI="D019331">NG-Nitroarginine Methyl Ester</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Ann Neurol. 2005 Nov;58(5):818</RefSource></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000906" MajorTopicYN="N">Antibodies</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069059" MajorTopicYN="N">Atorvastatin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000098" MajorTopicYN="Y">blood supply</QualifierName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004791" MajorTopicYN="N">Enzyme Inhibitors</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006538" MajorTopicYN="N">Heptanoic Acids</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019161" MajorTopicYN="N">Hydroxymethylglutaryl-CoA Reductase Inhibitors</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020928" MajorTopicYN="N">Mitogen-Activated Protein Kinases</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019331" MajorTopicYN="N">NG-Nitroarginine Methyl Ester</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018919" MajorTopicYN="N">Neovascularization, Physiologic</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009473" MajorTopicYN="N">Neuronal Plasticity</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019001" MajorTopicYN="N">Nitric Oxide Synthase</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017346" MajorTopicYN="Y">Protein Serine-Threonine Kinases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011518" MajorTopicYN="N">Proto-Oncogene Proteins</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051057" MajorTopicYN="N">Proto-Oncogene Proteins c-akt</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011758" MajorTopicYN="N">Pyrroles</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013569" MajorTopicYN="N">Synapses</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040301" MajorTopicYN="N">Vascular Endothelial Growth Factor Receptor-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>6</Month><Day>5</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>7</Month><Day>10</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>6</Month><Day>5</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12783420</ArticleId><ArticleId IdType="doi">10.1002/ana.10555</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12783912</PMID><DateCompleted><Year>2003</Year><Month>06</Month><Day>12</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>05</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0098-7484</ISSN><JournalIssue CitedMedium="Print"><Volume>289</Volume><Issue>21</Issue><PubDate><Year>2003</Year><Month>Jun</Month><Day>04</Day></PubDate></JournalIssue><Title>JAMA</Title><ISOAbbreviation>JAMA</ISOAbbreviation></Journal><ArticleTitle>Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial.</ArticleTitle><Pagination><StartPage>2819</StartPage><EndPage>2826</EndPage><MedlinePgn>2819-26</MedlinePgn></Pagination><Abstract><AbstractText Label="CONTEXT" NlmCategory="BACKGROUND">Laboratory evidence that inflammatory mechanisms contribute to neuronal injury in Alzheimer disease (AD), along with epidemiological evidence, suggests that nonsteroidal anti-inflammatory drugs (NSAIDs) may favorably influence the course of the disease.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To determine whether treatment with a selective cyclooxygenase (COX) -2 inhibitor (rofecoxib) or a traditional nonselective NSAID (naproxen) slows cognitive decline in patients with mild-to-moderate AD.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Multicenter, randomized, double-blind, placebo-controlled, parallel group trial, with 1-year exposure to study medications.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Forty ambulatory treatment centers affiliated with the Alzheimer's Disease Cooperative Study consortium.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Participants with mild-to-moderate AD (Mini-Mental State Examination score of 13-26) were recruited from December 1999 to November 2000 using clinic populations, referrals from community physicians, and local advertising. Stable use of cholinesterase inhibitors, estrogen, low-dose aspirin, and vitamin E was allowed. Participants with inflammatory diseases that might respond to the study medications were excluded. Of 474 participants screened, 351 were enrolled.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Once-daily rofecoxib, 25 mg, or twice-daily naproxen sodium, 220 mg, or placebo.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">The primary outcome measure was the 1-year change in the Alzheimer Disease Assessment Scale-Cognitive (ADAS-Cog) subscale score. Secondary outcome measures included the Clinical Dementia Rating scale sum-of-boxes, the Neuropsychiatric Inventory, the Quality of Life-AD, and the time to attainment of significant end points (4-point decline from baseline ADAS-Cog score, 1-step worsening on the global Clinical Dementia Rating scale, 15-point decline on the ADCS activities of daily living inventory, institutionalization, or death).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The 1-year mean (SD) change in ADAS-Cog scores in participants treated with naproxen (5.8 [8.0]) or rofecoxib (7.6 [7.7]) was not significantly different from the change in participants treated with placebo (5.7 [8.2]). Results of secondary analyses showed no consistent benefit of either treatment. Fatigue, dizziness, and hypertension were more commonly reported in the active drug groups, and more serious adverse events were found in the active treatment group than in the placebo group.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The results of this study indicate that rofecoxib or low-dose naproxen does not slow cognitive decline in patients with mild-to-moderate AD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aisen</LastName><ForeName>Paul S</ForeName><Initials>PS</Initials><AffiliationInfo><Affiliation>Department of Neurology, Georgetown University Medical Center, Washington, DC 20057, USA. psa@georgetown.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schafer</LastName><ForeName>Kimberly A</ForeName><Initials>KA</Initials></Author><Author ValidYN="Y"><LastName>Grundman</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Pfeiffer</LastName><ForeName>Eric</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Sano</LastName><ForeName>Mary</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Davis</LastName><ForeName>Kenneth L</ForeName><Initials>KL</Initials></Author><Author ValidYN="Y"><LastName>Farlow</LastName><ForeName>Martin R</ForeName><Initials>MR</Initials></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Shelia</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Ronald G</ForeName><Initials>RG</Initials></Author><Author ValidYN="Y"><LastName>Thal</LastName><ForeName>Leon J</ForeName><Initials>LJ</Initials></Author><Author ValidYN="Y"><CollectiveName>Alzheimer's Disease Cooperative Study</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U19 AG010483</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>5 M01-RR13297</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01-AG10483</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA</MedlineTA><NlmUniqueID>7501160</NlmUniqueID><ISSNLinking>0098-7484</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000894">Anti-Inflammatory Agents, Non-Steroidal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D052246">Cyclooxygenase 2 Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016861">Cyclooxygenase Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007527">Isoenzymes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007783">Lactones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013450">Sulfones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0QTW8Z7MCR</RegistryNumber><NameOfSubstance UI="C116926">rofecoxib</NameOfSubstance></Chemical><Chemical><RegistryNumber>57Y76R9ATQ</RegistryNumber><NameOfSubstance UI="D009288">Naproxen</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.99.1</RegistryNumber><NameOfSubstance UI="D051546">Cyclooxygenase 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.99.1</RegistryNumber><NameOfSubstance UI="C496540">PTGS2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.99.1</RegistryNumber><NameOfSubstance UI="D011451">Prostaglandin-Endoperoxide Synthases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2003 Jun 4;289(21):2865-7. doi: 10.1001/jama.289.21.2865.</RefSource><PMID Version="1">12783919</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Evid Based Ment Health. 2003 Nov;6(4):110. doi: 10.1136/ebmh.6.4.110.</RefSource><PMID Version="1">14585783</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000203" MajorTopicYN="N">Activities of Daily Living</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000894" MajorTopicYN="N">Anti-Inflammatory Agents, Non-Steroidal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051546" MajorTopicYN="N">Cyclooxygenase 2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D052246" MajorTopicYN="N">Cyclooxygenase 2 Inhibitors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016861" MajorTopicYN="N">Cyclooxygenase Inhibitors</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007527" MajorTopicYN="N">Isoenzymes</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="Y">antagonists &amp; inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007783" MajorTopicYN="N">Lactones</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009288" MajorTopicYN="N">Naproxen</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011451" MajorTopicYN="N">Prostaglandin-Endoperoxide Synthases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012044" MajorTopicYN="N">Regression Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013450" MajorTopicYN="N">Sulfones</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>6</Month><Day>5</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>6</Month><Day>13</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>6</Month><Day>5</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12783912</ArticleId><ArticleId IdType="doi">10.1001/jama.289.21.2819</ArticleId><ArticleId IdType="pii">289/21/2819</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12787504</PMID><DateCompleted><Year>2003</Year><Month>07</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0092-8674</ISSN><JournalIssue CitedMedium="Print"><Volume>113</Volume><Issue>5</Issue><PubDate><Year>2003</Year><Month>May</Month><Day>30</Day></PubDate></JournalIssue><Title>Cell</Title><ISOAbbreviation>Cell</ISOAbbreviation></Journal><ArticleTitle>The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells.</ArticleTitle><Pagination><StartPage>631</StartPage><EndPage>642</EndPage><MedlinePgn>631-42</MedlinePgn></Pagination><Abstract><AbstractText>Embryonic stem (ES) cells derived from the inner cell mass (ICM) of blastocysts grow infinitely while maintaining pluripotency. Leukemia inhibitory factor (LIF) can maintain self-renewal of mouse ES cells through activation of Stat3. However, LIF/Stat3 is dispensable for maintenance of ICM and human ES cells, suggesting that the pathway is not fundamental for pluripotency. In search of a critical factor(s) that underlies pluripotency in both ICM and ES cells, we performed in silico differential display and identified several genes specifically expressed in mouse ES cells and preimplantation embryos. We found that one of them, encoding the homeoprotein Nanog, was capable of maintaining ES cell self-renewal independently of LIF/Stat3. nanog-deficient ICM failed to generate epiblast and only produced parietal endoderm-like cells. nanog-deficient ES cells lost pluripotency and differentiated into extraembryonic endoderm lineage. These data demonstrate that Nanog is a critical factor underlying pluripotency in both ICM and ES cells.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mitsui</LastName><ForeName>Kaoru</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Laboratory of Animal Molecular Technology, Research and Education Center for Genetic Information, Nara Institute of Science and Technology, Nara 630-0192, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tokuzawa</LastName><ForeName>Yoshimi</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Itoh</LastName><ForeName>Hiroaki</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Segawa</LastName><ForeName>Kohichi</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Murakami</LastName><ForeName>Mirei</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Takahashi</LastName><ForeName>Kazutoshi</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Maruyama</LastName><ForeName>Masayoshi</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Maeda</LastName><ForeName>Mitsuyo</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Yamanaka</LastName><ForeName>Shinya</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>GENBANK</DataBankName><AccessionNumberList><AccessionNumber>AB093574</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell</MedlineTA><NlmUniqueID>0413066</NlmUniqueID><ISSNLinking>0092-8674</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018076">DNA, Complementary</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018398">Homeodomain Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C486780">NANOG protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071317">Nanog Homeobox Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C475540">Nanog protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050796">STAT3 Transcription Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C494087">Stat3 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015534">Trans-Activators</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001755" MajorTopicYN="N">Blastocyst</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019070" MajorTopicYN="N">Cell Lineage</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018076" MajorTopicYN="N">DNA, Complementary</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018507" MajorTopicYN="N">Gene Expression Regulation, Developmental</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018390" MajorTopicYN="N">Gene Targeting</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018398" MajorTopicYN="N">Homeodomain Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName><QualifierName UI="Q000196" MajorTopicYN="Y">embryology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071317" MajorTopicYN="N">Nanog Homeobox Protein</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039904" MajorTopicYN="N">Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050796" MajorTopicYN="N">STAT3 Transcription Factor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017386" MajorTopicYN="N">Sequence Homology, Amino Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015534" MajorTopicYN="N">Trans-Activators</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>6</Month><Day>6</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>7</Month><Day>17</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>6</Month><Day>6</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12787504</ArticleId><ArticleId IdType="doi">10.1016/s0092-8674(03)00393-3</ArticleId><ArticleId IdType="pii">S0092867403003933</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12787505</PMID><DateCompleted><Year>2003</Year><Month>07</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0092-8674</ISSN><JournalIssue CitedMedium="Print"><Volume>113</Volume><Issue>5</Issue><PubDate><Year>2003</Year><Month>May</Month><Day>30</Day></PubDate></JournalIssue><Title>Cell</Title><ISOAbbreviation>Cell</ISOAbbreviation></Journal><ArticleTitle>Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells.</ArticleTitle><Pagination><StartPage>643</StartPage><EndPage>655</EndPage><MedlinePgn>643-55</MedlinePgn></Pagination><Abstract><AbstractText>Embryonic stem (ES) cells undergo extended proliferation while remaining poised for multilineage differentiation. A unique network of transcription factors may characterize self-renewal and simultaneously suppress differentiation. We applied expression cloning in mouse ES cells to isolate a self-renewal determinant. Nanog is a divergent homeodomain protein that directs propagation of undifferentiated ES cells. Nanog mRNA is present in pluripotent mouse and human cell lines, and absent from differentiated cells. In preimplantation embryos, Nanog is restricted to founder cells from which ES cells can be derived. Endogenous Nanog acts in parallel with cytokine stimulation of Stat3 to drive ES cell self-renewal. Elevated Nanog expression from transgene constructs is sufficient for clonal expansion of ES cells, bypassing Stat3 and maintaining Oct4 levels. Cytokine dependence, multilineage differentiation, and embryo colonization capacity are fully restored upon transgene excision. These findings establish a central role for Nanog in the transcription factor hierarchy that defines ES cell identity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chambers</LastName><ForeName>Ian</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Institute for Stem Cell Research, University of Edinburgh, King's Buildings, West Mains Road, Edinburgh EH9 3JQ, Scotland. ichambers@ed.ac.uk</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colby</LastName><ForeName>Douglas</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Robertson</LastName><ForeName>Morag</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Nichols</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Sonia</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Tweedie</LastName><ForeName>Susan</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Austin</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>GENBANK</DataBankName><AccessionNumberList><AccessionNumber>AY278951</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell</MedlineTA><NlmUniqueID>0413066</NlmUniqueID><ISSNLinking>0092-8674</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018076">DNA, Complementary</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018398">Homeodomain Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C486780">NANOG protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071317">Nanog Homeobox Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C475540">Nanog protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050814">Octamer Transcription Factor-3</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C494174">Pou5f1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050796">STAT3 Transcription Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C494087">Stat3 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015534">Trans-Activators</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Cell. 2003 May 30;113(5):551-2. doi: 10.1016/s0092-8674(03)00394-5.</RefSource><PMID Version="1">12787492</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001755" MajorTopicYN="N">Blastocyst</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018076" MajorTopicYN="N">DNA, Complementary</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018507" MajorTopicYN="N">Gene Expression Regulation, Developmental</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018398" MajorTopicYN="N">Homeodomain Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName><QualifierName UI="Q000196" MajorTopicYN="Y">embryology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071317" MajorTopicYN="N">Nanog Homeobox Protein</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050814" MajorTopicYN="N">Octamer Transcription Factor-3</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039904" MajorTopicYN="N">Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050796" MajorTopicYN="N">STAT3 Transcription Factor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017386" MajorTopicYN="N">Sequence Homology, Amino Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012689" MajorTopicYN="N">Sequence Homology, Nucleic Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015534" MajorTopicYN="N">Trans-Activators</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>6</Month><Day>6</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>7</Month><Day>17</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>6</Month><Day>6</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12787505</ArticleId><ArticleId IdType="doi">10.1016/s0092-8674(03)00392-1</ArticleId><ArticleId IdType="pii">S0092867403003921</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12793519</PMID><DateCompleted><Year>2003</Year><Month>07</Month><Day>18</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1028-415X</ISSN><JournalIssue CitedMedium="Print"><Volume>6</Volume><Issue>3</Issue><PubDate><Year>2003</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Nutritional neuroscience</Title><ISOAbbreviation>Nutr Neurosci</ISOAbbreviation></Journal><ArticleTitle>Blueberry supplementation enhances signaling and prevents behavioral deficits in an Alzheimer disease model.</ArticleTitle><Pagination><StartPage>153</StartPage><EndPage>162</EndPage><MedlinePgn>153-62</MedlinePgn></Pagination><Abstract><AbstractText>Previously, we showed that blueberry (BB) supplementation reversed the deleterious effects of aging on motor behavior and neuronal signaling in senescent rodents. We now report that BB-fed (from 4 months of age) APP + PS1 transgenic mice showed no deficits in Y-maze performance (at 12 months of age) with no alterations in amyloid beta burden. It appeared that the protective mechanisms are derived from BB-induced enhancement of memory-associated neuronal signaling (e.g. extracellular signal-regulated kinase) and alterations in neutral sphingomyelin-specific phospholipase C activity. Thus, our data indicate for the first time that it may be possible to overcome genetic predispositions to Alzheimer disease through diet.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Joseph</LastName><ForeName>J A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>USDA-HNRCA at Tufts University, 711 Washington Street, Boston, MA 02111, USA. james.joseph@tufts.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denisova</LastName><ForeName>N A</ForeName><Initials>NA</Initials></Author><Author ValidYN="Y"><LastName>Arendash</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Gordon</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Diamond</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Shukitt-Hale</LastName><ForeName>B</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Morgan</LastName><ForeName>D</ForeName><Initials>D</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nutr Neurosci</MedlineTA><NlmUniqueID>100892202</NlmUniqueID><ISSNLinking>1028-415X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010936">Plant Extracts</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053764">Presenilin-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013109">Sphingomyelins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.13</RegistryNumber><NameOfSubstance UI="C496630">Prkca protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.13</RegistryNumber><NameOfSubstance UI="D011493">Protein Kinase C</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.13</RegistryNumber><NameOfSubstance UI="D051571">Protein Kinase C-alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.24</RegistryNumber><NameOfSubstance UI="D020928">Mitogen-Activated Protein Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.4.-</RegistryNumber><NameOfSubstance UI="D010738">Type C Phospholipases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="D020558">GTP Phosphohydrolases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001522" MajorTopicYN="Y">Behavior, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029798" MajorTopicYN="Y">Blueberry Plants</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004032" MajorTopicYN="Y">Diet</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005638" MajorTopicYN="Y">Fruit</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020558" MajorTopicYN="N">GTP Phosphohydrolases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008568" MajorTopicYN="N">Memory</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008811" MajorTopicYN="N">Mice, Inbred DBA</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020928" MajorTopicYN="N">Mitogen-Activated Protein Kinases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008517" MajorTopicYN="N">Phytotherapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010936" MajorTopicYN="N">Plant Extracts</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053764" MajorTopicYN="N">Presenilin-1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011493" MajorTopicYN="N">Protein Kinase C</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051571" MajorTopicYN="N">Protein Kinase C-alpha</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013109" MajorTopicYN="N">Sphingomyelins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010738" MajorTopicYN="N">Type C Phospholipases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>6</Month><Day>10</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>7</Month><Day>19</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>6</Month><Day>10</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12793519</ArticleId><ArticleId IdType="doi">10.1080/1028415031000111282</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12796482</PMID><DateCompleted><Year>2003</Year><Month>11</Month><Day>10</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0021-9258</ISSN><JournalIssue CitedMedium="Print"><Volume>278</Volume><Issue>33</Issue><PubDate><Year>2003</Year><Month>Aug</Month><Day>15</Day></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J Biol Chem</ISOAbbreviation></Journal><ArticleTitle>The crystal structure of DJ-1, a protein related to male fertility and Parkinson's disease.</ArticleTitle><Pagination><StartPage>31380</StartPage><EndPage>31384</EndPage><MedlinePgn>31380-4</MedlinePgn></Pagination><Abstract><AbstractText>DJ-1 is a multifunctional protein that plays essential roles in tissues with higher order biological functions such as the testis and brain. DJ-1 is related to male fertility, and its level in sperm decreases in response to exposure to sperm toxicants. DJ-1 has also been identified as a hydroperoxide-responsive protein. Recently, a mutation of DJ-1 was found to be responsible for familial Parkinson's disease. Here, we present the crystal structure of DJ-1 refined to 1.95-A resolution. DJ-1 forms a dimer in the crystal, and the monomer takes a flavodoxin-like Rossmann-fold. DJ-1 is structurally most similar to the monomer subunit of protease I, the intracellular cysteine protease from Pyrococcus horikoshii, and belongs to the Class I glutamine amidotransferase-like superfamily. However, DJ-1 contains an additional alpha-helix at the C-terminal region, which blocks the putative catalytic site of DJ-1 and appears to regulate the enzymatic activity. DJ-1 may induce conformational changes to acquire catalytic activity in response to oxidative stress.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Honbou</LastName><ForeName>Kazuya</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Structural Biology, Graduate School of Pharmaceutical Sciences, Hokkaido University, N-12, W-6, Kita-ku, Sapporo, 060-0812, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suzuki</LastName><ForeName>Nobuo N</ForeName><Initials>NN</Initials></Author><Author ValidYN="Y"><LastName>Horiuchi</LastName><ForeName>Masataka</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Niki</LastName><ForeName>Takeshi</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Taira</LastName><ForeName>Takahiro</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Ariga</LastName><ForeName>Hiroyoshi</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Inagaki</LastName><ForeName>Fuyuhiko</ForeName><Initials>F</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>PDB</DataBankName><AccessionNumberList><AccessionNumber>1UCF</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2003</Year><Month>06</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D047908">Intracellular Signaling Peptides and Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015513">Oncogene Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.2.-</RegistryNumber><NameOfSubstance UI="C105131">PARK7 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.1.2.-</RegistryNumber><NameOfSubstance UI="D000071617">Protein Deglycase DJ-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003001" MajorTopicYN="N">Cloning, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018360" MajorTopicYN="N">Crystallography, X-Ray</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019281" MajorTopicYN="N">Dimerization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005298" MajorTopicYN="N">Fertility</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007248" MajorTopicYN="N">Infertility, Male</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D047908" MajorTopicYN="N">Intracellular Signaling Peptides and Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015513" MajorTopicYN="N">Oncogene Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071617" MajorTopicYN="N">Protein Deglycase DJ-1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017433" MajorTopicYN="N">Protein Structure, Secondary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017434" MajorTopicYN="N">Protein Structure, Tertiary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013329" MajorTopicYN="N">Structure-Activity Relationship</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>6</Month><Day>11</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>11</Month><Day>11</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>6</Month><Day>11</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12796482</ArticleId><ArticleId IdType="doi">10.1074/jbc.M305878200</ArticleId><ArticleId IdType="pii">S0021-9258(20)84184-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">1279693</PMID><DateCompleted><Year>1992</Year><Month>12</Month><Day>23</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0027-8424</ISSN><JournalIssue CitedMedium="Print"><Volume>89</Volume><Issue>22</Issue><PubDate><Year>1992</Year><Month>Nov</Month><Day>15</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Identification of a mouse brain cDNA that encodes a protein related to the Alzheimer disease-associated amyloid beta protein precursor.</ArticleTitle><Pagination><StartPage>10758</StartPage><EndPage>10762</EndPage><MedlinePgn>10758-62</MedlinePgn></Pagination><Abstract><AbstractText>We have isolated a cDNA from a mouse brain library that encodes a protein whose predicted amino acid sequence is 42% identical and 64% similar to that of the amyloid beta protein precursor (APP). This 653-amino acid protein, which we have termed the amyloid precursor-like protein (APLP), appears to be similar to APP in overall structure as well as amino acid sequence. The amino acid homologies are concentrated within three distinct regions of the two proteins where the identities are 47%, 54%, and 56%. The APLP cDNA hybridizes to two messages of approximately 2.4 and 1.6 kilobases that are present in mouse brain and neuroblastoma cells. Polyclonal antibodies raised against a peptide derived from the C terminus of APLP stain the cytoplasm in a pattern reminiscent of Golgi staining. In addition to APP, APLP also displays significant homology to the Drosophila APP-like protein APPL and a rat testes APP-like protein. These data indicate that the APP gene is a member of a strongly conserved gene family. Studies aimed at determining the functions of the proteins encoded by this gene family should provide valuable clues to their potential role in Alzheimer disease neuropathology.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wasco</LastName><ForeName>W</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Biology, Massachusetts Institute of Technology, Cambridge 02139.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bupp</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Magendantz</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Gusella</LastName><ForeName>J F</ForeName><Initials>JF</Initials></Author><Author ValidYN="Y"><LastName>Tanzi</LastName><ForeName>R E</ForeName><Initials>RE</Initials></Author><Author ValidYN="Y"><LastName>Solomon</LastName><ForeName>F</ForeName><Initials>F</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>GENBANK</DataBankName><AccessionNumberList><AccessionNumber>L04538</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>CA53395</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS-30428-01</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C489697">APLP1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C078201">Aplp1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008869">Microtubule-Associated Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>24937-83-5</RegistryNumber><NameOfSubstance UI="D011061">Poly A</NameOfSubstance></Chemical><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance UI="D012313">RNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015152" MajorTopicYN="N">Blotting, Northern</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003001" MajorTopicYN="N">Cloning, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008869" MajorTopicYN="N">Microtubule-Associated Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009447" MajorTopicYN="N">Neuroblastoma</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011061" MajorTopicYN="N">Poly A</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015183" MajorTopicYN="N">Restriction Mapping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017386" MajorTopicYN="N">Sequence Homology, Amino Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014407" MajorTopicYN="N">Tumor Cells, Cultured</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1992</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1992</Year><Month>11</Month><Day>15</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1992</Year><Month>11</Month><Day>15</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>1993</Year><Month>5</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">1279693</ArticleId><ArticleId IdType="pmc">PMC50421</ArticleId><ArticleId IdType="doi">10.1073/pnas.89.22.10758</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Cell Biol. 1989 Oct;109(4 Pt 1):1609-20</Citation><ArticleIdList><ArticleId IdType="pubmed">2677023</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1980 Mar;77(3):1496-500</Citation><ArticleIdList><ArticleId IdType="pubmed">6929499</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1988 Feb 11;331(6156):525-7</Citation><ArticleIdList><ArticleId IdType="pubmed">2893289</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1988 Feb 11;331(6156):530-2</Citation><ArticleIdList><ArticleId IdType="pubmed">2893291</ArticleId></ArticleIdList></Reference><Reference><Citation>Biotechniques. 1988 Feb;6(2):114-6</Citation><ArticleIdList><ArticleId IdType="pubmed">2908499</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1987 Feb 20;235(4791):880-4</Citation><ArticleIdList><ArticleId IdType="pubmed">2949367</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cell Biol. 1988 May;106(5):1765-72</Citation><ArticleIdList><ArticleId IdType="pubmed">3131349</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1988 Oct;85(19):7341-5</Citation><ArticleIdList><ArticleId IdType="pubmed">3140239</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 1986 Jul 18;46(2):271-82</Citation><ArticleIdList><ArticleId IdType="pubmed">3487386</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1987 Feb 20;235(4791):877-80</Citation><ArticleIdList><ArticleId IdType="pubmed">3810169</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 1985 Jun 10;260(11):6654-62</Citation><ArticleIdList><ArticleId IdType="pubmed">3922977</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1984 Apr;81(7):1991-5</Citation><ArticleIdList><ArticleId IdType="pubmed">6326095</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 1984 Jan 25;12(2):857-72</Citation><ArticleIdList><ArticleId IdType="pubmed">6694911</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1990 Apr;87(7):2405-8</Citation><ArticleIdList><ArticleId IdType="pubmed">1690887</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 1990 Mar 15;265(8):4492-7</Citation><ArticleIdList><ArticleId IdType="pubmed">1968460</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1990 Aug;87(15):6003-6</Citation><ArticleIdList><ArticleId IdType="pubmed">2116015</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1988 Dec;85(23):8998-9002</Citation><ArticleIdList><ArticleId IdType="pubmed">2461560</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem Biophys Res Commun. 1989 Feb 15;158(3):906-12</Citation><ArticleIdList><ArticleId IdType="pubmed">2493250</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1990 Apr 27;248(4954):492-5</Citation><ArticleIdList><ArticleId IdType="pubmed">1691865</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 1990 Feb 25;265(6):3116-23</Citation><ArticleIdList><ArticleId IdType="pubmed">1968060</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1990 Jun 1;248(4959):1122-4</Citation><ArticleIdList><ArticleId IdType="pubmed">2111583</ArticleId></ArticleIdList></Reference><Reference><Citation>J Neurosci. 1990 Dec;10(12):3849-61</Citation><ArticleIdList><ArticleId IdType="pubmed">2125311</ArticleId></ArticleIdList></Reference><Reference><Citation>J Cell Biol. 1990 Dec;111(6 Pt 1):2295-306</Citation><ArticleIdList><ArticleId IdType="pubmed">2277061</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 1989 Aug 25;58(4):615-22</Citation><ArticleIdList><ArticleId IdType="pubmed">2475254</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1989 Apr;86(7):2478-82</Citation><ArticleIdList><ArticleId IdType="pubmed">2494667</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1989 Aug;86(16):6338-42</Citation><ArticleIdList><ArticleId IdType="pubmed">2503832</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 1989 Apr 7;57(1):115-26</Citation><ArticleIdList><ArticleId IdType="pubmed">2649245</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1989 Aug 11;245(4918):651-3</Citation><ArticleIdList><ArticleId IdType="pubmed">2569763</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuropathol Appl Neurobiol. 1989 Mar-Apr;15(2):135-47</Citation><ArticleIdList><ArticleId IdType="pubmed">2657471</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1989 Aug;86(15):5673-7</Citation><ArticleIdList><ArticleId IdType="pubmed">2788276</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1988 Feb 11;331(6156):528-30</Citation><ArticleIdList><ArticleId IdType="pubmed">2893290</ArticleId></ArticleIdList></Reference><Reference><Citation>EMBO J. 1988 Feb;7(2):367-72</Citation><ArticleIdList><ArticleId IdType="pubmed">2896589</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1987 Jun;84(12):4190-4</Citation><ArticleIdList><ArticleId IdType="pubmed">3035574</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1988 Aug;85(16):6218-21</Citation><ArticleIdList><ArticleId IdType="pubmed">3137567</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Cell Biol. 1987 Oct;7(10):3799-805</Citation><ArticleIdList><ArticleId IdType="pubmed">3316988</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 1985 Oct;82(19):6581-5</Citation><ArticleIdList><ArticleId IdType="pubmed">3863114</ArticleId></ArticleIdList></Reference><Reference><Citation>Anal Biochem. 1983 Jul 1;132(1):6-13</Citation><ArticleIdList><ArticleId IdType="pubmed">6312838</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1987 Feb 19-25;325(6106):733-6</Citation><ArticleIdList><ArticleId IdType="pubmed">2881207</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12801237</PMID><DateCompleted><Year>2003</Year><Month>07</Month><Day>15</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0022-2623</ISSN><JournalIssue CitedMedium="Print"><Volume>46</Volume><Issue>13</Issue><PubDate><Year>2003</Year><Month>Jun</Month><Day>19</Day></PubDate></JournalIssue><Title>Journal of medicinal chemistry</Title><ISOAbbreviation>J Med Chem</ISOAbbreviation></Journal><ArticleTitle>Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents.</ArticleTitle><Pagination><StartPage>2740</StartPage><EndPage>2754</EndPage><MedlinePgn>2740-54</MedlinePgn></Pagination><Abstract><AbstractText>The synthesis and evaluation of a series of neutral analogues of thioflavin-T (termed BTA's) with high affinities for aggregated amyloid and a wide range of lipophilicities are reported. Radiolabeling with high specific activity [(11)C]methyl iodide provided derivatives for in vivo evaluation. Brain entry in control mice and baboons was high for nearly all of the analogues at early times after injection, but the clearance rate of radioactivity from brain tissue varied by more than 1 order of magnitude. Upon the basis of its rapid clearance from normal mouse and baboon brain tissues, [N-methyl-(11)C]2-(4'-methylaminophenyl)-6-hydroxybenzothiazole (or [(11)C]6-OH-BTA-1) was selected as the lead compound for further evaluation. The radiolabeled metabolites of [(11)C]6-OH-BTA-1 were polar and did not enter brain. The binding affinities of [N-methyl-(3)H]6-OH-BTA-1 for homogenates of postmortem AD frontal cortex and synthetic Abeta(1-40) fibrils were similar (K(d) = 1.4 nM and 4.7 nM, respectively), but the ligand-to-Abeta peptide binding stoichiometry was approximately 400-fold higher for AD brain than Abeta(1-40) fibrils. Staining of AD frontal cortex tissue sections with 6-OH-BTA-1 indicated the selective binding of the compound to amyloid plaques and cerebrovascular amyloid. The encouraging in vitro and in vivo properties of [(11)C]6-OH-BTA-1 support the choice of this derivative for further evaluation in human subject studies of brain Abeta deposition.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mathis</LastName><ForeName>Chester A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA. mathisca@msx.upmc.edu</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yanming</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Holt</LastName><ForeName>Daniel P</ForeName><Initials>DP</Initials></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Guo-Feng</ForeName><Initials>GF</Initials></Author><Author ValidYN="Y"><LastName>Debnath</LastName><ForeName>Manik L</ForeName><Initials>ML</Initials></Author><Author ValidYN="Y"><LastName>Klunk</LastName><ForeName>William E</ForeName><Initials>WE</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>AG01039</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG05133</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG18402</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>AG20226</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Chem</MedlineTA><NlmUniqueID>9716531</NlmUniqueID><ISSNLinking>0022-2623</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C475519">2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000814">Aniline Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002250">Carbon Radioisotopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019275">Radiopharmaceuticals</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013844">Thiazoles</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C078592">amyloid beta-protein (1-40)</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000814" MajorTopicYN="N">Aniline Compounds</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="Y">chemical synthesis</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002250" MajorTopicYN="N">Carbon Radioisotopes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007553" MajorTopicYN="N">Isotope Labeling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010215" MajorTopicYN="N">Papio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019275" MajorTopicYN="N">Radiopharmaceuticals</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="Y">chemical synthesis</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013844" MajorTopicYN="N">Thiazoles</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="Y">chemical synthesis</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014055" MajorTopicYN="N">Tomography, Emission-Computed</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>6</Month><Day>13</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>7</Month><Day>16</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>6</Month><Day>13</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12801237</ArticleId><ArticleId IdType="doi">10.1021/jm030026b</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">12805290</PMID><DateCompleted><Year>2003</Year><Month>07</Month><Day>01</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1529-2401</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>11</Issue><PubDate><Year>2003</Year><Month>Jun</Month><Day>01</Day></PubDate></JournalIssue><Title>The Journal of neuroscience : the official journal of the Society for Neuroscience</Title><ISOAbbreviation>J Neurosci</ISOAbbreviation></Journal><ArticleTitle>Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport.</ArticleTitle><Pagination><StartPage>4499</StartPage><EndPage>4508</EndPage><MedlinePgn>4499-508</MedlinePgn></Pagination><Abstract><AbstractText>Several lines of evidence indicate that alterations in axonal transport play a critical role in Alzheimer's disease (AD) neuropathology, but the molecular mechanisms that control this process are not understood fully. Recent work indicates that presenilin 1 (PS1) interacts with glycogen synthase kinase 3beta (GSK3beta). In vivo, GSK3beta phosphorylates kinesin light chains (KLC) and causes the release of kinesin-I from membrane-bound organelles (MBOs), leading to a reduction in kinesin-I driven motility (Morfini et al., 2002b). To characterize a potential role for PS1 in the regulation of kinesin-based axonal transport, we used PS1-/- and PS1 knock-inM146V (KIM146V) mice and cultured cells. We show that relative levels of GSK3beta activity were increased in cells either in the presence of mutant PS1 or in the absence of PS1 (PS1-/-). Concomitant with increased GSK3beta activity, relative levels of KLC phosphorylation were increased, and the amount of kinesin-I bound to MBOs was reduced. Consistent with a deficit in kinesin-I-mediated fast axonal transport, densities of synaptophysin- and syntaxin-I-containing vesicles and mitochondria were reduced in neuritic processes of KIM146V hippocampal neurons. Similarly, we found reduced levels of PS1, amyloid precursor protein, and synaptophysin in sciatic nerves of KIM146V mice. Thus PS1 appears to modulate GSK3beta activity and the release of kinesin-I from MBOs at sites of vesicle delivery and membrane insertion. These findings suggest that mutations in PS1 may compromise neuronal function by affecting GSK-3 activity and kinesin-I-based motility.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pigino</LastName><ForeName>Gustavo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, University of Connecticut Health Center, Farmington, Connecticut 06030, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morfini</LastName><ForeName>Gerardo</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Pelsman</LastName><ForeName>Alejandra</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Mattson</LastName><ForeName>Mark P</ForeName><Initials>MP</Initials></Author><Author ValidYN="Y"><LastName>Brady</LastName><ForeName>Scott T</ForeName><Initials>ST</Initials></Author><Author ValidYN="Y"><LastName>Busciglio</LastName><ForeName>Jorge</ForeName><Initials>J</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HD038466</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS023868</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HD38466</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Neurosci</MedlineTA><NlmUniqueID>8102140</NlmUniqueID><ISSNLinking>0270-6474</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016564">Amyloid beta-Protein Precursor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508853">PSEN1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053764">Presenilin-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016708">Synaptophysin</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.26</RegistryNumber><NameOfSubstance UI="D038362">Glycogen Synthase Kinase 3</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.4</RegistryNumber><NameOfSubstance UI="D016547">Kinesins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016564" MajorTopicYN="N">Amyloid beta-Protein Precursor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001370" MajorTopicYN="N">Axonal Transport</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004789" MajorTopicYN="N">Enzyme Activation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D038362" MajorTopicYN="N">Glycogen Synthase Kinase 3</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020439" MajorTopicYN="N">Growth Cones</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016547" MajorTopicYN="N">Kinesins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName UI="Q000172" MajorTopicYN="N">deficiency</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011233" MajorTopicYN="N">Precipitin Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053764" MajorTopicYN="N">Presenilin-1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016708" MajorTopicYN="N">Synaptophysin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014162" MajorTopicYN="N">Transfection</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NASA"><Keyword MajorTopicYN="N">Non-programmatic</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>6</Month><Day>14</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>7</Month><Day>2</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>6</Month><Day>14</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2003</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12805290</ArticleId><ArticleId IdType="pmc">PMC6740780</ArticleId><ArticleId IdType="pii">23/11/4499</ArticleId><ArticleId IdType="doi">10.1523/JNEUROSCI.23-11-04499.2003</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Amtul Z, Lewis PA, Piper S, Crook R, Baker M, Findlay K, Singleton A, Hogg M, Younkin L, Younkin SG, Hardy J, Hutton M, Boeve BF, Tang-Wai D, Golde TE ( 2002) A presenilin 1 mutation associated with familial frontotemporal dementia inhibits &#x3b3;-secretase cleavage of APP and Notch. Neurobiol Dis 9: 269&#x2013;273.</Citation><ArticleIdList><ArticleId IdType="pubmed">11895378</ArticleId></ArticleIdList></Reference><Reference><Citation>Ancolio K, Marambaud P, Dauch P, Checler F ( 1997) &#x3b1;-Secretase-derived product of &#x3b2;-amyloid precursor protein is decreased by presenilin 1 mutations linked to familial Alzheimer's disease. J Neurochem 69: 2494&#x2013;2499.</Citation><ArticleIdList><ArticleId IdType="pubmed">9375682</ArticleId></ArticleIdList></Reference><Reference><Citation>Annaert WG, Levesque L, Craessaerts K, Dierinck I, Snellings G, Westaway D, George-Hyslop PS, Cordell B, Fraser P, De Strooper B ( 1999) Presenilin 1 controls &#x3b3;-secretase processing of amyloid precursor protein in pre-Golgi compartments of hippocampal neurons. J Cell Biol 147: 277&#x2013;294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2174229</ArticleId><ArticleId IdType="pubmed">10525535</ArticleId></ArticleIdList></Reference><Reference><Citation>Baum L, Hansen L, Masliah E, Saitoh T ( 1996) Glycogen synthase kinase 3 alteration in Alzheimer disease is related to neurofibrillary tangle formation. Mol Chem Neuropathol 29: 253&#x2013;261.</Citation><ArticleIdList><ArticleId IdType="pubmed">8971700</ArticleId></ArticleIdList></Reference><Reference><Citation>Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, Ratovitsky T, Prada CM, Kim G, Seekins S, Yager D, Slunt HH, Wang R, Seeger M, Levey AI, Gandy SE, Copeland NG, Jenkins NA, Price DL, Younkin SG, Sisodia SS ( 1996) Familial Alzheimer's disease-linked presenilin 1 variants elevate A&#x3b2;1&#x2013;42/1&#x2013;40 ratio in vitro and in vivo Neuron 17: 1005&#x2013;1013.</Citation><ArticleIdList><ArticleId IdType="pubmed">8938131</ArticleId></ArticleIdList></Reference><Reference><Citation>Busciglio J, Yankner BA ( 1995) Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro Nature 378: 776&#x2013;779.</Citation><ArticleIdList><ArticleId IdType="pubmed">8524410</ArticleId></ArticleIdList></Reference><Reference><Citation>Busciglio J, Hartmann H, Lorenzo A, Wong C, Baumann K, Sommer B, Staufenbiel M, Yankner BA ( 1997) Neuronal localization of presenilin-1 and association with amyloid plaques and neurofibrillary tangles in Alzheimer's disease. J Neurosci 17: 5101&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6573321</ArticleId><ArticleId IdType="pubmed">9185547</ArticleId></ArticleIdList></Reference><Reference><Citation>Busciglio J, Pelsman A, Wong C, Pigino G, Yuan M, Mori H, Yankner BA ( 2002) Altered metabolism of the amyloid &#x3b2; precursor protein is associated with mitochondrial dysfunction in Down's syndrome. Neuron 33: 677&#x2013;688.</Citation><ArticleIdList><ArticleId IdType="pubmed">11879646</ArticleId></ArticleIdList></Reference><Reference><Citation>Capell A, Saffrich R, Olivo JC, Meyn L, Walter J, Grunberg J, Mathews P, Nixon R, Dotti C, Haass C ( 1997) Cellular expression and proteolytic processing of presenilin proteins is developmentally regulated during neuronal differentiation. J Neurochem 69: 2432&#x2013;2440.</Citation><ArticleIdList><ArticleId IdType="pubmed">9375676</ArticleId></ArticleIdList></Reference><Reference><Citation>de Waegh SM, Lee VM, Brady ST ( 1992) Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell 68: 451&#x2013;463.</Citation><ArticleIdList><ArticleId IdType="pubmed">1371237</ArticleId></ArticleIdList></Reference><Reference><Citation>Doan A, Thinakaran G, Borchelt DR, Slunt HH, Ratovitsky T, Podlisny M, Selkoe DJ, Seeger M, Gandy SE, Price DL, Sisodia SS ( 1996) Protein topology of presenilin 1. Neuron 17: 1023&#x2013;1030.</Citation><ArticleIdList><ArticleId IdType="pubmed">8938133</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebinu JO, Yankner BA ( 2002) A RIP tide in neuronal signal transduction. Neuron 34: 499&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pubmed">12062033</ArticleId></ArticleIdList></Reference><Reference><Citation>Eldar-Finkelman H, Schreyer SA, Shinohara MM, LeBoeuf RC, Krebs EG ( 1999) Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice. Diabetes 48: 1662&#x2013;1666.</Citation><ArticleIdList><ArticleId IdType="pubmed">10426388</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira A, Niclas J, Vale RD, Banker G, Kosik KS ( 1992) Suppression of kinesin expression in cultured hippocampal neurons using antisense oligonucleotides. J Cell Biol 117: 595&#x2013;606.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2289440</ArticleId><ArticleId IdType="pubmed">1533397</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira A, Caceres A, Kosik KS ( 1993) Intraneuronal compartments of the amyloid precursor protein. J Neurosci 13: 3112&#x2013;3123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6576677</ArticleId><ArticleId IdType="pubmed">8331388</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiskum G, Murphy AN, Beal MF ( 1999) Mitochondria in neurodegeneration: acute ischemia and chronic neurodegenerative diseases. J Cereb Blood Flow Metab 19: 351&#x2013;369.</Citation><ArticleIdList><ArticleId IdType="pubmed">10197505</ArticleId></ArticleIdList></Reference><Reference><Citation>Frame S, Cohen P ( 2001) GSK3 takes centre stage more than 20 years after its discovery. Biochem J 359: 1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1222116</ArticleId><ArticleId IdType="pubmed">11563964</ArticleId></ArticleIdList></Reference><Reference><Citation>Frame S, Cohen P, Biondi RM ( 2001) A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol Cell 7: 1321&#x2013;1327.</Citation><ArticleIdList><ArticleId IdType="pubmed">11430833</ArticleId></ArticleIdList></Reference><Reference><Citation>Freemantle SJ, Portland HB, Ewings K, Dmitrovsky F, DiPetrillo K, Spinella MJ, Dmitrovsky E ( 2002) Characterization and tissue-specific expression of human GSK-3-binding proteins FRAT1 and FRAT2. Gene 291: 17&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">12095675</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldman WP, Baty JD, Buckles VD, Sahrmann S, Morris JC ( 1999) Motor dysfunction in mildly demented AD individuals without extrapyramidal signs. Neurology 53: 956&#x2013;962.</Citation><ArticleIdList><ArticleId IdType="pubmed">10496252</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein LS ( 2001) Kinesin molecular motors: transport pathways, receptors, and human disease. Proc Natl Acad Sci USA 98: 6999&#x2013;7003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC34613</ArticleId><ArticleId IdType="pubmed">11416178</ArticleId></ArticleIdList></Reference><Reference><Citation>Grace E, Busciglio J ( 2003) Aberrant activation of focal adhesion proteins mediates fibrillar A&#x3b2;-induced neuronal dystrophy. J Neurosci 23: 493&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6741895</ArticleId><ArticleId IdType="pubmed">12533609</ArticleId></ArticleIdList></Reference><Reference><Citation>Grace E, Rabiner C, Busciglio J ( 2002) Characterization of neuronal dystrophy induced by fibrillar amyloid &#x3b2;: implications for Alzheimer's disease. Neuroscience 114: 265&#x2013;273.</Citation><ArticleIdList><ArticleId IdType="pubmed">12207971</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Q, Fu W, Sopher BL, Miller MW, Ware CB, Martin GM, Mattson MP ( 1999) Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nat Med 5: 101&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pubmed">9883847</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, Johnson AB, Kress Y, Vinters HV, Tabaton M, Shimohama S, Cash AD, Siedlak SL, Harris PL, Jones PK, Petersen RB, Perry G, Smith MA ( 2001) Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 21: 3017&#x2013;3023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6762571</ArticleId><ArticleId IdType="pubmed">11312286</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurd DD, Saxton WM ( 1996) Kinesin mutations cause motor neuron disease phenotypes by disrupting fast axonal transport in Drosophila Genetics 144: 1075&#x2013;1085.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1207603</ArticleId><ArticleId IdType="pubmed">8913751</ArticleId></ArticleIdList></Reference><Reference><Citation>Janicki SM, Stabler SM, Monteiro MJ ( 2000) Familial Alzheimer's disease presenilin-1 mutants potentiate cell cycle arrest. Neurobiol Aging 21: 829&#x2013;836.</Citation><ArticleIdList><ArticleId IdType="pubmed">11124426</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal A, Stokin GB, Yang Z, Xia CH, Goldstein LS ( 2000) Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I. Neuron 28: 449&#x2013;459.</Citation><ArticleIdList><ArticleId IdType="pubmed">11144355</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal A, Almenar-Queralt A, LeBlanc JF, Roberts EA, Goldstein LS ( 2001) Kinesin-mediated axonal transport of a membrane compartment containing &#x3b2;-secretase and presenilin-1 requires APP. Nature 414: 643&#x2013;648.</Citation><ArticleIdList><ArticleId IdType="pubmed">11740561</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasa P, Papp H, Pakaski M ( 2001) Presenilin-1 and its N-terminal and C-terminal fragments are transported in the sciatic nerve of rat. Brain Res 909: 159&#x2013;169.</Citation><ArticleIdList><ArticleId IdType="pubmed">11478932</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirschenbaum F, Hsu SC, Cordell B, McCarthy JV ( 2001) Glycogen synthase kinase-3&#x3b2; regulates presenilin 1 C-terminal fragment levels. J Biol Chem 276: 30701&#x2013;30707.</Citation><ArticleIdList><ArticleId IdType="pubmed">11402035</ArticleId></ArticleIdList></Reference><Reference><Citation>Lah JJ, Heilman CJ, Nash NR, Rees HD, Yi H, Counts SE, Levey AI ( 1997) Light and electron microscopic localization of presenilin-1 in primate brain. J Neurosci 17: 1971&#x2013;1980.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6793763</ArticleId><ArticleId IdType="pubmed">9045726</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, Yu CE, Jondro PD, Schmidt SD, Wang K ( 1995) Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269: 973&#x2013;977.</Citation><ArticleIdList><ArticleId IdType="pubmed">7638622</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Greenwald I ( 1998) Additional evidence for an eight-transmembrane-domain topology for Caenorhabditis elegans and human presenilins. Proc Natl Acad Sci USA 95: 7109&#x2013;7114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC22757</ArticleId><ArticleId IdType="pubmed">9618547</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandelkow EM, Drewes G, Biernat J, Gustke N, Van Lint J, Vandenheede JR, Mandelkow E ( 1992) Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau. FEBS Lett 314: 315&#x2013;321.</Citation><ArticleIdList><ArticleId IdType="pubmed">1334849</ArticleId></ArticleIdList></Reference><Reference><Citation>Marambaud P, Alves da Costa C, Ancolio K, Checler F ( 1998) Alzheimer's disease-linked mutation of presenilin 2 (N141I-PS2) drastically lowers APP&#x3b1; secretion: control by the proteasome. Biochem Biophys Res Commun 252: 134&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pubmed">9813158</ArticleId></ArticleIdList></Reference><Reference><Citation>Marambaud P, Shioi J, Serban G, Georgakopoulos A, Sarner S, Nagy V, Baki L, Wen P, Efthimiopoulos S, Shao Z, Wisniewski T, Robakis NK ( 2002) A presenilin-1/&#x3b3;-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J 21: 1948&#x2013;1956.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC125968</ArticleId><ArticleId IdType="pubmed">11953314</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattson MP, Guo Q, Furukawa K, Pedersen WA ( 1998) Presenilins, the endoplasmic reticulum, and neuronal apoptosis in Alzheimer's disease. J Neurochem 70: 1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">9422341</ArticleId></ArticleIdList></Reference><Reference><Citation>Morfini G, Szebenyi G, Richards B, Brady ST ( 2001a) Regulation of kinesin: implications for neuronal development. Dev Neurosci 23: 364&#x2013;376.</Citation><ArticleIdList><ArticleId IdType="pubmed">11756752</ArticleId></ArticleIdList></Reference><Reference><Citation>Morfini G, Tsai MY, Szebenyi G, Brady ST ( 2001b) Approaches to study interactions between kinesin motors and membranes. Methods Mol Biol 164: 147&#x2013;162.</Citation><ArticleIdList><ArticleId IdType="pubmed">11217604</ArticleId></ArticleIdList></Reference><Reference><Citation>Morfini G, Pigino G, Beffert U, Busciglio J, Brady ST ( 2002a) Fast axonal transport misregulation and Alzheimer's disease. Neuromolecular Med 2: 89&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">12428805</ArticleId></ArticleIdList></Reference><Reference><Citation>Morfini G, Szebenyi G, Elluru R, Ratner N, Brady ST ( 2002b) Glycogen synthase kinase-3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility. EMBO J 21: 281&#x2013;293.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC125832</ArticleId><ArticleId IdType="pubmed">11823421</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulot SF, Hughes K, Woodgett JR, Anderton BH, Hanger DP ( 1994) PHF-tau from Alzheimer's brain comprises four species on SDS-PAGE that can be mimicked by in vitro phosphorylation of human brain tau by glycogen synthase kinase-3&#x3b2;. FEBS Lett 349: 359&#x2013;364.</Citation><ArticleIdList><ArticleId IdType="pubmed">8050597</ArticleId></ArticleIdList></Reference><Reference><Citation>Naruse S, Thinakaran G, Luo JJ, Kusiak JW, Tomita T, Iwatsubo T, Qian X, Ginty DD, Price DL, Borchelt DR, Wong PC, Sisodia SS ( 1998) Effects of PS1 deficiency on membrane protein trafficking in neurons. Neuron 21: 1213&#x2013;1221.</Citation><ArticleIdList><ArticleId IdType="pubmed">9856475</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura M, Yu G, Levesque G, Zhang DM, Ruel L, Chen F, Milman P, Holmes E, Liang Y, Kawarai T, Jo E, Supala A, Rogaeva E, Xu DM, Janus C, Levesque L, Bi Q, Duthie M, Rozmahel R, Mattila K, Lannfelt L, West-away D, Mount HT, Woodgett J, St. George-Hyslop P ( 1999) Presenilin mutations associated with Alzheimer disease cause defective intracellular trafficking of &#x3b2;-catenin, a component of the presenilin protein complex. Nat Med 5: 164&#x2013;169.</Citation><ArticleIdList><ArticleId IdType="pubmed">9930863</ArticleId></ArticleIdList></Reference><Reference><Citation>Okada Y, Yamazaki H, Aizawa Y, Hirokawa N ( 1995) The neuron-specific kinesin superfamily protein KIF1A is a unique monomeric motor for anterograde axonal transport of synaptic vesicle precursor. Cell 81: 769&#x2013;780.</Citation><ArticleIdList><ArticleId IdType="pubmed">7539720</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettersson AF, Engardt M, Wahlund LO ( 2002) Activity level and balance in subjects with mild Alzheimer's disease. Dement Geriatr Cogn Disord 13: 213&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">12006731</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfenninger KH, Ellis L, Johnson MP, Friedman LB, Somlo S ( 1983) Nerve growth cones isolated from fetal rat brain: subcellular fractionation and characterization. Cell 35: 573&#x2013;584.</Citation><ArticleIdList><ArticleId IdType="pubmed">6652678</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfister KK, Wagner MC, Stenoien DL, Brady ST, Bloom GS ( 1989) Monoclonal antibodies to kinesin heavy and light chains stain vesicle-like structures, but not microtubules, in cultured cells. J Cell Biol 108: 1453&#x2013;1463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2115510</ArticleId><ArticleId IdType="pubmed">2522455</ArticleId></ArticleIdList></Reference><Reference><Citation>Pigino G, Pelsman A, Mori H, Busciglio J ( 2001) Presenilin 1 mutations reduce cytoskeletal association, deregulate neurite growth, and potentiate neuronal dystrophy and tau phosphorylation. J Neurosci 21: 834&#x2013;842.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6762317</ArticleId><ArticleId IdType="pubmed">11157069</ArticleId></ArticleIdList></Reference><Reference><Citation>Pleasure SJ, Page C, Lee VM ( 1992) Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. J Neurosci 12: 1802&#x2013;1815.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6575890</ArticleId><ArticleId IdType="pubmed">1578271</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratner N, Bloom GS, Brady ST ( 1998) A role for cyclin-dependent kinase(s) in the modulation of fast anterograde axonal transport: effects defined by olomoucine and the APC tumor suppressor protein. J Neurosci 18: 7717&#x2013;7726.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6793030</ArticleId><ArticleId IdType="pubmed">9742142</ArticleId></ArticleIdList></Reference><Reference><Citation>Reid E, Kloos M, Ashley-Koch A, Hughes L, Bevan S, Svenson IK, Graham FL, Gaskell PC, Dearlove A, Pericak-Vance MA, Rubinsztein DC, Marchuk DA ( 2002) A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). Am J Hum Genet 71: 1189&#x2013;1194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC385095</ArticleId><ArticleId IdType="pubmed">12355402</ArticleId></ArticleIdList></Reference><Reference><Citation>Saitoh T, Moriwaki J, Koike J, Takagi A, Miwa T, Shiokawa K, Katoh M ( 2001) Molecular cloning and characterization of FRAT2, encoding a positive regulator of the WNT signaling pathway. Biochem Biophys Res Commun 281: 815&#x2013;820.</Citation><ArticleIdList><ArticleId IdType="pubmed">11237732</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheetz MP, Pfister KK, Bulinski JC, Cotman CW ( 1998) Mechanisms of trafficking in axons and dendrites: implications for development and neurodegeneration. Prog Neurobiol 55: 577&#x2013;594.</Citation><ArticleIdList><ArticleId IdType="pubmed">9670219</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K ( 1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375: 754&#x2013;760.</Citation><ArticleIdList><ArticleId IdType="pubmed">7596406</ArticleId></ArticleIdList></Reference><Reference><Citation>Sica RE, Pereyra S, Mangone CA ( 1998) Loss of motor units in Alzheimer's disease. Electromyogr Clin Neurophysiol 38: 475&#x2013;479.</Citation><ArticleIdList><ArticleId IdType="pubmed">9842482</ArticleId></ArticleIdList></Reference><Reference><Citation>Stenoien DL, Brady ST ( 1997) Immunochemical analysis of kinesin light chain function. Mol Biol Cell 8: 675&#x2013;689.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC276118</ArticleId><ArticleId IdType="pubmed">9247647</ArticleId></ArticleIdList></Reference><Reference><Citation>Summers SA, Kao AW, Kohn AD, Backus GS, Roth RA, Pessin JE, Birnbaum MJ ( 1999) The role of glycogen synthase kinase 3&#x3b2; in insulin-stimulated glucose metabolism. J Biol Chem 274: 17934&#x2013;17940.</Citation><ArticleIdList><ArticleId IdType="pubmed">10364240</ArticleId></ArticleIdList></Reference><Reference><Citation>Taccioli GE, Amatucci AG, Beamish HJ, Gell D, Xiang XH, Torres Arzayus MI, Priestley A, Jackson SP, Marshak Rothstein A, Jeggo PA, Herrera VL ( 1998) Targeted disruption of the catalytic subunit of the DNA-PK gene in mice confers severe combined immunodeficiency and radiosensitivity. Immunity 9: 355&#x2013;366.</Citation><ArticleIdList><ArticleId IdType="pubmed">9768755</ArticleId></ArticleIdList></Reference><Reference><Citation>Takashima A, Murayama M, Murayama O, Kohno T, Honda T, Yasutake K, Nihonmatsu N, Mercken M, Yamaguchi H, Sugihara S, Wolozin B ( 1998) Presenilin 1 associates with glycogen synthase kinase-3&#x3b2; and its substrate tau. Proc Natl Acad Sci USA 95: 9637&#x2013;9641.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC21391</ArticleId><ArticleId IdType="pubmed">9689133</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka Y, Kanai Y, Okada Y, Nonaka S, Takeda S, Harada A, Hirokawa N ( 1998) Targeted disruption of mouse conventional kinesin heavy chain, KIF5B, results in abnormal perinuclear clustering of mitochondria. Cell 93: 1147&#x2013;1158.</Citation><ArticleIdList><ArticleId IdType="pubmed">9657148</ArticleId></ArticleIdList></Reference><Reference><Citation>Tesco G, Tanzi RE ( 2000) GSK3&#x3b2; forms a tetrameric complex with endogenous PS1-CTF/NTF and &#x3b2;-catenin. Effects of the D257/D385A and FAD-linked mutations. Ann NY Acad Sci 920: 227&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pubmed">11193155</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai MY, Morfini G, Szebenyi G, Brady ST ( 2000) Release of kinesin from vesicles by hsc70 and regulation of fast axonal transport. Mol Biol Cell 11: 2161&#x2013;2173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC14910</ArticleId><ArticleId IdType="pubmed">10848636</ArticleId></ArticleIdList></Reference><Reference><Citation>Valla J, Berndt JD, Gonzalez-Lima F ( 2001) Energy hypometabolism in posterior cingulate cortex of Alzheimer's patients: superficial laminar cytochrome oxidase associated with disease duration. J Neurosci 21: 4923&#x2013;4930.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6762373</ArticleId><ArticleId IdType="pubmed">11425920</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner U, Utton M, Gallo JM, Miller CC ( 1996) Cellular phosphorylation of tau by GSK-3&#x3b2; influences tau binding to microtubules and microtubule organization. J Cell Sci 109: 1537&#x2013;1543.</Citation><ArticleIdList><ArticleId IdType="pubmed">8799840</ArticleId></ArticleIdList></Reference><Reference><Citation>Waite LM, Broe GA, Grayson DA, Creasey H ( 2000) Motor function and disability in the dementias. Int J Geriatr Psychiatry 15: 897&#x2013;903.</Citation><ArticleIdList><ArticleId IdType="pubmed">11044871</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang QM, Fiol CJ, DePaoli-Roach AA, Roach PJ ( 1994) Glycogen synthase kinase-3&#x3b2; is a dual specificity kinase differentially regulated by tyrosine and serine/threonine phosphorylation. J Biol Chem 269: 14566&#x2013;14574.</Citation><ArticleIdList><ArticleId IdType="pubmed">7514173</ArticleId></ArticleIdList></Reference><Reference><Citation>Weihl CC, Ghadge GD, Kennedy SG, Hay N, Miller RJ, Roos RP ( 1999) Mutant presenilin-1 induces apoptosis and downregulates Akt/PKB. J Neurosci 19: 5360&#x2013;5369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6782321</ArticleId><ArticleId IdType="pubmed">10377346</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson TL, Cleveland DW ( 1999) Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat Neurosci 2: 50&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">10195180</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong PC, Zheng H, Chen H, Becher MW, Sirinathsinghji DJ, Trumbauer ME, Chen HY, Price DL, Van der Ploeg LH, Sisodia SS ( 1997) Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm. Nature 387: 288&#x2013;292.</Citation><ArticleIdList><ArticleId IdType="pubmed">9153393</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodgett JR ( 1994) Regulation and functions of the glycogen synthase kinase-3 subfamily. Semin Cancer Biol 5: 269&#x2013;275.</Citation><ArticleIdList><ArticleId IdType="pubmed">7803763</ArticleId></ArticleIdList></Reference><Reference><Citation>Yonekawa Y, Harada A, Okada Y, Funakoshi T, Kanai Y, Takei Y, Terada S, Noda T, Hirokawa N ( 1998) Defect in synaptic vesicle precursor transport and neuronal cell death in KIF1A motor protein-deficient mice. J Cell Biol 141: 431&#x2013;441.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2148442</ArticleId><ArticleId IdType="pubmed">9548721</ArticleId></ArticleIdList></Reference><Reference><Citation>Yost C, Farr 3rd GH, Pierce SB, Ferkey DM, Chen MM, Kimelman D ( 1998) GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis. Cell 93: 1031&#x2013;1041.</Citation><ArticleIdList><ArticleId IdType="pubmed">9635432</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan H, Mao J, Li L, Wu D ( 1999) Suppression of glycogen synthase kinase activity is not sufficient for leukemia enhancer factor-1 activation. J Biol Chem 274: 30419&#x2013;30423.</Citation><ArticleIdList><ArticleId IdType="pubmed">10521419</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao C, Takita J, Tanaka Y, Setou M, Nakagawa T, Takeda S, Yang HW, Terada S, Nakata T, Takei Y, Saito M, Tsuji S, Hayashi Y, Hirokawa N ( 2001) Charcot&#x2013;Marie&#x2013;Tooth disease type 2A caused by mutation in a microtubule motor KIF1B&#x3b2;. Cell 105: 587&#x2013;597.</Citation><ArticleIdList><ArticleId IdType="pubmed">11389829</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>